# EDGAR Filing Document

**Accession Number:** 0001565025
**File Stem:** 0001292814-23-000992
**Filing Date:** 2023-3
**Character Count:** 1085984
**Document Hash:** ebc0b200632f9f2ec70fe8c51c0a1d5b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001292814-23-000992.hdr.sgml**: 20230317

**ACCESSION NUMBER**: 0001292814-23-000992

**CONFORMED SUBMISSION TYPE**: 20-F

**PUBLIC DOCUMENT COUNT**: 183

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230317

**DATE AS OF CHANGE**: 20230317

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AMBEV S.A.
- **CENTRAL INDEX KEY:** 0001565025
- **STANDARD INDUSTRIAL CLASSIFICATION:** BEVERAGES [2080]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** D5
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 20-F
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36165
- **FILM NUMBER:** 23743704

**BUSINESS ADDRESS:**
- **STREET 1:** RUA DR. RENATO PAES DE BARROS, 1017
- **STREET 2:** 3 ANDAR PARTE
- **CITY:** SAO PAULO
- **STATE:** D5
- **ZIP:** 04530-000
- **BUSINESS PHONE:** 55(11)2122-1414

**MAIL ADDRESS:**
- **STREET 1:** RUA DR. RENATO PAES DE BARROS, 1017
- **STREET 2:** 3 ANDAR PARTE
- **CITY:** SAO PAULO
- **STATE:** D5
- **ZIP:** 04530-000

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** InBev Corporate Holdings Inc.
- **DATE OF NAME CHANGE:** 20121219

?xml version="1.0" encoding="utf-8"?

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549**

**FORM** **20-F**

---

| | |
|:---|:---|
| **(Mark One)** | **(Mark One)** |
| ☐ | **REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934** |
|  | **OR** |
| ☒ | **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** |
|  | **For the fiscal year ended December 31, 2022** |
|  | **OR** |
| ☐ | **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** |
|  | **OR** |
| ☐ | **SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** |

---

**Commission file number: <u>001-36165</u>**

**AMBEV S.A. (Exact name of Registrant as specified in its charter)**

**Federative Republic of Brazil (Jurisdiction of incorporation or organization)**

**Rua Dr. Renato Paes de Barros, 1017, 3rd floor 04530-001 São Paulo, SP, Brazil (Address of principal executive offices) Lucas Machado Lira, Chief Financial and Investor Relations Officer Address: Rua Dr. Renato Paes de Barros, 1017, 3rd floor, 04530-001, São Paulo, SP, Brazil Telephone No.: +55 (11) 2122-1200 e-mail: ri@ambev.com.br (Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)**

**Securities registered or to be registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp; **Title of each class** | &nbsp;&nbsp; **Trading Symbol(s)** | &nbsp;&nbsp; **Name of each exchange on which registered** |
| &nbsp;&nbsp;American Depositary Shares, |  | &nbsp;&nbsp;New York Stock Exchange |
| &nbsp;&nbsp;evidenced by American Depositary | &nbsp;&nbsp;ABEV |  |
| &nbsp;&nbsp;Receipts, each representing |  |  |
| &nbsp;&nbsp;1 (one) common share\*, |  |  |
| &nbsp;&nbsp;no par value |  |  |

---

\* Not for trading, but in connection with the registration of American Depositary Shares, pursuant to the requirements of the Securities and Exchange Commission.

**Securities registered or to be registered pursuant to Section 12(g) of the Act: None**

**Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:**

---

| | |
|:---|:---|
| &nbsp;&nbsp; **Title of each class** | &nbsp;&nbsp; **Name of each exchange on which registered** |
| &nbsp;&nbsp;Not applicable | &nbsp;&nbsp;Not applicable |

---

**Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the annual report.**

15,750,216,851

**Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.**

**Yes ⌧ No ☐**

**If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.** 

**Yes ☐ No ⌧**

**Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.**

**Yes ⌧ No ☐**

**Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).**

**Yes ⌧ No ☐**

**Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of "accelerated filer," "large accelerated filer," and "emerging growth company" in Rule 12b-2 of the Exchange Act.** 

**Large accelerated filer ⌧ Accelerated filer ☐ Non-accelerated filer ☐ Emerging growth company ☐** 

**If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. ☐**

**† The term "new or revised financial accounting standard" refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.**

**Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.**

**Yes ⌧ No ☐**

**If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐**

**Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐**

**Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:**

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**U.S. GAAP ☐** | &nbsp;&nbsp;**International Financial Reporting Standards as issued by the International Accounting Standards Board ⌧** | &nbsp;&nbsp;**Other** ☐ |

---

**If "Other" has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow. N/A**

**Item 17 ☐ Item 18 ☐**

**If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).** 

**Yes ☐ No⌧**

**TABLE OF CONTENTS** 

Page

[INTRODUCTION](#a_001)<sub>1</sub>

[PRESENTATION OF FINANCIAL AND OTHER INFORMATION](#a_002)<sub>1</sub>

[MARKET DATA](#a_003)<sub>2</sub>

[CURRENCY TRANSLATION](#a_004)<sub>2</sub>

[TRADEMARKS](#a_005)<sub>3</sub>

[CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION](#a_006)<sub>3</sub>

[PART I](#a_007)<sub>6</sub>

---

| | |
|:---|:---|
| [ITEM 1.](#a_008) | [IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS](#a_008)<sub>6</sub> |

---

---

| | |
|:---|:---|
| [ITEM 2.](#a_009) | [OFFER STATISTICS AND EXPECTED TIMETABLE](#a_009)<sub>8</sub> |

---

---

| | |
|:---|:---|
| [ITEM 3.](#a_010) | [KEY INFORMATION](#a_010)<sub>9</sub> |

---

---

| | | |
|:---|:---|:---|
| [ITEM 4.](#a_011) | [INFORMATION ON THE COMPANY](#a_011) | [37](#a_011) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 4A.](#a_012) | [UNRESOLVED STAFF COMMENTS](#a_012) | [61](#a_012) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 5.](#a_013) | [OPERATING AND FINANCIAL REVIEW AND PROSPECTS](#a_013) | [62](#a_013) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 6.](#a_014) | [DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES](#a_014) | [90](#a_014) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 7.](#a_015) | [MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS](#a_015) | [105](#a_015) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 8.](#a_016) | [FINANCIAL INFORMATION](#a_016) | [110](#a_016) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 9.](#a_017) | [THE OFFER AND LISTING](#a_017) | [123](#a_017) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 10.](#a_018) | [ADDITIONAL INFORMATION](#a_018) | [126](#a_018) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 11.](#a_019) | [QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK](#a_019) | [150](#a_019) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 12.](#a_020) | [DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES](#a_020) | [154](#a_020) |

---

---

| | |
|:---|:---|
| [PART II](#a_036) | [156](#a_036) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 13.](#a_021) | [DEFAULT, DIVIDENDS ARREARAGES AND DELINQUENCIES](#a_021) | [156](#a_021) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 14.](#a_022) | [MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS](#a_022) | [157](#a_022) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 15.](#a_023) | [CONTROLS AND PROCEDURES](#a_023) | [160](#a_023) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 16A.](#a_024) | [AUDIT COMMITTEE FINANCIAL EXPERT](#a_024) | [161](#a_024) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 16B.](#a_025) | [CODE OF BUSINESS CONDUCT](#a_025) | [162](#a_025) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 16C.](#a_026) | [PRINCIPAL ACCOUNTANT FEES AND SERVICES](#a_026) | [163](#a_026) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 16D.](#a_027) | [EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES](#a_027) | [165](#a_027) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 16E.](#a_028) | [PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS](#a_028) | [166](#a_028) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 16F.](#a_029) | [CHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANT](#a_029) | [167](#a_029) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 16G.](#a_030) | [CORPORATE GOVERNANCE](#a_030) | [168](#a_030) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 16H.](#a_031) | [MINE SAFETY DISCLOSURE](#a_031) | [169](#a_031) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 16I.](#a_032) | [DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS](#a_032) | [170](#a_032) |

---

---

| | |
|:---|:---|
| [PART III](#a_037) | [171](#a_037) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 17.](#a_033) | [FINANCIAL STATEMENTS](#a_033) | [171](#a_033) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 18.](#a_034) | [FINANCIAL STATEMENTS](#a_034) | [172](#a_034) |

---

---

| | | |
|:---|:---|:---|
| [ITEM 19.](#a_035) | [EXHIBITS](#a_035) | [173](#a_035) |

---

[**Table of Contents**](#TableOfContents)

**INTRODUCTION**

This annual report on Form 20-F relates to the registered American Depositary Shares, or ADSs, of Ambev S.A., or Ambev, evidenced by American Depositary Receipts, or ADRs, each representing one common share, no par value, of Ambev.

In this annual report, except as otherwise indicated or as the context otherwise requires, the "Company," "Ambev," "we," "us" and "our" refers to Ambev S.A. and its subsidiaries and, unless the context otherwise requires, the predecessor companies that have been merged out of existence with and into it. All references to "Old Ambev" refer to *Companhia de Bebidas das Américas – Ambev*, our former subsidiary that had common and preferred shares listed on the São Paulo Stock, Commodities and Futures Exchange (*B3 S.A. – Brasil, Bolsa, Balcão*), or the B3 (previously named as *BM&FBovespa S.A. – Bolsa de Valores, Mercadorias e Futuros*), and common and preferred ADSs listed on the New York Stock Exchange, or the NYSE, and that was merged out of existence with and into us in January 2014. All references to "NAB" are to the non-alcoholic beverages in our portfolio other than non-alcoholic beer. All references to "Brazil" are to the Federative Republic of Brazil unless the context otherwise requires. All references to the "Brazilian government" are to the federal government of Brazil. All references to percent ownership interests in Ambev do not consider treasury shares.

**PRESENTATION OF FINANCIAL AND OTHER INFORMATION**

We prepare our audited consolidated financial statements in accordance with International Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards Board, or the IASB. The financial information and related discussion and analysis contained in this annual report on Form 20-F are presented in *reais*, except as otherwise specified. Unless otherwise specified, the financial information analysis in this annual report on Form 20-F is based on our consolidated financial statements as of December 31, 2022 and 2021 and for the three years ended December 31, 2022, included elsewhere in this document. Percentages and some amounts in this annual report on Form 20-F have been rounded for ease of presentation. Any discrepancies between totals and the sums of the amounts listed are due to rounding.

Unless otherwise specified, volumes, as used in this annual report on Form 20-F, include both beer (including future beverages) and NAB volumes. In addition, unless otherwise specified, our volumes refer not only to the brands that we own or license, but also third-party brands that we brew or otherwise produce as a subcontractor, and third-party products that we sell through our distribution network. Our volume figures in this annual report on Form 20-F reflect 100% of the volumes of entities that we fully consolidate in our financial reporting. In addition, market share data contained in this annual report on Form 20-F refers to volumes sold.

[**Table of Contents**](#TableOfContents)

***Tax Credits – 2022***

After the decision of the Supreme Federal Court ("STF") in the judgment of RE 574.706/PR, rendered in 2017 and ratified in May 2021, which declared the unconstitutionality of the inclusion of the ICMS in the taxable base of social contributions on gross revenues ("PIS and COFINS"), the General Attorney's Office ("PGFN"), with binding effects, ruled on the content and effects of this decision. The PGFN normative (PGFN Opinion 14,483/2021, which approved and complemented PGFN Opinion No. 12,943/2021) presented its understanding of the limits of the judgment and equated the procedures that must be observed by the Tax Administration in relation to the matter, especially with regard to issues related to the ICMS to be excluded from the taxable base of PIS and COFINS, temporal aspects regarding the applicability of the STF understanding (modulation of effects) and the impacts of said exclusion on the credits recorded by the purchasers upon acquisitions.

Considering the consolidation of PGFN's understanding on the subject with biding effects, with important clarifications regarding the content and effects of the decision rendered by the STF in the context of RE 574.706/PR, the Company carried out a set of analyses, with the support of its legal advisors and external consultants, with the purpose of deepening and exhausting all legal issues related to a specific portion of its transactions, which, as they involve transactions between subsidiaries, present greater complexity in terms of quantification of recoverable debt, notably considering aspects related to the system of non-cumulative calculation of PIS and COFINS within a Group structure.

Such analysis presented additional complexity when compared to the scenarios for recognition of credits resulting from the exclusion of ICMS in the tax base of PIS and COFINS previously registered by the Company, since it involves transactions with subsidiaries, as mentioned above, considering the necessity of combining the legal understandings referred to above with the specific taxation regime in which the Company is inserted.

In the second quarter of 2022, all relevant and necessary steps were concluded for the fulfillment of the requirements for the accounting recognition of the asset, including its measurement with reasonable assurance, the gathering of supporting documents and the quantification of the credit, the Company had its 2022 results positively impacted by an additional tax credit of R$1.2 billion.

With respect to the amount referred to above, R$0.9 billion was recorded in Other Operating Income, as described in Financial Statement Note 7 – Other Operating Income/(Expenses), and R$0.3 billion in Financial Income, as described in Note 11 – Financial Expenses and Income of our audited consolidated financial statements.

***Corporate Income Taxes Recovery – SELIC interest upon the recovery of taxes***

On September 24, 2021, in the judgment of RE No. 1,063,187/SC (*Recurso Extraordinário nº 1.063.187/SC – "Tema 962"*), the STF ruled, with binding effects, that the levy of IRPJ and CSLL (Brazilian income taxes) on the SELIC interest earned upon the recovery of taxes was unconstitutional.

[**Table of Contents**](#TableOfContents)

The Company and its subsidiaries have ongoing judicial proceedings on this subject. Based on the binding decision issued by STF and on the analysis of our external counsels, the Company assessed as probable the chances of such tax treatment being granted with regards to the recognition of the Company's right to recover/offset the amount of IRPJ and CSLL calculated and paid over the SELIC interest earned upon the recovery of taxes accounted in the period between 2006 and 2022, as well as the exclusion of amounts of this nature in the calculation of IRPJ/CSLL taxable basis.

The amounts related to this matter in the period of 2022 amounted R$329 million in taxes (IRPJ/CSLL).

**MARKET DATA**

Market information (including market share, market position and industry data for our operating activities and those of our subsidiaries or of companies acquired by us) or other statements presented in this Form 20-F regarding our position (or that of companies acquired by us) relative to our competitors largely reflect the best estimates of our management. These estimates are based upon information obtained from customers, trade or business organizations and associations, other contacts within the industries in which we operate and, in some cases, upon published statistical data. Except as otherwise stated, our market share data, as well as our management's assessment of our comparative competitive position, has been derived by comparing our sales volumes for the relevant period to our management's estimates of our competitors' sales volumes for such period, as well as upon published statistical data, and, in particular the reports published and the information made publicly available by, among others, the local brewers' associations and the national statistics bureaus in the various countries in which we sell our products. Although we have no reason to believe any of this information or these reports are inaccurate in any material respect and believe and act as if they are reliable, we have not independently verified it.

**CURRENCY TRANSLATION**

In this annual report, references to "*real*," "*reais*" or "R$" are to the legal currency of Brazil, references to "U.S. dollar" or "US$" are to the official currency of the United States and references to "Canadian dollar" or "C$" are to the legal currency of Canada.

We maintain our books and records in *reais*. However, solely for the convenience of the reader, we have translated certain amounts included in this annual report from *reais* into U.S. dollars using the selling rate as reported by the Central Bank of Brazil (*Banco Central do Brasil*), or the Central Bank, as of December 31, 2022 of R$5.22 to US$1.00 or, where expressly indicated, at an average exchange rate prevailing during a certain period. We have also translated some amounts from U.S. dollars and Canadian dollars into *reais*. All such currency translations should not be considered representations that any such amounts represent, or could have been, or could be, converted into, U.S. or Canadian dollars or *reais* at that or at any other exchange rate. See "Item 10. Additional Information—D. Exchange Controls and other Limitations Affecting Security Holders" for more detailed information regarding the translation of *reais* into U.S. dollars.

**TRADEMARKS**

This annual report includes the names of our products which constitute trademarks or trade names which we own, or which are owned by others and are licensed to us for our use. This annual report also contains other brand names, trade names, trademarks or service marks of other companies, and these brand names, trade names, trademarks or service marks are the property of those other companies.

**CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION**

Some of the information contained in this annual report may constitute forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, or the Exchange Act. We have based these forward-looking statements largely on our current expectations and projections about future events, industry and financial trends affecting our business.

Many of these forward-looking statements can be identified by the use of forward-looking words such as "anticipate," "project," "may," "believe," "could," "expect," "should," "plan," "intend," "estimate," "potential,"

[**Table of Contents**](#TableOfContents)

among others. These statements appear in a number of places in this annual report and include, but are not limited to, statements regarding our intent, belief or current expectations. Forward-looking statements are subject to certain risks and uncertainties that are outside our control and are difficult to predict. These risks and uncertainties could cause actual results to differ materially from those suggested by forward-looking statements. Factors that could cause actual results to differ materially from those contemplated by forward-looking statements include, among others:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; the economic, financial, political, public health and other effects of coronavirus pandemic, or COVID-19, (or other pandemics, epidemics and similar crises) and governmental responses thereto, particularly as such factors impact markets where we operate and continue to cause severe ongoing negative macroeconomic effects, thus heightening many of the other risks described in the "Item 3. Key Information—D. Risk Factors" in this annual report, which may impact our business operations, demand for our products, or overall economic activity globally;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; general economic, political and business conditions both in Brazil and abroad, developments and the perception of risks in connection with the administration of President Luiz Inácio Lula da Silva, as well as policies he may adopt or change during his term in office, including economic and fiscal reforms, responses and measures to address the ongoing COVID-19 pandemic and a worsening of the health crisis as a result of new variants of the virus or otherwise, any of which may negatively affect growth prospects in the Brazilian economy as a whole;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; the political climate resulting from the 2022 presidential elections in Brazil;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; uncertainty regarding the ongoing hostility between Russia and Ukraine and the related impact on global macroeconomic conditions as a result of such conflict;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; our ability to timely and efficiently implement any necessary measure in response to, or to mitigate the impacts of, natural disasters or health epidemics/pandemics, including the ongoing COVID-19 pandemic, on our business, operations, cash flows, perspectives, liquidity and financial condition;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; our ability to predict and efficiently react to the temporary or long-term changes in our customers and consumers' behavior, including as a result of the COVID-19 pandemic, even after the pandemic is sufficiently controlled;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; greater than expected costs (including taxes) and expenses;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; the risk of unexpected consequences resulting from acquisitions, joint ventures, strategic alliances, corporate reorganizations or divestiture plans, and our ability to successfully and cost-effectively implement these transactions and integrate the operations of businesses or other assets that we acquire;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; our expectations with respect to expansion plans, projected asset divestitures, premium growth, accretion to reported earnings, working capital improvements and investment income or cash flow projections;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; lower than expected revenue;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; greater than expected customer losses and business disruptions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; limitations on our ability to contain costs and expenses;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; local, regional, national and international economic conditions, including the risks of a global recession or a recession in one or more of our key markets, and the impact they may have on us, our customers and our consumers, and our assessment of that impact;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; the monetary, exchange rate and interest rate policies of central banks;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; continued availability of financing;

[**Table of Contents**](#TableOfContents)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; market and financial risks, such as interest rate risk, foreign exchange rate risk, commodity risk, asset price risk, equity market risk, inflation or deflation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; our ability to continue to introduce competitive new products and services on a timely, cost-effective basis;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; the effects of competition and consolidation in the markets in which we operate, which may be influenced by regulation, deregulation or enforcement policies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; changes in pricing environments and volatility in commodity prices;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; regional or general changes in asset valuations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; changes in consumer spending and consumptions habits;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; the outcome of pending and future litigation and governmental proceedings and investigations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; global political and economic developments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; changes in government policies, international trade policies, applicable laws, regulations and taxes in jurisdictions in which we operate including the laws and regulations governing our operations, as well as actions or decisions of courts and regulators;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; natural and other disasters;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; water and/or energy scarcity and changes in government regulations aimed at rationing water and/or energy consumption in Brazil or other countries in which we operate;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; any inability to economically hedge certain risks;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; inadequate impairment provisions and loss reserves;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; technological changes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; our success in managing the risks involved in the foregoing;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; governmental intervention, resulting in changes to the economic, tax or regulatory environment in Brazil or other countries in which we operate;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; inflation, appreciation, depreciation and devaluation of the *real* or other currencies in which we operate, which has been particularly affected by the COVID-19 pandemic and economic effects thereto;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; fluctuation and volatility of foreign exchange rates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; ability to declare and pay dividends and interest on equity ("IOC");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; changes in government policies regarding tax subsidies and incentives;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; availability and our ability to secure raw and packaging material that goes into our products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; the utilization of Ambev's subsidiaries' income tax loss carry forwards; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; other factors or trends affecting our financial condition or results of operations, including those factors identified or discussed under "Item 3. Key Information—D. Risk Factors."

[**Table of Contents**](#TableOfContents)

We caution you that forward-looking statements are not guarantees of future performance and involve risks and uncertainties. Forward-looking statements reflect only our current expectations and are based on our management's beliefs and assumptions and on information currently available to our management. Actual results may differ materially from those in forward-looking statements as a result of various factors, including, without limitation, those identified under "Item 3. Key Information—D. Risk Factors" in this annual report. As a result, investors are cautioned not to place undue reliance on forward-looking statements contained in this annual report when making an investment decision.

Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events.

Investors should consider these cautionary statements together with any written or oral forward-looking statements that we may issue in the future.

[**Table of Contents**](#TableOfContents)

**PART I**

ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS

Not Applicable.

[**Table of Contents**](#TableOfContents)

ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE

Not Applicable.

[**Table of Contents**](#TableOfContents)

ITEM 3. KEY INFORMATION

A.&nbsp;&nbsp;&nbsp;&nbsp; Selected Financial Data

[Reserved]

B.&nbsp;&nbsp;&nbsp;&nbsp; Capitalization and Indebtedness

Not applicable.

C.&nbsp;&nbsp;&nbsp;&nbsp; Reasons for the Offer and Use of Proceeds

Not applicable.

**D.&nbsp;&nbsp;&nbsp;&nbsp; Risk Factors**

Before making an investment decision, you should consider all of the information set forth in this annual report, including the consolidated financial statements and our periodic public information released by Ambev from time to time. In particular, you should consider the special features applicable to an investment in Brazil and applicable to an investment in Ambev, including those set forth below. In general, investing in the securities of issuers in emerging market countries, such as Brazil, involves a higher degree of risk than investing in the securities of issuers in the United States. Our business, financial condition and operational results may also be significantly affected not only by the risks set forth below but also by other risks that are currently unknown or considered irrelevant to us.

**Summary of Risk Factors**

**Risks Relating to Our Operations**

&nbsp;&nbsp;&nbsp;&nbsp;· We face operational risks that can result in the partial or temporary shutdown of our operations, which
may adversely affect our financial condition and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;· Our results of operations are affected by fluctuations in exchange rates, and devaluation of the
 real or other currencies with which we operate relative to other currencies, including the U.S. dollar, which may adversely affect
 our financial performance;

&nbsp;&nbsp;&nbsp;&nbsp;· Information technology failures, including failures to implement upgrades and new technologies effectively
or those that affect the privacy and security of sensitive customer and business information, could disrupt our operations;

&nbsp;&nbsp;&nbsp;&nbsp;· We are subject to risks associated with noncompliance with any data protection laws in the countries in
which we operate and can be adversely affected by any penalties or other sanctions imposed;

&nbsp;&nbsp;&nbsp;&nbsp;· We are exposed to the risk of litigation;

&nbsp;&nbsp;&nbsp;&nbsp;· We rely on the reputation of our brands and damages to their reputation may have an adverse effect on
our sales;

&nbsp;&nbsp;&nbsp;&nbsp;· If any of our products is defective or found to contain contaminants, we may be subject to product recalls,
individual or collective litigation and/or other liabilities;

&nbsp;&nbsp;&nbsp;&nbsp;· If we are not successful in obtaining and maintaining the necessary licenses in the countries in which
we operate, we may be subject to fines, penalties, or other regulatory sanctions, which could negatively impact our business and cause
us to incur additional costs;

&nbsp;&nbsp;&nbsp;&nbsp;· We may not be able to protect our intellectual property rights;

[**Table of Contents**](#TableOfContents)

&nbsp;&nbsp;&nbsp;&nbsp;· Our failure to obtain or renew surety bonds and letters of credit on acceptable terms or at all may adversely
affect our liquidity, financial condition and business;

&nbsp;&nbsp;&nbsp;&nbsp;· Our insurance coverage may be insufficient to make us whole on any losses that we may sustain in the future;

&nbsp;&nbsp;&nbsp;&nbsp;· The relative volatility and illiquidity of securities of Brazilian companies may substantially limit your
ability to sell our common shares and ADSs at the price and time you desire;

&nbsp;&nbsp;&nbsp;&nbsp;· Our shareholders may not receive any dividends or IOC;

&nbsp;&nbsp;&nbsp;&nbsp;· Future equity issuances may dilute the holdings of current holders of Ambev common shares or ADSs and
could materially affect the market price for those securities;

&nbsp;&nbsp;&nbsp;&nbsp;· Contractual and legal restrictions to which Ambev and its subsidiaries are potentially or allegedly subject
may be triggered upon the consummation of certain transactions involving our indirect controlling shareholder, Anheuser-Busch InBev SA/NV,
or ABI, resulting in adverse limitations to our operations;

&nbsp;&nbsp;&nbsp;&nbsp;· Our current controlling shareholder will be able to determine the outcome of our most significant corporate
actions;

&nbsp;&nbsp;&nbsp;&nbsp;· The ability of our foreign subsidiaries to distribute cash upstream may be subject to various conditions
and limitations;

&nbsp;&nbsp;&nbsp;&nbsp;· We may not be able to recruit or retain key personnel;

&nbsp;&nbsp;&nbsp;&nbsp;· We rely on key third parties, including key suppliers, and the termination or modification of the arrangements
with such third parties *or non-compliance with the Company's ESG guidelines* or any failure to comply with laws and regulations
by them could negatively affect our business;

&nbsp;&nbsp;&nbsp;&nbsp;· Demand for our products may be adversely affected by changes in consumer preferences and tastes;

**Risks Relating to the Economy Sector in Which We Operate**

&nbsp;&nbsp;&nbsp;&nbsp;· Volatility in commodities prices may adversely affect our financial performance;

&nbsp;&nbsp;&nbsp;&nbsp;· Negative publicity focusing on us or our products or on the way we conduct our operations may harm
 our business;

&nbsp;&nbsp;&nbsp;&nbsp;· Competition could lead to a reduction of our margins, increase costs and adversely affect our profitability;

&nbsp;&nbsp;&nbsp;&nbsp;· If we do not successfully comply with applicable anti-corruption laws and regulations, we could be subjected
to fines, penalties or other regulatory sanctions, as well as adverse press coverage, which could impact our reputation, operations and
sales;

&nbsp;&nbsp;&nbsp;&nbsp;· Increases in taxes levied on beverage products in the countries in which we operate and unfair competition
arising from tax evasion may adversely affect our results and profitability;

&nbsp;&nbsp;&nbsp;&nbsp;· Our business is subject to regulations in the countries in which we operate, and we may have our activities
impacted by foreign legislation regarding social, environmental and climate issues;

&nbsp;&nbsp;&nbsp;&nbsp;· We are subject to Brazilian and other antitrust regulations;

&nbsp;&nbsp;&nbsp;&nbsp;· The Brazilian government has exercised, and continues to exercise, significant influence over the Brazilian
economy. Brazilian economic and political conditions have a direct impact on our business and the market price of our shares and ADSs;

[**Table of Contents**](#TableOfContents)

&nbsp;&nbsp;&nbsp;&nbsp;· Economic and political uncertainty and volatility in Brazil, and the perception of these conditions in
the international financial markets, may adversely affect our business and the market price of our shares and ADSs;

**Risks Relating to Other Countries in Which We Operate**

&nbsp;&nbsp;&nbsp;&nbsp;· Our Latin America South operations are subject to substantial risks relating to the businesses and operations
conducted in Argentina and other South American countries;

&nbsp;&nbsp;&nbsp;&nbsp;· Deterioration in economic and market conditions in Brazil and other emerging market countries, as well
as in developed economies (including as a result of the COVID-19 virus pandemic), may adversely affect the market price of our common
shares and ADSs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· We operate a joint venture in Cuba, in which the Government of Cuba is our joint venture partner. Cuba
is still targeted by broad and comprehensive economic and trade sanctions of the United States. Our operations in Cuba may adversely affect
our reputation and the liquidity and value of our securities;

&nbsp;&nbsp;&nbsp;&nbsp;· The extent of the pandemic declared by the World Health Organization due to the spread of COVID-19, the
perception of its effects or the way in which this pandemic will continue to impact our business, depends on future developments which
are highly uncertain and unpredictable, and may result in a material adverse effect on our business, financial condition, results of operations
and cash flow;

***Social Issues***

&nbsp;&nbsp;&nbsp;&nbsp;· The Company is subject to obligations imposing respect for human rights, which
may cause the Company to incur additional costs, as well as significant contingencies related to social issues;

***Environment Issues***

&nbsp;&nbsp;&nbsp;&nbsp;· Our operations are subject to broad safety and environmental regulations, the non-compliance of which
may pose significant financial, operational, reputational, litigation and regulatory risks related to environmental issues for us;

&nbsp;&nbsp;&nbsp;&nbsp;· Natural and other disasters and accidents caused by human and technological errors could disrupt our operations;

***Climate issues, including physical and transition risks***

&nbsp;&nbsp;&nbsp;&nbsp;· Scarcity or poor quality of water may negatively affect our production costs and capacity;

&nbsp;&nbsp;&nbsp;&nbsp;· Climate change, or legal, regulatory or market measures to address climate change, may negatively affect
our business or operations;

&nbsp;&nbsp;&nbsp;&nbsp;· Seasonal
consumption cycles and adverse weather conditions may result in fluctuations in demand for our products;

**Risks Relating to Our Common Shares and ADSs**

&nbsp;&nbsp;&nbsp;&nbsp;· Brazilian foreign exchange controls and regulations could restrict conversions and remittances abroad
of the dividend payments and other shareholder distributions paid in Brazil in *reais* arising from Ambev's common shares (including
shares underlying the Ambev ADSs);

&nbsp;&nbsp;&nbsp;&nbsp;· The surrender of ADSs may cause the loss of the ability to remit foreign currency abroad and of certain
Brazilian tax attributes;

&nbsp;&nbsp;&nbsp;&nbsp;· Certain shareholder entitlements may not be available in the U.S. to holders of Ambev ADSs;

[**Table of Contents**](#TableOfContents)

&nbsp;&nbsp;&nbsp;&nbsp;· Holders of Ambev ADSs may be unable to fully exercise voting rights with respect to the Ambev shares underlying
their ADSs;

&nbsp;&nbsp;&nbsp;&nbsp;· Our status as a foreign private issuer allows us to follow Brazilian corporate governance practices and
exempts us from a number of rules under the U.S. securities laws and listing standards, which may limit the amount of public disclosures
available to investors and the shareholder protections afforded to them;

&nbsp;&nbsp;&nbsp;&nbsp;· As a Brazilian company, Ambev is subject to different corporate laws and regulations than those typically
applicable to U.S.-listed companies, which may result in Ambev's shareholders having fewer or less well-defined shareholder rights
than the shareholder rights of those companies;

&nbsp;&nbsp;&nbsp;&nbsp;· Foreign holders of our ADSs may face difficulties in serving process on or enforcing judgments against
us and other persons; and

&nbsp;&nbsp;&nbsp;&nbsp;· Judgments of Brazilian courts with respect to our shares will be payable only in *reais*.

**Risks Relating to Our Operations**

We face operational risks that can result in the partial or temporary shutdown of our operations, which may adversely affect our financial condition and results of operations.

We face operational risks that may result in partial or temporary suspension of our operations and in loss of production. Such outages may be caused by factors associated with equipment failure, information system disruptions or failures (including due to cyber-attacks), accidents, fires, strikes, weather, exposure to natural disasters, regional water crisis, electricity power outages and chemical product spills, accidents involving water reservoirs, availability of our suppliers to meet demand of raw and packaging materials, among other operational and environmental hazards. The occurrence of these events may, among other impacts, result in serious damage to our property, assets and reputation, a decrease in production or an increase in production costs, any of which may adversely affect our financial condition and results of operations.

During the normal course of our business, we depend on the continuous availability of logistics and transportation networks, including roads, railways, warehouses and ports, among others. Such operations may be disrupted by factors beyond our control, such as social movements, natural disasters, electricity shortages and labor strikes. Any interruption in the supply of inputs for the operation of our industrial units or in the delivery of our products to clients could cause a material adverse impact on our results of operations.

Moreover, the transportation and infrastructure system in Brazil and other countries we operate is under development and needs improvements so that it can work efficiently and serve better our business. Any significant interruptions or reductions in the use of transport infrastructure or in its operations in the cities where our distribution centers are located, may delay or impair our ability to distribute goods and cause our sales to drop, which may negatively impact our financial and operating results.

Our results of operations are affected by fluctuations in exchange rates, and devaluation of the real or other currencies with which we operate relative to other currencies, including the U.S. dollar, which may adversely affect our financial performance.

Most of our sales are in *reais*; however, a portion of our debt is denominated in foreign currencies, including U.S. dollars. In addition, a significant portion of our cost of sales, in particular those related to packaging such as aluminum cans and bottles made of polyethylene terephthalate, or PET, as well as sugar, hops and malt are denominated in or linked to the U.S. dollar, which was very volatile in recent years. Therefore, any devaluation of the *real* or other currencies with which we operate when compared to those foreign currencies may increase our financial expenses and operating costs and could affect our ability to meet our foreign currency obligations. Although our current policy is to hedge substantially our cost of sales against changes in foreign exchange rates, we cannot assure you that such hedging will be possible, accurate or available at reasonable costs at all times in the future.

In addition, we have historically reported our consolidated results in *reais*. In 2022, we derived 46.5% of our net revenues from operating companies that have functional currencies that are not *reais* (that is, in most cases, the local currency of the respective operating company). Consequently, any change in exchange rates between our operating companies' functional currencies and *reais* will affect our consolidated income statement and balance sheet. Decreases in the value of our operating companies' functional currencies against *reais* will tend to reduce those operating companies' contributions in terms of our financial condition and results of operations.

[**Table of Contents**](#TableOfContents)

We also incur currency transaction risks whenever one of our operating companies enters into transactions using currencies other than their respective functional currencies, including purchase or sale transactions and the issuance or incurrence of debt. Although we have hedging policies in place to manage commodity price and foreign currency risks, there can be no assurance that such policies will be able to successfully hedge against the effects of such foreign exchange exposure, particularly over the long term.

The Brazilian currency has devalued frequently, including during the last two decades. Throughout this period, the Brazilian government has implemented various economic plans and utilized a number of exchange rate policies, including sudden devaluations and periodic mini-devaluations, during which the frequency of adjustments has ranged from daily to monthly, floating exchange rate systems, exchange controls and dual exchange rate markets. There have been significant fluctuations in the exchange rates between Brazilian currency and the U.S. dollar and other currencies. For example, the U.S. dollar appreciated 17.1% against the *real* in 2018, closing at R$3.87 per U.S.$1.00 as of December 31, 2018, while in 2019, the U.S. dollar appreciated 4.0% against the *real*, closing at R$4.03 per U.S.$1.00 as of December 31, 2019. The U.S. dollar appreciated 28.9% against the *real* in 2020, closing at R$5.20 per U.S.$1.00 as of December 31, 2020, with a high degree of volatility over the course of 2020, particularly as a result of uncertainties arising from the COVID-19 pandemic. For example, in May 2020 the real depreciated to its lowest level since the commencement of the currency to R$5.94 per US$1.00. As of December 31, 2021, the Brazilian *real*/U.S. dollar selling exchange rate was R$5.58 per U.S. dollar, reflecting a 7.4% depreciation against the U.S. dollar as compared to the exchange rate as of December 31, 2020. As of December 31, 2022, the Brazilian *real*/U.S. dollar selling exchange rate was R$5.22 per U.S. dollar, reflecting a 6.5% appreciation against the U.S. dollar as compared to the exchange rate as of December 31, 2021. As of March 1st, 2023, the exchange rate was R$5.21 per US$1.00.

Devaluation of the *real* relative to the U.S. dollar may create additional inflationary pressures in Brazil by generally increasing the price of imported products and requiring recessionary governmental policies to curb aggregate demand. On the other hand, appreciation of the *real* against the U.S. dollar may lead to a deterioration of the current account and the balance of payments, as well as dampen export-driven growth. The potential impact of the floating exchange rate and measures of the Brazilian government aimed at stabilizing the *real* is uncertain. In addition, a substantial increase in inflation may weaken investor confidence in Brazil, impacting our ability to finance our operations through the international capital markets.

Other exchange rate devaluations or political decisions related to exchange rates may impact our business as well. For instance, during the first quarter of 2021, Cuba carried out the unification of currencies and the process of elimination of the Cuban Convertible Peso, which in 2022 resulted in a limited amount of hard currency available to transfer abroad and to acquire raw materials locally, mainly impacting Bucanero's beer volume sold due to increasing costs of production and price of our Cuban products

Information technology failures, including failures to implement upgrades and new technologies effectively or those that affect the privacy and security of sensitive customer and business information, could disrupt our operations.

We rely on information technology systems to process, transmit and store large amounts of electronic data, including personal information. A significant portion of the communication between our personnel, customers and suppliers depends on information technology. As with all large systems, our information systems may be vulnerable to a variety of interruptions due to events beyond our control, including, but not limited to, natural disasters, terrorist attacks, telecommunications failures, computer viruses, hackers' attacks or other security issues.

[**Table of Contents**](#TableOfContents)

We depend on information technology to enable us to operate efficiently and interface with customers, as well as to maintain in-house management and control. Looking ahead, we continue to implement strategic initiatives and new technologies designed to grow our business, which are critical for the efficient functioning of our business. We also collect and store non-public personal information that customers provide to purchase products or services, including personal information and payment information.

For instance, we are implementing a new version of our main enterprise resource planning (ERP) System -the S4 Hana a SAP platform-- which will help us book all the transactional data used in our Brazilian operations. Any replacement or upgrades to our system and related process to implement it may cause occasional system disruptions or delays to run our business operations, including to efficiently fulfill orders and provide services to our customers, subjecting us to inherent costs and risks. We cannot assure that our choices of technologies will prove correct, or that our initiatives will succeed and bring sufficient growth in revenue to offset the costs.

Additionally, we may experience occasional system interruptions and delays that make our websites, in-house controls and services unavailable or slow to run our business operations, including to respond and prevent us from efficiently accepting or fulfilling orders or providing services to our customers.

In addition, the concentration of processes in shared services centers means that any disruption could impact a large portion of our business within the operating regions we serve. Any implementation of new technology or transition of processes to, from or within shared services centers as well as other transformational projects, could lead to business disruptions. If we do not allocate, and effectively manage, the resources necessary to build and sustain the proper technology infrastructure, we could be subject to transaction errors, processing inefficiencies, the loss of customers, or failure to attract new customers, lost revenues resulting from the disruption or shutdown of computer systems, unexpected failure of devices and software in use by our IT platforms, operations or supply chain disruptions, alteration, corruption or loss of accounting financial or other data on which we rely for financial reporting and other purposes, which could cause errors or delays in our financial reporting or the loss of or damage to intellectual property through a security breach. As with all information technology systems, our system could also be penetrated by outside parties with the purpose of extracting information, corrupting information or disrupting business processes.

We take various actions with the aim of minimizing potential technology disruptions – such as investing in intrusion detection solutions, proceeding with internal and external security assessments, building and implementing business continuity plans and reviewing risk management processes – but all of these protections may be compromised as a result of third-party security breaches, burglaries, cyberattack, errors by employees or employees of third-party vendors, of contractors, misappropriation of data by employees, vendors or unaffiliated third parties, or other irregularities that may result in persons obtaining unauthorized access to company data or otherwise disrupting our business. Unauthorized or accidental access to, or destruction, loss, alteration, disclosure, misuse, falsification or unavailability of information could result in violations of data privacy laws and regulations, damage to our reputation or our competitive advantage, loss of opportunities to acquire or divest of businesses or brands and loss of ability to commercialize products developed through research and development efforts and, therefore, could have a negative impact on net operating revenues. More generally, these or other similar technology disruptions can have a material adverse effect on our business, results of operations, cash flows or financial condition.

We, as with all business organizations, are routinely subject to cyber-threats, however, while we continue to invest in new technology-monitoring and cyberattack prevention systems, no commercial or government entity can be entirely free of vulnerability to attack, or compromise given how rapidly and unpredictably techniques evolve to obtain unauthorized access or disable or degrade service.

We are subject to risks associated with noncompliance with any data protection laws in the countries in which we operate and can be adversely affected by any penalties or other sanctions imposed.

In the year 2018, ordinary course of our business, we receive, process, transmit and store large volumes of personal data, including that of employees, dealers, customers and consumers. As a result, we are subject to various laws and regulations relating to personal data. These laws have been subject to frequent changes, and new legislation in this area may be enacted in other jurisdictions at any time. For example, Law No. 13.709/2018, the *Lei Geral de Proteção de Dados Pessoais* (Brazilian General Data Protection Law) or LGPD, was enacted in 2018 and came into effect as of September 18, 2020. Inspired by the General Data Protection Regulation of the European Union, the LGPD sets forth a comprehensive set of rules that promise to reshape how companies, organizations and public authorities collect, use, process and store personal data when carrying out their activities.

[**Table of Contents**](#TableOfContents)

In relation to the LGPD's administrative sanctions, if we are not in compliance with the LGPD and other personal data protection laws in other jurisdictions, we may be subject to the sanctions, individually or cumulatively. In addition to the administrative sanctions provided for in the LGPD, failure to comply with any provisions set forth in the LGPD regarding the personal data collected by us has the following risks: (i) the filing of lawsuits, individual or collective, claiming damages resulting from violations, based not only on the LGPD, but also on the sparse legislation that address data protection matters; (ii) the application of specific penalties foreseen in the sparse legislation, such as the Consumer Protection Code ("*CDC*") and *Marco Civil da Internet* (Brazilian Internet Act), in case of violation of its provisions, by some consumer protection bodies and public prosecution offices. Therefore, we have designed and implemented a privacy governance framework in order to comply with all the regulations. We have also implemented security measures to protect our databases and prevent cyberattacks, thereby reducing risks of exposure to data breaches and information security incidents.

Additionally, as a result of the remote option implemented by the Company, there is a possibility of an increase in cyberattacks through our employees' personal computers, since the cyber security of the networks used by them in their homes may not maintain the same level of security as that of our corporate work environment, which may impair our ability to manage our business.

Despite the security measures that we have in place, our facilities and systems may be vulnerable to security breaches, cyber-attacks, acts of vandalism, computer viruses, misplaced or lost data, programming or human errors, or other similar events, and individuals may attempt to gain unauthorized access to our database in order to misappropriate such information for potentially fraudulent purposes. Our security measures may fail to prevent such incidents and breaches of our systems could result in adverse impact to our reputation, financial condition, and market value. In addition, if we are unable to prove that our systems are properly designed to detect and to try and detain a cyberattack, or even if we fail to respond to a cyberattack properly, we could be subject to severe penalties and loss of existing or future business, aside from damages awarded to our customers, dealers and employees whose personal data might have been mishandled or breached.

[**Table of Contents**](#TableOfContents)

We are exposed to the risk of litigation.

We are now and may in the future be party to legal proceedings and claims (including labor, tax and alcohol-related claims) and significant damages may be asserted against us. See "Item 8. Financial Information—A. Consolidated Financial Statements and Other Financial Information—Legal Proceedings" and Notes 27 and 30 to our audited consolidated financial statements as of and for December 31, 2022, included elsewhere in this annual report, for a description of our material litigation contingencies. Given the inherent uncertainty of litigation, it is possible that we might incur liabilities as a consequence of the proceedings and claims brought against us, including those that are not currently believed by us to present a reasonably possible chance of loss to us. Any changes to the risk assessments of chance of success of our cases could adversely affect our liquidity, financial positions and business. Our management may also be exposed to sanctions due to legal proceedings against its members involving our operations or due to their involvement in other businesses.

Our tax contingency in Brazil has grown in recent years – and we expect it will continue to grow in the coming years - mainly because (1) its principal amount is adjusted on a monthly basis in accordance with the SELIC rate, or other equivalent interest rate, and (2) of the highly litigious environment in Brazil in connection with tax disputes. In addition, the highly complex tax legislation in Brazil reduces certainty of interpretation by taxpayers. This environment affects the economic sector crosswise: according to a research conducted in 2020 by the Brazilian Teaching and Research Institute – *Insper*, tax disputes in Brazil reached the amount of R$5.44 trillion in 2019, which corresponds to approximately 75% of the national Gross Domestic Product – GDP.

As the administrative phase of our tax proceedings ends and the judicial proceedings begin, the Company may be required to guarantee the amounts under discussion, through insurance bonds, bank guarantees, bank deposits or other types of assets or rights subject to attachment by law. We will continue to vigorously defend our position in connection with such disputes.

Additionally, on February 8, 2023, the STF judged two leading cases (Extraordinary Appeals Nos. 949.297 and 955.227) and ruled that any given collegiate decision by the STF recognizing the constitutionality or unconstitutionality of taxes collected on an ongoing basis will cease the effects of the *res judicata* of a prior ruling that is contrary to the STF's position, even if this prior ruling had become final and unappealable in the past. This opinion from by the STF has created legal uncertainty for Brazilian companies, which relied on final judicial decisions to carry out their tax procedures and that are now faced with this binding STF decision that allows the overturn of past unappealable decisions, which could materially impact their business and results. Although this decision has no material impact on any tax credits already recognized by the Company and its subsidiaries, it may impact future tax credits in case the STF changes its binding view on a *res judicata* in place to the Company.

Moreover, companies in the alcoholic beverage and soft drink industries are, from time to time, exposed to collective suits (class actions) or other litigation relating to alcohol advertising, alcohol abuse problems or health consequences from the excessive consumption of beer, other alcoholic beverages and soft drinks. As an illustration, certain beer and other alcoholic beverage producers from Brazil have been involved in class actions and other litigation seeking damages.

Additionally, there has been an increase in litigation against large companies involving environmental, social and governance (ESG) matters, including claims related to climate justice, net-zero ambitions, greenwashing, climate-washing, supply chain commercial relationships, and diversity and sustainability disclosure practices. As a result, we may also be subject to class actions or other litigation, including administrative proceedings, with respect to our ESG ambitions since these issues have attracted increasing attention from investors and civil society on a global scale.

If any of these types of litigation were to result in fines, damages or reputational damages to us or our brands, this could have a material adverse effect on our business, results of operations, cash flows or financial position.

We rely on the reputation of our brands and damages to their reputation may have an adverse effect on our sales.

Our success depends on our ability to maintain and enhance the image and reputation of our existing products and to develop a favorable image and reputation for new products. The image and reputation of our products may be reduced in the future; concerns about product quality, even when unfounded, could tarnish the image and reputation of our products. An event or series of events that materially damages the reputation of one or more of our brands could have an adverse effect on the value of that brand and subsequent revenues from that brand or business. Restoring the image and reputation of our products may be costly or not possible.

Moreover, our marketing efforts are subject to restrictions on the permissible advertising style, media and messages used. In a number of countries, for example, television is a prohibited channel for advertising beer and other alcoholic products, and in other countries, television advertising, while permitted, is carefully regulated. Any additional restrictions in such countries, or the introduction of similar restrictions in other countries, may constrain our brand building potential and thus reduce the value of our brands and related revenues.

[**Table of Contents**](#TableOfContents)

If any of our products is defective or found to contain contaminants, we may be subject to product recalls, individual or collective litigation and/or other liabilities.

We take precautions to ensure that our beverage products and our associated packaging materials (such as bottles, crowns, cans and other containers) meet accepted food safety and regulatory standards. Such precautions include quality control programs for primary materials, the production process and our final products. We have established procedures to correct issues or concerns that are detected.

In the event that any failure to comply with accepted food safety and regulatory standards (such as a contamination or a defect) does occur in the future, it may lead to business interruptions, product recalls or liability, each of which could have an adverse effect on our business, reputation, prospects, financial condition and results of operations.

Although we maintain insurance policies against certain product liability (but not product recall) risks, we may not be able to enforce our rights in respect of these policies, and, in the event that a contamination or defect occurs, any amounts that we recover may not be sufficient to offset any damage we may suffer, which could adversely impact our business, results of operations and financial condition.

If we are not successful in obtaining and maintaining the necessary licenses in the countries in which we operate, we may be subject to fines, penalties, or other regulatory sanctions, which could negatively impact our business and cause us to incur additional costs.

Our business is subject to obtaining and maintaining the necessary licenses and regulatory approvals issued by the competent bodies in the countries in which we operate. We cannot guarantee that such licenses or regulatory approvals will be granted, renewed, or extended. Such licenses or regulatory approvals may be withdrawn or made subject to limitations or onerous conditions. The absence of such licenses or regulatory approvals may result in the interruption of the activities of a specific plant or distribution center, which may adversely affect our results. Additionally, for the granting or renewal of such licenses or regulatory approvals, the competent authorities may determine that we must make certain changes to our operations or facilities, potentially resulting in additional costs.

We may also be subject to the regulation and control of other public authorities, in addition to those that we currently understand as the competent ones and cannot guarantee that such authorities will not require further licenses, permits and authorizations.

Furthermore, if we are unable to timely obtain, maintain or renew the licenses and permits necessary for our activities, we may have to incur additional costs for the payment of any charges or even compromise our regular activities.

Any of these factors that impact the non-obtaining or non-renewal of licenses and permits may cause us to incur additional costs, which may force us to revert resources to meet the legal requirements or compromise the regular operation of our activities. Furthermore, the development of activities without the proper licenses or in non-compliance with the licenses and their technical requirements may result in adverse consequences, such as: (i) infraction notices; (ii) application of successive fines; (iii) impediment to opening and operating units, even temporarily; (iv) interdiction or closing of units, even temporarily; (v) exposure to additional risk or loss of insurance coverage in the event of a safety and security accident or similar event; (vi) affecting an installation while a license is pending; and (vii) exposure of us, as well as our representatives, to other civil, administrative, and criminal sanctions. We may be adversely affected if one of our establishments closes, even if temporarily.

We may not be able to protect our intellectual property rights.

Our future success depends significantly on our ability to protect our current and future brands and products and to defend our intellectual property rights, including trademarks, patents, domain names, industrial design, trade secrets and know-how. We have been granted numerous trademark registrations and patents covering our brands and products and have filed, and expect to continue to file, trademark and patent applications before the relevant intellectual property authorities in the variety of markets we conduct our business, always seeking to protect newly developed brands and products. We cannot be sure that trademark and patent registrations will be issued with respect to any of our applications. Therefore, events such as the definitive rejection of our trademark applications before the authorities, the unauthorized use or other misappropriation of our trademarks may diminish their value and reputation, so that we may suffer negative impact on the operating results. There is also a risk that we could, by omission, fail to renew a trademark, domain name, industrial design or patent on a timely basis or that our competitors will challenge, invalidate or circumvent any existing or future trademarks and patents requested by, issued to, or licensed by, us. In case of judicial questioning of any trademarks the judicial decision may negatively affect their use and may be prohibited from continuing to exploit them.

[**Table of Contents**](#TableOfContents)

As for the protection of patents registered before the Brazilian Patent and Trademark Office ("INPI"), in May 2021 the STF published its decision declaring unconstitutional the sole paragraph of article 40 of Industrial Property Law ("LPI"), which provided for a minimum term of patent protection of 10 years from the date of the patent grant, considering the delay in the analysis of the application by the INPI. As a result, the applicants only rely on a 20-year protection period counted as of the moment in which the patent is requested, regardless of the time elapsed during the analysis of the patent application.

Although we have put in place appropriate actions to protect our portfolio of intellectual property rights (including patent applications, trademark registration and domain names), we cannot be certain that the steps we have taken will be sufficient or that third parties will not infringe upon or misappropriate proprietary rights. If we are unable to protect our proprietary rights against infringement or misappropriation, it could have a material adverse effect on our business, results of operations, cash flows or financial condition, and in particular, on our ability to develop our business. In addition, any dispute or litigation related to intellectual property assets may be costly and time consuming due to the uncertainty of litigation on the matter.

*Our failure to obtain or renew surety bonds and letters of credit necessary in certain lawsuits on attractive terms or at all may adversely affect our liquidity, financial condition and business.* 

Certain agreements to which we are a party and certain legal proceedings in which we are involved require us to obtain and maintain surety bonds, letters of credit or similar financial instruments (e.g., bank products known as *fiança* and/or *seguro-garantia*) to secure the performance or payment of certain obligations and potential losses, respectively. We may be required to pay higher fees, post additional collateral or otherwise be subject to unfavorable terms and conditions when negotiating these products with financial institutions or insurers. In addition, if those negotiations fail, we may be required to use a substantial portion of our cash to secure such agreements and legal proceedings, which may materially and adversely affect our liquidity, financial condition and results of operations.

Our insurance coverage may be insufficient to make us whole on any losses that we may sustain in the future.

The cost of some of our insurance policies could increase in the future. In addition, some types of losses, such as losses resulting from wars, acts of terrorism, or natural disasters, generally are not insured because they are either uninsurable or it is not economically practical to obtain insurance. Moreover, insurers recently have become more reluctant to insure against these types of events. Should a material uninsured loss or a loss in excess of insured limits occur, this could adversely impact our business, results of operations and financial condition.

The relative volatility and illiquidity of securities of Brazilian companies may substantially limit your ability to sell our common shares and ADSs at the price and time you desire.

Investing in securities of companies in emerging markets, such as Brazil, involves greater risk than investing in securities of companies from more developed countries, and those investments are generally considered speculative in nature. Brazilian investments, such as investments in our common shares and ADSs, are subject to economic and political risks, involving, among other factors:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; changes in the Brazilian regulatory, tax, economic and political environment that may affect the ability of investors to receive payment, in whole or in part, in respect of their investments; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; restrictions on foreign investment and on repatriation of capital invested.

[**Table of Contents**](#TableOfContents)

The Brazilian securities markets are substantially smaller, less liquid and more concentrated and volatile than major U.S. and European securities markets. They are also not as highly regulated or supervised as those other markets. The relative illiquidity and smaller market capitalization of Brazilian securities markets may substantially limit your ability to sell the Ambev common shares and ADSs at the price and time you desire.

Our shareholders may not receive any dividends or IOC.

According to our bylaws, we generally pay our shareholders 40% of our annual adjusted net income, calculated and adjusted pursuant to Brazilian Corporation Law in accordance with the mechanisms described in our bylaws as presented in our consolidated financial statements prepared under IFRS. The main sources for these dividends are cash flows from our operations and dividends from our operating subsidiaries. Therefore, that net income may not be available to be paid out to our shareholders in a given year. In addition, we might not pay dividends to our shareholders in any particular fiscal year based on the opinion of the Board of Directors that any such distribution would be inadvisable in view of our financial condition. While the law does not establish the circumstances rendering the payment of dividends inadvisable, it is generally agreed that a company need not pay dividends if such payment threatens its existence as a going concern or harms its normal course of operations.

Future equity issuances may dilute the holdings of current holders of Ambev common shares or ADSs and could materially affect the market price for those securities.

We may in the future decide to offer additional equity to raise capital or for other purposes. Any such future equity offering could reduce the proportionate ownership and voting interests of holders of our common shares and ADSs, as well as our earnings and net equity value per common share or ADS. Any offering of shares and ADSs by us or our main shareholders, or a perception that any such offering is imminent, could have an adverse effect on the market price of these securities.

Contractual and legal restrictions to which Ambev and its subsidiaries are potentially or allegedly subject may be triggered upon the consummation of certain transactions involving our indirect controlling shareholder, ABI, resulting in adverse limitations to our operations.

Ambev and its subsidiaries are a party to certain joint venture, distribution and other agreements, guarantees and instruments that may contain restrictive provisions that our contractual counterparties may try to interpret as being triggered upon the consummation of certain unrelated transactions of ABI. Some of those contracts may be material and, to the extent they may contain any such restrictive provisions, our counterparties may seek to enforce certain contractual remedies that may curtail material contractual rights and benefits that we have thereunder under the argument that ABI's consummation of certain transactions has triggered the referred provisions. Similarly, unrelated transactions consummated by ABI may subject us to further antitrust restrictions in the countries in which we already operate. Any such restrictions may limit the amount and quality of business we conduct in each of those countries.

Our current controlling shareholder will be able to determine the outcome of our most significant corporate actions.

Our direct controlling shareholder, ABI, together with *Fundação Antonio e Helena Zerrenner Instituição Nacional de Beneficência*, or FAHZ, held in aggregate 72.0% of our total and voting capital stock (excluding treasury shares) as of December 31, 2022.

ABI indirectly held shares in us representing 61.8% of our total and voting capital stock (excluding treasury shares) as of December 31, 2022. ABI thus has control over us, even though (1) ABI is subject to the Ambev shareholders' agreement among IIBV, AmBrew and FAHZ dated April 16, 2013 and effective as of July 2, 2019, or the Shareholders' Agreement, and (2) ABI is controlled by Stichting Anheuser-Busch InBev, or Stichting, a foundation organized under the laws of the Netherlands, which represents an important part of interests of the founding Belgian families of Interbrew N.V./S.A. (as ABI was then called) (mainly represented by Eugénie Patri Sébastien S.A.) and the interests of the Brazilian families which were previously our controlling shareholders (represented by BRC S.à.R.L.), or the Interbrew Founding Families. For further information on these matters see "Item 4. Information on the Company—A. History and Development of the Company—The InBev-Ambev Transactions" and "Item 7. Major Shareholders and Related Party Transactions—A. Major Shareholders—Ambev's Major Shareholders—The Shareholders' Agreement."

[**Table of Contents**](#TableOfContents)

Our controlling shareholder is able to elect the majority of the members of our Board of Directors and Fiscal Council, and generally determine the outcome of most other actions requiring shareholder approval, including dividend distributions, the consummation of corporate restructurings, issuances of new shares, sales of materials assets and bylaw amendments.

Additionally, our controlling shareholder may have interests that differ from ours and may vote in a way that is adverse to the interests of our other shareholders. In addition, any reputational issues associated with our (direct or indirect) shareholders may adversely affect the trading price of our shares.

Under Brazilian Law No. 6,404/76, as amended, or the Brazilian Corporation Law, the protections afforded to non-controlling security holders may differ from, or be less comprehensive than, the corresponding protections and fiduciary duties of directors applicable in the U.S. or other jurisdictions. See "—As a Brazilian company, Ambev is subject to different corporate laws and regulations than those typically applicable to U.S.-listed companies, which may result in Ambev's shareholders having fewer or less well-defined shareholder rights than the shareholder rights of those companies."

The ability of our foreign subsidiaries to distribute cash upstream may be subject to various conditions and limitations.

Our foreign subsidiaries' ability to distribute cash (to be used, among other things, to meet our financial obligations) through dividends, intercompany advances, management fees and other payments is, to a large extent, dependent on the availability of cash flows at the level of such foreign subsidiaries and may be restricted by applicable laws and accounting principles. In particular, 46.5% (R$37.1 billion) of our total net revenues of R$79.7 billion in 2022 came from our foreign subsidiaries. In addition, some of our subsidiaries are subject to laws restricting their ability to pay dividends or the amount of dividends they may pay.

If we are not able to obtain sufficient cash flows from our foreign subsidiaries, this could negatively impact our business, results of operations and financial condition because the insufficient availability of cash at our company level may constrain us from paying all of our obligations.

*We may not be able to recruit or retain key personnel.*

In order to develop, support and market our products, we must hire and retain skilled employees with particular expertise and considering diversity attributions, whenever applicable. The implementation of our strategic business plans could be undermined by a failure to recruit or retain key personnel or the unexpected loss of senior employees, including in acquired companies. We face various challenges inherent in the management of a large number of employees over diverse geographical regions, with its particular social contexts. Key employees may choose to leave their employment for a variety of reasons, including reasons beyond our control. The impact of the departure of key employees cannot be determined and may depend on, among other things, our ability to recruit other individuals of similar experience and skill at an equivalent cost and our ability to convey, maintain and monitor the culture of a safe, friendly and non-discriminatory work environment. It is not certain that we will be able to attract or retain key employees and successfully manage them, which could disrupt our business and have an unfavorable material effect on our financial position, income from operations and competitive position.

*We rely on key third parties, including key suppliers, and the termination or modification of the arrangements with such third parties or non-compliance with the Company's ESG guidelines or any failure to comply with laws and regulations by them could negatively affect our business.*

We rely on third-party suppliers for a range of raw materials for our beer and non-beer products, and for packaging material, including aluminum cans, glass, kegs and PET bottles. We seek to limit our exposure to market fluctuations in the supply of these raw materials by entering into medium- and long-term fixed-price arrangements. We have a limited number of suppliers of aluminum cans, glass and PET bottles. Consolidation of the aluminum can industry, glass and PET bottle industry in certain markets in which we operate has reduced local supply alternatives and increased the risk of disruption to aluminum can, glass and PET bottle supplies. Although we generally have other suppliers of raw materials and packaging materials, the termination of or material change to arrangements with certain key suppliers, disagreements with those suppliers as to payment or other terms, or the failure of a key supplier to meet our contractual obligations or otherwise deliver materials consistent with current usage would or may require us to make purchases from alternative suppliers, in each case at potentially higher prices than those agreed with this supplier. Additionally, we may be subject to potential reputational damage if one of our suppliers violates applicable laws or regulations. These factors could have a material adverse effect on our business, results of operations, cash flows or financial condition.

[**Table of Contents**](#TableOfContents)

We have also entered into contracts with third parties to provide transportation and logistics services in connection with part of our products. The early termination of these contracts or our inability to renew them or negotiate new contracts with other service providers with similar conditions could adversely affect our financial and operating condition. In addition, the majority of our suppliers of transportation operate under concessions granted by the Brazilian government and the loss or non-renewal of such concessions may also adversely affect our results of operations and financial condition.

Moreover, if any of our suppliers and/or service providers fails to comply with laws or regulations, or applicable corporate policies and/or specific contractual clauses determined by us, including binding sustainability and ESG (environmental, social and corporate governance) practices, including social, environmental, climate, integrity, and labor laws, we may be subject to fines, administrative and legal proceedings, or other measures with an adverse impact on our business, results of operations and reputation. For further information, see "Item 8. Financial Information—A. Consolidated Financial Statements and Other Financial Information—Legal Proceedings—Ambev Third-Party Supplier – Labor Investigations."

Additionally, we have licenses to bottle and/or distribute brands held by companies over which we do not have control. See "Item 4. Information on the Company—B. Business Overview—Licenses." If we are unable to maintain such arrangements on favorable terms, this could have a material adverse effect on our business, results of operations, cash flows or financial condition.

Demand for our products may be adversely affected by changes in consumer preferences and tastes.

We depend on our ability to satisfy consumer preferences and tastes. Consumer preferences and tastes can change in unpredictable ways due to a variety of factors, such as changes in demographics, consumer health concerns regarding obesity, product attributes and ingredients, changes in travel, vacation or leisure activity patterns, weather, consumer concerns regarding environmental impact caused by the products and its manufacturing, negative publicity resulting from regulatory action or litigation against us or comparable companies or a downturn in economic conditions. Consumers also may begin to prefer the products of competitors or may generally reduce their demand for products of our business segment. Failure by us to anticipate or respond adequately to changes in consumer preferences and tastes could adversely impact our business, results of operations and financial condition.

***Risks Relating to the Economy Sector in Which We Operate***

Volatility in commodities prices may adversely affect our financial performance.

A significant portion of our cost of sales is comprised of commodities such as aluminum, sugar, corn, wheat and PET bottles, the prices of which fluctuated in 2022. An increase in commodities prices directly affects our consolidated operating costs. Although our current policy is to mitigate our exposure risks to commodity prices whenever financial instruments are available, we cannot assure that such hedging will be always possible or available at reasonable costs at all times in the future.

Set forth below is a table showing the volatility in 2022 prices of the principal commodities we purchase:

---

| | | | | |
|:---|:---|:---|:---|:---|
| &nbsp;&nbsp; **Commodity** | &nbsp;&nbsp; **High Price** | &nbsp;&nbsp; **Low Price** | &nbsp;&nbsp; **Average in 2022** | &nbsp;&nbsp; **Fluctuation** |
| &nbsp;&nbsp;Aluminum (US$/ton) | &nbsp;&nbsp;2602.5 | &nbsp;&nbsp;1967.0 | &nbsp;&nbsp;2138.1 | &nbsp;&nbsp;16% |
| &nbsp;&nbsp;Sugar (US$ cents/pounds) | &nbsp;&nbsp;15.45 | &nbsp;&nbsp;10.86 | &nbsp;&nbsp;13.71 | &nbsp;&nbsp;(13%) |
| &nbsp;&nbsp;Corn (US$ cents/bushel) | &nbsp;&nbsp;4.08 | &nbsp;&nbsp;3.30 | &nbsp;&nbsp;3.60 | &nbsp;&nbsp;12% |
| &nbsp;&nbsp;Wheat (US$ cents/bushel) | &nbsp;&nbsp;5.38 | &nbsp;&nbsp;4.00 | &nbsp;&nbsp;4.44 | &nbsp;&nbsp;22% |
| &nbsp;&nbsp;PET (US$/ton) | &nbsp;&nbsp;957.05 | &nbsp;&nbsp;742.45 | &nbsp;&nbsp;844.38 | &nbsp;&nbsp;16% |

---

Sources: Aluminum LME, Sugar ICE, Corn CBOT, Wheat CBOT and PET IHS (formerly CMAI).

[**Table of Contents**](#TableOfContents)

*Negative publicity focusing on us or our products or on the way we conduct our operations may harm our business.*

Media coverage and publicity generally can exert significant influence on consumer behavior and actions. If the social acceptability of beer, other alcoholic beverages or soft drinks were to decline significantly, sales of our products could materially decrease. In recent years, there has been increased public and political attention directed at the alcoholic beverage and soft drink industries. This attention is a result of public concern over alcohol-related problems, including drunk driving, underage drinking, drinking while pregnant and health consequences resulting from the misuse of beer (for example, alcoholism), as well as soft-drink related problems, including health consequences resulting from the excessive consumption of soft drinks (for example, obesity). Factors such as negative publicity regarding the consumption of beer, other alcoholic beverages or soft drinks, publication of studies indicating a significant health risk from consumption of those beverages, or changes in consumer perceptions affecting them could adversely affect the sale and consumption of our products and harm our business, results of operations, cash flows or financial condition to the extent consumers and customers change their purchasing patterns.

Key brand names are used by us, our subsidiaries, associates and joint ventures, and licensed to third-party brewers. To the extent that we or one of our subsidiaries, associates, joint ventures or licensees are subject to negative publicity, and the negative publicity causes consumers and customers to change their purchasing patterns, it could have a material adverse effect on our business, results of operations, cash flows or financial condition. As we continue to expand our operations, there is a greater risk that we may be subject to negative publicity or fake news, in particular in relation to our businesses, environmental impacts, taxes, labor rights, corporate transparency, local work conditions among others. Negative publicity or fake news that materially damages the reputation of one or more of our brands or our businesses could have an adverse effect on the value of that brand or our businesses and subsequent revenues from that brand or business, which could adversely impact our business, results of operations, cash flows and financial condition.

Competition could lead to a reduction of our margins, increase costs and adversely affect our profitability.

We compete with both brewers and other beverages companies. Globally, brewers, as well as other players in the beverage industry, compete mainly on the basis of brand image, price, quality, distribution networks and customer service. Consolidation has significantly increased the capital base and geographic reach of our competitors in some of the markets in which we operate.

Concurrently, competition in the beverage industry is expanding and the market is becoming more fragmented, complex and sophisticated as consumer preferences and tastes evolve. Competition may divert consumers and customers from our products. Competition in our various markets could cause us to reduce pricing, increase capital investment, increase marketing and other expenditures, prevent us from increasing prices to recover higher costs, and thereby cause us to reduce margins or lose market share. Any of the foregoing could have a material adverse effect on our business, financial condition and results of operations. Innovation faces inherent risks, and the new products we introduce may not be successful, while competitors may be able to respond more quickly than we can to emerging trends.

The purchasing decisions of consumers are affected by factors including brand recognition, product quality and performance, price and subjective preferences. Some of our competitors may have marketing investments substantially larger than ours. If our advertising, promotional and marketing strategies do not succeed and if we are unable to offer new products to meet the market demands, our market share and results may be adversely affected. If we cannot introduce new products in a timely manner or if our end consumers believe that our competitors' products are more attractive, our sales, profitability and our results of operations may be adversely affected.

Additionally, the unfair pricing practices in some markets and the lack of transparency, or even certain illicit practices, such as tax evasion and corruption, may skew the competitive environment, with material adverse effects on our profitability or ability to operate.

[**Table of Contents**](#TableOfContents)

If we do not successfully comply with applicable anti-corruption laws and regulations, we could be subjected to fines, penalties or other regulatory sanctions, as well as adverse press coverage, which could impact our reputation, operations and sales.

We are committed to conducting business in a legal and ethical manner in compliance with local and international laws and regulations applicable to our business. Nevertheless, there is a risk that our management, employees or other representatives may take actions that violate applicable anti-corruption laws, such as Brazilian Federal Law No. 12,846/2013 (known as the Clean Company Act or BCCA) and the U.S. Foreign Corrupt Practices Act (known as the FCPA).

The BCCA imposes strict liability on companies for certain acts against the public administration, including corrupt acts involving public officials, whether foreign or local. Under the BCCA, companies may be held liable for such acts and face administrative and judicial sanctions, including severe fines and disgorgement of profits, among other sanctions. When imposing sanctions under the BCCA, Brazilian authorities may consider whether a company has implemented an effective compliance program.

Notwithstanding the BCCA and related Brazilian enforcement efforts, Brazil still has a perceived elevated risk of corruption. To a certain degree, that may leave us exposed to potential violations of the BCCA, FCPA or other applicable anti-corruption laws and regulations. For example, a number of high-profile corporate corruption allegations have surfaced in Brazil, especially since the beginning of 2014. See "—D. Risk Factors—Risks Relating to Brazil and Other Countries in Which We Operate—Economic and political uncertainty and volatility in Brazil, and the perception of these conditions in the international financial markets, may adversely affect our business and the market price of our shares and ADSs".

Additionally, in the ordinary course of business, we regularly contract and deal with business partners and consulting firms. Some of these third parties have been managed or controlled by former government officials. Because Brazilian authorities are conducting ongoing investigations that target certain firms and business partners that we previously engaged, we have been cited as clients in connection with such investigations.

In the third quarter of 2019, there were news reports regarding alleged leaks of statements about Ambev by a former consultant, Mr. Antonio Palocci, in a legal procedure to which Ambev subsequently had access. In this regard, we have not identified evidence supporting Mr. Palocci's claims of illegal conduct by Ambev and remain committed to monitoring this matter.

We have implemented an anti-corruption compliance program designed to detect, prevent and remediate potential violations of applicable anti-corruption laws. Nevertheless, there remains some risk that improper conduct could occur, thereby exposing us to potential liability and the costs associated with investigating and remediating such potential misconduct. Our existing internal controls and compliance procedures may not be sufficient to prevent or detect all inappropriate conduct, fraud or violations of applicable law by management, employees, or other representatives (agents, and other business partners).

If we are not in compliance with anti-corruption and other similar laws, such as the BCCA and FCPA, we may be subject to administrative, civil and criminal penalties. This could harm our brand and reputation and have a material adverse impact on our business, financial condition, results of operations and prospects. Adverse press coverage also may result from having our name or brands associated with any misconduct and, even if unwarranted or baseless, could damage our reputation, brands and sales. Therefore, if we become involved in any investigations or other proceedings under the FCPA, BCCA or other applicable anti-corruption laws, our business could be adversely affected.

Increases in taxes levied on beverage products in the countries in which we operate and unfair competition arising from tax evasion may adversely affect our results and profitability.

Increases in levels of taxation in the countries in which we operate could adversely affect our profitability. Increases in taxes on beverage products usually result in higher beverage prices for consumers. Higher beverage prices generally result in lower levels of consumption and, therefore, lower net sales. Lower net sales result in lower margins because some of our costs are fixed and thus do not vary significantly based on the level of production. We cannot assure you that the countries' governments will not increase current tax levels and that this will not impact our business.

[**Table of Contents**](#TableOfContents)

For instance, in May 2018, the Brazilian Federal Government enacted Decree No. 9,394/2018 reducing the rate of the Excise Tax (*Imposto sobre Produtos Industrializados*), or IPI Excise Tax, applicable to transactions with concentrate units and, in so doing, effectively reduced the value of the IPI Excise Tax presumed credits that we had recorded on acquisitions of soft drinks concentrates from companies located in the Manaus Free Trade Zone from 20% to 4%, which was later revoked by the Decree No. 10, 5454/2020. Since then, other decrees were issued with temporary rates applicable to transactions with concentrate units. In 2022, Brazilian Federal Government altered IPI Excise Tax rates levied on transactions with several products, including beer, soft drinks and soft drinks concentrate units. As for concentrate units, the IPI Excise Tax rate was fixed in 8% (Decree No. 11,182/2022).

In 2022, the States of Acre, Alagoas, Amazonas, Bahia, Maranhão, Paraná, Pará, Piaui, Rio Grande do Norte, Roraima, Sergipe, Tocantins increased their ICMS Value-Added Tax rate applicable to beer and/or soft drinks (increases ranging from 1% to 4%), while both the States of Minas Gerais and Rio de Janeiro decreased their ICMS value-Added Tax rates with effect from early 2023 (decreases of 2% and 1%, respectively).

In addition, certain tax laws may be subject to controversial interpretations by tax authorities. If the tax authorities interpret the tax laws inconsistently with our interpretations, we may be adversely affected, including the full payment of taxes due, plus charges and penalties.

Furthermore, currently there are tax reform proposals pending evaluation by the Brazilian Congress. Among the proposals being evaluated, there is the possibility of a complete or partial modification of the consumption and income taxation systems. As per the income taxation, Congress is discussing possible changes on corporate rates as a means of balancing the impact of a possible taxation on dividends, as well as other changes that might impact its tax base, including attributes such as the deductibility of IOC, tax incentives, among other changes. With regards to the consumption taxation system, proposals suggest extinguishing all or some of the federal taxes, namely IPI Excise Tax, PIS and COFINS, as well as the state tax, ICMS, and the municipal tax, ISS, for the purposes of implementing new taxes to be levied upon consumption transactions. The implementation of a tax reform or of any modifications to the current applicable tax legislation, altering the taxes due and/or the tax incentives enjoyed by the companies could directly or indirectly impact our business.

Our business is subject to regulations in the countries in which we operate, and we may have our activities impacted by foreign legislation regarding social, environmental and climate issues.

Our business is regulated by federal, state and municipal laws and regulations governing many aspects of our operations, including brewing, marketing and advertising, consumer promotions and rebates, workplace safety, transportation, environmental aspects, distributor relationships, retail execution, sales and data privacy, among others. In addition, as a public company in Brazil, we are also subject to the Brazilian securities law and the oversight of the Brazilian Securities Commission (*Comissão de Valores Mobiliários*), or the CVM, in connection with our public securities. We may be subject to claims that we have not complied with existing laws and regulations, which could result in fines, penalties and additional obligations such as disclosure of additional information, change of current practices, among others.

In Brazil, the Ministry of Agriculture and Livestock ("MAPA") and its local departments are responsible for the registration, standardization, classification, labelling and for the inspection and surveillance of beverage production and commerce. MAPA regulation sets forth that the registration of establishments and beverages products is valid throughout the country and must be renewed every ten years, except for imported beverages that do not require registration with the MAPA. Moreover, some products and beverages (i.e., energy drinks) may be subject to prior registrations or post-production regulations issued by the Brazilian National Health Surveillance Agency ("ANVISA").

We may be subject to laws and regulations aimed at reducing the availability of beer and carbonated soft drink, or CSD beverages, in some of our markets to address alcohol abuse, underage drinking, health concerns and other social issues. For example, certain Brazilian states and small municipalities in which we operate have enacted legislation restricting the hours of operations of certain points of sale, prohibiting the sale of CSDs in schools and imposing restrictions on advertisement of alcoholic beverages. The Brazilian Congress is also evaluating proposed regulation imposing hygienic seals on beverage cans, as well as regulation on the consumption, sales and marketing of alcoholic beverages, including beer which, if enacted, may impose restrictions on the advertisement of alcoholic beverage products on television during specified times of the day and the hours of operation of certain points of sale, among other things. Furthermore, there are legal proceedings pending before Brazilian courts that may lead to restrictions on advertisement of alcoholic beverages. These rules and restrictions may adversely impact our results of operations. For further information, see "Item 4. Information on the Company—B. Business Overview—Regulation."

[**Table of Contents**](#TableOfContents)

We may be unable to timely comply with recently enacted laws and regulations in the countries we operate or to comply with laws and regulations in countries we recently started to operate. There is a global trend of increasing regulatory restrictions with respect to the sale of alcoholic and CSD beverages. Compliance with such regulatory restrictions can be costly and may affect earnings in the countries in which we operate.

Additionally, the trend towards the multiplication of regulations aimed at regulating ESG issues in the international jurisdictions where we conduct our businesses can result in complex regulatory obligations, with compliance actions to be implemented throughout the value chain, which may lead to high compliance costs and, in the event of non-compliance, reputational, financial and operational damage, as well as limitations on accessing external consumer markets.

We are subject to Brazilian and other antitrust regulations.

As any company operating in Brazil, we are subject to the Brazilian antitrust law and regulation, which sets forth the conducts that should be considered a violation to the economic order and the penalties applied. We have a substantial share of the beer market in Brazil and thus we are subject to scrutiny and enforcement by Brazilian antitrust authorities (mainly the Administrative Council for Economic Defense – CADE). We are committed to conducting business in a legal manner, having implemented what we understand to be a sound competition compliance program to prevent anticompetitive practices. Nevertheless, from time to time, we are and may become involved in litigation, investigations and other legal or administrative proceedings relating to antitrust claims arising from allegations of violations of laws, regulations or acts, either from competitors, clients and other third parties or initiated by CADE. Therefore, we cannot assure you that Brazilian antitrust regulation and decisions will not affect our business in the future.

We also have substantial share of the beer market in other countries, such as Argentina, Bolivia, Uruguay, Paraguay, Panama and the Dominican Republic, in which our operations are subject to scrutiny by local antitrust authorities. We cannot assure you that local antitrust regulations will not affect our business in such other countries in the future.

The Brazilian government has exercised, and continues to exercise, significant influence over the Brazilian economy; Brazilian economic and political conditions have a direct impact on our business and the market price of our shares and ADSs.

The Brazilian economy has been characterized by significant involvement on the part of the Brazilian government, which has historically changed monetary, credit and other policies to influence Brazil's economy. The Brazilian government's actions to control inflation and affect other policies have involved wage and price controls, the Central Bank's base interest rates, as well as other measures, such as the freezing of bank accounts, which occurred in 1990.

Actions taken by the Brazilian government concerning the economy may have important effects on Brazilian corporations and other entities, including Ambev, and on market conditions and prices of Brazilian securities. Our financial condition and results of operations may be adversely affected by the following factors and the Brazilian government's response to the following factors:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; devaluations and other exchange rate movements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; inflation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; investments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; exchange control policies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; employment levels and labor regulation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; social instability;

[**Table of Contents**](#TableOfContents)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; price instability;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; energy shortages;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; water rationing;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; natural and other disasters, including large scale epidemics and pandemics;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; interest rates and monetary policy;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; liquidity of domestic capital and lending markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; growth or downturn of the Brazilian economy;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; import and export controls;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; exchange controls and restrictions on remittances abroad;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; response to COVID-19 pandemic, including social benefits and restriction of businesses operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; fiscal policy and changes in tax laws; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; other political, diplomatic, social and economic developments in or affecting Brazil.

Uncertainty as to whether the Brazilian federal government will implement changes in policy or regulation affecting these or other factors in the future may affect economic performance and contribute to economic uncertainty in Brazil and to heightened volatility and lack of liquidity in the Brazilian capital market and securities issued by Brazilian companies. For example, the deterioration in federal, state and municipal governments' fiscal results in recent years has led to an unprecedented increase in gross debt as well as in the gross debt to GDP ratio, which led Brazil to lose its investment grade from credit rating agencies, decreasing the influx of foreign capital and contributing to a lower level of economic activity. In addition, the Brazilian economy has experienced a sharp drop in recent years due, in part, to the interventionist economic and monetary policies of the Brazilian federal government.

We cannot predict the measures that the Brazilian federal government will take due to mounting macroeconomic pressures or otherwise. Recent economic and political instability has led to a negative perception of the Brazilian economy and higher volatility in the Brazilian capital markets and the securities of Brazilian issuers, which also may adversely affect us. Indecision as to changes in policies and regulations implemented by the Brazilian federal government may contribute to economic uncertainty in Brazil and greater volatility in the Brazilian capital markets. Prior to the COVID-19 pandemic, Brazil was just emerging from a prolonged recession and a period of slow recovery, with only meager GDP growth in 2017, 2018 and 2019. Brazil's incipient economic recovery in 2020 was torpedoed with the onset of the COVID-19 pandemic and governmental measures in relation thereto, all of which have introduced an additional level of economic and political uncertainty. These dynamics further impacted 2021 and 2022 which, coupled with government stimulus reduction, amplified the uncertainty by adding volatility to the market through accelerated inflation, lower disposable income and higher SELIC rates in Brazil.

Economic and political uncertainty and volatility in Brazil, and the perception of these conditions in the international financial markets, may adversely affect our business and the market price of our shares and ADSs.

Our most significant market is Brazil, which has periodically experienced rates of inflation higher than expected. Inflation, along with governmental measures to fight inflation and public speculation about possible future measures, has had significant negative effects on the Brazilian economy. The annual rate of inflation, as measured by the *Índice Nacional de Preços ao Consumidor* (National Consumer Price Index), was 4.52% in 2020, 10.06% in 2021 and 5.79% in 2022. Brazil may experience high levels of inflation in the future and such inflationary pressures may lead to the Brazilian government intervening in the economy and introducing policies that could adversely affect the Brazilian economy, the securities market and our business. In the past, the Brazilian government's interventions included the maintenance of a restrictive monetary policy with high interest rates that restricted credit availability and reduced economic growth, causing volatility in interest rates. Recently, inflationary pressures have increased, including as a result of the ongoing COVID-19 pandemic, which has led to the return of a more restrictive monetary policy.

[**Table of Contents**](#TableOfContents)

The Central Bank's Monetary Policy Committee (*Comitê de Política Monetária do Banco Central do Brasil*, or "COPOM") frequently adjusts the interest rate in situations of economic uncertainty to achieve goals established in the Brazilian federal government's economic policy. In the event of an increase in inflation, the Brazilian federal government may choose to significantly increase interest rates. For example, the SELIC official interest rate oscillated from 2.75% in March 2021 to 9.75% in the end of 2021, with further increases in February, March, May and June 2022. As of the date hereof, the SELIC rate was 13.75%. We cannot assure you that inflation will not affect our business in the future. In addition, any effort on the part of the Brazilian government to preserve economic stability, as well as any public speculation about possible future initiatives, may contribute significantly to economic uncertainty in Brazil and may heighten volatility in the Brazilian securities markets and securities issued abroad by Brazilian issuers. It is also difficult to assess the impact that turmoil in the credit markets will have in the Brazilian economy, and as a result on our operations and financial results in the future.

A failure by the Brazilian government to implement reforms may result in diminished confidence in the Brazilian government's budgetary condition and fiscal stance, which could result in downgrades of Brazil's sovereign foreign credit rating by credit rating agencies, negatively impact Brazil's economy, lead to further depreciation of the *Real* and an increase in inflation and interest rates, adversely affecting our businesses, financial condition and results of operations.

Consumption of beer, other alcoholic beverages and soft drinks in many of the jurisdictions in which we operate, including Brazil, is closely linked to general economic conditions, such that levels of consumption tend to rise during periods of rising per capita income and to fall during periods of declining per capita income. Consumption of beer and other alcoholic beverages also varies in accordance with changes in disposable income. Any decrease in disposable income resulting from an increase in inflation, income taxes, cost of living, unemployment levels, political or economic instability or other factors would likely adversely affect the demand for beer, other alcoholic beverages, soft drinks and other non-alcoholic beverages, as well as our results of operations. Moreover, the instability and uncertainty in the Brazilian economic and political scenario may continue to adversely affect the demand for our products, which in turn may negatively impact our operations and financial results.

In addition, Brazil's political environment has historically influenced, and continues to influence, the performance of the country's economy. Political crises have affected and continue to affect the confidence of investors and the general public, which have historically resulted in economic deceleration and heightened volatility in the securities issued by Brazilian companies. For example, presidential elections occurred in October 2022, with Luiz Inácio Lula da Silva defeating Jair Messias Bolsonaro, in one of the closest presidential races in history. In the aftermath of the 2022 election results, there were mass protests and demonstrations throughout Brazil by supporters of former president Jair Bolsonaro disputing the election results. On January 8, 2023, protesters stormed government buildings in Brasilia, the country's capital, including the Congress, the Supreme Court and the Presidential Palace, which prompted the Supreme Court to order participants and certain politicians to be imprisoned and resulted in new investigations. It is unclear whether this heightened state of political and social tension will dissipate or intensify in coming months as the country awaits definition regarding the political and economic agenda of the new administration, which could contribute to increased macroeconomic and political instability.

Further, during the term of the former president Jair Messias Bolsonaro, who remained president until January 1, 2023, there were several inquiries related to potential misconduct, including a Supreme Court investigation focused on the president's handling of the COVID-19 pandemic. The potential outcome of these and other inquiries, as well as potential new inquiries involving Jair Messias Bolsonaro that may arise, are uncertain, but they had a negative impact on the general perception of the Brazilian economy and have adversely affected and may continue to affect our businesses, financial condition and results of operations, as well as the market price of our common shares.

[**Table of Contents**](#TableOfContents)

***Risks Relating to Other Countries in Which We Operate***

*Our Latin America South operations are subject to substantial risks relating to the businesses and operations conducted in Argentina and other South American countries.*

We own 100% of the total share capital of Latin America South Investment, S.L., or LASI, the net revenues from which corresponded to 21.8% of our consolidated results of operations in 2022. LASI is a holding company with operating subsidiaries in Argentina and other South American countries. As a result, LASI's financial condition and results of operations may be adversely affected by the political instability, fluctuations in the economy and governmental actions concerning the economy of Argentina and the other countries in which its subsidiaries operate and, consequently, affect our consolidated results.

The results of our Argentinian operations have been significantly impacted in recent years by political instability, fluctuations in the Argentine economy (such as the devaluation of the Argentine *peso* in 2020, 2021 and 2022 relative to the U.S. dollar), governmental actions concerning the economy of Argentina (such as Argentina's selective default on its restructured debt in July 2014), inflation and deteriorating macroeconomic conditions in the country. Continued deterioration of the Argentine economy, or new foreign exchange, price controls, export repatriation or expropriation regimes could adversely affect our liquidity and ability to access funds from Argentina, our financial condition and operating results.

The 2020, 2021 and 2022 devaluations of the Argentine *peso* relative to the *real*, and further devaluations of the Argentine *peso* in the future, if any, may decrease our net assets in Argentina, with a balancing entry in our equity. See "—Risks Relating to Our Operations—Our results of operations are affected by fluctuations in exchange rates and devaluation of the *real* or other currencies with which we operate relative to other currencies, including the U.S. dollar, which may adversely affect our financial performance."

Following the categorization of Argentina in our results for the third quarter of 2018 as a country with a three-year cumulative inflation rate greater than 100%, the country is considered as a hyperinflationary economy in accordance with IFRS rules (IAS 29), requiring us to restate the results of our operations for the year ended December 31, 2018, in hyperinflationary economies for the change in the general purchasing power of the local currency, using official indices before converting the local amounts at the closing rate of the period.

In 2020, the Argentine government implemented multiple measures in response to the economic crisis resulting from the COVID-19 pandemic including increased health spending, financial support for workers (including funding of wages), vulnerable groups and certain industry sectors, as well as price controls*.* In 2021, these actions were further enhanced with the freezing of housing rental prices (coupled with the prohibition of evictions upon payment delays), temporary suspensions of service interruption due to non-payment and the extension of credit card payment deadlines and reduced fees on public transportation. Argentina's inflation reached 95% in 2022 with the Central Bank increasing its reference interest rate (BADLAR) by nearly 35pp, ending the year at 69%, in an attempt to prevent further devaluation of the currency that went from 102 ARS/USD to 177 ARS/USD (a 72% devaluation).

In light of the country's ailing economy and market's concerns as to the current administration's commitment to fiscal responsibility, which includes a recent increase in corporate income tax, our liquidity and operations, as well as our ability to access funds from Argentina could be adversely affected to the extent the economic or political situation in Argentina deteriorates, or if foreign exchange restrictions are further implemented in the country. It is also difficult to assess the impact that the changes to the Argentine political scenario will have in the Argentine economy and, as a result, on our future operations and financial results.

[**Table of Contents**](#TableOfContents)

If the economic or political situation in Argentina further deteriorates, our Latin America South operations may be subject to restrictions under new Argentinean foreign exchange, export repatriation or expropriation regimes that could adversely affect our liquidity and operations, and our ability to access funds from Argentina.

In addition, On November 8, 2020, Luis Arce took office as the new president of Bolivia, having won the elections in the first round with the majority of votes. With these results, the Movement towards Socialism (*Movimiento al Socialismo* or MAS) was returned to power and obtained an absolute majority in the parliament after a one-year interregnum following the ballot in 2019. In March 2021, Jeanine Anez, the former Bolivian interim president appointed as the most senior parliamentarian, was charged with terrorism, sedition and conspiracy as part of a coup to depose longtime former president Evo Morales and has been detained since then.

Furthermore, In December 2021, Gabriel Boric was elected Chile's new president, defeating José Antonio Kast, in an election marked by political polarization. Boric's government plan includes aspects such as increasing taxes on the richest population and large companies, ending the current pension system, and creating a universal fund to finance public and private health. Even though Chile's GDP grew by nearly 2.5% in 2022, it has slowed down versus 2021 as tighter financial conditions, the withdrawal of pandemic-related support measures, and rising inflation dampened household consumption. It is difficult to assess the impact that the changes to the Bolivian and Chilean political scenario, as well as other Latin American countries, will have on their respective economies and, as a result, on our future operations and financial results.

Political developments in Latin America, including government deadlock, political instability and civil strife could impact our Latin America South operations and have a material adverse effect on our business, financial condition, and results of operations.

*Deterioration in economic and market conditions in Brazil and other emerging market countries, as well as in developed economies (including as a result of the COVID-19 virus pandemic), may adversely affect the market price of our common shares and ADSs.*

Economic and market conditions in Brazil and other emerging market countries, especially those in Latin America, influence the market for securities issued by Brazilian companies as well as investors' perception of economic conditions in Brazil. Crises in emerging markets, such as in Southeast Asia, Russia and Argentina, historically caused volatility in the Brazilian stock market and other emerging countries. In addition, global financial crisis originating in developed economies, including the subprime debt crisis in the United States and the sovereign debt crisis in Europe, have had an impact on many economies and capital markets around the world, including Brazil, which may adversely affect investors' interest in the securities of Brazilian issuers such as Ambev.

Our businesses, financial condition and results of operations may be materially and adversely affected by a general economic downturn and by instability and volatility in the financial markets and commodity prices, including as a result of the conflict between Ukraine and Russia.

More recently, the COVID-19 virus pandemic has resulted in significant financial market volatility and uncertainty around the globe. Therefore, the market value of our common shares and ADSs may be adversely affected by events occurring inside and outside of Brazil, such as the emergence or continuation of widespread health emergencies or pandemics, military conflicts, including the ongoing conflict between Russia and Ukraine, terrorism or other geopolitical events. Additionally, monetary policy changes and/or implementation of protectionist policies in the United States and other relevant countries for the international economy may impact, directly or indirectly, the economy in the countries where we operate, generating several risks, especially exchange rate, interest rate and increase in the price of commodities, and, consequently, affecting our results.

We operate a joint venture in Cuba, in which the Government of Cuba is our joint venture partner. Cuba is still targeted by broad and comprehensive economic and trade sanctions of the United States. Our operations in Cuba may adversely affect our reputation and the liquidity and value of our securities.

Ambev, through its Canadian subsidiary Cerbuco Brewing Inc., ("Cerbuco"),currently owns a controlling interest of 50% in Cerveceria Bucanero S.A., or Bucanero, a Cuban company in the business of producing and selling beer. The other 50% equity interest in Bucanero is owned by the Government of Cuba. We have the right to appoint the general manager of Bucanero. In 2021, Cerbuco initiated arbitration proceedings regarding potential breach of certain obligations relating to the joint venture. For more information regarding the arbitration proceedings, please see "Item 8. Financial Information—Civil Claims—Cerbuco Arbitration."

[**Table of Contents**](#TableOfContents)

Bucanero's main brands are *Bucanero* and *Cristal*. In 2022, Bucanero sold 0.70 million hectoliters of beer, representing about 0.38% of our total volume of 185.7 million hectoliters for the year. Although Bucanero's production is primarily sold in Cuba, a small portion of its production is exported to and sold by certain distributors in other countries outside Cuba (but not the United States).

Based on U.S. foreign policy, the U.S. Treasury Department's Office of Foreign Assets Control and the U.S. Commerce Department together administer and enforce broad and comprehensive economic and trade sanctions against Cuba. Although our operations in Cuba are quantitatively immaterial, our overall business reputation may suffer, or we may face additional regulatory scrutiny as a result of our activities in Cuba based on the fact that Cuba remains a target of U.S. economic and trade sanctions.

In addition, there have in the past been initiatives by federal and state lawmakers in the United States, and certain U.S. institutional investors, including pension funds, to adopt laws, regulations or policies requiring the divestment from, or reporting of interests in, companies that do business with countries designated as state sponsors of terrorism. On January 11<sup>th</sup>, 2021, the United States government designated Cuba as a state sponsor of terrorism, a list from which Cuba had previously been removed in 2015. If U.S. investors decide to liquidate or otherwise divest their investments in companies that have operations of any magnitude in Cuba, the market in and value of our securities could be adversely impacted.

Also, Title III of the Cuban Liberty and Democratic Solidarity (LIBERTAD) Act of 1996 (known as the "Helms-Burton Act") authorizes private lawsuits for damages against anyone who traffics in property confiscated without compensation by the Government of Cuba from persons who at the time were, or have since become, nationals of the United States.

The Helms-Burton Act also includes a section that authorizes the U.S. Department of State to prohibit entry into the United States of non-U.S. persons who traffic in confiscated property, and corporate officers and principals of such persons, and their families. Although Title III of the Helms-Burton Act had previously been suspended by discretionary presidential action following its inception in 1996. On May 2, 2019, the former Trump Administration activated Title III of the Helms-Burton Act, thereby allowing nationals of the United States that hold claims under the Helms-Burton Act to file suit in U.S. federal court against all persons trafficking in property confiscated by the Cuban government. As a result of the activation of Title III of the Helms-Burton Act, we may be subject to potential U.S. litigation exposure, including claims accrued during the prior suspension of Title III of the Helms-Burton Act. It remains uncertain how the activation of Title III of the Helms-Burton Act will impact our U.S. litigation exposure. ABI has received notices of claims purporting to be made under the Helms-Burton Act

The extent of the pandemic declared by the World Health Organization due to the spread of COVID-19, the perception of its effects or the way in which this pandemic will continue to impact our business, depends on future developments which are highly uncertain and unpredictable, and may result in a material adverse effect on our business, financial condition, results of operations and cash flow.

Outbreaks or potential disease outbreaks may have an adverse effect on our operations. Historically, some epidemics and regional or global outbreaks, such as the one caused by the Zika virus, the Ebola virus, the H5N5 virus (popularly known as avian influenza), the foot and mouth disease, the H1N1 virus (influenza A, popularly known as swine flu), the Middle East Respiratory Syndrome (MERS) and the Severe Acute Respiratory Syndrome (SARS), have affected certain sectors of the economy in the countries where these diseases have spread. On March 11, 2020, the World Health Organization, or the WHO, declared a pandemic due to the global spread of COVID-19, a disease caused by the new coronavirus (Sars-Cov-2), or COVID-19. This spread has generated significant macroeconomic uncertainties, volatility, and disruption. In response, many governments have implemented policies designed to prevent or delay the spread of the disease, such as the restriction on circulation of people and even social isolation, and some of these measures may remain in place for an extended and uncertain period.

[**Table of Contents**](#TableOfContents)

During 2020 and 2021, as the COVID-19 pandemic progressed in the countries in which we operate, including Brazil, Argentina, Canada and several other countries in Central and South America, states and municipalities have adopted guidelines that varied in terms of scope and intensity to control the spread of COVID-19, such as the restriction on circulation of people and social distancing, which resulted in the closing of and operating restrictions on stores, restaurants, hotels, shopping centers, crowded areas, parks and other public spaces. In 2022, most of such restrictions were lifted throughout the first half of the year as a result of improvements in the control of the pandemic. While these restrictions were in effect, they have changed consumer behavior and the dynamics of on-trade (e.g., bars and restaurants) and off-trade (e.g., supermarkets) channels, which adversely impacted our profitability. This changed dynamics had a severe effect on emerging market countries, such as Bolivia and Panama, where the on-trade channel is the predominant consumption occasion for consumers. See "Item 5. Operating Financial Review and Prospects—A. Operating Results."

The dissemination of COVID-19 made us change our business practices (including additional hygienic practices for workplaces and employees, in addition to canceling in-person meetings, events and conferences) during the pandemic. We may take additional actions, as required by government authorities, or as determined by management, considering the best interests of our employees, customers and business partners. We cannot guarantee that these measures will be sufficient to mitigate the risks posed by the pandemic or that they will meet the demands of government authorities.

The extent to which the COVID-19 pandemic will continue to affect our business, financial condition, results of operations or cash flows will depend on future developments, which are highly uncertain and unpredictable. These developments include, among others, the duration and geographic distribution of the outbreak, its severity, actions to contain the virus or minimize its impact, and how quickly and to what extent normal economic and operational conditions can be resumed. Even three years after the COVID-19 pandemic started, our business continues to suffer adverse and material impacts due to the global or regional economic impact, including recession, economic slowdown or increase in unemployment levels, which may affect the purchasing power of our customers.

In addition, we cannot guarantee that other regional and/or global outbreaks will not occur. If they do, we cannot guarantee that we will be able to take the necessary measures to prevent an adverse impact on our businesses of equal or greater dimension than the impact caused by the COVID-19 pandemic, in case of new regional and/or global outbreaks or new large-scale waves of COVID-19.

Any outbreak of a disease that affects human behavior or that requires public policies to restrict the circulation of people and/or social contact may change consumer behavior, having an adverse impact on our business, as well as on the economies in the countries in which we operate. Disease outbreaks may also make it impossible for our employees and customers to go to our facilities (including for preventative reasons or avoiding large-scale contamination), which would adversely affect the development of our business.

As there are no comparable recent events that can provide us with guidance regarding the effect of a severe global pandemic, we cannot predict the final impact of the COVID-19 outbreak. Finally, the impact of the COVID-19 pandemic can also precipitate or exacerbate the other risks described in this annual report.

***Social Issues***

The Company is subject to obligations imposing respect for human rights, which may cause the Company to incur additional costs, as well as significant contingencies related to social issues.

Exposure to social risks varies according to the specific characteristics of each company, its sector of activity and its geographic location, so that each company must consider such peculiarities to define the social risks considered material, according to its strategy and model of business. In general, social risks arise from the potential and effective adverse impacts of its business activities on the human rights of all stakeholders involved in its operation, including its own employees, consumers, suppliers, investors and the local community where a company operates, these being connected directly or indirectly to its activities.

If the measures we adopt are not sufficient to prevent, manage and mitigate the social risks applicable to our business, we will consequently be exposed to legal, regulatory, operational and reputational risks, which can materialize in different ways.

[**Table of Contents**](#TableOfContents)

We are also required to guarantee dignified working conditions for our employees, ensuring their health, safety, well-being and their right to associate and participate in unions, in compliance with local laws and regulations, respecting human rights. A workplace identified as dangerous, hostile or discriminatory may result in legal contingencies and inhibit the Company's ability to attract and retain talent, negotiate with associations and unions, prevent incidents of health and safety at work, and drive innovation.

Similarly, if we do not take well-structured initiatives that are integrated into long-term planning to foster diversity, equity and inclusion, in all levels regardless of the hierarchy, we may be challenged, including judicially, about the absence of clear goals and effective actions in this area.

There is no guarantee that the Company will be able to properly manage the social risks mentioned above, meeting all national and international laws, parameters and guidelines, which, consequently, may harm the Company's operating results and reputation.

***Environmental Issues***

Our operations are subject to broad safety and environmental regulations, the non-compliance of which may pose significant financial, operational, reputational, litigation and regulatory risks related to environmental issues for us.

The Company's operations are subject to a wide variety of federal, state and municipal environmental laws and regulations, related to the licenses or authorizations necessary for the development of the Company's business regarding the installation and operation of its projects and activities, the use of water resources, solid waste management, removal of vegetation, impact on protected areas, use of forestry products or raw materials, among other aspects possibly related to its activities.

The Company's activities require the constant obtaining and renewal of environmental licenses and authorizations, which depend on the installation and operation of activities and undertakings considered by the competent environmental agency, under the terms of current environmental legislation, as effectively or potentially polluting the environment. Technical difficulties, non-compliance with the related environmental legislation and the technical conditions established in the environmental licenses and authorizations may have harmful effects on the Company's business, since they may subject it to the imposition of various administrative sanctions (such as simple or successive fines, interruption or suspension of activities, embargo or closure of undertakings, revocation of licenses and authorizations, as applicable), payment of costs for the recovery of degraded areas and environmental regularization (resulting from environmental compensation and embargo, for example), as well as accountability in the civil, administrative and criminal spheres, as the case may be. There is no guarantee that the Company, even adopting appropriate practices and processes, will not incur environmental liability or that these applicable environmental laws and regulations will not change or become more stringent in the future. In this sense, non-compliance with the applicable legislation and the technical conditions established in the licenses and authorizations may harm the Company's operations, reputation, operating results and financial health.

As the scrutiny of environmental authorities, society and investors regarding the Company's practices in relation to the environment, as well as the Company's compliance with environmental legislation in the various federative spheres, as well as in the countries in which we operate, has become increasingly rigorous, the Company's costs to comply with environmental regulation, improve environmental practices and repair possible environmental damage can increase substantially in the future. Furthermore, processes related to environmental compliance can become more complex.

In this context, for the purpose of complying with current environmental legislation and addressing other environmental issues relevant to the Company, the following are considered material issues from a regulatory, operational, financial and reputational point of view: (i) the use of water resources; (ii) climate change; (iii) solid waste management, reverse logistics and circular packaging; (iv) sustainable agriculture and (v) responsible consumption. In view of their relevance, the Company internally manages the material topics by establishing and monitoring appropriate performance indicators to assess the variations, evolutions and challenges related to each of the aforementioned topics.

[**Table of Contents**](#TableOfContents)

Natural and other disasters and accidents caused by human and technological errors could disrupt our operations.

The economy of countries in which we operate, as well as our business activity and operating results, may be adversely impacted by natural (including floods, fires), social, technical (technological or human errors) or physical risks such as large-scale epidemics and pandemics, including the COVID-19 pandemic, the occurrence of natural disasters, terrorist events, military conflicts, including the ongoing conflict between Russia and Ukraine, which could disrupt the operations of our suppliers, affect the price or availability of certain raw materials or commodities required for our products and adversely affect our operations, as well as other actions that may result in significant widespread disruptions to commerce and the ability of businesses, including ours, to operate normally. The exemplified events and others can affect our business in general or be specific to certain strategic locations, where our plants, distribution center or logistic hubs may be located. Such disruptions may result in reduced economic activity and business sentiment, both in the Brazilian market and internationally.

***Climate issues, including physical and transition risks***

Scarcity or poor quality of water may negatively affect our production costs and capacity.

The Company faces risks related to water shortages. The availability of fresh water is a limited resource in many parts of the world, facing unprecedented challenges relating to climate change and the resulting change in rainfall patterns and frequency of extreme weather, overexploitation, increased pollution and poor water management. As the demand for water continues to increase worldwide, and as water becomes scarcer and the quality of available water deteriorates, the Company may be affected by increased production costs, capacity limitations or significant changes in water quality, which could adversely affect the Company's business and results of operations.

Water shortages can result in business interruptions and/or reduced production and increased treatment costs. The availability of water is critical for the Company's operations, as it is an essential input for the production of beer. Reduced water availability can also affect legislation regulating water use. In addition, water quality affected by scarcity can also affect water treatment costs and the ability to operate around the clock.

Droughts can cause malting barley harvests to fail*,* especially in South America, where most barley is rain-fed, so-called meteorological droughts (short-term droughts and impacted by precipitation) can significantly affect *barley crops* yields.

Climate change, or legal, regulatory or market measures to address climate change, may negatively affect our business or operations.

There is growing concern about adverse impacts caused by emissions of carbon dioxide and other greenhouse gases into the atmosphere such as rising global temperatures, changing weather patterns, and the increased frequency and severity of extreme weather events and natural disasters. If climate change has a negative effect on agricultural productivity in the locations where the Company operates, the Company may be subject to reduced availability or the offer at less favorable prices for certain agricultural products that are necessary for the Company's production process, such as barley, hops, sugar and corn. In addition, public expectations for reducing greenhouse gas emissions may result in increased cost of energy, transportation and raw materials and may require the Company to make additional investments in facilities and equipment due to increased regulatory or social pressures. As a result, the effects of climate change could have material adverse long-term impacts on the Company's business and results of operations. The Company's operations are subject to physical risks, with impacts on the production capacity and delivery of services and products, resulting from the effects of climate change. Tropical cyclones can cause disruptions and damage to businesses and breweries. Wildfires can cause malt barley crop failures, as occurred in 2021 in Canada, which led to significant crop failures. Non-seasonal rains can cause malting barley harvest failures, affecting barley quality. Changes in weather conditions can result in reduced malting barley yields. This reduction directly affects inputs for production and may consequently increase production costs and indirectly costs to markets. For instance, the growing demand for aluminum for packaging, combined with sourcing challenges, may result in higher procurement costs.

[**Table of Contents**](#TableOfContents)

The Company's operations are also subject to transition risks such as: (i) regulatory changes on water use and prices, which may increase the price of water or cause interruptions in supply, affect the availability and license to operate in certain localities and countries; (ii) carbon pricing mechanisms (both taxes and emissions trading systems) that affect both direct operations and emissions from packaging materials throughout the supply chain, may result in higher operating costs for the Company. For example, the aluminum and glass production process are energy high and greenhouse gas emissions intensive. Depending on the country where materials are sourced from, there is potential associated with a high carbon cost and carbon pricing mechanisms; (iii) current and emerging energy and fuel regulations and taxes may increase direct operating costs, given that the Company is exposed to such fuel and energy taxes; and (iv) fluctuations in demand for inputs prone to low availability, such as aluminum, may affect production capacity and increase the cost of purchasing packaging for the Company's products. The Company announced its 2025 Sustainability Goals focused on smart agriculture, efficient use of water resources, recycling of packaging, as well as actions to tackle climate change based on its ambition to achieve net zero emissions (i.e., a reduction of 90 % of greenhouse gas emissions offsetting residual emissions) across its value chain by 2040. If the Company fails to meet these targets for any reason, there is a risk of reputational damage, as well as possible questioning – including through litigation – of its interested parts. As a result, the effects of climate change could have a material adverse long-term impact on the Company's business and results of operations.

*Seasonal consumption cycles and adverse weather conditions may result in fluctuations in demand for our products*

Seasonal consumption cycles and adverse weather conditions in the markets in which we operate may have an impact on our operations. This is particularly true in the summer months, when unseasonably cool or wet weather can affect sales volumes.

Stakeholders concerns and changing consumer preferences for sustainable products could also result in reduced revenues if the Company is unable to meet these requirements.

**Risks Relating to Our Common Shares and ADSs**

Brazilian foreign exchange controls and regulations could restrict conversions and remittances abroad of the dividend payments and other shareholder distributions paid in Brazil in reais arising from Ambev's common shares (including shares underlying the Ambev ADSs).

Brazilian law provides that whenever there is a serious imbalance in Brazil's balance of payments or reasons to foresee such a serious imbalance, the Brazilian government may impose temporary restrictions on the remittance to foreign investors of the proceeds of their investments in Brazil. Such restrictions may hinder or prevent the Custodian or holders who have exchanged ADSs for Ambev's underlying shares from converting distributions or the proceeds from any sale of such shares into U.S. dollars and remitting such U.S. dollars abroad. In the event the Custodian is prevented from converting and remitting amounts owed to foreign investors, the Custodian will hold the reais it cannot convert for the account of the holders of ADSs who have not been paid. The Depositary will not invest the reais and will not be liable for interest on those amounts. Any reais so held will be subject to devaluation risk against the U.S. dollar.

In addition, the likelihood that the Brazilian government would impose such restrictions may be affected by the extent of Brazil's foreign currency reserves, the availability of foreign currency in the foreign exchange markets on the date a payment is due and the size of Brazil's debt service burden relative to the economy as a whole. We cannot assure you that the Brazilian Central Bank will not modify its policies or that the Brazilian government will not institute restrictions or delays on cross-border remittances in respect of securities issued in foreign capital markets. For further information on this matter, see "Item 10. Additional Information—D. Exchange Controls and other Limitations Affecting Security Holders."

*The surrender of ADSs may cause the loss of the ability to remit foreign currency abroad and of certain Brazilian tax attributes.*

While ADS holders benefit from the electronic certificate of foreign capital registration obtained in Brazil by the Custodian, which permits the Depositary to convert gains, dividends, profits or other payments under Ambev's shares with respect to the shares underlying the ADSs into foreign currency and remit the proceeds abroad, the availability and requirements of such electronic certificate may be adversely affected by future changes to the applicable regulation.

[**Table of Contents**](#TableOfContents)

If an ADS holder surrenders the ADSs and, consequently, receives shares underlying the ADSs, the investment in Ambev's shares would be registered with the Brazilian Central Bank either as (i) a foreign direct investment, subject to Brazilian Central Bank Resolution 278, dated December 31, 2022 ("BCB Resolution 278"), which will require an electronic certificate of foreign capital registration, the *Capital Information Provision System* of Foreign Direct Investment (SCE-IED), or (ii) a foreign investment in portfolio, subject to National Monetary Council's (*Conselho Monetário National)* ("CMN") Resolution 4,373, dated September 29, 2014 ("CMN Resolution 4,373"), which among other requirements, requires the appointment of a financial institution in Brazil as the custodian of the preferred shares and legal representative of the foreign investor in the Electronic Declaratory Registration of Portfolio (RDE – Portfolio).

The failure to register the investment in the Ambev's shares as foreign investment as described above (e.g., SCE – IED or RDE – Portfolio) will impact the ability of the holder to dispose of Ambev's shares and to receive gains, dividends, profits or other payments under Ambev's shares. Moreover, upon receipt of Ambev's shares underlying the ADSs, Brazilian regulations require the investor to enter into corresponding exchange rate transactions and pay taxes on these exchange rate transactions, as applicable.

In addition, if the SCE-IED or RDE-Portfolio are not properly registered the relevant holder may incur expenses or suffer delays in the application process, which could impact the investor's ability to receive gains, dividends, profits or other payments under Ambev's shares on a timely manner.

Certain shareholder entitlements may not be available in the U.S. to holders of Ambev ADSs.

Due to certain United States laws and regulations, U.S. holders of Ambev ADSs may not be entitled to all of the rights possessed by holders of Ambev common shares. For instance, U.S. holders of Ambev ADSs may not be able to exercise preemptive, subscription or other rights in respect of the Ambev common shares underlying their Ambev ADSs, unless a registration statement under the Securities Act is effective with respect to those rights or an exemption from the registration requirements thereunder is available.

Holders of Ambev ADSs may be unable to fully exercise voting rights with respect to the Ambev shares underlying their ADSs.

Under Brazilian law, only shareholders registered as such in the corporate books of Brazilian companies may attend shareholders' meetings. Because all the Ambev common shares underlying the Ambev ADSs are registered in the name of the Depositary (and not the ADS holder), only the Depositary (and not the ADS holder) is entitled to attend Ambev's shareholders' meetings. A holder of Ambev ADSs is entitled to instruct the Depositary as to how to vote the respective Ambev common shares underlying their ADSs only pursuant to the procedures set forth in the deposit agreement for Ambev's ADS program. Accordingly, holders of Ambev ADSs will not be allowed to vote the corresponding Ambev common shares underlying their ADSs directly at an Ambev shareholders' meeting (or to appoint a proxy other than the Depositary to do so), unless they surrender their Ambev ADSs for cancellation in exchange for the respective Ambev shares underlying their ADSs. We cannot ensure that such ADS cancellation and exchange process will be completed in time to allow Ambev ADS holders to attend a shareholders' meeting of Ambev.

Further, the Depositary has no obligation to notify Ambev ADS holders of an upcoming vote or to distribute voting cards and related materials to those holders, unless Ambev specifically instructs the Depositary to do so. If Ambev provides such instruction to the Depositary, it will then notify Ambev's ADS holders of the upcoming vote and arrange for the delivery of voting cards to those holders. We cannot ensure that Ambev's ADS holders will receive proxy cards in time to allow them to instruct the Depositary as to how to vote the Ambev common shares underlying their Ambev ADSs. In addition, the Depositary and its agents are not responsible for a failure to carry out voting instructions or for an untimely solicitation of those instructions.

As a result of the factors discussed above, holders of Ambev ADSs may be unable to fully exercise their voting rights.

[**Table of Contents**](#TableOfContents)

Our status as a foreign private issuer allows us to follow Brazilian corporate governance practices and exempts us from a number of rules under the U.S. securities laws and listing standards, which may limit the amount of public disclosures available to investors and the shareholder protections afforded to them.

We are a foreign private issuer, as defined by the Securities and Exchange Commission, or the SEC, for purposes of the Exchange Act. As a result, we are exempt from many of the corporate governance requirements of stock exchanges located in the United States, as well as from rules under the Exchange Act that impose certain disclosure obligations and procedural requirements for proxy solicitations under Section 14 of the Exchange Act. For example, our officers, directors and principal shareholders are exempt from the reporting and "short-swing" profit recovery provisions under Section 16 of the Exchange Act. Moreover, we are not required to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. Accordingly, there may be less publicly available information concerning us than there is for U.S. public companies.

In addition, for so long as we remain as a foreign private issuer, we will be exempt from most of the corporate governance requirements of stock exchanges located in the United States. Accordingly, you will not be provided with some of the benefits or have the same protections afforded to shareholders of U.S. public companies. The corporate governance standards applicable to us are considerably different than the standards applied to U.S. domestic issuers. For example, although Rule 10A-3 under the Exchange Act generally requires that a company listed in the United States have an audit committee of its board of directors composed solely of independent directors, as a foreign private issuer we are relying on an exemption from this requirement under Rule 10A-3(c)(3) of the Sarbanes-Oxley Act of 2002 that is available to us as a result of features of the Brazilian Corporation Law applicable to our Fiscal Council. In addition, we are not required under the Brazilian Corporation Law to, among other things:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; have a majority of our Board of Directors be independent (though our bylaws provide that two of our directors must be independent and, in certain circumstances pursuant to the Brazilian Corporation Law, our minority shareholders may be able to elect members to our Board of Directors);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; have a compensation committee, a nominating committee, or corporate governance committee of the Board of Directors (though we currently have a non-permanent People Committee that is responsible for evaluating our compensation policies applicable to management and a Governance Committee that is responsible for governance matters as related party transactions, antitrust matters, strategies related to ESG issues and cyber security and privacy and data protection matters);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; have regularly scheduled executive sessions with only non-management directors (though none of our current directors hold management positions in us); or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; have at least one executive session of solely independent directors each year.

For further information on the main differences in corporate governance standards in the United States and Brazil, see "Item 6. Directors, Senior Management and Employees—C. Board Practices—Differences Between United States and Brazilian Corporate Governance Practices."

As a Brazilian company, Ambev is subject to different corporate laws and regulations than those typically applicable to U.S.-listed companies, which may result in Ambev's shareholders having fewer or less well-defined shareholder rights than the shareholder rights of those companies.

Ambev's corporate affairs are governed by its bylaws and the Brazilian Corporation Law, which may differ from the legal principles that would apply to Ambev if the company were incorporated in a jurisdiction in the United States, such as Delaware or New York, or in other jurisdictions outside of Brazil. In addition, shareholder rights under the Brazilian Corporation Law to protect them from actions taken by the board of directors or controlling shareholders may be fewer and less well-defined than under the laws of jurisdictions outside of Brazil.

Although insider trading and price manipulation are restricted under applicable Brazilian capital markets regulations and treated as crimes under Brazilian law, the Brazilian securities markets may not be as highly regulated and supervised as the securities markets of the United States or other jurisdictions outside Brazil. In addition, rules and policies against self-dealing and for the preservation of shareholder interests may be less well-defined and enforced in Brazil than in the United States or other jurisdictions outside Brazil, potentially causing disadvantages to a holder of Ambev ADSs as compared to a holder of shares in a U.S. public company. Further, corporate disclosures may be less complete or informative than required of public companies in the United States or other jurisdictions outside Brazil.

[**Table of Contents**](#TableOfContents)

Any dividends not distributed would be allocated to a special reserve account for future payment to shareholders unless it is used to offset subsequent losses or as otherwise provided for in our bylaws. It is possible, therefore, that our shareholders will not receive dividends in any particular fiscal year.

Foreign holders of our ADSs may face difficulties in serving process on or enforcing judgments against us and other persons.

We are organized under the laws of Brazil and most of our directors and executive officers, as well as our independent registered public accounting firm, reside or are based in Brazil. In addition, substantially all of our assets and those of these other persons are located in Brazil. As a result, it may not be possible for foreign holders of our ADSs to expediently effect service of process upon us or those persons within the United States or other jurisdictions outside Brazil or to efficiently enforce against us or them judgments obtained in the United States or other jurisdictions outside Brazil. Because judgments of U.S. courts for civil liabilities based upon the U.S. federal securities laws may only be enforced in Brazil if certain formal and procedural conditions are met (including non-violation of Brazilian national sovereignty, public policy and "good morals"), holders of our ADSs may face greater difficulties in protecting their interests in the context of legal, corporate or other disputes between them and us, our directors and/or our executive officers than would shareholders of a U.S. corporation.

In addition, a plaintiff (whether or not Brazilian) residing outside Brazil during the course of litigation in Brazil must provide a bond to guarantee court costs and legal fees if the plaintiff owns no real property in Brazil that could secure such payment. The bond must have a value sufficient to satisfy the payment of court fees and defendant's attorney fees, as determined by a Brazilian judge. This requirement does not apply to (1) the enforcement of debt instruments or awards, including foreign judgments and arbitral awards that have been duly recognized by the Brazilian Superior Court of Justice (*Superior Tribunal de Justiça*); (2) counterclaims; and (3) circumstances where the plaintiff or other intervening parties (regardless of citizenship) resides in a country that is a party to a treaty in force in Brazil that establishes that no security, bond or deposit of any kind is required by reason only of their foreign nationality (e.g., the Hague Convention on International Access to Justice). Furthermore, Brazil does not have a treaty with the United States to facilitate or expedite the enforcement in Brazil of decisions issued by a state court in the United States, which shall necessarily be previously recognized by the Brazilian Superior Court of Justice in order to produce effects in Brazil. As to arbitral awards issued in the United States, it is important to note that Brazil has ratified the New York Convention on the Recognition and Enforcement of Foreign Arbitral Awards (Decree No. 4311/2002), and arbitral awards rendered outside of the Brazilian territory are enforceable if the requirements provided by such treaty are fulfilled, and the arbitral award is previously recognized by the Brazilian Superior Court of Justice.

Judgments of Brazilian courts with respect to our shares will be payable only in reais.

If proceedings are brought in the courts of Brazil seeking to enforce our obligations in respect of our common shares, we will not be required to discharge any such obligations in a currency other than *reais*. Under Brazilian exchange control limitations, an obligation in Brazil to pay amounts denominated in a currency other than *reais* may only be satisfied in Brazilian currency at the exchange rate, as determined by the Central Bank, in effect on the date of the effective payment. The then prevailing exchange rate may not afford non-Brazilian investors with full compensation for any claim arising out of, or related to, our obligations under our common shares.

[**Table of Contents**](#TableOfContents)

ITEM 4. INFORMATION ON THE COMPANY

Ambev's principal executive offices are located at Rua Dr. Renato Paes de Barros, 1017, 3rd floor, 04530-001, São Paulo, SP, Brazil, and its telephone number and email are: +55 (11) 2122-1414 and ri@ambev.com.br.

A.&nbsp;&nbsp;&nbsp;&nbsp; History and Development of the Company

**Overview**

We are the successor of Brahma and Antarctica, two of the oldest brewers in Brazil. Antarctica was founded in 1885. Brahma was founded in 1888 as Villiger & Cia. The *Brahma* brand was registered on September 6, 1888, and in 1904 Villiger & Cia. changed its name to Companhia Cervejaria Brahma. However, the legal entity that has become Ambev S.A., the current NYSE- and B3-listed company, was incorporated on July 8, 2005 as a non-reporting Brazilian corporation under the Brazilian Corporation Law and is the successor of Old Ambev. Until the stock swap merger of Old Ambev with Ambev S.A. approved in July 2013 (see "—Stock Swap Merger of Old Ambev with Ambev S.A."), Ambev S.A. did not conduct any operating activities and had served as a vehicle for ABI to hold a 0.5% interest in Old Ambev's capital stock.

In the mid-1990s, Brahma started its international expansion into Latin America, and since then we have been buying assets in different parts of the continent including the South America, Central America and the Caribbean.

In the late 1990s, Brahma obtained the exclusive rights to produce, sell and distribute Pepsi CSD products throughout Brazil, and since then we have been distributing these products throughout that country. In addition, certain of our subsidiaries have franchise agreements for Pepsi products in Argentina, Bolivia, Uruguay, Panama and the Dominican Republic. See "Item 4. Information on the Company—B. Business Overview—Licenses—Pepsi."

In the early 2000s, we acquired a 40.5% economic interest in Quinsa and the joint control of that entity, which we shared temporarily with Beverages Associates (BAC) Corp., or BAC, the former sole controlling shareholder of Quinsa. This transaction provided us with a leading presence in the beer markets of Argentina, Bolivia, Paraguay and Uruguay, and also set forth the terms for our future acquisition of Quinsa's full control from BAC. In April 2006, we increased our equity interest in Quinsa to 91% of its total share capital, after which we started to fully consolidate Quinsa upon the closing of that transaction in August 2006.

In August 2004, we and a Belgian brewer called Interbrew S.A./N.V. (as ABI was then called) completed a business combination that involved the merger of an indirect holding company of Labatt, one of the leading brewers in Canada, into us. At the same time, our controlling shareholder completed the contribution of all shares of an indirect holding company which owned a controlling stake in us to Interbrew S.A./N.V. in exchange for newly issued shares of Interbrew S.A./N.V. After this transaction, Interbrew S.A./N.V. changed its company name to InBev S.A./N.V. (and, since 2008, to Anheuser-Busch InBev S.A./N.V.) and became our majority shareholder through subsidiaries and holding companies. (see "—The InBev-Ambev Transactions").

**The InBev-Ambev Transactions**

The "InBev-Ambev transactions" consisted of two transactions negotiated simultaneously: (1) in the first transaction, BRC exchanged its Old Ambev shares for shares in Interbrew N.V./S.A. (as ABI was then called); and (2) in the second transaction, Old Ambev issued new shares to Interbrew N.V./S.A. in exchange for Interbrew's 100% stake in Labatt.

Exchange of Shares Between BRC and the Interbrew Founding Families

In March 2004, various entities controlled by BRC entered into a contribution and subscription agreement with Interbrew N.V./S.A. (as ABI was then called) and various entities representing the interests of the Interbrew Founding Families to exchange their controlling interest in Old Ambev for newly issued voting shares of Interbrew N.V./S.A., which represented 24.7% of Interbrew N.V./S.A.'s voting shares.

[**Table of Contents**](#TableOfContents)

Upon closing of this transaction in August 2004, (1) BRC received approximately 44% of the voting interest in Stichting, which thereupon owned approximately 56% of Interbrew N.V./S.A.'s common shares, and (2) Interbrew N.V./S.A. received approximately a 53% voting interest and a 22% economic interest in Old Ambev. Such voting interest was subject to our shareholders' agreement at the time, as amended in connection with the InBev-Ambev transactions. In addition, Interbrew N.V./S.A. changed its legal name to InBev N.V./S.A. (and, since its acquisition of Anheuser-Busch, Inc. in the U.S. in 2008, to Anheuser Busch-InBev N.V./S.A.).

Acquisition of Labatt

Pursuant to the *Incorporação* agreement dated March 3, 2004, Labatt Brewing Canada Holding Ltd., or Mergeco, was merged into Old Ambev by means of an upstream merger under the Brazilian Corporation Law, or the *Incorporação*. Mergeco held 99.9% of the capital stock of Labatt Holding ApS, or Labatt ApS, a corporation organized under the laws of Denmark, and Labatt ApS owned all the capital stock of Labatt. Upon completion of the *Incorporação*, Old Ambev held 99.9% of the capital stock of Labatt ApS, and, indirectly, of Labatt. As consideration for the acquisition of Labatt, Old Ambev issued common and preferred shares to Interbrew N.V./S.A. (as ABI was then called).

With the consummation of this transaction in August 2004, (1) Labatt became a wholly-owned subsidiary of Old Ambev, and (2) Interbrew N.V./S.A. (as ABI was then called) increased its stake in Old Ambev to approximately 68% of common shares and 34% of preferred shares.

Ownership Structure of InBev N.V./S.A. and Old Ambev Upon Consummation of the InBev-Ambev Transactions

**InBev N.V./S.A.**

Upon closing the InBev-Ambev transactions, 56% of InBev N.V./S.A.'s voting shares were owned by Stichting, 1% was jointly owned by Fonds Voorzitter Verhelst SPRL and Fonds InBev-Baillet Latour SPRL, 17% were owned directly by entities and individuals associated with the Interbrew Founding Families and the remaining 26% constituted the public float.

BRC became the holder of 44% of Stichting's voting interests, while the Interbrew Founding Families held the remaining 56% of Stichting's voting interests. In addition, BRC and entities representing the interests of the Interbrew Founding Families entered into a shareholders' agreement, providing for, among other things, joint and equal influence over the exercise of the Stichting voting rights in InBev N.V./S.A. (as ABI was then called).

**Old Ambev**

Upon closing of the InBev-Ambev transactions, InBev N.V./S.A. (as ABI was then called) became the owner of approximately 68% of Old Ambev's voting shares, FAHZ retained approximately 16% of such shares, and the remaining shares were held by the public.

Mandatory Tender Offer

Pursuant to the Brazilian Corporation Law, InBev N.V./S.A. (as ABI was then called) was required to conduct, following the consummation of the InBev-Ambev transactions, a mandatory tender offer, or the MTO, for all remaining outstanding common shares of Old Ambev. The MTO was completed in March 2005, and InBev N.V./S.A. (as ABI was then called) increased its stake in Old Ambev to approximately an 81% voting interest and a 56% economic interest in that company. FAHZ did not tender its Old Ambev shares in the MTO.

**Stock Swap Merger of Old Ambev with Ambev S.A.**

On July 30, 2013, the minority shareholders of Old Ambev approved a stock swap merger of Old Ambev with us, according to which each and every issued and outstanding common and preferred share of Old Ambev not held by Ambev S.A. (including in the form of ADSs) was exchanged for five newly issued common shares of Ambev S.A. (including in the form of ADSs). As a result of the stock swap merger, Old Ambev became a wholly-owned subsidiary of Ambev S.A., which continued the same operations of Old Ambev. The ratio adopted for the stock swap merger did not result in any ownership dilution in the equity interest held in us by our minority shareholders, including our former non-voting preferred shareholders, who were granted a separate class vote on the transaction without the interference of our controlling shareholder.

[**Table of Contents**](#TableOfContents)

The stock swap merger combined our former dual-class capital structure, comprised of voting common shares and non-voting preferred shares, into a new, single-class capital structure, comprised exclusively of voting common shares. The purpose of this transaction was to simplify our corporate structure and improve our corporate governance, with a view to increasing liquidity for all shareholders, eliminating certain administrative, financial and other costs and providing more flexibility for the management of our capital structure. As a result of the stock swap merger, all shareholders of Old Ambev, including former holders of that company's non-voting preferred shares, gained access to the same rights and privileges enjoyed by Old Ambev's common shareholders, including full voting rights and the right to be included in a change-of-control tender offer under the Brazilian Corporation Law that ensures that holders of common stock are offered 80% of the price per share paid to a selling controlling shareholder in a change-of-control transaction.

**Upstream Merger of Old Ambev with and into Ambev S.A.**

In January 2014, and as a subsequent step of the stock swap merger, an upstream merger of Old Ambev and one of its majority-owned subsidiaries with and into Ambev S.A. was consummated. This upstream merger had no impact on the shareholdings that our shareholders held in us. As a result of this upstream merger, our corporate structure was simplified.

**Recent Acquisitions, Divestments and Strategic Alliances**

On January 22, 2020, our subsidiary Labatt acquired Goodridge & Williams distillery known for spirits and canned cocktails. The acquisition includes the craft distiller's ready-to-drink brands along with an innovative range of sugar-free, low calorie NÜTRL products as we look to further expand our ready-to-drink offerings in the Canadian market.

On February 18, 2020, our subsidiary Cervecería y Maltería Quilmes acquired Dante Robino, an Argentine winery located in Mendoza, with almost 100 years of history. The acquisition puts itself as an opportunity to complement the beer portfolio and learn about a new segment that has grown consistently in Argentina over the years and has a significant market share in the country.

The long-term agreement with PepsiCo, under which the Cervecería Boliviana Nacional, subsidiary of the Company in Bolivia, has the exclusive right to produce, sell and distribute certain brands on PepsiCo's portfolio in Bolivia, was amended in June 1<sup>st</sup>, 2020, extending the agreement for 10 more years and reflecting certain changes in the commercial agreement between the parties.

On August 16, 2020, Cervecería Chile S.A., a Chilean subsidiary of the Company, entered into a long-term distribution agreement with Embotelladora Andina S.A., Coca-Cola Embonor S.A. and Embotelladora Iquique S.A. (the "Distributors"), by which the Distributors were granted the right to sell and distribute certain products within the Company's portfolio, with exclusivity in specific zones and sales channels in Chile.

B.&nbsp;&nbsp;&nbsp;&nbsp; Business Overview

**Description of Our Operations**

We are the largest brewer in Latin America in terms of sales volumes and one of the largest beer producers in the world, according to our estimates. We currently produce, distribute and sell beer, CSDs, other alcoholic beverages and non-alcoholic and non-carbonated products in 18 countries across the Americas.

Effective January 1, 2019, we reorganized our regional reporting structure. We no longer report the Latin America North business segment (LAN) and, from now on, we are reporting the Brazil, Central America and the Caribbean business segments separately. On December 31, 2022, we conducted our operations through four business segments, as follows:

[**Table of Contents**](#TableOfContents)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· **Brazil**, which includes the beer sales division and the NAB sales division;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· **Central America and the Caribbean**, or CAC, which includes our direct operations in the Dominican
Republic, Saint Vincent, Antigua, Dominica, Cuba, Guatemala (which also serves El Salvador, Honduras and Nicaragua), Barbados and Panama;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· **Latin America South**, or LAS, which
includes our operations in Argentina, Bolivia, Paraguay, Uruguay and Chile; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· **Canada**, represented by Labatt's operations, which includes domestic sales in Canada and some
exports to the U.S. market.

The following map illustrates our four business segments as of December 31, 2022:

![](abevform20f2022_001.jpg)

[**Table of Contents**](#TableOfContents)

An analysis of our consolidated net sales by business segment for the periods indicated is presented in the table below:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Net Sales (*in R$ million*)<br> Year Ended December 31,** | &nbsp;&nbsp; **Net Sales (*in R$ million*)<br> Year Ended December 31,** | &nbsp;&nbsp; **Net Sales (*in R$ million*)<br> Year Ended December 31,** | &nbsp;&nbsp; **Net Sales (*in R$ million*)<br> Year Ended December 31,** | &nbsp;&nbsp; **Net Sales (*in R$ million*)<br> Year Ended December 31,** | &nbsp;&nbsp; **Net Sales (*in R$ million*)<br> Year Ended December 31,** |
|  | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2020** | &nbsp;&nbsp; **2020** |
|  | &nbsp;&nbsp; **Sales** | &nbsp;&nbsp; **% of Total** | &nbsp;&nbsp; **Sales** | &nbsp;&nbsp; **% of Total** | &nbsp;&nbsp; **Sales** | &nbsp;&nbsp; **% of Total** |
| &nbsp;&nbsp;**Brazil** | &nbsp;&nbsp;**35857.8** | &nbsp;&nbsp;**53.5%** | &nbsp;&nbsp;**35586.5** | &nbsp;&nbsp;**48.8%** | &nbsp;&nbsp;**30196.5** | &nbsp;&nbsp;**51.7%** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beer Brazil | &nbsp;&nbsp;35857.9 | &nbsp;&nbsp;45.0% | &nbsp;&nbsp;30537.1 | &nbsp;&nbsp;41.9% | &nbsp;&nbsp;25953.0 | &nbsp;&nbsp;44.5**%** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NAB | &nbsp;&nbsp;6777.9 | &nbsp;&nbsp;8.5% | &nbsp;&nbsp;5049.4 | &nbsp;&nbsp;6.9% | &nbsp;&nbsp;4243.5 | &nbsp;&nbsp;7.3**%** |
| &nbsp;&nbsp;**CAC** | &nbsp;&nbsp;**9440.1** | &nbsp;&nbsp;**11.8%** | &nbsp;&nbsp;**9947.4** | &nbsp;&nbsp;**13.7%** | &nbsp;&nbsp;**7319.3** | &nbsp;&nbsp;**12.5%** |
| &nbsp;&nbsp;**Latin America South** | &nbsp;&nbsp;**17371.2** | &nbsp;&nbsp;**21.8%** | &nbsp;&nbsp;**16571.7** | &nbsp;&nbsp;**22.7%** | &nbsp;&nbsp;**11560.8** | &nbsp;&nbsp;**19.8%** |
| &nbsp;&nbsp;**Canada** | &nbsp;&nbsp; **10261.7** | &nbsp;&nbsp; **12.9%** | &nbsp;&nbsp; **10748.7** | &nbsp;&nbsp; **14.8%** | &nbsp;&nbsp; **9302.4** | &nbsp;&nbsp; **15.9%** |
| &nbsp;&nbsp;**Total** | &nbsp;&nbsp; **79708.8** | &nbsp;&nbsp; **100.0%** | &nbsp;&nbsp; **72854.3** | &nbsp;&nbsp; **100.0%** | &nbsp;&nbsp; **58379.0** | &nbsp;&nbsp; **100.0%** |

---

An analysis of our sales volume by business segment for the periods indicated is presented in the table below:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Sales Volumes ('*000 hl*)<br> Year Ended December 31,** | &nbsp;&nbsp; **Sales Volumes ('*000 hl*)<br> Year Ended December 31,** | &nbsp;&nbsp; **Sales Volumes ('*000 hl*)<br> Year Ended December 31,** | &nbsp;&nbsp; **Sales Volumes ('*000 hl*)<br> Year Ended December 31,** | &nbsp;&nbsp; **Sales Volumes ('*000 hl*)<br> Year Ended December 31,** | &nbsp;&nbsp; **Sales Volumes ('*000 hl*)<br> Year Ended December 31,** |
|  | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2020** | &nbsp;&nbsp; **2020** |
|  | &nbsp;&nbsp; **Volume** | &nbsp;&nbsp; **% of Total** | &nbsp;&nbsp; **Volume** | &nbsp;&nbsp; **% of Total** | &nbsp;&nbsp; **Volume** | &nbsp;&nbsp; **% of Total** |
| &nbsp;&nbsp;**Brazil** | &nbsp;&nbsp;**126184.4** | &nbsp;&nbsp;**67.9%** | &nbsp;&nbsp;**119530.6** | &nbsp;&nbsp;**66.3%** | &nbsp;&nbsp;**111285.4** | &nbsp;&nbsp;**67.1%** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beer Brazil | &nbsp;&nbsp;94042.6 | &nbsp;&nbsp;50.6% | &nbsp;&nbsp;90835.0 | &nbsp;&nbsp;50.4% | &nbsp;&nbsp;84791.7 | &nbsp;&nbsp;51.1**%** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NAB | &nbsp;&nbsp;32141.8 | &nbsp;&nbsp;17.3% | &nbsp;&nbsp;28695.5 | &nbsp;&nbsp;15.9% | &nbsp;&nbsp;26493.7 | &nbsp;&nbsp;16.0**%** |
| &nbsp;&nbsp;**CAC** | &nbsp;&nbsp;**11786.3** | &nbsp;&nbsp;**6.3%** | &nbsp;&nbsp;**13401.9** | &nbsp;&nbsp;**7.4%** | &nbsp;&nbsp;**11451.2** | &nbsp;&nbsp;**6.9%** |
| &nbsp;&nbsp;**Latin America South** | &nbsp;&nbsp;**38134.0** | &nbsp;&nbsp;**20.5%** | &nbsp;&nbsp;**37511.6** | &nbsp;&nbsp;**20.8%** | &nbsp;&nbsp;**33062.4** | &nbsp;&nbsp;**19.9%** |
| &nbsp;&nbsp;**Canada** | &nbsp;&nbsp; **9645.0** | &nbsp;&nbsp; **5.2%** | &nbsp;&nbsp; **9924.1** | &nbsp;&nbsp; **5.5%** | &nbsp;&nbsp; **9998.9** | &nbsp;&nbsp; **6.0%** |
| &nbsp;&nbsp;**Total** | &nbsp;&nbsp; **185749.7** | &nbsp;&nbsp; **100.0%** | &nbsp;&nbsp; **180368.2** | &nbsp;&nbsp; **100.0%** | &nbsp;&nbsp; **165797.9** | &nbsp;&nbsp; **100.0%** |

---

**Business Strategy**

We aim to continuously create value for our stockholders. The main components of our business strategy are:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· our people and culture;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· our strategic pillars;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· quality of our products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· sustainability;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· permanent cost efficiency; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· financial discipline.

[**Table of Contents**](#TableOfContents)

Our People and Culture

Strategic Pillars

We focus our efforts behind the following strategic pillars to lead and grow the category, digitize and monetize our ecosystem, as well as optimize our business:

&nbsp;&nbsp;&nbsp;&nbsp;· *Brands for each and everyone*: Building brands that are recognized by our clients and consumers.
We want our brands to be connected with consumers, and our products to the consumed in important moments of their lives.

&nbsp;&nbsp;&nbsp;&nbsp;· *Thirst to lead the future:* Expanding our beverages and assortment, going beyond the beer category
and including expansion into categories such as RTDs, canned cocktails and seltzers.

&nbsp;&nbsp;&nbsp;&nbsp;· *A toast to our clients' success*: Improving service level and leveraging technology to solve
business customers' issues that allow them to grow their business in partnership with us.

&nbsp;&nbsp;&nbsp;&nbsp;· *Experiences that come to you:* Keeping the consumer at the center of our decision-making process.
Through innovation and technology, we want to connect with and bring what we believe to be the best experiences and convenience to our
consumers.

 

&nbsp;&nbsp;&nbsp;&nbsp;· *Together for a Better World:* Generating a positive impact in the world and grow together with our
ecosystem, which goes from our farmers to our consumers.

We brew a wide variety of beers, including ales, lagers, clear, dark and full-bodied beers, amongst others, offering consumers a unique set of high-quality beers designed to satisfy different needs and tastes across different occasions. We also produce a number of non-alcoholic products, such as soft drinks, energy drinks and juices. The quality of our products is at the forefront of our priorities. We have strict processes, with more than 1,300 controls and more than 370 tests across our production lines, as we aim to provide to our consumers products matching the highest possible standards. Our R&D team is also constantly working to enhance our production process and the quality of our products.

Sustainability

Brewing quality beer starts with the search for the best ingredients. This requires a healthy, natural environment, as well as thriving communities. Therefore, we are pursuing to achieving five Sustainability Goals by 2025:

&nbsp;&nbsp;&nbsp;&nbsp;(i) empowering farmers: 100% of our direct farmers suppliers will be skilled, connected, and financially
self-sufficient as they will have access to an approved variety of inputs, crop protocol for that variety and two technical visits during
the crop year, in addition to access to *Agroportal*, Ambev digital platform;

&nbsp;&nbsp;&nbsp;&nbsp;(ii) securing water access: 100% of our communities in high-stress areas will have measurably
improved water availability and quality;

&nbsp;&nbsp;&nbsp;&nbsp;(iii) driving sustainable packaging: 100% of our product will be in packaging reusable
or made from majority recycled content;

&nbsp;&nbsp;&nbsp;&nbsp;(iv) championing low carbon technology: 100% of our purchased electricity will be from renewable
sources and we will have a 25% reduction in CO2 emissions across our value chain; and

&nbsp;&nbsp;&nbsp;&nbsp;(v) entrepreneurship: 100%
of our entrepreneurs will be skilled with the necessary tools to evolve through the *Compra Local* initiative (Local Purchase).
We direct our action to suppliers in communities that are closer to our operations (up to 80 km), helping them to develop in a sustainable
way and to assist the development of the business, as we share with our customers knowledge and tools that are available on the portals:

[**Table of Contents**](#TableOfContents)

The table below shows the status as of December 31, 2022 of the main key performance indicators related to our sustainability goals for 2025:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | **BRAZIL** | **LAS** | **CAC** | **CANADA** | **AMBEV** | **Goal<br> 2025** | **Status<br> 2022** |
| **WATER<br> Steward.** | **Watersheds & Forests**<br> (High risk sites in implementation phase as per 7-Step charter)<sup>(1)</sup> | 100% | 75% | - | - | **92%** | 100% | **On Track** |
| **WATER<br> Steward.** | **AMA**<br> (Number of people benefitted) | 630000 | - | - | - | **630000** | 1000000 | **Better** |
|  **CLIMATE**<br> **ACTION** | **Renewable energy**<br> (% of total electric energy contracted) | 100% | 92% | 40.6% | 100% | **97%** | 100.0% | **Better** |
|  **CLIMATE**<br> **ACTION** | **GHG emission – Intensity (kg CO2e/Hl)**<br> (% reduction of CO2 emissions versus baseline (2017); Scope 1, 2 and 3) | 12.4% | 31% | 60.7% | 9.9% | **17.4%** | 25.0% | **Better** |
|  **CLIMATE**<br> **ACTION** | **GHG emission – Intensity (kg CO2e/Hl)**<br> (% reduction of CO2 emissions versus baseline (2017); Scope 1 and 2 – Owned Operations) | 59% | 29% | 66% | 26.8% | **48.3%** | - | **Better** |
| **CIRCULAR<br> PACKAGING** | **Glass**<br> (% of glass used that was recycled) | 49.6% | 44.4% | 54.7% | 38.5% | **47.8%** | ≥ 50.1% | **On Track** |
| **CIRCULAR<br> PACKAGING** | **Aluminum**<br> (% of aluminum used that was recycled) | 76.4% | 75.9% | 64.2% | 68.3% | **75.2%** | ≥ 50.1% | **Better** |
| **CIRCULAR<br> PACKAGING** | **Plastic (PET)**<br> (% of plastic used that was recycled) | 40.8% | 10.5% | 18.3% | - | **32%** | ≥ 50.1% | **Worse** |
| **CIRCULAR<br> PACKAGING** | **Plastic Commitment** | 54.9% | - | - | - | **54.9%** | 100% | **On Track** |
| **SUSTAINABLE AGRICULTURE** | **Skilled producers**<sup>(2)</sup> | 82% | 100% | - | - | **89%** | 100% | **Better** |
| **SUSTAINABLE AGRICULTURE** | **Connected producers**<sup>(3)</sup> | 87% | 100% | - | - | **92%** | 100% | **Better** |
| **SUSTAINABLE AGRICULTURE** | **Financially empowered producers**<sup>(4)</sup> | 90% | 100% | - | - | **94%** | 100% | **Better** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) 7-Step Charter consists of: (i) engagement; (ii) problem identification/prioritization; (iii) solutions
agreed; (iv) plan implementation; (v) governance; (vi) communication; and (vii) monitoring.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Producer must have (i) access to a varieties of crops approved by Ambev for production, (ii) technical
protocol for production, and (iii) at least two technical visits during the culture cycle.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Producer must be registered in SmartBarley platform or another similar platform (e.g. ManejeBem, etc.).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Producer has access to the tools to reduce production risks (e.g. agricultural insurance, specific financing,
etc.).

Permanent Cost Efficiency

Cost control is one of the top priorities of our employees. Each of our departments must comply with its respective annual budget for fixed and variable costs. As a means of avoiding unnecessary expenses, we have designed a management control system inspired on "zero-base budgeting" concepts that requires every manager to build from scratch an annual budget for his/her respective department.

Financial Discipline

Our focus is not only on volumes and operating performance, but also on the disciplined management of our working capital and our cash flow generation. Our objective is to maximize the return to our shareholders through a combination of payments of dividends and interest on shareholders' equity, while at the same time keeping our investment plans and holding an adequate level of liquidity to accommodate the seasonality of our business and cope with often volatile and uncertain financial market conditions.

[**Table of Contents**](#TableOfContents)

*Zé Delivery, TaDa and BEES*

In order to increase convenience to our consumers, we developed solutions to deliver on demand cold beverages at reasonable prices directly to consumers. Our solutions solve several pain points identified in the consumers' buying journey: (i) late hours availability, (ii) fast service that is time saving for consumers, (iii) reasonable prices, and (iv) cold products ready to be consumed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· In Brazil, our direct-to-consumer platform Zé Delivery continued
to grow in 2022, being now present in more than 380 cities across all 27 Brazilian states and reaching more than 55% of the country's
entire population. Zé Delivery delivered more than 62 million orders in 2022 and had almost 5 million monthly active users as of
December 31, 2022.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· In
LAS, *Ta Da* in Argentina, which resulted from the merger of *App Bar* with other Direct-to-Consumer platforms named *Siempre en Casa* and *Craft Society*, continued to grow in 2022. The platform is present in 13 cities, with the number of orders growing
by 15% versus 2021, and monthly active users increasing by 14% year over year. In Paraguay, *Ta Da* is present in 24 cities, with
both number of orders and monthly active users triplicating versus 2021.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· In
 CAC, *Ta Da* in Dominican Republic continued to expand in 2022, , with the number of
 orders growing by 98% versus 2021, and monthly active users more than doubling year over
 year.

Our B2B route-to-market & marketplace platform, BEES, centralizes different solutions in one 24/7 platform, creating a constant and customized touchpoint with our customers, and improving overall service level by: (i) providing products suggestions based on customers' profile and product relevance, (ii) enhancing order tracking and real time support through the app, (iii) allowing our business development representatives to be focused on helping customers improve their sales performance (*sell out*), and (iv) increasing our total interaction time with our customers, directly connecting to our innovation strategy and increased portfolio complexity. On BEES marketplace, our customers can also buy non-Ambev products of different categories, enjoying the convenience provided by our platform.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· In Brazil, we continued to roll-out BEES and currently have more than 88%
of our active buyers purchasing through the platform. As part of our full digital strategy plan, nearly 75% of our clients currently purchase
exclusively through BEES. The platform helped us reach an all-time high number of clients, adding more than 200 thousand new clients to
our client base in 2022. In the BEES marketplace, we currently offer over 550 Stock Keeping Units ("SKUs") across different
categories, such as groceries, non-alcoholic beverages, and hard liquors. The number of customers buying in the marketplace corresponded
to 74% of BEES' customers on December 31, 2022.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· In LAS, our digital transformation journey is also evolving with the roll-out
of BEES. In Argentina, more than 65% of B2B buyers are purchasing through BEES, and over 75% of the country's net revenue comes from the platform. The number of customers buying in the marketplace corresponded to over 40% of BEES' customers on December
31, 2022. In Paraguay, 80% of B2B direct and indirect sales are made through BEES, with fully digital buyers accounting for 89% of the
total number of customers.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· In CAC, Dominican Republic continues to lead the expansion of the BEES platform,
actively sharing know-how and best practices with other operations. The country has already reached the status of a full digital operation,
with 99% of B2B buyers already purchasing through the platform, and over 90% of the country's net revenue coming from BEES. We are
also exploring BEES marketplace in the country with 13 different categories and 130 SKUs available for customers.
In Panama, we have also continued with the roll-out of BEES which has reached over 90% of the country's net revenue coming from
the platform.

[**Table of Contents**](#TableOfContents)

***Seasonality***

Sales of beverages in our markets are seasonal. Generally, sales are stronger during the summer and major holidays. Therefore, in the Southern Hemisphere (Brazil, Central America and the Caribbean and Latin America South) volumes are usually stronger in the fourth calendar quarter due to early summer and year-end festivities. In Canada, volumes are stronger in the second and third calendar quarters due to the summer season. This is demonstrated by the table below, which shows our volumes by quarter and business segment:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **2022 Quarterly Volumes<br> (*a<sup>s</sup> a percenta<sup>ge</sup> of annual <sup>v</sup>olumes*)** | &nbsp;&nbsp; **2022 Quarterly Volumes<br> (*a<sup>s</sup> a percenta<sup>ge</sup> of annual <sup>v</sup>olumes*)** | &nbsp;&nbsp; **2022 Quarterly Volumes<br> (*a<sup>s</sup> a percenta<sup>ge</sup> of annual <sup>v</sup>olumes*)** | &nbsp;&nbsp; **2022 Quarterly Volumes<br> (*a<sup>s</sup> a percenta<sup>ge</sup> of annual <sup>v</sup>olumes*)** |
|  | &nbsp;&nbsp; **1st Quarter** | &nbsp;&nbsp; **2nd Quarter** | &nbsp;&nbsp; **3rd Quarter** | &nbsp;&nbsp; **4th Quarter** |
| &nbsp;&nbsp;**Brazil** | &nbsp;&nbsp;23.4% | &nbsp;&nbsp;23.4% | &nbsp;&nbsp;24.9% | &nbsp;&nbsp;28.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beer Brazil | &nbsp;&nbsp;23.4% | &nbsp;&nbsp;23.3% | &nbsp;&nbsp;25.0% | &nbsp;&nbsp;28.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NAB | &nbsp;&nbsp;23.6% | &nbsp;&nbsp;23.5% | &nbsp;&nbsp;24.9% | &nbsp;&nbsp;28.1% |
| &nbsp;&nbsp;**CAC** | &nbsp;&nbsp;**24.5%** | &nbsp;&nbsp;**25.8%** | &nbsp;&nbsp;**23.3%** | &nbsp;&nbsp;**26.4%** |
| &nbsp;&nbsp;**Latin America South** | &nbsp;&nbsp;**28.3%** | &nbsp;&nbsp;**18.2%** | &nbsp;&nbsp;**24.1%** | &nbsp;&nbsp;**29.4%** |
| &nbsp;&nbsp;**Canada** | &nbsp;&nbsp; **18.7%** | &nbsp;&nbsp; **28.8%** | &nbsp;&nbsp; **29.7%** | &nbsp;&nbsp; **22.8%** |
| &nbsp;&nbsp;**Total** | &nbsp;&nbsp; **24.3%** | &nbsp;&nbsp; **22.7%** | &nbsp;&nbsp; **24.9%** | &nbsp;&nbsp; **28.1%** |

---

**Description of the Markets Where We Operate**

Brazil

**Brazil Beer**

**The Brazilian Beer Market**

In Brazil, the two main packaging presentations are standardized, returnable glass bottles largely present in the 300-milliliter and 600-milliliter formats, sold in bars for on-premise consumption, as well as in supermarkets for off-premise consumption, and 350-milliliter one-way aluminum cans, which are predominantly sold in supermarkets for off-premise consumption.

According to our estimates, in 2022 we were the market leader of the Brazilian market in terms of beer sales volumes, mainly through our three major families of brands: *Skol*, *Brahma* and *Antarctica*. Our closest competitors in Brazil are Heineken, particularly following its May 2017 acquisition of Brasil Kirin operations, and Cervejaria Petrópolis.

Distribution represents an important feature in this market, as the retail channel is fragmented into approximately one million points of sale. Our distribution is structured under two separate branches, comprising (1) our network of exclusive third-party distributors, involving 146 operations, and (2) our proprietary direct distribution system, involving 106 distribution centers located across most Brazilian regions. We have been focusing on direct distribution in large urban regions, while strengthening our third-party distribution system. See " —Business Overview—Business Strategy."

**Future Beverages**

Some of our products stretch beyond typical beer consumption occasions, such as the *Beats* family of beverages and Mike's, which are designed for new occasions and consumer groups in which beer is not present, Brahma 0.0%, a non-alcoholic beer, which, according to our estimates, is the leader in the Brazilian non-alcoholic beer segment, and Budweiser Zero, one of our most recent launches. Our Nutrl portfolio and Mike's in Canada and Dante Robino wines in Argentina add to our wide portfolio of future beverages, a market that we have been assessing in different regions and countries.

[**Table of Contents**](#TableOfContents)

**Brazil NAB**

**The Brazilian NAB Markets**

The NAB markets in Brazil are comprised of many different segments, including CSD, bottled water, isotonic beverages, energy drinks, coconut water, powdered and natural juices and ready-to-drink teas. The CSD segment is the most significant to our business representing approximately 94% of the volumes of our NAB unit. According to our estimates, the leading CSD flavors in Brazil are (1) cola (with 54.7% of the market in 2022), (2) *guaraná*, (3) orange, and (4) lime. Most CSDs in Brazil are sold in supermarkets in two-liter and one-liter non-returnable PET bottles for in-home consumption. The 350-milliliter one-way aluminum can is also an important packaging format for our business and is mainly sold in off-trade (e.g. supermarkets) and on-trade (e.g. bars and restaurants) channels.

Our main competitor in this market is The Coca-Cola Company. In addition to The Coca-Cola Company, we face competition from small regional bottlers that produce what are usually referred to as "B Brands." The B Brands compete mainly on price, usually being sold at a significantly lower price than our products.

Our main CSD brands are *Guaraná Antarctica*, the leader in the "non-cola" flavor segment, and *Pepsi Cola*. *Pepsi Cola* is sold under our exclusive production and bottling agreements with PepsiCo. Our NAB portfolio also includes brands such as *Gatorade* in the isotonic market, *H2OH!* in the non-sugar CSD market, and *Lipton Iced Tea* in the ready-to-drink tea market, which are also sold under license from PepsiCo, and, in the energy drink segment, Fusion, a proprietary brand, and Red Bull, which is sold under an exclusive distribution agreement (see "—Licenses—Red Bull"). Since 2016, when we acquired the Brazilian juice company "Do Bem", the brand has been integrated to our portfolio, improving our value proposition in health and wellness categories. In 2022, Pepsi Black was responsible for increasing our presence in the diet/light/zero segment, and we have continued to invest in lowering the sugar content in our portfolio, as well as offering different pack sizes for specific consumption occasions, such as the *Fusion* 500-milliliter PET for the gaming community.

CAC (Central America and the Caribbean)

**Central America**

In Guatemala, the main packaging presentations are the 12-ounce and the 16-ounce cans. Our main competitor in Guatemala is Cerveceria Centro Americana, the market leader, which is a private company owned by local investors. According to our estimates, the total annual sales volume of the Guatemalan beer market was 5.6 million hectoliters in 2022.

In El Salvador, Honduras and Nicaragua, we are currently selling imported brands, and our main packaging presentation is the returnable one-liter glass bottle. Specifically in Nicaragua, our main competitor is Compañía Cervecera de Nicaragua, the market leader, which is a joint venture between Guatemala's Cerveceria Centro Americana and Florida Ice & Farm Co, an investor group from Costa Rica.

In all of these markets, beer is predominantly sold in returnable bottles through small retailers. We sell our *Brahva*, *Budweiser*, *Bud Light*, *Stella Artois*, *Corona*, *Modelo Especial*, *Beck*, *Leffe* and *Hoegaarden* beer brands in Central America, which are distributed through the CBC distribution system, jointly with CBC's CSD portfolio.

In May 2016, we entered into an agreement with ABI pursuant to which we agreed to transfer to ABI our businesses in Colombia, Peru and Ecuador. In exchange, ABI has agreed to transfer SAB's Panamanian business to us. We formally began operations in Panama on December 31, 2016. According to our estimates, we currently lead the beer market in Panama. The main packaging presentations are 285-milliliter bottles and 355-milliliter cans and our main beer brands in Panama are *Atlas Golden Light* and *Balboa Ice*. The main competitor in the Panamanian beer market is Baru. According to our estimates, the total annual sales volume of the Panamanian beer market was 3.7 million hectoliters in 2022. Our Panamanian business also produces and commercializes soft drinks, under franchise, being *Pepsi*, *Canada Dry* and *Squirt* the main brands distributed. In Panama, the annual sales volume of the CSD market was 1.3 million hectoliters in 2022.

[**Table of Contents**](#TableOfContents)

In May 2018, our Board of Directors approved the distribution, sale and marketing of the brand *Budweiser* in Panama, which has helped on the strategy of growing the market segment of beers priced higher than the core segment.

**The Caribbean Beer Market**

In Cuba, our main packaging presentation is the 12-ounce can. Our main competitor in Cuba is State Brewery. We currently sell the *Bucanero*, *Cristal* and *Mayabe* local beer brands in Cuba. According to our estimates, the total annual sales volume of the Cuban beer market was approximately 1.9 million hectoliters in 2022.

In the Dominican Republic, the annual sales volume of the beer market was 4.7 million hectoliters in 2022, according to our estimates. The main packaging presentation in the Dominican beer market consists of the returnable 650-milliliter and 1-liter glass bottles, which are predominantly sold in small retail stores. We currently lead the beer market in the Dominican Republic after our acquisition of CND, with a leading portfolio of brands such as *Presidente*, *Presidente Light, Brahma Light*, *Bohemia*, *The One*, *Corona*, *Modelo Especial*, *Stella Artois* and *Budweiser*. Our distribution system in the Dominican Republic is comprised mainly of direct distribution operations.

In Barbados, the annual sales volume of the beer market was 0.1 million hectoliters in 2022, according to our estimates. We are the market leader in terms of sales volume according to our estimates, with brands such as *Banks* and *Deputy*, which are produced locally by BHL. The main packaging presentation in Barbados is the 250-milliliter and 275-milliliter returnable glass bottles.

**The Caribbean CSD Market**

According to our estimates, the annual sales volume of the Dominican CSD market was 4.4 million hectoliters in 2022. The main packaging presentation in the Dominican CSD market is the returnable half-liter bottle, in either glass or PET format, which is predominantly sold in small retail stores. Ajegroup, which adopts a low-price strategy has the leadership of the Dominican CSD Market, followed by The Coca-Cola Company, represented by Bepensa. We are currently the third player in that market in terms of sales volume according to our estimates.

Our main CSD brands in the Dominican Republic are Red Rock, Pepsi-Cola and Seven Up, all of which are marketed under an exclusive bottling agreement with PepsiCo. Our distribution system in the Dominican Republic is comprised of direct distribution operations and third-party distributors.

Latin America South

**Argentina**

Argentina is one of our most important regions, second only to Brazil in terms of volume.

We serve more than 300 thousand points of sale throughout Argentina both directly and through our exclusive third-party distributors.

**The Argentine Beer Market**

According to our estimates, the annual sales volume of the Argentine beer market was 22.7 million hectoliters in 2022. With a population of approximately 46 million, Argentina is Latin America South's largest and most important beer market.

In Argentina, 37% of our beer volume is distributed directly by us and 63% is distributed through exclusive third-party distributors. Our main package presentation in Argentina is the 1-liter returnable glass bottles, which accounted for 54% of our sales in 2022.

[**Table of Contents**](#TableOfContents)

According to our estimate, the on-premises consumption represented 7.9% of beer volumes in Argentina in 2022, and supermarkets sales represented 15.4% of beer volumes. The main channels of volume consumption in Argentina are through kiosks and small grocery stores.

Our most important beer brands in Argentina are *Brahma, Quilmes Clásica* and *Budweiser*. According to Scentia, we are the leading beer producers in Argentina, and our main competitor in Argentina is Compañía Cervecerías Unidas S.A.

***The Argentine CSD Market***

According to our estimates, in 2022, annual sales volume of the Argentine CSD market was 45.2 million hectoliters. In Argentina, 49% of our CSD volume is distributed directly by us and 51% is distributed through exclusive third-party distributors. Non-returnable bottles represented 80% of our CSD sales in Argentina in 2022.

We are the exclusive Pepsi bottlers in Argentina and our most important CSD brands in that country are *Pepsi-Cola* and *Seven-Up*. According to Scentia, we are the second player in the Argentine CSD market in 2022, only after The Coca-Cola Company.

**Bolivia**

**The Bolivian Beer Market**

According to our estimates, the annual sales volume of the Bolivian beer market was 4.0 million hectoliters in 2022. The Bolivian market is strongly influenced by macroeconomic trends and governmental regulatory and fiscal policies.

In Bolivia, 49% of our beer volumes is directly distributed by us and 51% is distributed through exclusive third-party distributors. Our main package presentation in Bolivia is the 620-milliliter returnable glass bottle, which accounted for 43% of our sales in 2022.

Our most important beer brands in Bolivia are *Paceña*, *Taquiña* and *Huari*. According to estimates, we are the leading beer producer in Bolivia.

***The Bolivian CSD Market***

In March 2009, we, through Quinsa, acquired from SAB 100% of Bebidas y Aguas Gaseosas Occidente S.R.L., becoming the exclusive bottler of Pepsi in Bolivia.

According to our estimates, in 2022, the annual sales volume of the Bolivian CSD market was 10.1 million hectoliters. Of our total CSD volumes in Bolivia in 2022, 87% was directly distributed by us and 13% was distributed through exclusive third-party distributors, while all our CSD sales in that country in 2022 were through non-returnable bottles.

**Chile**

According to our estimates, the annual sales volume of the Chilean beer market was 11.5 million hectoliters in 2022. Beer consumption in Chile has increased every year since 2009, except for 2017 and 2022. Our most important beer brands in Chile are *Corona*, *Budweiser*, *Becker*, *Stella Artois* and *Cusqueña*.

We are the second beer producers in Chile, according to our estimates, and our main competitor and the leader in the country is Compañía Cervecerías Unidas S.A.

In 2015, we became the exclusive distributors of the *Corona* brand in Chile, and since January 2016 we also started to import and distribute *Budweiser* in Chile, followed by *Cusqueña* in 2018.

**Paraguay**

According to our estimates, the annual sales volume of the Paraguayan beer market was 5.0 million hectoliters in 2022, excluding smuggling.

[**Table of Contents**](#TableOfContents)

The market for beer in Paraguay has traditionally distinguished itself from those in the southern cone countries in certain respects because (1) beer has not faced significant competition from wine as an alternative alcoholic beverage; (2) the domestic beer market has faced significant competition from imported brands, which accounted for a far higher market share in Paraguay than in neighboring countries; and (3) the seasonality of our products is lower due to warmer conditions throughout the year.

In Paraguay, 67% of our beer volumes is directly distributed by us and 33% is distributed through exclusive third-party distributors. Our main package presentation in Paraguay is the 940-millimeter returnable glass bottle, which accounted for 48% of our sales in 2022.

Our most important beer brands in Paraguay are *Brahma*, *Pilsen*, *Skol* and *Ouro Fino*, with a leader market position in the country in 2022, according to our estimates. We are also the exclusive distributor of the *Budweiser* brand in Paraguay.

**Uruguay**

**The Uruguayan Beer Market**

According to our estimates, the annual sales volume of the Uruguayan beer market was 1.1 million hectoliters in 2022. Our Latin America South business unit manages both the beer and CSD businesses in Uruguay out of a facility based in that country.

In Uruguay, 22% of our beer volumes is directly distributed by us and 78% is distributed through exclusive third-party distributors. Our main package presentation in Uruguay is the 1-liter returnable glass bottle, which accounted for 50.0% of our sales in 2022.

Our most important beer brands in Uruguay are *Pilsen* and *Patricia*, with a leading market position in 2022, according to our estimates.

**The Uruguayan CSD Market**

According to our estimates, in 2022, the annual sales volume of the Uruguayan CSD market was 3.6 million hectoliters.

In Uruguay, 38% of our CSD volume is directly distributed by us and 62% is distributed through exclusive third-party distributors. Non-returnable bottles accounted for 97.4% of our sales in that country in 2022. Our most important brand in Uruguay is *Pepsi-Cola*, with The Coca-Cola Company being our main competitor.

**Canada**

**The Canadian Beer Market**

Our Canada business segment is represented by the Labatt operations, which sells domestic and ABI beer brands, a portfolio of ready-to-drink and cider brands and exports the *Kokanee* beer brand to the United States.

According to our estimates, Labatt is the market leader in the Canadian beer market. The main packaging presentations in that country are the 355-milliliter and the 473-milliliter aluminum cans, which are predominantly sold in privately owned and government-owned retail stores in addition to privately owned on-trade establishments. Our main competitor in Canada is Molson, but we also compete with smaller brewers, such as Sleeman Breweries Ltd., or Sleeman, and Moosehead Breweries Ltd.

Our main brands in Canada are *Budweiser*, *Bud Light*, *Michelob Ultra* and *Busch* (brewed and sold under license from ABI's subsidiary Anheuser-Busch, Inc., or Anheuser-Busch), along with *Corona*, *Labatt Blue*, *Alexander Keith's*, *Stella Artois* and *Kokanee*. Our distribution system in Canada is structured in different ways across the country, as further explained below.

[**Table of Contents**](#TableOfContents)

**Other Canadian Markets**

The ready-to-drink beverages (RTD) industry in Canada declined low-single digit in 2022, after two years of unprecedent growth. Labatt's RTD portfolio in Canada includes the *Nutrl, Bud Light Seltzer, Palm Bay* and *Mike's* brands.

**Distribution in Ontario**

In Ontario, the province with the largest beer consumption in Canada, we own together with other brewers a distribution and retail company incorporated in 1927 named Brewers Retail Inc., operating as The Beer Store, or TBS. In 2015, we finalized a new Master Framework Agreement, or MFA, with the government of the Province of Ontario that specifies TBS's role as a retailer and distributor of beer.

Under the MFA, TBS continues to be the primary retailer for pack sizes larger than six bottles or cans of beer. The Liquor Control Board of Ontario, or LCBO, a chain of liquor stores owned by the government of the Province of Ontario, continues to have the ability to sell beer. Most LCBO stores are limited to selling pack sizes of six bottles or cans of beer or less. Under the MFA up to 450 grocery stores may also be granted a license to sell beer in pack sizes of six bottles or cans or less. The MFA came into force on January 1, 2016 and has an initial term of ten years, subject to renewal for successive five-year terms, unless the agreement is terminated after the initial term in accordance with the MFA.

TBS ownership is available to all qualifying Ontario-based brewers. TBS's 15-member Board of Directors is made up of the following members: four directors nominated by Labatt; four directors nominated by Molson; four independent directors initially nominated by a selection committee jointly represented by the Province of Ontario, Labatt and Molson and now nominated by a majority vote of the independent directors; two directors nominated by larger brewer shareholders (other than Labatt and Molson) with TBS sales greater than 50,000 hectoliters per year; and one director nominated by smaller brewer shareholders with TBS sales less than 50,000 hectoliters per year.

TBS operates as a self-funding corporation on a break-even cash flow basis under which it charges volume-based fees for services it provides to the brewers. The nature of TBS's business requires compliance with laws and regulations and oversight by the Province of Ontario and its agents, the Alcohol and Gaming Commission of Ontario, or AGCO, and the LCBO. The Liquor Licencing and Control Act and its regulations are administered by the AGCO, which is an Ontario provincial regulatory agency reporting to the Ministry of the Attorney General and affiliated with the Ministry of Finance. The Province of Ontario and its agents, the AGCO and LCBO, oversee all aspects of the beverage alcohol sector.

**Distribution in Quebec**

Quebec is the province in Canada with the second largest beer consumption. In this province there are no exclusive rights for the sales of beer, and both the on-premise and off-premise sales channels are mostly comprised of privately owned stores. The SAQ, a government-operated liquor store, sells a select few beer brands that are not available in the private retail system.

We (as well as our competitors) sell our products in Quebec through a direct sales and distribution system.

**Distribution in the Western Provinces**

Molson and Labatt are each a shareholder in Brewers Distributor Limited, which operates a distribution network primarily for beer in the four western provinces of British Columbia, Alberta, Manitoba and Saskatchewan, as well as three territories (Yukon, the Northwest Territories and Nunavut). In Alberta, some volume is also sold through a third-party wholesaler. In these Western Provincial markets, there are both privately controlled retail stores (such as in Alberta and British Columbia) and government-controlled retail stores (such as in British Columbia, Manitoba and Saskatchewan).

**Distribution in the Atlantic Provinces**

We distribute and sell our products in the Atlantic Provinces (including New Brunswick, Newfoundland, Nova Scotia and Prince Edward Island) through (1) distribution and retail networks controlled by the government in the provinces of Nova Scotia, New Brunswick and Prince Edward Island; and (2) private distributors in Newfoundland.

[**Table of Contents**](#TableOfContents)

**Beer and CSD Production Process**

The basic brewing process for most beers is straightforward, but significant know-how is involved in quality and cost control. The most important stages are brewing and fermentation, followed by maturation, filtering and packaging. Although malted barley (malt) is the primary ingredient, other grains such as unmalted barley, corn, rice or wheat are sometimes added to produce different beer flavors. The proportion and choice of other raw materials varies according to regional taste preferences and the type of beer.

The first step in the brewing process is making wort by mixing malt with warm water and then gradually heating it to approximately 75°C in large mash turns to dissolve the starch and transform it into a mixture, called "mash," of maltose and other sugars. The spent grains are filtered out and the liquid, now called "wort," is boiled. Hops are added at this point to give a special bitter taste and aroma to the beer and help preserve it. The wort is boiled for one to two hours to sterilize and concentrate it and extract the flavor from the hops. Cooling follows, using a heat exchanger. The hopped wort is saturated with air or oxygen, essential for the growth of the yeast in the next stage.

Yeast is a micro-organism that turns the sugar in the wort into alcohol and carbon dioxide. This process of fermentation takes five to eleven days, after which the wort finally becomes beer. Different types of beer are made using different strains of yeast and wort compositions. In some yeast varieties, the cells rise to the top at the end of fermentation. Ales and wheat beers are brewed in this way. Pilsen beers are made using yeast cells that settle to the bottom.

During the maturation process the liquid clarifies as yeast and other particles settle. Further filtering gives the beer more clarity. Maturation varies by type of beer and can take as long as three weeks. Then the beer is ready for packaging in kegs, cans or bottles.

CSDs are produced by mixing water, flavored concentrate and sugar or sweetener. Water is processed to eliminate mineral salts and filtered to eliminate impurities. Purified water is combined with processed sugar or, in the case of diet CSDs, with artificial sweeteners and concentrate. Carbon dioxide gas is injected into the mixture to produce carbonation. Immediately following carbonation, the mixture is packaged. In addition to these inputs, delivery of the product to consumers requires packaging materials such as PET bottles, aluminum cans, labels and plastic closures.

For information on our production facilities, see "—D. Property, Plant and Equipment."

**Sources and Availability of Raw Materials**

The COVID-19 pandemic had significant changes in consumer behavior and channel dynamics as governments-imposed restrictions that varied in terms of scope and intensity in response to the virus spread. As out-of-home consumption occasions gradually increased in 2021 and 2022, the demand for glass bottled packaging increased significantly, pressuring the supply chain and generating punctual product shortages.

Beer

The main raw materials used in our production are malt, non-malted cereals, hops and water.

**Barley and Malt** 

Malt is widely available, and our malt requirement is met by domestic and international suppliers as well as our own six malting facilities. In the case of our beer operations in Brazil, approximately 75% of our malt needs are supplied by our own malting facilities located in the south of Brazil, Argentina and Uruguay.

For the remaining malt demand, our main supplier is *Cooperativa Agroindustrial Agraria*, located in the State of Paraná in Brazil. Market prices for malt are volatile and depend on the quality and the level of production of the barley crop across the world, as well as on the intensity of demand.

[**Table of Contents**](#TableOfContents)

The barley used in our malting facilities is bought directly from South America farmers. Barley prices depend on local winter crop markets, wheat market prices on the main boards of trade across the world and on the barley quality during the harvest.

To avoid the impact of short-term volatility in barley and malt prices on our production costs, we enter into future contracts or financials instruments. See "Item 11. Quantitative and Qualitative Disclosures about Market Risk."

**Hops**

There are two types of hops used in our beer production: hops used to give beer its distinctive bitter flavor, which we generally import from the United States, and hops used to give beer its distinctive aroma, which we generally import from Europe. Hops industry is concentrated in a few international suppliers, such as Barth-Haas Group and Hopsteiner.

**Non-malted Cereals**

Non-malted cereals are purchased from domestic suppliers, the most relevant of which are *Ingredion, Cargill Agrícola, Louis Dreyfus Commodities* and *Arrozeira Pelotas*. Corn and rice grow in several regions in Brazil and are generally widely available.

To avoid the impact of short-term volatility in corn prices on our production costs, we enter into financials instruments. See "Item 11. Quantitative and Qualitative Disclosures about Market Risk."

**Water**

Water represents a small portion of our raw material costs. We obtain our water requirements from several sources, such as: lakes and reservoirs, deep wells located near our breweries, rivers adjoining our plants and public utility companies. We monitor the quality, taste and composition of the water we use, and treat it to remove impurities and to comply with our high-quality standards and applicable regulations. As a result of advances in technology, we have continuously reduced our water consumption per hectoliter produced.

Non-alcoholic Beverages

The main raw materials used in our production are concentrate (including guaraná extract), sugar, sweetener, juices, water and carbon dioxide gas. Most of these materials are obtained from local suppliers.

**Guaraná Berries**

We have a 1,070-hectare farm that provides us with 5-tons of guarana seeds (roasted grains) per year, or about 2% of our needs, with the balance currently being purchased directly from farmers and their organizations in Maués, with the remainder purchased directly from independent farmers in the Amazon region as well as other regions in Brazil where guaraná is available. The focus of our own farm is to supply Guaraná seedlings to local producers and to promote the sustainable cultivation of Guaraná in the Amazon Region. About 14 thousand seedlings are donated each year.

**Concentrates**

We have a concentrate facility in the north of Brazil which produces the concentrates to meet our requirements for the production of our proprietary brand Guaraná Antarctica among others. The concentrate for Pepsi CSD products is purchased from PepsiCo.

**Sugar**

Sugar is widely available and is purchased by our regional sourcing entity. We use sugar in our CSD products mainly in Brazil, Argentina, Bolivia, Uruguay, and the Caribbean. To avoid the impact of short-term volatility in sugar prices on our production costs, we enter into derivative instruments. See "Item 11. Quantitative and Qualitative Disclosures about Market Risk."

[**Table of Contents**](#TableOfContents)

**Juices**

Orange, lemon, grape, apple, and other juices used in our CSD, and juices products are purchased in Brazil. We also use lemon and grapefruit juices in our CSD products in Argentina and Uruguay. Our main suppliers are Louis Dreyfus Commodities, Cutrale, Citrus Juice, Litoral Citrus and San Miguel.

**Other**

We buy all of the fruit juice, pulp and concentrate that we use in the manufacture of our fruit flavored CSDs.

**Packaging**

Packaging costs are comprised of the cost of glass and PET bottles, aluminum cans, plastic film (shrink and stretch), paper labels, plastic closures, metal crowns and paperboard, and other materials. To mitigate the risks of short-term volatility in aluminum and some other packaging materials prices on our production costs, we enter into derivative instruments; for further information on this matter see "Item 11. Quantitative and Qualitative Disclosures About Market Risk." We also set a fixed price for the period in accordance with the prevailing macroeconomic conditions for some materials.

In April 2008, we started operating a glass bottle producing facility in Rio de Janeiro, which we expanded in November 2015. This unit's capacity is of approximately 255 thousand tons of glass and in 2022 such unit attended approximately 35% of our glass needs in Brazil.

We have supply contracts with respect to most packaging materials. The choice of packaging materials varies by cost and availability in different regions, as well as consumer preferences and the image of each brand.

Our aluminum cans are mainly sourced regionally by global companies, while our glass containers are sourced by a variety of suppliers, both regionally and globally. Also, in September 2020, we opened our can plant facility in the state of Minas Gerais, which has a production capacity of 2.5 billion cans per year. Our can plant served approximately 15% of our can needs in 2022 in Brazil.

We obtain the labels for our beer and CSD primarily from local suppliers; in Brazil, the majority of our beer label requirements are met by a printing house that belongs to FAHZ and is operated by us pursuant to a lease agreement. Plastic closures are principally purchased regionally, and PET pre-forms are principally purchased regionally by both local and global companies. Crown caps in Brazil are mainly sourced from our vertical operation in Manaus, Arosuco. These producers also supply some of our other Latin American operations.

**Regulation**

All our operations are subject to local governmental regulation and supervision, including (1) labor laws; (2) social security laws; (3) public health, consumer protection and environmental laws; (4) securities laws; (5) antitrust laws; (6) foreign exchange laws; and (7) international sanctions and embargoes. In addition, we may also be subject to regulations aimed at (1) ensuring healthy and safe conditions in facilities for the production, bottling, and distribution of beverages and (2) placing restrictions on beer and CSD consumption.

Environmental laws in the countries where we operate are mostly related to (1) the conformity of our operating procedures with environmental regulation and standards regarding, among other issues, the use of water resources, the emission of gas and liquid effluents, environmental permits and (2) the management and disposal of one-way packaging.

Governmental restrictions on beer consumption in the markets where we operate vary from one country to another, and in some instances, from one local region to another. The most relevant restrictions are:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; each country or province has a minimum legal drinking age that is established by the government; the beer legal drinking age varies from 18 to 21 years;

[**Table of Contents**](#TableOfContents)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; some local and federal governments require that retail stores own special licenses for the sale of alcohol; this is the case in some regions of Argentina, Bolivia, Chile, Panama and Canada;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; some local and federal governments (including Bolivia, Argentina, Uruguay and Canada) prohibit the sale of alcoholic beverages within a certain distance from schools, hospitals and other designated areas, as well as place certain restrictions on the time of sale and consumption of these products in public places and private clubs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; some local governments in Canada establish a minimum price for beer sales, which is named Social Reference Price, or SRP. There is a specific SRP for each different packaging presentation. The SRP may vary from one province to another;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; in some provinces in Canada the off-trade is restricted to government-owned or licensed stores. See "—Business Overview—Description of the Markets Where We Operate—Canada – Labatt"; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp; beer sales in the off-premise channel in Canada in the Province of Ontario are restricted to three retail channels. One of them is the LCBO, which is government-owned. The second retail channel is TBS, which is jointly owned by Labatt and 33 other brewers. The third retail channel is eligible grocery. The Alcohol and Gaming Commission of Ontario regulates the alcohol industry.

Many governments also impose restrictions on beer advertisement, which may affect, among other issues, (1) the media channels used, (2) the contents of advertising campaigns, which may also include restrictions to influencer marketing campaigns, and (3) the time and places where beer can be advertised.

**Marketing**

Our marketing initiatives are concentrated in off-trade and on-trade initiatives. Off-trade initiatives comprise mass media vehicles, such as television, radio, magazines and internet websites. On-trade initiatives include banners, and all types of enhancements to the point of sale, such as branded coolers and decorated furniture.

**Licenses**

Pepsi

We have a long-term agreement with PepsiCo whereby we have been granted the exclusive right to bottle, sell and distribute certain brands of PepsiCo's portfolio of CSDs in Brazil, including Pepsi-Cola, Gatorade, H2OH!, and Lipton Ice Tea. We are also, through our subsidiaries, PepsiCo's bottler for Argentina, Uruguay, Bolivia and Dominican Republic. In 2022, sales volumes of PepsiCo products represented approximately 34% of our total NAB sales volumes in Brazil, 53% of our total NAB sales volumes in the Dominican Republic and 96% of our NAB sales volumes in Argentina, 96% in Bolivia and 99% in Uruguay.

Red Bull

We have a long-term distribution agreement with Red Bull, providing for the exclusive right to sell and distribute certain brands of Red Bull's portfolio in specific limited points of sale of the on-trade channel in Brazil. We also have agreements with Red Bull to distribute their portfolio in a few limited channels in Argentina and the Dominican Republic.

Licensing Agreements with ABI

Effective January 1998, Labatt entered into long-term licensing agreements with ABI whereby Labatt was granted the exclusive right and license to manufacture, bottle, sell, distribute and market some of ABI's brands, including the *Budweiser* and *Bud Light* brands, in Canada, including the right to use ABI's trademarks for those purposes. The agreements expire in January 2098 and are renewable by either party for a second term of 100 years. In 2022, the ABI brands sold by Labatt represented approximately 58% of Labatt's total sales volumes. According to our estimates, the *Budweiser* brand is currently the largest selling brand, while *Bud Light* is the third largest selling brand, in Canada in terms of volume.

[**Table of Contents**](#TableOfContents)

We also have a licensing agreement with ABI which allows us to exclusively produce, distribute and market *Budweiser* in Brazil. We also have certain arrangements to sell and distribute *Budweiser* products in Paraguay, Guatemala, Dominican Republic, El Salvador, Nicaragua, Uruguay and Chile.

Furthermore, we have a cross-licensing agreement with ABI through which we are allowed to produce, bottle, sell and distribute beer under the *Stella Artois* and *Becks* brands in Latin America and Canada on an exclusive basis, and ABI is allowed to produce, bottle, sell and distribute beer under the brand Brahma in Europe, Asia, Africa and the United States on an exclusive basis. Ambev has agreed not to produce directly or indirectly, bottle, distribute, sell or resell (or have an interest in any of these), any other European premium branded beer in Latin America, and ABI has agreed to be bound by the same restrictions relating to any other Latin American premium branded beer in Europe, Asia, Africa and the United States. As a result, in June 2005 we launched *Stella Artois* in Brazil and, since March 2005, ABI has been distributing *Brahma* beer in the United States and several countries such as the United Kingdom, Spain, Sweden, Finland and Greece.

In addition, we have a licensing agreement with Grupo Modelo, S. de R.L. de C.V. ("Cervecería Modelo" - formerly Grupo Modelo, S.A.B. de C.V.), a subsidiary of ABI, to produce, import, promote and resell Corona products (*Corona Extra*, *Corona Light*, *Coronita*, *Pacifico* and *Negra Modelo*) in Latin America countries, including Brazil, as well as in Canada.

We also have a licensing agreement with Spaten-Franziskaner-Bräu GmbH, a subsidiary of ABI, to produce, promote, advertise and sell Spaten in Brazil.

We have ABI's subsidiary, Metal Container Corporation, as one of our can suppliers.

**Taxation**

Beer

Taxation on beer in the countries where we operate is comprised of different taxes specific to each jurisdiction, such as an excise tax and a value-added tax. The amount of sales tax charged on our beer products in 2022, represented as a percentage of gross sales, was: 41.7% in Brazil; 22% in Canada; 11.1% in Central America; 41.0% in the Dominican Republic; 14.5% in Panama; 1.0% in Cuba; 10.8% in Barbados; 15.8% in Argentina; 36.5% in Bolivia; 23.9% in Chile; 11.6% in Paraguay; and 31.8% in Uruguay.

NAB

Taxation on NAB in the countries where we operate is comprised of taxes specific to each jurisdiction, such as an excise tax and a value-added tax. The amount of taxes charged on our NAB products in 2022, represented as a percentage of gross sales, was: 34.6% in Brazil; 18.0% in the Dominican Republic; 7.0% in Panama; 12.2% in Argentina; 27.3% in Bolivia; and 29.3% in Uruguay.

Changes to Brazilian Taxes on Beverages

In May 2018, the Brazilian Federal Government enacted Decree No. 9,394/2018 reducing IPI Excise Tax rate applicable to transactions with concentrate units to 4% and, in so doing, effectively reduced the value of the IPI Excise Tax presumed credits that we had recorded on acquisitions of soft drinks concentrates from companies located in the Manaus Free Trade Zone. Since then, other decrees were issued with temporary rates applicable to transactions with concentrate units. In 2022, Brazilian Federal Government altered once again the IPI Excise Tax rates levied on transactions with several products, including beer, soft drinks and soft drinks concentrate units. As for concentrate units, the tax rate was set at 8% (Decree No. 11,182/2022).

[**Table of Contents**](#TableOfContents)

In 2022, the States of Acre, Alagoas, Amazonas, Bahia, Maranhão, Paraná, Pará, Piaui, Rio Grande do Norte, Roraima, Sergipe, Tocantins increased their ICMS Value-Added Tax rate applicable to beer and/or soft drinks (increases ranging from 1% to 4%), while both the States of Minas Gerais and Rio de Janeiro decreased their ICMS value-Added Tax rates with effect from early 2023 (decreases of 2% and 1%, respectively).

C.&nbsp;&nbsp;&nbsp;&nbsp; Organizational Structure

Our direct controlling shareholder, ABI, together with FAHZ, held in aggregate 72.0% of our total and voting capital stock (excluding treasury shares) as of December 31, 2022.

ABI indirectly holds shares in us representing 61.8% of our total and voting capital stock (excluding treasury shares) as of December 31, 2022. ABI thus has control over us, even though (1) ABI is subject to the Shareholders' Agreement and (2) ABI is controlled by Stichting that represents an important part of interests of BRC and the Interbrew Founding Families. For further information on these matters see "Item 4. Information on the Company—A. History and Development of the Company—The InBev-Ambev Transactions" and "Item 7. Major Shareholders and Related Party Transactions—A. Major Shareholders—Ambev's Major Shareholders—The Shareholders' Agreement."

We conduct the bulk of our operations in Brazil directly. We also indirectly control Labatt and the operations conducted by our CAC and Latin America South units. The following chart illustrates the ownership structure of our principal subsidiaries as of December 31, 2022 based on total share capital owned.

**Organizational Structure**

[**Table of Contents**](#TableOfContents)

![](abevform20f2022_002.jpg)

[**Table of Contents**](#TableOfContents)

**D. Property, Plant and Equipment**

Our properties consist primarily of brewing, soft drink production, malting, bottling, distribution and office facilities in the countries where we operate.

As of December 31, 2022, our aggregate beer and non-alcoholic beverages production capacity was 240.1 million hectoliters per year. In 2022, the total production at the facilities set forth below was equal to 179.9 million hectoliters.

The following is a list of our main production facilities as of December 31, 2022:

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Brazil** |  |
| &nbsp;&nbsp;**Plant** | &nbsp;&nbsp;**Type of Plant** |
| Almirante Tamandaré, Paraná | Soft Drinks |
| Anápolis, Goiás | Mixed |
| Aquiraz, Ceará | Mixed |
| Camaçari, Bahia | Mixed |
| Cuiabá, Mato Grosso | Mixed |
| Estancia, Sergipe | Mixed |
| Guarulhos, São Paulo | Beer |
| Itapissuma, Pernambuco | Mixed |
| Jacareí, São Paulo | Beer |
| Jaguariúna, São Paulo | Mixed |
| Juatuba, Minas Gerais | Mixed |
| Jundiai, São Paulo | Soft Drinks |
| Lages, Santa Catarina | Beer |
| Cachoeiras de Macacu, Rio de Janeiro | Mixed |
| Manaus, Amazonas | Mixed |
| Pirai, Rio de Janeiro | Mixed |
| Ponta Grossa, Paraná | Beer |
| Rio de Janeiro, Rio de Janeiro | Mixed |
| São Luis, Maranhão | Beer |
| Sapucaia do Sul, Rio Grande do Sul | Soft Drinks |
| Sete Lagoas, Minas Gerais | Mixed |
| Teresina, Piauí | Mixed |
| Uberlândia, Minas Gerais | Beer |
| Viamão, Rio Grande do Sul | Mixed |
| Crown Manaus, Amazonas | Crown Cap |
| Glass Rio, Rio de Janeiro | Glass Bottles |
| Label São Paulo, São Paulo | Labels |
| Malt. Navegantes, Rio Grande do Sul Malt | Malt |
| Malt. Passo Fundo, Rio Grande do Sul | Malt |
| Cans Minas, Minas Gerais | Cans |
| Contagem, Minas Gerais | Bag in box Plant |
| SAZ Zitec Research Pilot Brewery, Rio de Janeiro | Research Plant |
| Wals, Minas Gerais Beer | Beer |
| Colorado, São Paulo Beer | Beer |
| Bohemia, Rio de Janeiro Beer | Beer |
| Pratinha, São Paulo Beer | Beer |
| Joao Pessoa, Paraíba | CO2 Plant |
| SD Aromas, Manaus | Soft Drinks Kits |

---

[**Table of Contents**](#TableOfContents)

---

| | |
|:---|:---|
| &nbsp;&nbsp;**CAC** | &nbsp;&nbsp;**CAC** |
| &nbsp;&nbsp;**Plant&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;** | &nbsp;&nbsp;**Type of Plant** |
| Ambev Centroamerica, Guatemala | Beer |
| Santo Domingo, Dominican Republic | Mixed |
| Hato Nuevo, Dominican Republic | Mixed |
| Saint Vincent | Mixed |
| Cuba | Mixed |
| Barbados | Mixed |
| Panama | Mixed |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Latin America South** | &nbsp;&nbsp;**Latin America South** |
| &nbsp;&nbsp;**Plant&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;** | &nbsp;&nbsp;**Type of Plant** |
| Acheral, Argentina | Beer |
| Cordoba, Argentina | Soft Drinks |
| Corrientes, Argentina | Mixed |
| Manantial, Argentina | Soft Drinks |
| Mendoza, Argentina | Beer |
| Pompeya, Argentina | Beer |
| Quilmes, Argentina | Beer |
| Cerveceria Argentina, Argentina | Beer |
| Cochabamba, Bolivia | Beer |
| El Alto, Bolivia | Soft Drinks |
| Huari, Bolivia | Beer |
| La Paz, Bolivia | Beer |
| Sacaba, Bolivia | Soft Drinks |
| Santa Cruz, Bolivia | Beer |
| Santiago, Chile | Beer |
| Ypane, Paraguay | Beer |
| Minas, Uruguay | Beer |
| Montevideo, Uruguay | Mixed |
| Malt. Pampa, Argentina | Malt |
| Crown Coroplas, Argentina | Crown Cap |
| Malt Tres Arroyos, Argentina | Malt |
| Can Oruro, Bolivia | Cans |
| Glass Ypane, Paraguay | Glass Bottles |
| Malt Nueva Palmira, Uruguay | Malt |
| Malt Paysandu, Uruguay | Malt |
| Hop Fernandez Oro, Argentina | Hops Pellets |
| Zarate Research Pilot Brewery, Argentina | Research Plant |
| Patagonia, Argentina | Beer |
| Dante Robino, Argentina | Wine |
| Tarija, Bolivia | Beer |

---

[**Table of Contents**](#TableOfContents)

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Canada** | &nbsp;&nbsp;**Canada** |
| &nbsp;&nbsp;**Plant&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;** | &nbsp;&nbsp;**Type of Plant** |
| St. John's | Beer |
| Halifax | Beer |
| Montreal | Beer/RTD |
| London | Beer/RTD |
| Edmonton | Beer/RTD |
| Creston | Beer |
| Mill Street | Beer/Spirits |
| Turning Point | Beer/RTD/Cider |
| Archibald | Beer |
| Alexander Keith | Beer |
| Goodridge & Williams | RTD/Spirits |
| Banded Peak | Beer |

---

[**Table of Contents**](#TableOfContents)

ITEM 4A. UNRESOLVED STAFF COMMENTS

Not applicable.

[**Table of Contents**](#TableOfContents)

ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS

A.&nbsp;&nbsp;&nbsp;&nbsp; Operating Results

**Introduction**

The following management's discussion and analysis of financial condition and results of operations should be read in conjunction with our audited consolidated financial statements included elsewhere in this annual report on Form 20-F. This annual report contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those discussed in the forward-looking statements as a result of various factors including, without limitation, those set forth in "Cautionary Statement Regarding Forward-Looking Information" and the matters set forth in this annual report generally.

We have prepared our audited consolidated financial statements as of December 31, 2022, 2021 and for the three years ended December 31, 2022 in *reais* and in accordance with IFRS as issued by the IASB.

The financial information and related discussion and analysis contained in this item are in accordance with IFRS as issued by the IASB. The amounts are in million *reais*, unless otherwise stated.

**Impact of Ongoing COVID-19 Pandemic**

The impact of the pandemic on our operations and the restrictions imposed in response by national governments, especially since March 2020, have generated significant changes in market dynamics both in the off-trade sales channel, mainly comprised of supermarkets, and in the on-trade channel, which consists of bars and restaurants. In each case, the more severe the restrictions on the marketing and consumption of our products, the greater the reduction in volume, which is why Bolivia and Panama were the most affected countries, especially in fiscal year 2021. On the other hand, we observed an increase in sales related to e-commerce in all countries, although this channel represents a small portion of the Company's total volume.

In early 2022, our operations, mainly in Brazil, were impacted by the wave of the Omicron variant of COVID-19, which, combined with factors such as unfavorable weather, negatively impacted our sales. From the second quarter on, with the progress of the vaccination programs and the greater control over the advance of the COVID-19 pandemic, there was a relaxation of the restrictions in the regions in which we operate, favoring the recovery of the on-trade channel, despite the uncertainty about how the consumption recovery will evolve in each of these territories.

In Brazil, the consistent implementation of the Company's strategy combined with the context of relaxed restrictions and the return of occasions for out-of-home consumption generated a positive volume trend, with growth in both volume and net revenue compared to the same 2021 period. In the event that circumstances related to the COVID-19 pandemic evolve, government authorities may implement emergency measures to mitigate the spread of the disease. The pandemic and corresponding mitigation measures may have an adverse impact on global economic conditions as well as the Company's business. The extent of the pandemic COVID-19 impact on the Company's business will depend on future developments, such as the duration of further outbreaks, any possible trade shutdowns and restrictions, and the effectiveness of actions taken in the regions where we operate and in other countries to contain and treat the disease. As such events are highly uncertain, the Company cannot determine their financial impact at this moment. Any adverse impacts could result in a material adverse effect on our business, liquidity, financial condition and results of operations. However, we continue to manage our cash and capital resources with discipline and management concludes that there is no doubt about the Company's ability to continue operations.

See "Item 3.D. Key Information—Risk Factors—Risks Relating to Our Operations—The extent of the pandemic declared by the World Health Organization due to the spread of COVID-19, the perception of its effects or the way in which this pandemic will impact our business, depends on future developments which are highly uncertain and unpredictable, and may result in a material adverse effect on our business, financial condition, results of operations and cash flow", and other risk factors included herein and "—D. Trend Information" below.

[**Table of Contents**](#TableOfContents)

**Year Ended December 31, 2022 Compared to Year Ended December 31, 2021**

In the periods discussed below, we conducted our operations through four business segments as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· **Brazil**, which includes the beer sales division and the NAB sales division;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· **Central America and the Caribbean**, which includes our direct operations in the Dominican Republic,
Saint Vincent, Antigua, Dominica, Cuba, Guatemala (which also serves El Salvador, Honduras and Nicaragua), Barbados and Panama;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· **Latin America South**, which includes our operations in Argentina, Bolivia, Paraguay, Uruguay and
Chile; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· **Canada**, represented by Labatt's operations, which includes domestic sales in Canada and some
exports to the U.S. market.

The table below sets forth certain of our operating highlights for the years presented:

---

| | | | |
|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Consolidated Financial Highlights** | &nbsp;&nbsp; **Consolidated Financial Highlights** | &nbsp;&nbsp; **Consolidated Financial Highlights** |
|  | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **% Change** |
|  | &nbsp;&nbsp;***(in R$ million, except volume amounts, <br> percentages and per share amounts)*** | &nbsp;&nbsp;***(in R$ million, except volume amounts, <br> percentages and per share amounts)*** | &nbsp;&nbsp;***(in R$ million, except volume amounts, <br> percentages and per share amounts)*** |
| &nbsp;&nbsp;Sales volume—'000 hectoliters | &nbsp;&nbsp;185749.7 | &nbsp;&nbsp;180368.1 | &nbsp;&nbsp;3.0% |
| &nbsp;&nbsp;Net sales | &nbsp;&nbsp;79708.8 | &nbsp;&nbsp;72854.3 | &nbsp;&nbsp;9.4% |
| &nbsp;&nbsp;Net revenue per hectoliter—R$/hl | &nbsp;&nbsp;429.1 | &nbsp;&nbsp;403.9 | &nbsp;&nbsp;6.2% |
| &nbsp;&nbsp;Cost of sales | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(40422.1) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(35659.7) | &nbsp;&nbsp;13.4% |
| &nbsp;&nbsp;Gross profit | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 39286.7 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 37194.6 | &nbsp;&nbsp;5.6% |
| &nbsp;&nbsp;**Gross margin (%)** | &nbsp;&nbsp;**49.3%** | &nbsp;&nbsp;**51.1%** | &nbsp;&nbsp;180 bps |
| &nbsp;&nbsp;Sales, marketing and distribution expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (18732.7) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(16968.2) | &nbsp;&nbsp;10.4% |
| &nbsp;&nbsp;Administrative expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (5236.8) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4877.4) | &nbsp;&nbsp;7.4% |
| &nbsp;&nbsp;Other operating income/(expenses) net | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2513.9 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2124.1 | &nbsp;&nbsp;18.4% |
| &nbsp;&nbsp;Exceptional items | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (143.3) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (392.8) | &nbsp;&nbsp;(63.5%) |
| &nbsp;&nbsp;Income from operations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17687.9 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17080.3 | &nbsp;&nbsp;3.6% |
| &nbsp;&nbsp;**Operating margin (%)** | &nbsp;&nbsp;**22.2%** | &nbsp;&nbsp;**23.4%** | &nbsp;&nbsp;**120 bps** |
| &nbsp;&nbsp;Net income | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14891.2 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13122.6 | &nbsp;&nbsp;13.5% |
| &nbsp;&nbsp;**Net margin (%)** | &nbsp;&nbsp;**18.7%** | &nbsp;&nbsp;**18.0%** | &nbsp;&nbsp;**(70 bps)** |

---

*Margin Analysis*

The following table sets forth certain line items of our income statement expressed as percentages of net sales for the years ended December 31, 2022 and 2021:

---

| | | |
|:---|:---|:---|
|  | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** |
|  | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2021** |
|  | &nbsp;&nbsp;***(%)*** | &nbsp;&nbsp;***(%)*** |
| &nbsp;&nbsp;Net sales | &nbsp;&nbsp;100.0 | &nbsp;&nbsp;100.0 |
| &nbsp;&nbsp;Cost of sales | &nbsp;&nbsp;(50.7) | &nbsp;&nbsp;(48.9) |
| &nbsp;&nbsp;Gross profit | &nbsp;&nbsp;49.3 | &nbsp;&nbsp;51.1 |
| &nbsp;&nbsp;Sales, marketing and distribution expenses | &nbsp;&nbsp;(23.5) | &nbsp;&nbsp;(23.3) |
| &nbsp;&nbsp;Administrative expenses | &nbsp;&nbsp;(6.6) | &nbsp;&nbsp;(6.7) |
| &nbsp;&nbsp;Other operating income/(expenses) net | &nbsp;&nbsp;3.2 | &nbsp;&nbsp;2.9 |
| &nbsp;&nbsp;Exceptional items | &nbsp;&nbsp;(0.2) | &nbsp;&nbsp;(0.5) |
| &nbsp;&nbsp;Income from operations | &nbsp;&nbsp;22.2 | &nbsp;&nbsp;23.4 |

---

[**Table of Contents**](#TableOfContents)

***Selected Financial Data by Business Segment***

The following table sets forth selected financial data by business segment for the years ended December 31, 2022 and 2021:

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** |
|  | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** |
|  | &nbsp;&nbsp; **Brazil** | &nbsp;&nbsp; **CAC** | &nbsp;&nbsp; **LAS** | &nbsp;&nbsp; **Canada** | &nbsp;&nbsp; **Total** | &nbsp;&nbsp; **Brazil** | &nbsp;&nbsp; **CAC** | &nbsp;&nbsp; **LAS** | &nbsp;&nbsp; **Canada** | &nbsp;&nbsp; **Total** |
|  | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** |
| &nbsp;&nbsp;**Net sales** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 42635.7** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9440.1** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17371.2** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10261.7** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 79708.8** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 35586.5** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9947.4** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 16571.7** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10748.7** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 72854.3** |
| &nbsp;&nbsp;Cost of sales | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (22736.8) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4860.8) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (8553.1) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4271.4) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (40422.1) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (18309.1) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4727.9) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (8235.7) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4386.9) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (35659.7) |
| &nbsp;&nbsp;**Gross profit** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19898.9** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4579.3** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8818.1** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5990.3** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 39286.8** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17277.4** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5219.5** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8336.0** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6361.7** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 37194.6** |
| &nbsp;&nbsp;Sales, marketing, distribution and administrative expenses | (13522.0) | (1999.9) | (4421.4) | (4026.1) | (23969.4) | (11569.6) | (1993.7) | (4385.0) | (3897.3) | (21845.6) |
| &nbsp;&nbsp;Other operating income/ (expenses) | 2361.4 | (52.9) | 192.7 | 12.8 | 2513.9 | 2096.0 | 12.4 | 38.8 | (23.1) | 2124.1 |
| &nbsp;&nbsp;Exceptional items | (34.5) | (16.1) | (60.5) | (32.2) | (143.3) | (210.1) | (46.7) | (115.4) | (20.6) | (392.8) |
| &nbsp;&nbsp;**Income from operations** | **8703.7**  | **2510.5**  | **4528.9**  | **1944.7**  | **17687.8**  | **7593.7**  | **3191.5**  | **3874.4**  | **2420.7**  | **17080.3**  |

---

Net Sales

Net sales increased by 9.4% in 2022, to R$79,708.8 million from R$72,854.3 million in 2021, as a consequence of a 3.0% increase in volume sold, coupled with a 6.2% increase in net revenue per hectoliter, both driven by the continued execution of our commercial strategy, as shown in tables set forth below:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Net Sales<br> Year Ended December 31,** | &nbsp;&nbsp; **Net Sales<br> Year Ended December 31,** | &nbsp;&nbsp; **Net Sales<br> Year Ended December 31,** | &nbsp;&nbsp; **Net Sales<br> Year Ended December 31,** | &nbsp;&nbsp; **Net Sales<br> Year Ended December 31,** | &nbsp;&nbsp; **Net Sales<br> Year Ended December 31,** |
|  | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** |  |
|  | &nbsp;&nbsp; **Sales** | &nbsp;&nbsp; **% of Total** | &nbsp;&nbsp; **% of Total** | &nbsp;&nbsp; **Sales** | &nbsp;&nbsp; **% of Total** | &nbsp;&nbsp; **% Change** |
|  | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** |
| **Brazil** | &nbsp;&nbsp;**&nbsp;&nbsp;&nbsp;&nbsp; 42635.7** | &nbsp;&nbsp;**53.5%** | &nbsp;&nbsp;**53.5%** | &nbsp;&nbsp;**&nbsp;&nbsp;&nbsp;&nbsp; 35586.5** | &nbsp;&nbsp;**48.8%** | &nbsp;&nbsp;**19.8%** |
| &nbsp;&nbsp;&nbsp;&nbsp;Beer Brazil | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 35857.8 | &nbsp;&nbsp;45.0% | &nbsp;&nbsp;45.0% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30537.1 | &nbsp;&nbsp;41.9% | &nbsp;&nbsp;17.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;NAB | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6777.9 | &nbsp;&nbsp;8.5% | &nbsp;&nbsp;8.5% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5049.4 | &nbsp;&nbsp;6.9% | &nbsp;&nbsp;34.2% |
| **CAC** | &nbsp;&nbsp;**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9440.3** | &nbsp;&nbsp;**11.8%** | &nbsp;&nbsp;**11.8%** | &nbsp;&nbsp;**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9947.4** | &nbsp;&nbsp;**13.7%** | &nbsp;&nbsp;**(5.1%)** |
| **Latin America South** | &nbsp;&nbsp;**&nbsp;&nbsp;&nbsp;&nbsp; 17371.2** | &nbsp;&nbsp;**21.8%** | &nbsp;&nbsp;**21.8%** | &nbsp;&nbsp;**&nbsp;&nbsp;&nbsp;&nbsp; 16571.7** | &nbsp;&nbsp;**22.7%** | &nbsp;&nbsp;**4.8%** |
| **Canada** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **10261.7**  | &nbsp;&nbsp; **12.9%** | &nbsp;&nbsp; **12.9%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **10748.7**  | &nbsp;&nbsp; **14.8%** | &nbsp;&nbsp; **(4.5%)** |
| **Total** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **79708.8**  | &nbsp;&nbsp; **100.0%** | &nbsp;&nbsp; **100.0%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **72854.3**  | &nbsp;&nbsp; **100.0%** | &nbsp;&nbsp; **9.4%** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Sales Volumes<br> Year Ended December 31,** | &nbsp;&nbsp; **Sales Volumes<br> Year Ended December 31,** | &nbsp;&nbsp; **Sales Volumes<br> Year Ended December 31,** | &nbsp;&nbsp; **Sales Volumes<br> Year Ended December 31,** | &nbsp;&nbsp; **Sales Volumes<br> Year Ended December 31,** |
|  | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** |  |
|  | &nbsp;&nbsp; **Volume** | &nbsp;&nbsp; **% of Total** | &nbsp;&nbsp; **Volume** | &nbsp;&nbsp; **% of Total** | &nbsp;&nbsp; **% Change** |
|  | &nbsp;&nbsp;***(in thousands of hectoliters, except percentages)*** | &nbsp;&nbsp;***(in thousands of hectoliters, except percentages)*** | &nbsp;&nbsp;***(in thousands of hectoliters, except percentages)*** | &nbsp;&nbsp;***(in thousands of hectoliters, except percentages)*** | &nbsp;&nbsp;***(in thousands of hectoliters, except percentages)*** |
| **Brazil** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 126184.4 | &nbsp;&nbsp;67.9% | &nbsp;&nbsp; 119530.6 | &nbsp;&nbsp;66.3% | &nbsp;&nbsp;5.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Beer Brazil | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 94042.6 | &nbsp;&nbsp;50.6% | &nbsp;&nbsp; 90835.0 | &nbsp;&nbsp;50.4% | &nbsp;&nbsp;3.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;NAB | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 32141.8 | &nbsp;&nbsp;17.3% | &nbsp;&nbsp; 28695.5 | &nbsp;&nbsp;15.9% | &nbsp;&nbsp;12.0% |
| **CAC** | &nbsp;&nbsp;**&nbsp;&nbsp;&nbsp;&nbsp; 11786.3** | &nbsp;&nbsp;**6.3%** | &nbsp;&nbsp; 13401.9 | &nbsp;&nbsp;7.4% | &nbsp;&nbsp;(12.1%) |
| **Latin America South** | &nbsp;&nbsp;**&nbsp;&nbsp;&nbsp;&nbsp; 38134.0** | &nbsp;&nbsp;**20.5%** | &nbsp;&nbsp; 37511.6 | &nbsp;&nbsp;20.8% | &nbsp;&nbsp;1.7% |
| **Canada** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **9645.0**  | &nbsp;&nbsp; **5.2%** | &nbsp;&nbsp; 9924.1 | &nbsp;&nbsp; 5.5% | &nbsp;&nbsp; (2.8%) |
| **Total** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **185749.7**  | &nbsp;&nbsp; **100.0%** | &nbsp;&nbsp; **180368.1** | &nbsp;&nbsp; **100.0%** | &nbsp;&nbsp; 3.0% |

---

---

| | | | |
|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Net Revenue per Hectoliter<br> Year Ended December 31,** | &nbsp;&nbsp; **Net Revenue per Hectoliter<br> Year Ended December 31,** | &nbsp;&nbsp; **Net Revenue per Hectoliter<br> Year Ended December 31,** |
|  | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **% Change** |
|  | &nbsp;&nbsp;***(in R$, except percentages)*** | &nbsp;&nbsp;***(in R$, except percentages)*** | &nbsp;&nbsp;***(in R$, except percentages)*** |
| **Brazil** | &nbsp;&nbsp;**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 337.9** | &nbsp;&nbsp;**297.7** | &nbsp;&nbsp;**13.5%** |
| &nbsp;&nbsp;&nbsp;&nbsp;Beer Brazil | &nbsp;&nbsp;**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 381.3** | &nbsp;&nbsp;336.2 | &nbsp;&nbsp;**13.4%** |
| &nbsp;&nbsp;&nbsp;&nbsp;NAB | &nbsp;&nbsp;**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 210.9** | &nbsp;&nbsp;176.0 | &nbsp;&nbsp;**19.8%** |
| **CAC** | &nbsp;&nbsp;**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 801.0** | &nbsp;&nbsp;**742.2** | &nbsp;&nbsp;**7.9%** |
| **Latin America South** | &nbsp;&nbsp;**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 455.5** | &nbsp;&nbsp;**441.8** | &nbsp;&nbsp;**3.1%** |
| **Canada** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1063.9**  | &nbsp;&nbsp; **1083.1**  | &nbsp;&nbsp; **(1.8%)** |
| **Total** | &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**429.1**  | &nbsp;&nbsp; **403.9** | &nbsp;&nbsp; **6.2%** |

---

[**Table of Contents**](#TableOfContents)

**Brazilian Operations**

Total net sales from our Brazilian operations increased by 19.8% in 2022, to R$42,635.7 million from R$35,586.5 million in 2021.

Our net sales of beer in Brazil increased by 17.4% in 2022, to R$35,857.8 million from R$30,537.1 million in 2021. This variation is a consequence of a 3.5% increase in volume sold, coupled with a 13.4% increase in net revenue per hectoliter in 2022. We continued to seize the moment and grow volumes by consistently executing our commercial strategy, even after having reached a step change in volumes in the prior couple years. Revenue management initiatives combined with brand mix also led to better levels of net revenue per hectoliter performance.

Our net sales of NAB in Brazil increased by 34.2% in 2022, to R$6,777.9 million from R$5,049.4 million in 2021. This variation is a consequence of a 12.0% increase in volume sold, coupled with a 19.8% increase in net revenue per hectoliter in 2022. The strengthening of out of home consumption occasions throughout the year combined with a solid commercial strategy, and an improved distribution with BEES led to volume growth, while net revenue per hectoliter performance was driven by revenue management initiatives coupled with positive mix of single serve packages and premium brands.

**CAC Operations**

Net sales from our CAC operations decreased by 5.1% in 2022, to R$9,440.3 million from R$9,947.4 million in 2021. This variation is a consequence of a 12.1% decrease in volume sold, with net revenue per hectoliter growing by 7.9% in 2022. Volume decline was mainly due to supply chain constraints affecting the region in the first half of the year, a weak consumption environment in the second half, while net revenue per hectoliter performance driven by revenue management initiatives and mix was partially offset by currency translation impacts as local currencies depreciated in relation to the Brazilian *real* during the period.

**Latin America South Operations**

Net sales from our Latin America South operations increased by 4.8% in 2022, to R$17,371.2 million from R$16.571,7 million in 2021, as a consequence of a 1.7% increase in volume sold, coupled with a 3.1% increase in net revenue per hectoliter in 2022. Volume growth was mainly driven by a resilient volume performance in Argentina, and Bolivia recovering from COVID-19 impacts, while net revenue per hectoliter performance was due to the disciplined execution of revenue management initiatives amid a highly inflationary environment especially in Argentina, partially offset by currency translation impacts as local currencies depreciated in relation to the Brazilian *real* during the period.

**Canada Operations**

Net sales from our Canadian operations decreased by 4.5% in 2022, to R$10,261.7 million from R$10,748.7 million in 2021, as a consequence of a 2.8% decrease in volume sold, coupled with a 1.8% net revenue per hectoliter decrease in 2022. Volume decreased within the context of a weak industry both in beer and beyond beer segments, while positive net revenue per hectoliter performance mainly driven by revenue management initiatives was offset by currency translation impacts as local currency depreciated in relation to the Brazilian *real* during the period.

Cost of Sales.

Cost of sales increased by 13.4% in 2022, to R$40,422.1 million from R$35,659.7 million in 2021. As a percentage of our net sales, total cost of sales increased to 50.7% in 2022 from 48.9% in 2021.

The table below sets forth information on cost of sales per hectoliter for the periods presented:

[**Table of Contents**](#TableOfContents)

---

| | | | |
|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Cost of Sales per Hectoliter<br> Year Ended December 31,** | &nbsp;&nbsp; **Cost of Sales per Hectoliter<br> Year Ended December 31,** | &nbsp;&nbsp; **Cost of Sales per Hectoliter<br> Year Ended December 31,** |
|  | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **% Change** |
|  | &nbsp;&nbsp;***(in R$, except percentages)*** | &nbsp;&nbsp;***(in R$, except percentages)*** | &nbsp;&nbsp;***(in R$, except percentages)*** |
| **Brazil** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 180.2 | &nbsp;&nbsp; 153.2 | &nbsp;&nbsp;17.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Beer Brazil | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 199.5 | &nbsp;&nbsp; 169.3 | &nbsp;&nbsp;17.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;NAB | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 123.6 | &nbsp;&nbsp; 102.0 | &nbsp;&nbsp;21.1% |
| **CAC** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 412.4 | &nbsp;&nbsp; 352.8 | &nbsp;&nbsp;16.9% |
| **Latin America South** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 224.3 | &nbsp;&nbsp; 219.6 | &nbsp;&nbsp;2.2% |
| **Canada** | &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;442.9 | &nbsp;&nbsp; 442.0 | &nbsp;&nbsp; 0.2% |
| **Total** | &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;217.6 | &nbsp;&nbsp; 197.7 | &nbsp;&nbsp; 10.1% |

---

**Brazilian Operations**

Total cost of sales for our Brazilian operations increased by 24.2% in 2022, to R$22,736.8 million from R$18,309.1 million in 2021. On a per hectoliter basis, our Brazilian operations' cost of sales increased by 17.6% in 2022, to R$180.2 per hectoliter from R$153.2 per hectoliter in 2021.

Cost of sales for our Brazilian beer operations increased by 22.0% in 2022, to R$18,765.3 million from R$15,382.1 million in 2021, with cost of sales per hectoliter growing by 17.8% (R$199.5 in 2022 versus R$169.3 in 2021), mainly explained by higher commodity prices, driven by metal and agricultural commodities, and general inflation.

Cost of sales for our Brazilian NAB segment increased by 35.7% in 2022, to R$3,971.5 million from R$2,927.1 million in 2021, with the cost of sales per hectoliter growing by 21.1% (R$123.6 in 2022 versus R$102.0 in 2021), mainly as result of higher input costs given increased commodity prices (especially sugar and PET resin), and general inflation and package mix.

**CAC Operations**

Cost of sales for our CAC operations increased by 2.8% in 2022, to R$4,860.8 million from R$4,727.9 million in 2021, with the cost of sales per hectoliter growing by 16.9% (R$412.4 in 2022 versus R$352.8 in 2021), mainly driven by commodity price increases, coupled with general inflation, specially impacting diesel and ocean freight inflation, partially offset by currency translation impacts as local currencies depreciated in relation to the Brazilian *real* during the period.

**Latin America South Operations**

Cost of sales for our Latin America South operations increased by 3.9% in 2022, to R$8,553.1 million from R$8,235.7 million in 2021, with the cost of sales per hectoliter growing by 2.2% (R$224.3 in 2022 versus R$219.6 in 2021), mainly due to higher commodity prices and the high overall inflation in Argentina, partially offset by currency translation impacts as local currencies depreciated in relation to the Brazilian *real* during the period.

**Canada Operations**

Cost of sales for our Canadian operations decreased by 2.6% in 2022, to R$4,271.4 million from R$4,386.9 million in 2021, with the cost of sales per hectoliter increasing 0.2% (R$442.9 in 2022 versus R$442.0 in 2021), due to higher commodity prices, and general inflation, impacting diesel and freight prices, which more than offset by currency translation impacts as local currency depreciated in relation to the Brazilian *real* during the period.

[**Table of Contents**](#TableOfContents)

Gross Profit

As a result of the foregoing, gross profit increased by 5.6% in 2022, to R$39,286.8 million from R$37,194.6 million in 2021. The table below sets forth the contribution of each business segment to our consolidated gross profit:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Gross Profit** | &nbsp;&nbsp; **Gross Profit** | &nbsp;&nbsp; **Gross Profit** | &nbsp;&nbsp; **Gross Profit** | &nbsp;&nbsp; **Gross Profit** | &nbsp;&nbsp; **Gross Profit** |
|  | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** |
|  | &nbsp;&nbsp; **Amount** | &nbsp;&nbsp; **% of Total** | &nbsp;&nbsp; **Margin** | &nbsp;&nbsp; **Amount** | &nbsp;&nbsp; **% of Total** | &nbsp;&nbsp; **Margin** |
|  | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** |
| &nbsp;&nbsp;**Brazil** | &nbsp;&nbsp; 19898.9 | &nbsp;&nbsp;50.7% | &nbsp;&nbsp;47% | &nbsp;&nbsp; 17277.4 | &nbsp;&nbsp;46.5% | &nbsp;&nbsp;49% |
| &nbsp;&nbsp;&nbsp;&nbsp;Beer Brazil | &nbsp;&nbsp;17092.5 | &nbsp;&nbsp;43.5% | &nbsp;&nbsp;48% | &nbsp;&nbsp; 15155.1 | &nbsp;&nbsp;40.7% | &nbsp;&nbsp;50% |
| &nbsp;&nbsp;&nbsp;&nbsp;NAB | &nbsp;&nbsp;2806.4 | &nbsp;&nbsp;7.1% | &nbsp;&nbsp;41% | &nbsp;&nbsp; 2122.3 | &nbsp;&nbsp;5.7% | &nbsp;&nbsp;42% |
| &nbsp;&nbsp;**CAC** | &nbsp;&nbsp;4579.3 | &nbsp;&nbsp;11.7% | &nbsp;&nbsp;49% | &nbsp;&nbsp; 5219.5 | &nbsp;&nbsp;14.0% | &nbsp;&nbsp;52% |
| **Latin America South** | &nbsp;&nbsp;8818.1 | &nbsp;&nbsp;22.4% | &nbsp;&nbsp;51% | &nbsp;&nbsp; 8336.0 | &nbsp;&nbsp;22.4% | &nbsp;&nbsp;50% |
| **Canada** | &nbsp;&nbsp; 5990.3 | &nbsp;&nbsp; 15.2% | &nbsp;&nbsp; 58% | &nbsp;&nbsp; 6361.7 | &nbsp;&nbsp; 17.1% | &nbsp;&nbsp; 59% |
| **Total** | &nbsp;&nbsp; 39286.8 | &nbsp;&nbsp; 100.0% | &nbsp;&nbsp; 49% | &nbsp;&nbsp; 37194.6 | &nbsp;&nbsp; **100.0%** | &nbsp;&nbsp; 51% |

---

Sales, Marketing, Distribution and Administrative Expenses

Our sales, marketing, distribution and administrative expenses increased by 9.7% in 2022, to R$23,969.4 million from R$21,845.6 in 2021. An analysis of sales and marketing and administrative expenses for each business segment is set forth below.

**Brazilian Operations**

Total sales, marketing, distribution and administrative expenses in Brazil increased by 16.9% in 2022, to R$13,522.0 million from R$11,569.6 million in 2021.

Sales, marketing, distribution and administrative expenses for our Brazilian beer operations increased by 15.4% in 2022, to R$11,514.2 million from R$9,975.4 million in 2021, primarily due to higher investments in our brands and overall inflation over distribution expenses, mainly diesel.

Sales, marketing, distribution and administrative expenses for the NAB segment in Brazil increased by 26.0% in 2022, to R$2,008.0 million from R$1,594.2 million in 2021, mainly due to higher investments in our brands and increased distribution expenses driven by higher volumes and overall inflation.

**CAC Operations**

Sales, marketing, distribution and administrative expenses for our CAC operations increased by 0.3% in 2022, to R$1,999.9 million from R$1,993.7 million in 2021, mainly due to the effective management of our expenses in the region coupled with currency translation impacts as local currencies depreciated in relation to the Brazilian real during the period more than offsetting increased distribution expenses driven by diesel and ocean freight inflation.

**Latin America South Operations**

Sales, marketing, distribution and administrative expenses for our Latin America South operations increased by 0.8% in 2022, to R$4,421.4 million from R$4,385.0 million in 2021 driven by overall inflation especially in Argentina, despite effective management of our expenses in the region, partially offset by currency translation impacts as local currency depreciated in relation to the Brazilian *real* during the period.

**Canada Operations**

Sales, marketing, distribution and administrative expenses for our Canadian operations increased by 3.3% in 2022, to R$4,026.1 million from R$3,897.3 million in 2021 driven mainly by higher distribution expenses due to diesel and freight inflation, partially offset by currency translation impacts as local currency depreciated in relation to the Brazilian *real* during the period.

[**Table of Contents**](#TableOfContents)

Other Net Operating Income (Expense)

Other net operating income increased by 18.4% in 2022, to R$2,513.9 million from R$2,124.1 million in 2021. This result is mainly explained by a growth of tax incentives related to state long term ICMS Value Added Tax in Brazil.

*Exceptional Items*

Exceptional items expenses decreased by 63.5% in 2022, to R$(143.3) million from R$(392.8) million in 2021. Similar to 2021, the expenses recorded in 2022 were mainly due to restructuring expenses primarily related to centralization and sizing projects in Brazil and Latin America South.

*Income from Operations*

As a result of the foregoing, income from operations increased by 3.6% in 2022, to R$17,687.9 million from R$17,080.3 million in 2021.

*Net Finance Result*

Our net finance result decreased by 6.8% in 2022, to an expense of R$3,423.2 million from an expense of R$3,205.4 million in 2021. This result is mainly explained by an increase in carry costs for Brazil and Argentina as a result of macroeconomic volatility in both countries coupled with higher present value adjustment of accounts payables as per determined in IFRS 13 partially compensated by higher interest income due to increased SELIC rate, as well as higher recognition of monetary update of tax credits in financial results, compared to 2021, mainly related to a 2017 Brazilian Supreme Court decision that declared unconstitutional the inclusion of the ICMS state tax in the tax base of the PIS and the COFINS federal taxes.

Our total debt, including current and non-current interest-bearing loans and borrowing, increased by R$670.2 million in in 2022, while our cash and cash equivalents and current investment securities less bank overdrafts decreased by R$3,205.2 million in 2022.

Income Tax Expense

Our consolidated income tax and social contribution on profits totaled R$(655.6) million in 2022 from R$636.6 million in 2021. The effective tax rate in 2022 was (4.6)%, compared to 4.6% in the previous year. Such decrease in our effective tax rate in 2022 was primarily due to lower withholding taxes and the tax effects of the payment of interest on shareholders' equity – for further information see "—E. Taxation—Brazilian Tax Considerations—Income Tax—Distributions of Interest on Shareholders' Equity".

Net Income

As a result of the foregoing, net income increased by 13.5% in 2022, to R$14,891.3 million from R$13,122.6 million in 2021.

**Year Ended December 31, 2021 Compared to Year Ended December 31, 2020**

In the periods discussed below, we conducted our operations through four business segments as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· **Brazil**, which includes the beer sales division and the NAB sales division;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· **Central America and the Caribbean**, which includes our direct operations in the Dominican Republic,
Saint Vincent, Antigua, Dominica, Cuba, Guatemala (which also serves El Salvador, Honduras and Nicaragua), Barbados and Panama;

[**Table of Contents**](#TableOfContents)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· **Latin America South**, which includes our operations in Argentina, Bolivia, Paraguay, Uruguay and
Chile; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· **Canada**, represented by Labatt's operations, which includes domestic sales in Canada and some
exports to the U.S. market.

The table below sets forth certain of our operating highlights for the years presented:

---

| | | | |
|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Consolidated Financial Highlights** | &nbsp;&nbsp; **Consolidated Financial Highlights** | &nbsp;&nbsp; **Consolidated Financial Highlights** |
|  | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2020** | &nbsp;&nbsp; **% Change** |
|  | &nbsp;&nbsp;***(in R$ million, except volume amounts, <br> percentages and per share amounts)*** | &nbsp;&nbsp;***(in R$ million, except volume amounts, <br> percentages and per share amounts)*** | &nbsp;&nbsp;***(in R$ million, except volume amounts, <br> percentages and per share amounts)*** |
| &nbsp;&nbsp;Sales volume—'000 hectoliters | &nbsp;&nbsp;180368.1 | &nbsp;&nbsp;165797.9 | &nbsp;&nbsp;8.8% |
| &nbsp;&nbsp;Net sales | &nbsp;&nbsp;72854.3 | &nbsp;&nbsp;58379.0 | &nbsp;&nbsp;24.8% |
| &nbsp;&nbsp;Net revenue per hectoliter—R$/hl | &nbsp;&nbsp;403.9 | &nbsp;&nbsp;352.1 | &nbsp;&nbsp;14.7% |
| &nbsp;&nbsp;Cost of sales | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(35659.7) | &nbsp;&nbsp;(27066.1) | &nbsp;&nbsp;31.8% |
| &nbsp;&nbsp;Gross profit | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 37194.6 | &nbsp;&nbsp;31312.9 | &nbsp;&nbsp;18.8% |
| &nbsp;&nbsp;**Gross margin (%)** | &nbsp;&nbsp;**51.1%** | &nbsp;&nbsp;**53.6%** | &nbsp;&nbsp;**0.0 bps** |
| &nbsp;&nbsp;Sales, marketing and distribution expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(16968.2) | &nbsp;&nbsp;(14619.6) | &nbsp;&nbsp;16.1% |
| &nbsp;&nbsp;Administrative expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4877.4) | &nbsp;&nbsp;(2948.5) | &nbsp;&nbsp;65.4% |
| &nbsp;&nbsp;Other operating income/(expenses) net | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2124.1 | &nbsp;&nbsp;2679.4 | &nbsp;&nbsp;(20.7)% |
| &nbsp;&nbsp;Exceptional items | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (392.8) | &nbsp;&nbsp;(452.0) | &nbsp;&nbsp;(13.1)% |
| &nbsp;&nbsp;Income from operations | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17080.3 | &nbsp;&nbsp;15972.2 | &nbsp;&nbsp;6.9% |
| &nbsp;&nbsp;**Operating margin (%)** | &nbsp;&nbsp;**23.4%** | &nbsp;&nbsp;**27.4%** | &nbsp;&nbsp;**(396 bps)** |
| &nbsp;&nbsp;Net income | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13122.6 | &nbsp;&nbsp;11731.9 | &nbsp;&nbsp;11.9% |
| &nbsp;&nbsp;**Net margin (%)** | &nbsp;&nbsp;**18.0%** | &nbsp;&nbsp;**20.1%** | &nbsp;&nbsp;**(209 bps)** |

---

Margin Analysis

The following table sets forth certain line items of our income statement expressed as percentages of net sales for the years ended December 31, 2021 and 2020:

---

| | | |
|:---|:---|:---|
|  | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** |
|  | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2020** |
|  | &nbsp;&nbsp;***(%)*** | &nbsp;&nbsp;***(%)*** |
| &nbsp;&nbsp;Net sales | &nbsp;&nbsp;100.0 | &nbsp;&nbsp;100.0 |
| &nbsp;&nbsp;Cost of sales | &nbsp;&nbsp;(48.9) | &nbsp;&nbsp;(46.4) |
| &nbsp;&nbsp;Gross profit | &nbsp;&nbsp;51.1 | &nbsp;&nbsp;53.6 |
| &nbsp;&nbsp;Sales, marketing and distribution expenses | &nbsp;&nbsp;(23.3) | &nbsp;&nbsp;(25.0) |
| &nbsp;&nbsp;Administrative expenses | &nbsp;&nbsp;(6.7) | &nbsp;&nbsp;(5.1) |
| &nbsp;&nbsp;Other operating income/(expenses) net | &nbsp;&nbsp;2.9 | &nbsp;&nbsp;4.6 |
| &nbsp;&nbsp;Exceptional items | &nbsp;&nbsp;(0.5) | &nbsp;&nbsp;(0.8) |
| &nbsp;&nbsp;Income from operations | &nbsp;&nbsp;23.4 | &nbsp;&nbsp;27.4 |

---

[**Table of Contents**](#TableOfContents)

***Selected Financial Data by Business Segment***

The following table sets forth selected financial data by business segment for the years ended December 31, 2021 and 2020:

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** | &nbsp;&nbsp; **Year Ended December 31,** |
|  | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2020** | &nbsp;&nbsp; **2020** | &nbsp;&nbsp; **2020** | &nbsp;&nbsp; **2020** | &nbsp;&nbsp; **2020** |
|  | &nbsp;&nbsp; **Brazil** | &nbsp;&nbsp; **CAC** | &nbsp;&nbsp; **LAS** | &nbsp;&nbsp; **Canada** | &nbsp;&nbsp; **Total** | &nbsp;&nbsp; **Brazil** | &nbsp;&nbsp; **CAC** | &nbsp;&nbsp; **LAS** | &nbsp;&nbsp; **Canada** | &nbsp;&nbsp; **Total** |
|  | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** |
| &nbsp;&nbsp;**Net sales** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 35586.5** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9947.4** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 16571.7** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10748.7** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 72854.3** | **30196.5** | **7319.3** | **11560.8** | **9302.4** | **58379.0** |
| &nbsp;&nbsp;Cost of sales | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (18309.1) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4727.9) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (8235.7) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4386.9) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (35659.7) | (14112.9) | (3307.5) | (5937.4) | (3708.3) | (27066.1) |
| &nbsp;&nbsp;**Gross profit** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17277.4** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5219.5** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8336.0** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6361.7** | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 37194.6** | **16083.6** | **4011.8** | **5623.4** | **5594.1** | **31312.9** |
| &nbsp;&nbsp;Sales, marketing, distribution and administrative expenses | (11569.6) | (1993.7) | (4385.0) | (3897.3) | (21845.6) | <br>(9315.6) | (1598.9) | <br>(3233.3) | <br>(3420.3) | <br>(17568.1) |
| &nbsp;&nbsp;Other operating income/ (expenses) | 2096.0 | 12.4 | 38.8 | (23.1) | 2124.1 | <br>2887.2 | <br>(23.5) | <br>(159.9) | <br>(24.4) | <br>2679.4 |
| &nbsp;&nbsp;Exceptional items | (210.1) | (46.7) | (115.4) | (20.6) | (392.8) | (173.8) | (70.5) | (145.7) | (62.0) | (452.0) |
| &nbsp;&nbsp;**Income from operations** | **7593.7**  | **3191.5**  | **3874.4**  | **2420.7**  | **17080.3**  | <br> **9481.4**<br>| <br> **2318.9**<br>| <br> **2084.5**<br>| <br> **2087.4**<br>| <br> **15972.2**<br>|

---

Net Sales

Net sales increased by 24.8% in 2021, to R$72,854.3 million from R$58,379.0 million in 2020, as shown in tables set forth below:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Net Sales<br> Year Ended December 31,** | &nbsp;&nbsp; **Net Sales<br> Year Ended December 31,** | &nbsp;&nbsp; **Net Sales<br> Year Ended December 31,** | &nbsp;&nbsp; **Net Sales<br> Year Ended December 31,** | &nbsp;&nbsp; **Net Sales<br> Year Ended December 31,** | &nbsp;&nbsp; **Net Sales<br> Year Ended December 31,** |
|  | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2020** | &nbsp;&nbsp; **2020** | &nbsp;&nbsp; **2020** |  |
|  | &nbsp;&nbsp; **Sales** | &nbsp;&nbsp; **% of Total** | &nbsp;&nbsp; **% of Total** | &nbsp;&nbsp; **Sales** | &nbsp;&nbsp; **% of Total** | &nbsp;&nbsp; **% Change** |
|  | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** |
| **Brazil** | &nbsp;&nbsp; 35586.5 | &nbsp;&nbsp;48.8% | &nbsp;&nbsp;48.8% | &nbsp;&nbsp;**30196.5** | &nbsp;&nbsp;**51.7%** | &nbsp;&nbsp;17.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Beer Brazil | &nbsp;&nbsp; 30537.1 | &nbsp;&nbsp;41.9% | &nbsp;&nbsp;41.9% | &nbsp;&nbsp;25953.0 | &nbsp;&nbsp;44.5**%** | &nbsp;&nbsp;17.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;NAB | &nbsp;&nbsp; 5049.4 | &nbsp;&nbsp;6.9% | &nbsp;&nbsp;6.9% | &nbsp;&nbsp;4243.5 | &nbsp;&nbsp;7.3**%** | &nbsp;&nbsp;19.0% |
| **CAC** | &nbsp;&nbsp; 9947.4 | &nbsp;&nbsp;13.7% | &nbsp;&nbsp;13.7% | &nbsp;&nbsp;**7319.3** | &nbsp;&nbsp;**12.5%** | &nbsp;&nbsp;35.9% |
| **Latin America South** | &nbsp;&nbsp; 16571.7 | &nbsp;&nbsp;22.7% | &nbsp;&nbsp;22.7% | &nbsp;&nbsp;**11560.8** | &nbsp;&nbsp;**19.8%** | &nbsp;&nbsp;43.3% |
| **Canada** | &nbsp;&nbsp; 10748.7 | &nbsp;&nbsp; 14.8% | &nbsp;&nbsp; 14.8% | &nbsp;&nbsp; **9302.4** | &nbsp;&nbsp; **15.9%** | &nbsp;&nbsp; 15.5% |
| **Total** | &nbsp;&nbsp; 72854.3 | &nbsp;&nbsp; 100.0% | &nbsp;&nbsp; 100.0% | &nbsp;&nbsp; **58379.0** | &nbsp;&nbsp; **100.0%** | &nbsp;&nbsp; 24.8% |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Sales Volumes<br> Year Ended December 31,** | &nbsp;&nbsp; **Sales Volumes<br> Year Ended December 31,** | &nbsp;&nbsp; **Sales Volumes<br> Year Ended December 31,** | &nbsp;&nbsp; **Sales Volumes<br> Year Ended December 31,** | &nbsp;&nbsp; **Sales Volumes<br> Year Ended December 31,** |
|  | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2020** | &nbsp;&nbsp; **2020** |  |
|  | &nbsp;&nbsp; **Volume** | &nbsp;&nbsp; **% of Total** | &nbsp;&nbsp; **Volume** | &nbsp;&nbsp; **% of Total** | &nbsp;&nbsp; **% Change** |
|  | &nbsp;&nbsp;***(in thousands of hectoliters, except percentages)*** | &nbsp;&nbsp;***(in thousands of hectoliters, except percentages)*** | &nbsp;&nbsp;***(in thousands of hectoliters, except percentages)*** | &nbsp;&nbsp;***(in thousands of hectoliters, except percentages)*** | &nbsp;&nbsp;***(in thousands of hectoliters, except percentages)*** |
| **Brazil** | &nbsp;&nbsp; 119530.6 | &nbsp;&nbsp;66.3% | &nbsp;&nbsp;**111285.4** | &nbsp;&nbsp;**67.1%** | &nbsp;&nbsp;7.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Beer Brazil | &nbsp;&nbsp; 90835.0 | &nbsp;&nbsp;50.4% | &nbsp;&nbsp;84791.7 | &nbsp;&nbsp;51.1**%** | &nbsp;&nbsp;7.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;NAB | &nbsp;&nbsp; 28695.5 | &nbsp;&nbsp;15.9% | &nbsp;&nbsp;26493.7 | &nbsp;&nbsp;16.0**%** | &nbsp;&nbsp;8.3% |
| **CAC** | &nbsp;&nbsp; 13401.9 | &nbsp;&nbsp;7.4% | &nbsp;&nbsp;**11451.2** | &nbsp;&nbsp;**6.9%** | &nbsp;&nbsp;17.0% |
| **Latin America South** | &nbsp;&nbsp; 37511.6 | &nbsp;&nbsp;20.8% | &nbsp;&nbsp;**33062.4** | &nbsp;&nbsp;**19.9%** | &nbsp;&nbsp;13.5% |
| **Canada** | &nbsp;&nbsp; 9924.1 | &nbsp;&nbsp; 5.5% | &nbsp;&nbsp; **9998.9** | &nbsp;&nbsp; **6.0%** | &nbsp;&nbsp; (0.7)% |
| **Total** | &nbsp;&nbsp; 180368.1 | &nbsp;&nbsp; 100.0% | &nbsp;&nbsp; **165797.9** | &nbsp;&nbsp; **100.0%** | &nbsp;&nbsp; 8.8% |

---

---

| | | | |
|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Net Revenue per Hectoliter<br> Year Ended December 31,** | &nbsp;&nbsp; **Net Revenue per Hectoliter<br> Year Ended December 31,** | &nbsp;&nbsp; **Net Revenue per Hectoliter<br> Year Ended December 31,** |
|  | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2020** | &nbsp;&nbsp; **% Change** |
|  | &nbsp;&nbsp;***(in R$, except percentages)*** | &nbsp;&nbsp;***(in R$, except percentages)*** | &nbsp;&nbsp;***(in R$, except percentages)*** |
| **Brazil** | &nbsp;&nbsp;**297.7** | &nbsp;&nbsp;**271.3** | &nbsp;&nbsp;**9.7%** |
| &nbsp;&nbsp;&nbsp;&nbsp;Beer Brazil | &nbsp;&nbsp;336.2 | &nbsp;&nbsp;306.1 | &nbsp;&nbsp;9.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;NAB | &nbsp;&nbsp;176.0 | &nbsp;&nbsp;160.2 | &nbsp;&nbsp;9.8% |
| **CAC** | &nbsp;&nbsp;**742.2** | &nbsp;&nbsp;**639.2** | &nbsp;&nbsp;**16.1%** |
| **Latin America South** | &nbsp;&nbsp;**441.8** | &nbsp;&nbsp;**349.7** | &nbsp;&nbsp;**26.3%** |
| **Canada** | &nbsp;&nbsp; **1083.1** | &nbsp;&nbsp; **930.3** | &nbsp;&nbsp; **16.4%** |
| **Total** | &nbsp;&nbsp; **403.9** | &nbsp;&nbsp; **352.1** | &nbsp;&nbsp; **14.7%** |

---

[**Table of Contents**](#TableOfContents)

**Brazilian Operations**

Total net sales from our Brazilian operations increased by 17.8% in 2021, to R$35,586.5 million from R$30,196.5 million in 2020.

Our net sales of beer in Brazil increased by 17.7% in 2021, to R$30,537.1 million from R$25,953.0 million in 2020. This variation is a consequence of a 7.1% increase in volume sold, coupled with an increase in net revenue per hectoliter in 2021. Despite the continuing impacts generated by the COVID-19 pandemic, we were able to grow volumes as a result of the implementation of our commercial strategy, the success of our innovations and our flexibility and adaptability to changes in the market.

Our net sales of NAB in Brazil increased by 19.0% in 2021, to R$5,049.4 million from R$4,243.5 million in 2020 mainly due to the steady reopening of cities which drove the out of home consumption occasion recovery.

**CAC Operations**

Net sales from our CAC operations increased by 35.9% in 2021, to R$9,947.4 million from R$7,319.3 million in 2020, mainly driven by volume recovery leveraging on the gradual reopening of cities as COVID-19 restrictions on people circulation imposed by local governments eased in response to the increase in COVID-19 vaccinations, coupled with further premiumization of our portfolio through core brands, like Corona, which had a positive impact in net revenue per hectoliter. Reported variation increased due to currency translation impacts as local currencies appreciated in relation to the Brazilian *real* during the period.

**Latin America South Operations**

Net sales from our Latin America South operations increased by 43.3% in 2021, to R$16,571.7 million from R$11,560.8 million in 2020, mainly due to volume recovery in most countries coupled with the high inflation in Argentina and currency translation impacts as local currencies appreciated in relation to the Brazilian *real* during the period.

**Canada Operations**

Net sales from our Canadian operations increased by 15.5% in 2021, to R$10,748.7 million from R$9,302.4 million in 2020. The result was mainly due to our revenue management initiatives leading to more efficient discounts and pricing, which had a positive impact in net revenue per hectoliter, partially offset by a decrease in volumes of products sold in the region driven by restrictions imposed by local governments on people circulation in response to the COVID-19 pandemic. Reported variation increased mainly due to currency translation impacts as local currency appreciated in relation to the Brazilian *real* during the period.

Cost of Sales.

Cost of sales increased by 31.8% in 2021, to R$35,659.7 million from R$27,066.1 million in 2020. As a percentage of our net sales, total cost of sales increased to 48.9% in 2021 from 46.4% in 2020.

The table below sets forth information on cost of sales per hectoliter for the periods presented:

---

| | | | |
|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Cost of Sales per Hectoliter<br> Year Ended December 31,** | &nbsp;&nbsp; **Cost of Sales per Hectoliter<br> Year Ended December 31,** | &nbsp;&nbsp; **Cost of Sales per Hectoliter<br> Year Ended December 31,** |
|  | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2020** | &nbsp;&nbsp; **% Change** |
|  | &nbsp;&nbsp;***(in R$, except percentages)*** | &nbsp;&nbsp;***(in R$, except percentages)*** | &nbsp;&nbsp;***(in R$, except percentages)*** |
| **Brazil** | &nbsp;&nbsp; 153.2 | &nbsp;&nbsp;126.8 | &nbsp;&nbsp;20.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Beer Brazil | &nbsp;&nbsp; 169.3 | &nbsp;&nbsp;140.8 | &nbsp;&nbsp;20.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;NAB | &nbsp;&nbsp; 102.0 | &nbsp;&nbsp;82.0 | &nbsp;&nbsp;24.4% |
| **CAC** | &nbsp;&nbsp; 352.8 | &nbsp;&nbsp;288.8 | &nbsp;&nbsp;22.2% |
| **Latin America South** | &nbsp;&nbsp; 219.6 | &nbsp;&nbsp;179.6 | &nbsp;&nbsp;22.2% |
| **Canada** | &nbsp;&nbsp; 442.0  | &nbsp;&nbsp; 370.9 | &nbsp;&nbsp; 19.2% |
| **Total** | &nbsp;&nbsp; 197.7 | &nbsp;&nbsp; 163.2 | &nbsp;&nbsp; 21.1% |

---

[**Table of Contents**](#TableOfContents)

**Brazilian Operations**

Total cost of sales for our Brazilian operations increased by 29.7% in 2021, to R$18,309.1 million from R$14,112.9 million in 2020. On a per hectoliter basis, our Brazilian operations cost of sales increased by 20.8% in 2021, to R$153.2 per hectoliter from R$126.8 per hectoliter in 2020.

Cost of sales for our Brazilian beer operations increased by 28.8% in 2021, to R$15,382.0 million from R$11,941.7 million in 2020, mainly explained by higher commodity prices, driven by metal and agricultural commodities, as well as currency impact, mainly explained by Brazilian *real* devaluation relative to other currencies, which was partially offset by our hedging policy and volume growth.

Cost of sales for our Brazilian NAB segment increased by 34.8% in 2021, to R$2,927.1 million from R$2,171.2 million in 2020, mainly due to higher input costs. The cost of sales per hectoliter increased by 24.5% in 2021, totaling R$102.0 per hectoliter, from R$82.0 per hectoliter in 2020, mainly as result of the same factors.

**CAC Operations**

Cost of sales for our CAC operations increased by 42.9% in 2021, to R$4,727.9 million from R$3,307.5 million in 2020 mainly driven by volume recovery as COVID-19 restrictions imposed by local governments on people circulation eased, coupled with commodity price increases. Reported variation increased due to currency translation impacts as all local currencies appreciated in relation to the Brazilian *real* during the period.

**Latin America South Operations**

Cost of sales for our Latin America South operations increased by 38.7% in 2021, to R$8,235.7 million from R$5,937.4 million in 2020 mainly due to volume growth coupled with higher commodity and currency prices given our hedging policy and the high inflation in Argentina.

**Canada Operations**

Cost of sales for our Canadian operations increased by 18.3% in 2021, to R$4,386.9 million from R$3,708.3 million in 2020, mainly due to higher commodity and currency prices giving our hedging policy. Reported variation increased mainly due to currency translation impacts as local currency appreciated in relation to the Brazilian *real* during the period.

Gross Profit

As a result of the foregoing, gross profit increased by 18.8% in 2021, to R$37,194.6 million from R$31,312.9 million in 2020. The table below sets forth the contribution of each business segment to our consolidated gross profit:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Gross Profit** | &nbsp;&nbsp; **Gross Profit** | &nbsp;&nbsp; **Gross Profit** | &nbsp;&nbsp; **Gross Profit** | &nbsp;&nbsp; **Gross Profit** | &nbsp;&nbsp; **Gross Profit** |
|  | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2020** | &nbsp;&nbsp; **2020** | &nbsp;&nbsp; **2020** |
|  | &nbsp;&nbsp; **Amount** | &nbsp;&nbsp; **% of Total** | &nbsp;&nbsp; **Margin** | &nbsp;&nbsp; **Amount** | &nbsp;&nbsp; **% of Total** | &nbsp;&nbsp; **Margin** |
|  | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** |
| &nbsp;&nbsp;**Brazil** | &nbsp;&nbsp;17277.4 | &nbsp;&nbsp;46.5% | &nbsp;&nbsp;49% | &nbsp;&nbsp;**16083.6** | &nbsp;&nbsp;**51.4%** | &nbsp;&nbsp;**53%** |
| &nbsp;&nbsp;&nbsp;&nbsp;Beer Brazil | &nbsp;&nbsp;15155.1 | &nbsp;&nbsp;40.7% | &nbsp;&nbsp;50% | &nbsp;&nbsp;14011.3 | &nbsp;&nbsp;44.7**%** | &nbsp;&nbsp;54**%** |
| &nbsp;&nbsp;&nbsp;&nbsp;NAB | &nbsp;&nbsp;2122.3 | &nbsp;&nbsp;5.7% | &nbsp;&nbsp;42% | &nbsp;&nbsp;2072.3 | &nbsp;&nbsp;6.6**%** | &nbsp;&nbsp;**49%** |
| &nbsp;&nbsp;**CAC** | &nbsp;&nbsp;5219.5 | &nbsp;&nbsp;14.0% | &nbsp;&nbsp;52% | &nbsp;&nbsp;**4011.8** | &nbsp;&nbsp;**12.8%** | &nbsp;&nbsp;**55%** |
| **Latin America South** | &nbsp;&nbsp;8336.0 | &nbsp;&nbsp;22.4% | &nbsp;&nbsp;50% | &nbsp;&nbsp;**5623.4** | &nbsp;&nbsp;**18.0%** | &nbsp;&nbsp;**49%** |
| **Canada** | &nbsp;&nbsp; 6361.7 | &nbsp;&nbsp; 17.1% | &nbsp;&nbsp; 59% | &nbsp;&nbsp; **5594.1** | &nbsp;&nbsp; **17.9%** | &nbsp;&nbsp; **60%** |
| **Total** | &nbsp;&nbsp; 37194.6 | &nbsp;&nbsp; 100.0% | &nbsp;&nbsp; 51% | &nbsp;&nbsp; **31312.9** | &nbsp;&nbsp; **100.0%** | &nbsp;&nbsp; **54%** |

---

[**Table of Contents**](#TableOfContents)

Sales, Marketing, Distribution and Administrative Expenses

Our sales, marketing, distribution and administrative expenses increased by 24.3% in 2021, to R$21,845.6 million from R$17,568.1 in 2020. An analysis of sales and marketing and administrative expenses for each business segment is set forth below.

**Brazilian Operations**

Total sales, marketing, distribution and administrative expenses in Brazil increased by 24.2% in 2021, to R$11,569.6 million from R$9,315.6 million in 2020.

Sales, marketing, distribution and administrative expenses for our Brazilian beer operations increased by 25.7% in 2021, to R$9,975.4 million from R$7,933.2 million in 2020, primarily due to an increase in variable compensation to R$721.5 million, volume growth and the cost of last mile delivery.

Sales, marketing, distribution and administrative expenses for the NAB segment in Brazil increased by 15.3% in 2021, to R$1,594.2 million from R$1,382.4 million in 2020 mainly due to an increase in variable compensation to R$127.3 million and volume growth.

**CAC Operations**

Sales, marketing, distribution and administrative expenses for our CAC operations increased by 24.7% in 2021, to R$1,993.7 million from R$1,598.9 million in 2020, mainly due to an increase in variable compensation to R$159.6 million partially offset by the disciplined execution of our cost saving initiatives. Reported variation increased due to currency translation impacts as local currencies appreciated in relation to the Brazilian real during the period.

**Latin America South Operations**

Sales, marketing, distribution and administrative expenses for our Latin America South operations increased by 35.6% in 2021, to R$4,385.0 million from R$3,233.3 million in 2020 driven by an increase in variable compensation to R$297.0 million coupled with the high inflation in Argentina, despite effective management of our expenses in the region.

**Canada Operations**

Sales, marketing, distribution and administrative expenses for our Canadian operations increased by 13.9% in 2021, to R$3,897.3 million from R$3,420.3 million in 2020 driven by an increase in variable compensation to R$115.3 million partially offset by the disciplined execution of our cost saving initiatives. Reported variation increased due to currency translation impacts as local currency appreciated in relation to the Brazilian *real* during the period.

Other Net Operating Income (Expense)

Other net operating income decreased by 20.7% in 2021, to R$2,124.1 million from R$2,679.4 million in 2020. This result is mainly explained by a reduction in the recognition of tax credits related to a 2017 Brazilian Supreme Court decision that declared unconstitutional the inclusion of the ICMS in the PIS and COFINS calculation basis.

*Exceptional Items*

Exceptional items expenses decreased by 13.1% in 2021, to R$392.8 million from R$452.0 million in 2020. The expenses recorded in 2021 were mainly due to restructuring expenses primarily related to centralization and sizing projects in Brazil and Latin America South and exceptional expenses incurred in 2020 were mainly related to the COVID-19 pandemic, including the actions taken to ensure the health and safety of our employees, such as the acquisition of hand-sanitizer, masks and additional cleaning of our facilities, as well as donations to the broader community.

[**Table of Contents**](#TableOfContents)

*Income from Operations*

As a result of the foregoing, income from operations increased by 6.9% in 2021, to R$17,080.3 million from R$15,972.2 million in 2020.

*Net Finance Result*

Our net finance result increased by 31.7% in 2021, to an expense of R$3,205.4 million from an expense of R$2,434.5 million in 2020. This result is mainly explained by a lower recognition of tax credits, compared to 2020, related to a 2017 Brazilian Supreme Court decision that declared unconstitutional the inclusion of the ICMS state tax in the tax base of the PIS and the COFINS federal taxes. This is coupled with a higher SELIC rate and an increase in carry costs for Brazil and Argentina as a result of macroeconomic volatility.

Our total debt, including current and non-current interest-bearing loans and borrowing, decreased by R$1,691.7 million in 2021, while our cash and cash equivalents and current investment securities less bank overdrafts decreased by R$278.5 million in 2021.

Income Tax Expense

Our consolidated income tax and social contribution on profits totaled R$636.6 million in 2021 from R$1,762.5 million in 2020. The effective tax rate in 2021 was 4.6%, compared to 13.1% in the previous year. Such decrease in our effective tax rate in 2021 was primarily due to a decrease in taxable income, the reversal of amounts of IRPJ and CSLL calculated over the SELIC interest resulting from the tax credit recognized by the Company as a result of the decision rendered by the STF in the judgment of RE 574,706/PR, and also the recognition of recoverability of amounts taxed in the past over the same kind of interest.

Net Income

As a result of the foregoing, net income increased by 11.9% in 2021, to R$13,122.6 million from R$11,731.9 million in 2020.

[**Table of Contents**](#TableOfContents)

B.&nbsp;&nbsp;&nbsp;&nbsp; Liquidity and Capital Resources

**Sources and Uses**

The information in this section refers to 2022 and 2021. Our primary sources of liquidity have historically been cash flows from operating activities and borrowings. Our material cash requirements have included the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Opex expenses, such as raw and packaging material, sales & marketing investments and overheads;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· debt service;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· capital expenditures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· payments of dividends and interest on shareholders' equity;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· increases in ownership of our consolidated subsidiaries or companies in which we have equity investments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· investments in businesses participating in the brewing, NAB and malting industries; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· investments in businesses that address emerging consumer's needs, such as Future
Beverages and technology platforms.

In 2020, as a result of the COVID-19 pandemic, the market faced uncertainty about the period for the restrictions imposed by each government on commercial and operational activities, on the circulation of people and on the sale, distribution and consumption of alcoholic beverages, as well as the economic effects on the financial market and exchange rates. As a consequence, Ambev raised R$3,6 billion in new debt to improve its liquidity. As volume and profitability partially recovered towards the end of 2020, the loans were fully settled by the end of 2021. As the scenario and the market conditions remain uncertain, we may enter into new debts to protect our liquidity.

Our cash requirements from known contractual obligations within the next twelve months include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Short-term debts and the current portion of long-term debts in the amount of R$238.0 million. For more
information see "Item 5. Operating and Financial Review and Prospects—B. Liquidity and Capital Resources—Borrowings"
and Note 28 to our audited consolidated financial statements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Lease liabilities in the amount of R$962.9 million. For more information see Note 28 to our audited
consolidated financial statements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Trade and other payables in the amount of R$29,540.9 million, which include amounts related to suppliers,
taxes, fees and contributions payables, dividends and interest on equity payable, salaries and charges, put options related to our participation
in subsidiaries and other liabilities, except for related parties, with payment term of less than one year. For more information see Note
28 to our audited consolidated financial statements; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Sales tax deferrals in the amount of R$129.5 million. For more information see "Item 5. Operating
and Financial Review and Prospects—B. Liquidity and Capital Resources—Sales Tax Deferrals and Other Tax Credits" and
Note 17 to our audited consolidated financial statements.

Our long-term cash requirements under our various contractual obligations and commitments include:

[**Table of Contents**](#TableOfContents)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Long-term debt in the amount of R$766.7 million. For more information see "Item 5. Operating and
Financial Review and Prospects—B. Liquidity and Capital Resources—Borrowings" and Note 28 to our audited consolidated
financial statements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Lease liabilities in the amount of R$2,694.5 million. For more information see Note 28 to our audited
consolidated financial statements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Trade and other payables in the amount of R$1,964.0 million. For more information see Note 28 to our audited
consolidated financial statements; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· Sale tax deferrals in the amount of R$1,789.1 million. For more information see "Item 5. Operating
and Financial Review and Prospects—B. Liquidity and Capital Resources—Sales Tax Deferrals and Other Tax Credits" and
Note 17 to our audited consolidated financial statements.

Our cash and cash equivalents and current investment securities at December 31, 2022 and 2021 were R$15,380.9 million and R$18,542.3 million.

We believe that cash flows from operating activities, available cash and cash equivalents and current investment securities, along with our derivative instruments and our access to borrowing facilities, will be sufficient to fund our capital expenditures, debt service and dividend payments going forward.

**Cash Flows** 

Our financial guidelines focus on maximizing shareholder's value while keeping financial flexibility to execute strategic projects, key enablers of our future growth. Therefore, our cash management policy pursues constant protection of our short and long-term liquidity while minimizing financials risks and volatility. The continuous search for our optimal capital structure enables us to quickly react to market distress and ensures our solid financial position while working together with our suppliers, wholesalers, customers and credit market.

Operating Activities

Cash flows from our operating activities decreased by 9.9% in 2022, to R$20,642.1 million from R$22,901.3 million in 2021, mainly as a result of bonus and capex payments in the first quarter and lower cash generation in CAC and Canada.

*Investing Activities*

Cash flows used in our investing activities decreased by 35.3% in 2022, to R$5,004.2million from R$7,735.0 million in 2021, mainly explained by a decrease in intangible and fixed assets *acquisitions*.

*Surety Bonds*

In the ordinary course of our business, we use surety bonds, letters of credit and similar financial instruments (e.g., bank products known as fiança and/or seguro-garantia) to secure (i) the performance or payment of obligations under certain agreements and (ii) potential losses in connection with lawsuits. In case we are unable to obtain or renew these financial instruments under favorable conditions, or at all, we would be required to use our own cash to secure those agreements and lawsuits, which could adversely affect our liquidity position. For additional information on legal proceedings, see Item 8. Financial Information—A. Consolidated Financial Statements and Other Financial Information—Legal Proceedings.

Financing Activities

Cash flows used in our financing activities increased by 1.8% in 2022, to R$16,337.8 million from R$16,042.0 million cash outflow in 2021, mainly driven by higher capital distribution partially offset by lower payments from borrowings.

The table below shows the profile of our debt instruments:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Maturity Schedule of Debt Portfolio as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Debt Portfolio as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Debt Portfolio as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Debt Portfolio as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Debt Portfolio as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Debt Portfolio as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Debt Portfolio as of December 31, 2022** |
| &nbsp;&nbsp; **Debt Instrument** | &nbsp;&nbsp; **2023** | &nbsp;&nbsp; **2024** | &nbsp;&nbsp; **2025** | &nbsp;&nbsp; **2026** | &nbsp;&nbsp; **2027** | &nbsp;&nbsp; **Thereafter** | &nbsp;&nbsp; **Total** |
|  | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** |
| **BNDES + FINEP Currency Basket Debt Fixed Rate:** |  |  |  |  |  |  |  |
| Currency Basket Debt Fixed Rate | &nbsp;&nbsp;35.7 | &nbsp;&nbsp;1.2 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;36.8 |
| UMBNDES + Average Pay Rate | &nbsp;&nbsp;3.70% | &nbsp;&nbsp;3.70% | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| **International Debt:** |  |  |  |  | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| Other Latin America Currency Floating Rate | &nbsp;&nbsp;0 | &nbsp;&nbsp;0 | &nbsp;&nbsp;0 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| Average Pay Rate | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| Other Latin America Currency Fixed Rate | &nbsp;&nbsp;98.8 | &nbsp;&nbsp;217.5 | &nbsp;&nbsp;29.0 | &nbsp;&nbsp;26.7 | &nbsp;&nbsp;49.3 | &nbsp;&nbsp;- | &nbsp;&nbsp;421.3 |
| Average Pay Rate | &nbsp;&nbsp;10.39% | &nbsp;&nbsp;10.39% | &nbsp;&nbsp;10.39% |  | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| US$ Fixed Rate | &nbsp;&nbsp;6.2 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;6.2 |
| Average Pay Rate | &nbsp;&nbsp;14% | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| US$ Floating Rate | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| Average Pay Rate | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| CAD Fixed Rate | &nbsp;&nbsp;123.3 | &nbsp;&nbsp;117.1 | &nbsp;&nbsp;108.7 | &nbsp;&nbsp;117.5 | &nbsp;&nbsp;44.4 | &nbsp;&nbsp;- | &nbsp;&nbsp;511.0 |
| Average Pay Rate | &nbsp;&nbsp;5.32% | &nbsp;&nbsp;5.32% | &nbsp;&nbsp;5.32% | &nbsp;&nbsp;5.32% | &nbsp;&nbsp;5.32% | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| CAD Floating Rate | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| Average Pay Rate | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| ***Reais* Denominated Debt Floating Rate –TR:** |  |  |  |  | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| Notional Amount | &nbsp;&nbsp;12.3 | &nbsp;&nbsp;13.4 | &nbsp;&nbsp;14.7 | &nbsp;&nbsp;16.1 | &nbsp;&nbsp;17.6 | &nbsp;&nbsp;63.3 | &nbsp;&nbsp;137.3 |
| TR + Average Pay Rate | &nbsp;&nbsp;9.61% | &nbsp;&nbsp;9.61% | &nbsp;&nbsp;9.61% | &nbsp;&nbsp;9.61% | &nbsp;&nbsp;9.61% | &nbsp;&nbsp;9.61% | &nbsp;&nbsp;- |
| ***Reais* Debt – ICMS Fixed Rate:** |  |  |  |  | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| Notional Amount | &nbsp;&nbsp;144.4 | &nbsp;&nbsp;126.5 | &nbsp;&nbsp;132.7 | &nbsp;&nbsp;66.5 | &nbsp;&nbsp;2.4 | &nbsp;&nbsp;- | &nbsp;&nbsp;472.5 |
| Average Pay Rate | &nbsp;&nbsp;3.72% | &nbsp;&nbsp;3.72% | &nbsp;&nbsp;3.72% | &nbsp;&nbsp;3.72% | &nbsp;&nbsp;3.72% | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| ***Reais* Debt –Fixed Rate:** |  |  |  |  | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| Notional Amount | &nbsp;&nbsp;562.0 | &nbsp;&nbsp; 537.3 | &nbsp;&nbsp; 390.5 | &nbsp;&nbsp; 277.4 | &nbsp;&nbsp;<br> 418.3 | &nbsp;&nbsp;<br> - | &nbsp;&nbsp;<br> 2185.5 |
| Average Pay Rate | &nbsp;&nbsp;9.53% | &nbsp;&nbsp;9.53% | &nbsp;&nbsp;9.53% | &nbsp;&nbsp;9.53% | &nbsp;&nbsp;9.53% | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| ***Reais* Debt – Floating Rate:** |  |  |  |  | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| Notional Amount | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| Average Pay Rate | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - |
| **Total Debt** | &nbsp;&nbsp; **982.6** | &nbsp;&nbsp; **1013.0** | &nbsp;&nbsp; **675.6** | &nbsp;&nbsp; **504.2** | &nbsp;&nbsp; 532.0 | &nbsp;&nbsp; 63.3 | &nbsp;&nbsp; 3770.7 |

---

[**Table of Contents**](#TableOfContents)

***Borrowings***

Most of our borrowings are for general use, based upon strategic capital structure considerations. Although seasonal factors affect the business, they have little effect on our borrowing requirements. We accrue interest based on different interest rates, the most significant of which are: (1) fixed for loans of the Brazilian Economic and Social Development Bank (*Banco Nacional de Desenvolvimento Econômico e Social*), or the BNDES; (2) the Interest Rate Benchmark (*Taxa Referencial*)*,* or TR, for Brazilian real estate receivables certificates (*certificado de recebíveis imobiliários*) and (3) fixed for international loans. For further information, see Note 23 of our audited consolidated financial statements.

The following table sets forth our net cash consolidated position as of December 31, 2022 and 2021:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Net Cash Consolidated Position<br> As of December 31** | &nbsp;&nbsp; **Net Cash Consolidated Position<br> As of December 31** | &nbsp;&nbsp; **Net Cash Consolidated Position<br> As of December 31** | &nbsp;&nbsp; **Net Cash Consolidated Position<br> As of December 31** | &nbsp;&nbsp; **Net Cash Consolidated Position<br> As of December 31** | &nbsp;&nbsp; **Net Cash Consolidated Position<br> As of December 31** |
|  | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** |
|  | &nbsp;&nbsp; **LC(1)** | &nbsp;&nbsp; **FC(2)** | &nbsp;&nbsp; **Total** | &nbsp;&nbsp; **LC(1)** | &nbsp;&nbsp; **FC(2)** | &nbsp;&nbsp; **Total** |
|  | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** | &nbsp;&nbsp;***(in R$ million)*** |
| Short-term debt | &nbsp;&nbsp;(754.3) | &nbsp;&nbsp;(228.2) | &nbsp;&nbsp;(982.6) | &nbsp;&nbsp;(689.3) | &nbsp;&nbsp;(157.9) | &nbsp;&nbsp; (847.1) |
| Long-term debt | &nbsp;&nbsp; (2077.9) | &nbsp;&nbsp; (710.3) | &nbsp;&nbsp; (2788.1) | &nbsp;&nbsp; (1737.0) | &nbsp;&nbsp; (516.5) | &nbsp;&nbsp; (2253.5) |
| **Total** | &nbsp;&nbsp; **(2832.2)** | &nbsp;&nbsp; **(938.5)** | &nbsp;&nbsp; **(3770.7)** | &nbsp;&nbsp; **(2426.3)** | &nbsp;&nbsp; **(674.3)** | &nbsp;&nbsp; **(3100.6)** |
| Cash and cash equivalents (net of bank overdrafts) |  |  | &nbsp;&nbsp;14852.1 |  |  | &nbsp;&nbsp;16597.2 |
| Current Investment securities |  |  | &nbsp;&nbsp; 454.5 |  |  | &nbsp;&nbsp; 1914.6 |
| **Net cash position** |  |  | &nbsp;&nbsp; **11535.9** |  |  | &nbsp;&nbsp; **15411.2** |

---

(1) LC refers to our local currency indebtedness.

(2) FC refers to our foreign currency indebtedness.

[**Table of Contents**](#TableOfContents)

Short-term Debt

As of December 31, 2022, our short-term debt totaled R$982.6 million, 23.2% of which was denominated in foreign currencies. As of December 31, 2021, our short-term debt totaled R$847.1 million, 18.6% of which was denominated in foreign currencies.

Long-term Debt

As of December 31, 2022, our long-term debt, excluding the current portion of long-term debt, totaled R$2,788.1 million, of which R$2,077.9 million was denominated in local currency. As of December 31, 2021, our long-term debt, excluding the current portion of long-term debt, totaled R$2,253.5 million, of which R$1,737.0 million was denominated in local currency.

The table below shows a breakdown of our long-term debt by year:

---

| | |
|:---|:---|
|  | &nbsp;&nbsp; **As of December 31, 2022**  |
| &nbsp;&nbsp;Long-term Debt Maturity in: | &nbsp;&nbsp;***(in R$ million)*** |
| &nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1013.1 |
| &nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 675.6 |
| &nbsp;&nbsp;2026 and Later | &nbsp;&nbsp; 1099.4 |
| &nbsp;&nbsp;**Total** | &nbsp;&nbsp; 2788.1 |

---

In accordance with our foreign currency risk management policy, we have entered into forward and cross-currency interest rate swap contracts in order to mitigate currency and interest rate risks. See "Item 11. Quantitative and Qualitative Disclosures About Market Risk" for our policy with respect to mitigating foreign currency and interest rate risks through the use of financial instruments and derivatives.

As of December 31, 2022, our local currency long-term debt borrowings consisted primarily of lease liabilities (in accordance with IFRS 16) and loans from governmental agencies and BNDES. Long-term local currency also includes long-term plant expansion and other loans from governmental agencies and special BNDES credit lines and programs, such as the Fund for Financing the Acquisition of Industrial Machinery and Equipment (FINAME), the Enterprise Financing Program (FINEM) and leasing of furniture, vehicles, machinery and equipment.

Secured Debt

Certain loans provided by the BNDES are secured by some of our facilities and some of our equipment (mainly coolers).

**Sales Tax Deferrals and Other Tax Credits**

Many states in Brazil offer tax benefits programs to attract investments to their regions. We participate in ICMS Value-Added Tax Credit Programs offered by various Brazilian states which provide (1) tax credits to offset ICMS Value-Added Tax payables and (2) ICMS Value-Added Tax deferrals. In return, we are required to meet certain operational requirements including, depending on the state, production volume and employment targets, among others. All of these conditions are included in specific agreements between Ambev and the state governments. In the event that we do not meet the program's targets, future benefits may be withdrawn. The total amount deferred (financing) as of December 31, 2022 was R$472.5 million with a current portion of R$144.4 million, and R$328.1 million as non-current. Percentages deferred typically range from 46% to 75% over the life of the program. Balances deferred generally accrue interest and are partially inflation indexed, with adjustments generally set at 60% to 75% of a general price index. The grants (tax waivers) are received over the lives of the respective programs. In the years ended December 31, 2022 and 2021, we recorded R$2,535.1 million and R$1,883.1 million, respectively, of tax credits as gains on tax incentive programs.

[**Table of Contents**](#TableOfContents)

**Capital Investment Program**

In 2022, consolidated capital expenditures on property, plant and equipment and intangible assets totaled R$6,533.1 million, consisting of R$4,062.9 million for our Brazil business segment, R$968.4 million for our CAC business segment, R$1,112.8 million related to investments in our Latin America South operations and R$389.0 million related to investments in Canada. These expenditures primarily included investments in capacity expansion, quality controls, automation, modernization and replacement of packaging lines, innovations, warehousing for direct distribution, coolers, expenditures for the replacement of bottles and crates, and continued investments in information technology.

In 2021, consolidated capital expenditures on property, plant and equipment and intangible assets totaled R$7,677.1 million consisting of R$4,645.2 million for our Brazil business segment, R$801.6 million for our CAC business segment, R$1,665.4 million related to investments in our Latin America South operations and R$564.9 million related to investments in Canada. These expenditures primarily included investments in capacity expansion, quality controls, automation, modernization and replacement of packaging lines, innovations, warehousing for direct distribution, coolers, expenditures for the replacement of bottles and crates, market assets from former dealers, and continued investments in information technology.

C.&nbsp;&nbsp;&nbsp;&nbsp; Research and Development

Although the COVID-19 pandemic has created significant challenges for our business, it has also accelerated consumer trends that we have been investing on, primarily reinforcing the need for an innovative, consumer-centric mindset and advancing our business transformation enabled by technology. Innovation has become one of the main pillars of our business and front and center to our commercial strategy and despite a detailed revision of our discretionary expenses in order to ensure our liquidity, research and development is and continued to be seen as fundamental for us to continue providing our consumers with innovations.

We maintain an innovation, research and development center in the city of Rio de Janeiro, State of Rio de Janeiro, at the *Universidade Federal do Rio de Janeiro* (UFRJ). This new center (ZITEC – Zone Innovation and Technology Center) replaces the previous R&D structure based in Guarulhos. ZITEC commenced operations in the final months of 2017, ramping up activities in 2018, in order to accelerate product innovation by developing new liquids and the most modern packaging to assure continuous product differentiation and yearly increases in quality and efficiency. One of the main features of the development center is the prototype laboratory, which enables the creation of complete prototypes, supporting the process of creating new products. Another objective of the development center is to carry out studies of consumers' perception and behavior, in order to capture future trends. ZITEC made it possible for Ambev to reduce the time to launch innovations, from eight to four months. In 2020, continuing with our innovation driven strategy, we launched *Berrió* and *Esmera*, two brands made with local crop productions from in the States of *Piauí* and *Goiás*, respectively, *Andes Origens* and the most successful innovation in Ambev's history, *Brahma Duplo Malte*. In 2021, we continued to expand our assortment with the launch of Michelob Ultra and *Spaten* in Brazil, a Munich Helles style, pure-malt beer. In 2022, two of our main innovations were Budweiser Zero, which was recognized as the best non-alcoholic beer on the Brazilian market by the newspaper "O Estado de São Paulo", and Caipi Beats, a new member of Beats family with caipirinha (a popular Brazilian drink) flavor and made with cachaça. As for innovations in packaging, we developed the exclusive KEG 5L technology, which was awarded the Best Packaging Technology in 2022 by ABRE (*Associação Brasileira de Embalagem*), reinforcing our commitment to Sustainability. The investment made in the development center in the last three years was approximately R$96.0 million, including the R$11 million in 2021 and R$36 million in 2022.

D.&nbsp;&nbsp;&nbsp;&nbsp; Trend Information

Our strategy for 2023 will continue to be built around our brands, innovation, technology and collaboration with our ecosystem.

We are implementing a new version of our main ERP System - S4 Hana, a SAP platform- which will help us book all the transactional data used in our Brazilian operations, which, if not successful, may subject us to adverse effects, increased costs associated with diminished productivity and operating inefficiencies. For further information on risks related to modifications and upgrades to our systems, see "Item 3. Key Information—Risk Factors—Information technology failures, including failures to implement upgrades and new technologies effectively or those that affect the privacy and security of sensitive customer and business information, could disrupt our operations."

Also, in terms of costs, although input cost pressure remains a headwind, we expect to face less pressure than in 2022, with our average BRL/USD hedge rate for 2023 at 5.10, and aluminum hedge as a tailwind. Assuming current commodity prices, we expect our COGS excluding depreciation and amortization per hectoliter in Brazil Beer (excluding non-Ambev marketplace products) to increase between 6.0-9.9%, for the full year of 2023, mostly due to general inflation and higher costs of certain commodities.

[**Table of Contents**](#TableOfContents)

For detailed information regarding the latest trends in our business, see "—A. Operating Results—Year Ended December 31, 2022 Compared to Year Ended December 31, 2021" and "Item 4. Information on the Company—B. Business Overview—Description of the Markets Where We Operate."

E.&nbsp;&nbsp;&nbsp;&nbsp; Critical Accounting Estimates

Our audited consolidated financial statements are presented in accordance with IFRS, as issued by the IASB. The preparation of financial statements in conformity with IFRS requires our management to make judgments, estimates and assumptions that affect the application of accounting practices and the reported amounts of assets and liabilities, income and expenses. The estimates and associated assumptions are based on past experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for decision making regarding the judgments about carrying amounts of assets and liabilities that are not readily evident from other sources. Actual results may differ from these estimates. Notes 3 and 4 to our audited consolidated financial statements include a summary of the critical accounting policies and estimates applied in the preparation of these financial statements. The estimates and assumptions are reviewed on a regular basis. Changes in accounting estimates may affect the period in which they are realized, or future periods.

We have adopted these new accounting standards on the effective date required and, therefore, the audited financial statements included in this annual report as of December 31, 2020 the application of extemporaneous credits.

The following policy was adopted by management during the 2020 reporting period:

Accounting policies for the recognition of extemporaneous tax credits and debts – The accounting policy for the recognition of extemporaneous (related to previous periods) tax credits and debits considered the account origin of the credit or debit up to September 30, 2020. For example, "cost of products sold" is the account of origin for the extemporaneous tax credits or debits related to the acquisition of raw materials. In the same way, depreciation expenses are the account of origin of extemporaneous tax credits or debits related to acquisitions of property, plant and equipment. Following this accounting policy, which has been applied consistently up to the third quarter of 2020, credits referring to the exclusion of circulation of goods and services tax ("ICMS") from the social integration program ("PIS") and contribution to the financing of social security ("COFINS") calculation base have been recognized as a reduction in sales tax expenses, with a positive effect on Net Revenue.

In the third quarter of 2020, the Company (i) obtained final favorable decisions on: (a) lawsuits involving subsidiaries claiming refunds of the PIS and COFINS portion calculated with the inclusion of the ICMS and/or ICMS-ST relating to the period from 1990 onward, and (b) lawsuits involving the Company and its subsidiaries, specifically for the period in which the Special Beverage Regime – ("REFRI") was in place (2009 to 2015), and (ii) is awaiting decisions in lawsuits related to the current taxation model ("New Tax Model") from 2015 onwards. The amounts involved in these lawsuits, referred to in items (i.b) and (ii), are significantly higher than those previously recognized, both for credits of the same type, as for recoveries or tax payments.

[**Table of Contents**](#TableOfContents)

The Company changed its accounting policy to one which better reflects the effects of the recognition of credits arising from final favorable decisions in the lawsuits mentioned above. The previous accounting policy could have given a distorted analysis of the performance for the year, due to the significant increase in the value of credits, so the Company changed its accounting policy to record credits and other extemporaneous tax payments, of any nature, in Other Operating Income (expenses) and, thus is no longer following the original accounting treatment. However, this change in accounting policy does not impact the Net Income, or any of the other balance sheet schedules previously presented, or the amounts recorded in the financial results.

[**Table of Contents**](#TableOfContents)

 

*Predecessor basis of accounting*

In accordance with IAS 8, Management has adopted the predecessor basis of accounting, which is consistent with United States Generally Accepted Accounting Principles ("USGAAP") and United Kingdom Generally Accepted Accounting Principles ("UKGAAP"), to record the carrying amount of the asset received, as recorded by the parent company.

Under the predecessor basis of accounting, when accounting for a transfer of assets between entities under common control, the entity that receives the net assets or the equity interests (the acquirer) shall initially record the assets and liabilities transferred at their parent book value as at the transfer date. If the book value of the assets and liabilities transferred by the parent is different from the historical cost recorded by the controlling entity of the entities under common control (the ultimate parent), the financial statements of the acquirer shall reflect the assets and liabilities transferred at the same cost of the ultimate parent, as a counter-entry to shareholders' equity against the carrying value adjustments.

*Business combination between entities under common control*

Business combinations between entities under common control have not been addressed under IFRS how they should be disclosed remains unclear. IFRS 3 - Business Combinations is the standard applicable to business combinations, but its scope explicitly excludes business combinations between entities under common control, thus, in evaluating transactions of this nature, Management's judgment is required to adequately reflect the essence and economic reality of each transaction.

Goodwill

Goodwill arises on acquisitions of subsidiaries, associates, and joint arrangement and it is determined as the excess between the sum of (i) the consideration paid in exchange for control of the acquiree; plus (ii) the amount of any non-controlling interests in the acquiree (when applicable); and (iii) the fair value, at the acquisition date, of any previous equity interest in the acquiree, over the fair value of the net identifiable assets acquired and liabilities assumed, measured in accordance with IFRS 3 - "Business Combinations" as at the date of acquisition. All business combinations are accounted for using the purchase method.

In compliance with IFRS 3 - "Business Combinations", goodwill is carried at cost and not amortized, but is tested for impairment at least annually, or whenever there are indications that the cash generating unit ("CGU") to which the goodwill has been allocated could be impaired. Impairment losses recognized on goodwill are not reversed. Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold.

Goodwill is expressed in the functional currency of the CGU or joint operation to which it relates and translated into Reais using the year-end exchange rate.

If the Company's interest in the net fair value of the identifiable assets, liabilities and contingent liabilities recognized exceeds the costs of the business combination, such excess is recognized immediately in the income statement. Expenditure on internally generated goodwill is expensed as it is incurred.

Goodwill includes the effects of applying the predecessor basis of accounting (Note 3 (c) to our consolidated financial statements). For associates and joint ventures, goodwill is included in the carrying amount of the investment in the associate/joint venture.

*Joint arrangements*

Joint arrangements are all entities over which the Company shares control with one or more parties. Joint arrangements are classified either as joint operations or joint ventures depending on the contractual rights and obligations of each investor. 

[**Table of Contents**](#TableOfContents)

*Financial reporting in hyperinflationary economies*

Under IAS 29, the non-monetary assets and liabilities, the equity and the income statement of subsidiaries operating in hyperinflationary economies are restated to reflect changes in the general purchasing power of the local currency by applying a general price index. The financial statements of an entity whose functional currency is the currency of a hyperinflationary economy, whether using the historical costs approach or the current costs approach, shall be stated in terms of the unit of measurement in force at the end of the reporting period, and translated into Reais at the closing rate for the period.

[**Table of Contents**](#TableOfContents)

Income tax and social contribution

Income tax and social contribution for the year comprises current tax and deferred tax. Income tax and social contribution are recognized in the income statement, unless they relate to items recognized directly in comprehensive income or other equity accounts. In these cases, the tax effect is also recognized directly in comprehensive income or equity account (except interest on shareholder's equity – see Note 3(i) to our consolidated financial statements).

The current tax expense is the expectation of payment on the taxable income for the year, using tax rates enacted, or substantially enacted, at the balance sheet date, and any adjustment to tax payable in respect of previous years.

Deferred taxes are recognized using the balance sheet liability approach. This means that a deferred tax liability or asset is recognized for all taxable and tax-deductible temporary differences between the tax and accounting basis of assets and liabilities. Under this method, a provision for deferred taxes is also calculated on the differences between the fair value of assets and liabilities acquired in a business combination and their tax basis. IAS 12 prescribes that no deferred tax liability on goodwill recognition, and no deferred tax asset/liability is recorded: (1) at the initial recognition of an asset or liability in a transaction other than a business combination that at the time of the transaction affects neither accounting nor taxable profit or loss and (2) on differences related to investments in subsidiaries to the extent that they are not reversed in the foreseeable future. The amount of deferred tax provided is based on the expectation of the realization or settlement of the temporary difference, using currently or substantially enacted tax rates.

Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax liabilities and assets, and they relate to income taxes levied by the same tax authority on the same taxable entity, or on different taxable entities which intend either to settle current tax liabilities and assets on a net basis, or to realize the assets and settle the liabilities simultaneously.

The deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available. The deferred income tax asset is reduced to the extent that it is no longer probable that the future taxable benefit will occur.

Our aggregate weighted nominal tax rate applicable for the years ended December 31, 2022, 2021 and 2020 was 29.5%, 27.4% and 30.3%, respectively. For the years ended December 31, 2022, 2021 and 2020, our IFRS effective tax rate was (4.6%), 4.6% and 13.1%, respectively.

[**Table of Contents**](#TableOfContents)

The main events that impacted the effective tax rate in 2022 were:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· *government subsidies for sales taxes*: we have state tax incentives within certain local manufacturing
that when reinvested are not taxed for income tax purposes, which explains the impact in the effective tax rate. The amounts are impacted
by fluctuations in production volumes, pricing and eventual fluctuations in state taxation rates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· *complement of income tax on foreign subsidiaries due in Brazil*: our Brazilian resident subsidiaries
are subject to taxation on worldwide income, according to the regulations of Law 12,973/14;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· *withholding income tax:* the amount is mainly related to dividends already distributed and to be
distributed by subsidiaries located outside of Brazil, applicable according to local tax legislation. The amounts recorded in 2022 refer
mainly to the exchange variation of deferred income tax balances.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· *deductible interest on net equity*: under Brazilian law, companies have the option to distribute
interest on equity (or "JCP"), impacted by the taxable result, profit reserves and the long-term interest rate, or TJLP, which
are deductible for income tax purposes under the applicable legislation; in 2022 we distributed approximately R$12 billion as interest
on equity, resulting in a tax impact of approximately R$4 billion;

[**Table of Contents**](#TableOfContents)

Leases

With the adoption of IFRS 16 – Leasings, the Company began to recognize a right-of-use asset and a liability at the date of the beginning of the lease term.

The Company recognizes the right-of-use asset and a corresponding lease liability related to all lease contracts which is the lessee, except for short-term leases (defined as leases with terms of 12-month or less) and leases of low value assets, that comprehend goods with value equal or below US$5,000.00. To these leases, the Company recognizes the lease payments as operating expense during the lease course.

Currently, the main leases by the Company are related to trucks, forklifts, real estate, commercial vehicles and industrial equipment contracts.

The lease liability is initially measured at lease payments present value, discounted by using the rate implicit in the lease. If the rate cannot be promptly determined, the Company uses its incremental loan rate specific for the country, deadline and currency of the contract or other local criteria.

Lease payments include fixed payments, less any lease incentives, variable lease payments that depend on an index or known rate at the commencement date, and purchase options or extension options payments if the Company is reasonably certain to exercise these options. All contracts establish an annual readjustment of payments according to the rates established in the contract.

[**Table of Contents**](#TableOfContents)

A lease liability is remeasured upon a change in the lease term or on the future payments and the corresponding adjustment is also made in right-of-use assets.

The Company applies IAS 36 to determine if right-of-use assets are subject to impairment and to record eventual losses by impairment.

The lease liability is disclosed in the "Interest-bearing loans and borrowing" line and the right-of-use assets are disclosed in the "Property, plant and equipment" line of the balance sheet.

[**Table of Contents**](#TableOfContents)

Recognition of assets and liabilities relating to extemporaneous tax debits or credits

The accounting policy applied by the Company considers the extemporaneous tax credits and debits of any nature as determined by IAS 37 - Provisions, Contingent Liabilities and Contingent Assets, except for income taxes, which the Company applies the policy disclosed in item (i) – Income tax and social contribution of this note.

Credits are recognized only when Management has elements that guarantee (i) that the credit is virtually certain; and (ii) the amount could be estimated with sufficient reliability to enable it to be compensated or refunded. In cases where the recovery of the asset is probable, or the amount cannot be reliably measured, the amounts are not recognized in the account, but presented in Note 30 - Contingencies related to contingent assets. Management understands that, in cases of lawsuits involving contingent assets, a final and unappealable decision on the specific lawsuit of the Company is required to confirm the existence of its rights, except where specific circumstances pertinent to the case allow the recognition of its rights with sufficient objectivity and reliability.

Debits are recognized only when (i) these are based on a past event; (ii) there is a present obligation arising from this past event; (iii) it is probable that an outflow of resources will be required; and (iv) the amount can be estimated sufficiently reliably. If the expected disbursement is possible, or the amount cannot be sufficiently reliably measured, the amounts are presented in Note 30 - Contingencies to our consolidated financial statements.

Contingent assets and liabilities are assessed periodically to ensure that they are appropriately reflected and disclosed in the financial statements.

From October 1, 2020, the accounting policy for the recognition of assets and liabilities of extemporaneous tax credits and debits of any nature to record as "Other operating income/(expenses)", with an exception for amnesty payments, accounted for as exceptional items, given their one-off nature.

[**Table of Contents**](#TableOfContents)

Employee benefits

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(i) Post-employment benefits*

Post-employment benefits include pensions managed in Brazil by Instituto Ambev de Previdência Privada ("IAPP"), post-employment dental benefits and post-employment medical benefits managed by Fundação Zerrenner. Usually, pension plans are funded by payments made by both the Company and its participants, considering the recommendations of independent actuaries. Post-employment dental benefits and post-employment medical benefit obligations are funded using the returns on the assets of the Fundação Zerrenner plan. If necessary, the Company may contribute some of its profits to Fundação Zerrenner.

The Company manages defined benefit and/or defined contribution plans and/or medical and dental assistance plans for the employees of its companies located in Brazil and its subsidiaries located in the Dominican Republic, Barbados, Panama, Uruguay, Bolivia, Argentina and Canada.

The Company maintains both funded and unfunded plans.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(ii) Defined contribution plans*

A defined contribution plan is a pension plan under which the Company pays fixed contributions into a fund. The Company has no legal or constructive obligations to pay further contributions if the fund does not hold sufficient assets to pay all employees for the benefits relating to their service in the current and prior periods.

[**Table of Contents**](#TableOfContents)

The contributions to these plans are recognized as expenses in the period during which they are incurred.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(iii) Defined benefit plans*

Typically, defined benefit plans define an amount of pension benefit that an employee will receive upon retirement, usually dependent on one or more factors such as age, years of service and compensation level.

For defined benefit plans, expenses are assessed separately for each plan using the projected credit unit method. The projected credit unit method considers that each period of service gives rise to an additional unit of benefit and measures each such unit separately. Based on this method, the cost of providing pensions is charged to the income statement over the period of service of the employee. The amounts charged to the income statement consist of current service costs, interest costs, past service costs and the effect of any agreements and settlements. The obligations of the plan recognized in the balance sheet are measured at the present value of the estimated future cash outflows using a discount rate equivalent to the government´s bond rates with maturity terms similar to those of the respective obligation and the fair values of the plan assets.

Past service costs arise from the introduction of a new plan or changes to an existing plan. They are recognized immediately in the income statement, at the earlier of: (i) when the settlement/curtailment occurs; or (ii) when the Company recognizes the related restructuring or termination costs, unless those changes are conditional upon the employee's continued employment, for a specific period of time (the period in which the rights are acquired). In such cases, past services costs are amortized using the straight-line method over the period during which the rights were acquired.

Actuarial gains and losses consist of the effects of differences between the previous actuarial assumptions and the actual results, and the effects of changes in actuarial assumptions. Actuarial gains and losses are fully recognized in carrying value adjustments.

Remeasurements, representing actuarial gains and losses, the effect of the asset ceiling and the return on plan assets, both excluding net interest, are recognized in full in the period in which they occur in the statement of comprehensive income. Remeasurements are not reclassified to profit or loss in subsequent periods.

When the amount of the defined benefit obligation is negative (an asset), the Company recognizes those assets (prepaid expenses), to the extent of the value of the economic benefit available to the Company either from refunds or reductions in future contributions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(iv) Other post-employment obligations*

The Company and some of its subsidiaries provide post-employment medical benefits, the reimbursement of medication expenses and other benefits to certain retirees. These benefits are not granted to new retirees. The expected costs of these benefits are recognized over the period of employment, using an accounting methodology like that for defined benefit plans, including actuarial gains and losses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(v) Termination benefits*

Termination benefits are recognized as expenses at the earlier of: (i) when the Company is demonstrably committed, without a realistic possibility of withdrawal, to a formal detailed plan to terminate employment before the normal retirement date; and (ii) when the Company recognizes costs related to restructuring.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(vi) Bonuses*

Bonuses granted to employees and managers are based on pre-defined company and individual target achievement. The estimated amount of the bonus is recognized as an expense in the period during which the bonus is earned.

[**Table of Contents**](#TableOfContents)

Share-based payments

Different share based and stock option programs allow management and other members appointed by the Board of Directors and People Committee, as each case, to acquire shares in the Company as in Note 25 - Share-based payments to our consolidated financial statements.

Provisions and Contingent Liabilities

Provisions are recognized when: (i) the Company has a present obligation (legal or constructive) as a result of past events; (ii) it is likely that a future disbursement will be required to settle the current obligation; and (iii) the amount of the obligation can be estimated reliably

Provisions, except for those mentioned in the line item Disputes and litigation, are determined by discounting the expected future cash flow, to a pre-tax rate, which reflects the current market assessments of the time value of money and, where appropriate, the risks specific to the liability.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(i) Restructuring*

A provision for restructuring is recognized when the Company has approved a detailed restructuring plan, and the restructuring has either commenced or been announced. Costs relating to the ongoing and future activities of the Company are not provided for but are recognized when expenses are incurred. The provision includes the benefit commitments in connection with early retirement and redundancy schemes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(ii) Disputes and Litigations*

A provision for disputes and litigation is recognized when it is more likely than not that the Company will be required to make future payments as a result of past events. Such items may include but are not limited to, claims, suits and actions filed by or against the Company relating to antitrust laws, violations of distribution and license agreements, environmental matters, employment-related disputes, claims from the tax authorities, and other matters.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(iii) Contingent liabilities*

The Company and its subsidiaries have tax, civil and labor lawsuits defined as contingent liabilities, according to IAS 37, for which no provisions have been recorded, due to the judgment by management for developing the estimate. Possible contingent liabilities are not recognized but are disclosed in note 30 – Contingencies to our consolidated financial statements. The contingent liabilities with remote possibility of outflow in settlement are not disclosed, as the possibility of any disbursement in the settlement is remote, in accordance with IAS 37.

From the fourth quarter of 2022 onwards, the nomenclature of the accounting policy "provisions" was changed to "provisions and contingent liabilities".

Financial Instruments and hedge accounting

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(i) Classification and Measurement*

The company uses financial instruments to implement its risk management strategy and policy. Derivatives are generally used to mitigate the impact on the Company's performance due to changes in foreign currencies, interest rates, equity prices and commodity prices. The Company's financial risk management policy prohibits the use of derivatives not related to the Company's core business.

Financial assets (except for accounts receivable without a significant financing component) or financial liabilities are initially measured at fair value, plus, for an item not measured at fair value through profit or loss, transaction costs directly attributable to their acquisition or issue. Accounts receivable without a significant financing component are initially measured at the transaction price.

Upon initial recognition, a financial asset is classified either: (i) at amortized cost; (ii) at fair value through other comprehensive income - debt instruments; (iii) at fair value through other comprehensive income - equity instruments; or (iv) at fair value through profit or loss.

[**Table of Contents**](#TableOfContents)

Financial assets are not reclassified subsequently to initial recognition, unless the Group changes the business model for the management of financial assets, in which case all impacted financial assets are reclassified on the first day of the post-change business model.

The classification of the Company's financial assets is as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;▪ Debt instruments at fair value through other comprehensive income, with gains or losses recycled to profit or loss upon derecognition. Financial assets in this category quoted debt instruments held by the Company in line with its business model either to collect cash flow or for sale.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;▪ Equity instruments designated as at fair value through other comprehensive income, with no recycling of gains or losses to the profit or loss upon derecognition. This category only includes equity instruments which the company intends to hold for the foreseeable future, and which it has irrevocably elected to classify thus upon their initial recognition or transition. These instruments are not subject to impairment testing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;▪ Financial assets and liabilities at FVPL: comprise derivative instruments and equity instruments which were not designated as FVOCI. This category also includes debt instruments with cash flow characteristics which are not held within a business model with the objective either to collect contractual cash flow, or both to collect contractual cash flow and for sale.

The measurement of the Company's financial assets is as follows:

*Hedge accounting*

The company designates certain derivatives as hedging instruments to hedge the risk related to the variability of foreign exchange rates, interest rates and commodity prices. Derivative financial instruments, that are contracted to protect against the exposure, but that do not meet all of the hedge accounting requirements, will be recognized at fair value through profit or loss.

Derivative financial instruments are initially recognized at fair value. The fair value is the value at which an asset can be realized, or a liability settled, between knowledgeable and willing to negotiate parties of such financial instruments' characteristics under normal market conditions. The fair value of derivative financial instruments can be obtained from market prices or from pricing models that reflect current market rates, as well as the credit quality of the counterparty.

Subsequent to initial recognition, derivative financial instruments are remeasured to their fair value as at the date of the financial statements. Changes in the fair values of derivative financial instruments are recognized in current income, except when these instruments are cash flow hedges or net investment hedges, where portions of gains or losses on the hedge instrument defined as effective hedges are recognized in comprehensive income. The hedge designated instrument is the effective element present in the term contract, of which only the present element value change is recognized in comprehensive income. The term element, which can be separated and excluded from the financial instrument designation as hedge instrument is recognized in financial result, in accordance with IFRS 9 - Financial Instruments.

The Company contracts commodities derivatives which have similar terms to the hedged items. The Company applies component hedging to its commodities. The hedged component is contractually specified and matches with what is defined in the derivative contract, and therefore the hedge ratio is always 1:1. Hedge effectiveness is assessed on a qualitative basis. Whenever the terms do not match, the company uses the hypothetical derivatives method to assess the hedge effectiveness. Therefore, usually causes of ineffectiveness include changes in the timing of forecast transactions, changes in the quantity of the commodity to be hedged, or changes in the credit risk of either party to the derivative contract.

*Cash flow hedge accounting*

Cash flow hedges are used to protect the cash flow exposure of a recorded asset or liability, or the foreign currency risk or commodity price variations associated with a highly probable transaction, the effective portion of any (gain or loss) on the derivative financial instrument is recognized directly in the comprehensive income statement (cash flow hedge reserve), and will be reclassified from the cash flow hedge reserve to the same line item within which and the same period during which the cash flow futures were hedged. The ineffective portion of any gain or loss is recognized immediately in the current income statement, in the financial result.

[**Table of Contents**](#TableOfContents)

When a hedging instrument or a hedging relationship is terminated, but the hedged transaction is still expected to occur, the cumulative gains and losses (up to the date of termination) remain within comprehensive income, being reclassified in accordance with the above practice, when the transaction being protected occurs. If the hedged transaction is no longer probable, the accumulated gains and losses recognized in comprehensive income are reclassified immediately to the current income statement.

*Fair value hedge accounting*

When a derivative is intended to hedge the variability in the fair value of a recognized asset or liability, or of a firm commitment, any resulting (gain or loss) on the hedging instrument is recognized in profit or loss. The carrying amount of the hedged item is also adjusted for changes in the fair value related to the risk being hedged, with any gain or loss being recognized in the income statement.

*Net investment hedge accounting*

When a non-derivative foreign currency liability hedges a net investment in a foreign operation, exchange differences arising on the translation of the liability into the functional currency are recognized directly in other comprehensive income (translation reserves). Any ineffectiveness is recognized immediately in profit or loss.

When a derivative financial instrument hedges a net investment in a foreign operation, the portion of the gain or loss on the hedging instrument that is determined to be effective is recognized directly in other comprehensive income (translation reserves), while the ineffective portion is reported in profit or loss.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(ii) Derivatives at fair value through profit or loss*

Certain derivative financial instruments do not qualify for hedge accounting. Changes in the fair values of any of those derivative financial instruments are recognized immediately in profit or loss.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(iii) Impairment of financial assets* 

On an annual basis, Management performs impairment testing for financial assets or groups of financial assets. If a trigger event occurs, a financial asset or group of financial assets will be deemed to be impaired. An asset or group of financial assets is deemed impaired, and impairment losses are recorded, only if there is evidence of impairment as a result of one or more events occurring after the initial recognition of the assets (a "loss event") and that event (or events) has an impact on the estimated future cash flow from the financial asset or group of financial assets and can be estimated reliably.

Impairment of non-financial assets

The carrying amounts of non-financial assets, such as property, plant and equipment and intangible assets with defined useful lives are reviewed, at least, at each reporting date to determine the existence of any indication of impairment. If there is any indication, the asset's recoverable amount is estimated, and the non-recoverable amount is recognized as an impairment in the income statement.

The goodwill and intangible assets with indefinite useful life are tested for impairment on an annual basis, regardless of any indication, by comparing its accounting value with its recoverable value.

Goodwill, intangible assets not yet available for use, and intangibles with indefinite useful lives, are tested for impairment at the business unit level (one level below the reportable segment level) at least annually, or whenever there is any indication of impairment.

An impairment loss is recognized whenever the carrying amount of an asset or the related cash-generating unit ("CGU") exceeds its recoverable amount. Impairment losses are recognized in the income statement. Intangible assets with an indefinite useful life are tested on a fair value approach applying multiples that reflect current market transactions to indicators that drive the profitability of the asset or the royalty stream that could be obtained from licensing the intangible asset to another party in an arm's length transaction.

[**Table of Contents**](#TableOfContents)

The recoverable amounts of other assets are determined as the higher of their fair value less costs to sell and their value in use. For an asset that does not generate substantially independent cash inflows, the recoverable amount is allocated to the CGU to which the asset belongs. The recoverable amounts of the CGU to which the goodwill and the intangible assets with indefinite useful lives belong are based on the fair value net of selling expenses, using EBITDA multiples observed in the market for previous business combinations involving comparable businesses in the brewing industry. For some CGUs, these calculations are corroborated using the fair-value less costs of disposal approach, where the free cash flow of these CGUs is discounted to fair value using a discount rate after tax that reflects current valuation models for the time value of money, and the risks specific to the asset.

Non-financial assets, except for goodwill, are reviewed for the possible reversal of the impairment at the reporting date. Impairment losses are reversed only to the extent that the asset's carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

Tax incentives and subsidized loans

The Company is entitled to state tax benefits in Brazil, provided by government grants. Referred grants may be in the form of rate reduction, calculation basis reduction, financing or subsidized loans, presumed credits, effective collection, payment deferral or partial reductions of state tax payable. The effective collection incentives are recorded in the operating net revenue, due to its nature, as the others are recognized in other operating income.

As before mentioned, among the tax incentives granted to the Company, there are state tax incentive programs to promote industrial development either by financing or by deferring payment of taxes. These state programs are intended to promote, in the long-term, increases in employment rates, industrial decentralization, as well as to complement and diversify states industrial matrix.

In the case of these programs, the tax terms are set out in the respective state normative acts and state concessive acts, depending on their nature, when conditions for obtaining these grants exist, they are under the Company's control. Such benefits comply with the systematic set by Complementary Federal Law 160/2017 and by Convênio CONFAZ 190/2017. The benefit of deferred the payment of such taxes is recorded in the income statement, on an accrual basis.

The financing or payment deferral forms of benefits, as the interest rates and terms of these loans could be advantageous compared to market conditions, are considered as subsidized loans as intended by IAS 20. The respective subsidies consist of the gains identified by comparing the value of these operations under the market conditions to the value agreed in the contracts. Thereby, upon receipt of funding, the subsidy calculated is recorded in Other operating income, following the treatment for the other ICMS subsidies of similar nature. Management reviews the market conditions prevailing in the year to assess such subsidies on an annual basis.

Monthly, considering the value of the consideration, the period to maturity, the contract interest rate and the abovementioned discount rate, the reduction in present value adjustment is allocated to financial income, to bring the balance to zero by the time of settlement of each consideration

Such financing is recognized as liability adjusted to its present value. When there is an intervening financial institution in the transaction, the financing is recorded at "Interest-bearing loans and borrowings", otherwise, its recorded at "Trade payables", due to the underlying economic essence and nature of the transaction.

From the fourth quarter of 2022, "Government grants" nomenclature was changed to "Tax incentives and subsidized loans".

[**Table of Contents**](#TableOfContents)

ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES

A.&nbsp;&nbsp;&nbsp;&nbsp; Directors and Senior Management

The Board of Directors oversees Ambev's executive officers. The Board of Directors is currently comprised of eleven effective members and one alternate member and provides the overall strategic direction of Ambev. Directors are elected at general shareholders' meetings for a three-year term, re-election being permitted. Day-to-day management is delegated to the executive officers of Ambev, of which there are currently fourteen. The Board of Directors appoints executive officers for a three-year term, re-election being permitted. The Shareholders' Agreement regulates the election of directors of Ambev by the controlling shareholder. See "Item 7. Major Shareholders and Related Party Transactions—A. Major Shareholders—Ambev's Major Shareholders—The Shareholders' Agreement—Management of Ambev."

**Directors**

The following table sets forth information with respect to the current directors of Ambev:

---

| | | | | |
|:---|:---|:---|:---|:---|
| &nbsp;&nbsp; **Board of Directors(1)** | &nbsp;&nbsp; **Board of Directors(1)** | &nbsp;&nbsp; **Board of Directors(1)** | &nbsp;&nbsp; **Board of Directors(1)** | &nbsp;&nbsp; **Board of Directors(1)** |
| &nbsp;&nbsp; **Name** | &nbsp;&nbsp; **Age** | &nbsp;&nbsp; **Position** | &nbsp;&nbsp; **Director Since(2)** | &nbsp;&nbsp; **Term Expires(3)** |
| &nbsp;&nbsp;Victorio Carlos De Marchi | &nbsp;&nbsp;84 | &nbsp;&nbsp;Co-Chairman and Director | &nbsp;&nbsp;1999 | &nbsp;&nbsp;2023 |
| &nbsp;&nbsp;Michel Dimitrios Doukeris (5) | &nbsp;&nbsp;49 | &nbsp;&nbsp;Co-Chairman and Director | &nbsp;&nbsp;2018 | &nbsp;&nbsp;2023 |
| &nbsp;&nbsp;Milton Seligman | &nbsp;&nbsp;71 | &nbsp;&nbsp;Director | &nbsp;&nbsp;2018 | &nbsp;&nbsp;2023 |
| &nbsp;&nbsp;Roberto Moses Thompson Motta | &nbsp;&nbsp;65 | &nbsp;&nbsp;Director | &nbsp;&nbsp;1999 | &nbsp;&nbsp;2023 |
| &nbsp;&nbsp;Fabio Colletti Barbosa (4) | &nbsp;&nbsp;68 | &nbsp;&nbsp;Director | &nbsp;&nbsp;2021 | &nbsp;&nbsp;2023 |
| &nbsp;&nbsp;Fernando Mommensohn Tennenbaum (4) | &nbsp;&nbsp;46 | &nbsp;&nbsp;Director | &nbsp;&nbsp;2021 | &nbsp;&nbsp;2023 |
| &nbsp;&nbsp;Lia Machado de Matos (4) | &nbsp;&nbsp;45 | &nbsp;&nbsp;Director | &nbsp;&nbsp;2021 | &nbsp;&nbsp;2023 |
| &nbsp;&nbsp;Nelson José Jamel | &nbsp;&nbsp;51 | &nbsp;&nbsp;Director | &nbsp;&nbsp;2017 | &nbsp;&nbsp;2023 |
| &nbsp;&nbsp;Antonio Carlos Augusto Ribeiro Bonchristiano | &nbsp;&nbsp;55 | &nbsp;&nbsp;Director (Independent) | &nbsp;&nbsp;2014 | &nbsp;&nbsp;2023 |
| &nbsp;&nbsp;Marcos de Barros Lisboa | &nbsp;&nbsp;58 | &nbsp;&nbsp;Director (Independent) | &nbsp;&nbsp;2014 | &nbsp;&nbsp;2023 |
| &nbsp;&nbsp;Claudia Quintella Woods (4) | &nbsp;&nbsp;47 | &nbsp;&nbsp;Director (Independent) | &nbsp;&nbsp;2021 | &nbsp;&nbsp;2023 |
| &nbsp;&nbsp;Carlos Eduardo Klutzenschell Lisboa | &nbsp;&nbsp;54 | &nbsp;&nbsp;Director (Alternate) | &nbsp;&nbsp;2018 | &nbsp;&nbsp;2023 |

---

(1) Victorio Carlos De Marchi, Co-Chairman of the Board of Directors of Ambev, was appointed by FAHZ, the
former controlling shareholder of Antarctica, while Michel Dimitrios Doukeris was appointed by ABI and is also the Chief Executive Officer
of ABI. ABI appointed five directors: Milton Seligman, Roberto Moses Thompson Motta, Nelson José Jamel, Fernando Mommensohn Tennenbaum
and Lia Machado de Matos in addition to the alternate director Carlos Eduardo Klutzenschell Lisboa. FAHZ also appointed Fabio Colletti
Barbosa. The three independent directors Antonio Carlos Augusto Ribeiro Bonchristiano, Marcos de Barros Lisboa and Claudia Quintella Woods
were appointed jointly by ABI and FAHZ.

(2) Directors first elected to our board of directors prior to 2013 were originally appointed as directors
of Old Ambev. Directors first elected to our Board of Directors on or after 2013 were originally elected as directors of Ambev S.A.

(3) Annual Shareholders' General Meeting held in April 2023.

(4) Directors elected by the board of directors in March 2021 pursuant to our bylaws to replace directors
who previously resigned.

(5) Director elected by the board of directors in May 2021 pursuant to our bylaws to replace one director
who previously resigned.

The following are brief biographies of each of Ambev's directors:

**Victorio Carlos De Marchi**. Mr. De Marchi is Co-Chairman of the Board of Directors of Ambev. He also serves as president of the Operations and Finance Committee, the Governance Committee and the People Committee of Ambev. Mr. De Marchi joined Antarctica in 1961 and held various positions during his tenure, including Chief Executive Officer from 1998 to April 2000. Mr. De Marchi is currently the Chairman of the Board of Directors and the President of *Fundação Antônio e Helena Zerrenner –* FAHZ, a member of the board of *Instituto de Estudos para o Desenvolvimento Industrial*, an alternate member of the board of directors of Itausa S.A. and a member of the deliberative council of *Instituto Brasileiro de Ética Concorrencial* – ETCO. Mr. De Marchi has a degree in economics from *Faculdade de Economia, Finanças e Administração de São Paulo* and a law degree from *Faculdade de Direito de São Bernardo do Campo*.

**Michel Dimitrios Doukeris.** Mr. Doukeris is Co-chairman of the Board of Directors of Ambev. Mr. Doukeris is ABI's CEO since July 1, 2021. He joined the Company in 1996 and held a number of commercial operations roles in Latin America before moving to Asia where he led ABI's China and Asia Pacific operations for seven years. In 2016 he moved to the U.S. to assume the position of global Chief Sales Officer. In January 2018 he became the leader of Anheuser-Busch and the North American business. Mr. Doukeris holds a degree in chemical engineering from *Universidade Federal Santa Catarina* and a master's degree in marketing from *Fundação Getulio Vargas*. He has also completed post-graduate programs in marketing and marketing strategy from the Kellogg School of Management and Wharton Business School in the United States.

[**Table of Contents**](#TableOfContents)

**Milton Seligman.** Mr. Seligman is a member of the Board of Directors of Ambev. He served as Corporate Affairs Officer of the Company from 2004 until 2013 and was also a member of the board of directors of Tenedora CND S.A. from 2013 to 2016. He is currently the managing partner of *Milton Seligman e Associados Consultoria e Participações Ltda*., member of the board of directors of BRMalls Participações S.A. from 2022 to 2023, president of the board of directors of *Instituto Sonho Grande*, consultant member of *Fundação Lemann*, member of the board of directors of FAHZ, fellow of the INSPER Management and Public Policy Center and Global Fellow of the Brazil Institute at the Woodrow Wilson International Center for Scholars, in Washington D.C. Mr. Seligman has a degree in electrical engineering from *Universidade Federal de Santa Maria*.

**Roberto Moses Thompson Motta.** Mr. Thompson is a member of the Board of Directors and the Operations and Finance Committee of Ambev. Mr. Thompson was a co-founder and board member of 3G Capital and a former board member of Restaurant Brands International and a board member of StoneCo Ltd. He holds a degree in engineering from *Pontifícia Universidade Católica do Rio de Janeiro*, and an MBA from the Wharton School of the University of Pennsylvania where he is member of the Graduate Executive Board.

**Fabio Colletti Barbosa**. Mr. Barbosa is a member of the Board of Directors and the Governance Committee of Ambev. Mr. Barbosa is currently Natura&Co Holding S.A. CEO and a member of the board of directors of Itaú-Unibanco, Cia Brasileira de Metalurgia e Mineração, the United Nations Foundation, the Endeavor Institute and the Public Leadership Center in Brazil. Mr. Barbosa was a former CEO of Banco ABN Amro Real, Banco Santander (Brasil) S.A., Abril Media and Febraban. Mr. Barbosa holds a degree in business administration from *Fundação Getulio Vargas* and a MBA from the Institute for Management Development (Switzerland).

**Claudia Quintella Woods**. Ms. Woods is an independent member of the Board of Directors and a member of the People Committee of Ambev. She is Latin America Chief Executive Officer of WeWork, since June 2021. Ms. Woods was previously the General Manager of Uber in Brazil between 2019 and 2021, the CEO of Webmotors, a leading online marketplace for cars from 2018 until 2019 and Director and Superintendent of Banco Original from 2014 to 2018. She holds a bachelor's degree from Bowdoin College (USA), a MBA from COPPEAD/*Universidade Federal do Rio de Janeiro* and a certificate from Harvard Business School.

**Fernando M. Tennenbaum**. Mr. Tennenbaum is a member of the Board of Directors and of the Operations and Finance Committee of Ambev. Mr. Tennenbaum is ABI's Chief Financial Officer since April 29, 2020. He joined our Company in 2004 and has held various roles in the finance function including Treasury, Investor Relations and M&A. He most recently served as the Vice President of Finance for ABI's South America Zone and Ambev's Chief Financial and Investor Relations Officer. He is a dual citizen of Brazil and Germany and holds a degree in industrial engineering from *Escola Politécnica da Universidade de São Paulo* and a corporate MBA from Ambev.

**Lia Machado de Matos**. Ms. Matos is a member of the Board of Directors of Ambev. Since 2016 she is the Chief Strategy Officer of Stone Co. Prior to that, Ms. Matos was a Family Office Director for Varbra from 2012 through 2016 and previously she served in several positions at McKinsey Consulting Company from 2006 through 2012, including Associate Partner. Ms. Matos holds a degree in Physics from the *Universidade Federal do Rio de Janeiro* and a PhD in physics and electrical engineering from the Massachusetts Institute of Technology.

**Nelson José Jamel**. Mr. Jamel is a member of the Board of Directors and the People Committee of Ambev. He joined the Company in 1997 and has held various positions in the Company. From 2009 to 2015, he served as Chief Financial and Investor Relations Officer of the Company. From 2016 to 2019, he served as Vice President for ABI's North America Zone, initially as Finance Vice President and since 2017 as Finance and Solutions Vice President. Currently he is the Chief People Officer of ABI. Mr. Jamel holds a degree in production engineering from Universidade Federal do Rio de Janeiro and a M.Sc in production engineering from the Universidade Federal do Rio de Janeiro.

[**Table of Contents**](#TableOfContents)

**Antonio Carlos Augusto Ribeiro Bonchristiano**. Mr. Bonchristiano is an independent member of the Board of Directors of Ambev. He currently is a member of the board and the Chief Executive Officer of GP Investments Ltd. and also serves as a member of the board of directors of G2D Investments, *AKAD Seguros,* BR Properties S.A., of the Bodleian Library Advisory Board and University of Oxford. Mr. Bonchristiano has a degree in politics, philosophy and economics from the University of Oxford.

**Marcos de Barros Lisboa**. Mr. Barros Lisboa is an independent member of the Board of Directors and the Governance Committee of Ambev. He has also acted as an executive officer of Unibanco S.A and vice-president of Operational Insurance, Controls and Support of Itaú Unibanco S.A, both companies with main activities in the financial segment. Further, during 2005 and 2006 he was the president of Instituto Brasil Resseguros S.A, between 2003 and 2005, he acted as Secretary of Economic Politics of Federal Revenue Office (*Ministério da Fazenda*). He is currently a member of the board of directors of Cerradinho Bioenergia S.A., CERC - Central de Recebíveis S.A. and Meliuz. Mr. Barros Lisboa has a degree and a masters' degree in economics from *Universidade Federal do Rio de Janeiro* and a Ph.D. in economics from the University of Pennsylvania. Since the end of the 80s, he has developed activities in the faculty of several teaching institutions in Brazil and abroad.

**Carlos Eduardo Klutzenschell Lisboa**. Mr. Klutzenschell Lisboa is an alternate member of the Board of Directors of Ambev. He joined the Company in 1993 and, since then, has held several positions in the Company. He served as Ambev's Marketing Vice-President between 2005 and 2011, as President of BU Austral at Latin America South Zone of Ambev between 2011 and 2012, and as President of Labatt, our subsidiary in Canada, between 2013 and 2014. Mr. Klutzenschell Lisboa held the positions of Global Vice President for Global Brands at ABI, between 2014 and 2016, and of Zone President of Latin America South Zone of Ambev, between 2016 and 2018. Currently he serves as ABI's Zone President of Middle Americas Zone.

**Executive Officers**

The following table sets forth information with respect to the current executive officers of Ambev:

---

| | | | | |
|:---|:---|:---|:---|:---|
| &nbsp;&nbsp; **Name** | &nbsp;&nbsp; **Age** | &nbsp;&nbsp; **Position** | &nbsp;&nbsp; **Executive Officer Since** | &nbsp;&nbsp; **Term Expires(1)** |
| &nbsp;&nbsp;Jean Jereissati Neto | &nbsp;&nbsp;48 | &nbsp;&nbsp;Chief Executive Officer | &nbsp;&nbsp;2019 | &nbsp;&nbsp;2024 |
| &nbsp;&nbsp;Lucas Machado Lira | &nbsp;&nbsp;46 | &nbsp;&nbsp;Chief Financial, Investor Relations and Shared Services Officer | &nbsp;&nbsp;2020 | &nbsp;&nbsp;2024 |
| &nbsp;&nbsp;Leticia Rudge Barbosa Kina | &nbsp;&nbsp;46 | &nbsp;&nbsp;Legal and Compliance Vice President Officer | &nbsp;&nbsp;2019 | &nbsp;&nbsp;2024 |
| &nbsp;&nbsp;Ricardo Morais Pereira de Melo | &nbsp;&nbsp;51 | &nbsp;&nbsp;People and Management Vice President Officer | &nbsp;&nbsp;2016 | &nbsp;&nbsp;2024 |
| &nbsp;&nbsp;Eduardo Braga Cavalcanti de Lacerda | &nbsp;&nbsp;46 | &nbsp;&nbsp;Commercial Vice President Officer | &nbsp;&nbsp;2018 | &nbsp;&nbsp;2024 |
| &nbsp;&nbsp;Valdecir Duarte | &nbsp;&nbsp;42 | &nbsp;&nbsp;Industrial Vice President Officer | &nbsp;&nbsp;2022 | &nbsp;&nbsp;2024 |
| &nbsp;&nbsp;Paulo André Zagman | &nbsp;&nbsp;46 | &nbsp;&nbsp;Logistics Vice President Officer | &nbsp;&nbsp;2019 | &nbsp;&nbsp;2024 |
| &nbsp;&nbsp;Carla Smith de Vasconcellos Crippa Prado | &nbsp;&nbsp;40 | &nbsp;&nbsp;Corporate Affairs Vice President Officer | &nbsp;&nbsp;2022 | &nbsp;&nbsp;2024 |
| &nbsp;&nbsp;Rodrigo Figueiredo de Souza | &nbsp;&nbsp;46 | &nbsp;&nbsp;Procurement Vice President Officer | &nbsp;&nbsp;2015 | &nbsp;&nbsp;2024 |
| &nbsp;&nbsp;Eduardo Eiji Horai | &nbsp;&nbsp;37 | &nbsp;&nbsp;Information Technology Vice President Officer | &nbsp;&nbsp;2020 | &nbsp;&nbsp;2024 |
| &nbsp;&nbsp;Daniel Cocenzo | &nbsp;&nbsp;48 | &nbsp;&nbsp;Sales Vice President Officer | &nbsp;&nbsp;2020 | &nbsp;&nbsp;2024 |
| &nbsp;&nbsp;Daniel Wakswaser Cordeiro | &nbsp;&nbsp;38 | &nbsp;&nbsp;Marketing Vice President Officer | &nbsp;&nbsp;2020 | &nbsp;&nbsp;2024 |
| &nbsp;&nbsp;Pablo Firpo | &nbsp;&nbsp;42 | &nbsp;&nbsp;Non-Alcoholic Beverages Vice President Officer | &nbsp;&nbsp;2020 | &nbsp;&nbsp;2024 |
| &nbsp;&nbsp;Daniela Gavranic Cachich | &nbsp;&nbsp;49 | &nbsp;&nbsp;Future Beverages Vice President Officer | &nbsp;&nbsp;2022 | &nbsp;&nbsp;2024 |

---

(1) The term of office will be unified until December 31, 2024.

[**Table of Contents**](#TableOfContents)

The following are brief biographies of each of Ambev's executive officers:

**Jean Jereissati Neto**. Mr. Jereissati is Ambev's CEO. He joined Ambev in 1998 and has held various positions at Ambev and ABI, including Chief Executive Officer of the Central America and Caribbean business unit of Ambev, Chief Executive Officer of China's operations of ABI, Chief Executive Officer of Asia and Pacific North Zone of ABI and Chief Sales and Marketing Officer of Ambev. Mr. Jereissati holds a degree in business administration from *Fundação Getulio Vargas* and a Corporate MBA from Ambev.

**Lucas Machado Lira**. Mr. Lira is Ambev's Chief Financial, Investor Relations and Shared Services Officer. He joined the Company in 2005 and, since then, has held leadership positions in different functions, including Head of Investor Relations, Supply Chain PMO, Corporate & Compliance Director, and Legal Manager for HILA and M&A at Ambev, as well as Global Finance Vice President for M&A, Global Legal Vice President Commercial/M&A and Global Finance Director for M&A at ABI. Mr. Lira holds a degree in law from *Universidade Federal de Minas Gerais* – UFMG and an LL.M. from Columbia University School of Law.

**Leticia Rudge Barbosa Kina**. Ms. Kina is Ambev's Legal and Compliance Vice President Officer. She joined the Company in 2002 and has held several positions, including Legal Tax Manager and Corporate and Litigation Officer. Ms. Kina is also a member of the Board of Directors of WILL – Women in Leadership in Latin America, an international non-profit organization. Ms. Kina holds a law degree from *Pontifícia Universidade Católica de Campinas* and a degree in economics from *Universidade Estadual de Campinas,* in addition to a Corporate MBA from Ambev, a specialization in tax law from *Universidade de São Paulo* and a corporate reputation course from Stanford University.

**Ricardo Morais Pereira de Melo**. Mr. Melo is Ambev's People and Management Vice President Officer. Since he joined the Company in 1996, he has held various positions in the sales department, including Commercial Manager in Recife, Salvador and São Paulo, Regional Sales Director in the Northeast and Rio de Janeiro regions. Mr. Melo was also the Vice President of Sales at Labatt, Ambev's subsidiary in Canada, and Vice President of Sales Strategy at ABI, in the United States and Sales Vice President in Brazil before current position. Mr. Melo holds a degree in civil engineering from *Universidade Católica de Pernambuco* and a Corporate MBA from Ambev.

**Eduardo Braga Cavalcanti de Lacerda**. Mr. Lacerda is Ambev's Commercial Vice President Officer. Since 2001, when he joined the Company, he has held various positions, including Non-Alcoholic Vice President Officer for Ambev, Chief Executive Officer for CAC business unit of Ambev, Financial Vice President Officer in Europe for ABI, FP&A Global Vice President for ABI and head of M&A in Europe for ABI. Mr. Lacerda holds a degree in engineering from *Pontifícia Universidade Católica do Rio de Janeiro*.

**Valdecir Duarte**. Mr. Duarte is Ambev's Industrial Vice President Officer. Since he joined the Company in 1998, Mr. Duarte has held various positions, including Director of the Company's Engineering Center (CENG), Regional Director and Plant and Supply Chain Manager. Mr. Duarte holds a degree in engineering and a postgraduate degree in Global Business from Columbia Business School, in Corporate Management from INSPER and an Executive Program for Growing Companies from Stanford University.

**Paulo André Zagman**. Mr. Zagman is Ambev's Logistics Vice President Officer. Since 2002, when he joined the Company, he has held several positions, including Chief People Officer and Chief Logistics Officer in Latin America South zone of Ambev. Mr. Zagman holds a degree in civil engineering from *Pontifícia Universidade Católica do Rio de Janeiro* and a specialist degree in supply chain and logistics from Massachusetts Institute of Technology and Stanford Graduate School of Business Executive Education.

**Carla Smith de Vasconcellos Crippa Prado.** Ms. Prado is Ambev's Corporate Affairs Vice President Officer. In the last 5 years, she has held several positions in the Company, including Corporate Affairs Vice President of BU Brazil, Director of Communications and Sustainability, Social Responsibility Manager and Legal Manager. Between 2020 and 2021 she was President of SINDICERV-National Union of the Beer Industry. She holds a Law degree from *Pontifícia Universidade Católica de São Paulo* and an Economics degree from the *Universidade de São Paulo*, in addition to a Masters in Law from *Pontifícia Universidade Católica de São Paulo* and a Corporate MBA from *Insper*.

[**Table of Contents**](#TableOfContents)

**Rodrigo Figueiredo de Souza**. Mr. Figueiredo is Ambev's Procurement Vice President Officer. Since 1997, when he joined the Company as trainee, he has held various positions in Ambev and ABI, including Logistics & Procurement Vice President in Latin America Zone for ABI, Vice President of Supply Chain in Russia and Ukraine for ABI, Vice President of Logistics in Europe for ABI and Vice President People in Europe for ABI. Mr. Figueiredo holds a degree in civil engineering from Escola Politécnica da *Universidade de São Paulo*, an executive MBA from Wharton/INSEAD and a Corporate MBA from Ambev.

**Eduardo Eiji Horai.** Mr. Horai is Ambev's Information Technology Vice President Officer. Before joining the Company on January 1, 2020, he served as Technology, Solutions Architecture and Customer Solutions Director and officer for Latin America at Amazon Web Services and was also part of the Enterprise Architecture department at Toyota Motor Europe in Belgium. Mr. Horai holds a degree in computer science from *Universidade de Campinas – UNICAMP* and a degree in Innovation and Entrepreneurship from the Vlerick Leuven-Gent Management School.

**Daniel Cocenzo**. Mr. Cocenzo is Ambev's Sales Vice President Officer. Since 1999, when he joined the Company, he has held various positions, including Premium and High-End Executive Officer of Ambev, People and Management Officer for the Central America and Caribbean business unit of Ambev, Sales Officer in Dominican Republic and Regional Sales Officer in Rio de Janeiro and Espírito Santo. Mr. Cocenzo holds a degree in business administration from *Pontifícia Universidade Católica do Rio de Janeiro*, an MBA from *IBMEC* and a Corporate MBA from Ambev.

**Daniel Wakswaser Cordeiro**. Mr. Wakswaser is Ambev's Marketing Vice President Officer. He joined the Company as a trainee in 2008 and has held several positions in Ambev and ABI. Wakswaser created and led the digital strategy area at Ambev, at the start of 2010. He was also involved in the creation of ZX Ventures globally, and also led, in Brazil, the acquisition and integration of breweries Colorado and Wäls. In the recent years, he held leadership roles in Brazil, Europe and the United States, including Global Vice President of Adjacencies for ABI, Global Marketing Vice President of Consumer Connections & Capabilities for ABI, Craft & Specialties Beer Director in Europe for ABI and Craft Beer Officer in Brazil. Wakswaser holds a degree in marketing from *Escola Superior de Propaganda e Marketing – ESPM*.

**Pablo Firpo**. Mr. Firpo is Ambev's Non-Alcoholic Beverages Vice President Officer. Since 2002, when he joined the Company as a trainee, he held various positions at the Company and ABI in marketing organization, including Marketing Manager at Quilmes,a Company's subsidiary in Argentina, Marketing Head in Chile, Marketing Officer for Core Brands at the Company's Latin America South Zone and Global Communications Officer for Budweiser. In 2017 he became the Non-Alcoholic Beverages Vice President Officer at the Company's Rio de la Plata business unit and held such position until the beginning of 2020. Mr. Firpo has a bachelor's degree in economics from Universidad del CEMA, in Argentina.

**Daniela Gavranic Cachich**. Ms. Cachich is Ambev's Future Beverages Vice President Officer. Before joining the Company, she held senior leadership positions in the marketing area of other consumer goods companies, including Chief Marketing Officer at PepsiCo from 2016 to August 2021. Also, she currently holds the position of effective member of the Advisory Board of Grupo Boticário. Ms. Cachich holds a degree in Business Administration from *Universidade Mackenzie* and a postgraduate degree in Marketing from *Escola Superior de Propaganda e Marketing – ESPM*.

B.&nbsp;&nbsp;&nbsp;&nbsp; Compensation

The aggregate remuneration of all members of the Board of Directors, Executive Officers and Fiscal Council of Ambev in 2022 for services in all capacities amounted to R$127.9 million (fixed and variable remuneration and share-based payment), as presented below:

[**Table of Contents**](#TableOfContents)

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Management's Remuneration<br> Year Ended December 31, 2022** | **Management's Remuneration<br> Year Ended December 31, 2022** | **Management's Remuneration<br> Year Ended December 31, 2022** | **Management's Remuneration<br> Year Ended December 31, 2022** | **Management's Remuneration<br> Year Ended December 31, 2022** | **Management's Remuneration<br> Year Ended December 31, 2022** | **Management's Remuneration<br> Year Ended December 31, 2022** | **Management's Remuneration<br> Year Ended December 31, 2022** | **Management's Remuneration<br> Year Ended December 31, 2022** | **Management's Remuneration<br> Year Ended December 31, 2022** | **Management's Remuneration<br> Year Ended December 31, 2022** | **Management's Remuneration<br> Year Ended December 31, 2022** | **Management's Remuneration<br> Year Ended December 31, 2022** | **Management's Remuneration<br> Year Ended December 31, 2022** |
|  | ***(in R$ million, except where otherwise indicated)*** | ***(in R$ million, except where otherwise indicated)*** | ***(in R$ million, except where otherwise indicated)*** | ***(in R$ million, except where otherwise indicated)*** | ***(in R$ million, except where otherwise indicated)*** | ***(in R$ million, except where otherwise indicated)*** | ***(in R$ million, except where otherwise indicated)*** | ***(in R$ million, except where otherwise indicated)*** | ***(in R$ million, except where otherwise indicated)*** | ***(in R$ million, except where otherwise indicated)*** | ***(in R$ million, except where otherwise indicated)*** | ***(in R$ million, except where otherwise indicated)*** | ***(in R$ million, except where otherwise indicated)*** | ***(in R$ million, except where otherwise indicated)*** |
|  |  | **Fixed Remuneration** | **Fixed Remuneration** | **Fixed Remuneration** | **Fixed Remuneration** | **Variable Remuneration** | **Variable Remuneration** | **Variable Remuneration** | **Variable Remuneration** | **Variable Remuneration** |  |  |  |  |
|  | **Number of Members** | **Fees** | **Direct and Indirect Benefits** | **Remuneration for Sitting on Committees** | **Others** | **Bonus** | **Profit Sharing** | **Remuneration for Attending Meetings** | **Commissions** | **Others** | **Post-Employment Benefits** | **Termination Benefits** | **Share-based Payment** | **Total** |
| Board of Directors | 12 | 7.6 |  |  | 1.8 | 4.1 |  |  |  |  |  |  | 11.1 | 24.6 |
| Fiscal Council | 6 | 2 |  |  | 0.4 | 0 |  |  |  |  |  |  |  | 2.4 |
| Executive Officers | 14.0 | 21.1 | - | - | 5.5 | 21.9 | - | - | - | - | 1.0 | - | 51.3 | 100.9 |
| **Total** | **32.0** | **30.8** | **-** | **-** | **7.7** | **26.0** | **-** | **-** | **-** | **-** | **1.0** | **-** | **62.4** | **127.9** |

---

In addition, the executive officers and members of the Board of Directors received some additional benefits provided to all Ambev employees and their beneficiaries and covered dependents, such as health and dental care. Such benefits were provided through FAHZ. These executive officers and directors also received benefits pursuant to Ambev's pension and stock ownership plans. For a description of these plans, see Notes 24 and 25 to our audited consolidated financial statements.

The table below sets forth the minimum, maximum and average individual compensation figures attributable to our directors, executive officers and Fiscal Council members for each of the indicated periods:

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Management's Remuneration** <br> **Year Ended December 31,** | &nbsp;&nbsp; **Management's Remuneration** <br> **Year Ended December 31,** | &nbsp;&nbsp; **Management's Remuneration** <br> **Year Ended December 31,** | &nbsp;&nbsp; **Management's Remuneration** <br> **Year Ended December 31,** | &nbsp;&nbsp; **Management's Remuneration** <br> **Year Ended December 31,** | &nbsp;&nbsp; **Management's Remuneration** <br> **Year Ended December 31,** | &nbsp;&nbsp; **Management's Remuneration** <br> **Year Ended December 31,** | &nbsp;&nbsp; **Management's Remuneration** <br> **Year Ended December 31,** | &nbsp;&nbsp; **Management's Remuneration** <br> **Year Ended December 31,** | &nbsp;&nbsp; **Management's Remuneration** <br> **Year Ended December 31,** | &nbsp;&nbsp; **Management's Remuneration** <br> **Year Ended December 31,** | &nbsp;&nbsp; **Management's Remuneration** <br> **Year Ended December 31,** |
|  | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2020** | &nbsp;&nbsp; **2020** | &nbsp;&nbsp; **2020** | &nbsp;&nbsp; **2020** |
|  | &nbsp;&nbsp;***(in R$ million, except where otherwise indicated)*** | &nbsp;&nbsp;***(in R$ million, except where otherwise indicated)*** | &nbsp;&nbsp;***(in R$ million, except where otherwise indicated)*** | &nbsp;&nbsp;***(in R$ million, except where otherwise indicated)*** | &nbsp;&nbsp;***(in R$ million, except where otherwise indicated)*** | &nbsp;&nbsp;***(in R$ million, except where otherwise indicated)*** | &nbsp;&nbsp;***(in R$ million, except where otherwise indicated)*** | &nbsp;&nbsp;***(in R$ million, except where otherwise indicated)*** | &nbsp;&nbsp;***(in R$ million, except where otherwise indicated)*** | &nbsp;&nbsp;***(in R$ million, except where otherwise indicated)*** | &nbsp;&nbsp;***(in R$ million, except where otherwise indicated)*** | &nbsp;&nbsp;***(in R$ million, except where otherwise indicated)*** |
|  | &nbsp;&nbsp; **Number of Members** | &nbsp;&nbsp; **Minimum** | &nbsp;&nbsp; **Average** | &nbsp;&nbsp; **Maximum** | &nbsp;&nbsp; **Number of Members** | &nbsp;&nbsp; **Minimum** | &nbsp;&nbsp; **Average** | &nbsp;&nbsp; **Maximum** | &nbsp;&nbsp; **Number of Members** | &nbsp;&nbsp; **Minimum** | &nbsp;&nbsp; **Average** | &nbsp;&nbsp; **Maximum** |
| Board of Directors | &nbsp;&nbsp;12.0 | &nbsp;&nbsp;0.8 | &nbsp;&nbsp;2.9 | &nbsp;&nbsp;15.1 | &nbsp;&nbsp;12 | &nbsp;&nbsp;0.6 | &nbsp;&nbsp;1.2 | &nbsp;&nbsp;8.8 | &nbsp;&nbsp;13.0 | &nbsp;&nbsp;0.3 | &nbsp;&nbsp;1.5 | &nbsp;&nbsp;7.9 |
| Fiscal Council | &nbsp;&nbsp;6.0 | &nbsp;&nbsp;0.3 | &nbsp;&nbsp;0.3 | &nbsp;&nbsp;0.5 | &nbsp;&nbsp;6 | &nbsp;&nbsp;0.2 | &nbsp;&nbsp;0.3 | &nbsp;&nbsp;0.5 | &nbsp;&nbsp;6.0 | &nbsp;&nbsp;0.2 | &nbsp;&nbsp;0.3 | &nbsp;&nbsp;0.5 |
| Executive Officers | &nbsp;&nbsp;14.0 | &nbsp;&nbsp;3.7 | &nbsp;&nbsp;6.8 | &nbsp;&nbsp;26.6 | &nbsp;&nbsp;13 | &nbsp;&nbsp;2.7 | &nbsp;&nbsp;6.2 | &nbsp;&nbsp;23.7 | &nbsp;&nbsp;11.6 | &nbsp;&nbsp;1.7 | &nbsp;&nbsp;4.8 | &nbsp;&nbsp;16.5 |

---

**Ambev Stock Ownership Plans**

Under the Ambev Stock Option Plan dated as of July 30, 2013, or the Plan, senior employees and management of either Ambev or its direct or indirect subsidiaries are eligible to receive stock options for Ambev common shares, including in the form of ADRs. As of December 31, 2022, there were outstanding rights under the Plan providing for the acquisition of 99.7 million Ambev common shares by approximately 550 people (including executive management and employees).

The Plan establishes the general conditions for granting options, the criteria for defining the strike price and other general terms and conditions of these stock options. Restrictions apply to the divestment of the shares acquired through the Plan, which also defines the various duties and responsibilities of the Board of Directors as Plan Administrator.

Pursuant to the Plan, the Board of Directors is conferred with ample powers for the organization and management of the Plan in compliance with its general terms and conditions. The Board of Directors grants stock options and establishes the terms and conditions applicable to each grant through Stock Option Programs, or the Programs, which may define the relevant beneficiaries, the applicable number of Ambev common shares covered by the grant, the respective strike price, the exercise periods and the deadline for exercising the options, as well as the rules regarding option transfers and possible restrictions on the acquired shares, in addition to penalties. Additionally, targets may be set for Ambev's performance, with the Board of Directors also being empowered to define specific rules for Ambev employees who are transferred to other countries or to other companies of the group, including to ABI.

[**Table of Contents**](#TableOfContents)

Beneficiaries to whom stock options are granted must sign Stock Option Agreements, or the Agreements, with Ambev, according to which those beneficiaries have the option to purchase lots of Ambev common shares in compliance with the terms and conditions of the Plan, the corresponding Program and such Agreement.

There are currently three models of stock options that may be granted under the Plan. Under the first model, beneficiaries, in accordance with their internal category, may choose among allocating (1) 30% or 100%, (2) 40% or 100%, and (3) 60% or 100% of the amounts received by them as profit sharing during the year to the immediate exercise of options, thereby allowing them to acquire the corresponding amount of Ambev shares. Under this model, a substantial part of the shares acquired is to be delivered only within five years from the corresponding option grant date. During such five-year period, the beneficiary must remain employed at Ambev or any other company of its group. Under the second model, the beneficiary may exercise the options granted only after a period of up to five years from the corresponding grant date. Vesting of the options granted under the second model is not subject to company performance measures; however, the right to exercise such options may be forfeited in certain circumstances, including the beneficiary's resignation or dismissal prior to the options' vesting. Under the third model, the beneficiaries, in accordance with their internal category, may choose among allocating (1) 20% or 100%, (2) 30% or 100%, and (3) 50% or 100%, of the amounts received by them as profit sharing during the year to the immediate exercise of options, thereby allowing them to acquire the corresponding amount of Ambev shares. The totality of the shares acquired is to be delivered to the beneficiary within forty-five days from the corresponding exercising date (which shall not be later than forty-five days from the option grant date). The beneficiaries are under a five-year lock-up period.

As a means of creating a long-term incentive (wealth incentive) for certain senior employees and members of management considered as having "high potential," share appreciation rights in the form of phantom stocks have been granted to those employees, pursuant to which the beneficiary shall receive two separate lots of phantom stock – Lot A and Lot B – subject to lock-up periods of five and ten years, respectively. On the fifth or tenth anniversary of the granting of such lots, as the case may be, a beneficiary still employed with us shall receive, in cash, the amount corresponding to the B3 closing price of the relevant Ambev shares (or NYSE closing price in the case of ADRs), on the trading session immediately preceding such anniversary, with each phantom stock corresponding to one share (or ADR, as the case may be). Such share appreciation rights shall not give the beneficiary the right to actually receive any Ambev shares or ADRs; those securities shall merely serve as basis for the calculation of the cash incentive to be received by such beneficiary. Although not subject to performance measures, the right to receive the cash incentive deriving from the phantom stocks may be forfeited in certain circumstances, including the beneficiary's resignation or dismissal prior to the relevant anniversary of the share appreciation right.

We implemented a Share Based Payment Plan, or the Share Plan, dated as of April 29, 2016, which was amended on April 24, 2020 at the annual general shareholders' meeting. Under the Share Plan, employees and management of Ambev or its direct or indirect subsidiaries are eligible to receive Ambev shares, including in the form of ADRs. The shares which are subject to the Share Plan are designated as Restricted Shares.

Pursuant to the Share Plan, the Board of Directors is conferred with ample powers for the organization and management of the Share Plan in compliance with its general terms and conditions. The Board of Directors may appoint a committee to assist its members in the management of the Share Plan. The Board of Directors or the committee establishes the terms and conditions applicable to each Share Based Payment Programs, or the Share Plan Programs, which defines the relevant beneficiaries, the applicable number of Restricted Shares subject to the Share Plan Program, the Restricted Shares' transfer procedure and vesting periods, and any possible penalties.

In 2022, the Board of Directors appointed the People Committee to assist managing the decisions to be taken within the scope of the Share Plan, meanwhile some matters remained in the exclusive competence of the Board of Directors.

Under the Share Plan, up to 3.0% of the shares corresponding to Ambev's corporate capital may be granted in total in an amount that may vary according to Ambev internal policies. The delivery of the Restricted Shares is free of charges. Restricted Shares shall vest in three or five years from the corresponding grant date, depending on the Share Based Payment Programs, provided that the beneficiary remains employed at Ambev during such vesting period.

[**Table of Contents**](#TableOfContents)

Beneficiaries of the Share Plan must sign a Share Based Payment Agreement, or the Share Based Agreements, with Ambev, according to which, those beneficiaries have the right to receive a maximum number of Ambev Shares or ADRs, as applicable, provided that the terms and conditions set forth in the Share Plan, Share Plan Programs and in the Share Based Agreements are complied with.

The Restricted Shares may entitle beneficiaries to receive additional shares with the same vesting conditions as compensation for dividends and interest on shareholders' equity paid during the vesting period on the Restricted Shares, as the case may be. The right to receive the Restricted Shares and the additional shares may be totally or partially forfeited in certain circumstances, including the beneficiaries' resignation or dismissal during the vesting period.

**ABI Exceptional Stock Option Grants and Restricted Stock Units Grants** 

Since November 2008, ABI's Board of Directors has approved several special grants of stock options and restricted stock units ("RSUs") granted to certain executives, including Ambev executives. Each stock option gives its beneficiary the right to purchase one existing common share of ABI at an exercise price equal to their fair value at the time of granting of the options and with a term of 10 to 15 years as from grant date. Specific forfeiture rules apply in the event the executive leaves the company before the vesting date of the RSUs and stock options. Each RSU gives its beneficiary the right to receive one existing common share of ABI at vesting, subject to specific forfeiture rules and subject to a vesting period of at least five years. In addition to specific forfeiture rules, some grants of stock options and restricted stock units are subject to a performance test. On the date hereof, some of these options and restricted stock units are still held by Ambev executives. Although the exercise of these ABI exceptional stock options and/or RSUs will not cause any dilution to Ambev, we record an expense in connection with them on our income statement.

**Ambev Pension Plan**

Ambev's pension plans for employees in Brazil are administered by the IAPP. The IAPP operates both a defined benefit pension plan (closed to new participants since May 1998) and a defined contribution plan, which supplements benefits that the Brazilian government's social security system provides to our employees. The defined contribution plan covers substantially all new employees. The IAPP was established solely for the benefit of our employees and its assets are held independently. The IAPP is managed by a Governing Board (*Conselho Deliberativo*), which has three members, two of whom are appointed by Ambev, and one member represents active and retired employees. The IAPP also has an Executive Board (*Diretoria Executiva*) containing three members, all of whom are appointed by IAPP's Council Board. The IAPP also has a Fiscal Council with three members, two of whom appointed by Ambev, and one member represents active and retired employees.

Any employee upon being hired may opt to join the defined contribution plan. When pension plans members leave Ambev before retirement but having contributed at least three years to the IAPP plan, they have some options such as: (a) having their contributions refunded, (b) transferring their contributions to a bank or insurance company, (c) keeping their investment in IAPP to be paid in installments, and (d) continuing to IAPP for future retirement under the existing terms. In the event the employee leaves the Company prior to completing three years as a participant, such employee will only be entitled to refund his/her contributions to the plan.

As of December 31, 2022, we had 9,088 participants in our pension plans, including 304 participants in the defined benefit plan 7,627 participants in the defined contribution plan, and 1,157 retired or assisted participants. Plan assets are comprised mainly of equity securities, government and corporate bonds and real estate properties. All benefits are calculated and paid in inflation-indexed *reais*.

Labatt provides pension plan benefits in the defined contribution model and in the defined benefit model to its employees, as well as certain post-retirement benefits.

[**Table of Contents**](#TableOfContents)

For information on amount recorded by us on December 31, 2022 as liabilities for pension plan benefits, see Note 24 to our audited consolidated financial statements, included elsewhere in this annual report on Form 20-F.

**Profit-Sharing Plan**

Employees' performance-based variable payments are determined on an annual basis considering the achievement of corporate, department or business-unit and individual goals, established in accordance with the profit-sharing plan.

The distribution of these payments is subject to a three-tier system in which Ambev must first achieve performance targets approved by the Board of Directors in accordance with the profit-sharing plan. Following that, each department or business segment must achieve its respective targets. Finally, individuals must achieve their respective performance targets.

For employees involved in operations, we have a collective award for production sites and distribution centers with outstanding performances. The bonus award at the distribution centers and production sites is based on a ranking between the different distribution centers and production sites (as the case may be), which, based on their relative ranking, may or may not receive the bonus.

Our expenses under these programs amounted to R$1,119.2 million for the year ended December 31, 2022, R$1,420.6 million for the year ended December 31, 2021, and R$57.2 million for the year ended December 31, 2020.

C.&nbsp;&nbsp;&nbsp;&nbsp; Board Practices

During 2022, our management held individual and group meetings with shareholders, investors and analysts to talk about the performance of our business and our opportunities for growth both in the short-term as well as in the future and to update the market on our ESG initiatives. We also participated in conferences and non-deal road shows online. We hosted quarterly conference calls, transmitted simultaneously on the internet, to clarify financial and operating results as well as answered questions from the investment community.

**Fiscal Council (Conselho Fiscal)**

Ambev's Fiscal Council is a permanent body. At our annual general shareholders' meeting held on April 29, 2022, the following members of the Fiscal Council were appointed for a term expiring upon the annual general shareholders' meeting of 2023: José Ronaldo Vilela Rezende, Elidie Palma Bifano and Vinicius Balbino Bouhid, and, as alternates, Emanuel Sotelino Schifferle, Eduardo Rogatto Luque and Carlos Tersandro Fonseca Adeodato (the latter of whom serves as alternate only to Vinicius Balbino Bouhid). All of them are "independent" members as per Rule 10A-3(c)(3) of the Sarbanes-Oxley Act of 2002.

The responsibilities of the Fiscal Council include supervision of management, performing analyses and rendering opinions regarding our financial statements and performing other duties in accordance with the Brazilian Corporation Law and its charter. None of the members of the Fiscal Council is also a member of the Board of Directors or of any committee of the Board.

Minority holders representing at least 10% of our common shares are entitled to elect one member and respective alternate to the Fiscal Council without the participation of the controlling shareholder. CVM's interpretation is that such right is applicable as long as at least 10% of our shares are held by minority shareholders, regardless of the equity percentage held by the minority shareholders attending the shareholders' meeting having in the agenda the election of the Fiscal Council members.

We have relied on the exemption provided for under Rule 10(c)(3) of the Sarbanes-Oxley Act of 2002, which enables us to have our Fiscal Council perform the duties of an audit committee for the purposes of such Act, to the extent permitted by Brazilian law. We do not believe that reliance on this exemption would materially adversely affect the ability of our Fiscal Council to act independently and to satisfy the other requirements of such Act.

[**Table of Contents**](#TableOfContents)

**The Board of Directors**

Most of our Board members have been in office for several years and were elected or reelected to the Board of Directors of Ambev at the Company's extraordinary general shareholders' meeting held on April 24, 2020 for a term expiring at the annual general shareholders' meeting to be held in 2023. These Board members use their extensive knowledge of our business to help ensure that we reach our long-term goals, while maintaining our short-term competitiveness. Another objective of the Board of Directors is to encourage us to pursue our short-term business goals without compromising our long-term sustainable growth, while at the same time trying to make sure that our corporate values are observed.

Under our bylaws, at least two members of the Board of Directors shall be independent directors. For the applicable director independence criteria, see "Item 10. Additional Information—B. Memorandum and Articles of Association—Board of Directors." We currently have three independent members in our Board of Directors.

In 2021, Ambev received the Women on Board (WOB) certification, a UN Women-supported independent initiative whose purpose is to acknowledge, value and promote corporate environments in which women are part of the board of directors or at advisory councils. This certification is awarded to organizations that have at least two women sitting on their board of directors.

Pursuant to Brazilian law, Ambev's Chairman of the Board of Directors and the Chief Executive Officer are separate positions that must be held by different individuals.

The Board of Directors is supported in its decision-making by the following committees:

Operations and Finance Committee

The Operations and Finance Committee is the main link between the policies and decisions made by the Board of Directors and Ambev's management team. The Operations and Finance Committee's responsibilities include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· to monitor the Company's long term planning;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· to monitor the evolution of the Company's actuarial liabilities and investments in pension plans;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· to monitor the investors relations strategies and the performance of our rating, as issued by the official
rating agencies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· to analyze and issue an opinion on our annual investment plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· to analyze and issue an opinion on proposals by the Board of Executive Officers regarding opportunities
for corporate restructuring, mergers, acquisitions, spin-offs, incorporations or disposals of equity interests involving the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· to analyze and monitor our capital structure and cash flow; and provide an opinion on the Company's shareholder
compensation strategy;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· to verify compliance with the Company's Financial Risk Management Policy;
and,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· other matters that the Board of Directors considers relevant and in the
interest of the Company and may come to define as attribution of the Operations and Finance Committee.

The current members of the Committee are Messrs. Victorio Carlos De Marchi (Chairman), Fernando Mommensohn Tennenbaum and Roberto Moses Thompson Motta. The members of this committee are elected by the Board of Directors.

[**Table of Contents**](#TableOfContents)

Governance Committee

The responsibilities of the Governance Committee are to assist the Board of Directors with the following matters:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· related party transactions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· any general conflict of interest situations that may arise between the Company and related parties;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· compliance, by the Company, with legal, regulatory and statutory provisions concerning related party transactions
and antitrust matters;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· to monitor the Company's initiatives, as well as analyze and give opinions on issues related to cyber
security and privacy and data protection;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· to issue an opinion on the Company's strategies related to environmental, social and governance (ESG)
issues; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· other matters the Board of Directors may consider relevant and in the interest of the Company.

The current members of the Governance Committee are Messrs. Victorio Carlos De Marchi (Chairman), Fabio Colletti Barbosa, Marcos de Barros Lisboa, Everardo de Almeida Maciel and Carlos Emmanuel Joppert Ragazzo. The members of this committee are elected by the Board of Directors.

People Committee

The responsibilities of the People Committee are to assist the Board of Directors with the following matters:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to issue an opinion on matters that require a decision by the Board of Directors regarding the definition and review of the compensation policy for members of the Board of Executive Officers and high performance employees, as well as individual compensation incentives packages;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to define the targets and compensation for the Company's management, within the limit approved by the annual shareholders' meeting;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to monitor the evaluation of the members of the Board of Executive Officers, key executives and talents, in addition to the respective succession plans;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to approve policies and/or minimal rules to be observed in the nomination process of members of the Company's management;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to select and propose for Board of Directors' approval candidates to the positions of members of Executive Board of Officers and/or any other positions that may be required by the Board of Directors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to assist the Board of Directors with the monitoring and discussions related to diversity;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to approve the transfer of employees of the high-leadership;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to coordinate the management of compensation incentive plans and to approve the relevant programs, grants, exceptions and other obligations involving employees in general, as permitted by applicable rules; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; other matters the Board of Directors may consider relevant and in the interest of the Company.

[**Table of Contents**](#TableOfContents)

The current members of the People Committee are Messrs. Victorio Carlos De Marchi (Chairman), Nelson José Jamel and Claudia Quintella Woods. The members of this committee are elected by the Board of Directors.

**Differences Between United States and Brazilian Corporate Governance Practices**

In November 2003, the SEC approved corporate governance rules that had been adopted by the NYSE pursuant to the Sarbanes-Oxley Act of 2002. According to those governance rules, foreign private issuers that are listed on the NYSE must disclose the significant differences between their corporate governance practices and those required by the NYSE's regulations for U.S. companies.

In November 2016, the Brazilian Corporate Governance Code, which provides for corporate governance practices guidelines for publicly-held companies, was released by a workgroup formed by several entities, such as ABRAPP, ABRASCA, ANBIMA, ABVCAP, AMEC, APIMEC, B3, BRAIN, IBGC, IBRI and Instituto IBMEC, after the contribution and comments made by the CVM. In June 2017, the CVM approved a new rule, which establishes that companies must inform whether they adhere to the principles and practices set forth in the Brazilian Corporate Governance Code, or otherwise justify the reasons for non-compliance with such principles and practices. Our report on the Brazilian Code of Corporate Governance, prepared in accordance with such rules, is available on our website at http://ri.ambev.com.br/, and the updated report was filed with the SEC on July 22, 2022. Additionally, the B3 and the IBGC-Brazilian Institute of Corporate Governance have issued guidelines for corporate governance best practices.

The principal differences between the NYSE corporate governance standards and our corporate governance practices are as follows:

Independence of Directors and Independence Tests

NYSE corporate governance standards require listed companies to have a majority of independent directors and set forth the principles by which a listed company can determine whether a director is independent. "Controlled companies," such as Ambev, need not to comply with these requirements. Nonetheless, our bylaws require that (i) the majority of the members of our Board of Directors must be external directors (i.e. with no current employment or managerial relationship with the company) and (ii) at least two of our directors be independent. In addition, our bylaws set forth that directors elected by a separate ballot vote of minority shareholders holding at least 10% of our capital stock shall be deemed independent.

As of the date of this annual report on Form 20-F, all of our directors, including the independent ones, had been appointed by our controlling shareholder.

The Brazilian Corporation Law and the CVM establish rules in relation to certain qualification requirements and restrictions, compensation, duties and responsibilities of a company's officers and directors.

Executive Sessions

NYSE corporate governance standards require non-management directors of a listed company to meet at regularly scheduled executive sessions without management.

According to the Brazilian Corporation Law, up to one-third of the members of the Board of Directors can also hold executive officer positions. However, none of our directors holds an executive officer position in us at this time and, accordingly, we believe we would follow this NYSE corporate governance standard if we were a U.S. company.

Nominating/Corporate Governance and Compensation Committees

NYSE corporate governance standards require that a listed company have a nominating/corporate governance committee and a compensation committee each composed entirely of independent directors with a written charter that addresses certain duties. "Controlled companies" such as Ambev need not to comply with this requirement.

[**Table of Contents**](#TableOfContents)

In addition, we are not required under the Brazilian Corporation Law to have, and accordingly we do not have a nominating committee, but we do have a people committee and a governance committee. According to the Brazilian Corporation Law, Board committees may not have any specific authority or mandate since the exclusive duties of the full Board of Directors may not be delegated. The role of the corporate governance committee is generally performed by either our Board of Directors or our executive officers.

Audit Committee and Audit Committee Additional Requirements

NYSE corporate governance standards require that a listed company have an audit committee composed of a minimum of three independent members that satisfy the independence requirements of Rule 10A-3 under the Exchange Act, with a written charter that addresses certain duties.

We maintain a permanent Fiscal Council, which is a body contemplated by the Brazilian Corporation Law that operates independently from our management and from our registered independent public accounting firm. Its principal function is to examine the annual and quarterly financial statements and provide a formal report to our shareholders. We are relying on the exemption provided by Rule 10A-3(c)(3) and believe that our reliance on this exemption will not materially affect the ability of the Fiscal Council to act independently and to satisfy the other requirements of Rule 10A-3.

Shareholder Approval of Equity Compensation Plans

NYSE corporate governance standards require that shareholders of a listed company must be given the opportunity to vote on all equity compensation plans and material revisions thereto, subject to certain exceptions.

Under Brazilian Corporation Law, shareholder pre-approval is required for the adoption and revision of any equity compensation plans. Our existing stock ownership and share based payment plans were approved by our extraordinary general shareholders' meetings held on July 30, 2013 and on April 29, 2016. An amendment to the share-based payment plan was approved by the annual general shareholders' meeting held on April 24, 2020.

Corporate Governance Guidelines

NYSE corporate governance standards require that a listed company must adopt and disclose corporate governance guidelines that address certain minimum specified standards, which include, director qualification standards, director responsibilities, director access to management and independent advisors, director compensation, director orientation and continuing education, management succession and annual performance evaluation of the Board.

We believe the corporate governance guidelines applicable to us under the Brazilian Corporation Law are consistent with the guidelines established by the NYSE. We have adopted and observe our Manual on Disclosure and Use of Information and Policies for Trading with Securities issued by Ambev which deals with the public disclosure of all relevant information as per CVM's guidelines, as well as with rules relating to transactions involving the dealing by our management and controlling shareholder in our securities.

Code of Business Conduct

NYSE corporate governance standards require that a listed company must adopt and disclose a code of business conduct and ethics for directors, officers and employees and promptly disclose any waivers of the code for directors or officers. Each code of business conduct and ethics should address the following matters: (1) conflicts of interest; (2) corporate opportunities; (3) confidentiality; (4) fair dealing; (5) protection and proper use of company assets; (6) compliance with laws, rules and regulations (including insider trading laws); and (7) encouraging the reporting of any illegal or unethical behavior.

We have adopted a Code of Business Conduct that applies to all directors, officers and employees. Our Code of Business Conduct is available on our website at http://ri.ambev.com.br/. The information included on our website or that might be accessed through our website is not included in this annual report and is not incorporated into this annual report by reference. There are no waivers to our Code of Business Conduct.

[**Table of Contents**](#TableOfContents)

Certification Requirements

NYSE corporate governance standards require that each listed company's chief executive officer certify to the NYSE each year that he or she is not aware of any violation by the company of the NYSE corporate governance standards.

As required by Section 303A.12(b) of the NYSE corporate governance standards, our Chief Executive Officer will promptly notify the NYSE in writing after our executive officer becomes aware of any material non-compliance with any applicable provisions of the NYSE corporate governance standards.

D.&nbsp;&nbsp;&nbsp;&nbsp; Employees

As of December 31, 2022, we and our subsidiaries had a total of 47,108 employees, of whom approximately 42% were engaged in production, 40% in sales and distribution and 18% in administration.

The following table sets forth the total number of our employees as of the end of the periods indicated:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp; **As of December 31,** | &nbsp;&nbsp; **As of December 31,** | &nbsp;&nbsp; **As of December 31,** |
| &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2020** |
| &nbsp;&nbsp;47,108 | &nbsp;&nbsp;52,806 | &nbsp;&nbsp;50,479 |

---

The following table shows the geographical distribution of our employees as of December 31, 2022:

---

| | |
|:---|:---|
| &nbsp;&nbsp; **Geographical Distribution of Ambev Employees as of December 31, 2022** | &nbsp;&nbsp; **Geographical Distribution of Ambev Employees as of December 31, 2022** |
| &nbsp;&nbsp; **Location** | &nbsp;&nbsp; **Number of Employees** |
| &nbsp;&nbsp;**Brazil** | &nbsp;&nbsp;**28209** |
| &nbsp;&nbsp;CAC | &nbsp;&nbsp;**4870** |
| &nbsp;&nbsp;Dominican Republic | &nbsp;&nbsp;**2485** |
| &nbsp;&nbsp;Cuba | &nbsp;&nbsp;**769** |
| &nbsp;&nbsp;Guatemala | &nbsp;&nbsp;**160** |
| &nbsp;&nbsp;Panama | &nbsp;&nbsp;**1456** |
| &nbsp;&nbsp;**Latin America South** | &nbsp;&nbsp;**10340** |
| &nbsp;&nbsp;Argentina | &nbsp;&nbsp;**6281** |
| &nbsp;&nbsp;Bolivia | &nbsp;&nbsp;**1954** |
| &nbsp;&nbsp;Uruguay | &nbsp;&nbsp;**985** |
| &nbsp;&nbsp;Paraguay | &nbsp;&nbsp;**556** |
| &nbsp;&nbsp;Chile | &nbsp;&nbsp;**564** |
| &nbsp;&nbsp;**Canada** | &nbsp;&nbsp; **3689** |
| &nbsp;&nbsp;**Total** | &nbsp;&nbsp; **47108** |

---

**Industrial Relations**

As per the determined under Brazilian labor legislation, all of our employees in Brazil are represented by labor unions, but only less than 5% of our employees in Brazil are actually members of labor unions as of December 31, 2022. The number of administrative and distribution employees who are members of labor unions is not significant. Salary negotiations are conducted annually between the workers' unions and us. Collective bargaining agreements are negotiated separately for each facility or distribution center. Our Brazilian collective bargaining agreements have a one- or two-year term, and we usually enter into new collective bargaining agreements on or prior to the expiration of the existing agreements. We conduct salary negotiations with labor unions in accordance with local law for our employees located in our CAC, Latin America South and Canadian operations.

**Health and Severance Benefits**

In addition to wages, our employees receive additional benefits. Some of these benefits are mandatory under Brazilian law, some are provided for in collective bargaining conventions and/or agreements and others are voluntarily granted. The benefits packages of our employees in Brazil consist of benefits provided both directly by the Company and through FAHZ, which provides medical, dental, educational and social assistance to current and retired employees of Ambev and their beneficiaries and covered dependents, either for free or at a reduced cost. We may voluntarily contribute up to 10% of our consolidated net income towards the support of FAHZ in connection with these benefits, as determined pursuant to the Brazilian Corporation Law and our bylaws.

[**Table of Contents**](#TableOfContents)

We are required to contribute 8% of each Brazilian employee's monthly gross pay to an account maintained in the employee's name with the Brazilian government's Severance Indemnity Fund (*Fundo de Garantia por Tempo de Serviço*), or the FGTS. Under Brazilian law, we are also required to pay termination benefits to Brazilian employees dismissed without cause equal to 40% of the accumulated contributions made by us to the terminated employee's FGTS account throughout the employee's period of service, among other mandatory termination fees.

We provide health and benefits in accordance with local law for our employees located in our CAC, Latin America South and Canadian operations.

E.&nbsp;&nbsp;&nbsp;&nbsp; Share Ownership

The following table shows the amount and percentage of our shares held by members of our Board of Directors and by executive officers as of March 1<sup>st</sup>, 2023:

---

| |
|:---|
| &nbsp;&nbsp; **Name** |
| &nbsp;&nbsp;Victorio Carlos De Marchi(1) |
| &nbsp;&nbsp;Michel Dimitrios Doukeris |
| &nbsp;&nbsp;Milton Seligman |
| &nbsp;&nbsp;Roberto Moses Thompson Motta |
| &nbsp;&nbsp;Fabio Colletti Barbosa |
| &nbsp;&nbsp;Claudia Quintella Woods |
| &nbsp;&nbsp;Fernando Mommensohn Tennenbaum |
| &nbsp;&nbsp;Lia Machado de Matos |
| &nbsp;&nbsp;Nelson José Jamel |
| &nbsp;&nbsp;Antonio Carlos Augusto Ribeiro Bonchristiano |
| &nbsp;&nbsp;Marcos de Barros Lisboa |
| &nbsp;&nbsp;Carlos Eduardo Klutzenschell Lisboa |
| &nbsp;&nbsp;Jean Jereissati Neto |
| &nbsp;&nbsp;Lucas Machado Lira |
| &nbsp;&nbsp;Eduardo Braga Cavalcante de Lacerda |
| &nbsp;&nbsp;Ricardo Morais Pereira de Melo |
| &nbsp;&nbsp;Valdecir Duarte |
| &nbsp;&nbsp;Eduardo Eiji Horai |
| &nbsp;&nbsp;Carla Smith de Vasconcellos Crippa Prado |
| &nbsp;&nbsp;Rodrigo Figueiredo de Souza |
| &nbsp;&nbsp;Paulo André Zagman |
| &nbsp;&nbsp;Leticia Rudge Barbosa Kina |
| &nbsp;&nbsp;Daniel Cocenzo |
| &nbsp;&nbsp;Daniel Wakswaser Cordeiro |
| &nbsp;&nbsp;Pablo Firpo |
| &nbsp;&nbsp;Daniela Gavranic Cachich &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; \* |

---

\* Indicates that the individual holds less than 1% of the class of securities.

(1) This Board member is also trustee of FAHZ. For information regarding the shareholdings of FAHZ in Ambev,
see "Item 7. Major Shareholders and Related Party Transactions—A. Major Shareholders—Ambev's Major Shareholders."

[**Table of Contents**](#TableOfContents)

ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS

A.&nbsp;&nbsp;&nbsp;&nbsp; Major Shareholders

**Introduction** 

Ambev has only one class of shares (i.e., voting common shares), including in the form of ADSs (evidenced by ADRs), with each ADS representing one Ambev common share. The Ambev common shares and ADSs are registered under the Exchange Act. As of March 1st , 2023, Ambev had 15,741,734,691 shares outstanding. As of March 1<sup>st</sup> , 2023, there were 1,411,283,441 Ambev ADSs outstanding (representing 1,411,283,441 Ambev shares, which corresponds to 8.9% of the total Ambev shares outstanding). The Ambev shares held in the form of ADSs under the Ambev ADS facilities are deemed to be the shares held in the "host country" (i.e., the United States) for purposes of the Exchange Act. In addition, as of March 1<sup>st</sup>, 2023, there were 171 registered holders of Ambev ADSs.

Control

Our direct controlling shareholder, ABI, together with FAHZ, held in aggregate 72.0% our total and voting capital stock (excluding treasury shares) as of March 1<sup>st</sup> , 2023.

ABI indirectly holds shares in us representing 61.8% of our total and voting capital stock (excluding treasury shares) as of March 1<sup>st</sup>, 2023. ABI thus has control over us, even though (1) ABI is subject to the Shareholders' Agreement and (2) ABI is controlled by Stichting that represents an important part of interests of BRC and the Interbrew Founding Families. For further information on these matters see "Item 4. Information on the Company—A. History and Development of the Company—The InBev-Ambev Transactions" and "—Ambev's Major Shareholders—The Shareholders' Agreement."

In March 2021, our board of directors approved a share buyback program for the repurchase of up to 5,700,000 Ambev shares to cover the delivery of shares under our share-based compensation plans or to be held in treasury, cancelled or subsequently transferred in private or public transactions. As of December 31, 2022, we repurchased 5,700,000 Ambev shares.

In 2023, as of March 1<sup>st</sup>, we acquired 0 Ambev shares in connection with preemptive rights related to stock ownership plans at a total cost of R$0.00 million.

In 2022 we acquired 622,520 Ambev shares in connection with preemptive rights related to stock ownership plans at a total cost of R$9.2 million.

In 2021 we acquired 4,011,471 Ambev shares in connection with preemptive rights related to stock ownership plans at a total cost of R$71.4 million.

In 2020, we acquired 2,937,533 Ambev shares in connection with preemptive rights related to stock ownership plans at a total cost of R$47.4 million.

For a further description of our share buyback programs, see "Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers."

**Ambev's Major Shareholders**

The following table sets forth information as of March 1<sup>st</sup>, 2022, with respect to any person known to us to be the beneficial owner of 5% or more of our outstanding shares:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Shareholder** | &nbsp;&nbsp;**Amount and Percentage<br> of Common Shares** | &nbsp;&nbsp;**Amount and Percentage<br> of Common Shares** |
| &nbsp;&nbsp;The Bank of New York Mellon – ADR Department(1) | &nbsp;&nbsp;1411283441 | &nbsp;&nbsp;8.9% |
| &nbsp;&nbsp;Interbrew International B.V | &nbsp;&nbsp;8441916367 | &nbsp;&nbsp;53.6% |
| &nbsp;&nbsp;AmBrew S.A | &nbsp;&nbsp;1287671100 | &nbsp;&nbsp;8.2% |
| &nbsp;&nbsp;FAHZ(2) | &nbsp;&nbsp;1609987301 | &nbsp;&nbsp;10.2% |

---

(1) Represents the number of shares held in the form of ADSs. The Bank of New York Mellon is the depositary of
Ambev shares in accordance with the deposit agreement entered into with Ambev and the owners of Ambev ADSs.

(2) Mr. Victorio Carlos De Marchi, who is a FAHZ-appointed director of Ambev, is also member of Advisory Board
of FAHZ.

[**Table of Contents**](#TableOfContents)

For a description of our major shareholders' voting rights, see "—The Shareholders' Agreement."

The Shareholders' Agreement

The Shareholders' Agreement, effective since July 2, 2019, was executed on April 16, 2013 by IIBV, AmBrew and FAHZ, as well as Ambev, as intervening party. The Shareholders' Agreement may be terminated at any time upon FAHZ ceasing to hold at least 1,501,432,405 of Ambev's common shares (adjusted for any future share dividends, stock-splits and reverse stock-splits) or if FAHZ decides to early terminate it. Among other matters, the Shareholders' Agreement governs the voting of the Ambev common shares subject to the agreement and the voting by Ambev of the shares of its majority-owned subsidiaries.

**Management of Ambev**

The Shareholders' Agreement establishes that Ambev will be managed by a Board of Directors and by a Board of Executive Officers. Ambev's Board of Directors shall have one Chairman or two (2) Co-Chairmen.

Presently, under the Shareholders' Agreement, FAHZ is entitled to appoint two directors and their respective alternates to the Board of Directors of Ambev, provided it holds at least 1,501,432,405 Ambev common shares (adjusted for any future share dividends, stock-splits and reverse stock-splits). One of the FAHZ-appointed directors shall have the right to also be appointed as a member of Ambev's Operations and Finance Committee, of the Governance Committee and of the People Committee, as well as any other committee that may be established by Ambev's Board of Directors. Furthermore, the shareholders shall use their best efforts to allow one of the FAHZ-appointed directors to participate as an observer in meetings of Ambev's Fiscal Council, whenever such body is installed in lieu of the audit committee required by the Sarbanes-Oxley Act of 2002.

FAHZ may remove a director that it has appointed to the Board of Directors of Ambev, and also has the right to appoint the respective replacement or a new alternate, if the originally appointed alternate is confirmed for the vacant position.

The foregoing provisions of the Shareholders' Agreement regarding Ambev's management bodies do not apply to the management bodies of Ambev's majority-owned subsidiaries.

**Preliminary Meetings and Exercise of Voting Rights**

On matters submitted to a vote of the shareholders or their representatives on the Board of Directors of Ambev or its majority-owned subsidiaries, FAHZ, IIBV and AmBrew agreed to endeavor to first reach a consensus with respect to voting their common shares of each of Ambev and its majority-owned subsidiaries and agreed on the manner to direct their representatives to vote on the matter being submitted. The Shareholders' Agreement provides that the parties should hold a preliminary meeting in advance of all meetings of shareholders or the Board of Directors of Ambev or of its majority-owned subsidiaries, with the purpose of discussing and determining a consensus position to be taken by the parties in such meetings.

If the parties fail to reach a consensus with respect to a particular matter, the position to be adopted by the parties to the Shareholders' Agreement will be determined by the shareholder or group of shareholders holding a majority of Ambev common shares. The following matters are not subject to the foregoing rule: (1) election of members to the Board of Directors or to any committee of the Board of Directors, which shall follow the specific election procedure described above under "—Management of Ambev" and (2) matters that require unanimous approval by FAHZ, IIBV and AmBrew, as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; any amendment to the bylaws of Ambev and/or any of its majority-owned subsidiaries with the purpose of changing: (1) the corporate purpose of those companies with a view to causing them to cease the production, commercialization and distribution of beverages, (2) the allocation of Ambev's results of operations, as set forth in its bylaws, or other similar provisions in the bylaws of Ambev's majority-owned subsidiaries that are meant to provide financial support to FAHZ, (3) the minimum mandatory dividend of 40% of Ambev's adjusted net income, and/or (4) any other provision that affects FAHZ's rights under the Shareholders' Agreement; and

[**Table of Contents**](#TableOfContents)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the transformation of Ambev into a different form of legal entity.

FAHZ, IIBV and AmBrew, as well as any member appointed by them to our Board of Directors or any of its majority-owned subsidiaries, are not required to observe decisions reached at preliminary meetings when deciding on the following matters:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; analysis and approval of management accounts of Ambev and its majority-owned subsidiaries;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; analysis and approval of the financial statements and management reports of Ambev and its majority-owned subsidiaries;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; any matters or actions typified as abuse of control, as set forth in the first paragraph of Section 117 of the Brazilian Corporation Law; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; actions and practices relating to management's diligence, loyalty and other related duties, as established in Sections 153 to 158 of the Brazilian Corporation Law.

**Transfer of Shares**

Under the Shareholders' Agreement, the following rules shall apply:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in the event of a transfer of Ambev common shares subject to the Shareholders' Agreement (1) by IIBV and/or AmBrew, where such transfer results in these entities jointly holding a total equity interest in Ambev represented by less than 50% plus one Ambev common share, and/or (2) by FAHZ upon making one and only one eligible transfer of at least 1,501,432,405 Ambev common shares (adjusted for any future share dividends, stock-splits and reverse stock-splits) to a single buyer and subject to the first offer obligations described below, then, in either of those cases, the Ambev common shares subject to those transfers shall remain bound by the Shareholders' Agreement. Only in those two cases shall a third party acquiring the Ambev common shares in those transfers be able to adhere to the Shareholders' Agreement in order for the transfer to be effective;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; at any time FAHZ may elect to release its Ambev common shares subject to the Shareholders' Agreement for the exclusive purpose of selling them in the stock market or over-the-counter market, provided that (1) it maintains at least 1,501,432,405 Ambev common shares (adjusted for any future share dividends, stock-splits and reverse stock-splits) subject to the Shareholders' Agreement, and (2) it observes the first offer obligations described below; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in the event FAHZ intends to execute the above-referenced one and only one eligible transfer or release, it shall first offer the Ambev common shares to the remaining parties to the Shareholders' Agreement for their average quoted market price on the 20 trading sessions immediately prior to the date of the relevant first offer (or the last 40 trading sessions if no Ambev common shares were negotiated in at least half of the 20 immediately preceding trading sessions). The offerees will have five days, as of the first offer date, to accept or refuse the offer, and, if expressly or tacitly refused (or in the event the offerees fail to timely pay the applicable purchase price), then FAHZ may either proceed with such transfer or release its Ambev common shares from the Shareholders' Agreement and thereafter sell them to third parties within ten days.

**Specific Performance**

The obligations of the parties under the Shareholders' Agreement will be subject to specific performance under applicable Brazilian law.

[**Table of Contents**](#TableOfContents)

B.&nbsp;&nbsp;&nbsp;&nbsp; Related Party Transactions

**Overview**

We have executed and may in the future execute related party transaction with certain of our significant shareholders or other related parties and certain of their affiliates. These transactions include but are not limited to: (1) the purchase and sale of raw material with affiliated entities, (2) entering into distribution, sale, cross-licensing, transfer pricing, indemnification, service and other agreements with affiliated entities, (3) import agreements with affiliated entities, and (4) royalty agreements with affiliated entities. These transactions have been entered into only on an arm's length basis in accordance with our best interests and customary market practices at the time of their execution. In addition, the Governance Committee is responsible for assisting the Board in reviewing, analyzing and deciding on these transactions to help ensure that their terms are reasonable and that they comply with all applicable laws and regulations, as well as our corporate governance and best practices principles. See "Item 6. Directors, Senior Management and Employees—C. Board Practices—The Board of Directors—Governance Committee." Set forth below is a discussion of our material related party transactions. For further information on our related party transactions, see Note 31 to our audited consolidated financial statements.

Ambev, ABI and its subsidiaries, such as Anheuser-Busch Inbev USA LLC ("ABI USA") and Cervecería Modelo, among others, have entered into several agreements for the production, import, distribution and sale of branded products, such as Stella Artois, Beck's, Budweiser, Spaten, Michelob Ultra and Corona (including Corona Extra, Corona Light, Coronita, Pacífico and Modelo), among others ("ABI Products") by Ambev in Brazil and its subsidiaries located in countries in which the Company has operations, such as Canada, Argentina, Chile, Paraguay, Uruguay, Bolivia, Dominican Republic, Panama, Guatemala, among others. These agreements were duly approved by the Governance Committee and the Company's Board of Directors. See "Item 4. Information on the Company—B. Business Overview—Licenses—Licensing Agreements with ABI."

In November 2021, Ambev and ABI negotiated the general guidelines on royalties and transfer price for the royalty percentages and mark-ups applicable to the production, import, distribution and sale of (a) finished products of ABI and/or its respective subsidiaries by the Company and/or its respective subsidiaries; and (b) finished products of the Company and/or its respective subsidiaries by ABI and/or its respective subsidiaries. All metrics, prices and methodologies were stablished on similar arm's length basis, based on a study carried out by a top-tier external audit firm, duly approved by the Governance Committee and the Company's Board of Directors.

**Ambev and FAHZ**

Medical, Dental and Social Assistance

One of the activities of FAHZ, as described in its bylaws, is to provide medical and dental assistance and other benefits both to active and certain of our employees, retired employees and executive officers (including their dependents).

**Ambev and ABI**

Licensing Agreements

See "Item 4. Information on the Company—B. Business Overview—Licenses—Licensing Agreements with ABI."

Renegotiation of Tenedora's shareholders agreement

We and ELJ currently own 85% and 15% of the shares of Tenedora, respectively, which in turns owns Cervecería Nacional Dominicana, S.A. On July 2, 2020, we and ELJ amended the Tenedora's Shareholders Agreement (the "Shareholders Agreement") to extend our partnership and change some of the terms of the put and call options provided therein. Pursuant to this amendment, ELJ's put option currently covers two different tranches: (i) Tranche A, corresponding to 12.11% of the shares, is subject to a put option exercisable in 2022, 2023 and 2024; and (ii) Tranche B, corresponding to 2.89% of the shares, is subject to a put option starting in 2026. Our call option relating to Tranche A shares may be exercised starting in 2021 and our call option relating to the Tranche B shares may be exercised starting in 2029. As of the date hereof, these options have not been exercised. The terms and conditions of these options are further described in Note 28 Item IV (d) to our audited consolidated financial statements.

[**Table of Contents**](#TableOfContents)

C.&nbsp;&nbsp;&nbsp;&nbsp; Interests of Experts and Counsel

Not applicable.

[**Table of Contents**](#TableOfContents)

ITEM 8. FINANCIAL INFORMATION

A.&nbsp;&nbsp;&nbsp;&nbsp; Consolidated Financial Statements and Other Financial Information

**Consolidated Financial Statements**

See "Item 17. Financial Statements."

**Legal Proceedings**

We are subject to numerous claims with respect to tax, labor, civil and other matters (consisting of antitrust, environmental and other proceedings that do not fit in the other categories). Such proceedings involve inherent uncertainties including, but not limited to, as a result of court rulings, negotiations between affected parties and governmental actions, and, consequently, our management cannot at this stage estimate with certainty how and when these matters will be resolved.

To the extent that we believe contingencies arising from these proceedings will probably be materialized, they have been recorded in the balance sheet. As of December 31, 2022, our provisions for legal contingencies totaled R$990.8 million, of which R$907.9 million were recorded in provision account and R$82.9 million in income taxes (IRPJ and CSLL) contingencies, in accordance with IFRIC23. We have estimated the total exposures of possible (but not probable) losses, which are not recorded as liabilities, to be R$91.6 billion as of December 31, 2022. Our estimates are based on reasonable assumptions, external opinions and management assessments, but should the worst-case scenario develop, subjecting us to losses in all cases classified as possible (but not probable), our net impact on our results of operations would be an expense for this amount. Except as set forth herein, there are no legal proceedings to which we are a party, or to which any of our properties are subject which, either individually or in the aggregate, may have a material adverse effect on our results of operations, liquidity or financial condition. The Company and its subsidiaries have guarantee-insurance policies and letters of guarantee for some legal actions, presented as guarantee for civil, labor and tax executions or to enable resources of labor nature. For more information, see Notes 27 and 30 to our audited consolidated financial statements.

Tax Matters

As of December 31, 2022, we had several tax claims pending against us, including judicial and administrative proceedings. Most of these claims relate to income taxes (IRPJ and CSLL), Social Contributions on Gross Revenues (PIS and COFINS), ICMS Value-Added Tax and IPI Excise Tax. As of December 31, 2022, we had made provisions of R$403.3 million in connection with those tax proceedings for which we believe there is a probable chance of loss.

Among the pending tax claims, there are claims filed by us against Brazilian tax authorities alleging that certain taxes are unconstitutional. As these claims are contingent on obtaining favorable judicial decisions, the corresponding assets which might arise in the future are only recorded once it becomes certain that we will receive the amounts previously paid or deposited.

As of December 31, 2022, we were party to tax proceedings with a total estimated possible risk of loss of R$90.4 billion. Approximately 67% (R$60.5 billion) of this figure is related to controversies related to payment of IRPJ and CSLL, and approximately 32% (R$29.2 billion) is related to controversies involving the payment of PIS, COFINS, ICMS Value-Added and IPI Excise Tax, and the remainder relates to controversies involving other taxes. The most significant proceedings are discussed below.

In addition, if unfavorable final decisions are issued at the administrative level in connection with tax proceedings in which we are party, we may challenge these decisions in judicial courts and be required to post surety bonds or similar guarantees. As of December 31, 2022, approximately 70% (R$63.3 billion) of the ongoing tax proceedings with total estimated possible loss are at the administrative level of dispute and approximately 30% (R$27.1 billion) are at the judicial level of dispute.

**ICMS Value-Added Tax, IPI Excise Tax and PIS and COFINS** 

**Manaus Free Trade Zone – IPI Excise Tax / PIS and COFINS**

In Brazil, goods manufactured within the Manaus Free Trade Zone intended for remittance elsewhere in Brazil are exempt and/or zero rated from IPI Excise Tax, PIS and COFINS. With respect to IPI Excise Tax, we have been registering IPI Excise Tax presumed credits upon the acquisition of exempted goods manufactured therein. Since 2009, we have been receiving a number of tax assessments from the Brazilian Federal Tax Authorities ("RFB"), relating to the disallowance of such credits.

[**Table of Contents**](#TableOfContents)

We have also been receiving charges from the RFB in relation to (i) federal taxes allegedly unduly offset with the disallowed presumed IPI Excise Tax credits that are under discussion in these proceedings and (ii) PIS/COFINS amounts allegedly due on Arosuco's remittance to Ambev.

In April 2019, the STF announced its judgment on Extraordinary Appeal No. 592.891/SP, with binding effects, deciding on the rights of taxpayers registering IPI Excise Tax presumed credits on acquisitions of raw materials and exempted inputs originating from the Manaus Free Trade Zone. As a result of this decision, we reclassified part of the amounts related to the IPI Excise Tax cases as remote losses maintaining as possible losses only issues related to other additional discussions that were not included in the analysis of the STF, such as disputes encompassing the fiscal classification of concentrate units . The cases are being challenged at both the administrative and judicial levels. Our management estimates the possible losses related to these proceedings to be approximately R$5.9 billion as of December 31, 2022. We have not recorded any provision in connection with these assessments.

In addition, over the past years we and our subsidiaries have been imposed isolated fines due to the non-recognition of tax offsets. We have filed defenses in these cases and await judgment by the competent administrative level authority. The constitutionality of this penalty is under review by the Brazilian Supreme Court. The updated assessed amount of these fines as of December 31, 2022 is approximately R$0.2 billion. We have not recorded any provisions for this matter as we consider the chance of loss to be possible. Should a favorable binding decision be ruled by the STF under the matter, the provisions related to this matter will be altered for remote.

**IPI Excise Tax Suspension**

In 2014 and 2015, we received tax assessments from the RFB relating to IPI Excise Tax allegedly due over remittances of manufactured goods to other related factories. The cases are being challenged at both administrative and judicial levels. We've received partially favorable decisions at the administrative level. In July 2022, we received the first judicial decision on this matter; the decision was unfavorable to us, and we have filed an appeal.

In October 2022, the Upper Administrative Court rendered a partially favorable decision to us in one of the cases related to this matter. We await formal notification of this decision to assess whether any portion of the tax assessment may be challenged at the judicial level.

Our management estimates the possible losses related to these assessments to be approximately R$1.7 billion as of December 31, 2022. We have not recorded any provision in connection with these assessments.

**ICMS-ST Trigger**

Over the years, we and our subsidiaries received tax assessments charging alleged ICMS differences considered due in the tax substitution system when the price of the products sold by us is above the fixed price table basis established by certain Brazilian states, cases in which the tax authorities understand that the calculation basis should be based on a value-added percentage over the actual prices, not the fixed table price. We are currently challenging these charges at both the administrative and judicial levels of the courts. Our management estimates the amount related to these assessments to be approximately R$9.3 billion as of December 31, 2022, classified as a possible loss and, therefore, for which we have made no provision.

**ICMS tax incentives**

In 2015, we received a tax assessment issued by the State of Pernambuco charging ICMS differences due to an alleged non-compliance with the State Tax Incentive Program (PRODEPE) as a result of the rectification of our monthly reports. The state tax authorities decided that we were not able to use our tax incentives due to such rectifications. In 2017, we received a final favorable decision nullifying the assessment due to formal mistakes of the tax auditor. However, in September 2018, we received a new tax assessment with respect to the same matter. In June 2020, Ambev received the first level administrative decision, which was partially favorable to the Company in the sense of recognizing the miscalculation of the tax incentive credit by the tax authorities. The favorable portion of the aforementioned decision is final and unappealable. With regard to the unfavorable portion, Ambev filed an administrative appeal, and the judgement is pending. There are other assessments related to this same State Tax Incentive Program and some of them are being discussed at the judicial level. Our management estimates the amount related to these assessments to be approximately R$0.7 billion as of December 31, 2022, classified as a possible loss and, therefore, for which we have made no provision.

[**Table of Contents**](#TableOfContents)

Over the years, we have also received tax assessments issued by the State of Paraíba charging ICMS differences due to an alleged non-compliance with the State Tax Incentive Program (FAIN). We are currently challenging these charges at both the administrative and judicial levels of the courts. Our management estimates the possible losses related to these assessments to be approximately R$0.6 billion as of December 31, 2022. We have not recorded any provision in connection therewith.

**ICMS tax credits**

We are currently challenging tax assessments issued by the states of São Paulo, Rio de Janeiro, Minas Gerais, among others, questioning the legality of ICMS tax credits arising from transactions with companies that have tax incentives granted by other states. The cases are being challenged at both the administrative and judicial level of the courts. On August 2020, the STF issued a binding decision (Extraordinary Appeal No. 628.075) ruling that tax credits granted by the states in the context of the "ICMS tax war" shall be considered unlawful. The decision also recognized that the states should abide by the tax incentives validation process provided for in Complementary Law No. 160/17. This decision does not change the likelihood of loss in Ambev´s tax assessments. With respect to the assessments issued by the State of São Paulo regarding tax credits from the State of Amazonas, we received unfavorable decisions at the second administrative level in April, May and June 2022. In these cases, we have filed a motion for reconsideration with the second administrative level. Our management estimates the possible losses related to these assessments to be approximately R$1.7 billion as of December 31, 2022. We have not recorded any provision in connection therewith.

Our subsidiary Arosuco has also received tax assessments from the state of Amazonas charging alleged differences in ICMS due to questions about the calculation basis applied in certain sales transactions. The cases are being challenged at the administrative level. Arosuco management estimates the possible losses related to these assessments to be approximately R$0.6 billion as of December 31, 2022. We have not recorded any provisions in connection therewith.

In addition, in 2018 and 2021, we received tax assessments from the States of Rio Grande do Sul and São Paulo charging alleged differences in ICMS due to the disallowance of credits arising from transactions with suppliers located in the Manaus Free Trade Zone. With regards to the assessment issued by the State of Rio Grande do Sul, we received a favorable decision at the second administrative level in February 2022, which is still subject to appeal by tax authorities. With respect to the assessments issued by the State of São Paulo, we received unfavorable decisions at the first administrative level in May and June 2022. In these cases, we have filed appeals with the second administrative level. Our management estimates the possible losses related to these assessments to be approximately R$0.7 billion as of December 31, 2023. We have not recorded any provisions in connection therewith.

**PIS/COFINS bonus over products**

We have received tax assessments issued by the RFB charging PIS and COFINS allegedly due over bonus products granted to our customers. These charges are being challenged at both the judicial and administrative levels of the courts. In 2019 and 2020, we received final favorable decisions at the administrative level in some of these cases and favorable decisions in other cases that are still subject to review. At the judicial level, one case is pending decision by the second level judicial court after the first level judicial court rendered an unfavorable decision to us.

Our management estimates the possible losses related to these assessments to be approximately R$1.6 billion as of December 31, 2022. No related provision has been made.

[**Table of Contents**](#TableOfContents)

**Foreign Earnings**

Since 2005, we and certain of our subsidiaries have been receiving a number of assessments from the RFB relating to profits of our foreign subsidiaries. The cases are being challenged at both the administrative and judicial levels of the courts in Brazil.

The administrative proceedings have resulted in partially favorable decisions, which are still subject to review by the administrative court. In August 2022, the Upper Administrative Court rendered favorable decisions to us on two cases related to the taxation of profits of foreign subsidiaries, one of which recognized the application of the double tax treaty signed by Brazil to mitigate such taxation. In October 2022, the Lower Administrative Court rendered a favorable decision to us on a third related case. We are awaiting formal notification of this decision to analyze its content and any applicable legal motions or appeals. In the judicial proceedings, we have received favorable injunctions that suspend the enforceability of the tax credit, as well as favorable first level decisions, which remain subject to review by the second level judicial court.

The updated assessed amount related to this uncertain tax position, as per ICPC22/ IFRIC 23, as of December 31, 2022 is approximately R$7.3 billion. We have not recorded any provisions for this matter based on the probability of loss of the lawsuit. For proceedings where it considers the chance of loss to be probable, Ambev has recorded a provision in the total amount of R$58 million.

**Disallowance on Income Tax Deduction**

In January 2020, Arosuco (one of our subsidiaries) received a tax assessment from the RFB regarding the disallowance of the income tax reduction benefit provided for in the Provisional Measure No. 2199-14/2001, for calendar years 2015 to 2018. In response, an administrative defense was filed. In October 2020, the first level administrative Court rendered an unfavorable decision to Arosuco. Arosuco filed an appeal against the aforementioned decision and awaits judgment by the Lower Administrative Court.

The updated assessed amount related to this uncertain tax position, as per ICPC22/ IFRIC 23, as of December 31, 2022, is approximately R$2.3 billion. We have not recorded any provisions for this matter based on the probability of loss of the lawsuit.

This uncertain tax position, as per ICPC 22/IFRIC 23, continued to be adopted by Arosuco impacting calendar years following those assessed (2019-2022) in which it benefited from the income tax reduction provided for in Provisional Measure No. 2199-14/2001. In a scenario Arosuco is questioned on this matter for future periods, on the same basis and arguments as the aforementioned tax assessment, Arosuco management estimates that the outcome of such potential further assessments would be consistent to the already assessed periods.

**Goodwill - InBev Holding**

In December 2011, we received a tax assessment from the RFB related to the goodwill amortization resulting from Inbev Holding Brazil's merger. At the administrative level, decisions partially favorable to Ambev were rendered by both the Lower and Upper Administrative Court. Ambev filed judicial proceedings to discuss the unfavorable portion of the decisions of Administrative Courts and requested injunctions to suspend the enforceability of the remaining amount being charged. The injunctions were granted.

In June 2016, we received a new tax assessment charging the remaining value of the goodwill amortization (from 2011 to 2013) and filed a defense. Partially favorable decisions were rendered by the first level administrative court and the Lower Administrative Court. We filed a special appeal for analysis of the case by the Administrative Upper Court, and the judgment is pending. For the unfavorable portion of the decision which became final at the administrative level, we filed a judicial proceeding requesting an injunction to suspend the enforceability of the remaining amount being charged. The injunction was granted.

The updated assessed amount related to this uncertain tax position, as per ICPC22/ IFRIC 23, as of December 31, 2022 is approximately R$11.1 billion. The risk of loss has been classified as possible and accordingly, no related provision has been made. In the event we are required to pay these amounts, ABI will reimburse us in the amount proportional to the benefit received by us pursuant to the merger protocol as well as the related costs.

[**Table of Contents**](#TableOfContents)

**Goodwill - Beverage Associate Holding (BAH)**

In October 2013, we received a tax assessment related to the goodwill amortization resulting from the merger of Beverage Associates Holding Limited, or BAH, into us. The decision from the first level administrative court was unfavorable and we filed an appeal to the Lower Administrative Court against the decision which was partially granted. Given the partially favorable decision, both the Brazilian tax authorities and we appealed to the Upper Administrative Court. In July 2022, the Upper Administrative Court rendered a partially favorable decision to us. The decision did not recognize the Special Appeal filed by the tax authorities, thereby preserving the portion of the decision rendered by the Lower Administrative Court that was favorable to us with respect to the imposed qualified penalties and the statute of limitations for one of the calendar years under discussion; this portion of the decision that is favorable to us is final. In January 2023, Ambev filed a judicial proceeding to appeal against the unfavorable portion of the decision.

In April and August 2018, we received new tax assessments charging the remaining value of the goodwill amortization and filed defenses. The decisions rendered by the first level administrative court were unfavorable to us and we filed appeals to the Lower Administrative Court, which were partially granted. Given the partially favorable decisions, both the Brazilian tax authorities and we appealed to the Upper Administrative Court. The decision regarding these appeals is still pending.

The updated assessed amount related to this uncertain tax position, as per ICPC22/ IFRIC 23, as of December 31, 2022 is approximately R$2.2 billion. We have not recorded any provisions for this matter based on the probability of loss of the lawsuit.

**Goodwill - CND Holdings**

In November 2017, we received a tax assessment related to the goodwill amortization in calendar years 2012 to 2016 resulting from the merger of CND Holdings into Ambev. The decision issued by first level administrative court was unfavorable to us. We filed an appeal to the Lower Administrative Court which was partially granted. Given the partially favorable decision, both us and the Brazilian tax authorities appealed to the Upper Administrative Court. The decision regarding these appeals is still pending. In October 2022, we received a new tax assessment charging the remaining value of the goodwill amortization in calendar year 2017. We filed a defense and await judgment by the first level administrative court.

The updated assessed amount related to this uncertain tax position, as per ICPC 22/IFRIC 23, as of December 31, 2022 is approximately R$1.3 billion. We have not recorded any provisions for this matter based on the probability of loss of the lawsuit.

**Goodwill - MAG**

In December 2022, CRBS S.A (one of our subsidiaries) received a tax assessment related to the goodwill amortization in calendar years 2017 to 2020, resulting from the merger of RTD Barbados into CRBS, with the latter as the surviving entity. We filed a defense and await judgment by the first level administrative court.

The updated assessed amount to this uncertain tax position, as per ICPC22/IFRIC 23, as of December 31, 2022 is approximately R$251 million. We have not recorded any provisions for this matter as we consider the chance of loss to be possible.

This uncertain tax position, as per ICPC 22/IFRIC 23, continued to be applied by the Company impacting calendar years following those assessed (2021- 2022). In a scenario we are questioned on this matter for future periods, on the same basis and under the same arguments as the aforementioned tax assessments, we estimate that the outcome of such potential further assessments would be consistent to the already assessed periods.

**Disallowance of financial expenses and Deductibility of Losses**

In 2015, 2016 and 2020, we received tax assessments from the RFB related to the disallowance of alleged non-deductible expenses and the deduction of certain losses mainly associated with financial investments and loans. After we presented our defenses, the first level administrative court rendered a favorable decision with respect to the 2016 case and, in June 2021, we received a partially favorable decision in connection with the 2020 case, against which we filed an appeal to the Lower Administrative Court challenging the unfavorable portion of the decision. In June 2022, we received a partially favorable decision at the first level administrative court regarding the 2015 case and filed an appeal to the Lower Administrative Court. The favorable portion of these decisions are subject to mandatory review by the Lower Administrative Court.

The updated assessed amount related to this uncertain tax position, as per ICPC 22/ IFRIC 23, as of December 31, 2022 is approximately R$5.2 billion. We have not recorded any provisions for this matter based on the probability of loss of the lawsuit.

[**Table of Contents**](#TableOfContents)

**Disallowance of Taxes Paid Abroad**

Since 2014, we have been receiving tax assessments from the RFB related to the disallowance of deductions associated with alleged unproven taxes paid abroad by our subsidiaries and have been filing defenses. The cases are being challenged at both the administrative and judicial levels. In November 2019, the Lower Administrative Court rendered a favorable decision regarding an assessment from 2010, which became final.

In January 2020, the Lower Administrative Court rendered unfavorable decisions regarding four of these assessments, from 2015 and 2016. In these cases, we filed Special Appeals to the Upper Administrative Court which are pending judgment. With respect to the cases related to the periods of 2015 and 2016, tax assessments were filed to charge isolated fines due to the lack of monthly prepayments of income tax as a result of allegedly undue deductions of taxes paid abroad. We filed defenses to the first level administrative court. In 2021, the first level administrative court rendered unfavorable decisions with respect to both the 2015 and 2016 isolated fine cases in two of these assessments and we filed appeals in connection therewith, which are pending judgment by the Lower Administrative Court. In 2022, we received an unfavorable decision from the first level administrative court in the second assessment related to the 2016 isolated fine case, and filed an appeal in connection therewith, which awaits judgment by the Lower Administrative Court. In October 2022, we received a new tax assessment imposing such isolated fine related to the calendar year 2017. We filed a defense in this case and await judgment by the first level administrative court. There is a third tax assessment charging such isolated fine that awaits judgment by the first level administrative court.

The other cases are still awaiting final decisions at both administrative and judicial.

The updated assessed amount related to this uncertain tax position, as per ICPC 22/IFRIC 23, as of December 31, 2022 is approximately R$12.6 billion. We have not recorded any provisions for this matter based on the probability of loss of the lawsuit.

This uncertain tax position, as per ICPC 22/ IFRIC 23, continued to be applied by the Company impacting calendar years following those assessed (2018- 2022). In a scenario we are questioned on this matter for future periods, on the same basis and under the same arguments as the aforementioned tax assessments, we estimate that the outcome of such potential further assessments would be consistent to the already assessed periods.

In addition, over the past years we have been imposed isolated fines due to the non-recognition of tax offsets. We have filed defenses in these cases and awaits judgment by the competent administrative level authority. The constitutionality of this penalty is under review by the Brazilian Supreme Court. The updated assessed amount of these fines as of December 31, 2022 is approximately R$1.2 billion. We have not recorded any provisions for this matter as we consider the chance of loss to be possible. Should a favorable binding decision be ruled by the STF under the matter, the provisions related to this matter will be altered for remote.

**Presumed Profit**

In April 2016, Arosuco (one of our subsidiaries) received a tax assessment regarding the use of the "presumed profit" method for the calculation of income tax and the social contribution on net profit instead of the "real profit" method. In September 2017, Arosuco received an unfavorable first level administrative decision and filed an appeal. In January 2019, the Lower Administrative Court rendered a favorable decision to Arosuco, which became final.

[**Table of Contents**](#TableOfContents)

In March 2019, a new tax assessment regarding the same subject matter was received and we filed a defense. In October 2019, Arosuco received an unfavorable first level administrative decision and filed an appeal.

As of December 31, 2022, Arosuco's management estimated that the updated assessed amount related to this uncertain tax position, as per IFRIC 23, is approximately R$0.6 billion. The risk of loss has been classified as possible and, accordingly, no related provision has been made.

**Deductibility of IOC expenses**

In 2013, as approved at our Shareholders Meeting, we implemented a corporate restructuring to simplify our corporate structure and convert into a single class of shares, among other factors. One of the steps of such restructuring involved a contribution of shares followed by the merger of shares of its controlled entity Companhia de Bebidas das Américas into Ambev. As one of the results of this restructuring, the counterpart register of the positive difference between the value of shares issued for the merger and the net equity value of its controlled entity's share was accounted, as per IFRS 10/CPC 36 and ICPC09, in an equity account of Ambev referred to as carrying value adjustment.

In November 2019, we received a tax assessment from the RFB questioning the interest on capital, or IOC, deduction in 2014. The tax assessment refers primarily to the accounting and corporate effects of the corporate restructuring carried out by us in 2013 and its impacts on the increase in the deductibility of IOC expenses. In August 2020, Ambev received a partially favorable decision at the first level administrative Court and filed an Appeal to the Lower Administrative Court which awaits judgement. The favorable portion of the decision is also subject to mandatory review by the Lower Administrative Court.

In December 2020, Ambev received a new tax assessment related to the deduction of the IOC in 2015 and 2016. The defense against such new tax assessment was filed by Ambev in January 2021. In June 2021, Ambev received a partially favorable decision and filed an appeal to the Lower Administrative Court which also awaits judgement. Similar to the first tax assessment, the favorable portion of the decision is also subject to mandatory review by the Lower Administrative Court.

In December 2022, Ambev received a new tax assessment related to the deduction of the IOC in 2017. The defense against this new tax assessment was filed by Ambev in January 2023, which is pending judgment by the first level administrative court.

The updated assessed amount related to this uncertain tax position, as per ICPC 22/IFRIC 23, as of December 31, 2022 is approximately R$13.8 billion. We have not recorded any provisions for this matter based on the probability of loss of the lawsuit.

The uncertain tax position, as per ICPC 22/ IFRIC 23, continued to be adopted by the Company as it also distributed IOC in the years following the assessed period (2018-2022) and deducted such amounts from its Corporate Income Taxes taxable basis. Therefore, in a scenario where the IOC deductibility would also be questioned for the period after 2017, on the same basis and arguments as the aforementioned tax assessments, Ambev management estimates that the outcome of such potential further assessments would be consistent to the already assessed periods.

**Tax Loss Offset**

In 2008 and 2010 we received a number of assessments from the Brazilian Federal Tax Authorities relating to the offset of tax losses carried forward in the context of business combinations in calendar year 2005.

In February 2016, the Upper Administrative Court ruled unfavorably to us in two of these cases, following which we filed judicial proceedings. In September 2016, we received a favorable first level decision in one of the judicial claims which was confirmed by the second-level judicial court in December 2022. This decision is subject to appeal by the tax authorities. In March 2017, we received an unfavorable first level decision with respect to the second judicial case and filed an appeal, which is pending judgment by the second-level judicial court.

[**Table of Contents**](#TableOfContents)

There is a third case being challenged at the administrative level in which an unfavorable decision was rendered to us by the Lower Administrative Court in June 2019. We appealed against this decision and await judgment by the Upper Administrative Court.

The updated assessed amount related to this uncertain tax position, as per ICPC 22/ IFRIC 23, as of December 31, 2022 is approximately R$548 million. We have not recorded any provisions for this matter based on the probability of loss of the lawsuit.

**Adherence to the Special Tax Regularization Program**

In September 2017, we decided to participate in the Federal Tax Amnesty Program established by Provisional Measure No. 783/2017, converted into Law No. 13,496/2017, or PERT 2017, undertaking to pay certain tax assessments that were in dispute under administrative or judicial levels, including debts from our subsidiaries, in the total amount of R$3.5 billion (already considering discounts established by the program). The total amount paid in 2017 was approximately R$960.0 million and the balance will be paid in 145 monthly installments, with interest, as of January 2018. All installments due up to the date have been paid by the Company.

Despite our participation in this program, we could be subject to tax audits for subsequent periods, which may lead to tax challenges by the relevant authorities on similar claims. In addition, if we are delinquent in our payments under these programs or are otherwise unable to pay as scheduled, we may be barred from participating in this program and similar programs this.

**Tax Proceeding Initiated By Us**

*PIS and COFINS Recovery - exclusion of ICMS (VAT) from the basis of calculation*

In 2017, the STF declared, in the judgment of RE No. 574,706/PR, with binding effects, the unconstitutionality of the inclusion of ICMS in the tax base of PIS and COFINS. Such decision was reaffirmed by the STF in May 2021, in the judgment of the request for clarification presented by the PGFN, whereby the Court confirmed that the ICMS to be excluded from the PIS and COFINS tax base is the one stated in the invoice. The Court also determined that the decision should apply retroactively as of March 15, 2017 (date on which the decision on RE 574,706/PR was rendered), except for taxpayers who had judicial and administrative claims filed before said date (which is the case of the Company and its subsidiaries). As for ICMS under the tax substitution modality, the Brazilian Superior Court of Justice ("STJ") began the judgment of the so called Theme 1125 with a favorable vote for taxpayers, therefore determining the exclusion of this ICMS modality in the tax basis of PIS and COFINS.

The Company and its subsidiaries filed several lawsuits related to this matter, most with final and unappealable favorable decisions. As the federal tax regime applicable to the soft drinks and beer sector has changed over time, the Company and its subsidiaries are parties to lawsuits related to three different periods: (i) 1990 to 2009, (ii) 2009 to 2015 (period in which the "REFRI Taxation Model" was in force - special soft drinks and beer regime, provided for Article 58-J of Law No. 10,833, of 2003) and (iii) 2015 onwards (also known as "New Model Taxation").

In 2018, 2019, 2020, 2021 and 2022, the Company and its subsidiaries recognized, in accordance with IAS 37/CPC 25, recoverable tax credits related to this matter in the total amount of R$9.4 billion of which (i) R$0.7 billion is related to periods from 1990 to 2009, (ii) R$4 billion is related to the New Model Taxation, from March 2017, when the Company and its subsidiaries implemented the judicial decisions authorizing the exclusion of the ICMS from the PIS and COFINS tax base in its regular transactions and which right of recovery is assured by the decision rendered by the STF in the judgment of RE 574.706/PR and (iii) R$4.7 billion is related to periods from 2009 to 2015, during which the REFRI Taxation Model was in force. Part of this amount has already been used to offset other tax debts according to the final and unappealable decisions rendered in certain judicial lawsuits involving the Company and its subsidiaries. The outstanding amount of recoverable tax credits remain registered in the asset account (see Note 18 – Recoverable Taxes).

The accounting recognition of said amounts is due to (i) the gain being virtually certain considering the decision provided by the STF in RE 574,706/PR and the specific circumstances of each case; and (ii) the fact that the amount could be estimated with sufficient reliability, by collecting the respective documents and quantifying the related amount. As to the tax credits related to the period in which the REFRI Taxation Model was in place, the amount could be estimated with sufficient reliability after several analyses made with the assistance of our external consultants were made. These analyses allowed us to (i) identify the total ICMS included per liter in the retail selling prices that were verified by the Federal Government at the time and that had an impact on the reference prices used as a base for the determination of the PIS and COFINS; and (ii) calculate the exclusion of such ICMS from the tax base of PIS and COFINS in the transactions carried out by the Company and its subsidiaries.

In addition, with respect to the transactions performed after the implementation of the individual judicial decisions authorizing the exclusion of the ICMS from the PIS and COFINS tax base, the Company and its subsidiaries had a positive impact of R$5.1 billion, net of the amounts mentioned above, which represented a reduction in the PIS and COFINS expenses.

For additional matters, the Company estimates that the contingent asset corresponds to R$0.7 billion, which will be recognized once the realization of the gain is virtually certain given the specific circumstances of the case and upon confirmation of the estimated values with sufficient reliability.

**Subsequent Events** 

Not Applicable.

Labor Matters

We are involved in more than 18,000 labor claims. Most of the labor claims we face relate to our Brazilian operations. In Brazil, it is not unusual for a large company to be named as a defendant in such a significant number of claims. As of December 31, 2022, we made provisions totaling R$132 million in connection the above labor claims involving former, current and outsourced employees relating mainly to overtime, dismissals, severance, health and safety premiums, supplementary retirement benefits and other matters, all of which are awaiting judicial resolution and have probable chance of loss. As of December 31, 2022, we were party to labor claims with a total estimated possible risk of loss of R$179.4 million.

In connection with the labor matters, we are also involved in claims regarding the social charges on payroll. Management estimates the possible losses related to these claims to be, approximately, R$419 million as of December 31, 2022. We have recorded provisions of approximately R$36.6 million for proceedings where we consider the chance of loss to be probable.

**Ambev Third-Party Supplier – Labor Investigations and Lawsuits**

In May 2021, Ambev was notified by Brazilian labor authorities to join certain administrative proceedings together with (i) Transportadora Sider Limeira EIRELI ("Sider"), a transportation company contracted by Ambev on a recurring spot basis and (ii) a third-party competitor of Ambev to which Sider had also provided transportation services. Ambev was deemed to be jointly and severally liable for purported human rights violations committed by Sider with respect to the working conditions of 23 foreign employees, under the terms of Brazilian Labor Law, including violations of article 444 of Law-Decree No. 5,452 and article 2-C of Law No. 7,998.

[**Table of Contents**](#TableOfContents)

On March 12, 2021 Sider entered into a settlement with those foreign employees, paying them compensation for (i) severance pay and (ii) moral damages. However, after the settlement, since the end of 2022, 18 foreign employees rescued, as well as additional former employees of Sider, filed individual labor lawsuits against Sider, Ambev and the third-party competitor claiming, among other things, moral damages for the same alleged labor violations. The Plaintiffs in these lawsuits have alleged secondary liability in respect of Ambev.

In addition, the Brazilian Ministry of Labor and Social Security (the "Ministry of Labor & Social Security") issued infraction notices against Sider, Ambev and the third-party competitor. These labor administrative proceedings are currently ongoing, and Ambev strongly disputes any involvement in the alleged facts underlying these investigations. However, in the event that the infraction notices are confirmed by the administrative authority, Ambev may be subject to fines in the amount of approximately R$50,000 (plus any interest and monetary adjustments) and may be included in the Brazilian register of employers (*Cadastro de Empregadores*) that have subjected workers to poor working conditions ("Register of Employers"), under the terms of Brazilian Interministerial Ordinance MTPS/MMIRDH No. 4/2016. Ambev's inclusion in the Register of Employers may result in (i) restrictions on access to state-owned banks' credit lines and (ii) a negative impact on risk-assessments made by private banks and other parties. However, if an adverse administrative decision is rendered, Ambev can challenge such decision in court. As of December 31, 2022, Ambev has not recorded any provisions in connection with these infraction notices as it considers the chance of loss to be possible.

In addition, the Brazilian Public Labor Prosecutor's Office (the "Public Labor Prosecutor's Office") has opened a civil investigation to assess the underlying facts and the role of each of the three companies in the event. Ambev and the "Public Labor Prosecutor's Office" entered into a Conduct Adjustment Agreement in April 2022 without acknowledgment of guilt. Ambev paid damages amounting to R$500,000.00 and committed to a 3-year plan to oversee conditions of its logistics operators.

Civil Claims

As of December 31, 2022, we were involved in more than 3,500 civil claims that were pending, including third-party distributors and product-related claims. We have established provisions totaling R$335.9 million for proceedings where we consider the chance of loss to be probable reflecting applicable adjustments, such as accrued interest, as of December 31, 2022 in connection with civil claims. As of December 31, 2022, we were party to civil claims with a total estimated possible risk of loss of R$564.6 million.

**Subscription Warrants**

In 2002, we decided to request a ruling from the CVM in connection with a dispute between Old Ambev and some of its warrant holders regarding the criteria used in the calculation of the strike price of certain Old Ambev warrants. In March and April 2003, the CVM ruled that the criteria used by Old Ambev to calculate the strike price were correct. In response to the CVM's final decision and seeking to reverse it, some of the warrant holders filed separate lawsuits before the courts of São Paulo and Rio de Janeiro.

Although the warrants expired without being exercised, the warrant holders claim that the strike price should be reduced to consider the strike price of certain stock options granted by Old Ambev under its then-existing stock ownership program, as well as for the strike price of other warrants issued in 1993 by Brahma.

We are aware of at least seven claims in which the plaintiffs argue that they would be entitled to those rights. One of these cases was settled. The other six lawsuits were ruled favorably to Ambev by the STJ. Three cases were dismissed by the STJ's Special Court and were subject to a new appeal to the Brazilian Supreme Court. In February 2022, the plaintiffs' appeals to STF were denied by the Supreme Court Reporting Justice. The plaintiffs filed an appeal for further review by the STF Chamber, which was denied by the STF Chamber in a unanimous ruling. A final judgment has not yet been rendered in these three cases. One case was ruled favorably to Ambev by the STJ's Special Court, and the judgment became final. Another case was remitted to the STJ's lower court for a new judgment. The sixth case was ruled favorably to Ambev, and it was subject to an appeal to the Brazilian Supreme Court, which was denied. Such decision became final.

[**Table of Contents**](#TableOfContents)

In the event the plaintiffs prevail in the above four cases in which a final decision on the merits is still pending, we believe that the corresponding economic dilution for the existing shareholders would be the difference between the market value of the shares at the time they are issued, and the value ultimately established in liquidation proceedings as being the subscription price pursuant to the exercise of the warrants. We believe the warrants object of those four proceedings represented, on December 31, 2022, 172,831,574 Ambev common shares that would be issued at a value substantially below fair market value, should claimants ultimately prevail. The plaintiffs also claim they should receive past dividends related to these shares in the amount of approximately R$1.2 billion as of December 31, 2022.

Based on management assessments, our chances of receiving unfavorable final decisions in this matter are remote, and therefore we have not established a provision for this litigation in our audited consolidated financial statements. As these disputes are based on whether we should receive as a subscription price a lower price than the price that we consider correct, a provision of amounts with respect to these proceedings would only be applicable with respect to legal fees and past dividends.

**Lawsuit Against the Brazilian Beer Industry**

On October 28, 2008, the Brazilian Federal Prosecutor's Office (*Ministério Público Federal*) filed a suit for damages against us and two other brewing companies claiming total damages of approximately R$2.8 billion (of which approximately R$2.1 billion are claimed against us). The public prosecutor alleges that: (1) alcohol causes serious damage to individual and public health, and that beer is the most consumed alcoholic beverage in Brazil; (2) defendants have approximately 90% of the national beer market share and are responsible for heavy investments in advertising; and (3) the advertising campaigns increase not only the market share of the defendants but also the total consumption of alcohol and, hence, cause damage to society and encourage underage consumption.

Shortly after the above lawsuit was filed, a consumer-protection association applied to be admitted as a joint-plaintiff. The association has made further requests in addition to the ones made by the Public Prosecutor, including the claim for "collective moral damages" in an amount to be ascertained by the court; however, it suggests that it should be equal to the initial request of R$2.8 billion (therefore, doubling the initial amount involved). The court has admitted the association as joint-plaintiff and has agreed to hear the new claims. After the exchange of written submissions and documentary evidence, the case was dismissed by the Lower Court Judge, which denied all the claims submitted against Ambev and the other defendants. The Federal Prosecutor's Office appealed to the Federal Court, which decided for the annulment of the lower court decision, based on the understanding that more evidence should have been produced before the case's dismissal. Ambev filed a motion for clarification against the decision, which was rejected, and such decision became final. The case has now returned to the lower court for a new trial, which is currently pending. Ambev believes, based on management assessments, that its chances of loss remain remote and, therefore, has not made any provision with respect to such claim.

**Lawsuit Against F. Laeisz**

On April 4, 2018, F. Laeisz filed a lawsuit against us for collection of dividends relating to 74,211,825 ordinary shares issued by Ambev and held in our treasury since April 10, 2012. F. Laeisz alleges that: (1) it is the rightful owner of the shares; and (2) the ownership of registered shares shall be based on the registration under the shareholder's name on the company's Share Registry Book.

The Lower Court Judge granted our request to admit the Federal Government as joint defendant since it also claims to be the owner of such shares, as the Federal Government was entitled to incorporate such shares based on a decree enacted during World War II. In October 2019, the Lower Court Judge granted F. Laeisz's claims ordering Ambev to pay the amount equivalent to the dividends of 74,211,825 ordinary shares held in our treasury since April 10, 2012. On September 30, 2022, such decision was subject to a mandatory review by the Federal Court of Appeals, since the Federal Government lost its preliminary claims, and the decision was overturned by the Federal Court of Appeals, which considered the ordinary shares had been duly transferred and incorporated by the Federal Government based on the decree enacted during the World War II. In parallel, we have negotiated and executed a settlement agreement with F. Laeisz, aiming at reducing the total amount under dispute. Except for inflation adjustment, F. Laeisz has agreed on restrictions to the application of interests to adjust the dividends in the event there is a final decision confirming F. Laeisz as the rightful owner of the shares. We believe, based on management assessments, that our chances of loss are possible. Nonetheless, irrespective to whom is considered the rightful owner of the shares in question, we have duly accounted for all dividends relating to the relevant shares since April 10, 2012.

[**Table of Contents**](#TableOfContents)

**Cerbuco Brewing Arbitration**

Cerbuco Brewing Inc., ("Cerbuco") a Canadian subsidiary of Ambev, owns a 50% equity ownership in Cerveceria Bucanero S.A. ("Bucanero"), a joint venture in Cuba. In 2021, Cerbuco initiated an arbitration proceeding at the International Chamber of Commerce ("ICC"), relating to a potential breach of certain obligations relating to the joint venture, with the terms of reference being formally executed in 2022. Depending on the outcome of the arbitration proceedings there may be an impact on Cerbuco's ability to influence the management of Bucanero's operations. As a result, Ambev's ability to continue consolidating Bucanero into its financial statements may also be affected. Based on the opinion of Cerbuco's lawyers, the management estimate the chance of loss as possible. The amount involved has not yet been ascertained, as it depends on the outcome of the arbitration

**Dividend Policy**

The timing, frequency and amount of future dividend payments, if any, will depend upon various factors that our Board of Directors may consider relevant, including our earnings and financial condition. Our bylaws provide for a minimum mandatory dividend of 40% of our adjusted annual net income, if any, as determined under IFRS at our individual financial statements. Brazilian companies are permitted to make limited distributions to shareholders in the form of interest accrued on share capital, commonly referred to as "interest on shareholders' equity," and treat such payments as a deductible financial expense for purposes of Brazilian income tax and social contribution on profits. This notional interest distribution is treated for accounting purposes as a deduction from shareholders' equity in a manner similar to a dividend. The benefit from the tax-deductible interest on shareholders' equity is recorded in the income statement. The minimum mandatory dividend includes amounts paid as interest on shareholders' equity (net of taxes). However, payment of such interest on shareholders' equity is subject to Brazilian withholding income tax, whereas no such withholding is required in connection with dividends paid. For further information on this matter see "Item 10. Additional Information—E. Taxation—Brazilian Tax Considerations—Income Tax."

Annual adjusted net income not distributed as dividends or interest on shareholders' equity may be capitalized, used to absorb losses or otherwise appropriated as allowed under the Brazilian Corporation Law and our bylaws. Therefore, annual adjusted net income amounts may not necessarily be available to be paid as dividends. We may also not pay dividends to our shareholders in any particular fiscal year based on the opinion of the Board of Directors that such distribution would be inadvisable in view of our financial condition at the time. Any such dividends not distributed would be allocated to a special reserve account for future payment to shareholders, unless used to offset subsequent losses. For further information on this matter, see "Item 3. Key Information— D. Risk Factors—Risks Relating to Our Common Shares and ADSs—Our shareholders may not receive any dividends."

For further information on provisions of the Brazilian Corporation Law relating to required reserves and payment of dividends or interest on shareholders' equity, as well as specific rules applicable to the payment of dividends by us under our bylaws, see "Item 10. Additional Information—B. Memorandum and Articles of Association—Reserves."

Ambev S.A.

The following table shows the cash dividends paid by Ambev to holders of Ambev's common shares in *reais* and in U.S. dollars (translated from *reais* at the commercial exchange rate as of the date of payment) for each of the indicated periods. The amounts include interest on shareholders' equity, net of withholding tax. The last distribution of dividends approved, which relates to the 2022 fiscal year, was paid by Ambev on December 29, 2022.

[**Table of Contents**](#TableOfContents)

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp; **Date of Approval** | &nbsp;&nbsp; **First Payment Date** | &nbsp;&nbsp; ***Reais* per Shares(1)** | &nbsp;&nbsp; **U.S. Dollar Equivalent per Share at Payment Date(1)(2)** |
| &nbsp;&nbsp;Second half 2020 | &nbsp;&nbsp;December 30, 2020 | &nbsp;&nbsp;0.3516 | &nbsp;&nbsp;0.079 |
| &nbsp;&nbsp;Second half 2020 | &nbsp;&nbsp;January 28, 2021 | &nbsp;&nbsp;0.0767 | &nbsp;&nbsp;0.014 |
| &nbsp;&nbsp;Second half 2021 | &nbsp;&nbsp;December 30, 2021 | &nbsp;&nbsp;0.1334 | &nbsp;&nbsp;0.023 |
| &nbsp;&nbsp;Second half 2021 | &nbsp;&nbsp;December 30, 2021 | &nbsp;&nbsp;0.3996 | &nbsp;&nbsp;0070 |
| &nbsp;&nbsp;Second half 2022 | &nbsp;&nbsp;December 29, 2022 | &nbsp;&nbsp;0.6480 | &nbsp;&nbsp;0.124 |

---

(1) The amounts set forth above are amounts actually received by shareholders,
which are net of withholding tax. The financial statements present the amounts actually disbursed, including the withholding tax on interest
on shareholders' equity, which was paid by Ambev on behalf of shareholders. The dividends set forth above are calculated based on
the number of outstanding shares at the date the distributions were declared. See "Item 7. Major Shareholders and Related Party
Transactions—A. Major Shareholders."

(2) Translated to U.S. dollars at the exchange rate in effect at the first scheduled
payment date.

For more information on rules and procedures for shareholder distributions under our bylaws, see "Item 10. Additional Information—B. Memorandum and Articles of Association—Reserves."

B.&nbsp;&nbsp;&nbsp;&nbsp; Significant Changes

Except as otherwise disclosed in our audited consolidated financial statements and in this annual report, there have been no significant changes in our business, financial conditions or results in December 31, 2022.

[**Table of Contents**](#TableOfContents)

ITEM 9. THE OFFER AND LISTING

A.&nbsp;&nbsp;&nbsp;&nbsp; Offer and Listing Details

Not applicable. Information regarding the price history of the stock listed as required by Item 9.A.4 is set forth below in "—C. Principal Market and Trading Market Price Information."

B.&nbsp;&nbsp;&nbsp;&nbsp; Plan of Distribution

Not applicable.

C.&nbsp;&nbsp;&nbsp;&nbsp; Principal Market and Trading Market Price Information

We are registered as a publicly held company with the CVM. Our common shares are listed on the B3 under the symbol "ABEV3" and our ADSs are listed on the NYSE under the symbol "ABEV". Our shares and ADSs began trading on the B3 and the NYSE, both on November 11, 2013. The shares and ADSs of Old Ambev ceased all trading activities on those stock exchanges on the close of business of November 8, 2013.

Ambev has only one class of shares (i.e., voting common shares), including in the form of ADSs (evidenced by ADRs), with each ADS representing one Ambev common share. The Ambev common shares and ADSs are registered under the Exchange Act. As of March 1<sup>st</sup>, 2023, Ambev had 15,741,734,691 shares outstanding. As of March 1<sup>st</sup>, 2023, there were 1,411,283,441 Ambev ADSs outstanding (representing 1,411,283,441 Ambev shares, which corresponds to 8.9% of the total Ambev shares outstanding). The Ambev shares held in the form of ADSs under the Ambev ADS facilities are deemed to be the shares held in the "host country" (i.e., the United States) for purposes of the Exchange Act. In addition, as of March 1<sup>st</sup>, 2023 there were 171 registered holders of Ambev ADSs.

**Regulation of the Brazilian Securities Market**

The Brazilian securities market is regulated by the CVM, which has regulatory authority over the stock exchanges and securities markets, as well as by the Central Bank, which has, among other powers, licensing authority over brokerage firms and regulates foreign investment and foreign exchange transactions. The Brazilian securities market is governed primarily by Law No. 6,385 dated December 7, 1976, as amended, or the Brazilian Securities Law, and by the Brazilian Corporation Law, as amended and supplemented, as well as by rules and regulations issued by the CVM, the CMN and Brazilian Central Bank. These laws and regulations, among others, provide for disclosure requirements, criminal penalties for insider trading and price manipulation, and protection of minority shareholders, licensing procedures, supervision of brokerage firms and governance of Brazilian stock exchanges. However, the Brazilian securities markets are not as highly regulated and supervised as U.S. securities markets.

Under the Brazilian Corporation Law, a company is either publicly held (*companhia aberta*), such as Ambev, whose shares are publicly traded on the B3, or privately held (*companhia fechada*). A company is publicly held when it is authorized to have securities traded on the stock exchange or on over-the-counter markets. All listed companies are registered with the CVM and are subject to reporting and regulatory requirements relating to the periodic disclosure of information and material facts. Additionally, the CVM within its regulatory authority may request information or clarification from us regarding our business activities and/or transactions to which we are a party. A company registered with the CVM may trade its securities either on the Brazilian stock exchanges, including B3, or in the Brazilian over-the-counter market. Shares of companies like Ambev traded on the B3 may not simultaneously be traded on the Brazilian over-the-counter market. The over-the-counter market consists of direct trades between persons in which a financial institution registered with the CVM serves as an intermediary. The shares of a listed company, including Ambev, may also be traded privately subject to several limitations. To be listed on the B3, a company must be registered as a publicly held Company with the CVM and apply for registration with the B3.

The over-the-counter market is divided into two categories: (1) an organized over-the-counter market, in which the transactions are supervised by self-regulating entities authorized by the CVM; and (2) a non-organized over-the-counter market, in which the transactions are not supervised by self-regulating entities authorized by the CVM. In either case, transactions are directly traded among persons, outside of the stock exchange market, through a ﬁnancial institution authorized by the CVM. The institution is required to be registered with the CVM (and in the relevant over-the-counter market), but there is no need for a special license to trade securities of a publicly listed company on the over-the-counter market.

[**Table of Contents**](#TableOfContents)

The trading of securities on the Brazilian stock exchanges may be suspended under certain circumstances, including at the request of a company in anticipation of a disclosure of material announcement. Companies may be required by law to request such suspension. Trading may also be suspended on the initiative of a Brazilian stock exchange or the CVM, among other reasons, based on or due to a belief that a company has provided inadequate information regarding a significant event or has provided inadequate responses to inquiries by the CVM or a stock exchange.

**Trading on the Brazilian Stock Exchanges**

B3 is a stock exchange and leading operator of registration, clearing, custodial and settlement services for equities, financial securities, indices, rates, commodities, and currencies in Brazil. B3 is currently the only Brazilian stock exchange on which private equity and private debt may be traded.

Trading on the exchange is conducted by authorized members. B3 trading sessions take place every business day, from 10:00 a.m. to 5:55 p.m., BRT. Equity trading is executed fully electronically through an order-driven trading system called "PUMA Trading System," or "PUMA." Additionally, the home broker system through the Internet has been established allowing retail investors to transmit orders directly to the B3. B3 trading session hours may change from time to time due to daylight saving time in Brazil and in the United States, in such case B3 may shorten its sessions hours and permits trading after the session closure on an online system connected to PUMA and Internet brokers called the "after-market". CVM has discretionary authority to suspend trading in shares of a particular issuer under specific circumstances. Securities listed on the B3 may also be traded off the exchange under specific circumstances, but such trading is very limited.

Settlement of transactions is performed two business days after the trade date, without any adjustment to the purchase price. Delivery of and payment for shares are made through the facilities of an independent clearing house, B3 Central Depository, which is the clearing house for the transactions carried out on the B3 and handles the multilateral counterparty settlement of both financial obligations and transactions involving securities. According to the regulations of the B3 Central Depository, financial settlement is carried out through the funds transfer system of the Central Bank and the transactions involving the sale and purchase of shares are settled through the B3 Central Depository custody system. All deliveries against final payment are irrevocable. The seller is ordinarily required to deliver the shares to the exchange on the second business day following the trade date. The B3 Equities Clearing is responsible for the registration, settlement and risk management of trades with shares through the PUMA Trading System.

In order to better control volatility, B3 has adopted a "circuit breaker" mechanism pursuant to which trading sessions may be suspended for a period of 30 minutes or one hour whenever the index of the stock exchange falls below 10% or 15%, respectively, compared to the previous day's closing index. If the market falls more than 20% compared to the previous day, the B3 may determine the suspension of trading in all markets for a defined period, at its sole discretion, and such decision must be disclosed to the market. The "circuit breaker" is not allowed to be started during the last 30 minutes of the trading session.

Although the Brazilian equity market is Latin America's largest in terms of market capitalization, it is smaller, more volatile and less liquid than the major U.S. and European securities markets. As of December 31, 2022, the aggregate market capitalization of all companies included in the IBOVESPA index of the B3 was equivalent to approximately R$3.5 trillion. Although all of the outstanding shares of a listed company are actually available for trading by the public, in most cases fewer than half of the listed shares are actually traded by the public because the remainders of a listed company's shares are usually held by small groups of controlling persons, by governmental entities or by one principal shareholder. For this reason, data showing the total market capitalization of Brazilian stock exchanges tend to overstate the liquidity of the Brazilian equity securities market.

There is also significantly greater concentration in the Brazilian securities markets. For example, as of January 31, 2023 the ten shares with greatest representation on the IBOVESPA index of the B3 accounted for 54.13% of the total weight of all companies included in that stock index.

[**Table of Contents**](#TableOfContents)

Trading on Brazilian stock exchanges by non-residents of Brazil is subject to limitations under Brazilian foreign investment legislation. See "Item 10. Additional Information—D. Exchange Controls and other Limitations Affecting Security Holders" and "Item 10. Additional Information—B. Memorandum and Articles of Association—Restrictions on Foreign Investment."

D.&nbsp;&nbsp;&nbsp;&nbsp; Selling Shareholders

Not applicable.

E.&nbsp;&nbsp;&nbsp;&nbsp; Dilution

Not applicable.

F.&nbsp;&nbsp;&nbsp;&nbsp; Expenses of the Issue

Not applicable.

[**Table of Contents**](#TableOfContents)

ITEM 10. ADDITIONAL INFORMATION

A.&nbsp;&nbsp;&nbsp;&nbsp; Share Capital

Not applicable.

B.&nbsp;&nbsp;&nbsp;&nbsp; Memorandum and Articles of Association

Below is a brief summary of the material provisions concerning our common shares, bylaws and the Brazilian Corporation Law. In Brazil, the principal governing document of a corporation is its bylaws (Estatuto Social). This description is qualified in its entirety by reference to the Brazilian Corporation Law and our bylaws. An English translation of our bylaws has been filed with the SEC as an exhibit to this annual report. A copy of our bylaws (together with an English translation) is also available for inspection at the principal office of the depositary and at our website (<u>http://ri.ambev.com.br/</u>). Information on ownership of our shares is set forth under "Item 7. Major Shareholders and Related Party Transactions—A. Major Shareholders."

On April 27, 2022, our Board of Directors approved the issuance of 5,550,560 new common shares with no par value as a result of the exercise of options granted under the Stock Options Programs approved by our Board of Directors on March 25, 2019, pursuant to our Stock Option Plan that was approved by our Shareholders on July 30, 2013. The issuance price per share was R$15.20 and our capital stock following the increase sums R$58,130,517,165.22, represented by 15,750,216,851 common shares with no par value.

As of March 1<sup>st</sup>, 2023, our capital stock was equal to R$58,130,517,165.22 divided into 15,750,216,851 issued common shares, without par value, of which 8,482,160 were treasury shares, with no further changes since December, 2022. We are authorized to increase our capital up to 19,000,000,000 shares upon the decision of our Board of Directors, without the need to amend our bylaws. We have a single-class share structure, comprised exclusively of voting common shares, and there are no classes or series of preferred shares outstanding.

Pursuant to the Brazilian Corporation Law, we are allowed to sell in the open market any Ambev common shares that have been subscribed but not paid in full within the applicable deadline set forth in our bylaws or the applicable subscription bulletin under which those shares were issued. If an open market sale is impractical, any subscribed but unpaid Ambev common shares may be forfeited.

Each common share entitles the holder thereof to one vote at our shareholders' meetings. Holders of common shares are not entitled to any preference upon our liquidation.

The Board of Directors individualize the compensation for each member of our management (including Directors), subject to the maximum global compensation amount approved by our shareholders. Each individual Director is prevented from voting on the decision regarding their own compensation. For more information on management compensation, see "Item 6. Directors, Senior Management and Employees—C. Board Practices—The Board of Directors—Operations and Finance Committee."

There is no age limit for retirement applicable to the members of our Board of Director in our bylaws.

**General**

Our registered name is Ambev S.A., and our registered office is in the city of São Paulo, State of São Paulo, Brazil. Our registration number with the São Paulo Commercial Registry is 35,300,368,941. Our principal corporate purposes include the production and sale of beer, CSDs and other beverages. A more detailed description of our corporate purposes can be found in Chapter I, Article 3 of our bylaws.

**Rights of the Ambev Common Shares**

Each of our common shares is indivisible and entitles its holder to one vote at any shareholders' meeting of Ambev. In accordance with our bylaws and the Brazilian Corporation Law, shareholders have the right to receive dividends or other distributions in proportion to their equity interest in our share capital. For additional information regarding the payment of dividends and other distributions relating to our common shares, see "Item 8. Financial Information" and "Consolidated Financial Statements and Other Financial Information—Dividend Policy." In addition, our shareholders may freely transfer their shares and are entitled to be included in a statutory sale of control tender offer upon a disposition of our control (see item "Disclosure of the Ownership and Trading of our Shares by Us, our Principal Shareholders, Directors and Officers or Members of our Fiscal Council" for more information).

[**Table of Contents**](#TableOfContents)

Also, upon our liquidation, and after the discharge of all our liabilities, our common shares entitle its holders to a participation in our remaining assets as capital reimbursement in proportion to their equity interest in our share capital. Except under certain circumstances, holders of our common shares have the right, but not the obligation, to subscribe for our future capital increases.

Moreover, pursuant to the Brazilian Corporation Law, neither our bylaws nor actions taken at a shareholders' meeting may deprive a shareholder of the following rights:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· the right to participate in our profit distributions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· the right to participate in our remaining assets in proportion to its equity interest in our share capital
in the event of our liquidation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· preemptive rights to subscribe for our common shares, convertible debentures and warrants, except in certain
circumstances under the Brazilian Corporation Law, as described in "—Preemptive Rights";

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· the right to inspect and monitor our management, in accordance with the Brazilian Corporation Law;

and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· the right to exercise appraisal rights and withdraw from the Company in the cases provided under the Brazilian
Corporation Law, as described in "—Appraisal Rights."

**Shareholders' Meetings**

Pursuant to the Brazilian Corporation Law, shareholders, during shareholders' meetings regularly called and convened, are generally empowered to pass resolutions relating to our corporate purpose as they may deem necessary. Shareholders' meetings may be ordinary, such as the annual meeting, or extraordinary. Shareholders at the annual shareholders' meeting, which is required to be held within four months of the end of our fiscal year, have the exclusive power to approve our financial statements and to determine the allocation of our adjusted net income and the distribution of dividends with respect to the fiscal year ended immediately prior to the relevant annual meeting. Extraordinary shareholders' meetings are convened to approve the remaining matters within their competency as provided by law and/or our bylaws. An extraordinary shareholders' meeting may be held concurrently with an ordinary meeting.

A shareholders' meeting is convened by publishing a meeting call notice no later than 21 days prior to the scheduled meeting date, on first call, and no later than eight days prior to the date of the meeting, on second call, and no fewer than three times, in a newspaper with general circulation in São Paulo, where we have our registered office. In certain circumstances, however, the CVM may require that the first notice be published no later than 30 days prior to the meeting. At the shareholders' meeting held on March 1, 2013, our shareholders designated *Valor Econômico*, a newspaper with general circulation in São Paulo for this purpose. The call notice must contain the date, time, place and agenda of the meeting, and in case of amendments to the bylaws, the indication of the relevant matters. CVM Resolution No. 81 of March 29, 2022 ("CVM Resolution No. 81/22"), also requires that additional information be disclosed in the meeting call notice for certain matters. For example, in the event of an election of all directors, the meeting call notice shall also disclose the minimum percentage of equity interest required from a shareholder to request the adoption of cumulative voting procedures. All documents in connection with the shareholders' meeting's agenda shall be made available to shareholders either within at least one month prior to the meeting or upon publication of the first meeting call notice, as the case may be, except if otherwise required by law or CVM regulations.

A shareholders' meeting may be held on first call, if shareholders representing at least one quarter of the voting shares are present, except in some cases provided by law, such as in meetings seeking to amend the Company's bylaws, which requires the presence, on first call of shareholders representing at least two-thirds of the voting shares. If no such quorum is present, an eight-day prior notice must be given in the same manner as described above, and a meeting may then be convened, on second call, without any specific quorum requirement, subject to the minimum quorum and voting requirements for specific matters, as discussed below.

[**Table of Contents**](#TableOfContents)

Except as otherwise provided by law, resolutions of a shareholders' meeting are passed by a simple majority vote of the shares present or represented at the meeting, abstentions not being considered. Under the Brazilian Corporation Law, the approval of shareholders representing at least a majority of the votes granted by the issued and outstanding voting shares is required for the types of actions described below (among others):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· creating preferred shares or increasing disproportionately an existing class of preferred shares relative
to the other classes of shares, unless such action is provided for or authorized by the bylaws;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· modifying a preference, privilege or condition of redemption or amortization conferred upon one or more
classes of preferred shares, or creating a new class with greater privileges than those of the existing classes of preferred shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· reducing the minimum mandatory dividend;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· merging Ambev with another company or consolidating or executing a spin-off of Ambev;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· related party transactions, or the sale or contribution of assets to another company, in each case if
the amount involved exceeds 50% of the amount of our assets indicated in the most recently approved balance sheet;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· changing our corporate purpose; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· dissolving Ambev or ceasing its liquidation status.

Shareholders may not exercise voting rights with respect to the approval of the appraisal report of assets contributed by them in a capital increase paid in kind or with respect to the approval of their own accounts as managers of the company, as well as in those resolutions that may favor those shareholders specifically, or whenever there is a conflicting interest with the Company. Mergers between affiliated parties are subject to a special statutory valuation procedure intended to provide a parameter (based on the net equity at market prices of the companies involved) for comparing the proposed exchange ratio.

Shareholders' meetings may be called by our Board of Directors. Under the Brazilian Corporation Law, meetings may also be convened by our shareholders as follows: (1) by any shareholder, if the directors take more than 60 days to convene a shareholders' meeting after the date they were required to do so under applicable laws and our bylaws, (2) by shareholders holding at least 1% of our total capital stock, if our Board of Directors fails to call a meeting within eight days after receipt of a justified request to call a meeting by those shareholders indicating the proposed agenda, (3) by shareholders holding at least 5% of our voting capital stock, if the directors fail to call a general meeting within eight days after receipt of a request to call a shareholders' meeting for purpose of assembling a Fiscal Council, and (4) by our Fiscal Council, if the Board of Directors fails to call an annual shareholders' meeting within 30 days after the mandatory date for such call. The Fiscal Council may also call an extraordinary shareholders' meeting if it believes that there are important or urgent matters to be addressed.

To attend a shareholders' meeting, shareholders or their legal representatives willing to attend the meeting shall present proof of ownership of their Company shares, including identification and/or pertinent documentation that evidences their legal representation of such shareholder. A shareholder may be represented at a general meeting by an attorney-in-fact appointed no more than one year before the meeting, who must be another shareholder, a company officer, a lawyer or a financial institution. Notwithstanding the above, the CVM decided on November 4, 2014 that shareholders that are legal entities may be represented at general meetings by their legal representatives or by a duly appointed attorney-in-fact, pursuant to the bylaws and related corporate instruments of the legal entities and pursuant to the Brazilian Civil Code.

The participation and remote voting in general shareholders' meetings of publicly-held companies are regulated by CVM Resolution No. 81/22, as amended, which aims to facilitate the participation of shareholders in general meetings either through the vote or through the submission of proposals, as well as to enhance the corporate governance instruments available in the Brazilian market. For this purpose, this regulation provided the following:

[**Table of Contents**](#TableOfContents)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· the creation of a remote voting bulletin through which shareholders may exercise their right to vote prior
to the date the general meeting is held;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· the possibility of inclusion of candidates and proposals of deliberation of minority shareholders in that
bulletin, with due observance of certain percentages of equity interest, in order to facilitate shareholders' participation in general
meetings; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· the deadlines, procedures and ways of sending this bulletin, which may be forwarded by the shareholder:
(a) to the custodian (if the shares held by the shareholder are kept at a centralized deposit) or; (b) to the book-entry agent of the
shares issued by the company (if such shares are not kept at a centralized deposit); or (c) directly to the company.

CVM Resolution No. 81/22, also regulates the rules applicable to remote voting, including, but not limited to, (1) the deadlines for inclusion of candidates in the bulletin by request of minority shareholders and for the company to resend the bulletin in case of inclusion of candidates by minority shareholders and (2) the disclosure of the detailed final voting map of the shareholders' meetings, including the partial disclosure of each shareholders taxpayer's registry number and their respective votes on each matter.

Additionally, CVM Resolution No. 81/22, as amended, also regulates the possibility of publicly held companies to hold virtual or hybrid (i.e. physical and virtual) shareholders' meetings, including certain procedures that must be adopted by such companies when holding these types of meetings. The notice to a shareholders' meeting must indicate the format of the meeting and the actions that shareholders must take to participate remotely.

**Board of Directors**

In accordance with the Brazilian Corporation Law, as a general rule, any matters subject to the approval of our Board of Directors can be approved by the affirmative vote of a majority of our Board members present at the relevant meeting. Exceptions to this general rule are provided in the Shareholders' Agreement.

Under our bylaws, (i) the majority of the members of our Board of Directors must be external directors (i.e. with no current employment or managerial relationship with the company) and (ii) at least two members of our Board of Directors shall be independent directors. According to our bylaws, for a director to be considered independent he or she may not: (1) be a controlling shareholder, or a spouse or relative to the second degree of a controlling shareholder, (2) have been, within the last three years, an employee or executive officer of (a) Ambev or of any of our controlled companies or (b) our controlling shareholder or entities under common control with Ambev, (3) directly or indirectly, supply to, or purchase from, us, our controlled companies, controlling shareholder or entities under common control, any products or services, to such an extent as would cause that director to cease being independent, (4) be an employee or administrator of any corporation or entity that offers products or services to, or receives products or services from, us, our controlled companies, controlling shareholder or entities under common control, to such an extent as would cause that director to cease being independent, (5) be a spouse or relative to the second degree of any member of management of Ambev, its controlled companies, controlling company or entity under common control, or (6) receive any other compensation from Ambev, its controlled companies, controlling shareholder or entities under common control, aside from compensation for duties as a board member (gains arising from ownership of our stock are excluded from this restriction). Our bylaws also set forth that directors elected by a separate ballot vote of minority shareholders holding at least 10% of our capital stock, as provided in paragraphs 4 and 5 of Section 141 of the Brazilian Corporation Law, shall be deemed independent regardless of compliance with the abovementioned criteria. Furthermore, Brazilian law and CVM regulations requires that at least 20% of the members of the Board of Director shall be independent directors, who are qualified as such depending on certain criterion relating to the relationship between a director, and (i) Ambev, its controlling shareholder and their management; and (ii) companies controlled, affiliated or under common control.

According to the general principles of the Brazilian Corporation Law, if a director or an executive officer has a conflict of interest with a company in connection with any proposed transaction, the director or executive officer may not intervene nor vote in any resolution of the Board of Directors or of the Board of Executive Officers regarding such transaction and must disclose the nature and extent of the conflicting interest for purposes of recording such information in the minutes of the meeting. In any case, a director or an executive officer may not transact any business with a company, including any borrowings, except on reasonable or fair terms and conditions that are identical to the terms and conditions prevailing in the market or offered by third parties. Any transaction in which a director or executive officer may have an interest can only be approved if carried out on an arm's-length basis.

[**Table of Contents**](#TableOfContents)

Election of Directors

Each Ambev common share represents one vote at any shareholders' meeting in connection with the election of our Board of Directors.

Common shareholders holding at least 10% of our capital may elect one member and respective alternate to the Board of Directors without the participation of the controlling shareholder. To exercise these minority rights, shareholders must prove their continuous ownership of their Ambev common shares for at least three months prior to the shareholders' meeting convened to elect board members. If that prerogative is exercised with the adoption of cumulative voting procedures, as described below, the controlling shareholder will always have the right to elect the same number of members appointed by minority shareholders plus one, regardless of the number of directors provided in our bylaws.

Shareholders holding shares representing at least 10% of our capital, or a smaller applicable percentage according to a sliding scale determined by the CVM and based on a company's capital stock (currently 5% of the Ambev common shares, pursuant to the CVM's sliding scale), have the right to request that cumulative voting procedures be adopted. Under such procedures, each of our common shares shall entitle as many votes as the number of director positions to be filled, and each shareholder may cast all of his or her votes for a single candidate or distribute them among various candidates.

Pursuant to CVM Resolution No. 81/22, publicly-held companies shall adopt the following measures regarding voting process: (1) inform the market of the adoption of cumulative voting process in applicable meetings immediately upon the receipt of the first valid requirement; (2) disclose the voting final summary statements, the voting final detailed statements, as well as any voting statement presented by shareholders at the relevant meeting; and (3) register in the minutes of the annual shareholders' meeting the number of approving, rejecting or abstaining votes for each item of the agenda, including the votes received by each member of the Board of Directors and/or Fiscal Council elected in such shareholders' meeting.

Under our bylaws and applicable law, the number of directors may be reduced to a minimum of five.

The current members of our Board of Directors were elected by our controlling shareholder. Board members, regardless of the shareholder they represent, owe fiduciary duties to the Company and all of our shareholders. At the same time, any director appointed by shareholders bound by a shareholders' agreement is also bound by the terms of that agreement. For more information on our shareholders' agreements, see "Item 7. Major Shareholders and Related Party Transactions—A. Major Shareholders—Ambev's Major Shareholders."

**Dividends**

The discussion below summarizes the main provisions of the Brazilian Corporation Law regarding the establishment of reserves by corporations and rules with respect to the distribution of dividends, including provisions regarding interest on shareholders' equity.

Calculation of Distributable Amounts

At each annual shareholders' meeting, our Board of Directors is required to propose how Ambev's net income for the preceding fiscal year is to be allocated. For purposes of the Brazilian Corporation Law, a company's net income after income taxes and social contribution on profits for the immediately preceding fiscal year, net of any accumulated losses from prior fiscal years and amounts allocated to employees' and management's participation in earnings, represents its "adjusted net income" for such preceding fiscal year. In accordance with the Brazilian Corporation Law, an amount equal to such adjusted net income, which is also referred to in this section as the distributable amount, will be available for distribution to shareholders in any particular year. Such distributable amount is subject to:

[**Table of Contents**](#TableOfContents)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· reductions that may be caused by amounts contributed for the purpose of meeting the charges of the assistance
foundation for employees and management of the Company and its controlled companies, with due regard for the rules established by the
Board of Directors to this effect; up to 10% of the distributable amount may be contributed under this concept;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· reductions caused by amounts allocated to the Legal Reserve or Contingency Reserves (see "—Reserves");
and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· increases caused by reversals of reserves constituted in prior years.

Minimum Mandatory Dividend

We are required by our bylaws to distribute to shareholders as dividends in respect to each fiscal year ending on December 31 a minimum mandatory dividend equivalent to no less than 40% of the distributable amount. In addition to the minimum mandatory dividend, the Board of Directors may recommend payment of additional dividends to shareholders. The limit for dividend payment is the distributable amount plus the balance available in certain profit reserves, including our statutory "Investment Reserve," to which we allocate distributable amounts from previous fiscal years not paid as dividends (see "—Reserves") and retained profits. Furthermore, the Board of Directors may also resolve on the distribution of interim dividends and/or interest on shareholders' equity based on the accrued profits or existing profits (retained profits or certain profits reserves) presented in the latest annual or six-month balance sheet. Interim dividends and interest on shareholders' equity are always deemed as an advancement towards the minimum mandatory dividend.

In addition, the minimum mandatory dividend, whether the full amount or only a portion thereof, may not be distributed in any given year should the Board of Directors consider that such payment is incompatible with the Ambev's financial situation, subject to shareholder approval. While the law does not establish the circumstances in which distribution of the minimum mandatory dividend is incompatible with a company's financial situation, it is generally agreed that a company is allowed to refrain from paying the minimum mandatory dividend if such payment threatens its existence as a going concern or harms its normal course of operations. The Fiscal Council must opine on the nonpayment of minimum mandatory dividends, and management must submit to the CVM a report explaining the reasons considered by the Board of Directors to withhold the payment of the minimum mandatory dividend no later than five business days after the shareholders' meeting that decides on this topic.

Any postponed payment of minimum mandatory dividends must be allocated to a special reserve. Any remaining balance in such reserve not absorbed by losses in subsequent fiscal years must be paid to shareholders as soon as the Company's financial situation allows.

Payment of Dividends

Under the Brazilian Corporation Law any holder of record of shares at the time of a dividend declaration is entitled to receive such dividends, which are generally required to be paid within 60 days following the date of such declaration, unless otherwise resolved by the shareholders' meetings, which, in either case, must occur prior to the end of the fiscal year in which such dividends were declared. Our bylaws do not provide for a time frame for payment of dividends. The minimum mandatory dividend is satisfied through payments made both in the form of dividends and interest on shareholders' equity (amount net of taxes), which, from an economic perspective, is equivalent to a dividend but represents a tax efficient alternative to distribute earnings to shareholders because it is deductible for income tax purposes up to a certain limit established by Brazilian tax laws (see "—Interest on Shareholders' Equity"). Shareholders have a three-year period from the dividend payment date to claim the payment of dividends, after which we are no longer liable for such payment.

Shareholders that do not reside in Brazil must register their investment with the Central Bank in order for gains, dividends, profits or other payments under Ambev's shares to be eligible for remittance in foreign currency outside of Brazil. Our common shares underlying the Ambev ADSs will be deposited with the Brazilian custodian, Banco Bradesco S.A., which acts on behalf of and as agent for the Depositary, which is registered with the Central Bank as the fiduciary owner of those common shares underlying our ADSs. Payments of cash dividends and distributions on our common shares will be made in *reais* to the custodian on behalf of the Depositary. The custodian will then convert those proceeds into U.S. dollars and will deliver them to the Depositary for distribution to ADS holders. If the custodian is unable to immediately convert dividends in *reais* into U.S. dollars, ADS holders may be adversely affected by devaluations of the *real* or other exchange rate fluctuations before those dividends can be converted into U.S. dollars and remitted abroad. Fluctuations in the exchange rate between the *real* and the U.S. dollar may also affect the U.S. dollar equivalent of the trading price of our common shares in *reais* on the B3.

[**Table of Contents**](#TableOfContents)

Interest on Shareholders' Equity

Brazilian companies are permitted to distribute earnings to shareholders under the concept of an interest payment on shareholders' equity, calculated based on specific Ambev's shareholders' equity accounts multiplied by the TJLP rate. The TJLP is the official interest rate defined by the Central Bank and used as reference in long-term loans provided by the BNDES.

Amounts distributed by Ambev to its shareholders as interest on shareholders' equity is deductible for purposes of income tax and social contribution applicable to our profits. The amount of the deduction may not exceed the greater of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· 50% of net income (after the deduction of social contribution on net income but before taking into consideration
the provision for corporate income tax and the amounts attributable to shareholders as interest on shareholders' equity) for the
period in respect of which the payment is made; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· 50% of the sum of retained profits and profit reserves as of the date of the beginning of the period in
respect of which the payment is made.

Interest on shareholders' equity is treated similarly to dividends for purposes of distribution of profits. The only significant difference is that a 15% withholding income tax is due by nonexempt shareholders, resident or not of Brazil, upon receipt of such interest payment, which tax must be withheld by us on behalf of our shareholders when the distribution is implemented. If the shareholder is not a Brazilian resident and is resident or domiciled in a tax-haven jurisdiction, withholding income tax is due at a 25% rate. The amount shareholders receive as interest on shareholders' equity net of taxes is deducted from the minimum mandatory dividend owed to shareholders.

For further information on the taxation of interest on shareholders' equity, including the concept of tax haven jurisdiction for such purposes, see "—E. Taxation—Brazilian Tax Considerations—Income Tax—Distributions of Interest on Shareholders' Equity."

**Reserves**

General

The Brazilian Corporation Law provides that all discretionary allocations of adjusted net income, including the Unrealized Income Reserve and the Investment Reserve, are subject to shareholder approval and may be added to capital (except for the amounts allocated to the Unrealized Income Reserve) or distributed as dividends in subsequent years. In the case of Tax Incentive Reserve and the Legal Reserve, they are also subject to shareholder approval; however, the use of their respective balances is limited to having those balances added to capital or used to absorb losses. They cannot be used as a source for income distribution to shareholders.

Legal Reserve

Under the Brazilian Corporation Law, corporations are required to maintain a "Legal Reserve" to which they must allocate 5% of their adjusted net income for each fiscal year until the balance of the reserve equals 20% of their share capital. However, corporations are not required to make any allocations to their legal reserve in a fiscal year in which the Legal Reserve, when added to other established capital reserves, exceeds 30% of their share capital. Accumulated losses, if any, may be charged against the Legal Reserve. Other than that, the Legal Reserve can only be used to increase a company's share capital.

[**Table of Contents**](#TableOfContents)

Contingency Reserve

Under the Brazilian Corporation Law, a portion of a corporation's adjusted net income may also be discretionally allocated to a "Contingency Reserve" for an anticipated loss that is deemed probable in future years and which amount can be estimated. Any amount so allocated in a prior year must be either reversed in the fiscal year in which the loss was anticipated if that loss does not in fact occur or is not charged off in the event that the anticipated loss occurs.

Investment Reserve

Under Brazilian Corporation Law, we are permitted to provide for the allocation of part of our net income to discretionary reserve accounts that may be established in accordance with our bylaws. The allocation of our net income to discretionary reserve accounts may not be made if it serves to prevent the distribution of the minimum mandatory distributable amount. According to our bylaws, a portion of up to 60% of our adjusted net income may be allocated to an "Investment Reserve" for the expansion of our activities, including to be capitalized by us or for our investment in new business ventures.

Pursuant to our bylaws, the Investment Reserve balance is not allowed to be greater than 80% of our share capital. In case such limit is reached, shareholders may resolve to use the exceeding amount for conversion into share capital or to be distributed as dividends.

Unrealized Income Reserve

Pursuant to the Brazilian Corporation Law, the amount by which the minimum mandatory dividend exceeds the "realized" portion of net income for any particular year may be allocated to the Unrealized Income Reserve. The realized portion of net income is the amount by which the adjusted net income exceeds the sum of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· our net positive results, if any, from the equity method of accounting for earnings and losses of our
subsidiaries and certain affiliates; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· the net profits, net gains or net return obtained on transactions or on accounting of assets and liabilities
based on their market value, to be completed after the end of the following fiscal year.

Tax Incentive Reserve

Under the Brazilian Corporation Law, a portion of the adjusted net income may also be allocated to a general "Tax Incentive Reserve" in amounts corresponding to reductions in a company's income tax generated by credits for particular government-approved investments. This reserve is available only in connection with the acquisition of capital stock of companies undertaking specific government-approved projects.

Goodwill Premium from Shares Issued

Pursuant to the Brazilian Corporation Law, the amount received from subscription of shares in excess of the par value of the shares or the portion of the issuance price allocated to capital stock, in case of shares without par value, must be allocated to this reserve. The amount can be used (i) to absorb losses that surpass accumulated profits and profit reserves, (ii) for future capital increases without the issuance of new shares, (iii) to redeem or reimburse shares (including founder's shares, if applicable), (iv) for payment of dividends to preferred shares, if applicable, or (v) to support an approved share buyback program.

Fiscal Benefit of Goodwill Premium Amortization (CVM Resolution No. 78/22)

Pursuant to CVM Resolution No. 78/22, when a reporting company merges with its parent company, while remaining a reporting company, the goodwill previously paid by the parent company on its acquisition is deductible for purposes of income tax and social contribution on profits. This future tax benefit is recorded as a capital reserve by the reporting company. As this benefit is realized, the company increases its share capital proportionally to the benefit and is able to issue new shares to the parent company, pursuant to the terms of the merger agreement.

[**Table of Contents**](#TableOfContents)

**Liquidation**

In the event of our liquidation, an extraordinary general shareholders' meeting shall determine the form of liquidation and appoint a committee to supervise the process during the liquidation period. A liquidator shall be appointed by the Board of Directors.

**Restrictions on Foreign Investment**

There are no restrictions on ownership or voting rights in respect of our common shares owned by individuals or legal entities domiciled outside Brazil. For a description of voting rights, see "—Rights of the Ambev Common Shares" and "—Shareholders' Meetings." The right to convert payments of dividends (including interest on shareholders' equity) and proceeds from the sale of our common shares into foreign currency and to remit those amounts outside Brazil, however, is subject to exchange control and foreign investment legislation. For a description of these exchange control restrictions and foreign investment legislation, see "Item 10. Additional Information—D. Exchange Controls and other Limitations Affecting Security Holders."

**Appraisal Rights**

Under the Brazilian Corporation Law, dissenting shareholders have appraisal rights that allow them to withdraw from the Company and be reimbursed for the value of their Ambev common shares, whenever, among other instances, a decision is taken at a shareholders' meeting to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· create preferred shares or increase disproportionately an existing class of preferred shares relative
to the other classes of shares, unless such action is provided for or authorized by our bylaws;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· modify a preference, privilege or condition of redemption or amortization conferred upon one or more classes
of preferred shares, or create a new class with greater privileges than the existing classes of preferred shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· reduce the minimum mandatory dividend;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· merge or consolidate us with another company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· change our corporate purpose;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· conduct a spin-off of Ambev, if the new entities resulting from the spin-off have different primary corporate
purposes or a lower minimum mandatory dividend or such spin-off causes us to join a group of companies (as defined in the Brazilian Corporation
Law);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· transform us into another corporate type;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· conduct a stock swap merger of Ambev with another company, so that Ambev becomes a wholly-owned subsidiary
of that company; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· approve the acquisition of control of another company, the price of which exceeds the limits set forth
in the Brazilian Corporation Law.

In cases where Ambev merges or is consolidated with another company, participates in a group of companies (as defined in the Brazilian Corporation Law), or is a party to a share merger, dissenting shareholders will not be entitled to exercise appraisal rights if their Ambev common shares are (1) liquid, defined as being part of the IBOVESPA Index and (2) widely-held such that the controlling shareholder or companies under its control holds less than 50% of the referred common shares.

Appraisal rights expire within 30 days after publication of the minutes of the relevant shareholders' meeting that approved the transaction. We are entitled to reconsider any action triggering appraisal rights within 10 days following the expiration of the 30-day appraisal rights exercise period if the redemption of our common shares held by dissenting shareholders would jeopardize our financial stability.

[**Table of Contents**](#TableOfContents)

Any shareholder that exercises appraisal rights is, in general, entitled to receive the amount equivalent to its shares' book value as per the last balance sheet approved by our shareholders. If the resolution giving rise to appraisal rights is approved more than 60 days after the date of the last shareholder-approved balance sheet of Ambev, dissenting shareholders may require that the value of their shares be calculated on the basis of an updated balance sheet (*balanço especial*) dated no less than 60 days before the resolution date. In this case, we must (1) immediately advance 80% of the book value of the shares to be redeemed according to the most recent balance sheet approved by our shareholders and (2) pay the remaining balance within 120 days after the date of the resolution of the shareholders' meeting. However, if the advanced payment of 80% of the book value of the shares to be redeemed is greater than the actual appraisal rights value per share determined by the updated balance sheet, then the amount in excess advanced by the Company shall be refunded to us by the dissenting shareholders who exercised appraisal rights.

As a general rule, shareholders may not exercise appraisal rights with respect to shares acquired after the publishing of a first meeting call notice or the relevant press release concerning the matter giving rise to such appraisal rights.

**Preemptive Rights**

Each shareholder of Ambev generally has preemptive rights to subscribe for new shares of Ambev in our capital increases (including in the issuance of stock purchase warrants or convertible bonds) in proportion to its shareholdings. A minimum 30-day period following the publication of the capital increase notice is given for the exercise of preemptive rights. Preemptive rights may be purchased and sold by shareholders. Our bylaws provide that if the Board of Directors decides to increase our share capital within the limit of the authorized capital through sales in stock exchanges, public offerings or public tender offers, no preemptive rights will apply. In addition, Brazilian law provides that the grant or the exercise of stock options pursuant to certain stock option plans, such as our Stock Option Plan, is not subject to preemptive rights.

**Inspection of Corporate Records**

Shareholders that own 1% or more of our outstanding share capital have the right to inspect our corporate records, including shareholders' lists, corporate minutes, financial records and other documents, if (1) Ambev or any of its officers or directors have committed any act contrary to Brazilian law or our bylaws or (2) there are grounds to suspect that there are material irregularities in the Company. However, in either case, shareholders desiring to inspect our corporate records must obtain a court order authorizing the inspection.

**Form and Transfer**

Brazilian law provides that ownership of shares issued by a Brazilian corporation shall generally be evidenced only by a record of ownership maintained by either the corporation or an accredited intermediary, such as a bank, acting as a registrar for the shares. Banco Bradesco S.A. currently maintains our share ownership records.

Because our common shares are in registered book-entry form, a transfer of those shares is made under the rules of the Brazilian Corporation Law, which provides that a transfer of shares is effected by an entry made by the registrar for our shares in its books, by debiting the share account of the transferor and crediting the share account of the transferee.

Transfers of shares by a foreign investor are made in the same way and executed by that investor's local agent on the investor's behalf, except that, if the original investment was registered with the Central Bank pursuant to foreign investment regulations, the foreign investor should also seek, through its local agent, an amendment of the corresponding electronic registration to reflect the new ownership, if necessary.

The B3 operates a central clearing system and a stock exchange. A holder of our common shares may choose, at its discretion, to participate in this system, and all shares elected to be transferred to B3's market must be deposited in custody with the stock exchange through a Brazilian institution that is duly authorized to operate by the Central Bank and maintains a clearing account with the B3. Our common shares that are subject to custody with the stock exchange will be reflected in our registry of shareholders. Each participating shareholder will, in turn, be registered in our register of beneficial shareholders maintained by the stock exchange and will be treated in the same way as registered shareholders.

[**Table of Contents**](#TableOfContents)

**Disclosure of the Ownership and Trading of our Shares by Us, our Principal Shareholders, Directors and Officers or Members of our Fiscal Council** 

Pursuant to CVM rules, our directors and officers and members of our fiscal council or of any technical or advisory committee are required to disclose to us, to the CVM and to the B3 the number, type and manner of acquisition of any securities issued by us, or by our publicly held subsidiaries and held by them or any persons related to them (such as a spouse, companion or dependent). The information regarding the trade of any such securities (including the name and identification of the owner of the shares, amount and characteristics of the securities, form, price and date of the trade) must be provided to CVM within 10 days following the end of the month in which they were traded.

Under Brazilian law, shareholders owning more than 5% of a company's voting shares must publicly disclose their shareholder ownership to the CVM and to the Brazilian stock exchange. In addition, according to CVM Resolution No. 44, dated August 23, 2021 ("<u>CVM Resolution No. 44</u>"), if any such shareholder or any shareholder electing members of the board of directors increases or decreases its participation in our capital stock directly or indirectly exceeding thresholds of 5% multiples (i.e. 5%, 10%, 15% etc.), this person or entity must disclose its shareholder ownership to CVM in the terms mentioned above.

According to CVM Resolution No. 44, individual investment or disinvestment plans for direct or indirect controlling shareholders, members of any statutory governing bodies of a corporation, as well as any persons who, due to their responsibility, function or position in a listed company, its controlling company, subsidiaries or affiliates have potential access to insider information, are allowed, subject to certain requirements.

Other Significant Provisions of the Brazilian Corporation Law

The Brazilian Corporation Law, as applicable to us, also requires the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· upon a sale of our control, the acquirer is required to launch a tender offer to purchase all minority
voting shares at a price equal to at least 80% of the price per share paid for the controlling stake;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· our delisting is subject to an administrative proceeding before the CVM, having as a condition the launching
of a tender offer by the controlling shareholder or us for the acquisition of all our outstanding shares (defined as those owned by shareholders
other than the controlling shareholder, officers and directors) at their fair value, as determined by an independent appraiser. Shareholders
holding more than two-thirds of the free float of shares must accept the tender offer or must expressly agree with the delisting (for
this purpose, the free float of shares must be considered those held by shareholders that have either accepted the delisting or the offer);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· in addition, if a controlling shareholder or group of controlling shareholders acquires additional shares

offer to ensure share dispersion is required for all the outstanding shares in that class. The same requirement applies whenever (1) a
shareholder or group of shareholders representing the same interest and holding more than 50% of the shares in any class from March 7,
2002 (pursuant to CVM Resolution No. 85/22, except for public companies existing in September 5, 2000, in which case this date will prevail),
acquires a further interest of 10% or more of that same class of shares within a 12-month period and (2) the CVM determines, within six
months after being informed, that the acquisition restricts the liquidity of the shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· upon the occurrence of a tender offer aimed at delisting a company or through which the controlling shareholders
will acquire more than one-third of the free float shares, the purchase price shall be equal to the fair value of the shares considering
the total number of outstanding shares;

[**Table of Contents**](#TableOfContents)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· members of our Board of Directors elected by noncontrolling shareholders (in a separate voting mechanism)
have the right to veto the choice of the independent auditor by the Board;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· our controlling shareholder, the shareholders that elect members to our Board of Directors or Fiscal
Council, the members of our Board of Directors and Fiscal Council, and our executive officers are required to disclose any purchase or
sale of our shares to the CVM and to the B3; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· the chairman of any shareholders' meeting or directors shall disregard
any vote that is rendered against provisions of any shareholders' agreement if that shareholders' agreement has been duly
filed with us, as is the case with the Shareholders' Agreement.

C.&nbsp;&nbsp;&nbsp;&nbsp; Material Contracts

In addition to the contracts described in other sections of this annual report, the following is a summary of the material contracts to which we are a party.

**Shareholders' Agreement**

See "Item 7. Major Shareholders and Related Party Transactions—A. Major Shareholders—Ambev's Major Shareholders—The Shareholders' Agreement".

**Acquisitions, Dispositions and Joint Ventures**

We have discussed the details of some material acquisitions and agreements related thereto in "Item 4. Information on the Company—A. History and Development of the Company."

**Licensing Agreements**

Pepsi

See "Item 4. Information on the Company—B. Business Overview—Licenses—Pepsi."

Red Bull

See "Item 4. Information on the Company—B. Business Overview—Licenses—Red Bull."

Licensing Agreements with ABI

See "Item 4. Information on the Company—B. Business Overview—Licenses—Licensing Agreements with ABI."

**Tax Benefits**

Many states in Brazil offer tax benefits programs to attract investments to their regions. We participate in ICMS Value-added Tax Credit Programs offered by various Brazilian states which provide (1) tax credits to offset ICMS Value-Added Tax payables and (2) ICMS Value-Added Tax deferrals. In return, we are required to meet certain operational requirements including, depending on the state, production volume and employment targets, among others. All of these conditions are included in specific agreements between Ambev and the state governments. In the event that we do not meet the program's targets, future benefits may be withdrawn. Also, the State of São Paulo and others have challenged, in the Brazilian Supreme Court, state laws upon which certain of the above benefits have been granted, on the basis that they constitute tax benefits created without certain approvals required under Brazilian tax laws and regulations, which would render such state laws unconstitutional (Brazilian tax war). Accordingly, as far as the tax benefits are granted based on the state legislation, most companies apply for and use those benefits when granted. On August 8, 2017, Supplementary Law No. 160 was published authorizing the states and the Federal District to revalidate within 180 days the tax benefits allegedly created without the approvals required under Brazilian tax laws and regulations by means of an Interstate Agreement. Under the provisions of Supplementary Law No. 160, Confaz Interstate Agreement No. 190 was published on December 18, 2017, allowing the states to republish and reinstall the state tax benefits created up to August 8, 2017. The validation of such tax incentives, however, is not self-applicable and it depends on the fulfillment of certain conditions by the granting state. That is, in view of the Supplementary Law No. 160/2017 and Confaz Interstate Agreement No. 190/2017, the compliance by the states with the remission, amnesty and/or reinstitution requirements shall be assessed, especially regarding the registration and deposit of tax benefits and their deadline of enjoyment established by the Supplementary Law. So far, most of the tax benefits programs granted to Ambev have been republished and reinstalled by the granting state. Moreover, in August 2020, the Brazilian Supreme Court issued a binding decision (Extraordinary Appeal No. 628.075) ruling that tax credits granted by the states in the context of ICMS tax war shall be considered unconstitutional, except for the credits derived from tax benefits that have been complied with the validation process provided for in Supplementary Law No. 160 and Confaz Interstate Agreement No. 190. See "Item 5. Operating and Financial Review and Prospects—B. Liquidity and Capital Resources—Sales Tax Deferrals and Other Tax Credits", "Item 3. Key Information—D. Risk Factors" and "Item 8. Financial Information – A. Consolidated Financial Statements and Other Financial Information."

[**Table of Contents**](#TableOfContents)

D.&nbsp;&nbsp;&nbsp;&nbsp; Exchange Controls and other Limitations Affecting Security Holders

There are no restrictions on ownership of the ADSs or Ambev's preferred shares or common shares by individuals or legal entities based on location and/or nationality of the respective investor. However, the right to convert dividends and interest on shareholders' equity payments arising from Ambev's shares, as well as proceeds from the sale of Ambev's shares, into U.S. dollars and to remit those amounts outside Brazil is subject to exchange control constrains and foreign investment legislation. Such operations generally require that the relevant investments be registered with the Brazilian Central Bank and foreign investors are registered with the CVM.

Restrictions on the remittance of foreign capital abroad could hinder or prevent Banco Bradesco S.A., the custodian of Ambev's ADS program, or "Custodian", or holders who have exchanged Ambev's ADSs for Ambev's shares, from converting dividend distributions, interest on shareholders' equity or the proceeds from any sale of shares of Ambev into U.S. dollars and remitting such U.S. dollars abroad. Holders of Ambev's securities could be adversely affected by delays or difficulties to meet any regulatory requirement for conversions of payments in *reais* and remittances abroad.

Investors residing outside Brazil, including institutional investors, may either register their investments in securities in Brazil, (i) as a foreign direct investment under BCB Resolution 278; or (ii) as a portfolio investment under CMN Resolution No. 4,373, and CVM Resolution No. 13, dated November 18, 2020. Foreign investors, regardless of whether their investments are made as direct investments or portfolio investments, must be enrolled with the Brazilian Federal Revenue. This registration process is undertaken by financial institution or by an institution authorized to operate by the Brazilian Central Bank as the investor's legal representative in Brazil.

Foreign direct investors under BCB Resolution 278 may directly hold and sell securities in both private and open market transactions, but these investors are likely to be subject to a different tax treatment on gains, apart from being subject to taxation on the execution of foreign exchange transactions.

On the other hand, CMN Resolution 4,373 establishes the possibility for foreign investors to make investments in local currency with funds held in their brokerage accounts. With certain exceptions, CMN Resolution 4,373 allows investors to carry out various type of transactions in the Brazilian capital markets involving a security traded on a Brazilian stock or futures exchange, or through an organized over-the-counter market, but investors may not transfer the ownership of investments made under such regulation to other non-Brazilian holders through private transactions. Investments and remittances outside Brazil for gains, dividends, profits or other payments under Ambev's securities are made through the foreign exchange market.

In addition, any foreign investor must also be registered with the *Receita Federal do Brasil* (Brazilian Federal Revenue Service), or the RFB, pursuant to RFB Normative Instruction No. 1,548 of February 13, 2015, and RFB Normative Instruction No. 1,863 of December 28, 2018.

In order to be accredited to invest under CMN Resolution 4,373, foreign investor must:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· appoint a legal representative duly accredited with the Brazilian Central
Bank, t hat will be responsible for complying with the registration and periodically reporting requirements of the Brazilian Central
Bank and the CVM ;

[**Table of Contents**](#TableOfContents)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· appoint a custodian duly accredited with the CVM;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· hold a brokerage account with the accredited custodian;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· appoint a tax representative in Brazil;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· be registered with the Brazilian Federal Revenue, to obtain the enrollment of taxpayer registration;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· be registered as a foreign investor with the CVM; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· through the appointed representative in Brazil, register the foreign investment with the Brazilian Central
Bank.

The foreign investment in Ambev's shares underlying the ADSs was registered by the Custodian on behalf of The Bank of New York Mellon, the depositary for the ADS programs of Ambev, or "Depositary", enabling the Custodian to convert dividends and other amounts distributed by Ambev into foreign currency and remit such proceeds outside Brazil to the Depositary.

If a holder of ADSs decides to exchange such ADSs for the underlying Ambev's shares, the holder will be entitled to (i) immediately sell the shares in the stock exchange and rely on the Depositary's electronic registration to obtain and remit U.S. dollars abroad; (ii) convert its investment into a foreign portfolio investment under CMN Resolution 4,373, or (iii) convert its investment into a foreign direct investment under BCB Resolution 278. If a holder of ADSs wishes to convert its investment into either a foreign portfolio investment under CMN Resolution 4,373 or a foreign direct investment under CMN Resolution 3,844, it should begin the process of obtaining its own foreign investor registration with the Brazilian Central Bank and/or with the CVM, as the case may be, in advance of exchanging the ADSs for Ambev's shares.

In the event that a conversion of ADSs into foreign portfolio investments or foreign direct investment takes place, the Custodian is authorized to update the Depositary's electronic registration to reflect such transaction.

Under current legislation, the Brazilian government may impose temporary restrictions on remittances of foreign capital abroad in the event of a serious imbalance or an anticipated serious imbalance of Brazil's balance of payments. See "—D. Risk Factors—Risks Relating to Brazil and Other Countries in Which We Operate" and "—D. Risk Factors—Risks Relating to Our Common Shares and ADSs."

E.&nbsp;&nbsp;&nbsp;&nbsp; Taxation

The following summary contains a description of the material Brazilian and U.S. federal income tax considerations of the acquisition, ownership and disposition of our common shares or ADSs. This discussion is not a comprehensive discussion of all the tax considerations that may be relevant to a decision to purchase, hold or dispose of our common shares or ADSs and is not applicable to all categories of investors, some of which may be subject to special rules. Each prospective purchaser is urged to consult its own tax advisor about the particular Brazilian and U.S. tax considerations to it of an investment in our common shares or ADSs.

The summary is based upon tax laws of Brazil and the United States and the regulations thereunder, as in effect on the date hereof, which are subject to change (possibly with retroactive effect). Although there is at present no income tax treaty between Brazil and the United States, the tax authorities of the two countries have entered into a Tax Information Exchange Agreement and have had discussions that may culminate in a treaty. No assurance can be given, however, as to whether or when a treaty will enter into force or of how it will affect holders of our common shares or ADSs. This summary is also based on representations of the depositary and on the assumption that each obligation in the Deposit Agreement relating to our ADSs and the related documents will be performed in accordance with its terms.

**Brazilian Tax Considerations**

The following discussion summarizes the material Brazilian tax consequences of the acquisition, ownership and disposition of our common shares or ADSs by a holder that is not deemed to be domiciled in Brazil for purposes of Brazilian taxation and, in the case of a holder of common shares, which has registered its investment in such securities with the Central Bank as a U.S. dollar investment (in each case, a "Non-Brazilian Holder").

[**Table of Contents**](#TableOfContents)

The discussion does not purport to be a comprehensive description of all tax considerations that may be relevant to a decision to purchase our common shares or ADSs. The discussion below is based on Brazilian law as currently in effect. Any change in such law may change the consequences described below. The following discussion does not specifically address all of the Brazilian tax considerations applicable to any particular Non-Brazilian Holder, and each Non-Brazilian Holder should consult his or her own tax advisor concerning the Brazilian tax consequences of an investment in our common shares or ADSs.

The tax consequences described below do not consider the effects of any tax treaties or reciprocity of tax treatment entered into by Brazil and other countries. The summary below does not address any tax consequences under the tax laws of any state or locality of Brazil.

On 29 December 29, 2022, the Brazilian government issued Provisional Measure No. 1,152 (MP1152) which introduces changes to the legislation on corporate income tax and provides for new transfer pricing rules aiming to align the country's rules with international standards as proposed by the Organization of Economic Co-operation and Development ("OECD").

In essence, MP 1152 (i) is a result of an adaptation effort to conform the current transfer pricing rules to the OECD model which forsakes fixed criteria in favor of adopting the principle that transactions should be valued as if they had been carried out between unrelated parties, each acting in his own best interest. ("The Arm's Length Principle"); and (ii) brough forth express guidance in relation to some specific transactions.

Specifically in relation to the concept of Privileged Tax Regime, further detailed, MP 1152 has a minimum threshold tax rate of 17%, a change from the minimum rate of 20% foreseen in the current rules.

MP 1152 will produce effects as of January 2024, unless the taxpayer choses to anticipate its effects to January 2023, subject to further regulation. At this time, it is not possible to predict whether MP 1152 will be converted into law, or even the final wording of the resulting law since the text of the law may undergo amendments during the legislative process. Note that such amendments, in light of the end of year recess, may only be proposed up to February 3, 2023 or by Rapporteur, afterwards. Also, the new regime requires further regulation to clarify its full details. Therefore, given the uncertainties of the outcome of MP 1152 and its further regulation, the matter should be closely monitored.

The summary below does not address any tax issues that affect only the company, such as the deductibility of expenses.

Income Tax

**Taxation of Dividends**

Dividends paid by us, a Brazilian corporation, including our Company, to The Bank of New York Mellon in respect of the common shares underlying the respective ADSs, or to a Non-Brazilian Holder with respect to our common shares, are currently not be subject to Brazilian withholding income tax ("WHT") provided that they are paid out of profits generated as of January 1, 1996. Dividends paid from profits generated before January 1, 1996 may be subject to WHT at variable rates according to the tax legislation applicable to each corresponding year.

In this context, it should be noted that Law No. 11,638 dated December 28, 2007, effective as of 2008, significantly altered the Brazilian Corporate Law in order to align Brazilian GAAP with IFRS, as issued by the IASB. Nonetheless, Law No. 11,941 dated May 27, 2009 introduced the Transitory Tax Regime (*Regime Tributário de Transição*) ("RTT"), in order to render neutral, from a tax perspective, all the changes provided by Law 11,638/07. Under the RTT, for tax purposes, legal entities should observe the accounting methods and criteria that were effective on December 31, 2007 ("2007 Profits").

[**Table of Contents**](#TableOfContents)

Profits determined pursuant to Law 11,638/07 ("IFRS Profits") may differ from the profits calculated pursuant to the accounting methods and criteria as in force on December 31, 2007.

While it was a general market practice to distribute exempted dividends with reference to the IFRS Profits, Normative Ruling No. 1,397, issued by the Brazilian tax authorities on September 16, 2013, has established those legal entities should observe the 2007 Profits, in order to determine the amount of profits that could be distributed as exempted income to its beneficiaries.

Any profits paid in excess of said 2007 Profits ("Excess Dividends") should, in the tax authorities' view and in the specific case of non-resident beneficiaries, be subject to the following rules of taxation: (i) 15% WHT, in case of beneficiaries domiciled abroad, but not in Low or Nil Tax Jurisdiction (as defined below), and (ii) 25% WHT, in case of beneficiaries domiciled in Low or Nil Tax Jurisdiction (as defined below).

In order to mitigate potential disputes on the subject, Law No. 12,973, dated May 13, 2014, in addition to revoking the RTT, introduced a new set of tax rules, or the New Brazilian Tax Regime, including new provisions with respect to Excess Dividends.

There can be no assurance that the current tax exemption on dividends distributed by Brazilian companies will continue in the future.

**Taxation of Gains**

According to Article 26 of Law No. 10,833/2003, as amended, gains realized by a Non-Brazilian Holder (understood as a non-Brazilian tax resident) on a sale or disposition of assets located in Brazil, such as our common shares, are generally subject to WHT in Brazil, regardless of whether the sale or other disposition is made by a Non-Brazilian Holder to another non-Brazilian resident or to a Brazilian resident. With respect to the ADSs, arguably the gains realized by a Non-Brazilian Holder on the disposition of ADSs, including to another non-Brazilian resident are not taxed in Brazil, based on the argument that ADSs would not constitute assets located in Brazil for purposes of Law No. 10,833/03. However, we cannot assure you how Brazilian courts would interpret the definition of assets located in Brazil in connection with the taxation of gains realized by a Non-Brazilian Holder on the disposition of ADSs, including to another non-Brazilian resident. As a result, gains on a disposition of ADSs by a non-Brazilian holder to a Brazilian resident, or even to a non-Brazilian holder in the event that courts determine that ADSs would constitute assets located in Brazil, may be subject to income tax in Brazil according to the rules further described.

As a rule, capital gains realized as a result of a transaction carried out in a Brazilian stock exchange can be measured by the positive difference between the amount obtained as a result of the sale or exchange of a security and its respective acquisition cost. There is a controversy regarding the currency that should be considered for purposes of determining the capital gain realized by a Non-Brazilian Holder on a sale or disposition of shares in Brazil, more specifically, if such capital gain is to be determined in foreign or in local currency (BRL).

Until December 31, 2016, the applicable general income tax rate for non-residents was 15%. Law No. 13,259, dated March 17, 2016, or Law No. 13,259/16, increased the income tax rates applicable to gains derived by Brazilian individuals of up to 22.5%. Under Law No. 13,259/16, the income tax rates applicable to Brazilian individuals' capital gains are as follows: (i) 15% levied on gains of up to R$5 million, (ii) 17.5% levied on gains in excess of R$5 million up to R$10 million, (iii) 20% levied on gains in excess of R$10 million up to R$30 million and (iv) 22.5% levied on any gains exceeding R$30 million.

At the time, there was uncertainty around whether or not the new progressive income tax rates applied to Non-Brazilian Holders, because Law No. 13,259/16 made express reference to the capital gains tax applicable to Brazilian resident individuals but did not mention capital gains tax in respect of non-residents.

Therefore, Non-Brazilian Holders are advised to consult their own tax advisors regarding the possible consequences of Law No. 13,259/16 on the disposition of common shares.

The deposit of common shares in exchange for ADSs may be subject to Brazilian tax on capital gains at rates ranging from 15% to 22.5%, or 25% in the case of investors domiciled in a Low or Nil Tax Jurisdiction, as defined below, if the acquisition cost of the common shares is lower than (a) the average price per common share on a Brazilian stock exchange on which the greatest number of such shares were sold on the day of deposit or (b) if no common shares were sold on that day, the average price on the Brazilian stock exchange on which the greatest number of common shares were sold in the 15 trading sessions immediately preceding such deposit. In such case, the difference between the acquisition cost and the average price of the common shares calculated as described above, may be considered to be a capital gain subject to taxation. In some circumstances, there may be arguments to sustain that such taxation is not applicable in the case of a Non-Brazilian Holder that is a 4,373 Holder (as defined below) and is not resident in a Low or Nil Tax Jurisdiction.

[**Table of Contents**](#TableOfContents)

The withdrawal of ADSs in exchange for common shares should not be considered as giving rise to a capital gain subject to Brazilian income tax, provided that on the receipt of the underlying common shares, the non-Brazilian holder complies with the regulatory rules observed in respect to the registration of the investment before the Central Bank.

Gains realized by a Non-Brazilian Holder on a sale or disposition of our common shares carried out on the Brazilian stock exchange, which includes the transactions carried out on the organized over-the-counter market, are:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· exempt from income tax when realized by a Non-Brazilian Holder that (1) has registered its investment
in Brazil with the Central Bank under the rules of CMN Resolution No. 4,373/2014, or a 4,373 Holder, and (2) is not resident or domiciled
in a Low or Nil Taxation Jurisdiction, as defined below (it is controversial whether the exemption also applies to transactions carried
out on the organized over-the-counter market); or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· in all other cases, subject to income tax at a rate of up to 25%, depending on the type of investor and
its location.

Any other gains assessed on a sale or disposition of the shares that is not carried out on a Brazilian stock exchange are subject to WHT at rates ranging from 15% up to 25% depending on the type of investor and its location. Lower rates may be applicable as provided for in an applicable tax treaty entered into between Brazil and the country where the Non-Brazilian Holder resides.

If these gains are related to transactions conducted on the Brazilian non-organized over-the-counter market with intermediation of a financial institution, a withholding tax of 0.005% on the sale value will also apply and can be used to offset against any income tax due on the capital gain earned by the Non-Brazilian Holder.

In the case of a redemption of common shares (or ADSs if understood that these are assets located in Brazil) or a capital reduction by a Brazilian corporation, the positive difference between the amount received by the Non-Brazilian Holder and the acquisition cost of the common shares (or ADSs) redeemed is treated, for tax purposes, as capital gain derived from the sale (or exchange of shares in the case of ADSs) not carried out on a Brazilian stock exchange market and is therefore subject to income tax at the rate of 15%, or 25%, as the case may be.

There can be no assurance that the current preferential treatment for non-Brazilian holder of ADSs and 4,373 Holder of preferred shares will continue in the future.

Any exercise of preemptive rights relating to the Ambev common shares or ADSs will not be subject to Brazilian taxation. Gains on the sale of preemptive rights relating to the shares will be treated differently for Brazilian tax purposes depending on (1) whether the sale is made by The Bank of New York Mellon or the investor and (2) whether the transaction takes place on a Brazilian stock exchange. Gains on sales made by the depositary on a Brazilian stock exchange are not taxed in Brazil but gains on other sales may be subject to tax at rates of up to 25%.

**Discussion on Low or Nil Taxation Jurisdictions and Privileged Tax Regimes**

According to Law No 9,430/96, as amended, a Low or Nil Taxation Jurisdiction is a country or location that (1) does not impose taxation on income, (2) imposes income tax at a maximum rate lower than 20% or (3) imposes restrictions on the disclosure of shareholding composition or the ownership of the investment or the ultimate beneficiary of earnings attributed to non-residents. A regulation issued by the Ministry of Treasury on November 28, 2014 (Ordinance No. 488, of 2014) decreased from 20% to 17% this minimum threshold for certain specific cases. The reduced 17% threshold applies only to countries and regimes aligned with international standards of fiscal transparency in accordance with rules established by the Brazilian tax authorities in Normative Ruling No. 1,530, dated December 19, 2014. However, the Normative Ruling No. 1,037, of June 4, 2010 which identifies the countries considered to be Low or Nil Tax Jurisdictions and the locations considered as Privileged Tax Regimes, has not been amended to reflect the 17% rate.

[**Table of Contents**](#TableOfContents)

On June 24, 2008, and with effect as of January 1, 2009, Law No. 11,727/2008 created the concept of Privileged Tax Regime, in connection with transactions subject to Brazilian transfer pricing rules and also applicable to thin capitalization/cross border interest deductibility rules, which is broader than the concept of a Low or Nil Tax Jurisdiction. Pursuant to Law No. 11,727/08, a jurisdiction will be considered a Privileged Tax Regime if it: (1) does not tax income or taxes it at a maximum rate lower than 20% or 17%, provided that the requirements set forth in Normative Ruling No. 1,530 and Ordinance No. 488 are met; (2) grant tax advantages to a non-resident entity or individual (i) without the need to carry out a substantial economic activity in the country or a said territory or (ii) conditioned to the non-exercise of a substantial economic activity in the country or a said territory; (3) does not tax or tax proceeds generated abroad at a maximum rate lower than 20% or 17% as applicable provided that the requirements set forth in Normative Ruling No. 1,530 are met; or (4) restricts the ownership disclosure of assets and ownership rights or restricts disclosure about economic transactions carried out.

In addition, on June 4, 2010, the Brazilian Tax Authorities enacted Ordinance No. 1,037 listing (i) the countries and jurisdictions considered Low or Nil Tax Jurisdictions and (ii) the Privileged Tax Regimes. Normative Ruling 1,037 has not been amended thus far to reflect the threshold changes previously mentioned.

However, under the current legal framework it is still debatable whether the Privileged Tax Regime should apply solely to transactions subject to Brazilian transfer pricing and/or thin capitalization/cross border interest deductibility rules. Accordingly, there is no assurance that Brazilian tax authorities will not attempt to apply such regime to other types of transactions. Prospective purchasers should consult with their own tax advisors regarding the consequences of the implementation of Law No. 11,727, Normative Instruction No. 1,037 and of any related Brazilian tax laws or regulations concerning Nil or Low Tax Jurisdictions and Privileged Tax Regimes.

**Distributions of Interest on Shareholders' Equity**

In accordance with Law No. 9,249, dated December 26, 1995, Brazilian corporations may make payments to shareholders characterized as distributions of interest on their shareholders' equity (as an alternative to carrying out dividend distributions). Such interest is calculated by multiplying the Brazilian Long Term Interest Rate ("TJLP"), as determined by the Central Bank from time to time, by the sum of the determined Brazilian company's net equity accounts.

Distributions of interest on shareholders' equity in respect of the Ambev common shares paid to shareholders who are either Brazilian residents or Non-Brazilian Residents, including holders of ADSs, are subject to Brazilian WHT at the rate of 15% or 25% if the Non-Brazilian Resident is domiciled in a Low or Nil Taxation Jurisdictions , as defined above, or where applicable local laws impose restrictions on the disclosure of the shareholding composition or the ownership of investments or the ultimate beneficial owner of the income derived from transactions carried out and attributable to a Non-Brazilian Holder. As explained in "—Discussion on Low or Nil Taxation Jurisdictions and Privileged Tax Regimes," the RFB reduced to 17% the maximum income tax rate that may be imposed by a given jurisdiction for the purpose of characterization of a Low or Nil Taxation Jurisdiction, as long as the country complies with international tax transparency standards.

The amounts paid as distribution of interest on shareholders' equity are deductible from the taxable basis of the corporate income tax and social contribution on net profits, both of which are taxes levied on our profits, as long as the payment of a distribution of interest is approved at a general meeting of shareholders of the Company. The payment of interest on net equity cannot exceed the greater of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· 50% of net profits (after deduction of social contribution on net profits, and before considering
the provision for corporate income tax and the amount attributable to shareholders as interest on shareholders' equity) for the
period in respect of which the payment is made; or

[**Table of Contents**](#TableOfContents)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· 50% of the sum of retained earnings and profit reserves as of the initial date of the period in respect
of which the payment is made.

The distribution of interest on shareholders' equity may be determined by the Board of Directors. No assurance can be given that the Board of Directors will not determine those future distributions of profits may be made by means of interest on shareholders' equity instead of by means of dividends. These payments of interest on shareholders' equity may be included, at their net value, as part of any mandatory dividend. To the extent payment of interest on shareholders' equity is so included, the corporation may be required to distribute to shareholders an additional amount to ensure that the net amount received by them, after payment of the applicable WHT plus the amount of declared dividends is at least equal to the mandatory dividend.

Distributions of interest on shareholders' equity to Non-Brazilian Holders may be converted into U.S. dollars and remitted outside Brazil, subject to applicable exchange controls, to the extent that the investment is registered with the Brazilian Central Bank.

There are discussions in Congress regarding possible changes to the tax treatment of interest on shareholders' equity from time to time.

Tax on Foreign Exchange Transactions (IOF/Exchange Tax)

Brazilian Decree No. 6,306/2007 imposes a Tax on Foreign Exchange Transactions, or "IOF/Exchange," on the conversion of *reais* into foreign currency (e.g., for purposes of remitting funds outside Brazil or making investments into Brazil), and on the conversion of foreign currency into *reais*. As from October 7, 2014, the general IOF/Exchange rate applicable to almost all foreign currency exchange transactions was increased from zero to 0.38%, although other rates may apply in particular operations, such as:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· inflow related to transactions carried out in the Brazilian financial and capital markets, including investments
in our common shares by foreign investors (including a Non-Brazilian Holder, as applicable) which register their investment under Resolution
No. 4,373, zero;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· outflow related to the return of the investment mentioned under the first bulleted item above, zero; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· outflow related to the payment of dividends and interest on shareholders' equity in connection with
the investment mentioned under the first bulleted item above, zero.

Notwithstanding these rates of the IOF/Exchange, the Brazilian government is permitted to increase at any time the rate to a maximum of 25%, but only in relation to future transactions, with immediate effects.

**Tax on Bonds and Securities Transactions (IOF/Bonds)**

Tax on Transactions Involving Bonds and Securities, or "IOF/Bonds" may be levied on transactions involving shares, even if the transactions are effected on Brazilian stock, futures or commodities exchanges. IOF/Bonds may also be levied on transactions involving ADSs if they are considered assets located in Brazil by the Brazilian tax authorities. As mentioned in the above discussion on taxation of gains, we are unable to predict how Brazilian courts would view this issue, and to date, we are not aware of any judicial or administrative precedent on this specific matter.

As from December 24, 2013, the IOF/Bonds levies at a rate of zero percent on the transfer (*cessão*) of shares traded in a Brazilian stock exchange environment with the specific purpose of enabling the issuance of depositary receipts to be traded outside Brazil. The rate of IOF/Bonds with respect to other transactions related to shares and ADSs (if applicable) is currently zero.

[**Table of Contents**](#TableOfContents)

The Brazilian government may increase such rate up to 1.5% per day, with immediate effects but only with respect to future transactions.

Other Relevant Brazilian Taxes

There are no Brazilian federal inheritance, gift or succession taxes applicable to the ownership, transfer or disposition of shares or ADSs by a Non-Brazilian Holder except for gift and inheritance taxes which may be levied by some states of Brazil. There currently are no Brazilian stamp, issue, registration or similar taxes or duties payable by holders of shares or ADSs.

U.S. Federal Income Tax Considerations The following discussion is a summary of the U.S. federal income tax considerations generally applicable to the acquisition, ownership and disposition of our common shares or ADSs by a U.S. Holder (as defined below) who holds our common shares or ADSs as capital assets for U.S. federal income tax purposes (generally, property held for investment). This discussion is based on the U.S. Internal Revenue Code of 1986, as amended (the "Code"), U.S. Treasury regulations promulgated thereunder ("Regulations"), published positions of the Internal Revenue Service (the "Service"), court decisions and other applicable authorities, all as currently in effect as of the date hereof and all of which are subject to change or differing interpretations (possibly with retroactive effect).

This discussion does not describe all of the U.S. federal income tax considerations that may be applicable to U.S. Holders in light of their particular circumstances or U.S. Holders subject to special treatment under U.S. federal income tax law, such as:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· banks, insurance companies and other financial institutions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· tax-exempt entities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· real estate investment trusts;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· regulated investment companies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· dealers or traders in securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· certain former citizens or residents of the United States;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· persons that elect to mark their securities to market;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· persons holding our common shares or ADSs as part of a "straddle," conversion or other integrated
transaction;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· persons that have a functional currency other than the U.S. dollar; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· persons that actually or constructively own 10% or more of our equity (by vote or value).

In addition, this discussion does not address any U.S. state or local or non-U.S. tax considerations or any U.S. federal estate, gift, alternative minimum tax or Medicare contribution tax considerations. U.S. Holders should consult their tax advisors concerning the U.S. federal income tax considerations to them in light of their particular situation as well as any considerations arising under the laws of any other taxing jurisdiction.

For purposes of this discussion, a "U.S. Holder" is a beneficial owner of our common shares or ADSs that is for U.S. federal income tax purposes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· an individual who is a citizen or resident of the United States;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created
or organized in or under the laws of the United States, any state thereof or the District of Columbia;

[**Table of Contents**](#TableOfContents)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· an estate the income of which is subject to U.S. federal income taxation regardless of its source; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· a trust that (i) is subject to the primary supervision of a court within the United States and the
control of one or more U.S. persons or (ii) has a valid election in effect under applicable Regulations to be treated as a U.S. person.

If a partnership (or an entity or arrangement treated as a partnership for U.S. federal income tax purposes) acquires, owns or disposes of our common shares or ADSs, the tax treatment of a partner in such partnership will generally depend upon the status of the partner and the activities of the partnership. A partner in a partnership acquiring, owning or disposing of our common shares or ADSs should consult its tax advisor regarding the U.S. federal income tax considerations to it of acquiring, owning or disposing of our common shares or ADSs.

The discussion below assumes that the representations contained in the ADS deposit agreement are true and that the obligations in the ADS deposit agreement and any related agreements will be complied with in accordance with their terms. In general, for U.S. federal income tax purposes, U.S. Holders who own ADSs will be treated as the beneficial owners of the underlying common shares represented by those ADSs. Accordingly, the surrender of ADSs in exchange for common shares (or vice versa) will not result in the realization of gain or loss for U.S. federal income tax purposes. The rest of this discussion assumes that a U.S. Holder of ADSs will be treated for U.S. federal income tax purposes as directly holding the underlying common shares.

**Distributions**

Subject to the discussion below under "—Passive Foreign Investment Company Rules," the gross amount of distributions (including amounts withheld to pay Brazilian withholding taxes, if any) on our common shares or ADSs to a U.S. Holder out of our current or accumulated earnings and profits, as determined under U.S. federal income tax principles, will generally be includible in a U.S. Holder's gross income as dividend income on the day actually or constructively received by such holder. Because we do not intend to determine our earnings and profits on the basis of U.S. federal income tax principles, any distribution paid will generally be treated as dividend income for U.S. federal income tax purposes. Dividends received on our common shares or ADSs will not be eligible for the dividends received deduction allowed to corporations under the Code.

Individuals and other non-corporate U.S. Holders will be subject to tax at the lower capital gain tax rate applicable to "qualified dividend income," provided that certain conditions are satisfied, including that (1) our common shares or ADSs are readily tradable on an established securities market in the United States, (2) we are neither a passive foreign investment company (a "PFIC") nor treated as such with respect to a U.S. Holder (as discussed below) for the taxable year in which the dividend was paid and the preceding taxable year, and (3) certain holding period requirements are met. Our ADSs, but not our common shares, are listed on the NYSE so we anticipate that our ADSs should qualify as readily tradable on an established securities market in the United States, although there can be no assurances in this regard.

The amount of any dividend paid in *reais* (including amounts withheld to reflect Brazilian withholding tax) will be includible in income in a U.S. dollar amount based on the prevailing U.S. dollar-*reais* exchange rate in effect at the time the distribution is received by the depositary (in the case of ADSs) or by the U.S. Holder (in the case of common shares held directly by such U.S. Holder), regardless of whether such *reais* are converted into U.S. dollars on such date. Any foreign currency gain or loss recognized by a U.S. Holder on a subsequent sale or conversion of any *reais* received in a dividend will generally be U.S.-source ordinary income or loss.

For U.S. foreign tax credit purposes, dividends will generally be treated as income from foreign sources and will generally constitute passive category income. Depending on a U.S. Holder's particular circumstances, such holder may be eligible, subject to a number of complex limitations, to claim a foreign tax credit in respect of any Brazilian withholding taxes imposed on dividends received on our common shares or ADSs. If a U.S. Holder does not elect to claim a foreign tax credit for foreign tax withheld, such holder is permitted instead to claim a deduction, for U.S. federal income tax purposes, for the foreign tax withheld, but only for a year in which such holder elects to do so for all creditable foreign income taxes. The rules governing foreign tax credits and deductions are complex. U.S. Holders should consult their tax advisors regarding the availability of foreign tax credit or deductions under their particular circumstances.

[**Table of Contents**](#TableOfContents)

**Sale or Other Taxable Disposition**

Subject to discussion below under "—Passive Foreign Investment Company Rules," a U.S. Holder will generally recognize capital gain or loss upon the sale or other taxable disposition of our common shares or ADSs in an amount equal to the difference, if any, between the amount realized upon the disposition and such holder's adjusted tax basis in such common shares or ADSs. For these purposes, if Brazilian tax is withheld on the sale or other taxable disposition of our common shares or ADSs, the amount realized will include the gross amount of the proceeds of that sale or other taxable disposition before deduction of the Brazilian tax. Any capital gain or loss will be long-term if a U.S. Holder has held our shares for more than one year. Long-term capital gains of non-corporate U.S. Holders are eligible for reduced rates of taxation. The deductibility of capital losses is subject to limitations under the Code. Any gain or loss recognized by U.S. Holders will generally be treated as U.S.-source gain or loss for foreign tax credit purposes. Consequently, U.S. Holders may not be able to use the foreign tax credit arising from any Brazilian tax imposed on the disposition of our common shares or ADSs unless such credit can be applied (subject to applicable limitations) against tax due on other income treated as derived from foreign sources. If a U.S. Holder does not elect to claim a foreign tax credit for foreign tax withheld, such holder is permitted instead to claim a deduction, for U.S. federal income tax purposes, for the foreign tax withheld, but only for a year in which such holder elects to do so for all creditable foreign income taxes. The rules governing foreign tax credits and deductions are complex. U.S. Holders should consult their tax advisors regarding the availability of foreign tax credits or deductions under their particular circumstances.

**Passive Foreign Investment Company Rules**

A non-U.S. corporation will be classified as a PFIC for U.S. federal income tax purposes for any taxable year, if either (i) 75% or more of its gross income for such year consists of certain types of "passive" income or (ii) 50% or more of the value of its assets (determined on the basis of a quarterly average) during such year produce or are held for the production of passive income. Passive income generally includes dividends, interest, royalties, rents, annuities, net gains from the sale or exchange of property producing such income and net foreign currency gains. For this purpose, cash is categorized as a passive asset and the company's unbooked intangibles associated with active business activity are considered as a non-passive asset. We will be treated as owning our proportionate share of the assets and earning our proportionate share of the income of any other corporation in which we own, directly or indirectly, at least 25% (by value) of the stock.

If we are a PFIC for any taxable year during which a U.S. Holder holds our common shares or ADSs, such holder will be subject to special tax rules with respect to any "excess distribution" that such holder receives and any gain such holder realizes from a sale or other disposition (including a pledge) of our common shares or ADSs, unless such holder makes a certain election as discussed below. Distributions a U.S. Holder receives in a taxable year that are greater than 125% of the average annual distributions such holder received during the shorter of the three preceding taxable years or such holder's holding period for the common shares or ADSs will be treated as an excess distribution. Under these special tax rules:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· the excess distribution or gain will be allocated ratably over such holder's holding period for
the common shares or ADSs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· amounts allocated to the current taxable year and any taxable years in such holder's holding period
prior to the first taxable year in which we are classified as a PFIC (a "pre-PFIC year") will be taxable as ordinary income;
and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· amounts allocated to each prior taxable year, other than the current taxable year or a pre-PFIC year,
will be subject to tax at the highest tax rate in effect applicable to such holder for that year, and such amounts will be increased by
an additional tax equal to interest on the resulting tax deemed deferred with respect to such years.

If we are a PFIC for any taxable year during which a U.S. Holder holds our common shares or ADSs and any of our non-U.S. subsidiaries are also PFICs, such holder will be treated as owning a proportionate amount (by value) of the shares of each such non-U.S. subsidiary classified as a PFIC for purposes of the application of these rules.

[**Table of Contents**](#TableOfContents)

The determination as to whether or not we are a PFIC is a factual determination made at the close of the applicable tax year. Based on our income, assets and activities and the value of our ADSs, we do not believe that we were a PFIC for our taxable year ending December 31, 2022 and we do not expect to be classified as a PFIC in the foreseeable future. Although we do not anticipate becoming a PFIC, changes in the nature of our income or assets, or fluctuations in the market price of our ADSs, may cause us to become a PFIC for future taxable years.

If we are classified as a PFIC, certain elections may be available to mitigate the adverse U.S. federal income tax considerations of owning stock in a PFIC. In particular, a U.S. Holder may elect mark-to-market treatment for its common shares or ADSs, provided those common shares or ADSs constitute "marketable stock" as defined in the Regulations. Our ADSs are listed on the NYSE, which is a qualified exchange for these purposes, and, consequently, assuming that the ADSs are regularly traded, it is expected that the market-to-market election would be available to U.S. Holders of ADSs if we are or become a PFIC. A mark-to-market election is not available with respect to our common shares, however, because our common shares are not marketable stock.

If we are classified as a PFIC, a U.S. Holder must file an annual report with the Service. U.S. Holders should consult their tax advisors concerning the U.S. federal income tax considerations of acquiring, owning and disposing of our common shares or ADSs if we are or become a PFIC, including the availability and advisability of making certain elections and the annual PFIC filing requirements, if any.

**Foreign Asset Reporting**

Individual and certain other noncorporate U.S. Holders may be required to submit to the Service certain information with respect to their beneficial ownership of the common shares or ADSs, if such common shares or ADSs are not held on their behalf by a financial institution. This legislation also imposes penalties if a U S Holder is required to submit such information to the Service and fails to do so. U.S. Holders should consult their tax advisors regarding any foreign asset reporting requirements.

THE PRECEDING DISCUSSION OF U.S. FEDERAL INCOME TAX CONSIDERATIONS IS FOR GENERAL INFORMATION ONLY AND IS NOT TAX ADVICE. ACCORDINGLY, EACH INVESTOR SHOULD CONSULT ITS TAX ADVISOR AS TO THE PARTICULAR TAX CONSIDERATIONS OF THE ACQUISITION OWNERSHIP AND DISPOSITION OF OUR COMMON SHARES OR ADSs, INCLUDING THE APPLICABILITY AND EFFECT OF ANY STATE, LOCAL, FOREIGN OR OTHER TAX LAWS AND OF ANY PROPOSED CHANGES IN APPLICABLE LAW.

F.&nbsp;&nbsp;&nbsp;&nbsp; Dividends and Paying Agents

Not applicable.

G.&nbsp;&nbsp;&nbsp;&nbsp; Statement by Experts

Not applicable.

H.&nbsp;&nbsp;&nbsp;&nbsp; Where You Can Find More Information (Documents on Display)

We are subject to the informational reporting requirements of the Exchange Act, and file with or furnish to the SEC, as applicable, the following documents that apply to foreign private issuers:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· annual reports on Form 20-F;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· certain other reports on Form 6-K containing the information that we make public under Brazilian law,
file with the Brazilian stock exchanges or distribute to shareholders; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· other information.

[**Table of Contents**](#TableOfContents)

You may read and copy any reports or other information that we file at the SEC's public reference rooms at 100 F Street, NE, Washington, D.C. 20549. You may obtain information on the operation of the SEC's public reference rooms by calling the SEC at 1-800-SEC-0330. Electronic filings made through the Electronic Data Gathering, Analysis and Retrieval System are also publicly available through the SEC's website on the Internet at www.sec.gov.

As a foreign private issuer, we are exempt from the rules under the Exchange Act prescribing the furnishing and content of proxy statements and will not be required to file proxy statements with the SEC, and its officers, directors and principal shareholders will be exempt from the reporting and "short swing" profit recovery provisions contained in Section 16 of the Exchange Act.

You may obtain documents from us by requesting them in writing, at the following addresses or by telephone:

---

| | |
|:---|:---|
|  | &nbsp;&nbsp;**Ambev S.A.** |
| &nbsp;&nbsp;Attention: | &nbsp;&nbsp;Investor Relations Department |
| &nbsp;&nbsp;Telephone numbers: | &nbsp;&nbsp;(55-11) 2122-1415 |
|  | &nbsp;&nbsp;(55-11) 2122-1414 |
| &nbsp;&nbsp;Email: | &nbsp;&nbsp;ri@ambev.com.br |

---

You may obtain additional information about us on our website at http://ri.ambev.com.br/. The information contained therein is not part of this annual report.

I.&nbsp;&nbsp;&nbsp;&nbsp; Subsidiary Information

Not applicable.

[**Table of Contents**](#TableOfContents)

ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Our activities expose us to various market risks, including changes in foreign currency exchange rates and interest rates and changes in the prices of certain commodities, including malt, aluminum, sugar and corn. Market risk is the potential loss arising from adverse changes in market rates and prices. We enter into derivatives and other financial instruments, in order to manage and reduce the impact of fluctuations in commodity prices, in foreign currency exchange rates and in interest rates. We have established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial activities. Decisions regarding hedging are made according to our risk management policy, taking into consideration the amount and duration of the exposure, market volatility and economic trends.

These instruments are accounted for based on their characteristics. See Notes 3 and 28 to our audited consolidated financial statements for a discussion of the accounting policies and information on derivative financial instruments.

In order to minimize the credit risk of its investments, we have cash allocation and investment policies, taking into consideration financial institution credit limits and ratings, not allowing credit concentration. Thus, the credit risk is monitored and minimized because the negotiations are carried out only with a select group of highly qualified counterparties. The definition of financial institutions authorized to operate as a counterparty for us is described in our policy, which establishes maximum exposure limits for each counterparty based on each counterparty's risk rating and capitalization.

**Enterprise Risk Management (ERM)**

We have implemented a management strategy to promote enterprise-wide risk management (ERM), through an integrated framework that considers the impact on our business of not only market risks but also of compliance, strategic and operational risks. We believe that such integrated framework, which accounts for different kinds of business risks, enables us to improve management's ability to evaluate risks associated with our business.

The risk management department is responsible for reviewing and following up with management the risk factors and related mitigating initiatives consistent with our corporate strategy. Market risks, such as exposure in foreign currency, interest rates, commodity prices, liquidity and credit risk arise during the normal course of our business. We analyze each of these risks both individually and on an interconnected basis, defining strategies for managing the economic impact on its performance in line with our financial risk management policy.

**Commodity Risk**

We use a large volume of agricultural goods to produce our products, including malt and hops for our beer and sugar, *guaraná*, other fruits and sweeteners for our CSDs. See "Item 4. Information on the Company—B. Business Overview—Sources and Availability of Raw Materials." We purchase a significant portion of our malt and all of our hops outside of Brazil. We purchase the remainder of our malt and our sugar, *guaraná* and other fruits and sweeteners locally. Ambev also purchases substantial quantities of aluminum cans.

We produce approximately 75% of our consolidated malt needs and approximately 2% of our *guaraná* requirement. The remainder and all other commodities are purchased from third parties. We believe that adequate supplies of the commodities we use are available at the present time, but we cannot predict the future availability of these commodities or the prices we will have to pay for such commodities. The commodity markets have experienced and will continue to experience price fluctuations. We believe that the future price and supply of agricultural materials will be determined by, among other factors, the level of crop production, weather conditions, export demand, and government regulations and legislation affecting agriculture, and that the price of aluminum and sugar will be largely influenced by international market prices. See "Item 4. Information on the Company—B. Business Overview—Sources and Availability of Raw Materials."

[**Table of Contents**](#TableOfContents)

All of the hops we purchase in the international markets outside of South America are paid for in U.S. dollars. In addition, although we purchase aluminum cans and sugar in Brazil, their prices are directly influenced by the fluctuation of international commodity prices.

As of December 31, 2022, our derivative activities consisted of sugar, wheat, aluminum, corn and resin derivatives. The table below provides information about our significant commodity risk sensitive instruments as of December 31, 2022. The contract terms of these instruments have been categorized by expected maturity dates and are measured at market prices.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **<u>Maturity Schedule of Commodities Derivatives as of December 31, 2022</u>** | **<u>Maturity Schedule of Commodities Derivatives as of December 31, 2022</u>** | **<u>Maturity Schedule of Commodities Derivatives as of December 31, 2022</u>** | **<u>Maturity Schedule of Commodities Derivatives as of December 31, 2022</u>** | **<u>Maturity Schedule of Commodities Derivatives as of December 31, 2022</u>** | **<u>Maturity Schedule of Commodities Derivatives as of December 31, 2022</u>** | **<u>Maturity Schedule of Commodities Derivatives as of December 31, 2022</u>** | **<u>Maturity Schedule of Commodities Derivatives as of December 31, 2022</u>** |
| **<u>Derivatives Instruments</u>** | **<u>2023</u>** | **<u>2024</u>** | **<u>2025</u>** | **<u>2026</u>** | **<u>2027</u>** | **<u>Thereafter</u>** | **<u>Total</u>** | **<u>Fair Value</u>** |
|  | **(in R$ million, except price per ton/gallon/barrel/gigajoule)** | **(in R$ million, except price per ton/gallon/barrel/gigajoule)** | **(in R$ million, except price per ton/gallon/barrel/gigajoule)** | **(in R$ million, except price per ton/gallon/barrel/gigajoule)** | **(in R$ million, except price per ton/gallon/barrel/gigajoule)** | **(in R$ million, except price per ton/gallon/barrel/gigajoule)** | **(in R$ million, except price per ton/gallon/barrel/gigajoule)** | **(in R$ million, except price per ton/gallon/barrel/gigajoule)** |
| **Sugar Derivatives:** |  |  |  |  |  |  |  |  |
| Notional Amount | 350.0 | 95.2 |  |  |  |  | 445.2 | 22.5 |
| Average Price (R$/ton) | 2006.5 | 2027.6 |  |  |  |  | 2011.0 |  |
| **Wheat Derivatives:** |  |  |  |  |  |  |  |  |
| Notional Amount | 160.9 |  |  |  |  |  | 160.9 | (26.4) |
| Average Price (R$/ton) | 1788.4 |  |  |  |  |  | 1788.4 |  |
| **Aluminum Derivatives:** |  |  |  |  |  |  |  |  |
| Notional Amount | 3102.9 |  |  |  |  |  | 3102.9 | (162.1) |
| Average Price (R$/ton) | 12444.5 |  |  |  |  |  | 12444.5 |  |
| **Corn Derivatives:** |  |  |  |  |  |  |  |  |
| Notional Amount | 627.6 |  |  |  |  |  | 627.6 | (19.9) |
| Average Price (R$/ton) | 103.4 |  |  |  |  |  | 103.4 |  |
| **Resin Derivatives:** |  |  |  |  |  |  |  |  |
| Notional Amount | 473.3 |  |  |  |  |  | 473.3 | (89.4) |
| Average Price (R$/ton) | 6216.7 | - | - | - | - | - | 6216.7 |  |

---

**Interest Rate Risk**

We are exposed to interest rate volatility with respect to our cash and cash equivalents, current investment securities and fixed and floating rate debt. Our U.S. dollar-denominated cash equivalents generally bear interest at a floating rate. We are exposed to interest rate volatility with regard to existing issuances of fixed rate debt, existing issuances of floating rate debt, currency future and forward swaps agreements, cash and cash equivalents and current investment securities. We manage our debt portfolio in response to changes in interest rates and foreign currency rates by periodically retiring, redeeming and repurchasing debt and using derivative financial instruments.

The table below provides information about our significant interest rate sensitive instruments. For variable interest rate debt, the rate presented is the weighted average rate calculated as of December 31, 2022. The contract terms of these instruments have been categorized by expected maturity dates:

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **Maturity Schedule of Debt Portfolio as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Debt Portfolio as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Debt Portfolio as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Debt Portfolio as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Debt Portfolio as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Debt Portfolio as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Debt Portfolio as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Debt Portfolio as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Debt Portfolio as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Debt Portfolio as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Debt Portfolio as of December 31, 2022** |
| &nbsp;&nbsp; **Debt Instrument** | &nbsp;&nbsp; **2023** | &nbsp;&nbsp; **2023** | &nbsp;&nbsp; **2024** | &nbsp;&nbsp; **2024** | &nbsp;&nbsp; **2025** | &nbsp;&nbsp; **2025** | &nbsp;&nbsp; **2026** | &nbsp;&nbsp; **2026** | &nbsp;&nbsp; **2027** | &nbsp;&nbsp; **Thereafter** | &nbsp;&nbsp; **Total** |
|  | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** | &nbsp;&nbsp;***(in R$ million, except percentages)*** |
| &nbsp;&nbsp;**International Debt:** |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Other Latin America Currency Floating Rate | &nbsp;&nbsp; -<br>| &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; -<br>| &nbsp;&nbsp; -<br>|
| &nbsp;&nbsp;Average Pay Rate | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;Other Latin America Currency <br> Fixed Rate | &nbsp;&nbsp;98.8 | &nbsp;&nbsp;217.5 | &nbsp;&nbsp;217.5 | &nbsp;&nbsp;29.0 | &nbsp;&nbsp;29.0 | &nbsp;&nbsp;26.7 | &nbsp;&nbsp;26.7 | &nbsp;&nbsp;49.3 | &nbsp;&nbsp;49.3 | &nbsp;&nbsp;- | &nbsp;&nbsp;421.3 |
| &nbsp;&nbsp;Average Pay Rate | &nbsp;&nbsp;10.39% | &nbsp;&nbsp;10.39% | &nbsp;&nbsp;10.39% | &nbsp;&nbsp;10.39% | &nbsp;&nbsp;10.39% | &nbsp;&nbsp;10.39% | &nbsp;&nbsp;10.39% | &nbsp;&nbsp;10.39% | &nbsp;&nbsp;10.39% | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;US$ Fixed Rate | &nbsp;&nbsp;6.2 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;6.2 |

---

[**Table of Contents**](#TableOfContents)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;Average Pay Rate | &nbsp;&nbsp;14.00% | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;US$ Floating Rate | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;Average Pay Rate | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;CAD Fixed Rate | &nbsp;&nbsp;123.3 | &nbsp;&nbsp;117.1 | &nbsp;&nbsp;108.7 | &nbsp;&nbsp;117.5 | &nbsp;&nbsp;44.4 | &nbsp;&nbsp;- | &nbsp;&nbsp;511.0 |
| &nbsp;&nbsp;Average Pay Rate | &nbsp;&nbsp;5.32% | &nbsp;&nbsp;5.32% | &nbsp;&nbsp;5.32% | &nbsp;&nbsp;5.32% | &nbsp;&nbsp;5.32% | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;CAD Floating Rate | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;Average Pay Rate | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;***Reais* Denominated Debt Floating Rate – CDI & DI:** | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;Notional Amount | &nbsp;&nbsp;12.3 | &nbsp;&nbsp;13.4 | &nbsp;&nbsp;14.7 | &nbsp;&nbsp;16.1 | &nbsp;&nbsp;17.6 | &nbsp;&nbsp;63.3 | &nbsp;&nbsp;137.3 |
| &nbsp;&nbsp;Average Pay Rate | &nbsp;&nbsp;9.61% | &nbsp;&nbsp;9.61% | &nbsp;&nbsp;9.61% | &nbsp;&nbsp;9.61% | &nbsp;&nbsp;9.61% | &nbsp;&nbsp;9.61% | &nbsp;&nbsp;- |
| &nbsp;&nbsp;**Reais Debt - ICMS Fixed Rate:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Notional Amount | &nbsp;&nbsp;144.4 | &nbsp;&nbsp;126.5 | &nbsp;&nbsp;132.7 | &nbsp;&nbsp;66.5 | &nbsp;&nbsp;2.4 | &nbsp;&nbsp;- | &nbsp;&nbsp;472.5 |
| &nbsp;&nbsp;Average Pay Rate | &nbsp;&nbsp;3.72% | &nbsp;&nbsp;3.72% | &nbsp;&nbsp;3.72% | &nbsp;&nbsp;3.72% | &nbsp;&nbsp;3.72% | &nbsp;&nbsp;- | &nbsp;&nbsp; - |
| &nbsp;&nbsp;***Reais* Debt - Fixed Rate:** | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;Notional Amount | &nbsp;&nbsp;562.0&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;537.3&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;390.5&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;277.4&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;418.3&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;- | &nbsp;&nbsp;2185.5 |
| &nbsp;&nbsp;Average Pay Rate | &nbsp;&nbsp; 9.53% | &nbsp;&nbsp; 9.53% | &nbsp;&nbsp; 9.53% | &nbsp;&nbsp; 9.53% | &nbsp;&nbsp; 9.53% | &nbsp;&nbsp; - | &nbsp;&nbsp; - |
| &nbsp;&nbsp;***Reais* Debt - Fixed Rate (BNDES & Finep):** | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - |
| &nbsp;&nbsp;Notional Amount | &nbsp;&nbsp; 35.7 | &nbsp;&nbsp; 1.2 | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; 36.8 |
| &nbsp;&nbsp;Average Pay Rate | &nbsp;&nbsp; 3.70% | &nbsp;&nbsp; 3.70% | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; - |
| &nbsp;&nbsp;**Total Debt** | &nbsp;&nbsp;**982.6** | &nbsp;&nbsp; **1013.1** | &nbsp;&nbsp; **675.6** | &nbsp;&nbsp; **504.2** | &nbsp;&nbsp; **532.0** | &nbsp;&nbsp; **63.3** | &nbsp;&nbsp;**3770.7** |

---

Part of the floating rate debt accrues interest at TJLP. During the period set forth below the TJLP was:

---

| | | | |
|:---|:---|:---|:---|
|  | &nbsp;&nbsp; **2022** | &nbsp;&nbsp; **2021** | &nbsp;&nbsp; **2020** |
| &nbsp;&nbsp;4th Quarter | &nbsp;&nbsp;7.20 | &nbsp;&nbsp;5.32 | &nbsp;&nbsp;4.55 |
| &nbsp;&nbsp;3rd Quarter | &nbsp;&nbsp;7.01 | &nbsp;&nbsp;4.88 | &nbsp;&nbsp;4.91 |
| &nbsp;&nbsp;2nd Quarter | &nbsp;&nbsp;6.82 | &nbsp;&nbsp;4.61 | &nbsp;&nbsp;4.94 |
| &nbsp;&nbsp;1st Quarter | &nbsp;&nbsp;6.08 | &nbsp;&nbsp;4.39 | &nbsp;&nbsp;5.09 |

---

We have not experienced, and do not expect to experience, difficulties in obtaining financing or refinancing existing debt.

**Foreign Exchange Risk**

We are exposed to fluctuations in foreign exchange rate movements because a significant portion of our operating expenses, in particular those related to hops, malt, sugar, aluminum and corn, are also denominated in or linked to the U.S. dollar. We enter into derivative financial instruments to manage and reduce the impact of changes in foreign currency exchange rates in respect of our U.S. dollar-denominated debt. From January 1, 2016, until December 31, 2022, the U.S. dollar appreciated 60.1% against the *real*, and, as of December 31, 2022, the commercial market rate for purchasing U.S. dollars was R$5.22 per US$1.00. In 2020 and 2021, the U.S. dollar appreciated 28.9%, 7.4% respectively and in 2022 depreciated 6.5% against the *real*.

Our foreign currency exposure gives rise to market risks associated with exchange rate movements, mainly against the U.S. dollar. Foreign currency-denominated liabilities at December 31, 2022, included debt of R$938.5 million.

As of December 31, 2022, derivative activities consisted of foreign currency forward contracts, foreign currency swaps and future contracts. The table below provides information about our significant foreign exchange rate risk sensitive instruments as of December 31, 2022. The contract terms of these instruments have been categorized by expected maturity dates.

[**Table of Contents**](#TableOfContents)

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | &nbsp;&nbsp; **Maturity Schedule of Foreign Exchange Derivatives as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Foreign Exchange Derivatives as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Foreign Exchange Derivatives as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Foreign Exchange Derivatives as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Foreign Exchange Derivatives as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Foreign Exchange Derivatives as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Foreign Exchange Derivatives as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Foreign Exchange Derivatives as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Foreign Exchange Derivatives as of December 31, 2022** | &nbsp;&nbsp; **Maturity Schedule of Foreign Exchange Derivatives as of December 31, 2022** |
| <br>&nbsp;&nbsp;**Derivatives Instruments(1)** | &nbsp;&nbsp;**2023** | &nbsp;&nbsp;**2024** | &nbsp;&nbsp;**2025** | &nbsp;&nbsp;**2026** | &nbsp;&nbsp;**2027** | &nbsp;&nbsp;**Thereafter** | &nbsp;&nbsp;**Thereafter** | &nbsp;&nbsp;**Total** | &nbsp;&nbsp;**Total** | &nbsp;&nbsp;**Fair Value** |
|  | &nbsp;&nbsp;**(in R$ million, except percentages)** | &nbsp;&nbsp;**(in R$ million, except percentages)** | &nbsp;&nbsp;**(in R$ million, except percentages)** | &nbsp;&nbsp;**(in R$ million, except percentages)** | &nbsp;&nbsp;**(in R$ million, except percentages)** | &nbsp;&nbsp;**(in R$ million, except percentages)** | &nbsp;&nbsp;**(in R$ million, except percentages)** | &nbsp;&nbsp;**(in R$ million, except percentages)** | &nbsp;&nbsp;**(in R$ million, except percentages)** | &nbsp;&nbsp;**(in R$ million, except percentages)** |
| &nbsp;&nbsp;**BM&F Dollar Futures:** |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Notional Amount | &nbsp;&nbsp;2626.97 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;2626.97 | &nbsp;&nbsp;2626.97 | &nbsp;&nbsp;21.22 | &nbsp;&nbsp;21.22 |
| &nbsp;&nbsp;&nbsp;&nbsp;Average Unit Price | &nbsp;&nbsp;5.41 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;5.41 | &nbsp;&nbsp;5.41 | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;**FDF C$ x US$:** |  | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Notional Amount | &nbsp;&nbsp;1410.43 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;1410.43 | &nbsp;&nbsp;1410.43 | &nbsp;&nbsp;57.21 | &nbsp;&nbsp;57.21 |
| &nbsp;&nbsp;&nbsp;&nbsp;Average Unit Price | &nbsp;&nbsp;5.00 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;5.00 | &nbsp;&nbsp;5.00 | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;**FDF C$ x EUR:** |  | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Notional Amount | &nbsp;&nbsp;32.20 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;32.20 | &nbsp;&nbsp;32.20 | &nbsp;&nbsp;1.91 | &nbsp;&nbsp;1.91 |
| &nbsp;&nbsp;&nbsp;&nbsp;Average Unit Price | &nbsp;&nbsp;5.30 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;5.30 | &nbsp;&nbsp;5.30 | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;**NDF ARS x US$:** |  | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Notional Amount | &nbsp;&nbsp;1259.43 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;1259.43 | &nbsp;&nbsp;1259.43 | &nbsp;&nbsp;(29.74) | &nbsp;&nbsp;(29.74) |
| &nbsp;&nbsp;&nbsp;&nbsp;Average Unit Price | &nbsp;&nbsp;5.18 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;5.18 | &nbsp;&nbsp;5.18 | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;**NDF CLP x US$:** |  | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Notional Amount | &nbsp;&nbsp;745.52 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;745.52 | &nbsp;&nbsp;745.52 | &nbsp;&nbsp;(35.56) | &nbsp;&nbsp;(35.56) |
| &nbsp;&nbsp;&nbsp;&nbsp;Average Unit Price | &nbsp;&nbsp;5.56 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;5.56 | &nbsp;&nbsp;5.56 | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;**NDF UYU x US$:** |  | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Notional Amount | &nbsp;&nbsp;206.72 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;206.72 | &nbsp;&nbsp;206.72 | &nbsp;&nbsp;(15.44) | &nbsp;&nbsp;(15.44) |
| &nbsp;&nbsp;&nbsp;&nbsp;Average Unit Price | &nbsp;&nbsp;5.87 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;5.87 | &nbsp;&nbsp;5.87 | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;**NDF BOB x US$:** |  | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Notional Amount | &nbsp;&nbsp;424.25 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;424.25 | &nbsp;&nbsp;424.25 | &nbsp;&nbsp;(15.41) | &nbsp;&nbsp;(15.41) |
| &nbsp;&nbsp;&nbsp;&nbsp;Average Unit Price | &nbsp;&nbsp;5.62 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;5.62 | &nbsp;&nbsp;5.62 |  |  |
| &nbsp;&nbsp;**NDF PYG x US$:** |  | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Notional Amount | &nbsp;&nbsp;708.74 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;708.74 | &nbsp;&nbsp;708.74 | &nbsp;&nbsp;13.30 | &nbsp;&nbsp;13.30 |
| &nbsp;&nbsp;&nbsp;&nbsp;Average Unit Price | &nbsp;&nbsp;5.23 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;5.23 | &nbsp;&nbsp;5.23 | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;**NDF MXN x US$:** |  | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Notional Amount | &nbsp;&nbsp;95.48 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;95.48 | &nbsp;&nbsp;95.48 | &nbsp;&nbsp;6.10 | &nbsp;&nbsp;6.10 |
| &nbsp;&nbsp;&nbsp;&nbsp;Average Unit Price | &nbsp;&nbsp;0.24 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;0.24 | &nbsp;&nbsp;0.24 | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;**NDF US$ x R$:** |  | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Notional Amount | &nbsp;&nbsp;41.02 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;4102 | &nbsp;&nbsp;4102 | &nbsp;&nbsp;(188.65) | &nbsp;&nbsp;(188.65) |
| &nbsp;&nbsp;&nbsp;&nbsp;Average Unit Price | &nbsp;&nbsp;0.25 | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;- | &nbsp;&nbsp;5.54 | &nbsp;&nbsp;5.54 |  |  |

---

(1) Negative notional amounts represent an excess of liabilities over assets at any given moment.

[**Table of Contents**](#TableOfContents)

ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

A.&nbsp;&nbsp;&nbsp;&nbsp; Debt Securities

Not Applicable.

B.&nbsp;&nbsp;&nbsp;&nbsp; Warrants and Rights

Not Applicable.

C.&nbsp;&nbsp;&nbsp;&nbsp; Other Securities

Not Applicable.

D.&nbsp;&nbsp;&nbsp;&nbsp; American Depositary Shares

The Bank of New York Mellon, or the Depositary, is the depositary of the Ambev shares in accordance with the Deposit Agreement, dated July 9, 2013, entered into among Ambev, The Bank of New York Mellon, as depositary, and all owners from time to time of ADSs of Ambev, or the Depositary Agreement. A copy of this Depositary Agreement is filed as an exhibit to this annual report on Form 20-F.

The Depositary collects its fees for delivery and surrender of ADSs directly from investors depositing shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The Depositary collects fees for making distributions to investors by deducting those fees from the amounts distributed or by selling a portion of distributable property to pay the fees. The Depositary may collect its annual fee for depositary services by deduction from cash distributions or by directly billing investors or by charging the book-entry system accounts of participants acting for them. The Depositary may collect any of its fees by deduction from any cash distribution payable to ADS holders that are obligated to pay those fees. The Depositary may generally refuse to provide fee-attracting services until its fees for those services are paid. Pursuant to the Depositary Agreement, holders of our ADSs may have to pay to The Bank of New York Mellon, either directly or indirectly, fees or charges up to the amounts set forth in the table below.

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Persons depositing or withdrawing shares or ADS holders must pay:** | &nbsp;&nbsp;**For:** |
| &nbsp;&nbsp;US$5.00 (or less) per 100 ADSs (or portion of 100 ADSs) | &nbsp;&nbsp; issuance of ADSs, including issuances resulting from a distribution of shares, rights or other property; and<br>|
|  | &nbsp;&nbsp;cancellation of ADSs for the purpose of withdrawal, including if the deposit agreement terminates. |
| &nbsp;&nbsp;US$0.02 (or less) per ADS | &nbsp;&nbsp;any cash distribution to ADS holders. |
| &nbsp;&nbsp;A fee equivalent to the fee that would be payable if securities distributed to you had been shares and the shares had been deposited for issuance of ADSs | &nbsp;&nbsp;distribution of securities distributed to holders of deposited securities which are distributed by the Depositary to ADS holders. |
| &nbsp;&nbsp;US$0.02 (or less) per ADSs per calendar year | &nbsp;&nbsp;depositary services. |
| &nbsp;&nbsp;Registration or transfer fees | &nbsp;&nbsp;transfer and registration of shares on Ambev's share registry to or from the name of the Depositary or its agent when you deposit or withdraw shares. |
| &nbsp;&nbsp;Expenses of the Depositary | &nbsp;&nbsp; cable, telex and facsimile transmissions (when expressly provided in the deposit agreement); and<br>converting foreign currency to U.S. dollars. |
| &nbsp;&nbsp;Taxes and other governmental charges the Depositary or the Custodian may have to pay on any ADS or share underlying an ADS, for example, stock transfer taxes or stamp duty (which currently are inapplicable in Brazil) or withholding taxes | &nbsp;&nbsp;as necessary. |
| &nbsp;&nbsp;Any charges incurred by the Depositary or its agents for servicing the deposited securities | &nbsp;&nbsp;as necessary. |

---

[**Table of Contents**](#TableOfContents)

In performing its duties under the Deposit Agreement, the Depositary may use brokers, dealers or other service providers that are affiliates of the Depositary and that may earn or share fees or commissions.

Subject to certain terms and conditions, the Depositary has agreed to reimburse us for certain expenses it incurs that are related to establishment and maintenance expenses of the ADS program, including the standard out-of-pocket maintenance costs for the ADRs, which consist of the expenses of postage and envelopes for mailing annual and interim financial reports, printing and distributing dividend checks, electronic filing of U.S. federal tax information, mailing required tax forms, stationery, postage, facsimile, and telephone calls. There are limits on the amount of expenses for which the Depositary will reimburse us, but the amount of reimbursement available to us is not necessarily tied to the amount of fees the depositary collects from investors.

The Depositary has made payments to us in the amount of US$1,416,241.59 during 2022. These amounts were used for general corporate purposes such as the payment of costs and expenses associated with (1) the preparation and distribution of proxy materials, (2) the preparation and distribution of marketing materials and (3) consulting and other services related to investor relations.

[**Table of Contents**](#TableOfContents)

**PART II**

ITEM 13. DEFAULT, DIVIDENDS ARREARAGES AND DELINQUENCIES

Not Applicable.

[**Table of Contents**](#TableOfContents)

ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS

Not Applicable.

[**Table of Contents**](#TableOfContents)

ITEM 15. CONTROLS AND PROCEDURES

A.&nbsp;&nbsp;&nbsp;&nbsp; Disclosure Controls and Procedures

The Company has carried out an evaluation, as of December 31, 2022, of the effectiveness of the design and operation of the Company's disclosure controls and procedures under the supervision and with the participation of the Company's management, which is responsible for the management of the internal controls, including the Chief Executive Officer and Chief Financial Officer. While there are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures, the Company's disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives. Based upon the Company's evaluation, as of December 31, 2022, the Chief Executive Officer and Chief Financial Officer of the Company have concluded that the disclosure controls and procedures are (1) effective at the reasonable assurance level in ensuring that information required to be disclosed in the reports that are filed or submitted under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the Commissions' rules and forms and (2) effective at the reasonable assurance level in ensuring that information to be disclosed in the reports that are filed or submitted under the Exchange Act is accumulated and communicated to the management of the Company, including the Chief Executive Officer and the Chief Financial Officer, to allow timely decisions regarding required disclosure.

B.&nbsp;&nbsp;&nbsp;&nbsp; Management's Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting.

Internal control over financial reporting is defined in rules 13a-15(f) and 15d-15(f) under the Exchange Act as a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles, and includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company's assets that could have a material effect on the audited consolidated financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect material misstatements. Therefore, effective control over financial reporting cannot, and does not, provide absolute assurance of achieving our control objectives. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. The effectiveness of our internal control over financial reporting as of December 31, 2022, is based on the criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations (COSO) of the Treadway Commission. Based on those criteria, management has concluded that as of December 31, 2022, the Company's internal control over financial reporting is effective.

C.&nbsp;&nbsp;&nbsp;&nbsp; Attestation Report of the Registered Public Accounting Firm

The effectiveness of our internal control over financial reporting as of December 31, 2022, has been audited by PricewaterhouseCoopers Auditores Independentes Ltda., the Company's independent registered public accounting firm. Their integrated report, is included in our audited consolidated financial statements included in this Form 20-F.

[**Table of Contents**](#TableOfContents)

D.&nbsp;&nbsp;&nbsp;&nbsp; Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during the period covered by this annual report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

[**Table of Contents**](#TableOfContents)

**ITEM 15T. CONTROLS AND PROCEDURES**

Not applicable.

[**Table of Contents**](#TableOfContents)

**ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT**

We have relied on the exemption provided for under Rule 10A-3(c)(3) of the Exchange Act, pursuant to Section 301 of the Sarbanes-Oxley Act of 2002, which enables us to have the Fiscal Council perform the duties of an audit committee for the purposes of such Act, to the extent permitted by Brazilian law. In accordance with the charter of our Fiscal Council, at least one of its members has to fulfill the requirements of the Sarbanes-Oxley Act of 2002 for the purposes of qualifying as an audit committee financial expert. Accordingly, our Fiscal Council is comprised of one "audit committee financial expert" within the meaning of this Item 16A, namely José Ronaldo Vilela Rezende, who has an extensive work-related finance background and who is "independent" as set forth in Rule 10A-3(c)(3) of the Sarbanes-Oxley Act of 2002.

[**Table of Contents**](#TableOfContents)

ITEM 16B. CODE OF BUSINESS CONDUCT

We have adopted a Code of Business Conduct (as defined under the rules and regulations of the SEC) that applies to our principal executive officer, principal financial officer and principal accounting officer, among others. Our Code of Business Conduct has been incorporated by reference to this annual report and was approved by our Board of Directors on August 30, 2013 and amended on May 16, 2017 and on December 21, 2020 (though Old Ambev already had a Board-approved Code of Business Conduct since 2003). If the provisions of the code that apply to our principal executive officer, principal financial officer or principal accounting officer are amended, or if a waiver is granted, we will disclose such amendment or waiver.

[**Table of Contents**](#TableOfContents)

ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES

**Auditor Fees**

PricewaterhouseCoopers Auditores Independentes Ltda., or PwC, acted as our independent auditor for the fiscal years ended December 31, 2022 and 2021. The table below sets forth the total amount we were billed by PwC in 2022 and 2021 for services performed in those years, and breaks down the amount by category of service:

---

| | | |
|:---|:---|:---|
|  | &nbsp;&nbsp;**Year Ended December 31, 2022** | &nbsp;&nbsp;**Year Ended December 31, 2021** |
|  | &nbsp;&nbsp;***(in R$ thousand)*** | &nbsp;&nbsp;***(in R$ thousand)*** |
| &nbsp;&nbsp;Audit fees | &nbsp;&nbsp;12136 | &nbsp;&nbsp;9211 |
| &nbsp;&nbsp;Audit-related fees | &nbsp;&nbsp;2275 | &nbsp;&nbsp;- |
| &nbsp;&nbsp;Tax fees | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| &nbsp;&nbsp;All other fees | &nbsp;&nbsp;128 | &nbsp;&nbsp;165 |
| &nbsp;&nbsp;**Total** | &nbsp;&nbsp;14539 | &nbsp;&nbsp;9376 |

---

**Audit Fees**

Audit fees are fees billed for the audit of our consolidated financial statements and for the reviews of our quarterly financial statements in connection with statutory and regulatory filings or engagements (including audit of our subsidiaries for consolidated purpose).

**Audit-Related Fees**

Audit-related fees consisted of fees billed for assurance and related services that were reasonably related to the performance of the audit or review of our financial statements or that were traditionally performed by the external auditor.

**All Other Fees**

All other services consist primarily of fees billed for certain compliance reports to be filed with local regulators and certain comfort letters issued in connection with the issuance of debt.

**Independent Registered Public Accounting Firm**

Our audited consolidated financial statements as of and for the years ended December 31, 2022, 2021 and 2020 have been audited by PricewaterhouseCoopers Auditores Independentes Ltda., São Paulo, Brazil, independent registered public accounting firm. The office of PricewaterhouseCoopers Auditores Independentes Ltda. is located at Avenida Brigadeiro Faria Lima, 3732, São Paulo, Brazil. It is a member of the São Paulo State Regional Board of Accountants (*Conselho Regional de Contabilidade*) and the Public Company Accounting Oversight Board (PCAOB) and its registration numbers are SP 2SP0001/O-5 and 1351, respectively.

**Pre-Approval Policies and Procedures**

We have adopted pre-approval policies and procedures under which all audit and non-audit services provided by contracted external auditors must be pre-cleared by the Fiscal Council, which performs the duties of an audit committee for the purposes of the Sarbanes-Oxley Act of 2002, in accordance with Rule 10A-3(c)(3). The Fiscal Council adopts a list of services and amount limits for contracting for each external auditor under terms included in a "basic list," which is in turn approved by the Board of Directors. Any services provided from such list are deemed "pre-approved" for purposes of the Sarbanes-Oxley Act of 2002. The Fiscal Council periodically receive from our chief financial officer a summary report on the progress of the pre-approved services rendered and the corresponding fees duly authorized. Any services which are not included in such require a prior favorable opinion of our Fiscal Council. Our policy also contains a list of services which cannot be rendered by our external auditors.

[**Table of Contents**](#TableOfContents)

ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES

NYSE corporate governance standards require that a listed company have an audit committee composed of three independent members that satisfy the independence requirements of Rule 10A-3 under the Exchange Act, with a written charter that addresses certain duties.

The Fiscal Council is a permanent body which operates independently from our management and from our registered independent public accounting firm. Its principal function is to examine the financial statements of each fiscal year and provide a formal report to our shareholders. We are relying on the exemption provided for in Rule 10A-3(c)(3) and believe that our reliance on this exemption will not materially affect the ability of the Fiscal Council to act independently and to satisfy the other requirements of Rule 10A-3. In accordance with the charter of our Fiscal Council, at least one of its members has to fulfill the requirements of the Sarbanes-Oxley Act of 2002 for the purposes of qualifying as an audit committee financial expert. Accordingly, our Fiscal Council has designated one financial expert, namely José Ronaldo Vilela Rezende.

[**Table of Contents**](#TableOfContents)

ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS

As disclosed under "Major Shareholders—Control," we have purchased a number of our shares during the period covered by this annual report.

**Ambev S.A. Share Repurchases**

Set forth below, in tabular format, is some disclosure on the repurchases of Ambev S.A. shares for the periods indicated. Shares not purchased under publicly announced programs include those purchased from employees when no publicly announced program was in place and those bought from employees who were dismissed, in both cases, pursuant to the terms and conditions of our stock ownership plan.

---

| | | | | |
|:---|:---|:---|:---|:---|
| &nbsp;&nbsp; **Month** | &nbsp;&nbsp; **Total Number of Shares Purchased** | &nbsp;&nbsp; **Average Price Paid per Share** | &nbsp;&nbsp; **Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(1)** | &nbsp;&nbsp; **Maximum Number of Shares that May Be Purchased Under Publicly Announced Plans or Programs** |
| &nbsp;&nbsp;March-2023 | &nbsp;&nbsp;0 | &nbsp;&nbsp;0.00 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;February-2023 | &nbsp;&nbsp;0 | &nbsp;&nbsp;0.00 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;January-2023 | &nbsp;&nbsp;0 | &nbsp;&nbsp;0.00 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;December-2022 | &nbsp;&nbsp;7526 | &nbsp;&nbsp;14.52 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;November-2022 | &nbsp;&nbsp;0 | &nbsp;&nbsp;0.00 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;October-2022 | &nbsp;&nbsp;0 | &nbsp;&nbsp;0.00 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;September-2022 | &nbsp;&nbsp;40000 | &nbsp;&nbsp;15.48 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;August-2022 | &nbsp;&nbsp;0 | &nbsp;&nbsp;0.00 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;July-2022 | &nbsp;&nbsp;0 | &nbsp;&nbsp;0.00 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;June-2022 | &nbsp;&nbsp;0 | &nbsp;&nbsp;0.00 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;May-2022 | &nbsp;&nbsp;39700 | &nbsp;&nbsp;13.73 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;April-2022 | &nbsp;&nbsp;10395 | &nbsp;&nbsp;15.07 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;March-2022 | &nbsp;&nbsp;0 | &nbsp;&nbsp;0.00 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;February-2022 | &nbsp;&nbsp;516590 | &nbsp;&nbsp;14.84 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;January-2022 | &nbsp;&nbsp;8309 | &nbsp;&nbsp;15.01 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;December-2021 | &nbsp;&nbsp;0 | &nbsp;&nbsp;0.00 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;November-2021 | &nbsp;&nbsp;1812181 | &nbsp;&nbsp;16.72 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;October-2021 | &nbsp;&nbsp;84982 | &nbsp;&nbsp;16.81 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;September-2021 | &nbsp;&nbsp;5480 | &nbsp;&nbsp;15.30 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;August-2021 | &nbsp;&nbsp;0 | &nbsp;&nbsp;0.00 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;July-2021 | &nbsp;&nbsp;0 | &nbsp;&nbsp;0.00 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;June-2021 | &nbsp;&nbsp;1673389 | &nbsp;&nbsp;19.32 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;May-2021 | &nbsp;&nbsp;384904 | &nbsp;&nbsp;16.96 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;April-2021 | &nbsp;&nbsp;5474 | &nbsp;&nbsp;15.62 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;March-2021 | &nbsp;&nbsp;2515780 | &nbsp;&nbsp;15.47 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;February-2021 | &nbsp;&nbsp;0 | &nbsp;&nbsp;0.00 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;January-2021 | &nbsp;&nbsp;6981 | &nbsp;&nbsp;16.02 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;December-2020 | &nbsp;&nbsp;171479 | &nbsp;&nbsp;14.89 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;November-2020 | &nbsp;&nbsp;1480465 | &nbsp;&nbsp;14.97 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;October-2020 | &nbsp;&nbsp;3141 | &nbsp;&nbsp;13.34 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;September-2020 | &nbsp;&nbsp;23094 | &nbsp;&nbsp;13.16 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;August-2020 | &nbsp;&nbsp;0 | &nbsp;&nbsp;0.00 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;July-2020 | &nbsp;&nbsp;0 | &nbsp;&nbsp;0.00 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;June-2020 | &nbsp;&nbsp;9864 | &nbsp;&nbsp;13.57 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;May-2020 | &nbsp;&nbsp;0 | &nbsp;&nbsp;0.00 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;April-2020 | &nbsp;&nbsp;0 | &nbsp;&nbsp;0.00 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;March-2020 | &nbsp;&nbsp;256086 | &nbsp;&nbsp;13.17 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;February-2020 | &nbsp;&nbsp;1375 | &nbsp;&nbsp;14.54 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |
| &nbsp;&nbsp;January-2020 | &nbsp;&nbsp;992029 | &nbsp;&nbsp;18.99 | &nbsp;&nbsp;Not Specified | &nbsp;&nbsp;Not Specified |

---

(1) May differ from total number of shares purchased as they do not include all shares acquired from employees
under the stock ownership program.

[**Table of Contents**](#TableOfContents)

ITEM 16F. CHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANT

Not Applicable.

[**Table of Contents**](#TableOfContents)

ITEM 16G. CORPORATE GOVERNANCE

The principal differences between the NYSE corporate governance standards and our corporate governance practices are referred to in "Item 6. Directors, Senior Management and Employees—C. Board Practices—Differences Between the United States and Brazilian Corporate Governance Practices."

[**Table of Contents**](#TableOfContents)

ITEM 16H. MINE SAFETY DISCLOSURE

Not Applicable.

[**Table of Contents**](#TableOfContents)

ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

Not Applicable.

[**Table of Contents**](#TableOfContents)

**PART III**

ITEM 17. FINANCIAL STATEMENTS

Our audited consolidated financial statements, together with the audit report of the Independent Registered Public Accounting Firm thereon, are filed as part of this annual report, starting on page F-1 hereto, following the signature pages.

[**Table of Contents**](#TableOfContents)

ITEM 18. FINANCIAL STATEMENTS

See "Item 17.—Financial Statements."

[**Table of Contents**](#TableOfContents)

ITEM 19. EXHIBITS

1.1 [Restated Bylaws of Ambev S.A. (English-language translation) (incorporated by reference to the report on Form 6-K furnished by Ambev on May 2, 2022).](https://www.sec.gov/Archives/edgar/data/1565025/000129281422001980/abev20220429_6k.htm) https://www.sec.gov/Archives/edgar/data/1565025/000129281422001980/abev20220429_6k.htm

2.1 [Deposit Agreement among Ambev S.A., The Bank of New York Mellon, as Depositary, and all Owners and Holders from time to time of American Depositary Shares, representing Common Shares (incorporated by reference to Exhibit 4.1 to Form F-4 filed by Ambev on June 28, 2013).](https://www.sec.gov/Archives/edgar/data/1565025/000119312513276352/d529201dex41.htm) https://www.sec.gov/Archives/edgar/data/1565025/000119312513276352/d529201dex41.htm

[2.2](ex2-2.htm) [Description of Securities Registered under Section 12 of the Exchange Act.](ex2-2.htm)

3.1 [Shareholders' Agreement of Ambev S.A., dated April 16, 2013, effective as of July 2, 2019, among Fundação Antonio e Helena Zerrenner Instituição Nacional de Beneficência, Interbrew International B.V., AmBrew S.A. and Ambev S.A. (English-language translation) (incorporated by reference to Exhibit 9.2 to Form F-4 filed by Ambev on June 28, 2013).](https://www.sec.gov/Archives/edgar/data/1565025/000119312513276352/d529201dex92.htm) https://www.sec.gov/Archives/edgar/data/1565025/000119312513276352/d529201dex92.htm

3.2 [Voting Agreement between Stichting Anheuser-Busch InBev, Fonds Baillet Latour SPRL and Fonds Voorzitter Verhelst SPRL, effective November 1, 2015 (incorporated by reference to Exhibit 2.36 to Amendment No. 15 to Schedule 13D filed by former AB InBev on March 9, 2016).](https://www.sec.gov/Archives/edgar/data/1140467/000119312516498533/d12366dex99236.htm) https://www.sec.gov/Archives/edgar/data/1140467/000119312516498533/d12366dex99236.htm

3.3 [Amended and restated New Shareholders' Agreement, dated April 11, 2016, among BRC S.à.R.L., Eugénie Patri Sébastian S.A., EPS Participations S.à.R.L., Rayvax Société d'Investissements S.A. and Stichting Anheuser-Busch InBev (incorporated by reference to Exhibit 2.37 to Schedule 13D filed by former AB InBev on April 19, 2016).](https://www.sec.gov/Archives/edgar/data/1140467/000119312516545198/d168523dex99237.htm) https://www.sec.gov/Archives/edgar/data/1140467/000119312516545198/d168523dex99237.htm

3.4 [Voting and Support Agreement relating to Anheuser-Busch InBev SA/NV, dated October 8, 2016, among Stichting Anheuser-Busch InBev, Altria Group, Inc., BEVCO Ltd. and Anheuser-Busch InBev SA/NV (incorporated by reference to Exhibit 2.4 to Anheuser Busch InBev SA/NV's Schedule 13D filed by BRC S.à.R.L. on November 2, 2016).](https://www.sec.gov/Archives/edgar/data/1301486/000119312516757125/d276200dex9924.htm) https://www.sec.gov/Archives/edgar/data/1301486/000119312516757125/d276200dex9924.htm

[8.1](ex8-1.htm) [List of Material Subsidiaries of Ambev S.A.](ex8-1.htm)

11.1 [Code of Business Conduct dated August 30, 2013 and amended on May 16, 2017 and on December 20, 2020 (English-language translation). (incorporated by reference to the report on Form 6-K furnished by Ambev on December 22, 2020).](https://www.sec.gov/Archives/edgar/data/1565025/000129281420004846/ambevsa20201221_6k1.htm) https://sec.report/Document/0001292814-20-004846/ambevsa20201221_6k1.htm

11.2 [Manual on Disclosure and Use of Information and Securities Trading Policies for Ambev S.A., dated March 1, 2013 and amended on August 27, 2014, on March 28, 2016, on May 15, 2019 and on October 13 and 14, 2021 (English-language translation).](https://www.sec.gov/Archives/edgar/data/1565025/000129281421004013/ambevsa20211020_6k1.htm) https://sec.report/Document/0001292814-21-004013/ambevsa20211020_6k1.htm

[12.1](ex12-1.htm) [Principal Executive Officer Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex12-1.htm)

[12.2](ex12-2.htm) [Principal Financial Officer Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex12-2.htm)

[**Table of Contents**](#TableOfContents)

[13.1](ex13-1.htm) [Principal Executive Officer Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex13-1.htm)

[13.2](ex13-2.htm) [Principal Financial Officer Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex13-2.htm)

101. INS Inline XBRL Instance Document.

101. SCH Inline XBRL Taxonomy Extension Schema.

101. CAL Inline XBRL Taxonomy Extension Schema Calculation Linkbase.

101. DEF Inline XBRL Taxonomy Extension Schema Definition Linkbase.

101. LAB Inline XBRL Taxonomy Extension Schema Label Linkbase.

101. PRE Inline XBRL Taxonomy Extension Schema Presentation Linkbase.

104 Cover page interactive data (embedded within the Inline XBRL document).

[**Table of Contents**](#TableOfContents)

**SIGNATURES**

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.

**AMBEV S.A.**

By: <u>/s/ Jean Jereissati Neto</u> 

Name: Jean Jereissati Neto

Title: Chief Executive Officer

By: <u>/s/ Lucas Machado Lira</u> 

Name: Lucas Machado Lira

Title: Chief Financial Officer

Date: March 17, 2023.

[**Table of Contents**](#TableOfContents)

**Ambev S.A. Report of independent registered public accounting firm**

**Report of independent registered public accounting firm**

To the Shareholders and Board of Directors Ambev S.A.

**Opinions on the financial statements and internal control over financial reporting**

We have audited the accompanying consolidated balance sheets of Ambev S.A. and its subsidiaries (the "Company") as of December 31, 2022 and 2021, and the related consolidated income statements, statements of comprehensive income, of changes in equity and of cash flows for each of the three years in the period ended December 31, 2022, including the related notes (collectively referred to as the "consolidated financial statements"). We also have audited the Company's internal control over financial reporting as of December 31, 2022 based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022 in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

**Basis for opinions**

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Annual Report on Internal Control over Financial Reporting appearing under Part II, Item 15. Our responsibility is to express opinions on the Company's consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

[**Table of Contents**](#TableOfContents)

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.

Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

**Definition and limitations of internal control over financial reporting**

A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

**Critical audit matters**

The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that (i) relate to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

[**Table of Contents**](#TableOfContents)

**Tax contingencies and uncertain tax treatments**

As described in Note 30 to the consolidated financial statements, the Company has disclosed contingencies and uncertain tax treatments related to tax litigations of R$29,198.1 million and R$60,453.5 million, respectively, as of December 31, 2022. The Company discloses contingencies and uncertain tax treatments related to tax litigations in the consolidated financial statements when (i) the likelihood of loss of these lawsuits are classified as possible by management and (ii) in case of income taxes pending litigations, management determines that it is probable that taxation authorities will accept the uncertain tax treatment, and for which there are no provisions.

The principal considerations for our determination that performing procedures relating to tax contingencies and uncertain tax treatments are a critical audit matter are that there was significant judgment by management when determining whether a reasonable estimate of the loss and possible outcomes for each claim can be made, which in turn led to a high degree of auditor judgment, effort and subjectivity, including the use of professionals with specialized skill and knowledge, in evaluating management's assessment of the losses associated with tax contingencies and uncertain tax treatments.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management's evaluation of tax contingencies and uncertain tax treatments, as well as financial statement disclosures. These procedures also included among others, (1) obtaining and evaluating the letters of audit inquiry with external legal counsel, (2) evaluating the reasonableness of management's assessment regarding tax contingencies and uncertain tax treatments outcomes, and (3) evaluating the sufficiency of the Company's disclosures in the financial statements. Professionals with specialized skill and knowledge were used to assist in the evaluation of Company's assessment regarding tax contingencies and uncertain tax treatments outcomes.

**PIS and COFINS Recovery - exclusion of ICMS (VAT tax) from the basis of calculation**

As described in Note 1(b) to the consolidated financial statements, the Company recorded, in 2022, additional tax credit of R$1.2 billion resulting from the exclusion of circulation of goods and services tax (Brazilian VAT - "ICMS") from the tax calculation basis of the social integration program ("PIS") and the contribution to the financing of social security ("COFINS"), related to revenue transactions with subsidiaries, which reliable estimate became possible only after the consolidation of the General Attorney's Office ("PGFN") understanding on the subject, with important clarifications regarding the content and effects of the decision rendered by the Supreme Federal Court ("STF"), which declared the unconstitutionality of the inclusion of the ICMS in the taxable base of PIS and COFINS in previous years, and the conclusion of management´s analysis, gathering of supporting documents and quantification of the tax credit.

[**Table of Contents**](#TableOfContents)

The principal consideration for our determination that performing procedures relating to this tax credit recognition is a critical audit matter is that there was a significant judgment by management when determining that the amount was estimated with sufficient reliability, by obtaining the respective documents and quantifying the related amount. This in turn led to a high degree of auditor judgment, effort and subjectivity, including the use of professionals with specialized skill and knowledge, in performing the procedures designed to evaluate the recognition of this tax credit.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management's assessment, including controls over the recognition of this tax credit. These procedures also included, among others, (1) evaluation of the completeness and accuracy of the calculation obtained by management (principal and interest), (2) reading opinions provided by experts and legal advisors engaged by management, (3) evaluating the reasonableness of management's calculation regarding the total ICMS to be excluded from the calculation basis of PIS and COFINS, (4) evaluating the appropriateness of the Company's disclosures and (5) the involvement of professionals with specialized skill and knowledge to assist in the evaluation of the Company's tax credit calculation.

São Paulo, March 15, 2023

/s/ PricewaterhouseCoopers Auditores Independentes Ltda.

We have served as the Company's auditor since 2019.

[**Table of Contents**](#TableOfContents)

**SUMMARY**

---

| | |
|:---|:---|
| [CONSOLIDATED INCOME STATEMENTS](#f_001) | 3 |
| [CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME](#f_002) | 4 |
| [CONSOLIDATED BALANCE SHEETS](#f_003) | 5 |
| [CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY](#f_004) | 7 |
| [CONSOLIDATED STATEMENTS OF CASH FLOWS](#f_005) | 10 |
| **1. [CORPORATE INFORMATION](#f_006)** | 11 |
| **2. [STATEMENT OF COMPLIANCE](#f_007)** | 15 |
| **3. [SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES](#f_008)** | 15 |
| **4. [USE OF ESTIMATES AND JUDGMENTS](#f_009)** | 39 |
| **5. [SEGMENT REPORTING](#f_010)** | 42 |
| **6. [NET SALES](#f_011)** | 44 |
| **7. [OTHER OPERATING INCOME/(EXPENSES)](#f_012)** | 45 |
| **8. [EXCEPTIONAL ITEMS](#f_013)** | 46 |
| **9. [PAYROLL AND RELATED BENEFITS](#f_014)** | 46 |
| **10. [ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE](#f_015)** | 47 |
| **11. [FINANCE EXPENSES AND INCOME](#f_016)** | 47 |
| **12. [INCOME TAX AND SOCIAL CONTRIBUTION](#f_017)** | 48 |
| **13. [PROPERTY, PLANT AND EQUIPMENT](#f_018)** | 50 |
| **14. [GOODWILL](#f_019)** | 53 |
| **15. [INTANGIBLES](#f_020)** | 56 |
| **16. [INVESTMENT SECURITIES](#f_021)** | 57 |
| **17. [DEFERRED INCOME TAX AND SOCIAL CONTRIBUTION](#f_022)** | 57 |
| **18. [RECOVERABLE TAXES](#f_023)** | 60 |
| **19. [INVENTORY](#f_024)** | 60 |
| **20. [TRADE RECEIVABLES](#f_025)** | 60 |
| **21. [CASH AND CASH EQUIVALENTS](#f_026)** | 61 |
| **22. [CHANGES IN EQUITY](#f_027)** | 62 |
| **23. [INTEREST-BEARING LOANS AND BORROWING](#f_028)** | 71 |
| **24. [EMPLOYEE BENEFITS](#f_029)** | 73 |
| **25. [SHARE-BASED PAYMENTS](#f_030)** | 78 |
| **26. [TRADE PAYABLES](#f_031)** | 81 |
| **27. [PROVISIONS](#f_032)** | 82 |
| **28. [FINANCIAL INSTRUMENTS AND RISKS](#f_033)** | 84 |
| **29. [COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS](#f_034)** | 99 |
| **30. [CONTINGENCIES](#f_035)** | 100 |
| **31. [RELATED PARTIES](#f_036)** | 113 |
| **32. [GROUP COMPANIES](#f_037)** | 117 |
| **33. [INSURANCE](#f_038)** | 118 |

---

[**Table of Contents**](#toc)

**CONSOLIDATED INCOME STATEMENTS**

**For the year ended December 31**

All amounts in millions of Brazilian Reais unless otherwise stated

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Note** | **2022** | **2021** | **2020** |
| Net sales | 6 | 79708.8 | 72854.3 | 58379.0 |
| Cost of sales | 10 | (40422.1) | (35659.7) | (27066.1) |
| **Gross profit** |  | **39286.7** | **37194.6** | **31312.9** |
| Distribution expenses |  | (11395.3) | (9932.7) | (8245.0) |
| Sales and marketing expenses |  | (7337.4) | (7035.5) | (6374.6) |
| Administrative expenses |  | (5236.8) | (4877.4) | (2948.5) |
| Other operating income/(expenses), net | 7 | 2513.9 | 2124.1 | 2679.4 |
| Exceptional items | 8 | (143.3) | (392.8) | (452.0) |
| **Income from operations** |  | **17687.8** | **17080.3** | **15972.2** |
| Finance expenses | 11 | (7892.2) | (5427.8) | (5430.5) |
| Finance income | 11 | 4469.1 | 2222.4 | 2996.0 |
| **Net finance result** |  | **(3423.1)** | **(3205.4)** | **(2434.5)** |
| Share of results of joint ventures |  | (29.1) | (115.7) | (43.3) |
| **Income before income tax** |  | **14235.6** | **13759.2** | **13494.4** |
| Income tax expense | 12 | 655.6 | (636.6) | (1762.5) |
| **Net income** |  | **14891.2** | **13122.6** | **11731.9** |
| Attributable to: |  |  |  |  |
| Equity holders of Ambev |  | 14457.9 | 12671.0 | 11379.4 |
| Non-controlling interest |  | 433.3 | 451.6 | 352.5 |
| Basic earnings per share – common – R$ | 22 | 0.9184 | 0.8052 | 0.7233 |
| Diluted earnings per share – common – R$ | 22 | 0.9123 | 0.7991 | 0.7171 |

---

The accompanying notes are an integral part of these consolidated financial statements.

[**Table of Contents**](#toc)

**CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**

**For the year ended December 31**

All amounts in millions of Brazilian Reais unless otherwise stated

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| **Net income** | **14891.2** | **13122.6** | **11731.9** |
| **Items that may be subsequently reclassified to profit or loss:** |  |  |  |
| Exchange differences on the translation of foreign operations (gains/(losses)) |  |  |  |
| Investment hedge on foreign operations |  |  | (3.1) |
| Investment hedge – put option granted on subsidiaries | 203.8 | 193.6 | (371.7) |
| Gains/losses on translation of other foreign operations | (7067.0) | 2364.4 | 8061.0 |
| **Gains/losses on translation of foreign operations** | **(6863.2)** | **2558.0** | **7686.2** |
| **Cash flow hedge – gains/(losses)** |  |  |  |
| Recognized in Equity (Hedge reserve) | 38.0 | 2311.2 | 1837.9 |
| Reclassified from Equity (Hedge reserve) and included in profit or loss | (356.7) | (1829.9) | (1736.5) |
| **Total cash flow hedge** | **(318.7)** | **481.3** | **101.4** |
| **Items that will not be reclassified to profit or loss:** |  |  |  |
| Recognition of actuarial gains/(losses) | 470.7 | 340.0 | (258.0) |
| **Other comprehensive (loss)/income** | **(6711.2)** | **3379.3** | **7529.6** |
| **Total comprehensive income** | **8180.0** | **16501.9** | **19261.5** |
| **Attributable to:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity holders of Ambev | 7835.5 | 15943.3 | 18719.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-controlling interest | 344.5 | 558.6 | 541.9 |

---

The accompanying notes are an integral part of these consolidated financial statements. The consolidated statements of comprehensive income are presented net of income tax. The income tax effects of these items are disclosed in Note 17 - *Deferred income tax and social contribution.*

[**Table of Contents**](#toc)

**CONSOLIDATED BALANCE SHEETS**

All amounts in millions of Brazilian Reais unless otherwise stated

---

| | | | |
|:---|:---|:---|:---|
| **Assets** | **Note** | **2022** | **2021** |
| Property, plant and equipment | 13 | 30055.7 | 29224.3 |
| Goodwill | 14 | 40594.0 | 42411.3 |
| Intangible | 15 | 9222.2 | 8689.0 |
| Investments in joint ventures |  | 331.9 | 305.2 |
| Investment securities | 16 | 219.1 | 192.9 |
| Deferred tax assets | 17 | 6438.8 | 4727.7 |
| Employee benefits | 24 | 56.6 | 27.9 |
| Derivative financial instruments | 28 | 1.5 | 1.6 |
| Income tax and social contributions recoverable |  | 4607.5 | 6326.9 |
| Recoverable taxes | 18 | 6708.8 | 6005.4 |
| Other assets |  | 1905.2 | 2063.3 |
| **Non-current assets** |  | **100141.3** | **99975.5** |
| Investment securities | 16 | 454.5 | 1914.6 |
| Inventories | 19 | 12923.0 | 11000.3 |
| Trade receivables | 20 | 5349.1 | 4791.6 |
| Derivative financial instruments | 28 | 272.3 | 597.4 |
| Income tax and social contributions recoverable |  | 1808.7 | 631.5 |
| Recoverable taxes | 18 | 1044.8 | 1981.1 |
| Other assets |  | 1037.9 | 1082.8 |
| Cash and cash equivalents | 21 | 14926.4 | 16627.7 |
| **Current assets** |  | **37816.7** | **38627.0** |
| **Total assets** |  | **137958.0** | **138602.5** |

---

The accompanying notes are an integral part of these consolidated financial statements.

[**Table of Contents**](#toc)

**CONSOLIDATED BALANCE SHEETS**

All amounts in millions of Brazilian Reais unless otherwise stated

---

| | | | |
|:---|:---|:---|:---|
| **Equity and liabilities** | **Note** | **2022** | **2021** |
| **Equity** | 22 |  |  |
| Issued capital |  | 58130.5 | 58042.5 |
| Reserves |  | 92246.6 | 86378.8 |
| Carrying value adjustments |  | (68421.5) | (61778.3) |
| **Equity attributable to the equity holders of Ambev** |  | **81955.6** | **82643.0** |
| Non-controlling interests |  | 1372.2 | 1374.6 |
| **Total Equity** |  | **83327.8** | **84017.6** |
| Interest-bearing loans and borrowings | 23 | 2788.1 | 2253.5 |
| Employee benefits | 24 | 2161.1 | 3194.0 |
| Deferred tax assets | 17 | 3725.7 | 3214.0 |
| Income tax and social contribution payable |  | 1598.7 | 1686.9 |
| Taxes and contributions payable |  | 671.0 | 704.2 |
| Trade payables | 26 | 509.4 | 617.1 |
| Provisions | 27 | 739.0 | 603.8 |
| Put option granted on subsidiaries and other liabilities |  | 1896.8 | 3445.2 |
| **Non-current liabilities** |  | **14089.8** | **15718.7** |
| Bank overdrafts | 21 | 74.3 | 30.5 |
| Interest-bearing loans and borrowings | 23 | 982.6 | 847.1 |
| Wages and salaries |  | 2335.8 | 2439.4 |
| Dividends and interest on shareholders' equity payable |  | 1464.8 | 1425.0 |
| Derivative financial instruments | 28 | 729.4 | 492.5 |
| Income tax and social contribution payable |  | 1118.6 | 1491.0 |
| Taxes and contributions payable |  | 5812.9 | 4585.9 |
| Trade payables | 26 | 24328.5 | 25077.9 |
| Provisions | 27 | 180.7 | 172.3 |
| Put option granted on subsidiaries and other liabilities |  | 3512.8 | 2304.6 |
| **Current liabilities** |  | **40540.4** | **38866.2** |
| **Total liabilities** |  | **54630.2** | **54584.9** |
| **Total equity and liabilities** |  | **137958.0** | **138602.5** |

---

The accompanying notes are an integral part of these consolidated financial statements.

[**Table of Contents**](#toc)

**CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY**

**For the year ended December 31**

All amounts in millions of Brazilian Reais unless otherwise stated

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Attributable to equity holders of Ambev** | **Attributable to equity holders of Ambev** | **Attributable to equity holders of Ambev** | **Attributable to equity holders of Ambev** | **Attributable to equity holders of Ambev** | **Attributable to equity holders of Ambev** | | |
|  | **Capital** | **Capital reserves** | **Net income reserves** | **Retained earnings / (losses)** | **Carrying value adjustments** | **Total** | **Non-controlling interests** | **Total equity** |
| **At January 1, 2020** | **57866.8** | **54811.5** | **20874.2** | **-** | **(72274.5)** | **61278.0** | **1278.0** | **62556.0** |
|  Net Income | **-** | **-** | **-** | **11379.4** | **-** | **11379.4** | **352.5** | **11731.9** |
| *Comprehensive income:* |  |  |  |  |  |  |  |  |
| Gains/(losses) on the translation of foreign operations |  |  |  |  | 7493.1 | 7493.1 | 193.1 | 7686.2 |
| Cash flow hedges |  |  |  |  | 99.4 | 99.4 | 2.0 | 101.4 |
| Actuarial gains/(losses) |  |  |  |  | (252.3) | (252.3) | (5.7) | (258.0) |
| **Total comprehensive income** | **-** | **-** | **-** | **11379.4** | **7340.2** | **18719.6** | **541.9** | **19261.5** |
| Capital increase | 32.3 | (32.3) |  |  |  |  |  |  |
| Effect of application of IAS 29 (hyperinflation) | **-** | **-** | **-** | **1344.9** | **-** | **1344.9** | **(2.5)** | **1342.4** |
| Options granted on subsidiaries |  |  |  |  | (37.4) | (37.4) |  | (37.4) |
| Gains/(losses) of controlling interest |  |  |  |  | 0.4 | 0.4 | 0.5 | 0.9 |
| Tax on deemed dividends |  |  |  |  | (5.9) | (5.9) |  | (5.9) |
| Dividends paid |  |  |  | (1206.9) |  | (1206.9) | (482.4) | (1689.3) |
| Interest on shareholder´s equity |  |  |  | (6509.5) |  | (6509.5) |  | (6509.5) |
| Purchases of shares, results from treasury shares and share-based payments |  | 206.4 |  |  |  | 206.4 |  | 206.4 |
| Prescribed/(complementary) dividends |  |  |  | 26.1 |  | 26.1 |  | 26.1 |
| Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting (Note 22) |  |  |  | 11.8 | (11.8) |  |  |  |
| Fiscal incentive reserve |  |  | 1332.8 | (1332.8) |  |  |  |  |
| Investments reserve | - | - | 3713.0 | (3713.0) | - | - | - | - |
| **At December 31, 2020** | **57899.1** | **54985.6** | **25920.0** | **-** | **(64989.0)** | **73815.7** | **1335.5** | **75151.2** |

---

The accompanying notes are an integral part of these consolidated financial statements.

[**Table of Contents**](#toc)

**CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY**

**For the year ended December 31**

All amounts in millions of Brazilian Reais unless otherwise stated

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Attributable to equity holders of Ambev** | **Attributable to equity holders of Ambev** | **Attributable to equity holders of Ambev** | **Attributable to equity holders of Ambev** | **Attributable to equity holders of Ambev** | **Attributable to equity holders of Ambev** | | |
|  | **Capital** | **Capital reserves** | **Net income reserves** | **Retained earnings** | **Carrying value adjustments** | **Total** | **Non-controlling interests** | **Total equity** |
| **At January 1, 2021** | **57899.1** | **54985.6** | **25920.0** | **-** | **(64989.0)** | **73815.7** | **1335.5** | **75151.2** |
|  Net Income |  |  |  | 12671.0 |  | 12671.0 | 451.6 | 13122.6 |
| *Comprehensive income:* |  |  |  |  |  |  |  |  |
| Gains/(losses) on the translation of foreign operations |  |  |  |  | 2449.7 | 2449.7 | 108.3 | 2558.0 |
| Cash flow hedges |  |  |  |  | 480.8 | 480.8 | 0.5 | 481.3 |
| Actuarial gains/(losses) |  |  |  |  | 341.8 | 341.8 | (1.8) | 340.0 |
| **Total comprehensive income** | **-** | **-** | **-** | **12671.0** | **3272.3** | **15943.3** | **558.6** | **16501.9** |
| Capital increase (Note 22) | 143.4 | (134.4) |  |  |  | 9.0 |  | 9.0 |
| Effect of application of IAS 29 (hyperinflation) |  |  |  | 2063.7 |  | 2063.7 | 21.4 | 2085.1 |
| Options granted on subsidiaries |  |  |  |  | (1.9) | (1.9) |  | (1.9) |
| Gains/(losses) of controlling interest |  |  |  |  | (46.2) | (46.2) | 8.6 | (37.6) |
| Tax on deemed dividends |  |  |  |  | (1.7) | (1.7) |  | (1.7) |
| Dividends paid |  |  |  | (2099.5) |  | (2099.5) | (549.5) | (2649.0) |
| Interest on shareholder´s equity |  |  |  | (7400.1) |  | (7400.1) |  | (7400.1) |
| Purchases of shares, results from treasury shares and share-based payments |  | 336.0 |  |  |  | 336.0 |  | 336.0 |
| Prescribed/(complementary) dividends |  |  |  | 24.7 |  | 24.7 |  | 24.7 |
| Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting (Note 22) |  |  |  | 11.8 | (11.8) |  |  |  |
| Fiscal incentive reserve |  |  | 1423.5 | (1423.5) |  |  |  |  |
| Investments reserve | - | - | 3848.1 | (3848.1) | - | - | - | - |
| **At December 31, 2021** | **58042.5** | **55187.2** | **31191.6** | **-** | **(61778.3)** | **82643.0** | **1374.6** | **84017.6** |

---

The accompanying notes are an integral part of these consolidated financial statements.

[**Table of Contents**](#toc)

**CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY**

**For the year ended December 31**

All amounts in millions of Brazilian Reais unless otherwise stated

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Attributable to equity holders of Ambev** | **Attributable to equity holders of Ambev** | **Attributable to equity holders of Ambev** | **Attributable to equity holders of Ambev** | **Attributable to equity holders of Ambev** | **Attributable to equity holders of Ambev** | | |
|  | **Capital** | **Capital reserves** | **Net income reserves** | **Retained earnings** | **Carrying value adjustments** | **Total** | **Non-controlling interests** | **Total equity** |
| **At January 1, 2022** | **58042.5** | **55187.2** | **31191.6** | **-** | **(61778.3)** | **82643.0** | **1374.6** | **84017.6** |
|  Net Income | **-** |  |  | 14457.9 |  | 14457.9 | 433.3 | 14891.2 |
| *Comprehensive income:* |  |  |  |  |  |  |  |  |
| Gains/(losses) on the translation of foreign operations | **-** | **-** | **-** | **-** | **(6772.2)** | **(6772.2)** | **(91.0)** | (6863.2) |
| Cash flow hedges |  |  |  |  | (316.7) | (316.7) | (2.0) | (318.7) |
| Actuarial gains/(losses) |  |  |  |  | 466.5 | 466.5 | 4.2 | 470.7 |
| **Total comprehensive income** | **-** | **-** | **-** | **14457.9** | **(6622.4)** | **7835.5** | **344.5** | **8180.0** |
| Capital increase (Note 22) | 88.0 | (64.3) |  |  |  | 23.7 |  | 23.7 |
| Effect of application of IAS 29 (hyperinflation) |  |  |  | 3224.5 |  | 3224.5 | 9.2 | 3233.7 |
| Gains/(losses) of controlling interest |  |  |  |  | (2.8) | (2.8) | (0.3) | (3.1) |
| Tax on deemed dividends |  |  |  |  | (6.2) | (6.2) |  | (6.2) |
| Dividends paid |  |  |  |  |  |  | (357.4) | (357.4) |
| Interest on shareholder´s equity |  |  |  | (11999.8) |  | (11999.8) |  | (11999.8) |
| Purchases of shares, results from treasury shares and share-based payments |  | 216.8 |  |  |  | 216.8 | 1.6 | 218.4 |
| Prescribed/(complementary) dividends |  |  |  | 20.9 |  | 20.9 |  | 20.9 |
| Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting (Note 22) |  |  |  | 11.8 | (11.8) |  |  |  |
| Fiscal incentive reserve |  |  | 2018.6 | (2018.6) |  |  |  |  |
| Investments reserve | - | - | 3696.7 | (3696.7) | - | - | - | - |
| **At December 31, 2022** | **58130.5** | **55339.7** | **36906.9** | **-** | **(68421.5)** | **81955.6** | **1372.2** | **83327.8** |

---

The accompanying notes are an integral part of these consolidated financial statements.

[**Table of Contents**](#toc)

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

**For the year ended December 31**

All amounts in millions of Brazilian Reais unless otherwise stated

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Note** | **2022** | **2021** | **2020** |
| Net income |  | 14891.2 | 13122.6 | 11731.9 |
| Depreciation, amortization and impairment |  | 5956.3 | 5396.7 | 5167.4 |
| Impairment losses on receivables and inventory |  | 351.8 | 200.8 | 296.1 |
| Additions/(reversals) in provisions and employee benefits |  | 232.7 | 244.6 | 239.7 |
| Net finance costs | 11 | 3423.1 | 3205.4 | 2434.5 |
| Losses/(gains) on sale of property, plant and equipment and intangible assets |  | (88.8) | (142.8) | (78.8) |
| Equity-settled share-based payment expenses | 25 | 313.9 | 387.6 | 208.7 |
| Income tax expense | 12 | (655.6) | 636.6 | 1762.5 |
| Share of result of joint ventures |  | 29.1 | 115.7 | 43.3 |
| Hedge operations results |  | (466.6) | (1852.2) | (1769.9) |
| Other non-cash items included in profit |  | (17.4) | - | - |
| **Cash flow from operating activities before changes in working capital and use of provisions** |  | **23969.7** | **21315.0** | **20035.4** |
| (Increase)/decrease in trade and other receivables |  | (322.5) | 341.4 | (848.8) |
| (Increase)/decrease in inventories |  | (3088.0) | (3499.5) | (1303.4) |
| Increase/(decrease) in trade and other payables |  | 726.6 | 6157.5 | 3049.8 |
| **Cash generated from operations** |  | **21285.8** | **24314.4** | **20933.0** |
| Interest paid |  | (826.3) | (498.2) | (768.8) |
| Interest received |  | 1095.0 | 377.1 | 320.3 |
| Dividends received |  | 6.6 | 13.1 | 13.8 |
| Income tax paid |  | (919.0) | (1305.1) | (1642.5) |
| **Cash flow from operating activities** |  | **20642.1** | **22901.3** | **18855.8** |
| Proceeds from sales of property, plant and equipment and intangible assets |  | 133.9 | 301.7 | 108.0 |
| Proceeds from sales of subsidiaries' operations |  |  | 0.5 |  |
| Acquisitions of property, plant and equipment and intangible assets |  | (6533.1) | (7677.1) | (4692.7) |
| Acquisitions of subsidiaries, net of cash acquired |  | (3.0) | (133.8) | (431.5) |
| Acquisitions of other investments |  | (30.0) | (5.3) | (19.1) |
| Investments in short-term debt securities and net proceeds/(acquisitions) of debt securities |  | 1413.0 | (236.0) | (1764.3) |
| Net proceeds/(acquisitions) of other assets |  | 15.0 | 15.0 | - |
| **Cash flow from investing activities** |  | **(5004.2)** | **(7735.0)** | **(6799.6)** |
| Capital increase |  | 23.8 | 9.1 |  |
| Capital increase/(decrease) of non-controlling interest |  |  |  | 0.7 |
| Proceeds/(repurchases) of treasury shares |  | (54.1) | (44.2) | (7.4) |
| Acquisitions of non-controlling interest |  | (0.1) |  |  |
| Proceeds from borrowings |  | 274.9 | 315.2 | 3767.9 |
| Repayment of borrowings |  | (230.2) | (2454.0) | (2042.9) |
| Cash net of finance costs other than interests |  | (3255.1) | (2089.6) | (2971.5) |
| Payment of lease liabilities |  | (854.7) | (663.2) | (498.5) |
| Dividends and interest on shareholders' equity paid |  | (12242.3) | (11115.3) | (6850.3) |
| **Cash flow from financing activities** |  | **(16337.8)** | **(16042.0)** | **(8602.0)** |
| **Net increase/(decrease) in cash and cash equivalents** |  | **(699.9)** | **(875.7)** | **3454.2** |
| **Cash and cash equivalents less bank overdrafts at the beginning of the year** |  | **16597.2** | **17090.3** | **11900.7** |
| **Effect of exchange rate fluctuations on cash and cash equivalents** |  | **(1045.2)** | **382.6** | **1735.4** |
| **Cash and cash equivalents less bank overdrafts at the end of the year** |  | **14852.1** | **16597.2** | **17090.3** |

---

The accompanying notes are an integral part of these consolidated financial statements.

[**Table of Contents**](#toc)

**1.** **CORPORATE INFORMATION** 

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Description of business** 

Ambev S.A. (referred to as the "Company" or "Ambev") together with its subsidiaries (the "Group" or "Consolidated"), headquartered in São Paulo - SP, Brazil, has as its purpose, either directly or through participation in other companies, the production and sale of beer, draft beer, soft drinks, other non-alcoholic beverages, malt and food in general, as well as the advertising of its own and of third party products, the sale of promotional and advertising materials and the direct or indirect exploitation of bars, restaurants, snack bars and similar establishments, among others.

The Company's shares and American Depositary Receipts ("ADRs") are listed on the Brasil, Bolsa, Balcão S.A. ("B3") under the ticker "ABEV3" and on the New York Stock Exchange ("NYSE") under the ticker "ABEV", respectively.

The Company's direct controlling shareholders are Interbrew International B.V. ("ITW International"), AmBrew S.à.r.l ("Ambrew"), both of which are subsidiaries of Anheuser-Busch InBev N.V. ("AB InBev").

The consolidated financial statements were authorized for issue by the Board of Directors on March 15, 2023.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Major corporate events in 2022, 2021 and 2020** 

**Tax Credits - 2022**

After the decision of the Federal Supreme Court ("STF") in the judgment of RE 574,706/PR, rendered in 2017 and ratified in May 2021, which declared the unconstitutionality of the inclusion of the ICMS in the taxable base of PIS and COFINS, the General Attorney's Office ("PGFN"), with binding effects, ruled on the content and effects of this decision. The PGFN normative (PGFN Opinion 14,483/2021, which approved and complemented PGFN Opinion No. 12,943/2021) presented its understanding of the limits of the judgment and equated the procedures that must be observed by the Tax Administration in relation to the matter, especially with regard to issues related to the ICMS to be excluded from the taxable base of PIS and COFINS, temporal aspects regarding the applicability of the STF understanding (modulation of effects) and the impacts of said exclusion on the credits recorded by the purchasers upon acquisitions.

Considering the consolidation of PGFN's understanding on the subject with biding effects, with important clarifications regarding the content and effects of the decision rendered by the STF in the context of RE 574,706/PR, the Company carried out a set of analyses, with the support of its legal advisors and external consultants, with the purpose

[**Table of Contents**](#toc)

of deepening and exhausting all legal issues related to a specific portion of its transactions, which, as they involve transactions between subsidiaries, present greater complexity in terms of quantification of recoverable credit, notably considering aspects related to the system of non-cumulative calculation of PIS and COFINS within a Group structure.

Such analysis presented additional complexity when compared to the scenarios for recognition of credits resulting from exclusion of ICMS in the tax base of social contributions on gross revenues ("PIS and COFINS") previously registered by the Company, since it involves transactions with subsidiaries, as mentioned above, considering the necessity of combining the legal understandings referred to above with the specific taxation regime in which the Company is inserted.

In the second quarter of 2022, all relevant and necessary steps were concluded for the fulfillment of the requirements for the accounting recognition of the asset, including its measurement with reasonable assurance, the gathering of supporting documents and the quantification of the credit, the Company had its 2022 results positively impacted by an additional tax credit of R$1.2 billion.

With respect to the amount referred to above, R$0.9 billion was recorded in Other Operating Income, as described in Financial Statement Note 7 – *Other Operating Income/(Expenses),* and R$0.3 billion in Financial Income, as described in Note 11 – *Financial Expenses and Income*.

**COVID-19 pandemic impacts**

The impact of the pandemic on our operations and the restrictions imposed in response by national governments, especially since March 2020, have generated significant changes in market dynamics both in the off-trade sales channel, mainly comprised of supermarkets, and in the on-trade channel, which consists of bars and restaurants. In each case, the more severe the restrictions on the marketing and consumption of our products, the greater the reduction in volume, which is why Bolivia and Panama were the most affected countries, especially in the fiscal year 2021. On the other hand, we observed an increase in sales related to e-commerce in all countries, although this channel represents a small portion of the Company's total volume.

In early 2022, our operations, mainly in Brazil, were impacted by the spread of the Omicron variant of COVID-19, which, combined with factors such as unfavorable

[**Table of Contents**](#toc)

weather, negatively impacted our sales. From the second quarter on, with the progress of the vaccination programs and the greater control over the advance of the COVID-19 pandemic, there was a relaxation of the restrictions in the regions in which we operate, favoring the recovery of the on-trade channel, despite the uncertainty about how the consumption recovery will evolve in each of these territories.

In Brazil, the consistent implementation of the Company's strategy combined with the context of relaxed restrictions and the return of occasions for out-of-home consumption generated a positive volume trend, with growth in both volume and net revenue compared to the same period of 2021. In the event that circumstances related to the COVID-19 pandemic evolve, government authorities may implement emergency measures to mitigate the spread of the disease. The pandemic and corresponding mitigation measures may have an adverse impact on global economic conditions as well as the Company's business. The extent of the pandemic COVID-19 impact on the Company's business will depend on future developments, such as the duration of further outbreaks, any possible trade shutdowns and restrictions, and the effectiveness of actions taken in the regions where we operate and in other countries to contain and treat the disease. As such events are highly uncertain, the Company cannot determine their financial impact at this moment. Any adverse impacts could result in a material adverse effect on our business, liquidity, financial condition and results of operations. However, we continue to manage our cash and capital resources with discipline, and management concludes that there is no doubt about the Company's ability to continue operations.

As required by IAS 1 - *Presentation of Financial Statements*, the Company updated the analysis of the impact of COVID-19, as at December 31, 2022, which mainly involved, (i) a review of the assumptions of the annual impairment test, as described in Note 14 - *Goodwill*, (ii) an analysis of possible credit losses and inventory obsolescence, (iii) an analysis of the recoverability of deferred taxes, and (iv) the evaluation of the relevant estimates used for the preparation of the financial statements, among other analyses.

Any impacts arising from these analyses are reflected in the financial statements and disclosed in explanatory notes. In addition, due to the protective actions taken for its staff and the donations made by its community, the Company incurred exceptional expenses of R$16.7, at December 31, 2022, as reported in Note 8 - *Exceptional items*.

[**Table of Contents**](#toc)

**Share buyback program**

The Board of Directors, in a meeting held on March 18, 2021, approved, pursuant to article 30, 1<sup>st</sup> Paragraph, "b", of Law 6,404/76 and CVM Instruction 567/15 (revoked by CVM Resolution 77/22), a share buyback program of shares issued by the Company ("Program") up to the limit of 5,700,000 common shares, with the primary purpose of covering any share delivery requirements contemplated in the Company's share-based compensation plans or to be held in treasury, canceled and/or subsequently transferred. The program was closed in September 18, 2022, according to the deadline previously disclosed by the Company at the Material Fact disclosed to market on March 18, 2021. At the same date, the Company had 4,357,308,131 outstanding shares as defined in CVM Instruction 567/15 (revoked by CVM Resolution 77/22). The acquisitions occurred in 2022 and 2021 fiscal years as per a deduction of the capital reserve account recorded in the balance sheets dated as at December 31, 2022 and 2021, respectively. The transaction was carried out through the following financial institutions: UBS Brasil Corretora de Câmbio, Títulos e Valores Mobiliários S.A. and Itaú Corretora de Valores S.A.

**Renegotiation of Tenedora's shareholders agreement**

The Company and E. León Jimenes, S.A. ("ELJ"), as the shareholders of Tenedora CND, S.A. ("Tenedora"), a holding company headquartered in the Dominican Republic, the owner of almost the entire share capital of Cervecería Nacional Dominicana, S.A., on July 2, 2020, signed the second amendment to Tenedora's Shareholders Agreement (the "Shareholders Agreement"), extending their partnership in the country and postponing the terms of the put and call options defined in the original Agreement. ELJ is currently the owner of 15% of Tenedora's shares, and its put option is now divided into two tranches: (i) Tranche A, corresponding to 12.11% of the shares, exercisable in 2022, 2023 and 2024; and (ii) Tranche B, corresponding to 2.89% of the shares, exercisable starting in 2026. The Company, on the other hand, has a call option over the Tranche A shares exercisable starting in 2021 and over the Tranche B shares to be exercised starting in 2029.

At December 31, 2022, there were no exercises for these options. The details of the assumptions used for these options are described in Note 28 (Item IV (d)).

**Distribution agreement Cervecería Chile S.A.**

On August 16, 2020, Cervecería Chile S.A., a Chilean subsidiary of the Company, entered into a long-term distribution agreement with Embotelladora Andina S.A., Coca-Cola Embonor S.A. and Embotelladora Iquique S.A. (the "Distributors"), by which the Distributors were granted the right to sell and distribute certain products within the Company's portfolio, with exclusivity in specific zones and sales channels in Chile.

[**Table of Contents**](#toc)

**Addendum to the agreement with PepsiCo Bolivia**

The long-term agreement with PepsiCo, under which the Cervecería Boliviana Nacional, a subsidiary of the Company in Bolivia, has the exclusive right to produce, sell and distribute certain brands from PepsiCo's portfolio in Bolivia, was amended on June 1, 2020, extending the agreement for a further ten years and reflecting certain changes in the trade agreement between the parties.

**New acquisitions** 

On January 22, 2020, the company, through its subsidiary Labatt Brewing Company Limited, acquired G&W Distilling Inc., a company that produces a portfolio of ready-to-drink alcoholic beverages.

**Exchange contracts for future financial flows - Equity Swaps**

On May 13, 2020 and on December 9, 2020, the Board of Directors of Ambev approved equity-swap contracts, without impact on the liquidation, on the regulatory deadline, of the equity-swap contracts which were still in force. The settlement of these equity-swap contracts is to take place over a maximum term of 18 months from the date of approval, and such contracts may result to exposure of up to 65 million common shares (all or part of which may be in the form of ADRs), up to a value limit of R$1.0 billion and 80 million common shares (all or part of which may be in the form of ADRs), up to a value limit of R$1.2 billion, respectively. These contracts were settled during the year 2021, and on December 31, 2021, there is no balance or pending issue regarding these equity swap contracts.

**2.** **STATEMENT OF COMPLIANCE** 

The consolidated financial statements have been prepared using the going concern basis of accounting and are being presented in accordance with the International Financial Reporting Standards ("IFRS") issued by the International Accounting Standards Board ("IASB"), effective as at December 31, 2022 and disclose all (and only) the applicable significant information related to the financial statements, which is consistent with the information utilized by Management in the performance of its duties.

**3.** **SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES** 

There were no significant changes in the accounting policies and calculation methods used for the annual financial statements as at December 31, 2022 compared to those presented in the financial statements for the years ended December 31, 2021 and 2020.

[**Table of Contents**](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Basis of preparation and measurement** 

The financial statements are presented in millions of Brazilian Reais ("R$"), unless otherwise indicated, rounded to the nearest million. The measurement basis used in preparing the financial statements is the historical cost, net realizable value, fair value or recoverable amount.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Recently issued IFRS** 

The revised standards and new standards, which became effective in 2022 are not applicable or did not have any material impact for the Company for the preparation of these consolidated financial statements.

**Other Standards, Interpretations and Amendments to Standards** 

There are no other Standards, Interpretations and/or Amendments to Standards that are not in force and that the Company expects to have a material impact resulting from their application in the consolidated financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Consolidated financial statements** 

The financial statements of subsidiaries, joint arrangements and associates used in these consolidated financial statements are prepared for the same reporting period as Ambev, using a consistent accounting policy.

All intercompany transactions, balances and unrealized gains or losses on transactions between group companies have been eliminated.

**Subsidiaries**

The Company controls an entity when it is exposed to or has rights to variable returns due to its involvement with the entity, and it is able to affect those returns through its power over the entity. When assessing control, potential voting rights are considered. Control is presumed to exist where the Company owns, directly or indirectly, more than half of the voting rights (which does not always equate to economic ownership), unless it can be demonstrated that such ownership does not confer control.

Subsidiaries are consolidated from the date on which control is obtained by the Company, except when the predecessor basis of accounting is applied to transactions of business combinations under common control. Consolidation is discontinued from the date on which control ceases.

Ambev uses the purchase method to account for its business combinations. The consideration transferred for the acquisition of a subsidiary represents the fair value of the assets transferred, the liabilities incurred, and the equity interest issued by Ambev.

[**Table of Contents**](#toc)

The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration agreement, when applicable. Costs related to the acquisition are recognized in income as they are incurred. Assets, liabilities and contingent liabilities acquired or assumed in a business combination are recognized initially at their fair value as at the acquisition date. Ambev recognizes the non-controlling interest in the acquiree, either at its fair value or at the non-controlling interest's proportional share of the net assets acquired. The measurement of the non-controlling interest to be recognized is determined for each acquisition.

The excess of: (i) the consideration paid; plus (ii) the amount of any non-controlling interests in the acquiree (when applicable); and (iii) the fair value, at the acquisition date, of any previous equity interest in the acquiree, over the fair value of the net identifiable assets acquired, at the date of acquisition, is recorded as goodwill. When the consideration transferred is less than the fair value of the net assets acquired, the difference is recognized directly in income.

All intercompany transactions, balances and unrealized gains and losses on transactions between group companies have been eliminated. Unrealized losses are eliminated in the same way as unrealized gains, but only to the extent that there is no evidence of impairment.

**Associates**

Associates are companies which the Company has significant influence over the financial and operational policies but does not control.

The list of main associates and subsidiaries are disclosed in note 32 - *Group Companies*

**Joint arrangements**

Joint arrangements are all entities over which the Company shares control with one or more parties. Joint arrangements are classified either as joint operations or joint ventures depending on the contractual rights and obligations of each investor.

**Business combination between entities under common control**

Business combinations between entities under common control have not been addressed under IFRS how they should be disclosed remains unclear. IFRS 3 - *Business Combinations* is the standard applicable to business combinations, but its scope explicitly excludes business combinations between entities under common control, thus, in evaluating transactions of this nature, Management's judgment is required to adequately reflect the essence and economic reality of each transaction.

**i) Predecessor basis of accounting**

In accordance with IAS 8, Management has adopted the predecessor basis of accounting, which is consistent with United States Generally Accepted Accounting Principles ("USGAAP") and United Kingdom Generally Accepted Accounting Principles ("UKGAAP"), to record the carrying amount of the asset received, as recorded by the parent company.

[**Table of Contents**](#toc)

Under the predecessor basis of accounting, when accounting for a transfer of assets between entities under common control, the entity that receives the net assets or the equity interests (the acquirer) shall initially record the assets and liabilities transferred at their parent book value as at the transfer date. If the book value of the assets and liabilities transferred by the parent is different from the historical cost recorded by the controlling entity of the entities under common control (the ultimate parent), the financial statements of the acquirer shall reflect the assets and liabilities transferred at the same cost of the ultimate parent, as a counter-entry to shareholders' equity against the carrying value adjustments.

**ii) Assets Swap**

For transactions between entities under common control that involve the disposal or transfer of assets from the subsidiary to its parent company (i.e. above the level of the consolidated financial statements), the Company assesses the existence of: (i) any conflicts of interest; and (ii) the economic substance and purpose of the transaction. Having fulfilled these assumptions, the Company adopted as a policy the concepts of IAS 16 in order to provide adequate visibility and a fair impact on the amount of distributable results to its shareholders, specially the non-controlling interest. This policy also includes assets acquired through the swapping of non-cash assets, or swaps with a combination of cash and non-cash assets. The assets swapped may be of the same or a different nature. The cost of such assets is measured at fair value, unless: (i) the swap transaction is not commercial in nature; or (ii) the fair value of the asset received (and the asset assigned) cannot be reliably measured. The acquired asset is measured in this way even if the assignor entity cannot immediately remove the asset from its books. If the acquired asset is not measurable at fair value, its cost is determined based on the book value of the assigned asset.

Whenever assets distributed are not recorded as cash, the asset, before distribution, is recorded at its fair value in the income account. This procedure is applicable to distributions where the assets are of the same nature and therefore can be treated equally. However, similarly to IFRIC 17, in the absence of a specific accounting practice for transactions under common control, the Company applies these procedures as part of its accounting practices. We also apply the same procedures to sales (products, supplies, etc.) to its controlling entity, where the positive result of the sale is recognized in income.

&nbsp;&nbsp;&nbsp;&nbsp;**(d)** **Foreign currency translation** 

**Functional and presentation currency**

The items included in the financial statements of each subsidiary of the Company are measured using the currency of the primary economic environment in which the entity operates (the "functional currency").

[**Table of Contents**](#toc)

The functional and presentation currency of the Company financial statements is the Brazilian Real.

**Transactions and balances**

Foreign currency transactions are accounted for at the exchange rates prevailing as at the dates of the transactions. Monetary assets and liabilities denominated in foreign currencies are translated using the balance sheet date rate. Non-monetary assets and liabilities denominated in foreign currencies are translated at the foreign exchange rate prevailing as at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currencies stated at fair value are translated at the exchange rate in force as at the date on which the fair value was determined. Gains and losses arising from the settlement of transactions in foreign currencies and resulting from the conversion of assets and liabilities denominated in foreign currencies are recognized in the income statement.

Foreign exchange gains and losses related to loans and cash and cash equivalents are presented in the statement of income as finance expenses or finance income.

**Conversion of the financial statements of subsidiaries located abroad**

Assets and liabilities of subsidiaries located abroad are translated at the foreign exchange rates prevailing at the balance sheet date, while amounts from the income statement and cash flow are translated at the average exchange rate for the year, and changes in equity are translated at the historical exchange rate of each transaction. Translation adjustments arising from the difference between the average exchange rates and the historical rates are recorded directly in carrying value adjustments.

Upon consolidation, exchange differences arising from the translation of equity in foreign operations and borrowing and other currency instruments designated as net investment hedges are recognized in carrying value adjustments, an equity reserve, and included in other comprehensive income.

Even when recorded in the acquiring entity, the goodwill and fair value adjustments arising from the acquisition of a foreign entity are treated as assets and liabilities of the foreign entity and are translated at the foreign exchange rate at the balance sheet date.

**Net investments in foreign operations**

An entity may have a monetary item receivable from or payable to a foreign operation, the settlement of which is neither planned nor likely to occur in the foreseeable future, and which does not include trade receivables or trade payables. Exchange differences arising shall be recognized initially in other comprehensive income and reclassified from equity to profit or loss upon the disposal of the net investment.

[**Table of Contents**](#toc)

**Financial reporting in hyperinflationary economies**

Under IAS 29, the non-monetary assets and liabilities, the equity and the income statement of subsidiaries operating in hyperinflationary economies are restated to reflect changes in the general purchasing power of the local currency by applying a general price index. The financial statements of an entity whose functional currency is the currency of a hyperinflationary economy, whether using the historical costs approach or the current costs approach, shall be stated in terms of the unit of measurement in force at the end of the reporting period, and translated into Reais at the closing rate for the period.

**Exchange rates**

The most significant exchange rates used for the preparation of the Company's financial statements are as follow:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | | **Closing rate** | **Closing rate** | **Closing rate** | **Average rate** | **Average rate** | **Average rate** |
| <br>**Currency** | <br>**Name** | <br>**Country** | **2022** | **2021** | **2020** | **2022** | **2021** | **2020** |
| CAD | Canadian Dollar | Canada | 3.8540 | 4.3914 | 4.0791 | 3.9807 | 4.2960 | 3.6414 |
| DOP | Dominican Peso | Dominican republic | 0.0925 | 0.0970 | 0.0891 | 0.0937 | 0.0938 | 0.0885 |
| USD | US Dollar | Panamá and Cuba | 5.2177 | 5.5805 | 5.1967 | 5.1644 | 5.3687 | 4.9348 |
| GTQ | Quetzal | Guatemala | 0.6623 | 0.7201 | 0.6700 | 0.6649 | 0.6954 | 0.6405 |
| ARS | Argentinean Peso | Argentina | 0.0295 | 0.0543 | 0.0618 | 0.0403 | 0.0568 | 0.0750 |
| BOB | Bolivian Peso | Bolivia | 0.7497 | 0.8018 | 0.7467 | 0.7420 | 0.7714 | 0.7090 |
| PYG | Guarani | Paraguay | 0.0007 | 0.0008 | 0.0007 | 0.0007 | 0.0008 | 0.0007 |
| UYU | Uruguayan Peso | Uruguay | 0.1302 | 0.1249 | 0.1227 | 0.1253 | 0.1236 | 0.1218 |
| CLP | Chilean Peso | Chile | 0.0061 | 0.0066 | 0.0073 | 0.0059 | 0.0071 | 0.0062 |
| BBD | Barbadian Dollar | Barbados | 2.5721 | 2.7510 | 2.5618 | 2.5458 | 2.6465 | 2.4326 |

---

&nbsp;&nbsp;&nbsp;&nbsp;**(e)** **Segment reporting** 

Reportable segments are identified based on the internal reporting regularly reviewed by the chief operating decision maker of the Company, the Chief Executive Officer, for the purpose of evaluating the performance of each segment and allocating resources to those segments. Accordingly, segment information is presented by geographical area, since the risks and rates of return are affected predominantly by the fact that the Company operates in different regions.

Performance information by business unit (Beer and Non-alcoholic beverages ("NAB")), is also presented to the Company's chief decision maker and is disclosed as additional information, even though it does not qualify as a segment.

The Company conducts its operations across four business segments, as follow:

[**Table of Contents**](#toc)

▪ Brazil, where the Company operates two business subunits: (i) beer and (ii) non-alcoholic beverages (NAB);

▪ Central America and Caribbean ("CAC"), which includes direct operations in the Dominican Republic, Saint Vincent, Antigua, Dominica, Cuba, Guatemala (which also serves El Salvador, Nicaragua and Honduras), Barbados and Panama;

▪ Latin America South (LAS), which includes operations in Argentina, Bolivia, Chile, Paraguay and Uruguay; and

▪ Canada, represented by the operations of Labatt Brewing Company Ltd.

&nbsp;&nbsp;&nbsp;&nbsp;**(f)** **Revenue recognition** 

The Company recognizes revenue when the amount of revenue can be measured reliably and it is probable that the economic benefits associated with the transaction will flow to the Company, as described below.

Revenue represents the fair value of the amount received or receivable upon the sale of products or the rendering of services in the ordinary course of business. Revenue is presented net of taxes, returns, rebates and discounts, as well as net of the elimination of sales between group companies.

**Goods sold**

Revenue is measured based on the consideration which the Company expects to have the right to receive in contracts with customers and excludes amounts collected on behalf of third parties.

Revenue recognition is based on the five-step approach of IFRS 15 - "Revenue from Contracts with Customers":

&nbsp;&nbsp;&nbsp;&nbsp;· Identification of the contract with a customer;

&nbsp;&nbsp;&nbsp;&nbsp;· Identification of the performance obligations in the contract;

&nbsp;&nbsp;&nbsp;&nbsp;· Determination of the transaction price;

&nbsp;&nbsp;&nbsp;&nbsp;· Allocation of the transaction price to the performance obligations in the
contracts; and

&nbsp;&nbsp;&nbsp;&nbsp;· Revenue recognition when the performance obligations have been satisfied,
meaning when the company transfers control of a product to a customer.

[**Table of Contents**](#toc)

Revenue from the sale of goods is measured at the amount that reflects the best estimate of the consideration expected to be received in exchange for those goods. Contracts can include significant variable elements, such as discounts, rebates, refunds, credits, price concessions, incentives, performance bonuses and penalties. These trade incentives are treated as variable considerations. If the consideration includes a variable component, the company estimates the amount of consideration to which it will be entitled for transferring the promised goods or services to the customer. A variable consideration is only included in the transaction price if it is highly probable that the amount of revenue recognized would not be subject to significant future reversals when the respective uncertainty is resolved.

**Finance income**

Finance income consists of interest received or receivable on funds invested, monetary updates arising from legal disputes, foreign exchange gains, gains on currency hedging instruments intended for offsetting currency losses, gains on hedging instruments that are not part of a hedge accounting relationship, gains on financial assets classified as at fair value through profit or loss, and as any gains due to hedge ineffectiveness.

Interest income is recognized on an accruals basis unless collectability is in doubt.

&nbsp;&nbsp;&nbsp;&nbsp;**(g)** **Expenses** 

**Finance expenses**

Finance expenses comprise interest payable on borrowing, calculated using the effective interest rate method, present value adjustment for trade payables, foreign exchange losses, losses on currency hedging instruments intended for the offsetting of currency gains, results on interest rate hedging instruments, losses on hedging instruments that are not part of a hedge accounting relationship, losses on financial assets classified as held for trading, impairment losses on financial assets classified as available for sale, and any losses due to hedge ineffectiveness.

All interest costs incurred in connection with borrowing or financial transactions are expensed as incurred as part of finance expenses, except when capitalized. Any difference between the initial amount and the maturity amount of interest-bearing loans and borrowing, such as transaction costs and fair value adjustments, are recognized in the income statement over the expected life of the instrument based on the effective interest rate method. The interest expenses component of finance lease payments is also recognized in the income statement using the effective interest rate method.

[**Table of Contents**](#toc)

**Royalty expenses**

Royalties are classified as cost of goods sold.

&nbsp;&nbsp;&nbsp;&nbsp;**(h)** **Exceptional items** 

Exceptional items are those that, because of their peculiarities, in Management's judgment need to be disclosed separately. In determining whether an event or transaction is exceptional, Management considers quantitative as well as qualitative factors such as the frequency or predictability of occurrence, and the potential impact on the variations in profit or loss. These items are disclosed in the income statement or separately disclosed in the notes to the financial statements. Transactions that may give rise to exceptional items are principally restructuring activities, amnesties, acquisitions of subsidiaries, impairment losses, and gains or losses on disposal of assets and investments.

&nbsp;&nbsp;&nbsp;&nbsp;**(i)** **Income tax and social contribution** 

Income tax and social contribution for the year comprises current tax and deferred tax. Income tax and social contribution are recognized in the income statement, unless they relate to items recognized directly in comprehensive income or other equity accounts. In these cases, the tax effect is also recognized directly in comprehensive income or equity account (except interest on shareholder's equity. See Note 3 (q)).

The current tax expense is the expectation of payment on the taxable income for the year, using tax rates enacted, or substantially enacted, at the balance sheet date, and any adjustment to tax payable in respect of previous years.

Deferred taxes are recognized using the balance sheet liability approach. This means that a deferred tax liability or asset is recognized for all taxable and tax-deductible temporary differences between the tax and accounting basis of assets and liabilities. Under this method, a provision for deferred taxes is also calculated on the differences between the fair value of assets and liabilities acquired in a business combination and their tax basis. IAS 12 prescribes that no deferred tax liability on goodwill recognition, and no deferred tax asset/liability is recorded: (1) at the initial recognition of an asset or liability in a transaction other than a business combination that at the time of the transaction affects neither accounting nor taxable profit or loss and (2) on differences related to investments in subsidiaries to the extent that they are not reversed in the foreseeable future. The amount of deferred tax provided is based on the expectation of the realization or settlement of the temporary difference, using currently or substantially enacted tax rates. Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax liabilities and assets, and they relate to income taxes levied by the same tax authority on the same taxable entity, or on different taxable entities which intend either to settle current tax liabilities and assets on a net basis, or to realize the assets and settle the liabilities simultaneously.

The deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available. The deferred income tax asset is reduced to the extent that it is no longer probable that the future taxable benefit will occur.

[**Table of Contents**](#toc)

Furthermore, the Company applies the provisions of IFRIC 23 - Uncertainty on the Treatment of Income Taxes, in relation to the treatments that affected the calculation of income taxes (uncertain tax treatments), as disclosed in note 30 – *Contingencies* – Uncertainties about treatment of IRPJ and CSLL.

&nbsp;&nbsp;&nbsp;&nbsp;**(j)** **Property, plant and equipment** 

Property, plant and equipment are measured at cost less accumulated depreciation and impairment losses. The cost includes the purchase price, borrowing costs incurred during the construction period and any other costs directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management (e.g. nonrefundable tax, transportation and the costs of dismantling, removal and site restoration, if applicable). The cost of a self-constructed asset is determined using the same principles as an acquired asset. The depreciation methods, residual value, and the useful lives are reassessed and adjusted if appropriate, on an annual basis.

Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets are capitalized as part of the cost of such assets.

Land is not depreciated since it is deemed to have an indefinite useful life.

Property, plant and equipment, and depreciation include the effects of using the predecessor basis of accounting (Note 3 (c)).

**Subsequent expenditure**

The Company recognizes in the carrying amount of an item of property, plant and equipment the cost of replacing a component of such an item if it is probable that the future economic benefits of the component will flow to the Company and the cost of the component can be measured reliably. All other costs are expensed as incurred.

**Depreciation**

The depreciable amount is the cost of an asset less its residual value. The residual values, if significant, are reassessed annually. Depreciation is calculated from the date on which the asset is available for use, using the straight-line method over the estimated useful lives of the assets. The right-of-use assets are depreciated over the term of each contract.

[**Table of Contents**](#toc)

The estimated useful lives of the major classes of property, plant and equipment are as follows:

---

| | |
|:---|:---|
| &nbsp;&nbsp;Buildings | &nbsp;&nbsp;25 years |
| &nbsp;&nbsp;Plant and equipment | &nbsp;&nbsp;15 years |
| &nbsp;&nbsp;Fixtures | &nbsp;&nbsp;10 years |
| &nbsp;&nbsp;Fittings | &nbsp;&nbsp;10 years |
| &nbsp;&nbsp;Assets for external use / commercial assets | &nbsp;&nbsp; 2 - 5 years |

---

The assets' residual values and useful lives are reviewed when necessary. Management uses its judgment to assess and ascertain the useful lives of these assets.

**Gains and losses on sale**

Gains and losses on sales are determined by comparing the results with the carrying amounts and are recognized in other operating income/(expenses) in the income statement.

**Leases**

With the adoption of IFRS 16 – *Leasings*, the Company began to recognize a right-of-use asset and a liability at the date of the beginning of the lease term.

The Company recognizes the right-of-use asset and a corresponding lease liability related to all lease contracts which is the lessee, except for short-term leases (defined as leases with terms of 12-month or less) and leases of low value assets, that comprehend goods with value equal or below US$5,000.00. To these leases, the Company recognizes the lease payments as operating expense during the lease course.

Currently, the main leases by the Company are related to trucks, forklifts, real estate, commercial vehicles and industrial equipment contracts.

The lease liability is initially measured at lease payments present value, discounted by using the rate implicit in the lease. If the rate cannot be promptly determined, the Company uses its incremental loan rate specific for the country, deadline and currency of the contract or other local criteria.

Lease payments include fixed payments, less any lease incentives, variable lease payments that depend on an index or known rate at the commencement date, and purchase options or extension options payments if the Company is reasonably certain to exercise these options. All contracts establish an annual readjustment of payments according to the rates established in the contract.

[**Table of Contents**](#toc)

A lease liability is remeasured upon a change in the lease term or on the future payments and the corresponding adjustment is also made in right-of-use assets.

The Company applies IAS 36 to determine if right-of-use asset are subject to impairment and to record eventual losses by impairment.

The lease liability is disclosed in the "Interest-bearing loans and borrowing" line and the right-of-use assets are disclosed in the "Property, plant and equipment" line of the balance sheet.

&nbsp;&nbsp;&nbsp;&nbsp;**(k)** **Goodwill** 

Goodwill arises on acquisitions of subsidiaries, associates, and joint arrangement and it is determined as the excess between the sum of (i) the consideration paid in exchange for control of the acquiree; plus (ii) the amount of any non-controlling interests in the acquiree (when applicable); and (iii) the fair value, at the acquisition date, of any previous equity interest in the acquiree, over the fair value of the net identifiable assets acquired and liabilities assumed, measured in accordance with IFRS 3 - "Business Combinations" as at the date of acquisition. All business combinations are accounted for using the purchase method.

In compliance with IFRS 3 - "Business Combinations", goodwill is carried at cost and not amortized, but is tested for impairment at least annually, or whenever there are indications that the cash generating unit ("CGU") to which the goodwill has been allocated could be impaired. Impairment losses recognized on goodwill are not reversed. Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold.

Goodwill is expressed in the functional currency of the CGU or joint operation to which it relates and translated into Reais using the year-end exchange rate.

If the Company's interest in the net fair value of the identifiable assets, liabilities and contingent liabilities recognized exceeds the costs of the business combination, such excess is recognized immediately in the income statement.

Expenditure on internally generated goodwill is expensed as it is incurred.

Goodwill includes the effects of applying the predecessor basis of accounting (Note 3 (c)).

For associates and joint ventures, goodwill is included in the carrying amount of the investment in the associate/joint venture.

[**Table of Contents**](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;**(l)** **Intangible assets** 

**Brands**

When a portion of the consideration paid in a business combination relates to brands, this is recognized in a specific intangible assets account, and measured at fair values as at the acquisition date. Subsequently, the value of brands can be reduced in the case of impairment losses. Internally generated expenditure for brand development is recognized within expenses.

**Software**

Purchased software is measured at cost less accumulated amortization. Amortization related to software is included in the cost of sales, commercial expenses or administrative expenses, based on the business activity which the software is intended to support.

The expenditures related to software maintenance are recognized as expense, as incurred. The expenditures with development, as the expenditures with employees allocated in software development, which are directly attributed to identifiable and exclusive software, controlled by the Company, are recognized as intangible assets.

**Commercial intangibles**

The Company records supply rights, which consists in the Company's right to supply a customer and the customer's commitment to purchase the Company's products, and distribution rights which are the rights to sell specific products in a certain territory.

**Other intangible assets**

Other intangible assets, acquired by the Company, including multi-year sponsorship rights, are measured at cost less accumulated amortization and impairment losses.

**Amortization**

Intangible assets with definite useful lives are amortized on a straight-line basis over their estimated useful lives. Licenses, supply, and distribution rights are amortized over the period for which the rights exist, based on the contract terms, which vary, in general, from 1 to 8 years. Brands are considered to have indefinite lives, and therefore, are not amortized. Software and capitalized development costs related to technology are amortized over a period of 3 to 5 years.

Items that are not amortized are tested for impairment on an annual basis.

[**Table of Contents**](#toc)

**Gains and losses on sale**

Net gains on sale of intangible assets are presented in the income statement as other operating income. Net losses on sale are included as other operating expenses. Net gains and losses are recognized in the income statement when the control has been transferred to the buyer, recovery of the consideration is probable, the associated costs can be estimated reliably.

**(m) Recognition of assets and liabilities relating to extemporaneous tax debits or credits**

The accounting policy applied by the Company considers the extemporaneous tax credits and debits of any nature as determined by IAS 37 - *Provisions, Contingent Liabilities and Contingent Assets*, except for income taxes, which the Company applies the policy disclosed in item (i) – *Income tax and social contribution* of this note.

Credits are recognized only when Management has elements that guarantee (i) that the credit is virtually certain; and (ii) the amount could be estimated with sufficient reliability to enable it to be compensated or refunded. In cases where the recovery of the asset is probable, or the amount cannot be reliably measured, the amounts are not recognized in the account, but presented in Note 30 - *Contingencies* related to contingent assets. Management understands that, in cases of lawsuits involving contingent assets, a final and unappealable decision on the specific lawsuit of the Company is required to confirm the existence of its rights, except where specific circumstances pertinent to the case allow the recognition of its rights with sufficient objectivity and reliability.

Debits are recognized only when (i) these are based on a past event; (ii) there is a present obligation arising from this past event; (iii) it is probable that an outflow of resources will be required; and (iv) the amount can be estimated sufficiently reliably. If the expected disbursement is possible, or the amount cannot be sufficiently reliably measured, the amounts are presented in Note 30 - Contingencies.

Contingent assets and liabilities are assessed periodically to ensure that they are appropriately reflected and disclosed in the financial statements.

From October 1, 2020, the accounting policy for the recognition of assets and liabilities of extemporaneous tax credits and debits of any nature to record as "Other operating income/(expenses)", with an exception for amnesty payments, accounted for as exceptional items, given their one-off nature.

&nbsp;&nbsp;&nbsp;&nbsp;**(n)** **Inventory** 

Inventory is initially recorded at the acquisition cost and subsequent valued at the lower of their cost and net realizable value. Cost includes expenditure incurred to acquire the

[**Table of Contents**](#toc)

inventory and bring it to the location and condition required for use. The weighted average method is used to determine the cost of inventory.

The cost of finished products and work in progress includes raw materials, other production materials, direct labor, other direct costs, gains and losses on derivative financial instruments, and an allocation of fixed and variable overheads based on the normal operating capacity. Fixed costs not allocated or idle costs not held in inventory, are recognized directly in the income statement, as determined by IAS 2.

The amount of inventory is reduced on a case-by-case basis if the anticipated net realizable value declines below the carrying amount. The net realizable value is the estimated selling price in the ordinary course of business, less the costs of bringing the inventory to the condition required for sale, and the selling costs.

The calculation of the net realizable value takes into consideration the specific characteristics of each category of inventory, such as the expiry date, the remaining shelf life, and any indicators of slow-moving inventory, amongst others.

Provisions for impairment losses are constituted, when necessary, in compliance with write-offs, slow moving and obsolete inventory of the Company's policies.

&nbsp;&nbsp;&nbsp;&nbsp;**(o)** **Trade receivables** 

Trade receivables are amounts due from customers for goods sold or services performed in the ordinary course of business. Trade receivables are recognized initially at the amount of the unconditional consideration, unless they contain significant financing components, in which case they are recognized at fair value. The Company holds trade receivables with the objective of collecting the contractual cash flow, and therefore measures them subsequently at amortized cost using the effective interest rate method.

The Company applies the IFRS 9 simplified approach to measuring expected credit losses whereby impairment allowances for trade receivables are measured upon initial recognition on the basis of the expected 12-month credit losses. This is primarily based on past experience of credit losses, current data on overdue receivables and credit score information. Prospective information (such as forecast economic performance indicators) is also taken into consideration if, based on past experience, such indicators show a strong correlation with actual credit losses. Typically trade receivables which are outstanding for more than 90 days are fully provisioned.

Other assets are mainly composed of loans to customers, cash deposits on guarantees and tax receivables. These instruments are initially recognized at fair value and subsequently measured at amortized cost. Any impairment losses and foreign exchange results are directly recognized in profit or loss.

[**Table of Contents**](#toc)

If the receivable term is equivalent to one year or less, the accounts receivable are classified as current assets. Otherwise, they are presented as non-current assets.

&nbsp;&nbsp;&nbsp;&nbsp;**(p)** **Cash and cash equivalents** 

Cash and cash equivalents include all cash balances, bank deposits, and short-term highly liquid investments with an insignificant risk of changes in value which are readily convertible into cash. They are stated at their face value, which approximates the fair value.

For the purpose of the cash flow statement, cash and cash equivalents are presented net of bank overdrafts, when applicable.

&nbsp;&nbsp;&nbsp;&nbsp;**(q)** **Equity** 

**Issued capital**

The Company's issued capital consists only of common shares.

**Repurchase of shares**

When the Company repurchases its own shares, the amount paid, including any directly attributable additional costs is recognized as deductions from equity attributable to shareholders, in the line item "treasury shares".

**Share issuance costs**

Incremental costs directly attributable to the issuance of new shares or options are presented in equity as a deduction, net of tax, from the proceeds.

**Dividends and interest on shareholder's equity**

Dividends and interest on shareholders' equity are recognized in liabilities from the date on which they are approved by a Board of Directors' Meeting, except for the minimum statutory dividends provided for under the Company's bylaws, which are recognized as a liability, when applicable, at the end of each fiscal year.

The interest expense attributable to capital to shareholders is recognized in income for the purposes of the calculation of Brazilian income and social contribution tax, and is subsequently reclassified from shareholders' equity for presentation purposes in the financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;**(r)** **Interest-bearing loans and borrowings** 

[**Table of Contents**](#toc)

Interest-bearing loans and borrowing are recognized initially at fair value less attributable transaction costs. Subsequent to their initial recognition, interest-bearing loans and borrowing are stated at amortized cost, with any differences between the initial and maturity amounts recognized in the income statement over the expected life of the instrument on an effective interest rate basis.

Borrowing costs directly related to the acquisition, construction or production of a qualifying asset which requires a substantial period of time to prepare for its intended use or sale, are capitalized as part of the cost of that asset when it is probable that the future economic benefits associated with the item will flow to the Company, and the costs can be measured reliably. Other borrowing costs are recognized as finance expenses in the period in which they are incurred.

&nbsp;&nbsp;&nbsp;&nbsp;**(s)** **Employee benefits** 

**Post-employment benefits**

Post-employment benefits include pensions managed in Brazil by Instituto Ambev de Previdência Privada ("IAPP"), post-employment dental benefits and post-employment medical benefits managed by Fundação Zerrenner. Usually, pension plans are funded by payments made by both the Company and its participants, considering the recommendations of independent actuaries. Post-employment dental benefits and post-employment medical benefit obligations are funded using the returns on the assets of the Fundação Zerrenner plan. If necessary, the Company may contribute some of its profits to Fundação Zerrenner.

The Company manages defined benefit and/or defined contribution plans and/or medical and dental assistance plans for the employees of its companies located in Brazil and its subsidiaries located in the Dominican Republic, Barbados, Panama, Uruguay, Bolivia, Argentina and Canada.

The Company maintains both funded and unfunded plans.

**s.1) Defined contribution plans**

A defined contribution plan is a pension plan under which the Company pays fixed contributions into a fund. The Company has no legal or constructive obligations to pay further contributions if the fund does not hold sufficient assets to pay all employees for the benefits relating to their service in the current and prior periods.

The contributions to these plans are recognized as expenses in the period during which they are incurred.

**s.2) Defined benefit plans**

[**Table of Contents**](#toc)

Typically, defined benefit plans define an amount of pension benefit that an employee will receive upon retirement, usually dependent on one or more factors such as age, years of service and compensation level.

For defined benefit plans, expenses are assessed separately for each plan using the projected credit unit method. The projected credit unit method takes into account that each period of service gives rise to an additional unit of benefit and measures each such unit separately. Based on this method, the cost of providing pensions is charged to the income statement over the period of service of the employee. The amounts charged to the income statement consist of current service costs, interest costs, past service costs and the effect of any agreements and settlements. The obligations of the plan recognized in the balance sheet are measured at the present value of the estimated future cash outflows using a discount rate equivalent to the government´s bond rates with maturity terms similar to those of the respective obligation and the fair values of the plan assets.

Past service costs arise from the introduction of a new plan or changes to an existing plan. They are recognized immediately in the income statement, at the earlier of: (i) when the settlement/curtailment occurs; or (ii) when the Company recognizes the related restructuring or termination costs, unless those changes are conditional upon the employee's continued employment, for a specific period of time (the period in which the rights are acquired). In such cases, past services costs are amortized using the straight-line method over the period during which the rights were acquired.

Actuarial gains and losses consist of the effects of differences between the previous actuarial assumptions and the actual results, and the effects of changes in actuarial assumptions. Actuarial gains and losses are fully recognized in carrying value adjustments.

Remeasurements, representing actuarial gains and losses, the effect of the asset ceiling and the return on plan assets, both excluding net interest, are recognized in full in the period in which they occur in the statement of comprehensive income. Remeasurements are not reclassified to profit or loss in subsequent periods.

When the amount of the defined benefit obligation is negative (an asset), the Company recognizes those assets (prepaid expenses), to the extent of the value of the economic benefit available to the Company either from refunds or reductions in future contributions.

**Other post-employment obligations**

The Company and some of its subsidiaries provide post-employment medical benefits, the reimbursement of medication expenses and other benefits to certain retirees. These benefits are not granted to new retirees. The expected costs of these benefits are

[**Table of Contents**](#toc)

recognized over the period of employment, using an accounting methodology like that for defined benefit plans, including actuarial gains and losses.

**Termination benefits**

Termination benefits are recognized as expenses at the earlier of: (i) when the Company is demonstrably committed, without a realistic possibility of withdrawal, to a formal detailed plan to terminate employment before the normal retirement date; and (ii) when the Company recognizes costs related to restructuring.

**Bonuses**

Bonuses granted to employees and managers are based on pre-defined company and individual target achievement. The estimated amount of the bonus is recognized as an expense in the period during which the bonus is earned.

&nbsp;&nbsp;&nbsp;&nbsp;**(t)** **Share-based payments** 

Different share and share option programs allow management and other members appointed by the Board of Directors and People Committee, as each case, to acquire shares in the Company as in Note 25 - *Share-based payments*.

&nbsp;&nbsp;&nbsp;&nbsp;**(u)** **Trade payables** 

Trade payables are recognized initially at their fair values and subsequently at amortized cost using the effective interest method. When relevant, trade payables values are adjusted by their present value, considering the following assumptions to calculation: (i) the amount to be discounted; (ii) the settlement dates; and (iii) the discount rate, in accordance with IFRS 13.

**(v)** **Provisions and contingent liabilities**

Provisions are recognized when: (i) the Company has a present obligation (legal or constructive) as a result of past events; (ii) it is likely that a future disbursement will be required to settle the current obligation; and (iii) the amount of the obligation can be estimated reliably.

Provisions, except for those mentioned in the line item Disputes and litigation, are determined by discounting the expected future cash flow, to a pre-tax rate, which reflects the current market assessments of the time value of money and, where appropriate, the risks specific to the liability.

**Restructuring**

[**Table of Contents**](#toc)

A provision for restructuring is recognized when the Company has approved a detailed restructuring plan, and the restructuring has either commenced or been announced. Costs relating to the ongoing and future activities of the Company are not provided for but are recognized when expenses are incurred. The provision includes the benefit commitments in connection with early retirement and redundancy schemes.

**Disputes and Litigations**

A provision for disputes and litigation is recognized when it is more likely than not that the Company will be required to make future payments as a result of past events. Such items may include but are not limited to, claims, suits and actions filed by or against the Company relating to antitrust laws, violations of distribution and license agreements, environmental matters, employment-related disputes, claims from the tax authorities, and other matters.

**Contingent liabilities**

The Company and its subsidiaries have tax, civil and labor lawsuits defined as contingent liabilities, according to IAS 37, for which no provisions have been recorded, due to the judgment by management for developing the estimate. Possible contingent liabilities are not recognized but are disclosed in note 30 - *Contingencies*.

The contingent liabilities with remote possibility of outflow in settlement are not disclosed, as the possibility of any disbursement in the settlement is remote, in accordance with IAS 37.

From the fourth quarter of 2022 onwards, the nomenclature of the accounting policy "provisions" was changed to "provisions and contingent liabilities".

&nbsp;&nbsp;&nbsp;&nbsp;**(w)** **Financial Instruments and hedge accounting** 

**Classification and Measurement**

The company uses financial instruments to implement its risk management strategy and policy. Derivatives are generally used to mitigate the impact on the Company's performance due to changes in foreign currencies, interest rates, equity prices and commodity prices. The Company's financial risk management policy prohibits the use of derivatives not related to the Company's core business.

Financial assets (except for accounts receivable without a significant financing component) or financial liabilities are initially measured at fair value, plus, for an item not measured at fair value through profit or loss, transaction costs directly attributable to their acquisition or issue. Accounts receivable without a significant financing component are initially measured at the transaction price.

[**Table of Contents**](#toc)

Upon initial recognition, a financial asset is classified either: (i) at amortized cost; (ii) at fair value through other comprehensive income - debt instruments; (iii) at fair value through other comprehensive income - equity instruments; or (iv) at fair value through profit or loss.

Financial assets are not reclassified subsequently to initial recognition, unless the Group changes the business model for the management of financial assets, in which case all impacted financial assets are reclassified on the first day of the post-change business model.

The classification of the Company's financial assets is as follows:

▪ Debt instruments at fair value through other comprehensive income, with gains or losses recycled to profit or loss upon derecognition. Financial assets in this category quoted debt instruments held by the Company in line with its business model either to collect cash flow or for sale.

▪ Equity instruments designated as at fair value through other comprehensive income, with no recycling of gains or losses to the profit or loss upon derecognition. This category only includes equity instruments which the company intends to hold for the foreseeable future, and which it has irrevocably elected to classify thus upon their initial recognition or transition. These instruments are not subject to impairment testing.

▪ Financial assets and liabilities at FVPL: comprise derivative instruments and equity instruments which were not designated as FVOCI. This category also includes debt instruments with cash flow characteristics which are not held within a business model with the objective either to collect contractual cash flow, or both to collect contractual cash flow and for sale.

The measurement of the Company's financial assets is as follows:

**Hedge accounting**

The company designates certain derivatives as hedging instruments to hedge the risk related to the variability of foreign exchange rates, interest rates and commodity prices. Derivative financial instruments, that are contracted to protect against the exposure but that do not meet all of the hedge accounting requirements, will be recognized at fair value through profit or loss.

Derivative financial instruments are initially recognized at fair value. The fair value is the value at which an asset can be realized, or a liability settled, between knowledgeable and willing to negotiate parties of such financial instruments' characteristics under normal market conditions. The fair value of derivative financial instruments can be obtained from market prices or from pricing models that reflect current market rates, as well as the credit quality of the counterparty.

[**Table of Contents**](#toc)

Subsequent to initial recognition, derivative financial instruments are remeasured to their fair value as at the date of the financial statements. Changes in the fair values of derivative financial instruments are recognized in current income, except when these instruments are cash flow hedges or net investment hedges, where portions of gains or losses on the hedge instrument defined as effective hedges are recognized in comprehensive income. The hedge designated instrument is the effective element present in the term contract, of which only the present element value change is recognized in comprehensive income. The term element, which can be separated and excluded from the financial instrument designation as hedge instrument is recognized in financial result, in accordance with IFRS 9 - *Financial Instruments*.

The Company contracts commodities derivatives which have similar terms to the hedged items. The Company applies component hedging to its commodities. The hedged component is contractually specified and matches with what is defined in the derivative contract, and therefore the hedge ratio is always 1:1. Hedge effectiveness is assessed on a qualitative basis. Whenever the terms do not match, the company uses the hypothetical derivatives method to assess the hedge effectiveness. Therefore, usually causes of ineffectiveness include changes in the timing of forecast transactions, changes in the quantity of the commodity to be hedged, or changes in the credit risk of either party to the derivative contract.

**Cash flow hedge accounting**

Cash flow hedges are used to protect the cash flow exposure of a recorded asset or liability, or the foreign currency risk or commodity price variations associated with a highly probable transaction, the effective portion of any (gain or loss) on the derivative financial instrument is recognized directly in the comprehensive income statement (cash flow hedge reserve), and will be reclassified from the cash flow hedge reserve to the same line item within which and the same period during which the cash flow futures were hedged. The ineffective portion of any gain or loss is recognized immediately in the current income statement, in the financial result.

When a hedging instrument or a hedging relationship is terminated, but the hedged transaction is still expected to occur, the cumulative gains and losses (up to the date of termination) remain within comprehensive income, being reclassified in accordance with the above practice, when the transaction being protected occurs. If the hedged transaction is no longer probable, the accumulated gains and losses recognized in comprehensive income are reclassified immediately to the current income statement.

**Fair value hedge accounting**

When a derivative is intended to hedge the variability in the fair value of a recognized asset or liability, or of a firm commitment, any resulting (gain or loss) on the hedging

[**Table of Contents**](#toc)

instrument is recognized in profit or loss. The carrying amount of the hedged item is also adjusted for changes in the fair value related to the risk being hedged, with any gain or loss being recognized in the income statement.

**Net investment hedge accounting**

When a non-derivative foreign currency liability hedges a net investment in a foreign operation, exchange differences arising on the translation of the liability into the functional currency are recognized directly in other comprehensive income (translation reserves). Any ineffectiveness is recognized immediately in profit or loss.

When a derivative financial instrument hedges a net investment in a foreign operation, the portion of the gain or loss on the hedging instrument that is determined to be effective is recognized directly in other comprehensive income (translation reserves), while the ineffective portion is reported in profit or loss.

**Derivatives at fair value through profit or loss**

Certain derivative financial instruments do not qualify for hedge accounting. Changes in the fair values of any of those derivative financial instruments are recognized immediately in profit or loss.

**Impairment of financial assets** 

On an annual basis, Management performs impairment testing for financial assets or groups of financial assets. If a trigger event occurs, a financial asset or group of financial assets will be deemed to be impaired. An asset or group of financial assets is deemed impaired, and impairment losses are recorded, only if there is evidence of impairment as a result of one or more events occurring after the initial recognition of the assets (a "loss event") and that event (or events) has an impact on the estimated future cash flow from the financial asset or group of financial assets, and can be estimated reliably.

&nbsp;&nbsp;&nbsp;&nbsp;**(x)** **Impairment of non-financial assets** 

The carrying amounts of non-financial assets, such as property, plant and equipment and intangible assets with defined useful lives are reviewed, at least, at each reporting date to determine the existence of any indication of impairment. If there is any indication, the asset's recoverable amount is estimated, and the non-recoverable amount is recognized as an impairment in the income statement.

The goodwill and intangible assets with indefinite useful life are tested for impairment on an annual basis, regardless of any indication, by comparing its accounting value with its recoverable value.

[**Table of Contents**](#toc)

Goodwill, intangible assets not yet available for use, and intangibles with indefinite useful lives, are tested for impairment at the business unit level (one level below the reportable segment level) at least annually, or whenever there is any indication of impairment.

An impairment loss is recognized whenever the carrying amount of an asset or the related cash-generating unit ("CGU") exceeds its recoverable amount. Impairment losses are recognized in the income statement. Intangible assets with an indefinite useful life are tested on a fair value approach applying multiples that reflect current market transactions to indicators that drive the profitability of the asset or the royalty stream that could be obtained from licensing the intangible asset to another party in an arm's length transaction.

The recoverable amounts of other assets are determined as the higher of their fair value less costs to sell and their value in use. For an asset that does not generate substantially independent cash inflows, the recoverable amount is allocated to the CGU to which the asset belongs. The recoverable amounts of the CGU to which the goodwill and the intangible assets with indefinite useful lives belong are based on the fair value net of selling expenses, using EBITDA multiples observed in the market for previous business combinations involving comparable businesses in the brewing industry. For some CGUs, these calculations are corroborated using the fair-value less costs of disposal approach, where the free cash flow of these CGUs is discounted to fair value using a discount rate after tax that reflects current valuation models for the time value of money, and the risks specific to the asset.

Non-financial assets, except for goodwill, are reviewed for the possible reversal of the impairment at the reporting date. Impairment losses are reversed only to the extent that the asset's carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

**(y)** **Tax incentives and subsidized loans**

The Company is entitled to state tax benefits in Brazil, provided by government grants. Referred grants may be in the form of rate reduction, calculation basis reduction, financing or subsidized loans, presumed credits, effective collection, payment deferral or partial reductions of state tax payable. The effective collection incentives are recorded in the operating net revenue, due to its nature, as the others are recognized in other operating income.

As before mentioned, among the tax incentives granted to the Company, there are state tax incentive programs to promote industrial development either by financing or by deferring payment of taxes. These state programs are intended to promote, in the long-term, increases in employment rates, industrial decentralization, as well as to complement and diversify states industrial matrix.

[**Table of Contents**](#toc)

In the case of these programs, the tax terms are set in the respective state normative acts and state concessive acts, depending on their nature, when conditions for obtaining these grants exist, they are under the Company's control. Such benefits comply with the systematic set by Complementary Federal Law 160/2017 and by *Convênio* CONFAZ 190/2017. The financial component of these incentives is recorded in the income statement, on an accrual basis.

The financing or payment deferral forms of benefits, as the interest rates and terms of these loans could be advantageous compared to market conditions, are considered as subsidized loans as intended by IAS 20. The respective subsidies consist of the gains identified by comparing the value of these operations under the market conditions to the value agreed in the contracts. Thereby, upon receipt of funding, the subsidy calculated is recorded in Other operating income, following the treatment for the other ICMS subsidies of similar nature. Management reviews the market conditions prevailing in the year to assess such subsidies on an annual basis.

Monthly, considering of the value of the consideration, the period to maturity, the contract interest rate and the abovementioned discount rate, the reduction in present value adjustment is allocated to financial income, to bring the balance to zero by the time of settlement of each consideration.

Such financing is recognized as liability adjusted to its present value. When there is an intervening financial institution in the transaction, the financing is recorded at "interest-bearing loans and borrowings", otherwise, they are recorded at "trade payables", due to the underlying economic essence and nature of the transaction.

From the fourth quarter of 2022, the nomenclature of the accounting policy "government grants" was changed to "tax incentives and subsidized loans".

**4.** **USE OF ESTIMATES AND JUDGMENTS** 

The preparation of financial statements in compliance with IFRS requires Management to make use of judgments, estimates and assumptions that affect the application of accounting practices and the reported amounts of assets and liabilities, income and expenses. The estimates and assumptions are based on past experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for decision-making regarding judgments regarding the carrying amounts of assets and liabilities that are not readily evident from other sources. The actual results may differ from these estimates.

The estimates and assumptions are reviewed on a regular basis. Changes in accounting estimates may affect the period during which they are realized, or future periods.

[**Table of Contents**](#toc)

Although each significant accounting policy reflects judgments, assessments or estimates, the Company believes that the following accounting practices reflect the most critical judgments, estimates and assumptions that are important to its business operations and the understanding of its results:

(i) predecessor basis of accounting (Note 3 (c));

(ii) business combinations (Note 3 (c) and (k);

(iii) joint arrangements (Note 3 (c));

(iv) accounting and financial reporting in hyperinflationary economies (Note 3 (d));

(v) current and deferred tax (Note 3 (i));

(vi) leases (Note 3 (j));

(vii) assets and liabilities recognition related to extemporaneous tax credits and debits (Note 3 (m));

(viii) employee benefits (Note 3 (s));

(ix) share-based payments (Note 3 (t));

(x) provisions and contingent liabilities, including tax contingencies (Note 3 (v));

(xi) measurement of financial instruments, including derivatives (Note 3 (w));

(xii) impairment (Note 3 (w) and (x)) and

(xiii) Tax incentives and subsidized loans (Note 3 (y)).

The fair values of acquired identifiable intangibles with indefinite useful lives are based on an assessment of future cash flow. Impairment analyses of goodwill and intangible assets with indefinite useful lives are performed at least annually, or whenever a triggering event occurs, to determine whether the carrying value exceeds the recoverable amount.

The Company uses its judgment to choose between a variety of methods including the net fair value of expenses approach and option valuation models and makes assumptions about the fair value of financial instruments mainly based on the market conditions at each balance sheet date.

Actuarial assumptions regarding future events are used for the calculation of projected pension and other long-term employee benefit expenses and liabilities. These factors include assumptions regarding interest rates, rates of increase in healthcare costs, rates of future compensation increases, turnover rates, and life expectancy.

The company is subject to income tax in numerous jurisdictions. Significant judgment is required to determine the Company's worldwide provision for income tax. There are some transactions and calculations for which the ultimate tax determination is uncertain. Some of the subsidiaries of the Company are involved in tax audits, usually in relation to prior years. These audits are ongoing in various jurisdictions as at the balance sheet date, and by their nature, can take a considerable time to complete.

To measure the amounts of extemporaneous tax credits arising from lawsuits, the Company evaluates the documents for the period covered by the lawsuit, and applies the guidelines for the final decision, applicable legislation or other elements that enable the amount to be estimated with sufficient reliability.

[**Table of Contents**](#toc)

**5.** **SEGMENT REPORTING** 

(a)&nbsp;&nbsp;&nbsp;&nbsp; Reportable segments - Years ended:

---

| | | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Brazil** | **Brazil** | **Brazil** | **CAC** **<sup>(i)</sup>** | **CAC** **<sup>(i)</sup>** | **CAC** **<sup>(i)</sup>** | **Latin America - south** **<sup>(ii)</sup>** | **Latin America - south** **<sup>(ii)</sup>** | **Latin America - south** **<sup>(ii)</sup>** | **Canada** | **Canada** | **Canada** | **Consolidated** | **Consolidated** | **Consolidated** |
|  | **2022** | **2021** | **2020** | **2022** | **2021** | **2020** | **2022** | **2021** | **2020** | **2022** | **2021** | **2020** | **2022** | **2021** | **2020** |
| Net sales | 42635.8 | 35586.5 | 30196.5 | 9440.1 | 9947.4 | 7319.3 | 17371.2 | 16571.7 | 11560.8 | 10261.7 | 10748.7 | 9302.4 | 79708.8 | 72854.3 | 58379.0 |
| Cost of sales | (22736.8) | (18309.1) | (14112.9) | (4860.8) | (4727.9) | (3307.5) | (8553.1) | (8235.7) | (5937.4) | (4271.4) | (4387.0) | (3708.3) | (40422.1) | (35659.7) | (27066.1) |
| **Gross profit** | **19899.0** | **17277.4** | **16083.6** | **4579.3** | **5219.5** | **4011.8** | **8818.1** | **8336.0** | **5623.4** | **5990.3** | **6361.7** | **5594.1** | **39286.7** | **37194.6** | **31312.9** |
| Distribution expenses | (6111.1) | (5123.1) | (4241.9) | (1020.7) | (872.7) | (751.5) | (2159.5) | (2010.1) | (1492.8) | (2104.0) | (1926.8) | (1758.8) | (11395.3) | (9932.7) | (8245.0) |
| Sales and marketing expenses | (4065.0) | (3440.3) | (3444.1) | (645.5) | (693.3) | (542.4) | (1426.9) | (1542.9) | (1165.6) | (1200.0) | (1359.0) | (1222.5) | (7337.4) | (7035.5) | (6374.6) |
| Administrative expenses | (3346.0) | (3006.2) | (1629.6) | (333.6) | (427.7) | (305.0) | (835.0) | (832.0) | (574.9) | (722.2) | (611.5) | (439.0) | (5236.8) | (4877.4) | (2948.5) |
| Other operating income/(expenses) | 2361.3 | 2096.0 | 2887.2 | (52.9) | 12.4 | (23.5) | 192.7 | 38.8 | (159.9) | 12.8 | (23.1) | (24.4) | 2513.9 | 2124.1 | 2679.4 |
| Exceptional items | (34.5) | (210.1) | (173.8) | (16.1) | (46.7) | (70.5) | (60.5) | (115.4) | (145.7) | (32.2) | (20.6) | (62.0) | (143.3) | (392.8) | (452.0) |
| **Income from operations** | **8703.7** | **7593.7** | **9481.4** | **2510.5** | **3191.5** | **2318.9** | **4528.9** | **3874.4** | **2084.5** | **1944.7** | **2420.7** | **2087.4** | **17687.8** | **17080.3** | **15972.2** |
| Net finance costs | (1110.3) | (858.1) | (663.9) | (50.0) | (80.1) | 9.8 | (1933.2) | (2177.8) | (1731.4) | (329.6) | (89.4) | (49.0) | (3423.1) | (3205.4) | (2434.5) |
| Share of results of joint ventures | (38.3) | (11.7) | (7.2) | 0.1 | (79.7) | (4.9) | - | - | - | 9.1 | (24.3) | (31.2) | (29.1) | (115.7) | (43.3) |
| **Income before income tax** | **7555.1** | **6723.9** | **8810.3** | **2460.6** | **3031.7** | **2323.8** | **2595.7** | **1696.6** | **353.1** | **1624.2** | **2307.0** | **2007.2** | **14235.6** | **13759.2** | **13494.4** |
| Income tax expense | 2787.7 | 1953.2 | (203.1) | (771.2) | (1301.7) | (713.2) | (672.9) | (509.4) | (118.4) | (688.0) | (778.7) | (727.8) | 655.6 | (636.6) | (1762.5) |
| **Net income** | **10342.8** | **8677.1** | **8607.2** | **1689.4** | **1730.0** | **1610.6** | **1922.8** | **1187.2** | **234.7** | **936.2** | **1528.3** | **1279.4** | **14891.2** | **13122.6** | **11731.9** |
| **EBITDA** **<sup>(iii)</sup>** | **12028.8** | **10564.3** | **12388.7** | **3315.6** | **3789.2** | **2995.0** | **5725.4** | **5071.4** | **3182.6** | **2545.2** | **2936.4** | **2529.8** | **23615.0** | **22361.3** | **21096.1** |
| Depreciation, amortization and impairment | (3363.4) | (2982.3) | (2914.5) | (805.0) | (677.4) | (681.0) | (1196.5) | (1197.0) | (1098.1) | (591.4) | (540.0) | (473.6) | (5956.3) | (5396.7) | (5167.4) |
| Net finance costs | (1110.3) | (858.1) | (663.9) | (50.0) | (80.1) | 9.8 | (1933.2) | (2177.8) | (1731.4) | (329.6) | (89.4) | (49.0) | (3423.1) | (3205.4) | (2434.5) |
| Income tax expense | 2787.7 | 1953.2 | (203.1) | (771.2) | (1301.7) | (713.2) | (672.9) | (509.4) | (118.4) | (688.0) | (778.7) | (727.8) | 655.6 | (636.6) | (1762.5) |
| **Net income** | **10342.8** | **8677.1** | **8607.2** | **1689.4** | **1730.0** | **1610.6** | **1922.8** | **1187.2** | **234.7** | **936.2** | **1528.3** | **1279.4** | **14891.2** | **13122.6** | **11731.9** |
| **EBITDA margin as a %** **<sup>(iii)</sup>** | **28.2%** | **29.7%** | **41.0%** | **35.1%** | **38.1%** | **40.9%** | **33.0%** | **30.6%** | **27.5%** | **24.8%** | **27.3%** | **27.2%** | **29.6%** | **30.7%** | **36.1%** |
| **Acquisition of property, plant and equipment** | 4062.9 | 4645.1 | 3114.9 | 968.4 | 801.6 | 492.3 | 1112.8 | 1665.4 | 621.8 | 389.0 | 565.0 | 463.7 | 6533.1 | 7677.1 | 4692.7 |

---

[**Table of Contents**](#toc)

(continued)

---

| | | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** | **2022** | **2021** | **2020** | **2022** | **2021** | **2020** | **2022** | **2021** | **2020** | **2022** | **2021** | **2020** |
| Segment assets | 57353.8 | 54609.4 | 48970.2 | 15385.6 | 15351.9 | 13521.4 | 22044.5 | 21583.0 | 17211.2 | 16093.3 | 18016.6 | 16487.9 | 110877.2 | 109560.9 | 96190.7 |
| Intersegment elimination |  |  |  |  |  |  |  |  |  |  |  |  | (2533.0) | (2868.5) | (2187.6) |
| Non-segmented assets |  |  |  |  |  |  |  |  |  |  |  |  | 29613.8 | 31910.1 | 31193.2 |
| **Total assets** |  |  |  |  |  |  |  |  |  |  |  |  | **137958.0** | **138602.5** | **125196.3** |
| Segment liabilities | 29153.2 | 27611.2 | 25032.6 | 5098.0 | 5414.4 | 4114.2 | 6843.6 | 7843.6 | 5156.4 | 5053.7 | 6156.5 | 6256.6 | 46148.5 | 47025.7 | 40559.8 |
| Intersegment elimination |  |  |  |  |  |  |  |  |  |  |  |  | (2534.2) | (2869.1) | (2187.4) |
| Non-segmented liabilities |  |  |  |  |  |  |  |  |  |  |  |  | 94343.7 | 94445.9 | 86823.9 |
| **Total liabilities** |  |  |  |  |  |  |  |  |  |  |  |  | **137958.0** | **138602.5** | **125196.3** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) CAC: includes the Dominican Republic, Panama, Guatemala, Cuba, Barbados, Saint Vincent, Dominica, Nicaragua, Honduras and Antigua.

&nbsp;&nbsp;&nbsp;&nbsp;(ii) Latin America - South: includes operations in Argentina, Bolivia, Chile, Paraguay and Uruguay.

&nbsp;&nbsp;&nbsp;&nbsp;(iii) From 2021 onwards, the Adjusted EBITDA metric was changed to EBITDA, for presentation purposes, including for comparative purposes.

[**Table of Contents**](#toc)

(b)&nbsp;&nbsp;&nbsp;&nbsp; Additional information - by Business unit - Years ended:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Brazil** | **Brazil** | **Brazil** | **Brazil** | **Brazil** | **Brazil** | **Brazil** | **Brazil** | **Brazil** |
|  | **Beer** | **Beer** | **Beer** | **NAB** | **NAB** | **NAB** | **Total** | **Total** | **Total** |
|  | **2022** | **2021** | **2020** | **2022** | **2021** | **2020** | **2022** | **2021** | **2020** |
| Net sales | 35857.9 | 30537.1 | 25953.0 | 6777.9 | 5049.4 | 4243.5 | 42635.8 | 35586.5 | 30196.5 |
| Cost of sales | (18765.3) | (15382.0) | (11941.7) | (3971.5) | (2927.1) | (2171.2) | (22736.8) | (18309.1) | (14112.9) |
| **Gross profit** | **17092.6** | **15155.1** | **14011.3** | **2806.4** | **2122.3** | **2072.3** | **19899.0** | **17277.4** | **16083.6** |
| Distribution expenses | (4988.6) | (4263.1) | (3529.2) | (1122.5) | (860.0) | (712.7) | (6111.1) | (5123.1) | (4241.9) |
| Sales and marketing expenses | (3596.8) | (3096.2) | (3008.9) | (468.2) | (344.1) | (435.2) | (4065.0) | (3440.3) | (3444.1) |
| Administrative expenses | (2928.8) | (2616.1) | (1395.1) | (417.2) | (390.1) | (234.5) | (3346.0) | (3006.2) | (1629.6) |
| Other operating income/(expenses) | 1884.5 | 1711.3 | 2380.3 | 476.8 | 384.7 | 506.9 | 2361.3 | 2096.0 | 2887.2 |
| Exceptional items | (30.6) | (202.0) | (173.8) | (3.9) | (8.1) | - | (34.5) | (210.1) | (173.8) |
| **Income from operations** | **7432.3** | **6689.0** | **8284.6** | **1271.4** | **904.7** | **1196.8** | **8703.7** | **7593.7** | **9481.4** |
| Net finance costs | (1110.3) | (858.1) | (663.9) | - | - | - | (1110.3) | (858.1) | (663.9) |
| Share of results of joint ventures | (38.3) | (11.7) | (7.2) | - | - | - | (38.3) | (11.7) | (7.2) |
| **Income before income tax** | **6283.7** | **5819.2** | **7613.5** | **1271.4** | **904.7** | **1196.8** | **7555.1** | **6723.9** | **8810.3** |
| Income tax expense | 2787.7 | 1953.2 | (203.1) | - | - | - | 2787.7 | 1953.2 | (203.1) |
| **Net income** | **9071.4** | **7772.4** | **7410.4** | **1271.4** | **904.7** | **1196.8** | **10342.8** | **8677.1** | **8607.2** |
| **EBITDA** **<sup>(i)</sup>** | **10332.9** | **9302.4** | **10830.8** | **1695.9** | **1261.9** | **1557.9** | **12028.8** | **10564.3** | **12388.7** |
| Depreciation, amortization and impairment | (2938.9) | (2625.1) | (2553.4) | (424.5) | (357.2) | (361.1) | (3363.4) | (2982.3) | (2914.5) |
| Net finance costs | (1110.3) | (858.1) | (663.9) | - | - | - | (1110.3) | (858.1) | (663.9) |
| Income tax expense | 2787.7 | 1953.2 | (203.1) | - | - | - | 2787.7 | 1953.2 | (203.1) |
| **Net income** | **9071.4** | **7772.4** | **7410.4** | **1271.4** | **904.7** | **1196.8** | **10342.8** | **8677.1** | **8607.2** |
| **EBITDA margin as a %** **<sup>(i)</sup>** | **28.8%** | **30.5%** | **41.7%** | **25.0%** | **25.0%** | **36.7%** | **28.2%** | **29.7%** | **41.0%** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) From 2021 onwards, the Adjusted EBITDA metric was changed to EBITDA, for presentation purposes, including for comparative purposes.

**6.** **NET SALES** 

In compliance with the Federal Law 6,404/76, Company discloses the reconciliation between gross sales and net sales presented in the consolidated income statement. The values by each operational segment are disclosed in note 5 – *Segment reporting*:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| Gross sales and/or services | 125907.2 | 110162.7 | 85221.2 |
| Excise duty | (24851.4) | (22052.6) | (18259.7) |
| Discounts | (21347.0) | (15255.8) | (8582.5) |
| Total | **79708.8** | **72854.3** | **58379.0** |

---

At gross sales and/or services line, the Company recognizes the best estimate received or to be received regarding the products and services offered for its clients, according to note 3 (f) – *Summary of significant accounting policies – Revenue recognition*. Gross sales are disclosed before taxes and discounts.

The gross sales obtained by the Company, in general, are subject to the incidence of certain taxes and contributions, which are calculated and paid to fiscal authorities in accordance with current federal, municipal and state legislation, and do not result in equity increase for the Group. These taxes and contributions are deducted from gross

[**Table of Contents**](#toc)

sales and relate substantially to tax on transactions concerning the circulation of goods ("ICMS"), social integration program ("PIS"), contribution to social security financing ("COFINS"), tax on manufactured products ("IPI") and tax on services of any nature ("ISSQN") in Brazil. At December 31, 2022 the Company calculated R$1,245.8 million of fiscal incentives (R$1,048.3 million at December 31, 2021 and R$1,036.7 million at December 31, 2020), which are registered in the net revenue, in accordance with note 3 (y) – *Summary of significant accounting policies – Tax incentives and subsidized loans*.

The discounts and rebates are also deducted from the Company's gross sales, in the terms disclosed in note 3 (f) – *Summary of significant accounting policies – Revenue recognition*.

**7.** **OTHER OPERATING INCOME/(EXPENSES)** 

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| Government grants/net present value of long-term fiscal incentives | 1289.3 | 853.2 | 735.9 |
| Extemporaneous credits/(debits) <sup>(i)</sup> | 1013.9 | 1219.0 | 2121.3 |
| (Additions)/reversals of provisions | (77.2) | (71.4) | (70.1) |
| Gains/(losses) on disposals of property, plant and equipment, intangible assets and the operations of associates | 88.8 | 66.1 | 27.2 |
| Other operating income/(expenses), net | 199.1 | 57.2 | (134.9) |
| Total | **2513.9** | **2124.1** | **2679.4** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) As detailed in Note 30 – *Contingencies*, the Company recognized PIS and COFINS credits arising from the exclusion of ICMS
from its calculation basis, in the item Other operating income/(expenses).

According to the account policy disclosed in note 3 (y), the Company recognizes, in other operating income/(expenses) line, tax incentives granted as rate reduction, calculation basis reduction, financing or subsidized loans, presumed credit, deferred payment or partial reductions of due state tax payable.

Government grants are not recognized until there is reasonable assurance that the Company will meet the respective conditions and obligations related to governmental terms.

[**Table of Contents**](#toc)

**8.** **EXCEPTIONAL ITEMS** 

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| Costs arising from business combinations |  |  | (18.2) |
| COVID-19 impacts <sup>(ii)</sup> | (16.7) | (134.3) | (263.2) |
| Restructuring <sup>(i)</sup> | (101.8) | (165.4) | (146.5) |
| Effect of application of IAS 29 (hyperinflation) | (8.2) | (11.1) | (9.3) |
| Stella Recall |  |  | (14.8) |
| Distribution agreement <sup>(iii)</sup> |  | (82.0) |  |
| Write-off of investments <sup>(iv)</sup> | (16.6) | - | - |
|  Total | **(143.3)** | **(392.8)** | **(452.0)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) The restructuring expenses primarily related to centralized projects and resizing in the Latin America CAC and Brazil.

&nbsp;&nbsp;&nbsp;&nbsp;(ii) COVID-19 expenses refer to (a) additional administrative expenses to ensure the safety of the Company's people (increased frequency
of cleaning at the Company's facilities, providing alcohol gel and masks for our employees); (b) donations; (c) Company initiatives
providing support for some customer ecosystems, which were necessary due to the COVID-19 pandemic.

&nbsp;&nbsp;&nbsp;&nbsp;(iii) Refers to distribution agreement with our strategic partner in Guatemala.

&nbsp;&nbsp;&nbsp;&nbsp;(iv) Refers to an investment write-off of a business line in Canada.

**9.** **PAYROLL AND RELATED BENEFITS** 

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| Wages and salaries | 4496.1 | 4162.6 | 3736.5 |
| Social security contributions | 1239.7 | 1016.0 | 851.8 |
| Other personnel costs | 1075.9 | 1076.1 | 836.9 |
| Increase in liabilities for defined benefit plans | 157.8 | 178.2 | 131.2 |
| Share-based payments | 311.6 | 391.5 | 223.1 |
| Contributions to defined contribution plans | 82.0 | 74.1 | 61.1 |
|  Total | **7363.1** | **6898.5** | **5840.6** |

---

The payroll expenses and related benefits are presented in the income statement as shown below:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| Cost of sales | 2510.4 | 2247.9 | 2175.1 |
| Distribution expenses | 1396.3 | 1286.8 | 1130.4 |
| Sales and marketing expenses | 1504.8 | 1480.9 | 1333.7 |
| Administrative expenses | 1798.7 | 1699.1 | 1089.2 |
| Net finance costs | 107.8 | 115.6 | 44.1 |
| Other operating (income)/expenses, net | 1.5 |  | 2.2 |
| Exceptional items | 43.6 | 68.2 | 65.9 |
| Total | **7363.1** | **6898.5** | **5840.6** |

---

[**Table of Contents**](#toc)

**10.** **ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE** 

Depreciation, amortization and impairment expenses are included in the following income statement accounts for the years ended in December 31, 2022, 2021 and 2020:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Depreciation and impairment of property, plant and equipment** | **Depreciation and impairment of property, plant and equipment** | **Depreciation and impairment of property, plant and equipment** | **Amortization of intangible assets** | **Amortization of intangible assets** | **Amortization of intangible assets** |
|  | **2022** | **2021** | **2020** | **2022** | **2021** | **2020** |
| Cost of sales (i) | 3413.3 | 3326.6 | 2980.4 | 16.4 | 16.4 | 15.7 |
| Distribution expenses | 893.5 | 654.1 | 441.7 |  |  |  |
| Sales and marketing expenses | 660.7 | 700.3 | 787.9 | 113.2 | 84.3 | 219.9 |
| Administrative expenses | 474.4 | 331.4 | 453.6 | 372.6 | 304.2 | 276.1 |
|  | **5441.9** | **5012.4** | **4663.6** | **502.2** | **404.9** | **511.7** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) These amounts added to R$2,510.4 (R$2,247.9 and R$2,175.1 as at December 31, 2021 and 2020, respectively) mentioned in Note 9 - *Payroll and related benefits*, total R$5,940.1 (R$5,591.0 and R$5,171.2 as at December 31, 2021 and 2020, respectively). The remaining amount of R$34,482.0 (R$30,068.7 and R$21,894.9 as at December 31, 2021 and 2020, respectively), recorded in the cost of sales, refers to other production costs.

**11.** **FINANCE EXPENSES AND INCOME** 

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Finance expenses** 

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| Interest expense | (2328.3) | (1431.8) | (1786.6) |
| Net Interest on pension plans | (107.9) | (115.6) | (117.2) |
| Losses on hedging instruments | (3158.4) | (2540.2) | (1919.3) |
| Interest on provision for disputes and litigation | (456.6) | (290.0) | (208.8) |
| Exchange variations | (751.1) | (453.9) | (706.4) |
| Financial instruments at fair value through profit or loss |  |  | (4.3) |
| Tax on financial transactions | (339.6) | (216.6) | (335.0) |
| Bank guarantee expenses | (176.1) | (174.9) | (188.0) |
| Other financial results | (574.2) | (204.8) | (164.9) |
|  Total | **(7892.2)** | **(5427.8)** | **(5430.5)** |

---

Interest expenses are presented net of the effects of interest rate derivative financial instruments which mitigate Ambev's interest rate risk (Note 28 - *Financial instruments and risks*). The interest expenses are as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| Financial instruments measured at amortized cost | (764.0) | (466.0) | (776.0) |
| Financial instruments at fair value through profit or loss <sup>(i)</sup> | (1564.3) | (965.8) | (1010.6) |
|  Total | **(2328.3)** | **(1431.8)** | **(1786.6)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) Include R$1,231 million (R$656 million at December 31, 2021 and R$657 million at December 31, 2020) as accounts payable present value adjustment.

[**Table of Contents**](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Finance income** 

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| Interest income | 2167.7 | 1101.6 | 2245.5 |
| Interest and foreign exchange rate on loans to/from related parties | 37.1 | 42.5 | 10.6 |
| Financial instruments at fair value through profit or loss | 95.5 | 77.0 | 242.6 |
| Other financial results | 565.3 | 78.9 | 49.9 |
|  Finance income, before adoption of new accounting policies | **2865.6** | **1300.0** | **2548.6** |
| Effect of application of IAS 29 (hyperinflation) | 1603.5 | 922.4 | 447.4 |
|  Finance income | **4469.1** | **2222.4** | **2996.0** |

---

Interest income arises from the following financial assets:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| Cash and cash equivalents | 791.6 | 329.5 | 234.6 |
| Investment securities held for trading | 175.9 | 84.7 | 4.3 |
| Other receivables <sup>(i)</sup> | 1200.2 | 687.4 | 2006.6 |
|  Total | **2167.7** | **1101.6** | **2245.5** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) Refers, mainly, to monetary adjustment of recoverable taxes.

**12.** **INCOME TAX AND SOCIAL CONTRIBUTION** 

Income taxes reported in the income statement are analyzed as follow:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| **Income tax expense – current** | **(1718.9)** | **(1268.6)** | **(1048.9)** |
| Deferred tax expense on temporary differences | 1012.6 | 1072.9 | (1576.0) |
| Deferred tax on tax loss carryforward movements in the current period | 1361.9 | (440.9) | 862.4 |
| **Total deferred tax (expense)/income** | **2374.5** | **632.0** | **(713.6)** |
| **Total income tax expenses** | **655.6** | **(636.6)** | **(1762.5)** |

---

[**Table of Contents**](#toc)

The reconciliation between the weighted nominal tax rate and the effective tax rate is summarized as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| **Profit before tax** | **14235.6** | **13759.2** | **13494.4** |
| **Adjustment on a taxable basis** |  |  |  |
| Others non-taxable income | (883.3) | (611.0) | (6.2) |
| Government grants related to sales taxes | (2535.1) | (1883.1) | (1597.8) |
| Share of results of joint ventures | 29.1 | 115.7 | 43.3 |
| Non-deductible expenses | 192.8 | 99.2 | 119.6 |
| Worldwide taxation | 679.3 | (360.0) | 48.2 |
|  | **11718.4** | **11120.0** | **12101.5** |
| Aggregated weighted nominal tax rate | 29.47% | 27.39% | 30.26% |
| **Taxes payable – nominal rate** | **(3453.3)** | **(3045.3)** | **(3662.1)** |
| **Adjustment on tax expense** |  |  |  |
| Income tax Incentives | 234.0 | 213.2 | 123.2 |
| Deductible interest on shareholders' equity | 4079.9 | 2516.0 | 2213.2 |
| Tax savings from goodwill amortization | 27.2 | 77.5 | 77.5 |
| Withholding income tax | (164.5) | (876.0) | (628.2) |
| Recognition/(write-off) of deferred charges on tax losses | (58.2) | (1.5) | 123.2 |
| Effect of application of IAS 29 (hyperinflation) | (249.0) | (123.3) | (50.5) |
| Others with reduced taxation | 239.5 | 602.8 | 41.2 |
| **Income tax and social contribution expense** | **655.6** | **(636.6)** | **(1762.5)** |
| **Effective tax rate** | **-4.61%** | **4.63%** | **13.06%** |

---

The main events that impacted the effective tax rate for the period were:

&nbsp;&nbsp;&nbsp;&nbsp;· On September 24, 2021, the Brazilian Supreme Court of Justice ("STF")
issued a binding decision favorable to taxpayers on proceeding nº 1.063.187/SC (*Recurso Extraordinário nº 1,063,187/SC – Tema 962*), recognizing the unconstitutionality of Corporate Income Taxes ("IRPJ and CSLL") calculated over SELIC
interest earned upon the recovery of taxes.

The Company and its subsidiaries have judicial claims in process as per described above. Based on the binding decision issued by STF and on the analysis of the Company's external counsels, the Company evaluates as probable that such tax treatment will be accepted in its respective lawsuits, as they relate to the recognition of its right to recover/offset the amount of IRPJ and CSLL calculated and paid over SELIC interest earned upon the recovery of taxes accounted in the period between 2006 and 2022, as well as the exclusion of amounts of this nature in the calculation of its taxable basis.

The amount related to *Tema 962* that impacted the income tax rate in 2022 was R$329 million.

&nbsp;&nbsp;&nbsp;&nbsp;· Government subsidy for sales taxes: for regional incentives and economic
development policies, these are related primarily to local production, contributing to economic and social impact, and, when reinvested,
are not subject to income tax and social contribution purposes, which explains the impact on the effective tax rate. The amount above
is impacted by fluctuations in the volume, price and any eventual increases in state VAT ("ICMS"), reflected in other operating
income or net sales depending on its nature, according to note
3 (y) – *Summary of significant accounting policies – Tax incentives and subsidized loans.* 

[**Table of Contents**](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;· Complement of income tax on foreign subsidiaries due in Brazil: shows the
result of the calculation of universal taxation of profits, according to the regulations of Law 12,973/14.

&nbsp;&nbsp;&nbsp;&nbsp;· Withholding income tax: The amount is mainly related to dividends already
distributed and to be distributed by subsidiaries located outside of Brazil, applicable according to local tax legislation. The recorded
values in 2022 are mainly related to the exchange rate variation of the deferred income tax.

&nbsp;&nbsp;&nbsp;&nbsp;· Deductible interest on shareholders' equity: under Brazilian law,
companies have an option to remunerate their shareholders through the payment of interest on capital ("IOC"), which amount
is impacted by the taxable result, net income reserves of the Company and by the long-term interest rate ("TJLP"). These remunerations
are deductible for income tax purposes.

**13.** **PROPERTY, PLANT AND EQUIPMENT** 

---

| | | |
|:---|:---|:---|
|  | **2022** | **2021** |
| Property, plant and equipment | 26,961.3 | 26,664.0 |
| Right of use assets | 3,094.5 | 2,560.3 |
|  | **30,055.8** | **29,224.3** |

---

[**Table of Contents**](#toc)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Land and buildings** | **Plant and equipment** | **Fixtures and fittings** | **Under construction** | **Total** |
| **Acquisition cost** | | | | | |
| **At December 31, 2020** | **12385.1** | **34037.4** | **7219.4** | **2830.7** | **56472.6** |
| Effects of movements in foreign exchange in the balance sheet | 54.1 | 129.0 | 4.3 | 6.0 | 193.4 |
| Effects of application of IAS 29 (hyperinflation) | 544.2 | 1170.1 | 216.4 | 148.7 | 2079.4 |
| Acquisition through business combinations | 0.9 | 8.6 | 0.5 | 1.1 | 11.1 |
| Acquisitions | 11.3 | 960.1 | 45.2 | 6294.5 | 7311.1 |
| Disposals and write-offs | (117.7) | (1238.4) | (360.4) | (3.4) | (1719.9) |
| Transfers from/(to) other asset categories | 662.0 | 2402.9 | 401.5 | (3872.9) | (406.5) |
| **At December 31, 2021** | **13539.9** | **37469.7** | **7526.9** | **5404.7** | **63941.2** |
| Effects of movements in foreign exchange in the balance sheet | (1075.9) | (3378.4) | (879.5) | (360.7) | (5694.5) |
| Effects of application of IAS 29 (hyperinflation) | 870.5 | 2891.0 | 744.4 | 252.7 | 4758.6 |
| Acquisitions | 11.2 | 1283.5 | 87.3 | 4923.7 | 6305.7 |
| Disposals and write-offs | (24.6) | (1531.4) | (349.8) |  | (1905.8) |
| Transfers from/(to) other asset categories | 1173.1 | 3083.9 | 553.4 | (5870.4) | (1060.0) |
| **At December 31, 2022** | **14494.2** | **39818.3** | **7682.7** | **4350.0** | **66345.2** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Land and buildings** | **Plant and equipment** | **Fixtures and fittings** | **Under construction** | **Total** |
| **Depreciation** | | | | | |
| **At December 31, 2020** | **(3993.6)** | **(23831.0)** | **(5795.1)** | **-** | **(33619.7)** |
| Effects of movements in foreign exchange in the balance sheet | (39.7) | (52.4) | 10.6 |  | (81.5) |
| Effects of application of IAS 29 (hyperinflation) | (94.1) | (557.6) | (146.6) |  | (798.3) |
| Acquisition through business combinations | (0.3) | (1.1) | (0.2) |  | (1.6) |
| Depreciation | (398.1) | (3098.5) | (634.4) |  | (4131.0) |
| Disposals and write-offs | 46.6 | 1222.6 | 320.6 |  | 1589.8 |
| Transfers from/(to) other asset categories | 36.6 | 1.3 | 5.4 |  | 43.3 |
| Impairment losses | (7.1) | (269.0) | (2.1) | - | (278.2) |
| **At December 31, 2021** | **(4449.7)** | **(26585.7)** | **(6241.8)** | **-** | **(37277.2)** |
| Effects of movements in foreign exchange in the balance sheet | 243.8 | 2311.1 | 767.9 |  | 3322.8 |
| Effects of application of IAS 29 (hyperinflation) | (157.8) | (1938.4) | (647.7) |  | (2743.9) |
| Depreciation | (436.4) | (3161.0) | (579.7) |  | (4177.1) |
| Disposals and write-offs | 4.5 | 1515.7 | 335.2 |  | 1855.4 |
| Transfers from/(to) other asset categories | 0.1 | 32.7 | 7.3 |  | 40.1 |
| Impairment losses | (0.4) | (403.6) | - | - | (404.0) |
| **At December 31, 2022** | **(4795.9)** | **(28229.2)** | **(6358.8)** | **-** | **(39383.9)** |
| **Carrying amount:** |  |  |  |  |  |
| **At December 31, 2021** | **9090.2** | **10884.0** | **1285.1** | **5404.7** | **26664.0** |
| **At December 31, 2022** | **9698.3** | **11589.1** | **1323.9** | **4350.0** | **26961.3** |

---

The balances of fixed assets provided as security are not material.

[**Table of Contents**](#toc)

**Right-of-use asset:**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Buildings** | **Machinery, equipment and vehicles** | **Others** | **Total** |
| **Acquisition cost** | | | | |
| **At December 31, 2020** | **1791.6** | **1905.9** | **175.5** | **3873.0** |
| Effects of movements in foreign exchange in the balance sheet | 51.8 | 4.0 | 6.3 | 62.1 |
| Additions | 803.9 | 1409.6 | 71.2 | 2284.7 |
| Write-offs | (312.4) | (1327.8) | (122.7) | (1762.9) |
| Transfers from/(to) other asset categories | (27.7) | (76.5) | 90.3 | (13.9) |
| **At December 31, 2021** | **2307.2** | **1915.2** | **220.6** | **4443.0** |
| Effects of movements in foreign exchange in the balance sheet | (111.6) | (11.7) | (5.4) | (128.7) |
| Additions | 628.0 | 915.0 | 94.7 | 1637.7 |
| Write-offs | (11.2) | (252.5) |  | (263.7) |
| Transfers from/(to) other asset categories | (114.0) | 21.7 | (7.8) | (100.1) |
| **At December 31, 2022** | **2698.4** | **2587.7** | **302.1** | **5588.2** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Buildings** | **Machinery, equipment and vehicles** | **Others** | **Total** |
| **Depreciation** | | | | |
| **At December 31, 2020** | **(812.9)** | **(1017.9)** | **(126.7)** | **(1957.5)** |
| Effects of movements in foreign exchange in the balance sheet | (19.3) | (1.5) | (3.6) | (24.4) |
| Depreciation | (476.3) | (489.4) | (58.7) | (1024.4) |
| Write-offs | 205.8 | 794.9 | 109.6 | 1110.3 |
| Transfers (from)/to other asset categories | 1.5 | 43.1 | (31.2) | 13.4 |
| **At December 31, 2021** | **(1101.2)** | **(670.8)** | **(110.6)** | **(1882.6)** |
| Effects of movements in foreign exchange in the balance sheet | 47.3 | 6.0 | 2.8 | 56.1 |
| Depreciation | (391.6) | (415.3) | (38.6) | (845.5) |
| Write-offs | 20.9 | 58.0 |  | 78.9 |
| Transfers (from)/to other asset categories | 77.1 | 11.8 | 10.5 | 99.4 |
| **At December 31, 2022** | **(1347.5)** | **(1010.3)** | **(135.9)** | **(2493.7)** |
| **Carrying amount:** |  |  |  |  |
| **At December 31, 2021** | **1206.0** | **1244.4** | **110.0** | **2560.4** |
| **At December 31, 2022** | **1350.9** | **1577.4** | **166.2** | **3094.5** |

---

The average discount rate applied for IFRS 16, using the incremental rate was as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Rate %** | **Rate %** | **Rate %** |
| <br>**Lease Term** | **2022** | **2021** | **2020** |
| 2022 - 2026 | 9.46% | 7.29% | 10.54% |
| 2027 - 2031 | 10.27% | 9.78% | 8.19% |
| 2032 - 2036 | 15.16% | 14.47% | 10.97% |

---

[**Table of Contents**](#toc)

**14.** **GOODWILL** 

---

| | | |
|:---|:---|:---|
|  | **2022** | **2021** |
| **Balance at the end of the previous year** | **42411.3** | **40023.5** |
| Effects of movements in foreign exchange in the balance sheet | (3510.6) | 1255.3 |
| Effect of application of IAS 29 (hyperinflation) | 1709.9 | 1092.4 |
| Acquisitions, (write-offs) and disposal through business combinations | (16.6) | 40.1 |
| **Balance at the end of the year** | **40594.0** | **42411.3** |

---

The carrying amount of goodwill was allocated to the different CGU as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **Functional currency** | **2022** | **2021** |
| Brazil | BRL | 17702.4 | 17702.4 |
| Goodwill |  | 102945.0 | 102945.0 |
|  Non-controlling transactions <sup>(i)</sup> | Non-controlling transactions <sup>(i)</sup> | (85242.6) | (85242.6) |
| **CAC:** |  |  |  |
| Dominican Republic | DOP | 4231.6 | 4439.3 |
| Panama | PAB | 1813.8 | 1939.9 |
| **Latin America - South:** |  |  |  |
| Argentina | ARS | 3463.0 | 3232.6 |
| Bolivia | BOB | 1845.6 | 1973.9 |
| Chile | CLP | 53.1 | 57.4 |
| Paraguay | PYG | 953.8 | 1083.2 |
| Uruguay | UYU | 193.1 | 185.2 |
| Canada | CAD | 10337.6 | 11797.4 |
|  |  | **40594.0** | **42411.3** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) This refers to the shareholding exchange transaction in 2013 as a result of the adoption of the predecessor basis of accounting.

The impairment testing of assets with indefinite useful lives requires the use of a number of critical judgments, estimates and assumptions. Goodwill, which accounted for approximately 29% of total assets, as at December 31, 2022 (31% as at December 31, 2021) is tested for impairment at the cash-generating unit level at least annually. The cash-generating unit level is the lowest level at which assets are monitored for internal management purposes. When a business combination occurs, assets with indefinite useful lives are allocated, from the acquisition date, to each business unit that is expected to benefit from the synergies arising from the combination.

**Annual impairment testing**

The Company cannot predict whether an event that could trigger impairment will occur, when it will occur or how it will affect the value of the asset reported. The Company believes that all of its estimates are reasonable, are consistent with the Company's internal reporting and reflect Management's best estimates. However, inherent uncertainty exists which Management is not able to control. While changes in estimates could have a material impact on the calculation of fair values, and trigger impairment,

[**Table of Contents**](#toc)

the Company, based on the sensitivity analysis performed, is not aware of any reasonably possible changes in key assumptions that would cause a business unit's carrying amount to exceed its recoverable amount.

The Company completed its annual impairment testing for goodwill based on the assumptions described below and concluded that no impairment charge was warranted.

The methodology used by the Company to determine the recoverable value of all its CGUs is the net fair value of selling expenses, using multiples of the profit before financial result, income tax and depreciation and amortization expenses ("EBITDA"), observed in the market for previous comparable business transactions in the domestic and international brewing industry. The values used by the Company for this approach are based on external sources of information. This measurement is classified at Level 2 of the fair value hierarchy, since the main source of information used by the Company to determine the recoverable value was the EBITDA multiples of observable transactions involving comparable businesses. As part of this multiples analysis, the Company has established that CGUs with invested capital that exceeds seven times their EBITDA should have their recoverable value determined using the value-in-use approach, to determine whether the fair value less costs to sell exceeds the carrying amount of the CGU. Based on the most recent analysis carried out by the Company, only Chile and Panama met this criterion.

Thus, for Brazil, Panama and Chile CGUs, the Company also used discounted cash flow projections to determine the CGUs' recoverable amounts, in order to corroborate the conclusions reached by applying the fair value less disposal costs approach that he carrying amount of these CGUs does not exceed their recognized accounting values. The selection of these CGUs considered quantitative and qualitative aspects, since only the Brazil CGU, which is the most representative of the Company as a whole, and for Chile and Panama CGUs, have reached a multiple above the pre-determined parameter related to EBITDA.

**Sensitivity analysis** 

Based on the probable scenario, a sensitivity analysis was carried out for a 0.5 percentage point increase or decrease in the discount rate and growth rate. In any combination, the value of the cash flow is higher than its book value. As a result of this analysis, there is no need to record any provision to impairment from these assets.

The key judgments, estimates and key assumptions used for the discounted free cash flow calculations for these CGUs were as follow:

&nbsp;&nbsp;&nbsp;&nbsp;▪ The first year of the model is based on management's best estimate of the free cash flow outlook for
the current year;

[**Table of Contents**](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;▪ To the second year of the model, the free cash flow
is based on AB InBev's strategic plan, as approved by key management. AB InBev's strategic plan is prepared on a per country basis,
and is based on external sources of macroeconomic assumptions, industry trends, inflation and foreign exchange rates, past experience
and identified initiatives in terms of market share, revenue, variable and fixed costs, capital expenditure and working capital assumptions;

&nbsp;&nbsp;&nbsp;&nbsp;▪ From the third to the tenth year of the model,
 the cash flow is extrapolated using the growth in volumes, price indexes, and expected market share for each CGU. For the Chile and
 Panama CGU, the best estimates from local Management were considered; and

&nbsp;&nbsp;&nbsp;&nbsp;▪ Projections are made in the functional currency of
the business unit and discounted at the unit's weighted average cost of capital ("WACC"), considering sensitivities of this
metric.

Based on the cash flow analysis, the growth rates applied ranged from 3.3% to 8.7%.

The nominal WACC applied in the local currency for each CGU was as follows:

---

| | |
|:---|:---|
| **CGU** | **2022** |
| Chile | 11.4% |
| Panama | 10.0% |
| Brazil | 12.7% |

---

Although Ambev believes that its judgments, assumptions and estimates are appropriate, actual results may differ from these estimates based on different assumptions or conditions of market or macroeconomic.

[**Table of Contents**](#toc)

**15.** **INTANGIBLES** 

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  | **Commercial** | | | |
|  | **Brands** | **intangibles** | **Software** | **Others** | **Total** |
| **Acquisition cost** | | | | | |
| **At December 31, 2020** | **5653.3** | **3284.5** | **2238.2** | **1100.8** | **12276.8** |
| Effects of movements in foreign exchange in the balance sheet | 123.7 | 16.3 | (20.9) | (4.6) | 114.5 |
| Effects of application of IAS 29 (hyperinflation) | 622.0 | 56.1 | 103.8 | 149.1 | 931.0 |
| Additions |  |  | 26.0 | 340.1 | 366.1 |
| Disposal | (31.0) |  | (13.4) |  | (44.4) |
| Transfers from/(to) other asset categories | (39.0) | (8.5) | 625.3 | (206.9) | 370.9 |
| **At December 31, 2021** | **6329.0** | **3348.4** | **2959.0** | **1378.5** | **14014.9** |
| Effects of movements in foreign exchange in the balance sheet | (1096.2) | (114.3) | (351.3) | (308.4) | (1870.2) |
| Effects of application of IAS 29 (hyperinflation) | 930.3 | 71.3 | 338.7 | 292.3 | 1632.6 |
| Additions |  |  | 6.9 | 220.5 | 227.4 |
| Disposal |  |  | (0.1) |  | (0.1) |
| Transfers from/(to) other asset categories |  | 3.2 | 1400.7 | (364.1) | 1039.8 |
| **At December 31, 2022** | **6163.1** | **3308.6** | **4353.9** | **1218.8** | **15044.4** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  | **Commercial** |  |  |  |
|  | **Brands** | **intangibles** | **Software** | **Others** | **Total** |
| **Amortization** | | | | | |
| **At December 31, 2020** | **-** | **(2584.4)** | **(1458.3)** | **(653.5)** | **(4696.2)** |
| Effects of movements in foreign exchange in the balance sheet |  | 13.1 | 15.1 | 20.7 | 48.9 |
| Effects of application of IAS 29 (hyperinflation) |  | (56.0) | (83.8) | (139.7) | (279.5) |
| Amortization |  | (58.4) | (299.7) | (46.8) | (404.9) |
| Disposal |  |  | 14.1 |  | 14.1 |
| Transfers from/(to) other asset categories | - | 8.5 | (16.7) | (0.1) | (8.3) |
| **At December 31, 2021** | **-** | **(2677.2)** | **(1829.3)** | **(819.4)** | **(5325.9)** |
| Effects of movements in foreign exchange in the balance sheet |  | 69.6 | 220.7 | 212.4 | 502.7 |
| Effects of application of IAS 29 (hyperinflation) |  | (71.2) | (211.8) | (215.5) | (498.5) |
| Amortization |  | (58.1) | (401.1) | (43.0) | (502.2) |
| Disposal |  |  | 0.1 |  | 0.1 |
| Transfers from/(to) other asset categories | - | - | 1.6 | - | 1.6 |
| **At December 31, 2022** | **-** | **(2736.9)** | **(2219.8)** | **(865.5)** | **(5822.2)** |
| **Carrying amount:** |  |  |  |  |  |
| **At December 31, 2021** | **6329.0** | **671.2** | **1129.7** | **559.1** | **8689.0** |
| **At December 31, 2022** | **6163.1** | **571.7** | **2134.1** | **353.3** | **9222.2** |

---

The Company is the owner of some of the world's leading brands in the beer industry. As a result, brands are expected to generate positive cash flow for as long as the Company owns the brands, and accordingly they have been assigned indefinite useful lives. The most representative brands that have been recorded as a result of the fair value determination of past acquisitions are *Quilmes* in Argentina, *Pilsen* in Paraguay, *Paceña* and *Huari* in Bolivia and *Presidente* and *Presidente Light* in the Dominican Republic.

[**Table of Contents**](#toc)

The carrying value of intangible assets with indefinite useful lives classified as brands were allocated to the following CGUs:

---

| | | |
|:---|:---|:---|
|  | **2022** | **2021** |
| Argentina | 2,019.2 | 1,917.1 |
| Bolivia | 894.5 | 956.7 |
| Canada | 206.4 | 235.2 |
| Chile | 78.5 | 84.8 |
| Luxembourg | 339.6 | 339.6 |
| Paraguay | 542.7 | 616.3 |
| Dominican Republic | 1,593.0 | 1,670.4 |
| Panama | 358.8 | 383.8 |
| Uruguay | 130.4 | 125.1 |
|  | **6,163.1** | **6,329.0** |

---

Intangible assets with indefinite useful lives have been tested for impairment on a CGU level basis, which is consistent with the approach described in Note 14 - *Goodwill*.

**16.** **INVESTMENT SECURITIES** 

---

| | | |
|:---|:---|:---|
|  | **2022** | **2021** |
| Investment on debt securities <sup>(i)</sup> | 219.1 | 192.9 |
| **Non-current investment securities** | **219.1** | **192.9** |
| Financial assets at fair value through profit or loss | 454.5 | 1914.6 |
| **Current investment securities** | **454.5** | **1914.6** |
| **Total** | **673.6** | **2107.5** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) The balance refers substantially to financial investments linked to tax incentives that do not have immediate convertibility into a
known amount of cash.

**17.** **DEFERRED INCOME TAX AND SOCIAL CONTRIBUTION** 

Deferred taxes for income tax and social contribution taxes are calculated on temporary differences between the tax bases of these taxes and the accounting calculations of the Company, which include tax losses. The tax rates in Brazil, which are expected to be applicable upon the realization of the deferred taxes, are 25% for income tax and 9% for social contribution. For other regions in which the Company operates, the expected nominal rates are as follows:

---

| | |
|:---|:---|
| &nbsp;&nbsp;Central America and the Caribbean | &nbsp;&nbsp;from 15% to 27% |
| &nbsp;&nbsp;Latin America - South <sup>(i)</sup> | &nbsp;&nbsp;from 10% to 35% |
| &nbsp;&nbsp;Canada | &nbsp;&nbsp;26.5% |
| &nbsp;&nbsp;Luxembourg | &nbsp;&nbsp;24.94% |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) Amendments to Argentine tax legislation enacted in June 2021 and applicable from January 2021 increased the income tax rate from 30 %
to 35 %.

Deferred tax assets are recognized to the extent that it is probable that future taxable profits are probable, which may be offset against recorded temporary differences at December 31, 2022.

[**Table of Contents**](#toc)

The details of the amount of deferred income tax and social contribution by type of temporary difference are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **2022** | **2022** | **2022** | **2021** | **2021** | **2021** |
|  | **Assets** | **Liabilities** | **Net** | **Assets** | **Liabilities** | **Net** |
| Investment securities | 7.5 |  | 7.5 | 12.5 | (2.5) | 10.0 |
| Intangible |  | (1690.2) | (1690.2) |  | (1634.5) | (1634.5) |
| Employee benefits | 951.2 |  | 951.2 | 1278.2 | (2.0) | 1276.2 |
| Trade payables | 3232.8 | (2.9) | 3229.9 | 4113.3 | (1.1) | 4112.2 |
| Trade receivables | 38.6 | (3.8) | 34.8 | 50.6 |  | 50.6 |
| Derivatives | 95.1 | (44.8) | 50.3 | 232.2 | (72.4) | 159.8 |
| Interest-Bearing Loans and Borrowings | 0.5 | (0.9) | (0.4) |  | (1.6) | (1.6) |
| Inventories | 413.9 | (139.3) | 274.6 | 328.2 | (49.1) | 279.1 |
| Property, plant and equipment | 899.5 | (2177.1) | (1277.6) | 645.4 | (2027.0) | (1381.6) |
| Withholding tax on undistributed profits and royalties |  | (1877.6) | (1877.6) |  | (2079.5) | (2079.5) |
| Investments in joint ventures |  | (421.6) | (421.6) |  | (421.6) | (421.6) |
| Losses carried forward | 2660.7 |  | 2660.7 | 1298.8 |  | 1298.8 |
| Provisions | 819.3 |  | 819.3 | 696.9 | (0.2) | 696.7 |
| Impact of the adoption of IFRS 16 (Leases) | 35.1 | (11.4) | 23.7 | 78.6 | (0.3) | 78.3 |
| ICMS on the assessment bases of PIS/COFINS |  | (168.2) | (168.2) |  | (1019.6) | (1019.6) |
| Other items | 260.8 | (164.1) | 96.7 | 110.3 | (19.9) | 90.4 |
| **Gross deferred tax assets/(liabilities)** | **9415.0** | **(6701.9)** | **2713.1** | **8845.0** | **(7331.3)** | **1513.7** |
| Netting by taxable entity | (2976.2) | 2976.2 | - | (4117.3) | 4117.3 | - |
| **Net deferred tax assets/(liabilities)** | **6438.8** | **(3725.7)** | **2713.1** | **4727.7** | **(3214.0)** | **1513.7** |

---

The Company only reclassifies the balances of deferred income tax and social contribution assets against liabilities to a net presentation basis when the applicable compensation criteria are met.

The critical estimates of Ambev's Management, as well the main contingent liabilities related to uncertainty about the tax treatment of income, are disclosed in Notes 3 (i) and 30, respectively.

As at December 31, 2022 the deferred tax assets and liabilities related to combined tax losses which are expected to be utilized or settled using temporary differences, as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2022** | **2022** |
| **Deferred taxes not related to tax losses** | **to be realized within 12 months** | **to be realized after 12 months** | **Total** |
| Investment securities |  | 7.5 | 7.5 |
| Intangible | (1.3) | (1688.9) | (1690.2) |
| Employee benefits | 230.8 | 720.4 | 951.2 |
| Trade payables | (209.4) | 3439.3 | 3229.9 |
| Trade receivables | 25.8 | 9.0 | 34.8 |
| Derivatives | (199.9) | 250.2 | 50.3 |
| Interest-bearing loans and borrowings | (0.6) | 0.2 | (0.4) |
| Inventories | 403.3 | (128.7) | 274.6 |
| Property, plant and equipment | 51.7 | (1329.3) | (1277.6) |
| Withholding tax on undistributed profits and royalties | (172.7) | (1704.9) | (1877.6) |
| Investments in joint ventures |  | (421.6) | (421.6) |
| Provisions | 465.2 | 354.1 | 819.3 |
| Impact of the adoption of IFRS 16 (Leases) |  | 23.7 | 23.7 |
| ICMS on the assessment bases of PIS/COFINS |  | (168.2) | (168.2) |
| Other items | 29.0 | 67.7 | 96.7 |
| **Total** | **621.9** | **(569.5)** | **52.4** |

---

[**Table of Contents**](#toc)

The majority of tax losses and negative social contribution bases on which deferred income tax and social contribution were calculated do not have a statute of limitations. The use of credits related to tax losses is based on the projected future existence of taxable profits, limited to 30% of taxable income for the year, according to the actual figures for prior years, and the projections of the Company's business in the economies in which they are located, and thus is in compliance with the applicable fiscal and accounting rules.

---

| | |
|:---|:---|
| **Deferred tax related to tax losses** | **2022** |
| 2023 | 256.9 |
| 2024 | 168.7 |
| 2025 | 102.9 |
| 2026 | 106.6 |
| 2027 | 1146.6 |
| 2028 a 2030 | 799.5 |
| 2031 a 2032 <sup>(i)</sup> | 79.5 |
| **Total** | **2660.7** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) There is no expectation of realization beyond a term of ten years.

As at December 31, 2022, the tax credits related to accumulated tax losses in the amount of R$875.3 (R$1,055.6 in 2021) were not recorded, as realization is not probable.

A significant portion of the deferred tax asset related to tax losses amount does not have any limits on carrying forward or utilization, and the tax losses carried forward in relation to credit are equivalent to R$3,359.5 in 2022 (R$4,122.5 in 2021).

The net change in deferred income tax and social contribution is as follows:

---

| | |
|:---|:---|
| **At December 31, 2020** | **1517.4** |
| Recognition of actuarial gains/(losses) | (116.6) |
| Investment hedge – put option granted on subsidiaries | (99.7) |
| Cash flow hedge – gains/(losses) | (239.9) |
| Gains/(losses) on translation of other foreign operations | 398.0 |
| **Recognized in other comprehensive income** | **(58.2)** |
| **Recognized in the income statement** | **632.0** |
| **Changes directly in the balance sheet** | **(577.5)** |
| Recognized in deferred tax | (256.1) |
| Effect of application of IAS 29 (hyperinflation) | (256.1) |
| Recognized in other balance sheet group | (321.4) |
| **At December 31, 2021** | **1513.7** |
| Recognition of actuarial gains/(losses) | (146.9) |
| Investment hedge – put option granted on subsidiaries | (105.0) |
| Cash flow hedge – gains/(losses) | 41.3 |
| Gains/(losses) on translation of other foreign operations | (419.3) |
| **Recognized in other comprehensive income** | **(629.9)** |
| **Recognized in the income statement** | **2374.5** |
| **Changes directly in the balance sheet** | **(545.2)** |
| Recognized in deferred tax | (595.5) |
| Effect of application of IAS 29 (hyperinflation) | (595.5) |
| Recognized in other balance sheet group | 50.3 |
| **At December 31, 2022** | **2713.1** |

---

[**Table of Contents**](#toc)

**18.** **RECOVERABLE TAXES** 

---

| | | |
|:---|:---|:---|
|  | **2022** | **2021** |
| PIS/COFINS exclusion of ICMS <sup>(i)</sup> | 5992.8 | 5360.0 |
| ICMS | 423.2 | 383.6 |
| Other | 292.8 | 261.8 |
| **Non-current** | **6708.8** | **6005.4** |
| PIS/COFINS exclusion of ICMS <sup>(i)</sup> | 73.5 | 517.0 |
| PIS/COFINS | 242.7 | 648.5 |
| ICMS | 542.2 | 565.6 |
| IPI | 131.0 | 168.6 |
| Other | 55.4 | 81.4 |
| **Current** | **1044.8** | **1981.1** |
| **Total** | **7753.6** | **7986.5** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) As detailed in Note 30 - *Contingencies*, the Company recognized PIS and COFINS credits arising from the exclusion of ICMS from
the calculation basis. The corresponding entry for recognition is recorded in the item PIS/COFINS - exclusion of ICMS, according
to the table above.

**19.** **INVENTORY** 

---

| | | |
|:---|:---|:---|
|  | **2022** | **2021** |
| Finished goods | 4094.0 | 3626.7 |
| Work in progress | 845.7 | 672.5 |
| Raw materials and consumables | 6798.3 | 5306.2 |
| Spare parts and others | 986.9 | 906.8 |
| Prepayments | 358.3 | 645.9 |
| Impairment losses | (160.2) | (157.8) |
| Total | **12923.0** | **11000.3** |

---

The changes in impairment losses on inventory, are as follows:

---

| | |
|:---|:---|
| **At December 31, 2020** | **(141.1)** |
| Effects of movements in foreign exchange in the balance sheet | (2.0) |
| Provisions | (191.6) |
| Write-off | 176.9 |
| **At December 31, 2021** | **(157.8)** |
| Effects of movements in foreign exchange in the balance sheet | 17.8 |
| Provisions | (305.8) |
| Write-off | 285.6 |
| **At December 31, 2022** | **(160.2)** |

---

**20.** **TRADE RECEIVABLES** 

---

| | | |
|:---|:---|:---|
|  | **2022** | **2021** |
| Trade receivables | 5737.5 | 5304.7 |
| Bad debt provision | (679.1) | (668.3) |
| **Net, trade receivables** | **5058.4** | **4636.4** |
| Related parties (Note 31) | 290.7 | 155.2 |
| **Total current trade receivables** | **5349.1** | **4791.6** |

---

[**Table of Contents**](#toc)

The details of the aging of the Company's current trade receivables, net of impairment losses, are as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Net carrying amount as of December 31,** | **No past due** | **Past due – within 30 days** | **Past due – between 31 - 60 days** | **Past due – between 61 - 90 days** | **Past due – between 91 - 180 days** | **Past due – between 181 - 360 days** | **Past due over 360 days** |
| Trade receivables | 5737.5 | 4573.0 | 343.8 | 100.5 | 49.4 | 19.3 | 40.2 | 611.3 |
| Bad debt provision | (679.1) | - | - | (0.3) | (10.8) | (16.5) | (40.2) | (611.3) |
| **2022** | **5058.4** | **4573.0** | **343.8** | **100.2** | **38.6** | **2.8** | **-** | **-** |
| Trade receivables | 5304.7 | 4201.9 | 358.2 | 52.1 | 31.5 | 21.6 | 33.8 | 605.6 |
| Bad debt provision | (668.3) | (10.4) | - | - | (2.3) | (16.2) | (33.8) | (605.6) |
| **2021** | **4636.4** | **4191.5** | **358.2** | **52.1** | **29.2** | **5.4** | **-** | **-** |

---

The changes in bad debt provision, are as follows:

---

| | |
|:---|:---|
| **At December 31, 2020** | **(676.5)** |
| Effects of movements in foreign exchange in the balance sheet | (5.2) |
| Provisions | (32.4) |
| Reversals | 21.7 |
| Write-off | 24.1 |
| **At December 31, 2021** | **(668.3)** |
| Effects of movements in foreign exchange in the balance sheet | 14.0 |
| Provisions | (47.0) |
| Reversals | 1.7 |
| Write-off | 20.5 |
| **At December 31, 2022** | **(679.1)** |

---

The Company's exposure to credit risks, currency and interest rate risks is disclosed in Note 28 - *Financial instruments and risks*.

**21.** **CASH AND CASH EQUIVALENTS** 

---

| | | |
|:---|:---|:---|
|  | **2022** | **2021** |
| Short-term bank deposits <sup>(i)</sup> | 8655.2 | 11393.6 |
| Current bank accounts | 5990.3 | 4582.9 |
| Cash | 280.9 | 651.2 |
| **Cash and cash equivalents** | **14926.4** | **16627.7** |
| Bank overdrafts | (74.3) | (30.5) |
| **Cash and cash equivalents less bank overdraft** | **14852.1** | **16597.2** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) The balance refers mostly to Bank Deposit Certificates ("CDB"), with high liquidity, which are readily convertible into known
amounts of cash and which are subject to an insignificant risk of change in value.

The cash and cash equivalents balance include the amount of R$3,083 million in 2022 (R$2,858 million in 2021) held in Cuba and Argentina, which is not freely transferable to the parent company due to remittance restrictions.

[**Table of Contents**](#toc)

**22.** **CHANGES IN EQUITY** 

**(a) Capital stock** 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | | **2022** | | **2021** | | **2020** |
|  | **Million common shares** | **Million Reais** | **Million common shares** | **Million Reais** | **Million common shares** | **Million Reais** |
| Beginning balance | 15744.4 | 58042.5 | 15735.1 | 57899.1 | 15733.6 | 57866.8 |
| Capital increase <sup>(i)</sup> | 5.8 | 88.0 | 9.3 | 143.4 | 1.5 | 32.3 |
| **Final balance** **<sup>(ii)</sup>** | **15750.2** | **58130.5** | **15744.4** | **58042.5** | **15735.1** | **57899.1** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) Capital increase related to the issue of shares.

&nbsp;&nbsp;&nbsp;&nbsp;(ii) The capital stock is fully subscribed and paid up.

**(b) Capital reserves**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Capital Reserves** | **Capital Reserves** | **Capital Reserves** | **Capital Reserves** | |
|  | **Treasury shares** | **Share Premium** | **Other capital reserves** | **Share-based Payments** | **Total** |
| **At January 1, 2020** | **(955.2)** | **53662.8** | **700.9** | **1403.0** | **54811.5** |
| Capital Increase | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | (32.3) | (32.3) |
| Purchases of shares, results of treasury shares and share-based payments | 13.5 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 192.9 | 206.4 |
| **At December 31, 2020** | **(941.7)** | **53662.8** | **700.9** | **1563.6** | **54985.6** |
| Capital Increase | (60.0) |  |  | (74.4) | (134.4) |
| Purchases of shares, results of treasury shares and share-based payments | (36.1) |  |  | 372.1 | 336.0 |
| **At December 31, 2021** | **(1037.8)** | **53662.8** | **700.9** | **1861.3** | **55187.2** |
| Capital Increase |  |  |  | (64.2) | (64.2) |
| Purchases of shares, results of treasury shares and share-based payments | (35.6) |  |  | 252.4 | 216.8 |
| **At December 31, 2022** | **(1073.4)** | **53662.8** | **700.9** | **2049.5** | **55339.8** |

---

**(b.1) Purchase of shares and result of treasury shares**

Treasury shares represent the Company's own issued shares reacquired by the Company, and the results of treasury shares related to gains and losses on share-based payment transactions and others.

The changes in treasury shares are as follow:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Acquisition /realization of shares** | **Acquisition /realization of shares** | **Result of Treasury Shares** | **Total Treasury Shares** |
|  | **Million shares** | **Million Brazilian Reais** | **Million shares** | **Million Brazilian Reais** |
| **At January 1, 2020** | **3.6** | **(68.2)** | **(887.0)** | **(955.2)** |
| Changes during the year | (3.4) | 65.0 | (51.5) | 13.5 |
| **At December 31, 2020** | **0.2** | **(3.2)** | **(938.5)** | **(941.7)** |
| Changes during the year | 5.6 | (95.1) | (1.0) | (96.1) |
| **At December 31, 2021** | **5.8** | **(98.3)** | **(939.5)** | **(1037.8)** |
| Changes during the year | 2.7 | (33.5) | (2.1) | (35.6) |
| **At December 31, 2022** | **8.5** | **(131.8)** | **(941.6)** | **(1073.4)** |

---

[**Table of Contents**](#toc)

**(b.2) Share premium**

The share premium refers to the difference between the subscription price that the shareholders paid for the shares and their nominal value. Since this is a capital reserve, it can only be used to increase capital, offset losses, or for the redemption, reimbursement or repurchase of shares.

**(b.3) Share-based payment**

Different share-based payment programs and stock purchase option plans allow the senior management from Ambev's economic group to acquire shares in the Company.

The share-based payment reserve recorded a charge of R$313.9 in 2022 (R$387.6 and R$208.7 in 2021 and 2020, respectively) (Note 25 - *Share-based payments*).

**(c) Net income reserves**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Net income reserves** | **Net income reserves** | **Net income reserves** | **Net income reserves** |
|  | **Investments reserve** | **Legal reserve** | **Fiscal incentive** | **Total** |
| **At January 1, 2020** | **10798.1** | **4.5** | **10071.6** | **20874.2** |
| Fiscal incentive reserve |  |  | 1332.8 | 1332.8 |
| Investments reserve | 3713.0 | - | - | 3713.0 |
| **At December 31, 2020** | **14511.1** | **4.5** | **11404.4** | **25920.0** |
| Fiscal incentive reserve |  |  | 1423.5 | 1423.5 |
| Investments reserve | 3848.1 | - | - | 3848.1 |
| **At December 31, 2021** | **18359.2** | **4.5** | **12827.9** | **31191.6** |
| Fiscal incentive reserve |  |  | 2018.7 | 2018.7 |
| Investments reserve | 3696.7 | - | - | 3696.7 |
| **At December 31, 2022** | **22055.9** | **4.5** | **14846.6** | **36907.0** |

---

**(c.1) Investments reserve**

From the net income after applicable deductions, there will be a target allocating of no more than 60% (sixty per cent) of the adjusted net profit to the investment reserve, to be used to support future investments, as defined in the Company's bylaws.

**(c.2) Legal reserve**

From the net income, 5% will be applied before any other allocation, to the legal reserve, which cannot exceed 20% of the capital stock. The Company is not required to supplement the legal reserve for the year when the balance of this reserve, plus the amount of the capital reserves, exceeds 30% of the capital stock.

**(c.3) Tax incentives**

The Company recognizes in its equity, in the net income reserves line, the fiscal incentives regarding tax benefits at the respective fiscal year. All the tax incentives are under certain state and federal industrial development programs in the form of rate reduction, reduction

[**Table of Contents**](#toc)

of calculation basis, financing or subsidized loans, assumed credit, effective collection, the deferred payment or partial reductions in the payable state tax amount.

These programs aim to generate employment, promote regional decentralization, and complement and diversify the industrial base of the states. In these states, the grace periods and use and reductions are set out according to the legislation upon which those incentives are based on, depending on their nature, when conditions for obtaining these grants exist, they are under Company's control. Such benefits comply with the systematic set by Complementary Federal Law 160/2017 and by *Convênio* CONFAZ 190/2017. Due to change in article 30 of Federal Law 12,973/14 by Complementary Federal Law 160/2017, state fiscal incentives related to sales taxes are recognized as government subsidies for investments.

**(c.4) Interest on shareholders' equity/dividends**

Brazilian companies are permitted to distribute the interest attributed to shareholders' equity calculated based on the long-term interest rate ("TJLP"), with such interest being tax-deductible, in accordance with the applicable law and, when distributed, may be considered part of the minimum mandatory dividends.

As determined by its by-laws, the Company is required to distribute to its shareholders, as a minimum mandatory dividend in respect of each fiscal year ending December 31, an amount of not less than 40% of its net income determined under Brazilian law, adjusted in accordance with the applicable law, unless the payment of such amount would be incompatible with Ambev's financial situation. The minimum mandatory dividend includes amounts paid as interest on shareholders' equity.

*Events during the year ended 2022:*

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Event** | **Approval** | **Type** | **Date of payment** | **Year** | **Type of share** | **Amount per share** | **Total amount** |
| Board of Directors Meeting | 6/12/2022 | Interest on shareholder´s equity | 12/29/2022 | 2022 | ON | 0.7623 | 11999.8 |
|  |  |  |  |  |  |  | **11999.8** |

---

 

<u>Distribution of interest on shareholders' equity</u>. In accordance with the Operations and Finance Committee recommendation at the meeting held on December 5, 2022, a distribution of interest on shareholders' equity in the amount of R$0.7623 per share was approved, based on available balances, in the Company's extraordinary balance sheet dated as at October 31, 2022, and in the Company's investment reserve, pursuant to the balance sheet dated as at December 31, 2021, which were attributed to the minimum mandatory dividends of the same fiscal year. The interest on the shareholders' equity distribution was taxed pursuant to the applicable law, which resulted in a net interest on shareholder's equity distribution of R$0.6480 per Company share in fiscal year 2022.

[**Table of Contents**](#toc)

The indicated payment was made on December 29, 2022, considering the shareholding position of December 19, 2022 with respect to B3 S.A. – ("Brasil, Bolsa, Balcão"), and December 21, 2022 with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.

 

*Events during the year ended 2021:*

 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Event** | **Approval** | **Type** | **Date of payment** | **Year** | **Type of share** | **Amount per share** | **Total amount** |
| Board of Directors Meeting | 12/09/2021 | Dividends | 12/30/2021 | 2021 | ON | 0.1334 | 2099.5 |
| Board of Directors Meeting | 12/09/2021 | Interest on shareholder´s equity | 12/30/2021 | 2021 | ON | 0.4702 | 7400.1 |
|  |  |  |  |  |  |  | **9499.6** |

---

 

<u>Distribution of Dividends</u>. In accordance with the recommendation of the Operations, Finance and Compensation Committee at a meeting held on December 7, 2021, a distribution of dividends of R$0.1334 per share was approved, based on available balance and the Company's extraordinary balance sheet dated as at November 30, 2021 and attributed to the minimum mandatory dividends for the same fiscal year, without income tax withholding in accordance with current legislation.

The indicated payment was made on December 30, 2021 considering the shareholding position of December 17, 2021 with respect to B3 S.A. – ("Brasil, Bolsa, Balcão"), and December 21, 2021 with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.

<u>Distribution of interest on shareholders' equity</u>. In accordance with the recommendation of the Operations, Finance and Compensation Committee at a meeting held on December 7, 2021, a distribution of interest on shareholders' equity of R$0.4702 per share was approved, based on the available balance and the Company's extraordinary balance sheet dated as at November 30, 2021 and attributed to the minimum mandatory dividends for the same fiscal year. The distribution of interest on shareholder's equity was taxed pursuant to applicable law, which resulted in a net distribution of interest on shareholder's equity of R$0.3996 per share.

The indicated payment was made on December 30, 2021, considering the shareholding position of December 17, 2021 with respect to B3 S.A. – ("Brasil, Bolsa, Balcão"), and December 21, 2021 with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.

 

[**Table of Contents**](#toc)

*Events during the year ended 2020:*

 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Event** | **Approval** | **Type** | **Date of payment** | **Year** | **Type of share** | **Amount per share** | **Total amount** |
| Board of Directors Meeting | 12/21/2020 | Dividends | 01/28/2021 | 2020 | ON | 0.0767 | 1206.9 |
| Board of Directors Meeting | 12/09/2020 | Interest on shareholder´s equity | 12/30/2020 | 2020 | ON | 0.4137 | 6509.5 |
|  |  |  |  |  |  |  | **7716.4** |

---

<u>Distribution of Dividends</u>. In accordance with the recommendation of the Operations, Finance and Compensation Committee at a meeting held on December 21, 2020, a distribution of dividends of R$0.0767 per share was approved, based on available balance and the Company's extraordinary balance sheet dated as at November 30, 2020 and attributed to the minimum mandatory dividends for the same fiscal year, without income tax withholding in accordance with current legislation.

The indicated payment was made on January 28, 2021 considering the shareholding position of January 13, 2021 with respect to B3 S.A. – ("Brasil, Bolsa, Balcão"), and January 15, 2021 with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.

<u>Distribution of interest on shareholders' equity</u>. In accordance with the recommendation of the Operations, Finance and Compensation Committee at a meeting held on December 9, 2020, a distribution of interest on shareholder's equity of R$0.4137 per share was approved, based on available balance and the Company's extraordinary balance sheet dated as at November 30, 2020 and attributed to the minimum mandatory dividends for the same fiscal year. The distribution of interest on shareholder's equity was taxed pursuant to applicable law, which resulted in a net distribution of interest on shareholders' equity of R$0.3517 per share.

The indicated payment was made on December 30, 2020, considering the shareholding position of December 17, 2020 with respect to B3 S.A. – ("Brasil, Bolsa, Balcão"), and December 21, 2020 with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.

[**Table of Contents**](#toc)

**(d) Carrying value adjustments**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Carrying value adjustments** | **Carrying value adjustments** | **Carrying value adjustments** | **Carrying value adjustments** | **Carrying value adjustments** | **Carrying value adjustments** | **Carrying value adjustments** | |
|  | **Translation reserves** | ***Cash flow hedge*** | **Actuarial gains/ (losses)** | **Put option granted on subsidiary** | **Gains/(losses) of non-controlling interest's share** | **Business combination** | **Accounting adjustments for transactions between shareholders** | **Total** |
| **At January 1, 2020** | **3583.4** | **645.1** | **(1221.0)** | **(50.2)** | **14.5** | **156.1** | **(75402.4)** | **(72274.5)** |
| Comprehensive income: |  |  |  |  |  |  |  |  |
| Gains/(losses) on the translation of foreign operations | 7493.1 |  |  |  |  |  |  | 7493.1 |
| Cash flow hedges |  | 99.4 |  |  |  |  |  | 99.4 |
| Actuarial gains/(losses) |  |  | (252.3) |  |  |  |  | (252.3) |
| **Total Comprehensive income** | **7493.1** | **99.4** | **(252.3)** | **-** | **-** | **-** | **-** | **7340.2** |
| Options granted on subsidiaries |  |  |  | 45.2 | (82.6) |  |  | (37.4) |
| Gains/(losses) of controlling interest |  |  |  |  | 0.4 |  |  | 0.4 |
| Tax on deemed dividends |  |  |  |  | (5.9) |  |  | (5.9) |
| Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting | - | - | - | - | - | - | (11.8) | (11.8) |
| **At December 31, 2020** | **11076.5** | **744.5** | **(1473.3)** | **(5.0)** | **(73.6)** | **156.1** | **(75414.2)** | **(64989.0)** |
| Comprehensive income: |  |  |  |  |  |  |  |  |
| Gains/(losses) on the translation of foreign operations | 2449.7 |  |  |  |  |  |  | 2449.7 |
| Cash flow hedges |  | 480.8 |  |  |  |  |  | 480.8 |
| Actuarial gains/(losses) |  |  | 341.8 |  |  |  |  | 341.8 |
| **Total Comprehensive income** | **2449.7** | **480.8** | **341.8** | **-** | **-** | **-** | **-** | **3272.3** |
| Options granted on subsidiaries |  |  |  | (1.9) |  |  |  | (1.9) |
| Gains/(losses) of controlling interest |  |  |  |  | (46.2) |  |  | (46.2) |
| Tax on deemed dividends |  |  |  |  | (1.7) |  |  | (1.7) |
| Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting | - | - | - | - | - | - | (11.8) | (11.8) |
| **At December 31, 2021** | **13526.2** | **1225.3** | **(1131.5)** | **(6.9)** | **(121.5)** | **156.1** | **(75426.0)** | **(61778.3)** |
| Comprehensive income: |  |  |  |  |  |  |  |  |
| Gains/(losses) on the translation of foreign operations | (6772.2) |  |  |  |  |  |  | (6772.2) |
| Cash flow hedges |  | (316.7) |  |  |  |  |  | (316.7) |
| Actuarial gains/(losses) |  |  | 466.5 |  |  |  |  | 466.5 |
| **Total Comprehensive income** | **(6772.2)** | **(316.7)** | **466.5** | **-** | **-** | **-** | **-** | **(6622.4)** |
| Gains/(losses) of controlling interest |  |  |  |  | (2.8) |  |  | (2.8) |
| Tax on deemed dividends |  |  |  |  | (6.2) |  |  | (6.2) |
| Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting | - | - | - | - | - | - | (11.8) | (11.8) |
| **At December 31, 2022** | **6754.0** | **908.6** | **(665.0)** | **(6.9)** | **(130.5)** | **156.1** | **(75437.8)** | **(68421.5)** |

---

[**Table of Contents**](#toc)

**(d.1) Translation reserves**

The translation reserves comprise all foreign currency exchange differences arising from the translation of the financial statements with a functional currency different to the Real.

The translation reserves also comprise the portion of the gain or loss on the foreign currency liabilities and on the derivative financial instruments determined to be effective net of investment hedges.

**(d.2) Cash flow hedge reserves**

The hedging reserves represent the effective portion of the cumulative net change in the fair value of cash flow hedges to the extent that the hedged risk has not yet impacted profit or loss (for additional information, see Note 28 - *Financial instruments and risks)*.

**(d.3) Actuarial gains and losses**

Actuarial gains and losses include expectations regarding future pension plan obligations. Consequently, the results of actuarial gains and losses are recognized on a timely basis considering the best estimates available to Management. Accordingly, the Company recognizes the results of these estimated actuarial gains and losses, on a monthly basis, based on the expectations presented in the independent actuarial report.

In March, 2021, an actuarial loss of R$56,940 arising from the deficit on the defined benefits plan was fully recorded under actuarial gains and losses as a counterpart to the balance receivable originally recorded. There were no actuarial gains or losses arising from surplus or deficit in 2022.

**(d.4) Accounting adjustments for transactions between shareholders**

As determined by IFRS 10, any difference between the amount paid (fair value) for the acquisition of a non-controlling interest and the carrying amount of such non-controlling interest shall be recognized directly in the controlling shareholders' equity. The acquisition of the non-controlling interest related to Former Ambev and the abovementioned adjustment was recognized in Carrying value adjustments when applicable.

[**Table of Contents**](#toc)

**(e) Earnings per share**

**Basic and diluted earnings per share of the stock option and deferred stock**

The calculation of the basic earnings per share is based on the net income attributable to the equity holders of Ambev and the proportional weighted average number of shares outstanding during the year.

The diluted earnings per share of the stock option and deferred stock is based on the net income attributable to the equity holders of Ambev, adjusted by the weighted average number of shares outstanding during the year to assume the conversion of all potentially dilutive shares, as follows:

---

| | | | |
|:---|:---|:---|:---|
| Million shares | **2022** | **2021** | **2020** |
|  | **Common** | **Common** | **Common** |
| Weighted average number of shares at December 31 <sup>(i)</sup> | 15741.9 | 15736.9 | 15733.1 |
| Effect of shares options | 106.7 | 120.5 | 134.5 |
| **Weighted average number of shares (diluted) at December 31** | **15848.6** | **15857.4** | **15867.6** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) Not including treasury shares.

The tables below present the calculation of earnings per share ("EPS"):

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
|  | **Common** | **Common** | **Common** |
| Income attributable to the equity holders of Ambev | 14457.9 | 12671.0 | 11379.4 |
|  Weighted average number of shares (non diluted) | 15741.9 | 15736.9 | 15733.1 |
|  **Basic EPS** **<sup>(i)</sup>** | **0.9184** | **0.8052** | **0.7233** |
| Income attributable to the equity holders of Ambev | 14457.9 | 12671.0 | 11379.4 |
|  Weighted average numbers of shares (diluted) | 15848.6 | 15857.5 | 15867.6 |
|  **Diluted EPS** **<sup>(i)</sup>** | **0.9123** | **0.7991** | **0.7171** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) Expressed in Brazilian Reais.

**(f) Destinations**

At December 31, 2022, the Company made appropriations to retained earnings, in accordance with the Brazilian Corporate law and the Company's bylaws. The dividends payments made up to December 31, 2022 were approved at the Board of Directors' Meeting.

Regarding the basis for dividends, the Company believes that the predecessor basis of accounting, as well as its presentation for comparative purposes, will not affect the determination of the minimum mandatory dividend. Therefore, the Company intends to adjust the calculation basis of the minimum mandatory dividend to cancel out any current and future impacts on net income arising from the adoption of this accounting practice, related to the amortization or depreciation of surplus assets or even a possible impairment of goodwill, thus preserving the mandatory minimum dividends.

[**Table of Contents**](#toc)

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| **Net income, attributable to equity holders of Ambev** | **14457.9** | **12671.0** | **11379.4** |
| Prescribed/(complementary) dividends | 20.9 | 24.7 | 26.1 |
| Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting | 11.8 | 11.8 | 11.8 |
| Effect of application of IAS 29 (hyperinflation) | 3224.4 | 2063.7 | 1344.9 |
| **Retained earnings basis for dividends and destinations** | **17715.0** | **14771.2** | **12762.2** |
| **Dividends and interest on capital distributed and accrued for distribution based on the net income for the year** |  |  |  |
| Dividends and interest on capital paid based on profit | 11999.8 | 9499.6 | 7716.4 |
| **Total of dividends and interest on capital** | **11999.8** | **9499.6** | **7716.4** |
| Percentage of distributed profit | 68% | 64% | 60% |

---

**23.** **INTEREST-BEARING LOANS AND BORROWING** 

---

| | | |
|:---|:---|:---|
|  | **2022** | **2021** |
| Secured bank loans | 126.2 | 174.3 |
| Other unsecured loans | 328.1 | 92.9 |
| Lease liabilities | 2333.8 | 1986.3 |
| **Non-current liabilities** | **2788.1** | **2253.5** |
| Secured bank loans | 54.5 | 72.8 |
| Unsecured bank loans |  | 84.1 |
| Other unsecured loans | 144.5 | 37.2 |
| Lease liabilities | 783.6 | 653.0 |
| **Current liabilities** | **982.6** | **847.1** |

---

Additional information regarding the exposure of the Company to interest rate, foreign currency risk and debt repayment schedule is disclosed in Note 28 - *Financial instruments and risks*.

At December 31, 2022 and 2021 the Company's debts were exposed to the following interest rates:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  |  | **2022** | **2022** |  | **2021** | **2021** |
| **Debt instruments** | **Average rate %** | **Current** | **Non-current** | **Average rate %** | **Current** | **Non-current** |
| Debt denominated in US Dollars fixed rate | 14.00% | 6.2 |  | 13.12% | 17.5 |  |
| Reais denominated floating rate (CDI and DI) |  |  |  | 11.56% | 83.0 |  |
| Other Latin American currencies fixed rate | 10.39% | 98.8 | 322.5 | 11.34% | 48.7 | 177.3 |
| Debt denominated in CAD Dollars fixed rate | 5.32% | 123.3 | 387.7 | 2.49% | 91.6 | 339.2 |
| Reais denominated floating rate (TJLP and TR) | 9.61% | 12.3 | 125.1 |  |  |  |
| Reais debt - ICMS fixed rate | 2.95% | 113.3 | 266.4 | 5.06% | 37.3 | 92.9 |
| Reais debt - ICMS floating rate | 6.97% | 31.1 | 61.7 |  |  |  |
| Reais debt - fixed rate | 9.43% | 597.6 | 1624.7 | 7.33% | 569.0 | 1644.1 |
| **Total** |  | **982.6** | **2788.1** |  | **847.1** | **2253.5** |

---

[**Table of Contents**](#toc)

**Reconciliation of liabilities arising from financing activities**

The tables below detail the changes in the Company's liabilities arising from financing activities, including both cash and non-cash changes. Liabilities arising from financing activities are those for which cash flow was, or future cash flow will be classified in the company's consolidated statement of cash flow from financing activities.

---

| | | |
|:---|:---|:---|
|  | **Current liabilities** | **Non - current liabilities** |
| **December 31, 2021** | **847.1** | **2253.5** |
| Proceeds | 7.9 | 267.0 |
| Payments | (230.2) |  |
| Foreign exchange | (17.4) | (56.8) |
| Transfers between current and non-current | 761.0 | (761.0) |
| New lease agreements | 469.2 | 905.3 |
| Interest on leases | 159.3 |  |
| Payment of lease liabilities | (1014.0) |  |
| Other movements | (0.3) | 180.1 |
| **December 31, 2022** | **982.6** | **2788.1** |

---

**Contractual clauses (Covenants)**

As at December 31, 2022, as well as at December 31, 2021 the Company's loans had equal rights to payment without subordination clauses. For the credit lines due to FINAME contracted by the Company with Banco Nacional de Desenvolvimento Econômico e Social ("BNDES"), the assets acquired using the credit granted were placed as collateral. Other loans and financing contracted by the Company require various guarantees as collateral, such as warranty or real estate, or are unsecured. Most loan contracts contain contractual covenants, including: financial covenants, including actions that can reduce the ability to pay the loans; maintenance of the Company's assets, purposing to assure that all remain under usage condition; restrictions on acquisitions, mergers, sales or disposals of its assets; disclosure of financial statements and the balance sheet; no prohibitions related to new guarantees for loans contracted, except if: (i) expressly authorized under the agreement; (ii) new loans contracted from financial institutions linked to the Brazilian government including BNDES or foreign governments; or foreign governments, multilateral financial institutions (e.g. the World Bank) or in jurisdictions in which the Company operates.

Additionally, all agreements with BNDES are subject to certain "provisions applicable to agreements entered into with BNDES" ("Provisions"). Such Provisions require the borrower to obtain prior consent from BNDES if they, for instance, wish to: (i) raise new loans (except for the loans described in the Provisions); (ii) give preference and/or priority to other debts; and/or (iii) dispose of or encumber any items of their fixed assets (except as provided for within the Provisions).

These clauses are applicable from the date of execution and effectiveness of each contract to the extent that the events mentioned in the contract occur. Depending on the materiality of each event and its potential adverse effects on the Company and /or its subsidiaries or the rights of its creditors, contractual penalties may be applied, including the early maturity of the respective contract. In certain contracts, in the event of occurrence of any of the events

[**Table of Contents**](#toc)

set out in the restrictive clauses, the Company may be granted a grace period to resolve any contractual defaults, in order to avoid any penalties resulting from the breach of its obligations.

Lastly, regarding the tax incentives on financing or subsidized loans, these are subject to the fulfillment of several commitments according to the legislation or contracts upon which those incentives are based on, such as (i) maintenance of jobs or job creation; (ii) realization of investments; (iii) increase in production capacity; (iv) commitment to collect ICMS; (v) maintenance of fiscal good standing; among others, obligations that refer to facts under the Company's control. These commitments are applicable as from the signature date of the respective contracts related to fiscal benefits.

As at December 31, 2022, as well as at December 31, 2021 the Company was in compliance with all of its contractual obligations for its loans and financing.

**24.** **EMPLOYEE BENEFITS** 

The Company sponsors post-employment benefits, such as retirement plans, medical and dental care, among others for employees in Brazil and subsidiaries located in the Dominican Republic, Barbados, Panama, Uruguay, Bolivia, Argentina and Canada based on employees' salaries and length of service. The entities are governed by the local regulations and practices of each individual country as well as the relationship with the Company's pension funds and their composition.

Post-employment benefits of retirement are managed through pension funds and are classified as either defined contribution or defined benefit plans.

Defined benefit plans and the other post-employment benefits are not granted to new retirees.

**Defined contribution plans**

These plans are funded by the participants and the sponsor and are managed by administered pension funds. During 2022, the Company contributed R$82.0 (R$74.1 and R$61.1 during 2021 and 2020) to these funds, which was recorded in expenses. Once the contributions have been paid, the Company has no further payment obligations.

[**Table of Contents**](#toc)

**Defined benefit plans**

At December 31, 2022, 2021 and 2020 the net liability for defined benefit plans consisted of the following:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| Present value of funded obligations | (5476.5) | (7354.3) | (7582.0) |
| Fair value of plan assets | 4543.3 | 5638.0 | 5533.3 |
| **Present value of net obligations** | **(933.2)** | **(1716.3)** | **(2048.7)** |
| Present value of unfunded obligations | (921.0) | (1165.4) | (1195.6) |
| **Present value of net obligations** | **(1854.2)** | **(2881.7)** | **(3244.3)** |
| Asset ceiling | (163.3) | (180.1) | (160.5) |
| **Net liabilities** | **(2017.5)** | **(3061.8)** | **(3404.8)** |
| Other long term employee benefits | (87.1) | (104.3) | (105.5) |
| **Total employee benefits** | **(2104.6)** | **(3166.1)** | **(3510.3)** |
| Employee benefits amount in the balance sheet |  |  |  |
| Liabilities | (2161.2) | (3194.0) | (3543.9) |
| Assets | 56.6 | 27.9 | 33.6 |
| **Net liabilities** | **(2104.6)** | **(3166.1)** | **(3510.3)** |

---

The changes in the present value of the defined benefit obligations were as follow:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| **Defined benefit obligation at January 1** | **(8519.7)** | **(8777.6)** | **(6845.0)** |
| Service costs | (47.0) | (58.0) | (51.4) |
| Interest costs | (353.2) | (324.3) | (339.4) |
| Gains and (losses) on settlements or reductions in benefits | 3.8 | 3.6 | 44.1 |
| Contributions by plan participants | (5.6) | (6.9) | (6.1) |
| Actuarial gains and (losses) - geographical assumptions |  | 52.3 | 54.5 |
| Actuarial gains and (losses) - financial assumptions | 1333.6 | 726.8 | (443.6) |
| Experience adjustments | (171.5) | (213.0) | (180.9) |
| Reclassifications |  | (1.0) |  |
| Effect of exchange rate fluctuations | 787.7 | (495.3) | (1531.7) |
| Benefits paid | 574.4 | 573.7 | 521.9 |
| **Defined benefit obligation at December, 31** | **(6397.5)** | **(8519.7)** | **(8777.6)** |

---

The present value of funded obligations includes R$665.4 at December 31, 2022 (R$603.9 at December 31, 2021 and R$705.0 at December 31, 2020) of two health care plans for which the benefits were provided directly by Fundação Zerrenner. Fundação Zerrenner is a legally distinct entity whose main goal is to provide the Company's current and retired employees and managers with health care and dental assistance, technical and higher education courses, and to maintain facilities for assisting and helping elderly people, among other matters, either through direct initiatives or through financial assistance agreements with other entities.

[**Table of Contents**](#toc)

The changes in the fair value of plan assets are as follow:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| **Fair value of plan assets at January 1** | **5638.0** | **5533.3** | **4582.4** |
| Interest income | 262.1 | 223.9 | 245.2 |
| Administrative costs | (5.2) | (5.8) | (5.2) |
| Expected return, excluding interest income | (614.6) | (148.3) | 89.4 |
| Contributions by employer | 316.0 | 342.0 | 306.8 |
| Contributions by plan participants | 5.8 | 7.1 | 6.3 |
| Exchange differences | (482.6) | 263.1 | 812.1 |
| Transfers |  |  | 20.0 |
| Curtailments, settlements and other | (1.8) | (3.6) | (1.8) |
| Benefits paid, excluding administrative costs | (574.4) | (573.7) | (521.9) |
| **Fair value of plan assets at December, 31** | **4543.3** | **5638.0** | **5533.3** |

---

At December 31, 2022, the Company recorded R$56.6 (R$27.9 at December 31, 2021) up to the asset ceiling not exceeding the present value of future benefits.

The changes in the asset ceiling not exceeding the present value of future benefits are as follow:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| **Asset ceiling impact at January 1** | **27.9** | **33.6** | **56.2** |
| Interest income/(expenses) |  | 1.3 | 12.2 |
| Change in asset ceiling excluding amounts included in interest income/(expenses) | 30.2 | (9.0) | (48.9) |
| Effects of exchange rate fluctuations | (1.5) | 2.0 | 14.1 |
| **Asset ceiling impact at December 31** | **56.6** | **27.9** | **33.6** |

---

The income/(expense) recognized in the income statement with regard to defined benefit plans is detailed as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| Current service costs | (47.0) | (58.0) | (51.4) |
| Administrative costs | (5.2) | (5.8) | (5.2) |
| (Gains) losses on settlement and curtailment | 2.2 | 1.2 | 42.6 |
| **Income from operations** | **(50.0)** | **(62.6)** | **(14.0)** |
| Financial costs | (107.8) | (115.6) | (117.2) |
| **Total employee benefit expenses** | **(157.8)** | **(178.2)** | **(131.2)** |

---

[**Table of Contents**](#toc)

The employee benefit revenue/(expenses) is included in the following line items in the income statement:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| Other operating income/(expenses), net | (0.1) | (0.2) |  |
| Cost of sales | (26.4) | (33.0) | (28.9) |
| Sales and marketing expenses | (9.4) | (11.7) | (9.9) |
| Administrative income/(expenses) | (14.1) | (17.7) | 24.8 |
| Financial expense | (107.8) | (115.6) | (117.2) |
|  | **(157.8)** | **(178.2)** | **(131.2)** |

---

The assumptions used in the calculation of the obligations are as follow:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** **<sup>(i)</sup>** | **2021** **<sup>(i)</sup>** | **2020** **<sup>(i)</sup>** |
| Discount rate | 5.1% to 11.0% | 2.9% to 10.0% | 2.4% to 10.0% |
| Inflation | 2.0% to 3.5% | 2.0% to 3.5% | 2.0% to 3.5% |
| Future salary increases | 1.0% to 7.1% | 1.0% to 7.1% | 1.0% to 7.1% |
| Future pension increases | 2.7% to 3.8% | 2.5% to 3.8% | 2.0% to 3.8% |
| Medical cost trend rate | 6.4% to 7.1% p.a. reducing to 7.1% | 4.2% to 6.9% p.a. reducing to 6.9% | 4.5% to 6.9% p.a. reducing to 6.9% |
| Dental claims trend rate | 3.5% | 3.3% | 3.3% |
| Life expectancy for an over 65 years old male | 84 to 87 | 85 to 87 | 84 to 87 |
| Life expectancy for an over 65 years old female | 86 to 89 | 87 to 89 | 86 to 89 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) Includes assumptions in Brazil, Central America and Caribbean, Latin America - South and Canada.

Through its defined benefit pension plans and post-employment medical plans, the Company is exposed to a number of risks, the most significant of which are detailed below:

**Asset volatility**

The plan liabilities are calculated using a discount rate pegged to high-quality private securities; if plan assets underperform this yield, the Company's net defined benefit obligation may increase. Most of the Company's funded plans hold a significant proportion of equities, which are expected to outperform corporate bonds in the long-term while providing volatility and risk in the short-term. As the plans mature, the Company usually reduces the level of investment risk by investing more in assets that better match the liabilities.

**Changes in bond yields**

A decrease in corporate bond yields will increase plan liabilities, although this will be partially offset by an increase in the value of the plans' bond holdings.

**Inflation risk**

Some of the Company's pension obligations are linked to inflation, and higher inflation will lead to higher liabilities. The majority of the plan's assets are either unaffected by or only

[**Table of Contents**](#toc)

loosely correlated with inflation, meaning that an increase in inflation could potentially increase the Company's net benefit obligation.

**Life expectancy**

Most of the plans' obligations are to provide benefits for the life of the member, so increases in life expectancy will result in an increase in the plans' liabilities.

**Investment strategy**

In the case of funded plans, the Company ensures that the investment positions are managed within an asset-liability matching ("ALM") framework to ensure long-term investments that are in line with the Company's obligations under the pension schemes. Within this framework, the Company's ALM objective is to match the assets to the pension obligations by investing in long-term fixed interest securities with maturities that match the benefit payments as they fall due and in the appropriate currency.

The sensitivity of the defined benefit obligation to changes in the weighted principal assumptions is as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **In millions of Brazilian Reais** |  | **2022** | **2022** | **2021** | **2021** | **2020** | **2020** |
|  | **Change in assumption** | **Increase in assumption** | **Decrease in assumption** | **Increase in assumption** | **Decrease in assumption** | **Increase in assumption** | **Decrease in assumption** |
| Medical cost trend rate | 100 bases points | (94.3) | 81.8 | (114.7) | 98.6 | (139.4) | 118.6 |
| Discount rate | 50 bases points | 307.9 | (328.0) | 442.0 | (470.3) | 461.0 | (492.6) |
| Future salary increase | 50 bases points | (17.6) | 16.5 | (19.8) | 18.6 | (24.3) | 23.3 |
| Longevity | One year | (221.5) | 213.5 | (287.6) | 279.5 | (295.6) | 287.1 |

---

The data presented in these tables are purely hypothetical and are based on changes in individual assumptions holding all other assumptions constant: economic conditions and changes therein always affect the other assumptions at the same time and their effects are not linear. Therefore, the above information is not necessarily a reasonable representation of future results.

The plans assets at December 31, 2022, 2021 and 2020 consisted of the following:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **2022** | **2022** | **2022** | **2021** | **2021** | **2021** | **2020** | **2020** | **2020** |
|  | **Rated** | **Unrated** | **Total** | **Rated** | **Unrated** | **Total** | **Rated** | **Unrated** | **Total** |
| Government bonds | 43% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 43% | 43% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 43% | 52% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 52% |
| Corporate bonds | 10% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 10% | 10% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 10% | 6% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 6% |
| Equity instruments | 15% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 15% | 15% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 15% | 6% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 6% |
| Cash | 6% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 6% | 6% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 6% | 1% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 1% |
| Others | 26% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 26% | 26% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 26% | 35% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 35% |

---

The overall expected rate of return is calculated by weighting the individual rates in accordance with Ambev's expected share of the total investment portfolio.

[**Table of Contents**](#toc)

Ambev expects to contribute approximately R$309.7 to its defined benefit plans in 2023.

**25.** **SHARE-BASED PAYMENTS** 

Currently the Company has two plans for share-based payment programs: (i) the Stock Option Plan, approved in Extraordinary General Meeting of July 30, 2013 ("Stock Option Plan") and (ii) the Share-based Payment Plan approved in Extraordinary General Meeting of April 29, 2016, as amended in Extraordinary General Meeting of April 24, 2020 ("Share-Based Plan"). In each plan different restricted stock options and share-based payment programs are issued periodically which allow the employees and senior management of the Company and its subsidiaries to acquire, through the exercise of stock options, or receive shares of the Company.

**(i) Stock Option Plan**

There are three models of stock options that may be granted under the Stock Option Plan.

Under the first model, beneficiaries, in accordance with their internal category, could choose between allocating (a) 30% or 100%, (b) 40% or 100%, and (c) 60% or 100% of the amounts received by them as profit-sharing regarding the immediate year to the exercise of stock options, thereby allowing them to acquire the corresponding amount of Ambev shares. Under this model, a substantial part of the shares acquired is to be delivered only within five years from the corresponding stock option grant date. During such five-year period, the beneficiary must remain employed at Ambev or in any other company of its group.

Under the second model, the beneficiary may exercise the stock options granted only after a period of up to five years from the corresponding grant date. Vesting of the stock options granted under the second model is not subject to the company's performance measures; however, the right to exercise such options may be forfeited in certain circumstances, including the beneficiary's resignation or dismissal prior to the stock options' vesting.

Under the third model, the beneficiaries, in accordance with their internal category, may choose between allocating (a) 20% or 100%, (b) 30% or 100%, and (b) 50% or 100%, of the amounts received by them as profit-sharing regarding the immediate year, to the exercise of stock options, acquisition of the corresponding amount of Ambev shares. The totality of the shares acquired is to be delivered to the beneficiary within forty-five days from the corresponding stock option exercising date (which shall not be later than forty-five days from the stock option grant date). The beneficiaries of this third model are under a five-year lock-up period.

For all stock option programs, the fair value of the shares is estimated as at the option grant date, using the "Hull Binomial" pricing model, adjusted to reflect the IFRS 2 - *Share-based Payment* requirement that assumptions regarding forfeiture before the end of the vesting period cannot impact the fair value of the option. The fair value of the share options is estimated at the grant date, using an option pricing model. Based on the expected number of options that will be

[**Table of Contents**](#toc)

exercised, the fair value of the options granted is recognized as an expense over the vesting period with a corresponding credit to equity. When the options are exercised, the equity is increased by the amount of the proceeds received.

**(ii) Share-Based Plan**

In this plan, certain employees and members of the Management of the Company or its subsidiaries are eligible to receive shares in the Company including in the form of ADRs. The shares that are subject to the Share-Based Plan are designated as "restricted shares" (RSUs) or "performance shares" (PSUs).

The delivery of restricted shares and performance shares are made free, and the waiting period may vary between three and five years from the corresponding share-based plan stock grant date, during which the beneficiary must remain employed at Ambev or any other company of its group.

The restricted shares and performance shares give to participates the right to receive additional shares with the same conditions, such as compensation dividends and Interest on shareholder´s equity declared and paid by the Company during the waiting period. The right to receive restricted, performance and additional shares, can be fully or partially lost depending on circumstances, including cases of resignation or resignation during the grace period.

Under the Share-Based Plan, the reference price per restricted share is defined on the stock-grant date based on the share price of the trading session on B3 S.A. immediately prior to the granting of the shares, except for the performance shares, which the fair value is defined at the grant date based on "Monte Carlo" pricing method. After defining the reference price, based on number of grant shares, the calculated amount is recorded as expense against equity. The shares are transferred to attendees according to the terms and periods by the respective programs.

The weighted average fair value of the options and assumptions used to apply the Company's option pricing model for 2022, 2021 and 2020 was as follows:

---

| | | | |
|:---|:---|:---|:---|
| *In R$* | **2022** | **2021** | **2020**<sup>(i)</sup> |
| Fair value of options granted | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 4.04 |
| Share price | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 18.05 |
| Exercise price | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 18.05 |
| Expected volatility | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 22.3% |
| Vesting year | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 5 |
| Expected dividends | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 5% |
| Risk-free interest rate | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 6.8% <sup>(ii)</sup> |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) Information based on weighted average plans granted, except for the expected dividends and risk-free interest rate.

&nbsp;&nbsp;&nbsp;&nbsp;(ii) The percentages include the grants of stock options and ADRs during the period, with the risk-free interest rate of ADRs calculated in
U.S. Dollar.

[**Table of Contents**](#toc)

The total number of outstanding options developed was as follows:

---

| | | | |
|:---|:---|:---|:---|
| *Thousand options* | **2022** | **2021** | **2020** |
| **Options outstanding at January** | **113760** | **127265** | **141736** |
| Options issued during the period | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 22 |
| Options exercised during the period | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | (5247) | (5730) |
| Options forfeited during the period | (14043) | (8258) | (8763) |
| **Options outstanding at the end of the year** | **99717** | **113760** | **127265** |

---

The range of exercise prices of the outstanding options was from R$15.95 (R$15.95 in 2021 and R$11.972 in 2020) to R$39.04 (R$45.97 in 2021 and R$43.95 in 2020) and the weighted average remaining contractual life was approximately 4.29 years (6.70 years in 2021 and 6.43 years in 2020).

Of the 99,717 thousand outstanding options (113,760 thousand in 2021 and 127,265 thousand in 2020), 63,850 thousand options were vested in 2022 (59,250 thousand in 2021 and 36,459 thousand in 2020).

The weighted average exercise price of the options was as follows:

---

| | | | |
|:---|:---|:---|:---|
| *In R$ per share* | **2022** | **2021** | **2020** |
| Options outstanding at January 1 | 19.92 | 19.81 | 18.53 |
| Options issued during the period | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 18.05 |
| Options forfeited during the period | 22.60 | 25.27 | 22.96 |
| Options exercised during the period | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 13.16 | 8.30 |
| Options outstanding at the end of the period | 19.39 | 19.92 | 19.81 |
| Options exercisable at the end of the period | 20.12 | 21.14 | 23.70 |

---

There were no options exercised during the year ended December 31, 2022, (for options exercised in the year ended December 31, 2021, the weighted average share price on the exercise date was R$17.87 and on December 31, 2020 was R$15.23).

To settle the exercised stock options, the Company may use treasury shares. The current limit on the authorized capital is considered sufficient to meet the Company's obligations under all stock option plans if the issue of new shares is required to meet the grants awarded under the Programs.

During the period, the Company granted 44 thousand deferred shares under the stock option plan which are valued based on the share market price prior to the grant, which represents a fair value of R$0.6 (at December 31, 2021, 110 thousand deferred shares had been granted, which are valued based on the share market price prior to the grant, which represented a fair value of R$1.7 and at December 31, 2020, 153 thousand deferred shares had been granted, which are valued based on the share market price prior to the grant, which represented a fair value of R$2.4. Such deferred shares are subject to a vesting period of five years from the grant date.

During the period, the Company granted 49,328 thousand (20,629 thousand in 2021 and 21,066 thousand in 2020) restricted shares and performance shares under the Share-Based Plan, which are valued based on the parameters referenced above, representing a fair value of approximately R$766.6 in 2022 (R$325.7 in 2021 and R$315.4 in 2020).

[**Table of Contents**](#toc)

The total number of shares purchased by or granted to employees, as the case may be, under the Stock Option Plan and Share-Based Plan, which will be delivered in the future based on the fulfilment of certain conditions (deferred stock, restricted and performance shares), is as set out below:

**Deferred shares**

---

| | | | |
|:---|:---|:---|:---|
| *Thousand deferred shares* | **2022** | **2021** | **2020** |
| **Deferred shares outstanding at January** | **1168** | **6065** | **7926** |
| New deferred shares during the period | 44 | 110 | 153 |
| Deferred shares granted during the period | (214) | (4964) | (1901) |
| Deferred shares forfeited during the period | (109) | (43) | (113) |
| **Deferred shares outstanding at the end of the year** | **889** | **1168** | **6065** |

---

**Restricted and performance shares**

---

| | | | |
|:---|:---|:---|:---|
| *Thousand restricted shares* | **2022** | **2021** | **2020** |
| **Restricted shares outstanding at January** | **62545** | **43458** | 23836 |
| New restricted shares during the period | 49328 | 20629 | **21066** |
| Restricted shares granted during the period | (12) | (22) | **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -** |
| Restricted shares forfeited during the period | (3007) | (1520) | **(1444)** |
| **Restricted shares outstanding at the end of the year** | **108854** | **62545** | **43458** |

---

Additionally, certain employees and managers of the Company received options to acquire AB InBev shares, the compensation costs of which are recognized in the income statement against equity.

The transactions with share-based payments described above generated an expense of R$311.6 in 2022 (R$391.5 and R$223.1 in 2021 and 2020, respectively), recorded as administrative expenses.

**26.** **TRADE PAYABLES** 

---

| | | |
|:---|:---|:---|
|  | **2022** | **2021** |
| Trade payables | 165.8 | 209.2 |
| Related parties (Note 31) | 343.6 | 407.9 |
| **Non-current** | **509.4** | **617.1** |
| Trade payables | 23498.1 | 23867.2 |
| Related parties (Note 31) | 830.4 | 1210.7 |
| **Current** | **24328.5** | **25077.9** |
| **Total** | **24837.9** | **25695.0** |

---

The Company recognizes its third party and related party vendor obligations in trade payables line. As mentioned in note 3 (u) – *Summary of significant accounting policies, Trade Payables*, when relevant, vendor trade payables are adjusted at present value.

[**Table of Contents**](#toc)

Therefore, the present value adjustment recorded for trade payables, at December 31, 2022 is R$367 million (R$239 million at December 31, 2021).

The controlled companies in Argentina, Chile, Paraguay and Panama have transactions with discounted trade bills with endorsement (trade payables securitization) with vendors in the amount of R$219.3 million at December 31, 2022 (R$370.0 million at December 31, 2021). In general, the abovementioned discounted trade bills transactions occur by legal impositions existing in these jurisdictions. These transactions maintain commercial characteristics since there are no changes in previously established conditions and its vendor's choice to carry out the anticipation of its trade receivables with the Company.

**27.** **PROVISIONS** 

**(a) Provision changes** 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| Schedule of provision changes |  |  |  |  |  |  |
|  | **Balance as of December 31, 2020** | **Effect of changes in foreign exchange rates** | **Additions** | **Provisions used** | **Provisions reversed** | **Balance as of December 31, 2021** |
| **Provision for disputes and litigation** |  |  |  |  |  |  |
| Taxes on sales | 184.1 |  | 198.5 | (57.3) | (106.7) | 218.6 |
| Labor | 129.9 | (0.8) | 163.1 | (147.2) | (20.8) | 124.2 |
| Civil | 86.8 | (2.2) | 273.9 | (71.8) | (33.8) | 252.9 |
| Other taxes | 156.7 | 2.0 | 14.6 | (5.2) | (5.1) | 163.0 |
| **Total provision for disputes and litigation** | **557.5** | **(1.0)** | **650.1** | **(281.5)** | **(166.4)** | **758.7** |
| **Restructuring** | 14.5 | 1.2 | 6.8 | (5.1) |  | 17.4 |
| **Total provisions** | **572.0** | **0.2** | **656.9** | **(286.6)** | **(166.4)** | **776.1** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Balance as of December 31, 2021** | **Effect of changes in foreign exchange rates** | **Additions** | **Provisions used** | **Provisions reversed** | **Balance as of December 31, 2022** |
| **Provision for disputes and litigation** |  | | | | | |
| Taxes on sales | 218.6 |  | 157.6 | (85.8) | (43.3) | 247.1 |
| Labor | 124.2 | (4.6) | 194.2 | (162.0) | (19.7) | 132.1 |
| Civil | 252.9 | (17.5) | 312.7 | (196.6) | (15.6) | 335.9 |
| Other taxes | 163.0 | (8.1) | 60.1 | (7.2) | (15.0) | 192.8 |
| **Total provision for disputes and litigation** | **758.7** | **(30.2)** | **724.6** | **(451.6)** | **(93.6)** | **907.9** |
| **Restructuring** | 17.4 | (2.0) |  | (3.6) |  | 11.8 |
| **Total provisions** | **776.1** | **(32.2)** | **724.6** | **(455.2)** | **(93.6)** | **919.7** |

---

[**Table of Contents**](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Expected settlement** 

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **2022** | **2022** | **2021** | **2021** |
|  | **Non-current** | **Current** | **Non-current** | **Current** |
| **Provision for disputes and litigation** |  |  |  |  |
| Taxes on sales | 193.8 | 53.3 | 163.2 | 55.4 |
| Labor | 104.9 | 27.2 | 96.2 | 28.0 |
| Civil | 263.0 | 72.9 | 194.1 | 58.8 |
| Other taxes | 170.1 | 22.7 | 142.1 | 20.9 |
| **Total provision for disputes and litigation** | **731.8** | **176.1** | **595.6** | **163.1** |
| **Restructuring** | 7.2 | 4.6 | 8.2 | 9.2 |
| **Total provisions** | **739.0** | **180.7** | **603.8** | **172.3** |

---

The expected settlement of provisions was based on management's best estimate at the balance sheet date.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Main lawsuits with a probable likelihood of loss:** 

**(c.1) Sales taxes**

In Brazil, the Company and its subsidiaries are parties to various administrative and judicial proceedings related to ICMS, IPI, PIS and COFINS taxes, considered as probable likelihood of loss. Such proceedings include, among others, tax offsetting, appropriation of tax credits and alleged insufficient payment of the respective taxes.

**(c.2) Labor**

The Company and its subsidiaries are parties to labor proceedings with former employees or former employees of service providers. The main issues involve overtime and related effects and respective charges.

**(c.3) Civil**

The Company and its subsidiaries are involved in civil lawsuits considered as representing a probable likelihood of loss. The most relevant portion of these lawsuits refers to former distributors, mainly in Brazil, mostly claiming damages resulting from the termination of their contracts.

The processes representing possible probabilities are disclosed in Note 30 *- Contingencies*.

[**Table of Contents**](#toc)

**28.** **FINANCIAL INSTRUMENTS AND RISKS** 

**Risk factors**

The Company is exposed to foreign currency, interest rate, commodity price, liquidity and credit risk in the ordinary course of its business. The Company analyzes each of these risks both individually and on a consolidated basis, to define strategies to manage the economic impact on risk's performance consistent with its Financial Risk Management Policy (the "Policy").

The Company's use of derivatives strictly follows the Financial Risk Management Policy approved by the Board of Directors. The policy is intended to provide guidelines for the management of the financial risks inherent to the capital markets in which Ambev operates. The policy includes four main aspects: (i) capital structure; financing and liquidity; (ii) transactional risks related to the business; (iii) financial statement translation risk; and (iv) credit risks of financial counterparties.

The policy establishes that all the financial assets and liabilities in each country in which Ambev operates must be denominated in their respective local currencies. The policy also sets out the procedures and controls required to identify, measure and minimize market risks, such as variations in foreign exchange rates, interest rates and commodities (mainly aluminum, wheat, corn and sugar) that may affect Ambev's revenue, costs and/or investment amounts. The policy states that all of the known risks (e.g. foreign currency and interest) shall be hedged by contracting derivative financial instruments. Existing risks which are not yet recorded (e.g. future contracts for the purchase of raw materials or property, plant and equipment) shall be mitigated using projections for the period required for the Company to adapt to the new costs scenario, which may vary from ten to fourteen months, also through the use of derivative financial instruments. Most translation risks are not hedged. The exceptions to the policy must be approved by the Operations and Finance Committee ("COF" – previously addressed by Operations, Finance and Compensation Committee, changed, and approved by the Board of Directors at a meeting on October 14, 2022).

[**Table of Contents**](#toc)

**Derivative financial instruments**

The derivative financial instruments authorized under the Financial Risk Management Policy include futures contracts traded on exchanges, full deliverable forwards, non-deliverable forwards, swaps and options. At December 31, 2022, the Company and its subsidiaries had no target forwards, swaps with currency verification, or any other derivative transactions representing a risk level above the nominal value of the contracts. The derivative operations are managed on a consolidated basis and classified based on the strategy according to their purposes, as follows:

i) Cash flow hedge derivative instruments - Highly probable forecast transactions contracted to minimize the Company's exposure to fluctuations in exchange rates and the prices of raw materials, investments, equipment and services to be procured, protected by cash flow hedges that shall occur at various different dates over the next fourteen months. Gains and losses classified as hedging reserves in equity are recognized in the income statement in the period or periods during which the forecast and hedged transaction affects the income statement.

ii) Fair value hedge derivative instruments - operations contracted for the purpose of mitigating the Company's net indebtedness against foreign exchange and interest rate risk. Net cash positions and foreign currency debts are continually assessed to identify new indications of exposure.

The results of these operations, measured according to their fair value, are recognized in financial results.

iii) Net investment hedge derivative instruments - transactions entered into to minimize the exposure to exchange differences arising from the conversion of net investments in the Company's subsidiaries located abroad for the purpose of translating the account balance. The effective portion of the hedge is allocated to equity, while the ineffective portion is recorded directly in the financial income statement when identified.

In accordance with the hedge accounting, the effective hedge amount is recorded in equity and, in the event of an ineffective portion this result is recorded immediately in finance result during the period ineffectiveness was identified, for cash flow hedge and net investment hedge.

The following tables summarize the exposure identified and protected in accordance with the Company's Risk Policy.

**Non-derivative financial instruments**

Put options granted on subsidiaries: the Company constituted a liability related to the acquisition of a non-controlling interest of the operations in the Dominican Republic. This financial instrument is denominated in US Dollars (Tranche A) and Dominican Pesos (Tranche B) and is recorded by an entity, whose functional currency is the Real. The

[**Table of Contents**](#toc)

Company assigned this financial instrument as a hedging instrument for a portion of its net assets located in subsidiaries whose functional currency is the US Dollar and the Dominican Peso, in such a manner that the hedge result can be recorded in other comprehensive income of the group, following the result of the hedged item.

[**Table of Contents**](#toc)

**Transactions protected by derivative financial instruments in accordance with the Financial Risk Management Policy**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **2022** | **2022** | **2022** | **2022** | **2022** | **2022** | **2022** | **2022** |
|  |  |  | **Fair Value** | **Fair Value** | **Gain / (Losses)** | **Gain / (Losses)** | **Gain / (Losses)** |
| **Exposure** | **Risk** | **Notional** | **Assets** | **Liability** | **Finance Result** | **Operational Result** | **Equity** |
| **Cost** |  | **19853.3** | **271.8** | **(719.4)** | **(3075.2)** | **452.7** | **134.3** |
|  | *Commodities* | 4809.9 | 100.8 | (376.0) | 63.5 | (32.3) | (475.0) |
|  | US Dollars | 14874.7 | 157.7 | (342.9) | (3139.2) | 477.1 | 596.6 |
|  | Euros | 32.2 | 1.9 |  | (0.7) | (0.3) | 1.2 |
|  | Mexican Pesos | 136.5 | 11.4 | (0.5) | 1.2 | 8.2 | 11.5 |
| **Fixed Assets** |  | **226.8** | **1.5** | **(5.4)** | **(5.9)** | **4.9** | **(13.0)** |
|  | US Dollars | 226.8 | 1.5 | (5.4) | (5.9) | 4.9 | (13.0) |
| **Expenses** |  | **204.9** | **0.5** | **(4.6)** | **(42.5)** | **9.1** | **(14.8)** |
|  | US Dollars | 204.9 | 0.5 | (4.6) | (42.5) | 9.1 | (14.8) |
| **Cash** |  | **-** | **-** | **-** | **(17.1)** | **-** | **-** |
|  | US Dollars | - | - | - | (17.1) | - | - |
| **As at December 31, 2022** |  | **20285.0** | **273.8** | **(729.4)** | **(3140.7)** | **466.7** | **106.5** |

---

[**Table of Contents**](#toc)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **2021** | **2021** | **2021** | **2021** | **2021** | **2021** | **2021** |
|  | | | **Fair Value** | **Fair Value** | **Gain / (Losses)** | **Gain / (Losses)** | **Gain / (Losses)** |
| **Exposure** | **Risk** | **Notional** | **Assets** | **Liability** | **Finance Result** | **Operational Result** | **Equity** |
| **Cost** |  | **18911.7** | **597.4** | **(421.1)** | **(2113.5)** | **1710.2** | **2277.4** |
|  | *Commodities* | 3179.9 | 455.3 | (41.2) | (126.8) | 1168.1 | 684.7 |
|  | US Dollars | 15516.2 | 136.2 | (378.4) | (1970.7) | 541.8 | 1792.7 |
|  | Euros | 31.8 |  | (0.8) | (0.1) | 0.5 | (1.9) |
|  | Mexican Pesos | 183.8 | 5.9 | (0.7) | (15.9) | (0.2) | (198.1) |
| **Fixed Assets** |  | **1111.4** | **1.1** | **(53.3)** | **(368.8)** | **105.3** | **103.2** |
|  | US Dollars | 1111.4 | 1.1 | (53.3) | (368.8) | 105.3 | 103.2 |
| **Expenses** |  | **365.8** | **0.5** | **(18.1)** | **(124.5)** | **36.9** | **192.9** |
|  | US Dollars | 365.8 | 0.5 | (18.1) | (124.5) | 36.9 | 192.9 |
| **Equity Instrument** |  | **-** | **-** | **-** | **78.0** | **-** | **-** |
|  | Stock exchange prices | - | - | - | 78.0 | - | - |
| **As at December 31, 2021** |  | **20388.9** | **599.0** | **(492.5)** | **(2528.8)** | **1852.4** | **2573.5** |

---

[**Table of Contents**](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;**I.** **Market risk**

***a.1) Foreign currency risk***

 **

The Company is exposed to foreign currency risk on borrowings, investments, purchases, dividends and/or interest expenses/income where these are denominated in a currency other than the functional currency of the subsidiary. The main derivative financial instruments used to manage foreign currency risk are futures contracts, swaps, options, non-deliverable forwards and full deliverable forwards.

***a.2) Commodity Risk***

 ****

A significant portion of the Company's inputs is made up of commodities, which have historically experienced substantial price fluctuations. The Company therefore uses both fixed-price purchasing contracts and derivative financial instruments to minimize its exposure to volatility in the commodity prices of aluminum, sugar, wheat, corn and paraxylene. These derivative financial instruments have been designated as cash flow hedges.

***a.3) Interest rate risk***

 ****

The Company applies a dynamic interest rate hedging approach, whereby the target mix between fixed and floating rate debt is reviewed periodically. The purpose of the Company's policy is to achieve an optimal balance between the cost of funding and the volatility of financial results, considering market conditions, as well as the Company's overall business strategy, which is reviewed periodically.

The table below demonstrates the Company and its subsidiaries are exposure related to debts. In 2022, the Company and its subsidiaries do not hold hedge positions to the exposure described below:

---

| | | |
|:---|:---|:---|
|  | **2022** | **2022** |
|  | **Risk** | **Risk** |
|  | **Interest rate** | **Amount** |
| Brazilian Reais | 8.5% | 230.1 |
| **Post fixed interest rate** |  | **230.1** |
| Brazilian Reais | 8.5% | 2602.1 |
| Working Capital in Argentinean Peso | 73.5% | 74.3 |
| Other | 10.4% | 421.3 |
| US Dollars | 14.0% | 6.2 |
| Canadian Dollars | 5.3% | 511.0 |
| **Pre-fixed interest rate** |  | **3614.9** |

---

[**Table of Contents**](#toc)

---

| | | |
|:---|:---|:---|
|  | **2021** | **2021** |
|  | **Risk** | **Risk** |
|  | **Interest rate** | **Amount** |
| Brazilian Reais | 11.6% | 83.0 |
| **Post fixed interest rate** |  | **83.0** |
| Brazilian Reais | 7.2% | 2343.3 |
| Working capital in Argentinean Peso | 34.7% | 30.5 |
| Other | 11.3% | 226.0 |
| US Dollars | 13.1% | 17.5 |
| Canadian Dollars | 2.5% | 430.8 |
| **Pre-fixed interest rate** |  | **3048.1** |

---

**Sensitivity analysis**

The Company substantially mitigates the risks arising from non-derivative financial assets and liabilities, through the use of derivative financial instruments. In this context, the Company has identified the main risk factors that could generate losses from these derivative financial instruments, and has developed a sensitivity analysis based on three scenarios, which may impact the Company's future results and/or cash flow, as described below:

1 - Probable scenario: Management's expectations regarding the deterioration of each transaction's main risk factor. To measure the possible effects on the results of derivative transactions, the Company uses the parametric Value at Risk ("VaR"), a statistical measure developed based on estimates of standard deviation and correlation between the returns of several risk factors. This model gives the loss limit expected for an asset over a certain time period and confidence interval. Under this methodology, the potential exposure of each financial instrument, a range of 95% and a horizon of 21 days from December 31, 2022 were used for the calculation, which are presented in the model.

2 - Adverse scenario: 25% deterioration in each transaction's main risk factor compared to the level observed as at December 31, 2022.

3 - Remote scenario: 50% deterioration in each transaction's main risk factor compared to the level observed as at December 31, 2022.

[**Table of Contents**](#toc)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Transaction** | **Risk** | **Fair value** | **Probable scenario** | **Adverse scenario** | **Remote<br> scenario** |
| *Commodities hedge* | Decrease in commodities price | (275.2) | (466.3) | (1477.8) | (2680.3) |
| Input purchases |  | 275.2 | 466.3 | 1477.8 | 2680.3 |
| *Foreign exchange hedge* | Foreign currency decrease | (172.4) | (425.5) | (3933.1) | (7694.0) |
| Input purchases |  | 172.4 | 425.5 | 3933.1 | 7694.0 |
| **Cost effects** |  |  |  |  |  |
| *Foreign exchange hedge* | Foreign currency decrease | (3.9) | (5.2) | (60.6) | (117.3) |
| Capex Purchases |  | 3.9 | 5.2 | 60.6 | 117.3 |
| **Fixed asset effects** |  | **-** | **-** | **-** | **-** |
| *Foreign exchange hedge* | Foreign currency decrease | (4.1) | (5.1) | (55.3) | (106.5) |
| Expenses |  | 4.1 | 5.1 | 55.3 | 106.5 |
| **Expense effects** |  | **-** | **-** | **-** | **-** |
|  |  | **-** | **-** | **-** | **-** |

---

As at December 31, 2022 the Notional and Fair Value amounts per instrument and maturity were as follow:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | **Notional Value** | **Notional Value** | **Notional Value** | **Notional Value** | **Notional Value** | **Notional Value** |
| **Exposure** | **Risk** | **2023** | **2024** | **2025** | **2026** | **>2026** | **Total** |
| **Cost** |  | **19758.1** | **95.2** | **-** | **-** | **-** | **19853.3** |
|  | Commodities | 4714.7 | 95.2 |  |  |  | 4809.9 |
|  | US Dollars | 14874.7 |  |  |  |  | 14874.7 |
|  | Euros | 32.2 |  |  |  |  | 32.2 |
|  | Mexican Pesos | 136.5 |  |  |  |  | 136.5 |
| **Fixed assets** |  | **226.8** | **-** | **-** | **-** | **-** | **226.8** |
|  | US Dollars | 226.8 |  |  |  |  | 226.8 |
| **Expenses** |  | **204.9** | **-** | **-** | **-** | **-** | **204.9** |
|  | US Dollars | 204.9 | - | - | - | - | 204.9 |
|  |  | **20189.8** | **95.2** | **-** | **-** | **-** | **20285.0** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | **Fair Value** | **Fair Value** | **Fair Value** | **Fair Value** | **Fair Value** | **Fair Value** |
| **Exposure** | **Risk** | **2023** | **2024** | **2025** | **2026** | **>2026** | **Total** |
| **Costs** |  | **(449.1)** | **1.5** | **-** | **-** | **-** | **(447.6)** |
|  | Commodities | (276.7) | 1.5 |  |  |  | (275.2) |
|  | US Dollars | (185.2) |  |  |  |  | (185.2) |
|  | Euros | 1.9 |  |  |  |  | 1.9 |
|  | Mexican Pesos | 10.9 |  |  |  |  | 10.9 |
| **Fixed assets** |  | **(3.9)** | **-** | **-** | **-** | **-** | **(3.9)** |
|  | US Dollars | (3.9) |  |  |  |  | (3.9) |
| **Expenses** |  | **(4.1)** | **-** | **-** | **-** | **-** | **(4.1)** |
|  | US Dollars | (4.1) | - | - | - | - | (4.1) |
|  |  | **(457.1)** | **1.5** | **-** | **-** | **-** | **(455.6)** |

---

[**Table of Contents**](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;**II.** **Credit Risk** 

 

***Concentration of counterparty credit risk***

 ****

A substantial portion of the Company's sales is made to distributors, supermarkets and retailers, through a broad distribution network. Credit risk is reduced due to the large number of customers and control procedures used to monitor risk. Historically, the Company has not incurred significant losses on receivables from customers.

***Concentration of counterparty credit risk***

In order to minimize the credit risk of its investments, the Company has adopted procedures for the allocation of cash and investments, taking into consideration the credit limits and credit analysis of financial institutions, avoiding credit concentration, i.e. the credit risk is monitored and minimized by restricting negotiations to a select group of highly rated counterparties.

The selection process for financial institutions authorized to operate as counterparties of the Company is set forth in the Credit Risk Policy, which also establishes exposure limits for each counterparty based on each counterparty's risk rating and capitalization.

Any deposits or cash available, must be kept in accounts with top tier banks, or banks with a high credit rating in the respective country. Any position of a short-term nature (less than six months) should be considered as a deposit or cash.

Counterparty risk must be managed by the Company globally, with product limits established by the treasury area, considering: (i) the counterparty's credit rating (ii) the transaction term (iii) the amount; and (iv) the split between assets and liabilities, in the absence of a clearing clause in derivative contracts.

The counterparty risk is reassessed on a quarterly basis.

The carrying amounts of cash and cash equivalents, investment securities, trade receivables excluding prepaid expenses, recoverable taxes and derivative financial instruments are disclosed net of provisions for impairment, and represent the maximum exposure to credit risk as at December 31, 2022. As at December 31, 2022, there was no concentration of credit risk on any counterparties in excess of the limits established by the Company's risk policy.

&nbsp;&nbsp;&nbsp;&nbsp;**III.** **Liquidity Risk** 

Historically, the Company's primary sources of cash flow have been cash flow from operating activities, the issuance of debt, bank borrowings and equity securities. Ambev's material cash requirements have included the following:

· Debt servicing;

[**Table of Contents**](#toc)

· Capital expenditure;

· Investments in companies;

· Increases in the ownership of Ambev's
subsidiaries or companies in which it holds equity investments;

· Share buyback programs; and

· Payments of dividends and interest on shareholders' equity.

The Company believes that cash flows from operating activities, cash and cash equivalents and short-term investments, together with derivatives and access to loan facilities are sufficient to finance capital expenditures, financial liabilities and dividend payments in the future.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **2022** | **2022** | **2022** | **2022** | **2022** | **2022** | **2022** |
|  | **Carrying amount** | **Contractual cash flows** | **Less than 1 year** | **1-2 years** | **2-3 years** | **3-5 years** | **More than 5 years** |
| Trade and other payables (i) | 39354.4 | 40656.4 | 36818.5 | 86.8 | 1275.1 | 1008.4 | 1467.6 |
| Secured bank loans | 180.8 | 245.7 | 68.2 | 26.4 | 25.2 | 50.4 | 75.5 |
| Other unsecured loans | 472.5 | 759.1 | 169.9 | 156.7 | 151.6 | 165.4 | 115.5 |
| Lease liabilities | 3117.4 | 3657.4 | 962.9 | 1008.4 | 621.0 | 696.9 | 368.2 |
|  | **43125.1** | **45318.6** | **38019.5** | **1278.3** | **2072.9** | **1921.1** | **2026.8** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) Mainly includes amounts related to suppliers, taxes, fees and contributions payables, dividends and interest on equity payable, salaries
and charges, put options related to the Company's participation in subsidiaries and other liabilities, except for related parties,
with payment term of less than one year.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **2021** | **2021** | **2021** | **2021** | **2021** | **2021** | **2021** |
|  | **Carrying amount** | **Contractual cash flows** | **Less than 1 year** | **1-2 years** | **2-3 years** | **3-5 years** | **More than 5 years** |
| Trade and other payables (i) | 38976.2 | 40186.2 | 34690.6 | 1279.7 | 2248.8 | 327.2 | 1639.9 |
| Secured bank loans | 247.0 | 328.1 | 88.9 | 61.7 | 26.4 | 50.4 | 100.7 |
| Unsecured bank loans | 84.1 | 84.1 | 84.1 |  |  |  |  |
| Other unsecured loans | 130.1 | 234.7 | 46.5 | 48.2 | 29.1 | 20.7 | 90.2 |
| Lease liabilities | 2639.3 | 3070.9 | 788.5 | 756.1 | 550.7 | 422.4 | 553.2 |
|  | **42076.7** | **43904.0** | **35698.6** | **2145.7** | **2855.0** | **820.7** | **2384.0** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) Mainly includes amounts related to suppliers, taxes, fees and contributions payables, dividends and interest on equity payable, salaries
and charges, put options related to the Company's participation in subsidiaries and other liabilities, except for related parties,
with payment term of less than one year.

**Equity price risk**

Through the equity swap transactions approved on May 13, 2020 and December 9, 2020 by the Board of Directors of Ambev (see Note 1 - *Corporate information*), the Company, or its subsidiaries, will receive price variations related to its shares traded on the stock exchange, or on its ADRs, thus neutralizing the possible effects of stock price fluctuations on the share-based payments made by the Company. As these derivative instruments are not eligible for hedge accounting, they were not therefore allocated to any hedging arrangements.

On December 31, 2022, the Company did not have any equity swap positions (on December 31, 2021 equity swap operations resulted in a gain of R$78.0).

[**Table of Contents**](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;**IV.** **Capital management** 

The Company is continuously optimizing its capital structure in order to maximize shareholder value while maintaining the desired financial flexibility to execute its strategic projects. Besides the statutory minimum equity funding requirements applicable to the Company's subsidiaries in different countries, the Company is not subject to any externally imposed capital requirements. When analyzing the capital structure, the Company uses the same debt ratings and capital classifications applied to the financial statements.

**Financial instruments**

**(a) Financial instruments categories**

The financial instruments held by the Company are managed through operational strategies and internal controls to assure liquidity, profitability, and transaction security. Transactions involving financial instruments are regularly reviewed to assess the effectiveness of the risk exposure that management intends to cover (foreign exchange, and interest rate, among others).

The table below shows all of the consolidated financial instruments recognized in the financial statements, segregated by category:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2022** | **2022** |
|  | **Amortized cost** | **Fair value through profit or loss** | **Total** |
| **Financial assets** |  |  |  |
| Cash and cash equivalents less bank overdrafts | 14852.1 |  | 14852.1 |
| Trade receivables excluding prepaid expenses | 7791.4 |  | 7791.4 |
| Investment securities | 219.1 | 454.5 | 673.6 |
| Derivatives hedges | - | 273.8 | 273.8 |
| **Total** | **22862.6** | **728.3** | **23590.9** |
| **Financial liabilities** |  |  |  |
| Trade payables | 24837.9 |  | 24837.9 |
| Put options granted on subsidiaries |  | 3060.3 | 3060.3 |
| Derivatives hedges |  | 729.4 | 729.4 |
| Interest-bearing loans and borrowing | 3770.7 |  | 3770.7 |
| Other liabilities | 2015.6 | 333.7 | 2349.3 |
| **Total** | **30624.2** | **4123.4** | **34747.6** |

---

[**Table of Contents**](#toc)

---

| | | | |
|:---|:---|:---|:---|
|  | **2021** | **2021** | **2021** |
|  | **Amortized cost** | **Fair value through profit or loss** | **Total** |
| **Financial assets** |  |  |  |
| Cash and cash equivalents less bank overdrafts | 16597.2 |  | 16597.2 |
| Trade receivables excluding prepaid expenses | 7084.7 |  | 7084.7 |
| Investment securities | 192.9 | 1914.6 | 2107.5 |
| Derivatives hedges | - | 599.0 | 599.0 |
| **Total** | **23874.8** | **2513.6** | **26388.4** |
| **Financial liabilities** |  |  |  |
| Trade payables | 25695.0 |  | 25695.0 |
| Put options granted on subsidiaries |  | 3291.4 | 3291.4 |
| Derivatives hedges |  | 492.5 | 492.5 |
| Interest-bearing loans and borrowing | 3100.6 |  | 3100.6 |
| Other liabilities | 2263.7 | 194.7 | 2458.4 |
| **Total** | **31059.3** | **3978.6** | **35037.9** |

---

**(b) Classification of financial instruments by type of fair value measurement**

IFRS 13 defines the fair value as the price that would be received for the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

Pursuant to IFRS 13, financial instruments measured at fair value shall be classified within the following categories:

Level 1 - quoted prices (unadjusted) in active markets available to the entity for identical assets or liabilities as at the valuation date;

Level 2 - inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly; and

Level 3 - inputs which are not observable for the asset or liability.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **2022** | **2022** | **2022** | **2022** | **2021** | **2021** | **2021** | **2021** |
|  | **Level 1** | **Level 2** | **Level 3** | **Total** | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **<u>Financial assets</u>** |  |  |  |  |  |  |  |  |
| Financial asset at fair value through profit and loss | 454.5 |  |  | 454.5 | 1914.6 |  |  | 1914.6 |
| Derivatives - operational hedge | 57.0 | 216.8 | - | 273.8 | 159.1 | 439.9 | - | 599.0 |
|  Total | **511.5** | **216.8** | **-** | **728.3** | **2073.7** | **439.9** | **-** | **2513.6** |
| **<u>Financial liabilities</u>** |  |  |  |  |  |  |  |  |
| Financial liabilities at fair value through profit and loss |  |  | 3393.9 | 3393.9 |  |  | 3486.0 | 3486.0 |
| Derivatives - operational hedge | 76.1 | 653.3 | - | 729.4 | 193.4 | 299.1 | - | 492.5 |
|  Total | **76.1** | **653.3** | **3393.9** | **4123.3** | **193.4** | **299.1** | **3486.0** | **3978.5** |

---

[**Table of Contents**](#toc)

**Reconciliation of changes in the assets categorized at Level 3**

---

| | |
|:---|:---|
| **Financial liabilities at December 31, 2021** | **3486.0** |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition of investments | 161.4 |
| Total gains and losses during the period | **(253.5)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Losses/(gains) recognized in net income | (46.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Losses/(gains) recognized in equity | (207.2) |
| **Financial liabilities at December 31, 2022** | **3393.9** |

---

**(c) Fair value of financial liabilities measured at amortized cost**

The Company's liabilities, interest-bearing loans and borrowing, and trade payables excluding tax payables, are recorded at amortized cost based on the effective rate method, plus indexation and foreign exchange gains/losses, based on the closing indices for each exercise.

The financial instruments recorded at amortized cost are similar to the fair value and are not of sufficiently material to require disclosure.

**(d) Fair value of liabilities measured through profit or loss**

As part of the negotiations regarding the acquisition of the shares of Tenedora, the Company signed the second amendment to the Shareholders' Agreement extending the partnership between the Company and ELJ. ELJ is currently the owner of 15% of the shares of Tenedora, and its put options are now divided into two tranches: (i) Tranche A, corresponding to 12.11% of the shares, exercisable in 2023 and 2024; and (ii) Tranche B, corresponding to 2.89% of the shares, exercisable from 2026. The Company, on the other hand, has a call option over Tranche A shares, exercisable from 2021, and Tranche B shares, exercisable from 2029, whereas until December 31, 2022, no options were exercised. On December 31, 2022, the sum of the two ELJ tranches is R$3,053.7 (R$3,284.8 on December 31, 2021).

The fair value of (i) Tranche A is calculated considering the interest under the contract, plus foreign exchange variations, less the dividends paid between the date of signature of the amendment and the exercise of the option.

The fair value of (ii) Tranche B is calculated based on the EBITDA multiple defined in the contract, less the net debt, brought to its present value, calculated using standard valuation techniques (the present value of the principal amount and future interest, discounted by the local currency's WACC rate as at the date of the calculation). The criteria used are based on market information from reliable sources and are categorized as "Level 3".

**Calculation of the fair value of derivatives**

The Company measures derivative financial instruments by calculating their fair value, using market curves that impact the value of the instrument as at the computation date. In the case of swaps, the asset and the liability positions are estimated independently and

[**Table of Contents**](#toc)

brought to their fair value, equivalent to the difference between the results of the asset and liability amounts, which generates the swap's market value. For traded derivative financial instruments, the fair value is calculated based on the exchange-listed price.

**Margins pledged as guarantees**

In order to comply with the guarantee requirements regarding derivative exchanges and/or counterparties to certain operations with derivative financial instruments, as at December 31, 2022 the Company held R$376.9 in highly liquid financial investments or in cash, classified as cash and cash equivalents and investment securities (R$1,152.8 as at December 31, 2021).

**Offsetting of financial assets and liabilities**

For financial assets and liabilities subject to settlement agreements on a net basis or similar agreements, each agreement between the Company and the counterparty allows this type of settlement when both parties opt for this. In the absence of such a decision, the assets and liabilities will be settled at their gross amounts, but each party will have the option to settle on a net basis, in case of a default by the counterparty.

**Risks of climate change and the sustainability strategy**

Considering the nature of the Company's operations, there is an inherent exposure to certain risks related to climate change, and relevant ESG (Environmental, Social and Governance) aspects.

In the period finished in December 31, 2022 the Management considered as main risks the aspects below:

&nbsp;&nbsp;&nbsp;&nbsp;**(i)** **Commodities prices** 

There is a growing concern that the current level of carbon dioxide and other greenhouse gases in the atmosphere will have adverse impacts on global temperatures, weather patterns and the frequency and severity of extreme weather and natural disasters, such as droughts, floods, unseasonal rains, tropical cyclones, among others. In the event that climate changes has a negative effect on agricultural productivity, the Company may be subject to decreased availability or less favorable pricing for certain agricultural commodities that are necessary for our products, such as barley, hops, sugar and corn. In addition, public expectations for reductions in greenhouse gas emissions could result in increased energy, transportation and raw material costs and may require us to make additional investments in facilities and equipment due to increased regulatory pressures. As a result, the effects of climate change could have a long-term, material adverse impact on our business and results of operations.

[**Table of Contents**](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;**(ii)** **Water crisis** 

We also face water scarcity and quality risks. The availability of clean water is a limited resource in many parts of the world, facing unprecedented challenges from climate change and the resulting change in precipitation patterns and frequency of extreme weather, overexploitation, increasing pollution, and poor water management. We have implemented an internal strategy in order to considerably reduce the use of water in our operative plants. However, as demand for water continues to increase around the world, and as water becomes scarcer and the quality of available water deteriorates, we may be affected by increasing production costs or capacity constraints, which could adversely affect our business and results of operations.

Droughts can cause barley crop failures, especially in South America, where most barley is rain-fed, the meteorological droughts (short-term, precipitation-impacted droughts) can significantly affect barley crop performance.

As a result, the effects of climate change could have a substantial long-term detrimental impact on the Company's business and operating results.

&nbsp;&nbsp;&nbsp;&nbsp;**(iii)** **Environmental regulations** 

Our operations are subject to a wide range of Brazilian federal, state and municipal safety and environmental laws and regulations related to licenses or authorizations necessary to our business, as well as use of water resources and management of solid waste and take-back scheme obligations.

The Company activities require the constant obtaining and renewal of environmental licenses, in which the production units operation depends. Technical difficulties or failure to meet license renewal terms and the requirements of environmental agencies may have adverse effects on our business, as we may be subject to (i) the imposition of several administrative penalties (such as fines, interruption or shutdown of activities, license cancellation, among others), (ii) payment of recovering costs to of degraded areas and (iii) accountability in the civil, administrative and criminal spheres, depending on the case.

While we have a budget for future capital and operating expenditures to maintain compliance with environmental laws and regulations, there is no guarantee that the Company, even if it adopts adequate practices and processes, will not incur environmental liability or that these applicable environmental laws and regulations will not change or become more strict in the future. Accordingly, non-compliance with applicable laws and the technical conditions established in licenses and permits may harm the Company's reputation, results of operations and financial health.

[**Table of Contents**](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;**(iv)** **Social** 

The Company is subject to obligations regarding the respect for human rights of all stakeholders, which may lead the Company to incur additional costs as well as significant contingencies relating to social issues. In general, social risks arise from the potential and actual adverse impacts of its business activities on the human rights of all stakeholders involved in its operation, including its own employees, consumers, suppliers, investors and the local community where the Company operates, whether directly or indirectly connected to its activities.

If the Company does not adopt well-structured and integrated long-term planning initiatives to promote diversity, equality and inclusion, both in its workforce and in the composition of statutory bodies and leadership, it may be challenged, including in court, about the absence of clear goals and effective actions in this area.

There is no guarantee that the Company will be able to adequately manage the social risks mentioned above in compliance with all national and international parameters and guidelines, which, consequently, may eventually harm the Company's operating results and reputation and expose it to legal and regulatory risks, which may materialize in different ways.

As the events mentioned in this section are highly uncertain, the Company cannot determine their financial impact at this moment. Any mentioned impacts may result in a material adverse effect on our business, liquidity, financial condition and results of operations. The Company continues to manage liquidity and capital resources with discipline to meet the costs of the eventual materialization of such risks.

**29.** **COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS** 

---

| | | |
|:---|:---|:---|
|  | **2022** | **2021** |
| Collateral given for the Company's own liabilities | 764.5 | 788.6 |
| Other commitments | 1,368.1 | 1,719.1 |
|  | **2,132.6** | **2,507.7** |
| Commitments to suppliers | 50,365.3 | 51,562.0 |
|  | **50,365.3** | **51,562.0** |

---

The collateral provided for liabilities totaled approximately R$2,132.6 as at December 31, 2022 (R$2,507.7 as at December 31, 2021), including R$744.0 (R$682.6 as at December 31, 2021) of cash guarantees. The deposits in cash used as guarantees are presented as part of other assets. To provide the guarantees required for derivatives exchanges and/or counterparties contracted in certain derivative financial instrument transactions, as at December 31, 2022, Ambev maintained R$376.9 (R$1,152.8 as at December 31, 2021) in highly liquid financial investments or in cash, classified as cash and cash equivalents and investment securities (Note 28 - *Financial instruments and risks*).

[**Table of Contents**](#toc)

Most of the balance relates to commitments to suppliers of packaging.

Future contractual commitments as at December 31, 2022 and 2021 are as follow:

---

| | | |
|:---|:---|:---|
|  | **2022** | **2021** |
| Less than 1 year | 12,491.0 | 11,559.9 |
| Between 1 and 2 years | 10,315.3 | 9,982.2 |
| More than 2 years | 27,559.0 | 30,019.9 |
|  | **50,365.3** | **51,562.0** |

---

**30.** **CONTINGENCIES** 

The Company has contingent liabilities related to lawsuits arising in the normal course of its business. Due to their nature, such legal proceedings involve certain uncertainties including, but not limited to, court and tribunal rulings, negotiations between affected parties and governmental actions, and therefore the Company's management cannot estimate the likely timing of the resolution of these matters at this stage.

Contingent liabilities with a probable outcome are fully recorded as liabilities (Note 27 - *Provisions*).

The Company and its subsidiaries have administrative and judicial discussions with tax authorities in Brazil related to certain tax treatments adopted when calculating the income tax and social contribution, for which, based on Management's current evaluation, is probable that the tax authorities will accept the uncertain tax treatment, in accordance with IFRIC 23. The Company also has lawsuits related to other taxes, which involve risk of a possible loss. To these uncertain tax treatments and possible contingencies there are no provisions recorded, due to the assessment carried out by Management, with the following composition and estimates:

---

| | | |
|:---|:---|:---|
|  | **2022** | **2021** |
| Income tax and social contribution | 60,453.5 | 54,258.7 |
| Value-added and excise taxes | 25,904.6 | 23,912.4 |
| PIS and COFINS | 3,293.5 | 2,667.6 |
| Others | 1,909.1 | 1,606.3 |
|  | **91,560.7** | **82,445.0** |

---

The Company and its subsidiaries have guarantee-insurance policies and letters of guarantee for some legal actions, presented as guarantee for civil, labor and tax executions or to enable resources of labor nature.

**Principal lawsuits with a likelihood of possible loss**

**Brazilian Federal Taxes**

*Goodwill InBev Holding*

 

[**Table of Contents**](#toc)

In December 2011, Ambev received a tax assessment related to the goodwill amortization in calendar years 2005 to 2010 resulting from the InBev Holding Brasil S.A. merger with Ambev. At the administrative level, Ambev received partially favorable decisions at both the Lower and Upper Administrative Court. Ambev filed judicial proceedings to discuss the unfavorable portion of the decisions of the Lower and the Upper Administrative Court and requested injunctions to suspend the enforceability of the remaining tax credit, which were granted.

In June 2016, Ambev received a new tax assessment charging the remaining value of the goodwill amortization in calendar years 2011 to 2013 and filed a defense. Ambev received partially favorable decisions at the first level administrative court and Lower Administrative Court. Ambev filed a Special Appeal which was partially admitted and awaits judgment by the Upper Administrative Court. For the unfavorable portion of the decision, which became final at the administrative level, Ambev filed a judicial proceeding requesting an injunction to suspend the enforceability of the remaining tax credit, which was granted.

The updated assessed amount related to this uncertain tax position, as per IFRIC 23 and according to explanatory note 3 (q) - *Summary of Significant Accounting Policie*s, as at December 31, 2022 was approximately R$11.1 billion (R$10.4 billion as at December 31, 2021). Ambev has not recorded any provisions for this matter based on the probability of loss of the lawsuit. In the event Ambev is required to pay these amounts, AB-Inbev will reimburse Ambev the amount proportional (70%) to the benefit received by the company pursuant to the merger protocol, as well as the related costs.

 

*Goodwill Beverage Associate Holding (BAH)*

 

In October 2013, Ambev received a tax assessment related to the goodwill amortization in calendar years 2007 to 2012 resulting from the merger of Beverage Associates Holding Limited ("BAH") into Ambev. The decision from the first level administrative court was unfavorable to Ambev. Ambev filed an appeal with the Lower Administrative Court against the decision, which was partially granted. Ambev and the tax authorities filed Special Appeals to the Upper Administrative Court. In July 2022, the Upper Administrative Court rendered a partially favorable decision to Ambev. The decision did not recognize the Special Appeal filed by the tax authorities, thereby preserving the portion of the decision rendered by the Lower Administrative Court that was favorable to Ambev with respect to the qualified penalties applied and the statute of limitation for one of the calendar years under discussion; this portion of the decision is final. Ambev will file a judicial proceeding to appeal the unfavorable portion of the decision.

In April and August 2018, Ambev received new tax assessments charging the remaining value of the goodwill amortization in calendar years 2013 to 2014 and filed defenses. In April 2019, the first level administrative court rendered unfavorable decisions to Ambev. As a result, thereof, Ambev appealed to the Lower Administrative Court. In November and

[**Table of Contents**](#toc)

December 2019, Ambev received partially favorable decisions at the Lower Administrative Court. Ambev and the tax authorities filed Special Appeals to the Upper Administrative Court. The Special Appeals filed in both tax assessments are awaiting judgment by the Upper Administrative Court.

The updated assessed amount related to this uncertain tax position, as per IFRIC 23 and according to explanatory note 3 (q) - *Summary of Significant Accounting Policies*, as at December 31, 2022 was approximately R$2.2 billion (R$2.3 billion as at December 31, 2021). Ambev has not recorded any provisions for this matter based on the probability of loss of the lawsuit.

 

*Goodwill CND Holdings*

 

In November 2017, Ambev received a tax assessment related to the goodwill amortization in calendar years 2012 to 2016 resulting from the merger of CND Holdings into Ambev. The decision from the first level administrative court was unfavorable to Ambev. Ambev filed an appeal to the Lower Administrative Court. In February 2020, the Lower Administrative Court rendered a partially favorable decision. Ambev and the tax authorities filed Special Appeals to the Upper Administrative Court. The Special Appeal filed by Ambev was partially admitted and is awaiting judgment.

In October 2022, Ambev received a new tax assessment charging the remaining value of the goodwill amortization in calendar year 2017. Ambev has filed a defense and awaits judgment by the first level administrative court.

The updated assessed amount related to this uncertain tax position, as per IFRIC 23 and according to explanatory note 3 (q) - *Summary of Significant Accounting Policies*, as at December 31, 2022 was approximately R$1.3 billion (R$0.9 billion as at December 31, 2021). Ambev has not recorded any provisions for this matter based on the probability of loss of the lawsuit.

 

*Goodwill MAG* 

In December 2022, CRBS S.A (a subsidiary of Ambev) received a tax assessment related to the goodwill amortization in calendar years 2017 to 2020, resulting from the merger of RTD Barbados into CRBS. Ambev filed a defense and awaits judgment by the first level administrative court.

The updated assessed amount related to this uncertain tax position, as per IFRIC 23 and according to explanatory note 3 (q) - *Summary of Significant Accounting Policies*, as at December 31, 2022 was approximately R$251 million. Ambev has not recorded any provisions for this matter based on the probability of loss of the lawsuit.

[**Table of Contents**](#toc)

This uncertain tax position, as per IFRIC 23 and according to explanatory note 3 (q) - *Summary of Significant Accounting Policies*, continued to be applied by the Company impacting calendar years following those assessed (2021- 2022). In a scenario CRBS is questioned on this matter for future periods, on the same basis and under the same arguments as the aforementioned tax assessments, Ambev management estimates that the outcome of such potential further assessments would be consistent to the already assessed periods.

 

*Foreign earnings*

 

Since 2005, Ambev and certain of its subsidiaries have been receiving assessments from the Brazilian Federal Tax Authorities relating to the profits of its foreign subsidiaries. The cases are being challenged at both the administrative and judicial levels of the courts in Brazil.

The administrative proceedings have resulted in partially favorable decisions, most of which are still subject to review by the Administrative Court. In August 2022, the Upper Administrative Court rendered favorable decisions to Ambev on two cases related to the taxation of profits of foreign subsidiaries, one of which recognized the application of the double tax treaty signed by Brazil to mitigate such taxation; both decisions are final. In October 2022, the Lower Administrative Court rendered a favorable decision to Ambev on a third related case. Ambev is awaiting formal notification of this decision to analyze its content and any applicable legal motions or appeals. In the judicial proceedings, Ambev has received favorable injunctions that suspend the enforceability of the tax credit, as well as favorable first level decisions, which remain subject to review by the second-level judicial court.

The updated assessed amount related to this uncertain tax position, as per IFRIC 23 and according to explanatory note 3 (q) - *Summary of Significant Accounting Policies*, as at December 31, 2022 was approximately R$7.3 billion (R$7.5 billion as at December 31, 2021). Ambev has not recorded any provisions for this matter based on the probability of loss of the lawsuit. For proceedings where it considers the chance of loss to be probable, Ambev recorded a provision in the total amount of R$58 million (R$54.1 million as at December 31, 2021)

*Disallowance of Expenses and Deductibility of Losses*

In 2015, 2016 and 2020, Ambev received tax assessments related to the disallowance of alleged non-deductible expenses and the deduction of certain losses mainly associated to financial investments and loans. Ambev presented defenses and, in November 2019, received a favorable decision at the first level administrative court regarding the 2016 case, which is subject to mandatory review by the Lower Administrative Court. In June 2021, Ambev received a partially favorable decision for the 2020 case at the first level administrative court and filed an appeal to the Lower Administrative Court. The favorable portion of the decision is also subject to mandatory review by the Lower Administrative Court. In June 2022, Ambev received a partially favorable decision at the first level administrative court regarding the 2015 case and filed an appeal to the Lower Administrative Court. The favorable portion of the decision is also subject to mandatory review by the Lower Administrative Court.

[**Table of Contents**](#toc)

The updated assessed amount related to this uncertain tax position, as per IFRIC 23 and according to explanatory note 3 (q) - *Summary of Significant Accounting Policies*, as at December 31, 2022 was approximately R$5.2 billion (R$5 billion as at December 31, 2021). Ambev has not recorded any provisions for this matter based on the probability of loss of the lawsuit.

*Disallowance of taxes paid abroad*

Since 2014, Ambev has been receiving tax assessments from the Brazilian Federal Tax Authorities, for calendar years as of 2007, related to the disallowance of deductions associated with alleged unproven taxes paid abroad by its subsidiaries and has been filing defenses. The cases are being challenged at both the administrative and judicial levels. In November 2019, the Lower Administrative Court rendered a favorable decision to Ambev in one of the cases (related to the 2010 tax period), which became definitive.

In January 2020, the Lower Administrative Court rendered unfavorable decisions regarding four of these assessments related to the periods of 2015 and 2016. In these cases, Ambev filed Special Appeals to the Upper Administrative Court which are pending judgment. With respect to the cases related to the periods of 2015, 2016, tax assessments were filed to charge isolated fines due to the lack of monthly prepayments of income tax as a result of allegedly undue deductions of taxes paid abroad. In 2021, Ambev received unfavorable decisions from the first level administrative court in two of these assessments with respect to the 2015 and 2016 isolated fine cases, and filed appeals in connection therewith, which are pending judgment by the Lower Administrative Court. In 2022, Ambev received an unfavorable decision from the first level administrative court in the second assessment related to the 2016 isolated fine case and filed an appeal in connection therewith which awaits judgment by the Lower Administrative Court. In October 2022, Ambev received a new tax assessment charging such isolated fine related to calendar year 2017. Ambev has filed a defense in this case and awaits judgment by the first level administrative court.

The other cases are still awaiting final decisions at both administrative and judicial courts.

The updated assessed amount related to this uncertain tax position, as per IFRIC 23 and according to explanatory note 3 (q) - *Summary of Significant Accounting Policies*, as at December 31, 2022 was approximately R$12.6 billion (R$11.3 billion as at December 31, 2021). Ambev has not recorded any provisions for this matter based on the probability of loss of the lawsuit.

This uncertain tax position, as per IFRIC 23 and according to explanatory note 3 (q) - *Summary of Significant Accounting Policies*, continued to be applied by the Company impacting calendar years following those assessed (2018- 2022). In a scenario Ambev is questioned on this matter for future periods, on the same basis and under the same arguments as the aforementioned tax assessments, Ambev management estimates that the outcome of such potential further assessments would be consistent to the already assessed periods.

[**Table of Contents**](#toc)

In addition, Ambev has been charged isolated fines due to the non-recognition of tax offsets. Ambev has filed defenses in these cases and awaits judgment by the Administrative Level. The constitutionality of this penalty is under review at the Supreme Court of Justice (RE 796,939 e ADI 4,905). The updated assessed amount as at 31 December 2022 was approximately R$1.2 billion (R$1.1 billion as at December 31, 2021). Ambev has not recorded any provisions for this matter as it considers the chance of loss to be possible.

*Presumed Profit*

 

In April 2016, Arosuco (a subsidiary of Ambev) received a tax assessment regarding the use of the "presumed profit" method for the calculation of income tax and the social contribution on net profits instead of the "real profit" method. In September 2017, Arosuco received an unfavorable first level administrative decision and filed an appeal. In January 2019, the Lower Administrative Court rendered a favorable decision to Arosuco, which became definitive.

In March 2019, Arosuco received a new tax assessment regarding the same subject and filed a defense. In October 2019, Arosuco received an unfavorable first level administrative decision and filed an appeal which is pending judgment.

The updated assessed amount related to this uncertain tax position, as per IFRIC 23 and according to explanatory note 3 (q) - *Summary of Significant Accounting Policies*, as at December 31, 2022 was approximately R$581.5 million (R$534.5 million as at December 31, 2021). Arosuco has not recorded any provisions for this matter based on the probability of loss of the lawsuit.

*Disallowance of Income Tax deduction*

In January 2020, Arosuco (Ambev's subsidiary), received a tax assessment from the Federal Revenue Service of Brazil regarding the disallowance of the income tax reduction benefit provided for in Provisional Measure No. 2199-14/2001, for calendar years 2015 to 2018, and an administrative defense was filed. In October 2020, the first level administrative Court rendered an unfavorable decision to Arosuco. Arosuco filed an appeal against the aforementioned decision and awaits judgment by the Lower Administrative Court.

The updated assessed amount as at December 31, 2022 was approximately R$2.3 billion (R$2.1 billion as at December 31, 2021). Arosuco has not recorded any provision for this matter based on the probability of loss of the lawsuit.

This uncertain tax position, as per IFRIC 23 and according to explanatory note 3 (q) - *Summary of Significant Accounting Policies*, continued to be applied by the Company impacting calendar years following those assessed (2019-2022) in which it benefited from

[**Table of Contents**](#toc)

the income tax reduction provided for in Provisional Measure No. 2199-14/2001. In a scenario Arosuco is questioned on this matter for future periods, on the same basis and arguments as the aforementioned tax assessment, Arosuco management estimates that the outcome of such potential further assessments would be consistent to the already assessed periods.

*Deductibility of IOC expenses*

In 2013, as approved in a Shareholders Meeting, Ambev implemented a corporate restructuring with the purpose of simplifying its corporate structure and converting into a single class of shares company, among other factors. One of the steps of such restructuring involved a contribution of shares followed by the merger of shares of its controlled entity, Companhia de Bebidas das Américas, into Ambev. As one of the results of such restructuring, the counterpart register of the positive difference between the value of shares issued for the merger and the net equity value of its controlled entity's share was accounted, as per IFRS 10, in an equity account of Ambev referred to as carrying value adjustment.

In November 2019, Ambev received a tax assessment from the Brazilian Federal Tax Authorities related to the interest on capital ("IOC") deduction in 2014. The assessment refers primarily to the accounting and corporate effects of the restructuring carried out by Ambev in 2013 and the impact on the increase in the deductibility of IOC expenses. In August 2020, Ambev received a partially favorable decision at the first level administrative court and filed an Appeal to the Lower Administrative Court, which awaits judgment. The favorable portion of the decision is subject to mandatory review by the Lower Administrative Court.

In December 2020, Ambev received a new tax assessment related to the deduction of the IOC in 2015 and 2016. The defense against such new tax assessment was filed by Ambev in January 2021. In June 2021, Ambev received a partially favorable decision and filed an appeal to the Lower Administrative Court, which also awaits judgment. Similar to the first tax assessment, the favorable portion of the decision is also subject to mandatory review by the Lower Administrative Court.

In December 2022, Ambev received a new tax assessment related to the deduction of the IOC in 2017. The defense against this new tax assessment was filed by Ambev in January 2023, which is pending judgment by the first level administrative court.

The updated assessed amount related to this uncertain tax position, as per IFRIC 23 and according to explanatory note 3 (q) - *Summary of Significant Accounting Policies*, as at December 31, 2022 is approximately R$13.8 billion (R$10.5 billion as at December 31, 2021). Ambev has not recorded any provisions for this matter based on the probability of loss of the lawsuit.

The uncertain tax position, as per IFRIC 23 and according to explanatory note 3 (q) - *Summary of Significant Accounting Policies*, continued to be adopted by the Company as it also distributed IOC in the years following the assessed period (2018-2022) and deducted

[**Table of Contents**](#toc)

such amounts from its Corporate Income Taxes taxable basis. Therefore, in a scenario where the IOC deductibility would also be questioned for the period after 2017, on the same basis and arguments as the aforementioned tax assessments, Ambev management estimates that the outcome of such potential further assessments would be consistent to the already assessed periods.

*Tax Loss Offset*

Ambev and certain of its subsidiaries received a number of assessments from the Brazilian Federal Tax Authorities relating to the offset of tax losses carried forward in the context of business combinations.

In February 2016, the Upper Administrative Court ruled unfavorably to Ambev in two of these cases, following which Ambev filed judicial proceedings. In September 2016, Ambev received a favorable first level decision in one of the judicial claims which was confirmed by the second-level judicial court in December 2022. This decision is subject to appeal by the tax authorities. In March 2017, Ambev received an unfavorable first level decision with respect to the second judicial case and filed an appeal, which is pending judgment by the second-level judicial court.

There is a third case being challenged at the administrative level in which an unfavorable decision was rendered to Ambev by the Lower Administrative Court in June 2019. Ambev has appealed this decision and awaits judgment by the Upper Administrative Court.

The updated assessed amount related to this uncertain tax position, as per IFRIC 23 and according to explanatory note 3 (q) - *Summary of Significant Accounting Policies*, as at December 31, 2022 was approximately R$548 million (R$411.9 million as at December 31, 2021). Ambev has not recorded any provisions for this matter based on the probability of loss of the lawsuit.

**PIS and COFINS**

*PIS/COFINS over bonus products*

Since 2015, Ambev has received tax assessments issued by the Brazilian Federal Tax Authorities relating to PIS/COFINS amounts allegedly due over bonus products granted to its customers. The cases are being challenged at both the administrative and judicial levels of the courts. In 2019 and 2020, Ambev received final favorable decisions at the administrative level in some of these cases and favorable decisions in other cases that are still subject to review. At the judicial level, one case is pending decision by the second level judicial court after the first level judicial court rendered an unfavorable decision to Ambev.

Ambev management estimates the possible losses related to these assessments at approximately R$1.6 billion as at December 31, 2022 (R$1.8 billion as at December 31, 2021).

[**Table of Contents**](#toc)

**ICMS and IPI**

*ICMS tax war*

 

Ambev is currently challenging tax assessments issued by the states of São Paulo, Rio de Janeiro, Minas Gerais, among others, questioning the legality of ICMS tax credits arising from transactions with companies that have had tax incentives granted by other states. The cases are being challenged at both the administrative and judicial level of the courts.

In August 2020, the STF issued a binding decision (Extraordinary Appeal No. 628.075) recognizing the constitutionality ruling that tax credits granted by the states in the context of the ICMS tax war shall be consider unlawful. The decision also recognized that potential enforcement of tax assessments previously issued by the states should abide by the tax incentives validation process provided for in Complementary Law No. 160/17.

With respect to the assessments issued by the State of São Paulo regarding tax credits from the State of Amazonas, Ambev received unfavorable decisions at the second administrative level in April, May and June 2022. In these cases, Ambev has filed a motion for reconsideration to the second administrative level. In turn, regarding assessments received by the States of São Paulo and Minas Gerais, among others, there were favorable decisions in 2022, which reduced the reported contingency by approximately R$0.3 billion.

Ambev's management estimates the possible losses related to these assessments to be approximately R$1.7 billion as at December 31, 2022 (R$2.0 billion as at December 31, 2021) and have not recorded any provisions in connection therewith.

 

*ICMS-ST Trigger*

 

Over the year, Ambev has received tax assessments to charge supposed ICMS differences considered due when the price of the products sold by Ambev is above the fixed price table basis established by the relevant States, cases in which the State tax authorities understand that the calculation basis should be based on a value-added percentage over the actual prices and not the fixed table price. Ambev is currently challenging those charges before the courts. The cases are being challenged at both the administrative and judicial levels of the courts. Ambev management estimates the amount related to this issue to be approximately R$9.3 billion as at December 31, 2022 (R$8.4 billion as at December 31, 2021), which is classified as a possible loss and, therefore, for which Ambev has made no provision for the period.

 

*ICMS - PRODEPE*

In 2015, Ambev received a tax assessment issued by the State of Pernambuco to charge ICMS differences due to an alleged non-compliance with the state tax incentive agreement ("PRODEPE") as a result of the rectification of its monthly reports. The state tax authorities understood that Ambev was not able to use the incentive due to this rectification. In 2017, Ambev had a final favorable decision in the sense that such

[**Table of Contents**](#toc)

assessment was null due to formal mistakes of the tax auditor. However, in September 2018, Ambev received a new tax assessment to discuss the same matter. With regards to this new tax assessment, in June 2020 Ambev received the First Level Administrative decision, which was partially favorable to the Company in the sense of recognizing the miscalculation of the tax incentive credit by the tax auditor. The favorable portion of the aforementioned decision is final and unappealable. As to the unfavorable portion, Ambev filed an administrative appeal which is awaiting judgment. Furthermore, there are other assessments related to PRODEPE, some of which are already being discussed in the judicial level.

Ambev management estimates the possible losses related to this issue to be approximately R$663.9 million as at December 31, 2022 (R$596.3 million as at December 31, 2021) and has made no provision for the period.

*Manaus Free Trade Zone - IPI and PIS/COFINS*

In Brazil, goods manufactured within the Manaus Free Trade Zone intended for remittance elsewhere in Brazil are exempt and/or zero rated from IPI excise tax and social contributions (PIS/COFINS). With respect to IPI, Ambev has been registering IPI excise tax presumed credits upon the acquisition of exempted goods manufactured therein. Since 2009, Ambev has been receiving several tax assessments from the Brazilian Federal Tax Authorities relating to the disallowance of such credits.

Ambev has also been receiving charges from the Brazilian Federal Tax Authorities in relation to (i) federal taxes allegedly unduly offset with the disallowed presumed IPI excise tax credits that are under discussion in these proceedings and (ii) amounts of PIS and COFINS allegedly due over Arosuco's remittances to Ambev.

In April 2019, the Federal Supreme Court ("STF") announced its judgment on Extraordinary Appeal No. 592,891/SP, with binding effects, deciding on the rights of taxpayers registering presumed IPI excise tax credits on acquisitions of raw materials and exempted inputs originating from the Manaus Free Trade Zone. As a result of this decision, Ambev reclassified part of the amounts related to the IPI cases as remote losses maintaining as possible losses only issues related to other additional discussions that were not included in the analysis of the STF.

The cases are being challenged at both the administrative and judicial levels. Ambev management estimates the possible losses in relation to these assessments to be R$5.8 billion as at December 31, 2022 (R$4.9 billion as at December 31, 2020). Ambev has not recorded any provision in connection with these assessments.

In addition, Ambev has been charged isolated fines due to the non-recognition of tax offsets. Ambev has filed defenses in these cases and awaits judgment by the Administrative Level. The constitutionality of this penalty is under review at the Supreme Court of Justice (RE

[**Table of Contents**](#toc)

796,939 e ADI 4,905). The updated assessed amount as at 31 December 2022 was approximately R$271.6 million (R$224 million as at December 31, 2021). Ambev has not recorded any provisions for this matter as it considers the chance of loss to be possible.

 

*IPI Suspension*

In 2014 and 2015, Ambev received tax assessments from the Brazilian federal tax authorities relating to IPI excise tax allegedly due over remittances of manufactured goods to other related factories. The cases are being challenged at both administrative and judicial levels. We've received partially favorable decision at the administrative level. In July 2022, Ambev received the first judicial decision on this matter; the decision was unfavorable to Ambev and Ambev have filed an appeal.

In October 2022, the Upper Administrative Court rendered a partially favorable decision in one of the cases related to this matter. Ambev awaits the formal notification of this decision to assess whether any portion of the tax assessment may be challenged at the judicial level.

Ambev management estimates the possible losses related to these assessments to be approximately R$1.7 billion as at December 31, 2022 (R$1.6 billion as at December 31, 2021). Ambev has not recorded any provision in connection with these assessments.

 

*ICMS – AM*

In 2016, Arosuco (Ambev's subsidiary) received tax assessments issued by the State of Amazonas to charge alleged differences in ICMS due to questions about the calculation basis applied in sales transactions by Ambev to its subsidiaries. The cases are being challenged at the administrative court. Arosuco management estimates the possible losses related to these assessments to be approximately R$561.5 million as at December 31, 2022 (R$521.3 million as at December 31, 2021) and has not recorded any provisions in connection therewith.

*ICMS – ZFM*

In 2018 and 2021, Ambev received tax assessments from the States of Rio Grande do Sul and São Paulo charging alleged differences in ICMS due to the disallowance of credits arising from transactions with suppliers located in the Manaus Free Trade Zone. With regard to the assessment issued by the State of Rio Grande do Sul, Ambev received a favorable judgment at the second administrative level in February 2022, which is still subject to appeal by tax authorities.

With respect to the assessments issued by the State of São Paulo, Ambev received unfavorable judgments at the first administrative level in May and June 2022. In these cases, we have filed appeals to the second administrative level.

[**Table of Contents**](#toc)

Our management estimates the possible losses related to these assessments to be approximately R$730.3 million as at December 31, 2022 (R$663.3 million as at December 31, 2021). We have not recorded any provisions in connection therewith.

*ICMS – FAIN*

Over the last years, Ambev received tax assessments issued by the State of Paraíba due to an alleged non-compliance with the State Tax Incentive Program ("FAIN"). The State tax authorities' position was that Ambev could not enjoy the tax incentive granted to Companhia de Bebidas (incorporated company), among other allegations related to the calculation method of the tax incentive itself.

Ambev management estimates the possible losses related to these assessments to be approximately R$591.4 million as at December 31, 2022 (R$540.5 million as at December 31, 2021) and has not recorded any provisions in connection therewith.

**Contingent assets**

*PIS and COFINS Recovery - exclusion of ICMS (VAT) from the basis of calculation*

In 2017, the Brazilian Supreme Federal Court ("STF") decided for, in the judgment of RE No. 574,706/PR, with binding effects, the unconstitutionality of the inclusion of ICMS in the tax base of social contributions on gross revenues ("PIS and COFINS"). The decision was reaffirmed by the STF in May 2021, in the judgment of the request for clarification presented by the General Attorney's Office (PGFN), whereby the Court confirmed that the ICMS to be excluded from the PIS and COFINS tax base is that declared in the invoice. The Court also determined that the decision should apply retroactively as of March 15, 2017 (date on which the decision on RE 574,706/PR was rendered), except for taxpayers who had judicial and administrative claims filed before said date (which is the case of the Company and its subsidiaries). As for ICMS under the tax substitution modality, the Superior Court of Justice ("STJ") began the judgment of Theme 1125 with a favorable vote for taxpayers, therefore determining the exclusion of this ICMS modality in the tax bases of social contributions on gross revenues ("PIS and COFINS").

The Company and its subsidiaries filed several lawsuits related to this matter, most with final and unappealable favorable decisions. As the federal tax regime applicable to the soft drinks and beer sector has changed over time, the Company and its subsidiaries are parties to lawsuits related to three different periods: (i) 1990 to 2009, (ii) 2009 to 2015 (period in which the "REFRI Taxation Model" was in force - special soft drinks and beer regime, provided for Article 58-J of Law No. 10,833, of 2003) and (iii) 2015 onwards (also known as "New Model Taxation").

[**Table of Contents**](#toc)

From 2018 to 2022, the Company and its subsidiaries recognized, in accordance with IAS 37, recoverable tax credits related to this matter in the total amount of R$9.4 billion, of which (i) R$0.7 billion is related to periods from 1990 to 2009, (ii) R$4 billion is related to the New Model Taxation, from March 2017, when the Company and its subsidiaries implemented the judicial decisions authorizing the exclusion of the ICMS from the PIS and COFINS tax base in its regular transactions and which right of recovery is assured by the decision rendered by the STF in the judgment of RE 574.706/PR, and (iii) R$4.7 billion is related to periods from 2009 to 2015, during which the REFRI Taxation Model was in force.

Part of this amount has already been used to offset other tax debts according to the final and unappealable decisions rendered in certain judicial lawsuits involving the Company and its subsidiaries. The outstanding amount of recoverable tax credits remain registered in the asset account (see Note 18 – *Recoverable Taxes*).

The accounting recognition of said amounts is due to (i) the gain being virtually certain considering the decision provided by the STF in RE 574,706/PR and the specific circumstances of each case; and (ii) the fact that the amount could be estimated with sufficient reliability, by collecting the respective documents and quantifying the related amount. As to the tax credits related to the period in which the REFRI Taxation Model was in place, the amount could be estimated with sufficient reliability after several analyses made with the assistance of our external consultants were made. These analyses allowed us to (i) identify the total ICMS included per liter in the retail selling prices that were verified by the Federal Government at the time and that had an impact on the reference prices used as a base for the determination of the PIS and COFINS; and (ii) calculate the exclusion of such ICMS from the tax base of PIS and COFINS in the transactions carried out by the Company and its subsidiaries.

In addition, with respect to the transactions performed after the implementation of the individual judicial decisions authorizing the exclusion of the ICMS from the PIS and COFINS tax base, the Company and its subsidiaries had a positive impact of R$5.1 billion, net of the amounts mentioned above, which represented a reduction in the PIS and COFINS expenses.

For additional matters, the Company estimates that the contingent asset corresponds to R$0.7 billion, which will be recognized once the realization of the gain is virtually certain given the specific circumstances of the case and upon confirmation of the estimated values with sufficient reliability.

*Cerbuco Brewing Inc. arbitration*

Cerbuco Brewing Inc., ("Cerbuco") a Canadian subsidiary of Ambev, owns a 50% equity ownership in Cerveceria Bucanero S.A. ("Bucanero"), a joint venture in Cuba. In 2021, Cerbuco initiated an arbitration proceeding at the International Chamber of Commerce ("ICC"), relating to a potential breach of certain obligations relating to the joint venture, with the terms of reference being formally executed in 2022. Depending on the outcome of the arbitration proceedings, there may be an impact on Cerbuco's ability to influence the management of Bucanero's operations. As a result, Ambev's ability to continue consolidating Bucanero into its financial statements may also be affected. Based on the opinion of Cerbuco's Lawyers, the management estimate the chance of loss as possible. The amount involved has not yet been ascertained, as it depends on the outcome of the arbitration.

[**Table of Contents**](#toc)

**31.** **RELATED PARTIES** 

**Policy and practices regarding the realization of transactions with related parties**

The Company adopts the corporate governance practices recommended and/or required by the applicable laws.

Under the Company's by-laws, the Board of Directors is responsible for approving any transactions or agreements between the Company and/or any of its subsidiaries (except for full subsidiaries), its directors and/or shareholders (including direct or indirect shareholders of the Company). The Governance Committee of the Company (previously known as Antitrust Compliance and Related Parties Committee, as update approved by the Board of Directors at meeting attended on October 14, 2022) is required to advise the Board of Directors on all transactions with related parties, among other subjects.

Management is prohibited from interfering in any transaction in which a conflict of interest exists, even in theory, with the Company's interests. Management also are not permitted to interfere in decisions of any other members of management, and the Minutes of Meeting of the Board are required to document any decision to abstain from the respective deliberations.

The Company's guidelines on related parties require it to follow reasonable or commutative terms, similar to those prevailing in the market, or under which the Company would contract similar transactions with third parties. These related parties transactions are clearly disclosed in the financial statements as formalized in the written contracts.

**Transactions with management members**

In addition to short-term benefits (primarily salaries), management members are entitled to participate in the Stock Option Plan and Share-Based Payments Plan (Note 25 - *Share-based payments*).

[**Table of Contents**](#toc)

Total expenses related to the Company's management members are as follow:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| Short-term benefits <sup>(i)</sup> | 74.2 | 68.3 | 26.0 |
| Share-based payments <sup>(ii)</sup> | 66.0 | 65.3 | 42.7 |
| **Total key management remuneration** | **140.2** | **133.6** | **68.7** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(i) These mainly correspond to management's salaries and profit sharing (including performance bonuses).

&nbsp;&nbsp;&nbsp;&nbsp;(ii) These correspond to the compensation cost of share options and restricted stocks granted to management. These amounts exclude remuneration
paid to members of the Fiscal Council.

Excluding the above mentioned plan (Note 25 - *Share-based payments*), the Company no longer has any types of transaction with the Management members or pending balances receivable or payable in its balance sheet.

**Transactions with the Company's shareholders:**

*a) Medical, dental and other benefits*

 ****

Fundação Zerrenner is one of Ambev's shareholders, and at December 31, 2022 held 10.2% of its total share capital. Fundação Zerrenner is also an independent legal entity whose main goal is to provide Ambev's employees, both active and retired, with health care and dental assistance, technical and higher education courses, facilities for assisting elderly people, either directly or through financial assistance agreements with other entities. As at December 31, 2022 and December 31, 2021, actuarial obligations related to the benefits provided directly by Fundação Zerrenner were fully funded by plan assets, held for that purpose, which significantly exceeded the liabilities at these dates. Ambev recognizes the assets (prepaid expenses) of this plan to the extent of the economic benefits available to the Company, arising from reimbursements or from reductions in future contributions.

The expenses incurred by Fundação Zerrenner with third parties, for providing these benefits totaled R$308.8 (R$279.4 as at December 31, 2021), of which R$270.7 and R$38.1 were related to active employees and retirees respectively (R$247.2 and R$32.2 as at December 31, 2021 related to active employees and retirees respectively).

*b) Licensing agreement*

The Company have a licensing agreement with Anheuser-Busch, Inc. to produce, bottle, sell and distribute *Budweiser* products in Brazil, Canada and Argentina, and sales and distribution agreements for Budweiser products in Guatemala, the Dominican Republic, Paraguay, El Salvador, Nicaragua, Uruguay, Chile, Panama, Costa Rica and Puerto Rico. In addition, the Company produces and distributes *Stella Artois* products under a license to ABI in Brazil and Canada and, through a license granted to ABI, also distributes *Brahma* products in the United States and several other countries such as the United Kingdom, Spain, Sweden, Finland and Greece.

[**Table of Contents**](#toc)

The Company and its subsidiaries have licensing agreements with the Group Modelo, subsidiaries of AB Inbev to import, produce, promote and sell Corona products (*Corona Extra*, *Corona Light*, *Coronita*, *Pacifico* and *Modelo*) in Latin America and Canada and with Spaten-Franziskaner-Bräu GmbH, a subsidiary of ABI, to produce, promote, advertise and sell *Spaten* in Brazil.

In this context, the Company recorded R$22.6 (R$17.0 as at December 31, 2021 and R$2.1 as at December 31, 2020) and R$736.7 (R$819.0 as at December 31, 2021 and R$644.0 as at December 31, 2020) as licensing income and expenses, respectively.

**Transactions with related parties**

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2022** | **2022** |
| **Current** | **Trade receivables** **<sup>(i)</sup>** | **Other trade receivables** **<sup>(i)</sup>** | **Trade payables** **<sup>(i)</sup>** |
| AB Africa | 1.6 |  |  |
| AB InBev | 142.7 |  | (82.0) |
| AB Package |  |  | (79.3) |
| AB Services | 23.7 |  | (5.7) |
| AB USA | 71.1 |  | (237.7) |
| Bavaria | 13.9 |  | (6.9) |
| Cervecería Modelo | 12 |  | (345.5) |
| Cervecerías Peruanas | 0.9 |  | (46.4) |
| Inbev | 1 | 23.9 | (12.2) |
| Panamá Holding | 3.9 |  |  |
| Others | 19.9 | 0.9 | (14.7) |
|  | **290.7** | **24.8** | **(830.4)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **2021** | **2021** | **2021** | **2021** |
| **Current** | **Trade receivables** **<sup>(i)</sup>** | **Other trade receivables** **<sup>(i)</sup>** | **Trade payables** **<sup>(i)</sup>** | **Dividends receivables** |
| AB Africa | 5.3 |  |  |  |
| AB InBev | 45.4 |  | (167.0) |  |
| AB Package |  |  | (63.1) |  |
| AB Services | 32.7 |  | (3.0) |  |
| AB USA | 34.5 | 11.5 | (330.7) |  |
| Bavaria | 3.6 |  | (11.0) |  |
| Cervecería Modelo | 6.1 |  | (548.4) |  |
| Cervecerías Peruanas | 3.4 |  | (16.6) |  |
| Inbev | 0.8 | 26.4 | (26.4) |  |
| Panama Holding | 4.6 |  |  | 1.5 |
| Others | 18.7 | 1.1 | (44.5) | - |
|  | **155.1** | **39.0** | **(1210.7)** | **1.5** |

---

(i) The amount represents trading operations (purchase and sale) and reimbursements between the companies of the group.

---

| | | |
|:---|:---|:---|
|  | **2022** | **2021** |
| **Non-current** | **Trade payables** | **Trade payables** |
| ITW International | (343.6) | (407.9) |
|  | **(343.6)** | **(407.9)** |

---

[**Table of Contents**](#toc)

The tables below represent transactions with related parties, recognized in the income statement:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **2022** | **2022** | **2022** | **2022** | **2022** |
| **Company** | **Sales and other** | **Service fees / reimbursement of expenses and other receivables** | **Product purchases and other** | **Service fees / reimbursement of expenses and other payables** | **Net finance cost** |
| AB InBev | 0.1 | 5.2 | (117.3) | (8.5) | 208.7 |
| AB Package |  |  | (356.8) |  |  |
| AB Procurement |  |  |  | (18.1) |  |
| AB USA | 25.5 |  | (1129.7) | (3.2) |  |
| Ambev Peru | 0.6 |  |  |  |  |
| Bavaria | 32.0 |  | (56.7) |  |  |
| Cervecería Modelo | 124.4 |  | (1323.6) |  |  |
| Cervecerías Peruanas | 1.7 |  | (49.6) |  |  |
| GCC India |  |  |  | (7.1) |  |
| Inbev |  |  | (129.8) |  |  |
| ITW International |  |  |  |  | 37.3 |
| Other | 84.8 | 9.6 | (87.2) | - | 1.9 |
|  | **269.1** | **14.8** | **(3250.7)** | **(36.9)** | **247.9** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **2021** | **2021** | **2021** | **2021** | **2021** |
| **Company** | **Sales and other** | **Service fees / reimbursement of expenses and other receivables** | **Product purchases and other** | **Service fees / reimbursement of expenses and other payable** | **Net finance cost** |
| AB InBev | 0.7 |  | (180.3) | (10.7) |  |
| AB Package |  |  | (286.7) |  |  |
| AB Procurement |  |  |  | (16.1) |  |
| AB USA | 32.1 |  | (1209.9) | (3.9) | 0.3 |
| Ambev Peru | 3.2 |  |  |  |  |
| Bavaria | 30.9 |  | (57.0) |  |  |
| Cervecería Modelo | 0.8 |  | (1708.2) |  |  |
| Cervecerías Peruanas | 3.2 |  | (32.9) |  |  |
| GCC India |  |  |  | (8.2) |  |
| Inbev |  |  | (107.9) |  |  |
| ITW International |  |  |  |  | 42.2 |
| Other | 19.5 | 3.6 | (143.0) | - | - |
|  | **90.4** | **3.6** | **(3725.9)** | **(38.9)** | **42.5** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **2020** | **2020** | **2020** | **2020** | **2020** |
| **Company** | **Sales and other** | **Service fees / reimbursement of expenses and other receivables** | **Product purchases and other** | **Service fees / reimbursement of expenses and other payables** | **Net finance cost** |
| AB InBev | 0.3 |  | (80.6) | (9.9) |  |
| AB Package |  |  | (159.2) |  |  |
| AB Procurement | 0.2 |  | (0.6) | (17.3) |  |
| AB USA | 35.2 |  | (977.0) | (3.2) |  |
| Bavaria | 26.1 |  | (48.0) |  |  |
| Cervecería Modelo | (0.1) |  | (1269.6) |  |  |
| Cervecerías Peruanas | 13.3 |  | (40.3) |  |  |
| GCC India |  |  |  | (7.3) |  |
| Inbev | (0.9) |  | (102.3) |  |  |
| ITW International |  |  |  |  | 10.5 |
| Oriental Brewery | 2.0 |  |  |  |  |
| Other | 22.1 | 0.2 | (83.9) | - | 1.5 |
|  | **98.2** | **0.2** | **(2761.5)** | **(37.7)** | **12.0** |

---

[**Table of Contents**](#toc)

<u>List of companies included in the tables above</u>:

---

| |
|:---|
| AB InBev Procurement GmbH ("AB Procurement") |
| Ambrew S.A.R.L. ("Ambrew") |
| Anheuser-Busch Inbev Africa (Pty) Ltd. ("AB Africa") |
| Anheuser-Busch InBev N.V. ("AB InBev") |
| Anheuser-Busch Inbev Services LLC ("AB Services") |
| Anheuser-Busch Inbev USA LLC ("AB USA") |
| Anheuser-Busch Packaging Group Inc. ("AB Package") |
| Bavaria S.A. ("Bavaria") |
| Cervecería Modelo de Mexico S. de R.L. de C.V. ("Cervecería Modelo") |
| Cervecería Nacional S de RL ("Panamá Holding") |
| Compañia Cervecera Ambev Peru S.A.C. ("Ambev Peru") |
| GCC Services India Private Ltd. ("GCC India") |
| Inbev Belgium N.V. ("Inbev") |
| Interbrew International B.V. ("ITW International") |
| Oriental Brewery Co. Ltd. ("Oriental Brewery") |
| Unión de Cervecerias Peruanas Backus Y Johnston S.A.A. ("Cervecerías Peruanas") |

---

**32.** **GROUP COMPANIES** 

List of most significant fully consolidated companies:

---

| | |
|:---|:---|
| &nbsp;&nbsp;<br> **Argentina** |  |
| &nbsp;&nbsp; CERVECERÍA Y MALTERIA QUILMES SAICA Y G<br> Charcas 5160 - Buenos Aires | &nbsp;&nbsp;99.75% |
| &nbsp;&nbsp;**Bolivia** |  |
| &nbsp;&nbsp; CERVECERÍA BOLIVIANA NACIONAL S.A.<br> Avenida Montes 400 e Rua Chuquisaca 121 - La Paz | &nbsp;&nbsp;85.34% |
| &nbsp;&nbsp;**Brazil** |  |
| &nbsp;&nbsp; AMBEV S.A.<br> Rua Dr. Renato Paes de Barros, 1.017, 3º andar, Itaim Bibi, São Paulo | &nbsp;&nbsp;Consolidating |
| &nbsp;&nbsp; AROSUCO AROMAS E SUCOS LTDA.<br> Avenida Buriti, 5.385, Distrito Industrial - Manaus - AM | &nbsp;&nbsp;100.00% |
| &nbsp;&nbsp; CRBS S.A.<br> Avenida Antarctica, 1.891, Fazenda Santa Úrsula - Jaguariúna - SP | &nbsp;&nbsp;100.00% |
| &nbsp;&nbsp; CERVEJARIA Z.X. S.A.<br> Avenida Antarctica, 1.891, Fazenda Santa Úrsula - Jaguariúna - SP | &nbsp;&nbsp; <br> 100.00% |
|  | &nbsp;&nbsp; <br> 100.00% |
| &nbsp;&nbsp;**Canada** |  |
| &nbsp;&nbsp; LABATT BREWING COMPANY LTD.<br> 207 Queens Quay West, Suite 299 - M5J 1A7 - Toronto | &nbsp;&nbsp;100.00% |

---

[**Table of Contents**](#toc)

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Chile** |  |
| &nbsp;&nbsp; CERVECERÍA CHILE S.A.<br> Avenida Presidente Eduardo Frei Montalva, 9.600 - Quilicura - Santiago | &nbsp;&nbsp;100.00% |
| &nbsp;&nbsp;**Spain** |  |
| &nbsp;&nbsp; JALUA SPAIN, S.L.<br> Juan Vara Terán, 14 - Ilhas Canárias | &nbsp;&nbsp;100.00% |
| &nbsp;&nbsp;**Luxembourg** |  |
| &nbsp;&nbsp; AMBEV LUXEMBOURG<br> 15 Breedewues - L1259 - Senningerberg | &nbsp;&nbsp;100.00% |
| &nbsp;&nbsp;**Guatemala** |  |
| &nbsp;&nbsp; INDUSTRIAS DEL ATLÁNTICO S.A.<br> KM 122 Ruta al Atlantico - C.P 01012 Teculutan, Zacapa | &nbsp;&nbsp;50.00% |
| &nbsp;&nbsp;**Paraguay** |  |
| &nbsp;&nbsp; CERVECERÍA PARAGUAYA S.A.<br> Ruta Villeta KM 30 - Ypané | &nbsp;&nbsp;87.35% |
| &nbsp;&nbsp;**Dominican Republic** |  |
| &nbsp;&nbsp; CERVECERÍA NACIONAL DOMINICANA, S.A.<br> Autopista 30 de Mayo, Distrito Nacional | &nbsp;&nbsp;85.00% |
| &nbsp;&nbsp;**Uruguay** |  |
| &nbsp;&nbsp; LINTHAL S.A.<br> 25 de Mayo 444, office 401 - Montevideo | &nbsp;&nbsp;100.00% |
| &nbsp;&nbsp; CERVECERÍA Y MALTERIA PAYSANDU S.A.<br> Cesar Cortinas, 2.037 - Montevideo | &nbsp;&nbsp;100.00% |
| &nbsp;&nbsp; MONTHIERS S.A.<br> Cesar Cortinas, 2.037 - Montevideo | &nbsp;&nbsp;100.00% |
| &nbsp;&nbsp;**Panama** |  |
| &nbsp;&nbsp; CERVECERÍA NACIONAL S. DE R.L.<br> Avenida Ricardo J. Alfaro, Corregimiento de Betania, Distrito de Panamá | &nbsp;&nbsp;100.00% |

---

**33.** **INSURANCE** 

The Company has a program of risk management requiring it to obtain insurance coverage compatible with its size and operations. Coverage was contracted at amounts considered sufficient by management to cover possible losses, considering the nature of the Company's activities, the risks involved in its operations and the guidance of its insurance advisors.

## Exhibit 2.2

**Exhibit 2.2** 

**DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT** 

As of December 31, 2022, Ambev S.A. ("Ambev," the "Company," "we," "us," and "our") had the following classes of securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading symbol(s)** | **Name of each exchange<br> on which registered** |
| Common shares without par value\* | ABEV | New York Stock Exchange\* |
| American Depositary Shares\*\*,<br> each representing one common share | ABEV | New York Stock Exchange\*\* |

---

\* Not for trading, but only in connection with the registration of the American depositary shares (the "ADSs"), representing such common shares, pursuant to the requirements of the SEC.

\*\* Evidenced by American depositary receipts ("ADRs").

Capitalized terms used but not defined in this Exhibit 2.2 shall have the meaning given to such terms in the Ambev's Annual Report on Form 20-F for the fiscal year ended December 31, 2022 (the "2022 Form 20-F").

**COMMON SHARES**

The following description of Ambev's common shares is a summary of the material provisions concerning our common shares, bylaws and the Brazilian Corporation Law. In Brazil, the principal governing document of a corporation is its bylaws (*Estatuto Social*). This description is qualified in its entirety by reference to the Brazilian Corporation Law and our bylaws. An English translation of the bylaws is incorporated by reference as Exhibit 1.1 to the 2022 Form 20-F. A copy of our bylaws (together with an English translation) is also available for inspection at the principal office of the depositary and at our website (www.ri.ambev.com.br).

**General**

Our common shares are listed and admitted to trade on the traditional segment of the B3 under the ticker symbol "ABEV". Our common shares are listed on the New York Stock Exchange not for trading, but only in connection with the registration of the ADS representing such common shares, pursuant to the requirements of the SEC.

Our registered name is Ambev S.A., and our registered office is in the city of São Paulo, State of São Paulo, Brazil. Our registration number with the São Paulo Commercial Registry is 35,300,368,941. Our principal corporate purposes include the production and sale of beer, CSDs and other beverages. A more detailed description of our corporate purposes can be found in Chapter I, Article 3 of our bylaws.

**Description of Capital Stock** 

As of December 31, 2022, our subscribed and paid-in capital stock consisted of 15,750,216,851 common shares, all of which have equal voting and equity rights, with no par value, of which 8,482,160 common shares were held in treasury.

**Rights of the Ambev Common Shares**

Each of our common shares is indivisible and entitles its holder to one vote at any shareholders' meeting of Ambev. In accordance with our bylaws and the Brazilian Corporation Law, shareholders have the right to receive dividends or other distributions in proportion to their equity interest in our share capital. For additional information regarding the payment of dividends and other distributions relating to our common shares, see "Item 8. Financial Information—A. Consolidated Financial Statements and Other Financial Information—Dividend Policy." In addition, our shareholders may freely transfer their shares and are entitled to be included in a statutory sale of control tender offer upon a disposition of our control (see item "Disclosure of the Ownership and Trading of our Shares by Us, our Principal Shareholders, Directors and Officers or Members of our Fiscal Council" for more information).

Also, upon our liquidation, and after the discharge of all our liabilities, our common shares entitle its holders to a participation in our remaining assets as capital reimbursement in proportion to their equity interest in our share capital. Except under certain circumstances, holders of our common shares have the right, but not the obligation, to subscribe for our future capital increases (see "—Preemptive Rights").

Moreover, pursuant to the Brazilian Corporation Law, neither our bylaws nor actions taken at a shareholders' meeting may deprive a shareholder of the following rights:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· the right to participate in our profit distributions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· the right to participate in our remaining assets in proportion to its equity interest in our share capital
in the event of our liquidation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· preemptive rights to subscribe for our common shares, convertible debentures and warrants, except in certain
circumstances under the Brazilian Corporation Law, as described in "—Preemptive Rights";

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· the right to inspect and monitor our management, in accordance with the Brazilian Corporation Law; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· the right to exercise appraisal rights and withdraw from the Company in the cases provided under the Brazilian
Corporation Law, as described in "—Appraisal Rights."

**Shareholders' Meetings** 

Pursuant to the Brazilian Corporation Law, shareholders, during shareholders' meetings regularly called and convened, are generally empowered to pass resolutions relating to our corporate purpose as they may deem necessary. Shareholders' meetings may be ordinary, such as the annual meeting, or extraordinary. Shareholders at the annual shareholders' meeting, which is required to be held within four months of the end of our fiscal year, have the exclusive power to approve our financial statements and to determine the allocation of our adjusted net income and the distribution of dividends with respect to the fiscal year ended immediately prior to the relevant annual meeting. Extraordinary shareholders' meetings are convened to approve the remaining matters within their competency as provided by law and/or our bylaws. An extraordinary shareholders' meeting may be held concurrently with an ordinary meeting.

A shareholders' meeting is convened by publishing a meeting call notice no later than 21 days prior to the scheduled meeting date, on first call, and no later than eight days prior to the date of the meeting, on second call, and no fewer than three times, in a newspaper with general circulation in São Paulo, where we have our registered office. In certain circumstances, however, the CVM may require that the first notice be published no later than 30 days prior to the meeting. At the shareholders' meeting held on March 1, 2013, our shareholders designated *Valor Econômico*, a newspaper with general circulation in São Paulo for this purpose. The call notice must contain the date, time, place and agenda of the meeting, and in case of amendments to the bylaws, the indication of the relevant matters. CVM Resolution No. 81/22, also requires that additional information be disclosed in the meeting call notice for certain matters. For example, in the event of an election of all directors, the meeting call notice shall also disclose the minimum percentage of equity interest required from a shareholder to request the adoption of cumulative voting procedures. All documents in connection with the shareholders' meeting's agenda shall be made available to shareholders either within at least one month prior to the meeting or upon publication of the first meeting call notice, as the case may be, except if otherwise required by law or CVM regulations.

A shareholders' meeting may be held on first call, if shareholders representing at least one quarter of the voting shares are present, except in some cases provided by law, such as in meetings seeking to amend the Company's bylaws, which requires the presence, on first call, of shareholders representing at least two-thirds of the voting shares. If no such quorum is present, an eight-day prior notice must be given in the same manner as described above, and a meeting may then be convened, on second call, without any specific quorum requirement, subject to the minimum quorum and voting requirements for specific matters, as discussed below.

Except as otherwise provided by law, resolutions of a shareholders' meeting are passed by a simple majority vote of the shares present or represented at the meeting, abstentions not being considered. Under the Brazilian Corporation Law, the approval of shareholders representing at least a majority of the votes granted by the issued and outstanding voting shares is required for the types of actions described below (among others):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· creating preferred shares or increasing disproportionately an existing class of preferred shares relative
to the other classes of shares, unless such action is provided for or authorized by the bylaws;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· modifying a preference, privilege or condition of redemption or amortization conferred upon one or more
classes of preferred shares, or creating a new class with greater privileges than those of the existing classes of preferred shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· reducing the minimum mandatory dividend;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· merging Ambev with another company or consolidating or executing a spin-off of Ambev;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· related party transactions, or the sale or contribution of assets to another company, in any case if the
amount involved exceeds 50% of the amount of our assets indicated in the most recently approved balance sheet;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· changing our corporate purpose; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· dissolving Ambev or ceasing its liquidation status.

Shareholders may not exercise voting rights with respect to the approval of the appraisal report of assets contributed by them in a capital increase paid in kind or with respect to the approval of their own accounts as managers of the company, as well as in those resolutions that may favor those shareholders specifically, or whenever there is a conflicting interest with the Company. Mergers between affiliated parties are subject to a special statutory valuation procedure intended to provide a parameter (based on the net equity at market prices of the companies involved) for comparing the proposed exchange ratio.

Shareholders' meetings may be called by our Board of Directors. Under the Brazilian Corporation Law, meetings may also be convened by our shareholders as follows: (1) by any shareholder, if the directors take more than 60 days to convene a shareholders' meeting after the date they were required to do so under applicable laws and our bylaws, (2) by shareholders holding at least 1% of our total capital stock, if our Board of Directors fails to call a meeting within eight days after receipt of a justified request to call a meeting by those shareholders indicating the proposed agenda, (3) by shareholders holding at least 5% of our voting capital stock, if the directors fail to call a general meeting within eight days after receipt of a request to call a shareholders' meeting for purpose of assembling a Fiscal Council, and (4) by our Fiscal Council, if the Board of Directors fails to call an annual shareholders' meeting within 30 days after the mandatory date for such call. The Fiscal Council may also call an extraordinary shareholders' meeting if it believes that there are important or urgent matters to be addressed.

To attend a shareholders' meeting, shareholders or their legal representatives willing to attend the meeting shall present proof of ownership of their Company shares, including identification and/or pertinent documentation that evidences their legal representation of such shareholder. A shareholder may be represented at a general meeting by an attorney-in-fact appointed no more than one year before the meeting, who must be another shareholder, a company officer, a lawyer or a financial institution. Notwithstanding the above, the CVM decided on November 4, 2014 that shareholders that are legal entities may be represented at general meetings by their legal representatives or by a duly appointed attorney-in-fact, pursuant to the bylaws and related corporate instruments of the legal entities and pursuant to the Brazilian Civil Code.

The participation and remote voting in general shareholders' meetings of publicly-held companies are regulated by CVM Resolution No. 81/22, as amended, which aims to facilitate the participation of shareholders in general meetings either through the vote or through the submission of proposals, as well as to enhance the corporate governance instruments available in the Brazilian market. For this purpose, this regulation provided the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· the creation of a remote voting bulletin through which shareholders may exercise their right to vote prior
to the date the general meeting is held;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· the possibility of inclusion of candidates and proposals of deliberation of minority shareholders in that
bulletin, with due observance of certain percentages of equity interest, in order to facilitate shareholders' participation in general
meetings; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· the deadlines, procedures and ways of sending this bulletin, which may be forwarded by the shareholder:
(a) to the custodian (if the shares held by the shareholder are kept at a centralized deposit) or; (b) to the book-entry agent of the
shares issued by the company (if such shares are not kept at a centralized deposit); or (c) directly to the company.

CVM Resolution No. 81/22, also regulates the rules applicable to remote voting, including, but not limited to, (1) the deadlines for inclusion of candidates in the bulletin by request of minority shareholders and for the company to resend the bulletin in case of inclusion of candidates by minority shareholders and (2) the disclosure of the detailed final voting map of the shareholders' meetings, including the partial disclosure of each shareholders taxpayer's registry number and their respective votes on each matter.

Additionally, CVM Resolution No. 81/22, as amended, also regulates the possibility of publicly-held companies to hold virtual or hybrid (i.e. physical and virtual) shareholders' meetings, including procedures that must be adopted by such companies when holding these types of meetings. The documents calling a shareholders' meeting must indicate the format of the meeting and the arrangements that shareholders must take to participate remotely.

**Board of Directors** 

In accordance with the Brazilian Corporation Law, as a general rule, any matters subject to the approval of our Board of Directors can be approved by the affirmative vote of a majority of our Board members present at the relevant meeting. Exceptions to this general rule are provided in the Shareholders' Agreement.

Under our bylaws, (i) the majority of the members of our Board of Directors must be external directors (i.e. with no current employment or managerial relationship with the company) and (ii) at least two members of our Board of Directors shall be independent directors. According to our bylaws, for a director to be considered independent he or she may not: (1) be a controlling shareholder, or a spouse or relative to the second degree of a controlling shareholder, (2) have been, within the last three years, an employee or executive officer of (a) Ambev or of any of our controlled companies or (b) our controlling shareholder or entities under common control with Ambev, (3) directly or indirectly, supply to, or purchase from, us, our controlled companies, controlling shareholder or entities under common control, any products or services, to such an extent as would cause that director to cease being independent, (4) be an employee or administrator of any corporation or entity that offers products or services to, or receives products or services from, us, our controlled companies, controlling shareholder or entities under common control, to such an extent as would cause that director to cease being independent, (5) be a spouse or relative to the second degree of any member of management of Ambev, its controlled companies, controlling company or entity under common control, or (6) receive any other compensation from Ambev, its controlled companies, controlling shareholder or entities under common control, aside from compensation for duties as a board member (gains arising from ownership of our stock are excluded from this restriction). Our bylaws also set forth that directors elected by a separate ballot vote of minority shareholders holding at least 10% of our capital stock, as provided in paragraphs 4 and 5 of Section 141 of the Brazilian Corporation Law, shall be deemed independent regardless of compliance with the abovementioned criteria. Furthermore, Brazilian law and CVM regulations requires that at least 20% of the members of the Board of Director shall be independent directors, who are qualified as such depending on certain criterion relating to the relationship between a director, and (i) Ambev, its controlling shareholder and their management; and (ii) companies controlled, affiliated or under common control.

According to the general principles of the Brazilian Corporation Law, if a director or an executive officer has a conflict of interest with a company in connection with any proposed transaction, the director or executive officer may not intervene nor vote in any resolution of the Board of Directors or of the Board of Executive Officers regarding such transaction and must disclose the nature and extent of the conflicting interest for purposes of recording such information in the minutes of the meeting. In any case, a director or an executive officer may not transact any business with a company, including any borrowings, except on reasonable or fair terms and conditions that are identical to the terms and conditions prevailing in the market or offered by third parties. Any transaction in which a director or executive officer may have an interest can only be approved if carried out on an arm's-length basis.

Election of Directors

Each Ambev common share represents one vote at any shareholders' meeting in connection with the election of our Board of Directors.

Common shareholders holding at least 10% of our capital may elect one member and respective alternate to the Board of Directors without the participation of the controlling shareholders. To exercise these minority rights, shareholders must prove their continuous ownership of their Ambev common shares for at least three months prior to the shareholders' meeting convened to elect board members. If that prerogative is exercised with the adoption of cumulative voting procedures, as described below, the controlling shareholder will always have the right to elect the same number of members appointed by minority shareholders plus one, regardless of the number of directors provided in our bylaws.

Shareholders holding shares representing at least 10% of our capital, or a smaller applicable percentage according to a sliding scale determined by the CVM and based on a company's capital stock (currently 5% of the Ambev common shares, pursuant to the CVM's sliding scale), have the right to request that cumulative voting procedures be adopted. Under such procedures, each of our common shares shall entitle as many votes as the number of director positions to be filled, and each shareholder may cast all of his or her votes for a single candidate or distribute them among various candidates.

Pursuant to CVM Resolution No. 81/22, publicly-held companies shall adopt the following measures regarding voting process: (1) inform the market of the adoption of cumulative voting process in applicable meetings immediately upon the receipt of the first valid requirement; (2) disclose the voting final summary statements, the voting final detailed statements, as well as any voting statement presented by shareholders at the relevant meeting; and (3) register in the minutes of the annual shareholders' meeting the number of approving, rejecting or abstaining votes for each item of the agenda, including the votes received by each member of the Board of Directors and/or Fiscal Council elected in such shareholders' meeting.

Under our bylaws and applicable law, the number of directors may be reduced to a minimum of five.

The current members of our Board of Directors were elected by our controlling shareholder. Board members, regardless of the shareholder they represent, owe fiduciary duties to the Company and all of our shareholders. At the same time, any director appointed by shareholders bound by a shareholders' agreement is also bound by the terms of that agreement. For more information on our shareholders' agreements, see "Item 7. Major Shareholders and Related Party Transactions—A. Major Shareholders—Ambev's Major Shareholders."

**Dividends**

The discussion below summarizes the main provisions of the Brazilian Corporation Law regarding the establishment of reserves by corporations and rules with respect to the distribution of dividends, including provisions regarding interest on shareholders' equity.

Calculation of Distributable Amounts

At each annual shareholders' meeting, our Board of Directors is required to propose how Ambev's net income for the preceding fiscal year is to be allocated. For purposes of the Brazilian Corporation Law, a company's net income after income taxes and social contribution on profits for the immediately preceding fiscal year, net of any accumulated losses from prior fiscal years and amounts allocated to employees' and management's participation in earnings, represents its "adjusted net income" for such preceding fiscal year. In accordance with the Brazilian Corporation Law, an amount equal to such adjusted net income, which is also referred to in this section as the distributable amount, will be available for distribution to shareholders in any particular year. Such distributable amount is subject to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· reductions that may be caused by amounts contributed for the purpose of meeting the charges of the assistance
foundation for employees and management of the Company and its controlled companies, with due regard for the rules established by the
Board of Directors to this effect; up to 10% of the distributable amount may be contributed under this concept;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· reductions caused by amounts allocated to the Legal Reserve or Contingency Reserves (see "—Reserves");
and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· increases caused by reversals of reserves constituted in prior years.

Minimum Mandatory Dividend

We are required by our bylaws to distribute to shareholders as dividends in respect to each fiscal year ending on December 31 a minimum mandatory dividend equivalent to no less than 40% of the distributable amount. In addition to the minimum mandatory dividend, the Board of Directors may recommend payment of additional dividends to shareholders. The limit for dividend payment is the distributable amount plus the balance available in certain profit reserves (including our statutory "Investment Reserve," to which we allocate distributable amounts from previous fiscal years not paid as dividends. See "—Reserves.") and retained profits. Furthermore, the Board of Directors may also resolve on the distribution of interim dividends and/or interest on shareholders' equity based on the accrued profits or existing profits (retained profits or certain profits reserves) presented in the latest annual or six-month balance sheet. Interim dividends and interest on shareholders' equity are always deemed as an advancement towards the minimum mandatory dividend.

In addition, the minimum mandatory dividend, whether the full amount or only a portion thereof, may not be distributed in any given year should the Board of Directors consider that such payment is incompatible with the Ambev's financial situation, subject to shareholder approval. While the law does not establish the circumstances in which distribution of the minimum mandatory dividend is incompatible with a company's financial situation, it is generally agreed that a company is allowed to refrain from paying the minimum mandatory dividend if such payment threatens its existence as a going concern or harms its normal course of operations. The Fiscal Council must opine on the nonpayment of minimum mandatory dividends, and management must submit to the CVM a report explaining the reasons considered by the Board of Directors to withhold the payment of the minimum mandatory dividend no later than five business days after the shareholders' meeting that takes such decision.

Any postponed payment of minimum mandatory dividends must be allocated to a special reserve. Any remaining balance in such reserve not absorbed by losses in subsequent fiscal years must be paid to shareholders as soon as the Company's financial situation allows.

Payment of Dividends

Under the Brazilian Corporation Law any holder of record of shares at the time of a dividend declaration is entitled to receive such dividends, which are generally required to be paid within 60 days following the date of such declaration, unless otherwise resolved by the shareholders' meetings, which, in either case, must occur prior to the end of the fiscal year in which such dividends were declared. Our bylaws do not provide for a time frame for payment of dividends. The minimum mandatory dividend is satisfied through payments made both in the form of dividends and interest on shareholders' equity (amount net of taxes), which, from an economic perspective, is equivalent to a dividend but represents a tax efficient alternative to distribute earnings to shareholders because it is deductible for income tax purposes up to a certain limit established by Brazilian tax laws (see "—Interest on Shareholders' Equity"). Shareholders have a three-year period from the dividend payment date to claim the payment of dividends, after which we are no longer liable for such payment.

Shareholders that do not reside in Brazil must register their investment with the Central Bank in order for gains, dividends, profits or other payments under Ambev's shares to be eligible for remittance in foreign currency outside of Brazil. Our common shares underlying the Ambev ADSs will be deposited with the Brazilian custodian,Banco Bradesco S.A., which acts on behalf of and as agent for the Depositary, which is registered with the Central Bank as the fiduciary owner of those common shares underlying our ADSs. Payments of cash dividends and distributions on our common shares will be made in *reais* to the custodian on behalf of the Depositary. The custodian will then convert those proceeds into U.S. dollars and will deliver them to the Depositary for distribution to ADS holders. If the custodian is unable to immediately convert dividends in *reais* into U.S. dollars, ADS holders may be adversely affected by devaluations of the *real* or other exchange rate fluctuations before those dividends can be converted into U.S. dollars and remitted abroad. Fluctuations in the exchange rate between the *real* and the U.S. dollar may also affect the U.S. dollar equivalent of the trading price of our common shares in *reais* on the B3.

Interest on Shareholders' Equity

Brazilian companies are permitted to distribute earnings to shareholders under the concept of an interest payment on shareholders' equity, calculated based on specific Ambev's shareholders' equity accounts multiplied by the TJLP rate. The TJLP is the official interest rate defined by the Central Bank and used as reference in long-term loans provided by the BNDES.

Amounts distributed by Ambev to its shareholders as interest on shareholders' equity is deductible for purposes of income tax and social contribution applicable to our profits. The amount of the deduction may not exceed the greater of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· 50% of net income (after the deduction of social contribution on net income but before taking into consideration
the provision for corporate income tax and the amounts attributable to shareholders as interest on shareholders' equity) for the
period in respect of which the payment is made; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· 50% of the sum of retained profits and profit reserves as of the date of the beginning of the period in
respect of which the payment is made.

Interest on shareholders' equity is treated similarly to dividends for purposes of distribution of profits. The only significant difference is that a 15% withholding income tax is due by nonexempt shareholders, resident or not of Brazil, upon receipt of such interest payment, which tax must be withheld by us on behalf of our shareholders when the distribution is implemented. If the shareholder is not a Brazilian resident and is resident or domiciled in a tax-haven jurisdiction, withholding income tax is due at a 25% rate. The amount shareholders receive as interest on shareholders' equity, net of taxes, is deducted from the minimum mandatory dividend owed to shareholders.

For further information on the taxation of interest on shareholders' equity, including the concept of tax haven jurisdiction for such purposes, see "—E. Taxation—Brazilian Tax Considerations—Income Tax—Distributions of Interest on Shareholders' Equity."

**Reserves** 

General

The Brazilian Corporation Law provides that all discretionary allocations of adjusted net income, including the Unrealized Income Reserve and the Investment Reserve, are subject to shareholder approval and may be added to capital (except for the amounts allocated to the Unrealized Income Reserve) or distributed as dividends in subsequent years. In the case of Tax Incentive Reserve and the Legal Reserve, they are also subject to shareholder approval; however, the use of their respective balances is limited to having those balances added to capital or used to absorb losses. They cannot be used as a source for income distribution to shareholders.

Legal Reserve

Under the Brazilian Corporation Law, corporations are required to maintain a "Legal Reserve" to which they must allocate 5% of their adjusted net income for each fiscal year until the balance of the reserve equals 20% of their share capital. However, corporations are not required to make any allocations to their legal reserve in a fiscal year in which the Legal Reserve, when added to other established capital reserves, exceeds 30% of their share capital. Accumulated losses, if any, may be charged against the Legal Reserve. Other than that, the Legal Reserve can only be used to increase a company's share capital.

Contingency Reserve

Under the Brazilian Corporation Law, a portion of a corporation's adjusted net income may also be discretionally allocated to a "Contingency Reserve" for an anticipated loss that is deemed probable in future years and which amount can be estimated. Any amount so allocated in a prior year must be either reversed in the fiscal year in which the loss was anticipated if that loss does not in fact occur or is not charged off in the event that the anticipated loss occurs.

Investment Reserve

Under Brazilian Corporation Law, we are permitted to provide for the allocation of part of our net income to discretionary reserve accounts that may be established in accordance with our bylaws. The allocation of our net income to discretionary reserve accounts may not be made if it serves to prevent the distribution of the minimum mandatory distributable amount. According to our bylaws, a portion of up to 60% of our adjusted net income may be allocated to an "Investment Reserve" for the expansion of our activities, including to be capitalized by us or for our investment in new business ventures.

Pursuant to our bylaws, the Investment Reserve balance is not allowed to be greater than 80% of our share capital. In case such limit is reached, shareholders may resolve to use the exceeding amount for conversion into share capital or to be distributed as dividends.

Unrealized Income Reserve

Pursuant to the Brazilian Corporation Law, the amount by which the minimum mandatory dividend exceeds the "realized" portion of net income for any particular year may be allocated to the Unrealized Income Reserve. The realized portion of net income is the amount by which the adjusted net income exceeds the sum of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· our net positive results, if any, from the equity method of accounting for earnings and losses of our
subsidiaries and certain affiliates; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· the net profits, net gains or net return obtained on transactions or on accounting of assets and liabilities
based on their market value, to be completed after the end of the following fiscal year.

Tax Incentive Reserve

Under the Brazilian Corporation Law, a portion of the adjusted net income may also be allocated to a general "Tax Incentive Reserve" in amounts corresponding to reductions in a company's income tax generated by credits for particular government-approved investments. This reserve is available only in connection with the acquisition of capital stock of companies undertaking specific government-approved projects.

Goodwill Premium from Shares Issued

Pursuant to the Brazilian Corporation Law, the amount received from subscription of shares in excess of the par value of the shares or the portion of the issuance price allocated to capital stock, in case of shares without par value, must be allocated to this reserve. The amount can be used (i) to absorb losses that surpass accumulated profits and profit reserves, (ii) for future capital increases without the issuance of new shares, (iii) to redeem or reimburse shares (including founder's shares, if applicable), (iv) for payment of dividends to preferred shares, if applicable, or (v) to support an approved share buyback program.

Fiscal Benefit of Goodwill Premium Amortization (CVM Resolution No. 78/22)

Pursuant to CVM Resolution No. 78/22, when a reporting company merges with its parent company, while remaining a reporting company, the goodwill previously paid by the parent company on its acquisition is deductible for purposes of income tax and social contribution on profits. This future tax benefit is recorded as a capital reserve by the reporting company. As this benefit is realized, the company increases its share capital proportionally to the benefit and is able to issue new shares to the parent company, pursuant to the terms of the merger agreement.

**Appraisal Rights** 

Under the Brazilian Corporation Law, dissenting shareholders have appraisal rights that allow them to withdraw from the Company and be reimbursed for the value of their Ambev common shares, whenever, among other instances, a decision is taken at a shareholders' meeting to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· create preferred shares or increase disproportionately an existing class of preferred shares relative
to the other classes of shares, unless such action is provided for or authorized by our bylaws;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· modify a preference, privilege or condition of redemption or amortization conferred upon one or more classes
of preferred shares, or create a new class with greater privileges than the existing classes of preferred shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· reduce the minimum mandatory dividend;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· merge or consolidate us with another company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· change our corporate purpose;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· conduct a spin-off of Ambev, if the new entities resulting from the spin-off have different primary corporate
purposes or a lower minimum mandatory dividend or such spin-off causes us to join a group of companies (as defined in the Brazilian Corporation
Law);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· transform us into another corporate type;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· conduct a stock swap merger of Ambev with another company, so that Ambev becomes a wholly-owned subsidiary
of that company; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· approve the acquisition of control of another company, the price of which exceeds the limits set forth
in the Brazilian Corporation Law.

In cases where Ambev merges or is consolidated with another company, participates in a group of companies (as defined in the Brazilian Corporation Law), or is a party to a share merger, dissenting shareholders will not be entitled to exercise appraisal rights if their Ambev common shares are (1) liquid, defined as being part of the IBOVESPA Index and (2) widely-held such that the controlling shareholder or companies under its control holds less than 50% of the referred common shares.

Appraisal rights expire within 30 days after publication of the minutes of the relevant shareholders' meeting that approved the transaction. We are entitled to reconsider any action triggering appraisal rights within 10 days following the expiration of the 30-day appraisal rights exercise period if the redemption of our common shares held by dissenting shareholders would jeopardize our financial stability.

Any shareholder that exercises appraisal rights is, in general, entitled to receive the amount equivalent to its shares' book value as per the last balance sheet approved by our shareholders. If the resolution giving rise to appraisal rights is approved more than 60 days after the date of the last shareholder-approved balance sheet of Ambev, dissenting shareholders may require that the value of their shares be calculated on the basis of an updated balance sheet (*balanço especial*) dated no less than 60 days before the resolution date. In this case, we must (1) immediately advance 80% of the book value of the shares to be redeemed according to the most recent balance sheet approved by our shareholders and (2) pay the remaining balance within 120 days after the date of the resolution of the shareholders' meeting. However, if the advanced payment of 80% of the book value of the shares to be redeemed is greater than the actual appraisal rights value per share determined by the updated balance sheet, then the amount in excess advanced by the Company shall be refunded to us by the dissenting shareholders who exercised appraisal rights.

As a general rule, shareholders may not exercise appraisal rights with respect to shares acquired after the publishing of a first meeting call notice or the relevant press release concerning the matter giving rise to such appraisal rights.

**Redemption** 

Under Brazilian Corporate Law, our shareholders may resolve in an extraordinary shareholders' meeting to require us to redeem its outstanding shares. Share redemption may be paid for using our profits, profit reserves or capital reserves. If the share redemption is not applicable to all shares, the redemption will be made by lottery. If custody shares are picked in the lottery and there are no rules established in the custody agreement, the financial institution will specify the shares to be redeemed on a pro rata basis.

**Registration of Shares** 

All of our shares are kept in book-entry form and held in a deposit account with a financial institution authorized by the CVM, in the name of their holders, without certificates issued. The transfer and record cost, as well as the cost of the services relating to our book-entry shares, may be charged directly to the shareholder by the bookkeeping institution.

**Preemptive Rights** 

Each shareholder of Ambev generally has preemptive rights to subscribe for new shares of Ambev in our capital increases (including in the issuance of stock purchase warrants or convertible bonds) in proportion to its shareholdings. A minimum 30-day period following the publication of the capital increase notice is given for the exercise of preemptive rights. Preemptive rights may be purchased and sold by shareholders. Our bylaws provide that if the Board of Directors decides to increase our share capital within the limit of the authorized capital through sales in stock exchanges, public offerings or public tender offers, no preemptive rights will apply. In addition, Brazilian law provides that the grant or the exercise of stock options pursuant to certain stock option plans, such as our Stock Option Plan, is not subject to preemptive rights.

**Inspection of Corporate Records** 

Shareholders that own 1% or more of our outstanding share capital have the right to inspect our corporate records, including shareholders' lists, corporate minutes, financial records and other documents, if (1) Ambev or any of its officers or directors have committed any act contrary to Brazilian law or our bylaws or (2) there are grounds to suspect that there are material irregularities in the Company. However, in either case, shareholders desiring to inspect our corporate records must obtain a court order authorizing the inspection.

**Form and Transfer**

Brazilian law provides that ownership of shares issued by a Brazilian corporation shall generally be evidenced only by a record of ownership maintained by either the corporation or an accredited intermediary, such as a bank, acting as a registrar for the shares. Banco Bradesco S.A. currently maintains our share ownership records.

Because our common shares are in registered book-entry form, a transfer of those shares is made under the rules of the Brazilian Corporation Law, which provides that a transfer of shares is effected by an entry made by the registrar for our shares in its books, by debiting the share account of the transferor and crediting the share account of the transferee.

Transfers of shares by a foreign investor are made in the same way and executed by that investor's local agent on the investor's behalf, except that, if the original investment was registered with the Central Bank pursuant to foreign investment regulations, the foreign investor should also seek, through its local agent, an amendment of the corresponding electronic registration to reflect the new ownership, if necessary.

The B3 operates a central clearing system and a stock exchange. A holder of our common shares may choose, at its discretion, to participate in this system, and all shares elected to be transferred to B3's market must be deposited in custody with the stock exchange through a Brazilian institution that is duly authorized to operate by the Central Bank and maintains a clearing account with the B3. Our common shares that are subject to custody with the stock exchange will be reflected in our registry of shareholders. Each participating shareholder will, in turn, be registered in our register of beneficial shareholders maintained by the stock exchange and will be treated in the same way as registered shareholders.

**Disclosure of the Ownership and Trading of our Shares by Us, our Principal Shareholders, Directors and Officers or Members of our Fiscal Council**

Pursuant to CVM rules, our directors and officers and members of our fiscal council or of any technical or advisory committee are required to disclose to us, to the CVM and to the B3 the number, type and manner of acquisition of any securities issued by us, or by our publicly held subsidiaries and held by them or any persons related to them (such as a spouse, companion or dependent). The information regarding the trade of any such securities (including the name and identification of the owner of the shares, amount and characteristics of the securities, form, price and date of the trade) must be provided to CVM within 10 days following the end of the month in which they were traded.

Under Brazilian law, shareholders owning more than 5% of a company's voting shares must publicly disclose their shareholder ownership to the CVM and to the Brazilian stock exchange. In addition, according to CVM Resolution No. 44, if any such principal shareholder or any shareholder electing members of the board of directors increases or decreases its participation in our capital stock directly or indirectly exceeding thresholds of 5% multiples (i.e. 5%, 10%, 15% etc.), this person or entity must disclose its shareholder ownership to CVM in the terms mentioned above.

According to CVM Resolution No. 44, individual investment or disinvestment plans for direct or indirect controlling shareholders, members of any statutory governing bodies of a corporation, as well as any persons who, due to their responsibility, function or position in a listed company, its controlling company, subsidiaries or affiliates have potential access to insider information, are allowed, subject to certain requirements.

**Other Significant Provisions of the Brazilian Corporation Law**

The Brazilian Corporation Law, as applicable to us, also requires the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· upon a sale of our control, the acquirer is required to launch a tender offer to purchase all minority
voting shares at a price equal to at least 80% of the price per share paid for the controlling stake;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· our delisting is subject to an administrative proceeding before the CVM, having as a condition the launching
of a tender offer by the controlling shareholder or us for the acquisition of all our outstanding shares (defined as those owned by shareholders
other than the controlling shareholder, officers and directors) at their fair value, as determined by an independent appraiser. Shareholders
holding more than two-thirds of the free float of shares must accept the tender offer or must expressly agree with the delisting (for
this purpose, the free float of shares must be considered those held by shareholders that have either accepted the delisting or the offer);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· in addition, if a controlling shareholder or group of controlling shareholders
acquires additional shares in excess of one-third of the free float of shares in any class (as calculated according to a formula created
by CVM), a mandatory tender offer to ensure share dispersion is required for all the outstanding shares in that class. The same requirement
applies whenever (1) a shareholder or group of shareholders representing the same interest and holding more than 50% of the shares in
any class from March 7, 2002 (pursuant to CVM Resolution No. 85/22, except for public companies
existing in September 5, 2000, in which case this date will prevail), acquires a further interest of 10% or more of that same class of
shares within a 12-month period and (2) the CVM determines, within six months after being informed, that the acquisition restricts the
liquidity of the shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· upon the occurrence of a tender offer aimed at delisting a company or through which the controlling shareholders
will acquire more than one-third of the free float shares, the purchase price shall be equal to the fair value of the shares considering
the total number of outstanding shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· members of our Board of Directors elected by noncontrolling shareholders (in a separate voting mechanism)
have the right to veto the choice of the independent auditor by the Board;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· our controlling shareholder, the shareholders that elect members to our Board of Directors or Fiscal
Council, the members of our Board of Directors and Fiscal Council, and our executive officers are required to disclose any purchase or
sale of our shares to the CVM and to the B3; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;· the chairman of any shareholders' meeting or directors shall disregard any vote that is rendered
against provisions of any shareholders' agreement if that shareholders' agreement has been duly filed with us, as is the case
with the Shareholders' Agreement.

**Restriction on Certain Transactions by Controlling Shareholders, Directors and Officers** 

We, our direct or indirect controlling shareholders, if any, members of our Board of Directors, Board of Executive Officers, members of our fiscal council, if installed, members of any technical or advisory body or whomever which, by virtue of its title, duty or position in us, or in our controlling shareholders, controlled companies or affiliates, have knowledge of a material fact, and any other person who has knowledge of material information and knows it has not been disclosed to the market (persons who have a business, professional or trust relationship with the Company, including auditors, analysts, underwriters and advisers), are considered insiders. Insiders may not trade our securities or derivatives of our securities prior to the disclosure of such material information to the market to obtain an advantage, for themselves or for others. In addition, former members of our Board of Directors or Board of Executive Officers who are in possession of material, as yet undisclosed information also may not use such information to trade in securities issued by the Company within three (3) months of their dismissal.

Such restriction will apply, without limitation, (i) as from the moment when studies or analyses are initiated relating to operations of merger, total or partial spin-off, consolidation, transformation, or any form of corporate reorganization, business combination, change in the Company's control (including by means of the execution, alteration or rescission of a shareholders' agreement), decision to promote the cancellation of the Company's registration as a publicly-held company, or change in the trading environment or segment of the shares issued by us; (ii) during the 15-day period prior to the disclosure of our quarterly and annual financial statements required by CVM, regardless of whether such persons are aware of the contents of the Company's quarterly financial information and annual financial statements; and (iii) to the controlling shareholders, if any, the officers, and members of the Board of Directors, whenever we, or any of our controlled companies, affiliates or companies subject to the same control, whenever an option or mandate is in course or has been granted for the purpose of acquisition or disposal of shares issued by us; and (iv) if we intend to request for judicial or extrajudicial reorganization and bankruptcy as from the moment when studies or analyses are started regarding such requests by us.

**Restriction on Certain Transactions outside Our Corporate Purposes** 

Brazilian Corporate Law prohibits us from undertaking any business practices inconsistent with our corporate purpose and core business.

**Restrictions on Non-Brazilian Holders**

There are no restrictions on ownership of our common shares by individuals or legal entities domiciled outside Brazil. Foreign investors may trade their shares through ADSs on the NYSE or directly on the B3.

However, the right to convert dividend payments and proceeds from the sale of common shares into foreign currency and to remit such amounts outside Brazil is subject to exchange control restrictions and foreign investment legislation, which generally require, among other things, obtaining an electronic registration with the Central Bank of Brazil. Nonetheless, any non-Brazilian holder who registers with the CVM may use the dividend payments and proceeds from the sale of shares to buy and sell securities directly on the B3.

**AMERICAN DEPOSITARY SHARES**

The following description of Ambev's ADSs is a summary and does not purport to be complete. This description is subject to and qualified in its entirety by reference to the deposit agreement dated July 9, 2013, between Ambev, The Bank of New York Mellon, as depositary (the "depositary") and all owners and beneficial owners from time to time of the American depositary shares ("ADSs") issued thereunder (the "deposit agreement"), including the form of ADRs. For more complete information, you should read the entire deposit agreement and the form of ADR. The form of deposit agreement (including the form of ADR) is incorporated by reference as Exhibit 2.1 to the 2022 Form 20-F. As used in this section, "you" means an owner or beneficial owner of ADSs.

**General** 

The ADRs are listed and traded on the New York Stock Exchange. Our common shares are listed on the New York Stock Exchange not for trading, but only in connection with the registration of the ADS representing such common shares, pursuant to the requirements of the SEC.

The depositary has executed and delivered, and may from time to time execute and deliver, ADRs. Each ADR is a certificate representing a specific number of ADSs. Each ADS represents one common share (or a right to receive one common share) deposited with the principal office of Banco Bradesco S.A., as agent for the depositary. Each ADS also represent any other securities, cash or other property, which may be held by the depositary. The depositary's office at which the ADRs are administered, and its principal executive office is located at 240 Greenwich Street, New York, New York 10286.

You may hold ADSs either directly (by having an ADR registered in your name) or indirectly through your broker or other financial institution. If you hold ADSs directly, you are an ADR holder. This description assumes you hold your ADSs directly. If you hold the ADSs indirectly, you must rely on the procedures of your broker or other financial institution to assert the rights of ADR holders described in this section. You should consult with your broker or financial institution to find out what those procedures are.

As an ADR holder, we will not treat you as one of our shareholders and you will not have shareholder rights, which are governed by Brazilian law. The depositary will be the holder of the shares underlying your ADSs. As a holder of ADRs, you will have ADR holder rights. The deposit agreement sets out the ADR holder rights as well as the rights and obligations of the depositary. New York law governs the deposit agreement and the ADRs.

**Dividends and Other Distributions** 

***How will you receive dividends and other distributions on the shares?***

The depositary has agreed to pay you the cash dividends or other distributions it or the custodian receives on shares or other deposited securities, after deducting its fees and expenses. You will receive these distributions in proportion to the number of shares your ADSs represent.

•  ***Cash.*** The depositary will convert any cash dividend or other cash distribution we pay on the shares into U.S. dollars, if it can do so on a reasonable basis and can transfer the U.S. dollars to the United States. If that is not possible, or if any government approval is needed and cannot be obtained, the deposit agreement allows the depositary to distribute the foreign currency only to those ADR holders to whom it is possible to do so. With respect to the foreign currency that is not distributed, the depositary may either (i) distribute such foreign currency to the ADR holder upon its request or (ii) hold the foreign currency for the account of the ADR holders who have not been paid. It will not invest the foreign currency and it will not be liable for any interest.

Before making a distribution, the depositary will deduct any withholding taxes that must be paid. It will distribute only whole U.S. dollars and cents and will round fractional cents to the nearest whole cent. *If the exchange rates fluctuate during a time when the depositary cannot convert the foreign currency, you may lose some or all of the value of the distribution.*

•  ***Shares.*** The depositary, after consulting with us, may, and if we request, must, distribute additional ADSs representing any shares we distribute as a dividend or free distribution. The depositary will only distribute whole ADSs. It will try to sell shares which would require it to deliver a fractional ADS and distribute the net proceeds in the same way as it does with cash. The depositary may also sell a portion of the distributed shares to pay fees and expenses in connection with the distribution. If the depositary does not distribute additional ADRs, the outstanding ADSs will also represent the new shares.

•  ***Rights to purchase additional shares.*** If we offer holders of our securities any rights to subscribe for additional shares, or any other rights, the depositary may, after consulting with us, make these rights available to you. If the depositary decides it is not legal and practical to make these rights available after consulting with us, it may sell the rights and distribute the proceeds in the same way it does with cash. The depositary will allow rights that are not distributed or sold to lapse. *In that case, you will receive no value for them.* 

If the depositary makes rights available to you, it will exercise the rights and acquire the shares on your behalf. The depositary will then deposit the shares and deliver ADSs to you. It will only exercise these rights if you pay the exercise price and any other charges the rights require you to pay.

U.S. securities laws may restrict transfers and cancellation of the ADSs represented by shares purchased upon exercise of rights. For example, you may not be able to trade these ADSs freely in the United States. In this case, the depositary may deliver restricted depositary shares that have the same terms as the ADRs described in this section except for changes needed to put the necessary restrictions in place.

•  ***Other Distributions*** . The depositary will, after consulting with us, send you anything else we distribute on deposited securities by any means it believes is legal, fair and practical. If it cannot make the distribution in that way, the depositary has a choice. It may decide to sell what we distributed and distribute the net proceeds, in the same way as it does with cash. Alternatively, it may decide to hold what we distributed, in which case ADSs will also represent the newly distributed property. The depositary may sell a portion of the distributed property to pay fees and expenses in connection with the distribution.

The depositary is not responsible if it decides that it is unlawful or impractical to make a distribution available to any ADR holders. We have no obligation to register ADSs, shares, rights or other securities under the Securities Act. We also have no obligation to take any other action to permit the distribution of ADRs, shares, rights or anything else to ADR holders. *This means that you may not receive the distributions we make on our shares or any value for them if it is illegal or impractical for us to make them available to you.*

**Deposit and Withdrawal** 

***How are ADSs issued?***

The depositary will deliver ADSs if you or your broker deposits shares or evidence of rights to receive shares with the custodian. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will register the appropriate number of ADSs in the names you request and will deliver the ADRs at its office to the persons you request.

***How do ADS holders cancel an ADR and obtain shares?***

You may surrender your ADRs at the depositary's office. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will deliver the shares and any other deposited securities underlying the ADR to you or a person you designate at the office of the custodian. Alternatively, at your request, risk and expense, the depositary will deliver the deposited securities at its office, if feasible.

**Voting Rights** 

***How do you vote?***

You may instruct the depositary to vote the number of shares your ADSs represent. The depositary will notify you of shareholders' meetings and arrange to deliver our voting materials to you if we ask it to. Those materials will describe the matters to be voted on and explain how you may instruct the depositary how to vote. For instructions to be valid, they must reach the depositary by the date set by the depositary.

The depositary will try, as far as practical, subject to Brazilian law and the provisions of our organizational documents, to vote the number of shares, or other deposited securities represented by your ADSs, as you instruct. The depositary will only vote or attempt to vote as you instruct, or as described below.

We cannot ensure that you will receive voting materials or otherwise learn of an upcoming shareholders' meeting in time to ensure that you can instruct the depositary to vote your shares. In addition, the depositary and its agents are not responsible for failing to carry out voting instructions or for the manner in which the voting instructions are carried out. This means that you may not be able to vote, and you may have no recourse if your shares are not voted as you requested.

If we asked the depositary to solicit your instructions and the depositary does not receive voting instructions from you by the specified date, it will consider you to have authorized and directed it to give a discretionary proxy to a person designated by us to vote the number of deposited securities represented by your ADSs. The depositary will give a discretionary proxy in those circumstances to vote on all questions to be voted upon.

**Fees and Expenses** 

The following table summarizes the fees and expenses payable by holders of ADSs:

---

| | |
|:---|:---|
| **Persons depositing or withdrawing shares must pay:**<br>| &nbsp;&nbsp; **For**<br>|
| $5.00 (or less) per 100 ADSs (or portion of 100 ADSs) | (i) Issuance of ADSs, including issuances resulting from a distribution of shares or rights or other property; and<br> (ii) Cancellation of ADSs for the purpose of withdrawal, including if the Deposit Agreement terminates |
| $0.02 (or less) per ADSs | Any cash distribution |
| A fee equivalent to the fee that would be payable if securities distributed to you had been shares and the shares had been deposited for issuance of ADSs | Distribution of securities to holders of deposited securities which are distributed by the depositary to ADS holders |
| $0.02 (or less) per ADSs per calendar year | Depositary services. |
| Registration or transfer fees | Transfer and registration of shares on Ambev's share registry to or from the name of the Depositary or its agent when you deposit or withdraw shares. |
| Expenses of the depositary | (i) Cable, telex and facsimile transmissions (when expressly provided in the deposit agreement); and<br> (ii) Converting foreign currency to U.S. dollars |
| Taxes and other governmental charges the depositary or the custodian have to pay on any ADS or share underlying an ADS, for example, stock transfer taxes, stamp duty (which currently are inapplicable in Brazil) or withholding taxes | As necessary |
| Any charges incurred by the depositary or its agents for servicing the deposited securities | As necessary |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The depositary collects its fees for delivery and surrender of ADSs directly from investors depositing shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The depositary collects fees for making distributions to investors by deducting those fees from the amounts distributed or by selling a portion of distributable property to pay the fees. The depositary may collect its annual fee for depositary services through a deduction from cash distributions, by directly billing investors or by charging the book-entry system accounts of participants acting for them. The Depositary may collect any of its fees by deduction from any cash distribution payable to ADS holders that are obligated to pay those fees. The depositary may generally refuse to provide fee-attracting services until its fees for those services are paid.

**Payment of Taxes** 

The depositary may deduct the amount of any taxes owed from any payments to you. It may also sell deposited securities, by public or private sale, to pay any taxes owed. You will remain liable if the proceeds of the sale are not sufficient to pay the taxes. If the depositary sells deposited securities, it will, if appropriate, reduce the number of ADSs to reflect the sale and pay to you any proceeds, or send you any property, remaining after it has paid the taxes.

**Reclassifications, Recapitalizations and Mergers** 

---

| | |
|:---|:---|
| ***If we:*** | ***Then:*** |
| • Change the par value of our shares<br>• Reclassify, split up or consolidate any of the deposited securities<br>• Distribute securities on the shares that are not distributed to you<br>• Recapitalize, reorganize, merge, liquidate, sell all or substantially all of our assets, or take any similar action | The cash, shares or other securities received by the depositary will become deposited securities. Each ADS will automatically represent its equal share of the new deposited securities.<br>The depositary may distribute some or all of the cash, shares or other securities it received. It may also deliver new ADRs or ask you to surrender your outstanding ADRs in exchange for new ADRs identifying the new deposited securities. |

---

**Amendment and Termination** 

***How may the deposit agreement be amended?***

We may agree with the depositary to amend the deposit agreement and the ADRs without your consent for any reason. If an amendment adds or increases fees or charges, except for taxes and other governmental charges or expenses of the depositary for registration fees, facsimile costs, delivery charges or similar items, or prejudices a substantial right of ADR holders, it will not become effective for outstanding ADRs until 30 days after the depositary notifies ADR holders of the amendment. At the time an amendment becomes effective, you are considered, by continuing to hold your ADR, to agree to the amendment and to be bound by the ADRs and the deposit agreement as amended.

***How may the deposit agreement be terminated?***

The depositary will terminate the deposit agreement if we ask it to do so. The depositary may also terminate the deposit agreement if the depositary has told us that it would like to resign, and we have not appointed a new depositary bank within 60 days. In either case, the depositary must notify you at least 30 days before termination.

After termination, the depositary and its agents' actions under the deposit agreement will be limited to the following: (1) advise you that the deposit agreement is terminated, (2) collect distributions on the deposited securities (3) sell rights and other property, and (4) deliver shares and other deposited securities upon cancellation of ADRs. One year or more after termination, the depositary may sell any remaining deposited securities by public or private sale. After that, the depositary will hold the money it received from the sale, as well as any other cash it is holding under the deposit agreement for the pro rata benefit of the ADR holders that have not surrendered their ADRs. It will not invest the money and has no liability for interest. The depositary's only obligations will be to account for the money and other cash. After termination of the deposit agreement our only obligations will be to indemnify the depositary and to pay fees and expenses of the depositary that we agreed to pay.

**Limitations on Obligations and Liability** 

The deposit agreement expressly limits our obligations and the obligations of the depositary. It also limits our liability and the liability of the depositary. We and the depositary:

• are only obligated to take the actions specifically set forth in the deposit agreement without negligence or bad faith;

• are not liable if either of us is prevented or delayed by law or circumstances beyond our control from performing our obligations under the deposit agreement;

• are not liable if either of us exercises discretion permitted under the deposit agreement;

• have no obligation to become involved in a lawsuit or other proceeding related to the ADRs or the deposit agreement on your behalf or on behalf of any other person unless it is indemnified on a basis satisfactory to it; and

• may rely upon any documents we believe in good faith to be genuine and to have been signed or presented by the proper party.

In the deposit agreement, we agree to indemnify the depositary for acting as depositary, except for losses caused by the depositary's own negligence or bad faith, and the depositary agrees to indemnify us for losses resulting from its negligence or bad faith.

**Requirements for Depositary Actions** 

Before the depositary will deliver or register a transfer of an ADR, make a distribution on an ADR, or permit withdrawal of shares or other property, the depositary may require:

• payment of stock transfer or other taxes or other governmental charges and transfer or registration fees charged by third parties for the transfer of any shares or other deposited securities;

• satisfactory proof of the identity and authenticity of any signature or other information it deems necessary; and

• compliance with regulations it may establish, from time to time, consistent with the deposit agreement, including presentation of transfer documents.

The depositary may refuse to deliver ADRs or register transfers of ADRs generally when the transfer books of the depositary or our transfer books are closed or at any time if the depositary or we think it advisable to do so.

**Your Right to Receive the Shares Underlying your ADRs** 

You have the right to cancel your ADRs and withdraw the underlying shares at any time except:

• When temporary delays arise because: (i) the depositary has closed its transfer books, or we have closed our transfer books; (ii) the transfer of shares is blocked to permit voting at a shareholders' meeting; or (iii) we are paying a dividend on our shares.

• When you owe money to pay fees, taxes or similar charges.

• When it is necessary to prohibit withdrawals in order to comply with any laws or governmental regulations that apply to ADRs or to the withdrawal of shares or other deposited securities.

This right of withdrawal may not be limited by any other provision of the deposit agreement.

**Pre-release of ADRs** 

The deposit agreement permits the depositary to deliver ADRs before deposit of the underlying shares, which is referred to as a pre-release of the ADR. The depositary may also deliver shares upon surrender of pre-released ADRs (even if the ADRs are surrendered before the pre-release transaction has been closed out). A pre-release is closed out as soon as the underlying shares are delivered to the depositary. The depositary may receive ADRs instead of shares to close out a pre-release. The depositary may pre-release ADRs only under the following conditions: (i) before or at the time of the pre-release, the person to whom the pre-release is being made represents to the depositary in writing that it or its customer owns the shares or ADRs to be deposited; (ii) the pre-release is fully collateralized with cash or other collateral that the depositary considers appropriate; (iii) the depositary must be able to close out the pre-release on not more than five business days' notice; and (iv) any other indemnities and credit regulations are provided in which the depositary may deem necessary. In addition, the depositary will limit the number of ADSs that may be outstanding at any time as a result of pre-release, although the depositary may disregard the limit from time to time, if it thinks it is appropriate to do so.

**Shareholder communications; inspection of register of holders of ADSs** 

The depositary will make available for your inspection at its office all communications that it receives from us as a holder of deposited securities that we make generally available to holders of deposited securities. The depositary will send you copies of those communications if we ask it to. You have a right to inspect the register of holders of ADSs, but not for the purpose of contacting those holders about a matter unrelated to our business or the ADSs.

\*\*\*

## Exhibit 8.1

**Exhibit 8.1. List of AMBEV'S Material Subsidiaries**

Our operations are conducted principally by Ambev, and, in the case of our CAC, Latin America South and Canadian operations, by direct and indirect subsidiaries of Ambev. The following is a list of the significant companies that Ambev controlled, either directly or indirectly, as of December 31, 2022:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Company indirectly owns 99.75% of the economic and voting interests in Cerveceria Y Malteria Quilmes
Saica Y G (incorporated in Argentina).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The Company indirectly owns 85.34% of the economic and voting interests in Cerveceria Boliviana Nacional
S.A. (incorporated in Bolivia).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. The Company, directly and indirectly, owns 100% of the economic and voting interests in Arosuco Aromas
e Sucos Ltda. (incorporated in Brazil).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The Company, directly and indirectly, owns 100% of the economic and voting interests in CRBS S.A (incorporated
in Brazil).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The Company, directly and indirectly, owns 100% of the economic and voting interests in Cervejaria ZX
S.A. (incorporated in Brazil).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. The Company indirectly owns 100% of Labatt Brewing Co. Ltd. (incorporated in Canada).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. The Company indirectly owns 100% of the economic and voting interests in Cerveceria Chile S.A. (incorporated
in Chile).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. The Company directly owns 100% of the economic and voting interests in Jalua Spain S.L. (incorporated
in Spain).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. The Company directly owns 100% of the economic and voting interests in Ambev Luxembourg S.à R.L.
(incorporated in Luxembourg).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. The Company indirectly owns 50.0% of the economic and voting interests in Industrias Del Atlántico,
Sociedad Anónima (incorporated in Guatemala).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. The Company indirectly owns 87.35% of the economic and voting interests in Cerveceria Paraguaya S.A. (incorporated
in Paraguay).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. The Company indirectly owns 85.00% of the economic and voting interests in Cervecería Nacional
Dominicana S.A. (incorporated in Dominican Republic).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. The Company indirectly owns 100% of the economic and voting interests in Linthal S.A., (incorporated in
Uruguay).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. The Company indirectly owns 99.93% of the economic and voting interests in Cerveceria Y Malteria Payssandú
S.A. (incorporated in Uruguay).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15. The Company indirectly owns 100% of the economic and voting interests in Monthiers S.A. (incorporated
in Uruguay).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16. The Company, directly and indirectly, owns 100% of the economic and voting interests in Cervecería
Nacional S. de R.L. (incorporated in Panama).

\*\*\*

## Exhibit 12.1

**Exhibit 12.1**

**PRINCIPAL EXECUTIVE OFFICER CERTIFICATION**

I, Jean Jereissati Neto, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this annual report on Form 20-F of Ambev S.A. (the "Company");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The Company's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to
be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the Company's disclosure controls and procedures and presented in
this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by
this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the Company's internal control over financial reporting that
occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the
Company's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The Company's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company's auditors and the audit committee of Company's Board of Directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the Company's ability to record, process, summarize and report
financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant
role in the Company's internal control over financial reporting.

Date: March 17, 2023.

/s/ Jean Jereissati Neto

Name: Jean Jereissati Neto

Title: Chief Executive Officer

## Exhibit 12.2

**Exhibit 12.2**

**PRINCIPAL FINANCIAL OFFICER CERTIFICATION**

I, Lucas Machado Lira, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this annual report on Form 20-F of Ambev S.A. (the "Company");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The Company's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to
be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the Company's disclosure controls and procedures and presented in
this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by
this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the Company's internal control over financial reporting that
occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the
Company's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The Company's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company's auditors and the audit committee of Company's Board of Directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the Company's ability to record, process, summarize and report
financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant
role in the Company's internal control over financial reporting.

Date: March 17, 2023.

/s/ Lucas Machado Lira

Name: Lucas Machado Lira

Title: Chief Financial Officer

## Exhibit 13.1

**Exhibit 13.1**

**Certification of the Principal Executive Officer<br> Pursuant to 18 U.S.C. Section 1350,<br> As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

In connection with the annual report of Ambev S.A. (the "Company") on Form 20-F for the year ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof, or the Report, I, Jean Jereissati Neto, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange
Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company.

Date: March 17, 2023.

/s/ Jean Jereissati Neto

Name: Jean Jereissati Neto

Title: Chief Executive Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

## Exhibit 13.2

**Exhibit 13.2**

**Certification of the Principal Financial Officer<br> Pursuant to 18 U.S.C. Section 1350,<br> As Adopted Pursuant to Section 906 of the Sarbanes - Oxley Act of 2002**

In connection with the annual report of Ambev S.A. (the Company) on Form 20–F for the year ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof, or the Report, I, Lucas Machado Lira, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes–Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange
Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company.

Date: March 17, 2023.

/s/ Lucas Machado Lira

Name: Lucas Machado Lira

Title: Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.